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 بِۡسِم ٱللهِ ٱلرَّ ۡحَم ٰـ ِن ٱلرَّ ِحيم ِ
 
 
 
 َواْعبُدْ َربََّك َحتَّٰى يَأْتِيََك اْليَِقين ُ
 َمْن َعِمَل َصاِلًحا م ِ ن ذََكٍر أَْو أُنثَٰى َوهَُو ُمْؤِمٌن فَلَنُْحيِيَنَّه َُحيَاة ًَطي ِبَةً ۖ َولَنَْجِزيَنَُّهْم 
 أَْجَرهُم بِأَْحَسِن َما َكانُوا يَْعَملُون َ 
 َرب  ِ أَْوِزْعنِي أَْن أَْشكَُر نِْعَمتََك الَّتِي أَْنعَْمَت َعلَيَّ َوَعلَٰى َواِلدَيَّ َوأَْن أَْعَمَل َصاِلًحا 
  تَْرَضاه َُوأَدِْخْلنِي بَِرْحَمتَِك فِي ِعبَاِدَك الصَّاِلِحين َ 
  يا رب   بالمصطفى بل غ مقاصدنا..واغفر لنا ما مضى يا واسع َ الكَرم
 اللهم أحسن لوالدي في الدنيا والآخرة كما أحسنوا إلي
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Summary 
Suggestive evidence points that exogenous exposure to steroid hormones has detrimental 
consequences that are not well explored specifically in the gut, where nutrient uptake 
occurs. The human gastrointestinal (GI) tract expresses endogenous steroid hormone 
receptors in the crypts and the enterocytes but their functions are not well understood. 
Accumulating epidemiological data suggest that GI tumor progression in most cases 
maybe endocrine dependent. Given the complexity of the mammalian gut yet, the genetic 
amenability of cell-type specific gene manipulation in Drosophila melanogaster, I studied 
the effect of exogenously fed or endogenous steroid hormone signaling on the gut and its 
implications during homeostasis and disease.  
In this PhD thesis, I discover the gut to be a sexually dimorphic organ that is regulated by 
steroid sex hormone: 20-hydroxyecdysone (20HE), which binds EcRUsp receptor 
complex and activates downstream target gene transcription during aging and after 
mating, but not after stress (the receptors have non-overlapping functions). 20HE 
stimulates intestinal stem cell (ISC) division in a biphasic manner when fed for 16-20hrs, 
with males being insensitive to the 1st peak and both sexes competent to divide at the 2nd 
peak of ISC division. EcR functions in the ISCs cell autonomously and in enteroblasts 
(EBs) non-autonomously to regulate the ISC division. Females have higher levels of 
circulating 20HE than the males and I identified the ovaries as an endogenous ecdysone 
source to control mating-induced ecdysone-dependent ISC mitoses and post-mating-
dependent gut growth to promote optimal egg-laying. This reproductive advantage given 
by the highly active female gut comes at the expense of a faster aging epithelium and 
higher propensity to tumors. Interestingly, exogenous 20HE feeding to males overrides 
the restricted ability of male ISCs to divide and abolishes the sex differences in ISC 
division accompanied by transcriptional regulation of metabolic and cell-cycle related 
genes and subsequent gut growth. 
All in all, this study identifies sexually dimorphic 20HE levels as a regulator of ISC 
behavior and intestinal growth at the expense of gut deterioration and aging.  
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Zusammenfassung 
Hinweise deuten darauf hin, dass eine exogene Exposition mit Steroidhormonen 
nachteilige Folgen hat, die speziell im Darm, wo die Nährstoffaufnahme auftritt, nicht gut 
erforscht sind. Der menschliche Magen-Darm-Trakt (GI) exprimiert endogene 
Steroidhormonrezeptoren in den Krypten und den Enterozyten, aber ihre Funktionen sind 
nicht gut verstanden. Akkumulierende epidemiologische Daten legen nahe, dass das 
Fortschreiten des GI-Tumors in den meisten Fällen möglicherweise endokrinabhängig ist. 
Angesichts der Komplexität des Säugetierdarms und der genetischen Eignung zur 
zelltypspezifischen Genmanipulation bei Drosophila melanogaster untersuchte ich die 
Wirkung von exogen gefütterten oder endogenen Steroidhormonsignalen auf den Darm 
und ihre Auswirkungen während der Homöostase und Krankheit. In dieser Doktorarbeit 
entdecke ich, dass der Darm ein sexuell dimorphes Organ ist, das durch das Steroid-
Sexualhormon reguliert wird: 20-Hydroxyecdyson (20HE), das den EcR-Usp-
Rezeptorkomplex bindet aktiviert die nachgeschaltete Transkription von Zielgenen 
während des Alterns und nach der Paarung aber nicht nach Stress (die Rezeptoren haben 
nicht überlappende Funktionen). 20HE stimuliert die Teilung von Darmstammzellen 
(ISC) zweiphasig, wenn es 16 bis 20 Stunden lang gefüttert wird, wobei Männechen 
unempfindlich gegenüber dem 1. Peak sind und beide Geschlechter faehig sind, sich am 
2. Peak der ISC-Teilung zu teilen. EcR funktioniert in der ISC-Zelle autonom und in 
Enteroblasten (EBs) nicht autonom, um deren ISC-Teilung zu regulieren. Weibchen 
haben einen höheren zirkulierenden 20HE-Spiegel als die Männchen. Ausserdem 
identifiziere  ich die Eierstöcke als endogene Ecdysonquelle zur Kontrolle der durch 
Paarung induzierten Ecdyson-abhängigen ISC-Mitosen und des nach der Paarung 
abhängigen Darmwachstums, was eine optimale Eiablage zu fördert. Dieser 
Fortpflanzungsvorteil des hochaktiven weiblichen Darms geht zu Lasten eines schneller 
alternden Epithels und einer höheren Neigung zu Tumoren. Interessanterweise 
überschreibt die exogene 20HE-Fütterung von Männern die eingeschränkte Fähigkeit 
männlicher ISCs, sich zu teilen, und hebt die Geschlechtsunterschiede bei der ISC-
Teilung auf, begleitet von der Transkriptionsregulation von metabolischen und 
zellzyklusbezogenen Genen und dem anschließenden Darmwachstum. Insgesamt 
identifiziert diese Studie sexuell dimorphe 20HE-Spiegel als Regulator des ISC-
Verhaltens und des Darmwachstums auf Kosten der Darmverschlechterung und des 
Alterns. 
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Introduction 
1.1. Drosophila and mammalian midgut morphology 
 
The Drosophila gut is analogous to the mammalian gut. They are both tubes with 
distinctive compartments where different steps of food utilization take place. They both 
undergo continuous homeostatic turnover across the organism’s lifetime by a stem cell 
compartment that reside basally. Both have a microbiome which are commensal bacterial 
species populating the gut which are  essential for the health of the organism1.  
 
The Drosophila and mammalian gastrointestinal (GI) tracts share a high degree of 
similarity in their structures, their overall physiology, and the signaling pathways 
directing tissue turnover1. Both Drosophila and mammalian digestive systems comprise 
an upper region where food uptake occurs, followed by a middle region where food 
digestion takes place then, and a last region where nutrient absorption occurs. In 
mammals, the GI tract evolved into complex structures composed of histologically 
distinct regions. But in Drosophila, regionalization is achieved through physical 
separation by major constrictions referred to as anatomical boundaries. The upper region 
in the mammalian GI tract consists of the mammalian mouth, pharynx, and esophagus 
while in Drosophila it comprises the esophagus, the crop and the cardia. The middle 
region consists of a mammalian stomach and duodenum, and it is analogous to the 
Drosophila middle acidic copper cell and iron region2. The final region of the digestive 
tract consists of the mammalian small intestine and colon that are the functional 
equivalents of the Drosophila midgut and hindgut respectively. The anatomical 
boundaries in the midgut alone divide it into 6 histologically different regions with 
distinct gene expression patterns: R0-R5. R4-R5 is the region where most nutrient 
absorption takes place 1,3. At the cellular level the two GI tracts are organized similarly 
and the relative position of the ISCs within the epithelium is also highly alike, even 
though the mammalian intestine has a more complex ISC lineage. The mammalian 
intestine consists of layered crypt-villi structures whereby the gastrointestinal stem cells 
reside at the bottommost positions of the stomach, small intestine, and colon crypts4.  
 
 
16 
Figure 1.1: Comparison of the 
physiological resemblance between 
the mammalian and Drosophila 
Digestive Tracts. (A) Anatomy of the 
gut. The upper region of the gut is 
comprised of mouth and esophagus in 
mammals and esophagus, crop and 
cardia in Drosophila. The middle 
region consists of the stomach in 
mammals and copper cell region in 
Drosophila. The final region consists 
of the small intestine and the colon in 
mammals and the midgut and hindgut 
in Drosophila. Excrement elimination 
takes place via the rectum. 
Malpighian tubules are the functional 
analogs of the mammalian kidney and 
they branch at the midhindgut 
junction (shown in purple).  (B) 
Cellular composition of the gut. The 
mammalian gut is organized in crypts 
and villi. The crypt base columnar 
(CBC) stem cells reside at the bottom 
of the crypt together with Paneth 
cells. Drosophila gut is organized in a 
simple epithelial monolayer where 
ISCs basally reside, situated between 
other differentiated cells. (C) ISC lineage in mammals and Drosophila. Actively cycling 
stem cells asymmetrically divide to give rise to transit amplifying (TA) cells that divide 
and terminally differentiate into all secretory and absorptive epithelial lineages of the 
villus in mammals. In Drosophila, ISCs asymmetrically divide to self-renew and give rise 
to an enteroblast (EB) daughter cell. The EB differentiates into either an enterocyte (EC) 
or enteroendocrince (ee) cell. Adopted from Pitsouli et al,2009. 
 
Similarly the adult Drosophila ISCs reside basally within the simple epithelial monolayer 
of the gut5.The mammalian ISCs divide to give rise to transient amplifying cells (TAs) 
that expand and differentiate into epithelial cells as they migrate upwards from the crypt. 
Mammalian epithelial cells are either absorptive enterocytes, mucus-secreting goblet 
cells, secretory enteroendocrine cells or paneth cells that secrete antimicrobial peptides 
and essential factors for stem cell maintenance. Additionally, the mammalian intestine 
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has two more rare cell populations: secretory mechanosensing Tuft cells that sense the 
intestinal luminal contents and M (microfold) cells that are located above Peyer's patches 
of lymphatic tissue to communicate with the gut's immune system and monitor intestinal 
microflora (reviewed in6). The nutrient-absorbing enterocytes constitute most of the villi 
lining. Those enterocytes have microvilli projections that form the striated or brush 
border, providing a greater surface area for nutrient absorption. The mammalian 
gastrointestinal tract is profusely innervated along its entire length and is surrounded by 
longitudinal and circular muscles that initiate peristaltic contractions. When Drosophila 
ISCs divide, they self-renew and give rise to daughter cells that turn into transient but 
committed progenitor cells, called enteroblasts. Drosophila midgut enteroblasts directly 
differentiate into large absorptive polyploid enterocytes (ECs) or diploid enteroendocrine 
cells (EEs), with secretory properties. The structure of the Drosophila gut is organized in 
a simple monolayer, yet it remains quite complex because it is extensively regionalized 
into six regions with their major constrictions referred to as anatomical boundaries. Each 
region has its specific histological and cellular features (villi length, lumen width), 
nutrient content, physical properties (e.g., luminal pH), and gene expression profiles2,3. 
The Drosophila intestine is ensheathed along its length by circular and longitudinal layers 
of mesodermally derived visceral muscle (VM). Within the epithelium, the ISCs are 
located just above the extracellular matrix-rich basement membrane, which separates the 
epithelium from the underlying visceral muscle cells. Inside the intestinal lumen, a 
glycoprotein-based chitinous membrane, called the peritrophic membrane or matrix 
(PM), lines the epithelium, isolating it from the ingested food and serves as a structural 
barrier against the gut bacteria. An extensively branched network of intestinal trachea is 
present in close proximity to the VM and reaches the epithelium to deliver oxygen to the 
cells. Neuronal innervations are present around parts of the anterior midgut: (esophagus 
and cardia), the midgut-hindgut boundary and the rectum, whereas most of the midgut 
has no neuronal innervations (reviewed in 7). 
1.2. ISC behavior during homeostasis or regenerative damage 
 
The intestinal epithelial lining of the digestive system represents one of the most 
intensively self-replenishing organs whereby self-renewal occurs through the intestinal 
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stem cells (ISCs) to replenish dead or lost cells. Normally, the entire epithelium gets 
replaced every 5-7 days in both Drosophila8 and mammals6. In both systems, the ISCs 
integrate extracellular cues, provided by neighboring niche cells through a multitude of 
local, paracrine, and systemic signals and signaling pathways. Collectively, these 
decisions direct the ISC behavior to meet the homeostatic function or regenerative 
demands upon insult of the organ.  
 
Both mammalian and Drosophila guts contain sub-populations of stem cells that display 
distinct behavioral characteristics. In the mammalian small intestine, there are two 
different ISC populations: a predominant population (crypt base columnar cells, or CBCs) 
which are the only cell type with long-term self-renewing ability and a slow dividing, 
Bmi1+ ‘reserve stem cell’ population, also called position 4/+4 cells or label-retaining 
cells (LRCs) which are located four cell diameters above the base of the crypt and are 
directly adjacent to the CBC/Paneth region9. Also in the Drosophila midgut, ISCs of the 
different morphological regions divide at different rates2 however there are no known 
subpopulations of ISCs with varying cycling rhythmicity defined within a region. 
 
Stem cells cycle between two modes of cell division: symmetric whereby two identical 
daughter cells are produced, both of which are stem cells, and asymmetric division which 
results in only one stem cell and a committed progenitor cell. Asymmetric division is 
associated with unequal segregation of proteins or RNA within the daughters, resulting in 
different genetic programs to direct the fate of the newly formed progenitor. In the 
mammalian intestine, symmetric cell divisions occur during continuous homeostatic 
renewal of the gut epithelium, however during inflammation asymmetric stem cell 
divisions are enforced 9. Similarly, in the Drosophila midgut, expansion of stem cell 
populations during early feeding-induced organ growth10 or during clonal competition11,12 
occurs mainly via symmetric ISC divisions. Upon acute regenerative stress response, 
asymmetric ISC division occurs13. Hence, strikingly, both digestive systems follow a 
pattern of neutral drift dynamics during homeostasis in which stem cell-derived clones 
expand and contract at random until they either take over the crypt or they are lost. 
Interestingly, under extreme instances of extensive tissue damage, mammalian progenitor 
or early enterocyte populations can de-differentiate and revert to stem-like cells to 
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replenish the crypt6. In Drosophila, physical or functional loss of ISCs during starvation 
or aging likewise induces amitotis: a process through which polyploid enterocytes 
dedifferentiate leading to a depolyploidization to give rise to functional ISCs14. 
1.3. ISC niche in mammals vs Drosophila  
 
The ISC niche is a complex cellular structure of several cell types that supports and 
regulates the ISC functions. The mammalian and Drosophila niche share some similarity 
in their organization and in the signaling ligands that the niche provides to ISCs. The 
mammalian ISC niche consists of the neighboring epithelial Paneth cells and sub-
epithelial mesenchymal myofibroblasts, fibroblasts, telocytes, neuronal and smooth 
muscle cells surrounding the crypt base basal lamina15. The physical proximity of the 
niche cells with ISCs enables the supply of essential factors for ISC division and 
maintenance6. The mesenchymal part of the niche provides the ISCs with various Wnt 
ligands and R-spondins (Wnt agonists) bone morphogenetic protein  (BMP) inhibitors to 
repress BMP-mediated differentiation, and epidermal growth factor (EGF) to maintain the 
ISCs and trigger their division. The intestinal integrity is disrupted and ISCs are lost when 
the functions of the neighboring epithelial Paneth cells or mesenchymal component are 
compromised respectively though Paneth cells seem to have a more redundant role in-
vivo16-18. Similarly, the Drosophila ISC niche consists of mesodermally-derived visceral 
muscle, the neighboring enteroblasts and enterocytes. VM expresses the EGFR ligand: 
vein19, a JAK-STAT ligand: upd120, Drosophila insulin-like peptide3 (Dilp3)10, and 
Drosophila WNT ligand wingless (wg)21, which contribute to the ISC proliferation, long-
term ISC maintenance or both. Additionally, muscle-derived bone morphogenetic 
proteins (BMPs) Drosophila homolog Decapentaplegic (Dpp) limits over-expansion of 
ISCs through regulating EGF and Jak-Stat signaling22,23. Most studies focused on the 
requirement of EBs or ECs as niche components during regenerative ISC responses24 
Fewer homeostatic epithelial components of the niche have been identified, except for 
EB-derived wg and EGF signaling which contribute to the homeostatic ISC renewal25 and 
division26 respectively and the requirement of Notch or restrictive Hippo signaling in EBs 
to keep the ISCs in check, avoiding accumulation of hyper-dividing ISCs27,28.  
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1.4 Signaling Pathways controlling intestinal stem cell division during homeostasis 
and stress. 
Both the Drosophila and mammalian adult intestine displays a remarkable regenerative 
response to many stressors or damaging agents, which disrupt epithelial integrity. In 
Drosophila, subjecting the flies to stress-inducing agents such as Dextran sulfate sodium 
(DSS), bleomycin29, ROS producing agents such as paraquat and hydrogen peroxide 
(H2O2)30. Examples of bacterial infections that stimulate host immune responses include 
infection with the Gram-negative lethal bacteria Pseudomonas entomophila (P.e.)31, and 
non-pathogenic Erwinia carotovora carotovora 1532. 
 
Below is a summary of the most important pathways governing the ISC division during 
intestinal homeostasis and damage.  
 
a. Wnt/wingless signaling:  
Wnt signaling promotes ISC division and maintenance in both the Drosophila and 
mammals GI tracts. Wnt ligands are produced in mammals by Paneth cells33 and 
mesenchymal cells34 which bind to their receptors Frizzled (FZD) and low-density 
lipoprotein receptor-related protein 5/6 (Lrp5/6) at the surface of on ISCs. In Drosophila, 
muscle21 and enteroblasts25 secrete wingless which binds Frizzled (Fz) and Frizzled 2 
(Fz2) in ISCs. Wnt/wg activation leads to the stabilization and nuclear entry of the 
transcriptional co-activator β-catenin (mammals) or Armadillo (Drosophila) to drive 
target genes expression involved in ISC division or maintenance21,35. Adenomatous 
polyposis coli (Apc) is a part of a destruction complex that marks β-catenin (mammals) or 
Armadillo (Drosophila) for proteosomal degradation. Remarkably, Apc mutation is 
considered a cancer driver mutation, which leads to the activation of wnt/wg signaling, 
thereby, promoting the formation of small adenomas in both mammals36 and 
Drosophila37. Subsequently, additional mutations in KRAS, BRAF, p53, MLH1, or TGF-
β signaling promote the progression to colorectal carcinomas38,39. 
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Figure 1.2: An illustration of the canonical Wnt signaling in mammals. (a) In the 
absence of Wnt ligands, APC (adenomatous polyposis coli) and Axin are recruited into 
the “β-catenin destruction complex”. The phosphorylations by CK1α (casein kinase 1α) 
and GSK3β (glycogen synthase kinase 3β) recruit β‑TrCP E3 linker (β-transducin repeat-
containing protein, an E3 ubiquitin ligase), which signal β‑catenin for its ubiquitination 
and degradation via the proteasome pathway. (b) The presence of Wnt ligands causes the 
association of Axin with phosphorylated LRP5/6 (lipoprotein receptor-related protein 
5/6) and recruitment of phosphorylated DVL (dishevelled) to FZD (frizzled) lead to the 
dissociation of the destruction complex. This causes the accumulation and stabilization of 
β-Catenin, leading to its translocation into the nucleus, forms the complex with TCF/LEF 
(T-cell factor/lymphoid enhancer factor), and subsequently activates the target genes. 
CCND1, cyclin D1; EGFR, epidermal growth factor receptor; LGR5, Leucine-rich 
repeat-containing G protein coupled receptor 5, CD44 cell-surface glycoprotein involved 
in cell adhesion and CD133 transmembrane glycoprotein that is enriched in the stem 
cells. P, phosphorylation; U, ubiquitination. Adopted from: Jeong Jeong et al,2018. 
b. EGF signaling: 
EGF signaling is yet another highly conserved pathway that is required for intestinal stem 
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cell proliferation and maintenance in both mammals40 and Drosophila41. EGF 
extracellular ligands stimulate cell growth, proliferation, and differentiation by binding to 
its cognate receptor the epidermal growth factor receptor (EGFR). Upon activation of 
EGFR, it dimerizes and its intrinsic intracellular protein-tyrosine kinase activity is 
activated leading to downstream signaling effectors including mitogen-activated protein 
kinase (MAPK), phosphatidyl- inositol 3-kinase (PI3K)/Akt, c-Jun N-terminal kinases 
(JNK), Jak/STAT and phospholipase C (PLC) pathways42. In mammals, similar to Wnt 
signaling, EGF ligands are produced in the ISC niche by the neighboring Paneth cells33 
and activate signaling in ISCs and transient amplifying cells43. In Drosophila, there are 
three EGF ligands, vein (vn), spitz (spi), and Keren (Krn) that are produced from visceral 
muscle, ISC, enteroblasts or enterocytes. Rhomboid (Rho) is an intramembrane protease 
that cleaves and activates EGF ligands, which act in a paracrine or autocrine manner on 
ISCs to stimulate ISC proliferation through the RAS/RAF/MAPK pathway19,41. 
Activation of EGFR signaling results in intestinal hyperplasia19,44 and it is cell-
autonomously required for homeostatic and regenerative ISC mitoses44,45. Ras-null 
mutant clones have differentiated ECs suggesting that EGFR signaling is not required for 
EC differentiation26. However, EGFR is required for EB to EC growth and 
endoreplication during stress- induced midgut regeneration26. 
 
c. JAK/Stat pathway: 
The Janus kinase (JAK), signal transducer of activation (stat) pathway is another 
evolutionarily conserved signaling cascade from Drosophila to vertebrates that 
transduces cytokine signals and functions in ISC proliferation and maintenance. 
Mammals have a wide variety of extracellular ligands such as interferons and 
interleukins, which bind to the transmembrane receptors, causing the activation of the 
receptor-associated JAKs. Upon conformational activation and active phosphorylation, 
JA phosphorylates and activates STATs. Activated STATs translocate to the nucleus 
where they bind promoters of their target genes, activating their transcription46. In 
mammals there are four JAKs that activate seven downstream stats whereas in 
Drosophila only one transmembrane receptor called Domeless (dome) and one receptor-
associated Janus Kinase Hopscotch (Hop) activate the downstream STAT3-like 
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transcription factor STAT92E47,48. Activation of the JAK/stat pathway cell autonomously 
and non-cell autonomously stimulates ISC mitoses. Indeed, EGFR and Jak/Stat pathways 
function synergistically to induce ISC proliferation8,19,41. Notably, Jak/Stat signaling is 
also required for ISC self-renewal and EB to EC differentiation. High Jak/Stat signaling 
and low Notch preferentially directs the fate of differentiating cells towards 
enteroendocrine (ee) cells48. STAT92E is normally expressed in both ISCs and EBs48,49. 
After stress-induced damage, dying enterocytes 41 and the surrounding muscle 45 
presumably inactivate wingless signaling which in turn activate the expression of Upds50. 
Secreted Upd ligands non-cell autonomously act to drive ISC proliferation. Jak/Stat 
activation in ISCs is essential for the P.e.-induced ISC mitoses8. Similarly after intestinal 
injury in mammals, innate lymphoid cells (ILCs) produce interleukin-22 (IL-22) that 
activates Jak/Stat signaling in ISCs promoting their expansion 51. Additionally, pervasive 
inflammation also activates JAK/STAT-1 signaling in reserve-ISCs to functionally 
contribute to epithelial restitution52. 
 
d. Insulin signaling 
Insulin-like growth factors (IGFs) in Drosophila closely resemble insulin/IGF signaling 
and function in mammals functions53. Both pathways synchronize the nutritional 
homeostasis with systemic growth control. In mammals, three insulin ligands exist: 
insulin, insulin-like growth factor 1 (IGF1),and insulin-like growth factor 2 (IGF2), that 
bind and activate five distinct receptor isoforms: two insulin receptor isoforms, IRα and 
IRβ; the insulin-like growth factor receptor, IGF1R; and two hybrid dimer receptors53. 
Upon ligand binding to the receptor, tyrosine phosphorylation activates cellular 
substrates, include insulin receptor substrate (IRS)1, IRS2, IRS3 or IRS4, or other 
scaffold proteins—SHC, CBL, APS and SH2B, GAB1, GAB2, DOCK1 and DOCK2,and 
CEACAM1. These substrates activate downstream signaling cascades such as PI3K and 
AKT53. Similarly, the Drosophila genome encodes eight insulin-like peptides (Dilps). At 
least three of these (Dilp2, Dilp3 and Dilp5) are secreted from the insulin-producing cells 
(IPCs) in the brain, which are homologous to pancreatic beta cells in mammals54. Dilps 
regulate organ growth, triglyceride storage and glucose/trehalose levels in circulation53. 
Dilps interact with a single orthologous insulin-like receptor tyrosine kinase. Chico is the 
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Drosophila homolog of insulin receptor substrate that gets phosphorylated to activate 
phosphatidylinositol 3-kinase (PI3K) and AKT (Akt1). Among the downstream targets of 
AKT is the Forkhead box transcription factor Drosophila Foxo (dFOXO), which is 
negatively regulated by insulin and regulates many cell cycle, apoptosis, DNA repair, 
metabolic homeostasis, redox balance genes. FOXO phosphorylation promotes its 
accumulation in the cytosol and nuclear exclusion to regulate its target genes53. AKT also 
inhibits the tumor suppressor proteins TSC1 and TSC2, which inhibit a small GTPase 
called Rheb, an activator of Drosophila Tor (dTOR). dTOR also regulates the nutritional 
status through direct amino acid sensing independent of Dilp/InR. The mechanism how 
AKT regulates FOXO or mTOR is conserved from flies to humans 55,56. 
 
Although not much is known about insulin signaling in the mammalian intestine, it is 
required for both homeostatic and regenerative aspects of the Drosophila midgut. 
Feeding behavior regulates adaptive gut growth, which requires visceral muscle secretion 
of Dilp3 as well as systemic Dilps to activate insulin receptor in ISCs leading to 
homeostatic ISC division10. Moreover, locally-secreted insulin from the niche is required 
to regulate intestinal cell density and organ growth10. Interestingly, scute mutant flies 
which are devoid of enteroendocrine cells have impaired Dilp3 expression from the 
visceral muscle and hence, the feeding-stimulated midgut growth is diminished and flies 
have a shorter lifespan57. 
Figure 1.3.: Insulin signaling pathway in 
Drosophila (left) or mammals (right). Insulin-
like peptides (dilp1-7 or Insulin, Insulin-like 
growth factors I,II) bind Insulin receptors (INR or 
IGF-IR,IRR) leading to its phosphorylation. 
Insulin Receptor Substrates (chico or IRS 1-4). 
Downstream of Insulin receptor activation, PI3K, 
Phosphatidylinositol-dependent kinase-1 
(Dstpk61 or PDK-1) and  serine/threonine-
specific protein kinase B Akt (Drosophila akt or 
Akt/Protein Kinase B) homologs are activated. 
PI3K is negatively regulated at this step by 
homologs of the lipid phosphatase PTEN 
(Drosophila PTEN or PTEN). Akt/PKB inhibits 
the kinase Glycogen synthase kinase-3 (shaggy or 
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GSK-3), and Forkhead-related transcription factor (FKHR) in mammals though their 
homologs have been identifies in Drosophila but their relationship to the insulin signaling 
has not yet been demonstrated (broken line). In both species though, Target of rapamycin 
(dTOR, Drosophila TOR; mTOR, mammalian TOR) are upstream activators of p70 
ribosomal S6 kinase (dS6k or S6K), most probably in response to nutrients, and act 
together with PI3K to upregulate translation and growth. Not included: Akt inactivation 
activates the downstream transcription factor: forkhead transcription factor (dFOXO or 
FOXO), which regulates the expression of target genes, which contribute to longevity. 
Adopted from: Garofalo,2002. 
 
Collectively, these findings postulate a comprehensible model how different cell types 
communicate: enteroendocrine cells and visceral muscle to influence ISC mitoses and 
drive adaptive midgut growth through insulin signaling. Upon feeding with detergent or 
the DNA-damaging agent bleomycin, impaired systemic insulin signaling blocks the 
regenerative ISC mitoses58. Insulin signaling mutants are robustly long-lived59-61, 
suggesting that the reduction of insulin signaling in intestinal dysplasia could extend 
longevity. Indeed, direct moderate depletion of insulin signaling or overexpression of 
FOXO targets in ISCs and EBs may significantly delay the onset of age-related dysplasia 
and extend lifespan62. The role of mammalian insulin in the gut remains far less 
understood. Nevertheless, insulin is reported to increase proliferation in the colorectal 
epithelium63. Analogous to the insulin-dependent midgut growth in Drosophila, diet-
induced obesity increases insulin-like growth factor 1 (IGF1) levels and intestinal Igf1 
mRNA, increased crypt density and ISC numbers 64 Human studies also suggest that 
insulin receptor isoform A, which is expressed in highly proliferative ISCs in the crypts65 
is linked to development of adenoma cases in patients with high plasma insulin66. 
 
e. JNK pathway: 
Jun-N-terminal Kinase (JNK) is a stress-activated protein MAPK-type kinase that is 
involved in compensatory injury-induced cell division in both Drosophila and mammals. 
Though its role in the mammalian gut is not well characterized, Drosophila JNK is 
upregulated upon UV irradiation, ROS or DNA damage, bacterial or fungal infection, and 
aging. Drosophila contains a single JNK, Basket (Bsk), and two JNK Kinases, 
Hemipterous (Hep) and dMKK4. After infection8 or as the flies age62, JNK is activated in 
ECs to stimulate compensatory ISC mitoses. While JNK activation in ECs is not required 
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for P.e.-induced ISC mitoses, its downregulation in either ISCs or ECs is sufficient to 
slow down aging-dependent elevation of ISC mitoses. Remarkably, dFOXO can also be 
phosphorylated and activated by JNK67. Indeed, ECs have a chronic age-dependent 
activation of JNK/dFOXO, which represses intestinal lipases leading to disruption of the 
systemic lipid homeostasis and of the ability the ECs to activate the innate immune 
responses68. In a more physiological context, long-lived insulin mutants similarly have 
lower levels of JNK signaling62. Moreover, Upd3 production is downstream of the 
activation of JNK signaling in weak/unfit cells, which is necessary for their elimination 
by fitter wild-type cells11. Similarly, activated JNK triggers apoptosis of enterocytes to 
stimulate compensatory ISC division69. JNK signaling also boosts APC−/− adenoma 
growth and drives cell competition70. In detergent-induced regenerative responses, JNK 
signaling in ISCs and EBs is necessary and sufficient to stimulate Hedgehog production 
and drive compensatory ISC division71.  
f. Hippo/Wts pathway: 
The Hippo pathway is another highly conserved signaling pathway that regulates global 
growth and cell proliferation across Drosophila and mammals. Thus, it in interacts with 
several signaling cascades including TGFβ/BMP, Wnt, EGFR/MAPK, and others to 
regulate cell proliferation, tissue growth, apoptotic resistance, and tumor progression72-74. 
Hippo pathway deregulation is tightly associated with tumorigenesis, metastasis and 
chemo-resistance75. Hippo signaling regulates ISC division in Drosophila both cell 
autonomously and non-cell autonomously. Hippo pathway is comprised of genes that act 
as tumor suppressor genes such as hippo (hpo) and warts (wts), and oncogenes such as 
yorkie (yki). The mammalian homologs of yorkie are YAP and TAZ. In Drosophila, 
canonical Hippo signaling acts through a kinase cascade and involves activation of Hippo 
(Hpo) serine/threonine kinase, which forms a complex with Salvador (Sav) scaffold 
protein and Mob as a tumour suppressor (Mats) adaptor protein to phosphorylate and 
activate serine/threonine kinase Warts (Wts). Activated Wts phosphorylates Yki leading 
to its cytoplasmic sequestration, signaling it for proteasomal degradation and preventing 
its nuclear interaction with Scalloped (Sd) to regulate the target genes. Similarly, in 
mammals, mammalian sterile 20-like kinase 1/2 (MST1/2) kinases form a complex with 
Salvador family WW domain containing protein 1 (SAV1) and Mps one binder kinase 
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activator-like 1A and 1B (MOB1A/B or collectively, MOB1) to phosphorylate large 
tumour suppressor 1/2 (LATS1/2). LATS1/2 phosphorylation of Yes-associated protein 
(YAP) and its paralog, WW domain-containing transcription regulator 1 (TAZ) blocks 
the nuclear translocation of YAP/TAZ and their subsequent interaction with transcription 
factors (i.e., TEAD family members and others) to regulate downstream target gene 
transcription76.  
The precise roles of Hippo signaling in the mammalian intestine are gradually revealed. 
Endogenous YAP1 protein expression is restricted to the stem cell niche at the bottom of 
the intestinal crypts and its high activity promotes ISC division through positively 
regulating intestinal Notch15,77. mst1/2 mutations or YAP1 overactivity are associated 
with expansion of the ISC pool and undifferentiated progenitors, that replace 
differentiated cells in the villi78,79. This leads to dysplastic epithelia enlarged crypt 
structures, increased polyps, adenoma formation and colorectal cancer progression79-81.  
 
Figure 1.4: Hippo signaling pathway in Drosophila (A) and mammals (B). Hippo 
signaling is initiated by a variety of upstream stimuli such as cell-cell contact, 
mechanotransduction, cellular stress and oxygen availability. Activation of Drosophila 
Hippo or mammalian MST1/2 causes phosphorylation of Warts or mammalian LATS1/2. 
Downstream of the Hippo pathway is the effector Drosophila Yorkie or mammalian 
YAP/TAZ. Warts or LATS1/2 phosphorylation of Yorkie or YAP/TAZ leads to its 
cytoplasmic sequestration by 14-3-3 proteins and degradation. Unphosphorylated Yorkie 
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or YAP/TAZ translocates to the nucleus where it interacts with its Drosophila Scalloped 
or mammalian TEAD transcription factors to upregulate the transcription of a variety of 
genes involved in cell cycle progression and cell survival. 
 
Nuclear YAP1/TAZ complex is also required for differentiation of progenitor cells 
towards the goblet cell secretory lineage82. After dextran sulfate sodium (DSS) or whole 
body irradiation-induced intestinal injury, YAP1 is essential for the crypt regenerative 
proliferation and survival83. Of note, over proliferation and liver enlargement is also 
associated with sav1 and mst1/2 mutations84. In Drosophila, Yki is required to control 
ISC division in cell-autonomously and non-cell autonomously from the niche 
components such as EBs and ECs. Under unstressed conditions, members of the Hippo 
complex function in the progenitors to restrict ISC division by limiting the nuclear 
activity of Yki/Sd complex. In contrast, Yki does not seem to function in regulating 
differentiation. Under stress conditions or Hippo pathway deregulation, Yki is cell-
autonomously activated to regulate downstream genes such as Cyclin E, Diap1 (apoptosis 
inhibitor) and bantam miRNA to stimulate ISC mitoses85,86. Yki is also activated in the 
ECs to induce a dramatic increase in the production of Jak/Stat and EGFR ligands to 
initiate non-cell autonomous compensatory ISC mitoses87. Additionally, Misshapen 
(Msn), a member of the germinal center protein kinase (GCK) family acts within the EBs 
to restrict the expression of Upd3, through interaction with Wts to inhibit Yki activity28.  
g. Notch pathway: 
Both mammals and Drosophila ISCs require Notch signaling as a niche factor for ISC 
maintenance though they require it differently. Notch is a type I integral membrane cell 
surface receptor that forms a heterodimer after being cleaved. Notch signaling is initiated 
when Notch receptor (signal-receiving) binds one of several ligands (signal-sending) 
belonging to the Delta, Serrate, and Lag-2 (DSL) family of integral membrane proteins, 
which are expressed on the surface of neighboring cells. Ligand binding induces a 
conformational change in the Notch extracellular region that gets cleaved and releases 
Notch intracellular domain (NICD, a transcription factor) into the cytoplasm, which can 
then translocate to the nucleus, to recruit a transcriptional co-activator complex and 
regulate target gene expression. The level of Notch signaling is determined by receptor 
exposure to the ligand on the surface of the signal-sending cells i.e. Delta-positive cells88. 
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In the mammalian gut, there are four Notch receptors (Notch 1–4) and five Notch ligands 
(Delta-like (DLL) 1, 3, 4 and Jagged (JAG) 1, 2), which are all transmembrane proteins89. 
Active Notch signaling defines the mammalian stem cells of the gut. The intestinal fast-
cycling crypt base columnar stem cells express Notch1, 2 receptors while the 
neighbouring Paneth cells express Notch ligands Dll1 and Dll490 and Notch critically 
regulates the cell fate decision between absorptive and secretory cell types. Notch 
signaling induces expression of the transcription factor Hes1 (hairy and enhancer of split 
1) that consequently represses cyclin-dependent kinase (CDK) inhibitors p27Kip1 and 
p57Kip2 and also suppresses the expression of Math1 (or Atoh1 (atonal homolog 1))-
dependent differentiation towards secretory lineages90,91. 
 
 
Figure 1.5: An illustration of Notch regulation in Drosophila and mammalian 
intestine. (A) In the Drosophila midgut, intestinal stem cells (ISCs) (escargot+) reside 
basally in an 
epithelial 
monolayer 
that consists 
of 
enteroblasts 
(EBs), 
enteroendocr
ine (EE) 
cells and 
enterocytes 
(ECs). ISCs 
express the 
Notch ligand 
Delta to bind 
to the Notch 
receptor 
expressing 
EBs. Strong Notch signaling in EBs favors the EC cell fate. Activated Notch signaling in 
EBs also blocks proliferation of ISCs by antagonizing the JAK-STAT and JNK pathways 
under physiological and stress conditions. (B) Role of Notch in mammalian ISCs: long-
lived Bmi1+ SCs reside at the +4 position in the crypt compartment and when needed, 
divides to give rise to mitotically active Lgr5+ SCs. In the crypt compartment, Notch 
expressing Lgr5+ SCs are sandwiched between Delta-like 4+ Paneth cells. Activation of 
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Notch signaling in Lgr5+ cells maintains SC self-renewal and proliferation by negative 
regulation of the cyclin-dependent kinase inhibitors p27KIP1 and p57KIP2, and the 
transcription factor Math1, which is necessary for differentiation of the secretory cell 
lineages. Notch thus biases cell fate choice towards the absorptive lineage. Adopted from: 
Koch et al,2017. 
 
Overexpression of Notch pathway components blocks the commitment of cells towards a 
secretory lineage fate and is highly associated with gastric and intestinal cancers90. 
Conversely, inhibition of Notch signaling leads to a loss of the proliferative ISCs and the 
crypt compartment and conversion of crypt progenitors into goblet secretory cells90. In 
contrast, in the Drosophila midgut, ISCs are always Delta-positive, and are located at the 
basal side of the epithelium. The daughter cells lack delta and express different levels of 
Notch that define fate specification of the ISC progeny. pre-ECs invariably express high 
levels of Delta in cytoplasmic vesicles, but EE precursor contained few or no cytoplasmic 
Delta vesicles27. Notch activates dTOR through the inhibition of TSC2 in the EB, leading 
to endoreplication and EC differentiation26,92. Ectopic activation of Notch signaling in 
ISCs causes a loss of ISCs through their differentiation27 and Notch loss results in 
accumulation of ISC tumors with increased numbers of EEs and a loss of ECs93.  
Accordingly, Notch signaling acts in concert with Jak-Stat and EC-JNK or Yki/YAP 
signaling to determine the balance between ISCs and other cells of the midgut. For 
intestinal tumor outgrowth to develop in the Drosophila midgut, Notch-defective ISCs 
stimulate Spi production in an autocrine fashion, which is necessary for ISC divisions to 
initiate tumor growth. After a series of initial divisions, the adjacent ECs show elevated 
JNK and Yki/YAP activity, which promote their detachment, extrusion and apoptosis. 
Consequently, tumor-adjacent ECs express unpaired cytokines, while domeless and 
Stat92E are expressed in tumor cells and are necessary for tumor growth94,95. 
Interestingly, Stat92E is epistatic to Delta/Notch signaling in cell fate specification of the 
ISC daughters suggesting that Jak/Stat pathway functions downstream or in parallel 
during the differentiation of the ISC daughters such that low Notch signaling is associated 
with high Jak/Stat and results in EE differentiation49.  
Exogenous lipids strongly also influence Delta ligand and Notch extracellular domain 
stability and alter their trafficking and turnover in endosomal vesicles. This suggests an 
intriguing link between the dietary effects on the intestine relative to the levels of Delta 
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/Notch signaling that reflect the ISC number and differentiation towards EE secretory 
lineage96. In fact, intestinal tumor progression is slowed down on a low sterol diet97. 
Similarly, high fed diets in mammals also boost ISC numbers and their tumorigenicity98 
which suggest that the underlying concept of regulation is conserved.  
 
h. Dpp/BMP signaling: 
BMP signaling is conserved in both Drosophila and mammals. It functions to suppress 
ISC differentiation through secretion of Dpp/BMP ligands by the niche components in 
both GI tracts. Nevertheless, it is also cell-autonomously required in Drosophila ISCs to 
initiate stress-induced mitoses. BMP receptors are single transmembrane proteins that 
possess serine/threonine kinase activity in their intracellular domains. In Drosophila, 
Decapentaplegic (Dpp) and Glass bottom boat (Gbb) are the two major BMP ligands 
which synergistically act to bind two type-I receptors Thickvein (Tkv) and Saxophone 
(Sax), and a type-II receptor Punt (Put). Activated receptors causes phosphorylation of 
the Drosophila Smad Mothers-against-Dpp (Mad), which forms a complex with the co-
Smad Medea and activate target gene expression in the nucleus. Dpp establishes an 
activity gradient that regulates expression of target genes in a concentration-dependent 
manner99. Both Dpp and Gbb are produced by ECs100 and trachea23. Dpp is also expressed 
in the VM22. BMP signaling altogether plays complex and opposing roles in progenitors 
and ECs depending on the degree of activation of the signaling and in which cell type this 
occurs to regulate the balance between ISC self-renewal and proliferation of the adult 
Drosophila midgut. Below is a brief description of some observations. Firstly, clonal 
analyses of ISC with perturbed BMP signaling revealed that injury-induced BMP 
signaling acts autonomously in ISCs to inhibit over-proliferation. Thus, ectopic 
expression of BMP signaling components dampen the stress-induced ISC mitoses22. 
Secondly, BMP signaling seems to regulate differentiation and survival of ECs. EC-
derived BMP stabilizes the EC fate and consequently dampens the production of JAK-
STAT and EGFR pathway ligands also to limit unnecessary over-proliferation of ISCs23. 
As a result, Dpp inhibition in ECs leads to ectopic activation of EGF ligands that non-cell 
autonomously promote ISC over-proliferation23,101. Thirdly, BMP pathway is 
asymmetrically activated between ISC/EB pair such that ISCs, located basally, have 
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higher levels of BMP signaling activity than the apical EBs. BMP acts together with 
Notch to regulate the ISC/EB fate choice. Under homeostatic conditions, loss of Dpp in 
progenitors results in a significant loss of ISCs that differentiate into EBs and give rise to 
atypical EB/EB pairs. In contrast, BMP abundance within the ISCs favors symmetric 
ISC/ISC outcome of an ISC division and formation of large ISC-like cell clusters100. This 
evidence indicates that BMP signaling regulates ISC self-renewal. Fourthly, inhibition of 
Dpp receptors with a progenitor-specific driver suppress detergent- or bleomycin-induced 
ISC mitoses indicating that Dpp signaling is cell-autonomously required for ISC mitoses 
as well as lineage differentiation100.  
 
 
Figure 1.6a: An illustration of the complex mammalian and Drosophila TGF-β 
signaling. In mammals, TGFβ1 ligand activates TGFβ receptors (RI,RII) to activate the 
Smad2/3 
that 
assembles 
with 
Smad4 to 
form a 
complex 
that, upon 
nuclear 
translocat
ion, limits 
cell 
division. 
Loss of 
the inhibitory Smad4 in over-activated KrasG12D- or BRAFV600E-mutant cells alter the 
phosphorylated Smad2/3 activity to promote cell proliferation and survival. In 
Drosophila, Decapentaplegic (Dpp) ligand binds Punt (Put) and Thickveins (Tkv) 
receptors to activate the canonical nuclear complex that is comprised of Mothers against 
dpp (Mad) and Co-Smad Medea (Med), to regulate genes promoting cellular quiescence. 
Similarly, over-activated EGFR/Fos and Jak/Stat signaling re-directs Dpp to activate the 
alternate Put–Saxophone (Sax) receptor complex. This complex then activates dSmad2, 
which translocates into the nucleus independently of Med and induces tumor-like stem 
cell growth and dysplasia. Modified from: Ayyaz et al,2017. 
 
Remarkably, beside its complex roles in intestinal homeostasis, Dpp secreted from 
enterocytes at the regional boundaries between the posterior midgut and the middle 
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midgut sets up a morphogen gradient that determines the regional identity of the ISCs and 
defines the size of the gastric acidic copper cell region102. Similarly, in mammals, BMP 
ligands that belong to the transforming growth factor-β (TGF-β) superfamily of proteins 
bind BMP type I and type II receptors (Bmpr1–2) that form a hetero- tetrameric complex. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6b: An illustration of mammalian TGF-β and BMP signaling in the 
intestine. Ligands of the (TGF-β) superfamily includes TGF-βs and bone morphogenetic 
proteins (BMPs) which bind type II and I receptors (T-βR II and T-βR I) or (BMPR II 
and BMPR I) respectively. TGF-β R activation phosphorylates SMAD2/3 which forms a 
heterodimeric complex with SMAD4 and translocate to the nucleus to control target gene 
transcription. BMP R activation phosphorylates SMAD1/5/8 that also forms a complex 
with SMAD4 leading to its translocation to the nucleus to control target gene 
transcription. Adopted from: Zhao et al,2018 
 
This causes phosphorylation of BMP-specific receptor-bound R-Smads1/5/8 (receptor-
regulated Smads) which forms a complex with core mediator Smad4 to regulate target 
gene transcription. Several extracellular antagonists, such as Noggin, follistatin or 
gremlin sequester BMP ligands, thereby blocking their interaction with their receptors103. 
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BMP pathway is activated to drive the differentiation of the mature epithelial cells and its 
inactivation is correlated with development of colorectal cancer. BMP ligands are 
expressed by the intravillus and intercrypt mesenchymal cells as well as differentiated 
epithelial cells to ensure that the epithelial villus cells are kept in their differentiated 
state104. BMP antagonists are tightly produced around the crypts to ensure ISCs remain 
functional and are capable of self-renewal. BMP represses the nuclear accumulation of β-
catenin and is expressed in an opposing gradient along the crypt–villus axis, with highest 
BMP signaling in the differentiated cells at the luminal surface. Unlike Drosophila 
midgut, it is unclear whether BMP signaling plays a cell-autonomous role in the ISCs, 
though BMP receptor is present in ISCs.   
 
Figure 1.7:  Enterocyte (EC) damage causes compensatory ISC proliferation in the 
Drosophila midgut. Damaged and dying ECs activate Jun N-terminal kinase (JNK) and 
inhibit Yorkie (Yki) signaling respectively to upregulate Janus Kinas-Signal Transducer 
and Activator of Transcription (Jak-Stat) ligands (unpaireds: upds) and EGF ligands 
production that activate EGFR and Jak-Stat signaling to stimulate regenerative ISC 
mitoses. Jak-Stat signaling activation in enteroblasts promotes their differentiation into 
enterocytes to compensate for the lost cells. EGFR signaling is required for the 
endoreplication of enterocytes. Adopted from Lucchetta and Ohlstein, 2012. 
 
1.5. Epithelial aging and loss of integrity. 
Continual bouts of ISCs division across the organismal lifespan bring about dysfunction 
in the homeostatic signaling mechanisms, which lead to chronic intestinal inflammation 
in both Drosophila and mammals. The ISCs are highly plastic, as they respond to stress 
and nutritional cues to sustain the epithelial integrity and to adjust epithelial size to 
changing dietary conditions105. Hence, maintaining the ISC function is critical for optimal 
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lifespan. In aging Drosophila animals however, deregulated elevated ISC divisions cause 
epithelial dysplasia and perturb epithelial function. This is accompanied by a prominent 
gut-wide increase in oxidative DNA damage, and increased ROS levels that is primarily 
sensed by ECs to promote accelerated ISC mitoses105,106. Consequently, this results in 
disruption of metabolic homeostasis68, loss of barrier function, systemic infection107, and 
ultimately mortality. Similarly, in aging mammalian intestines, the loss of regulatory 
mechanisms leads to intestinal barrier break down and increased microbiota loads 
(dysbiosis) accompanied by increasing cellular stress and DNA damage that disrupt the 
tissue homeostasis. Accordingly, individuals become more susceptible to infectious 
diseases, including inflammatory disorders108, colorectal cancer109, metabolic 
imbalances110 and gastrointestinal infections111. The reports on the aging effects of crypt 
architecture are mixed. Some studies counter-intuitively reported a decline in crypt 
number but increased crypt length and width, decreased number of mitotic cells and 
attenuated regenerative capacity of aged crypts at the expense of increased ISC 
differentiation112. Others reported that aged mice or rat intestines have increased crypt 
numbers accompanied with hyperproliferation of active ISCs, activatable reserve ISC and 
enteroendocrine cells 113,114. This disparity could be due to differences in the animal 
strains, housing conditions and whether or not they were cultured in a germ-free 
environment112. 
 
Besides the cell-autonomous deregulation of the pathways controlling ISC divisions or 
ISC maintenance, several signaling pathways non-cell autonomously lead to excessive 
activation of ISC divisions and eventually, intestinal dysplasia. In Drosophila, these 
include hyper-activation of innate immunity components115, JNK signaling and insulin 
signaling62 in ECs. Notably despite the limited knowledge of pathways involved in 
mammalian intestinal aging, mechanisms driving age-related dysplasia of the stem cell 
function are conserved from Drosophila62,116 to mammals117 such as expression of stress-
protective FOXO target genes, that is sufficient to limit ISC over-division and maintain 
metabolic homeostasis62.  
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1.6. Differences in male and female Drosophila ISC division and its consequences: 
There were reported longstanding differences between the rate of the ISC epithelial 
homeostatic8 or regenerative turnover in males and females in Drosophila 8,118 that are 
only recently beginning to be understood. Female fly intestines turn over at faster rates 
relative to males, which result in females being more susceptible to develop progressive 
age-mediated intestinal hyperplasia then dysplasia. These gut epithelial deregulation 
together with dysbiosis drive a loss of intestinal integrity and gut immune barrier119, 
which may lead to compromised life span62,120-122. Further studies revealed that sex 
differences are owed to a combination of factors including: differences in food uptake123, 
cell autonomous differences in stem cell behavior118, differences in epithelial structure 
and loss of gut barrier function124 possibly due to differential activation and hyper activity 
of pathways such as JNK or insulin signaling in females relative to males62,120. It remains 
much less carefully examined in mammals if the sexual identity also affects the intestinal 
turnover and response to regeneration. Indeed, studies usually report results of mixed 
intestines of males and females or prefer males to females to exclude the effects of the 
reproductive status on the intestinal function. 
 
1.7. Nuclear Receptors 
Cholesterol, fatty acids, fat-soluble vitamins, and other lipids are an essential component 
of the diet of both Drosophila and mammals. They do not only function in providing 
metabolic building blocks for macromolecules but, they also serve as precursors for 
ligands that bind to a class of transcription factors in the nucleus called nuclear receptors 
(NRs). NRs are integrators of hormonal and nutritional signals, mediating changes to 
metabolic pathways within the body. For lipids to become biologically active, they first 
get absorbed by the intestine then are enzymatically converted to metabolically active 
signaling molecules. Ultimately, a tight balance is achieved between the lipid absorption 
and elimination to maintain a normal physiological state. Hence, the need to study the 
detailed functions of NRs in the organ where nutrient absorption and excrement discharge 
occurs becomes crucial to our understanding of how the intestinal physiology is regulated 
and how impaired functions of NRs result in disease states125. 
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NRs are best described as ligand regulated DNA-binding transcription factors that exert 
activating or repressive effects on target genes, thereby directly modulating target gene 
expression126. The human genome has 48 members of this highly conserved transcription 
factor family and the Drosophila genome has 18 members127. This superfamily includes: 
classic endocrine receptors that mediate the steroid hormones actions such as estrogen 
receptor (ER), androgen receptor (AR) glucocorticoid receptor (GR) or Drosophila 
ecdysone receptor (EcR), Drosophila Hormone Receptor 96 (Hr96). Receptors that bind 
non-steroid hormones include thyroid hormone receptor (TR) and retinoic acid receptor 
(RAR). Receptors that bind products of lipid metabolism i.e. fatty acids and their 
derivatives such as prostaglandins include peroxisome proliferator activated receptors 
(PPAR), liver X receptors (LXR), farnesoid X receptors (FXR) and the highly conserved 
Drosophila and mammalian Hepatocyte Nuclear Factor 4α128. Finally, the rest are 
grouped into orphan receptor subfamily for which the regulatory ligands were/are 
unknown127.  
Figure 1.8: Schematic illustrating the basic structural components of a Nuclear 
receptor and how it mediates its function. a) Nuclear receptors are comprised of three 
domains, a highly conserved DNA-binding domain (DBD), a ligand-binding domain 
(LBD) that are joined by a flexible hinge region and a N-terminal domain that contains 
AF-1 transactivation domain. The DBD consists of two C4 zinc fingers that mediate 
specificity of target DNA binding. The less conserved LBD is located C-terminal to the 
DBD and has a strong dimerization surface to bind different receptors. The LBD 
comprises 11–13 α helices that form a hydrophobic pocket for the binding of small 
lipophilic molecules. Recruitment of coactivators takes place through ligand dependent 
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AF-2 and ligand independent AF-1 transactivation domains. b) Each nuclear receptor 
binds to a half site that is derived from, or identical to, the standard AGGTCA sequence 
through a stretch of five amino acids known as the P-box located in the DBD. Adopted 
from: Sara Ahmed’s master thesis,2015464 and originally from Krist-Jones & Thummel, 
2005. 
 
NRs consist of an amino terminus with a trans-activation domain (AF-1), highly 
conserved DNA- binding domain (DBD) and a less conserved C-terminal ligand-binding 
and dimerization domain (LBD). The AF-1 acts in a ligand-independent fashion and 
facilitates the recognition of NR by transcriptional co-regulators such as co-activators or 
co-repressors. The DBD comprises zinc-finger domains that provide DNA-binding 
specificity and a dimerization interface through which the interaction with a target DNA 
takes place129. The LBD consists of a hydrophobic binding pocket where the ligand docks 
and a transactivation domain AF-2, that recruits co-activators, often through a ligand-
dependent fashion. NR bind target genes through receptor-specific conserved DNA 
sequences termed nuclear response elements127. 
 
Most ligand-bound activated NRs translocate to the nucleus to modulate transcriptional 
regulation of target genes themselves. However, reports also describe the existence of 
extranuclear receptor pools that coordinate the classic nuclear pools130,131. The actions of 
NRs can be non-genomic, genomic or epi-genetic132. Non-genomic functions include 
interaction with membrane-localized cell-signaling effectors such as estrogen-induced 
generation of cyclic AMP133 or progesterone-induced interference with G-protein 
signaling to activate Erk134, among many others135. Genomic functions include direct 
modification of the activity of transcription factors136 such as estrogen-mediated down-
regulation of transcriptional repressors such as Mad4 and JunB and up-regulation of cell 
cycle progression genes such as cyclin D137. The action of NR even extends to regulating 
epigenome132,138 through regulating histone deacetylases (HDACs)139,140, histone 
methyltransferase141 or altering chromatin compaction142,143. Owing to their wide 
functions, dysfunction of nuclear receptor signaling is associated with proliferative, 
neuronal reproductive and metabolic diseases such as cancer, infertility, obesity and 
diabetes144-147. 
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1.8. Drosophila ecdysone in development and adulthood: 
Drosophila has two main physiologically active lipophilic hormones, the steroid hormone 
ecdysone and a sesquiterpinoid, juvenile hormone. Ecdysone signaling works in concert 
with juvenile hormone to regulate major developmental transitions in the Drosophila life 
cycle, including the larval molts and metamorphosis, as well as sexual maturation148. 
Most of the ecdysone signaling effects reported in the literature are investigating the 
actions of a 20-hydroxylated derivative of ecdysone (referred to as 20HE). Though it is 
becoming more evident that only studying the actions of 20HE is an all-too-simple view.  
Though it was recently described that Drosophila can produce different classes of 
ecdysteroids, which are derived from four types of dietary sterol precursors: cholesterol, 
C27 sterol, C28 and C29 plant sterols and C28 fungal sterols (e.g. ergosterol) with an epi-
C-24methyl group, which has the opposite chirality to plant sterols149. In total, 
ecdysteroidome of Drosophila comprises seven major ecdysteroids: α-Ecdysone, 20HE, 
20-hydroxylated derivative makisteroneA (MaA), 24-methylecdysone (24-methylE), 24-
epi-methylE, 24-epi-MaA, 24(28)-dehydromakisterone (dhMaA), and two catabolites – 
20-hydroxyecdysonoic acid (20Eoic) and MaAoic acids149. It remains very interesting to 
figure out how those different classes differ in their actions during development and in 
adulthood, whether they all bind EcRUsp, and how they would dynamically regulate 
target gene expression. To date, 8 CYP450 enzymes (Halloween genes) are implicated in 
ecdysone synthesis from dietary cholesterol150. During larval development prothoracic 
glands are the principal source of ecdysone synthesis151. However, the main site of 
ecdysone synthesis during adulthood is the female ovaries and the male accessory glands 
are reported to express 20HE-synthesizing enzymes152. Higher levels of circulating 
ecdysone exist in females than males153,154. Accordingly, α-Ecdysone is released into the 
hemolymph after which it gets converted by the sexually dimorphic enzyme shade into 
20HE at the target tissues118,155. After mating, there is a boost of ecdysone production in 
the female ovarian follicles and its levels double as early as 24 hours after mating156-158. 
Classically, the ecdysone receptor dimer consists of the ligand-binding EcR subunit and 
the DNA-binding subunit Ultraspiracle (Usp), which are orthologous to human farnesoid 
X and liver X receptors (FXR, LXR), and the retinoid X receptor (RXR) respectively127. 
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Drosophila ecdysone receptor gene (EcR) encodes up to six protein isoforms (Flybase 
Apr 14, 2020 release) including the functionally distinct, well characterized EcR-A, EcR-
B1, and EcR-B2159,160. The difference in the isoforms lies in their N-terminal, A/B region 
but they share a common DBD and LBD. During Drosophila larval development, 
ecdysone-liganded EcRUsp heterodimers activate transcription of “early” genes 
including the Broad Complex (BR-C) and the ecdysone-inducible puff 75B (Eip75B), 
which in turn induce transcription of a set of ‘‘late’’ genes that orchestrate major 
developmental events in the life cycle161-163. In adults, ecdysone functions to regulate 
sleep 164, courtship memory formation165, lifespan and stress resistance166, and establishes 
a female metabolic state conducive to reproduction123. Ecdysone signaling has also been 
shown to be involved in terminal differentiation of neural stem cells in the 
adult Drosophila brain 167 and to maintain germline stem cells in the ovaries 168 and cyst 
stem cells in testes169. To date, a role of ecdysone EcR signaling in the adult gut has not 
yet been described, and it is this subject of this thesis, though its mammalian orthologs 
LXR and FXR regulate a multitude of metabolic pathways in the GI tract including bile 
acid, lipid and carbohydrate metabolism170,171. 
Downstream of the ecdysone cascade, there are many ecdysone-inducible targets that 
relay the ecdysone effects172. Below is a short summary of the ecdysone targets whose 
functions were examined during the course of this project. 
1.9. Eip75B, Hr3 and Hr51 as hormone nuclear receptors in Drosophila: 
Ecdysteroid-inducible protein 75B (Eip75B) is encoded by the early gene E75 that maps 
to the 75B early puff. Puffs are enlargements of specific loci on the giant salivary gland 
polytene chromosomes after ecdysone binds them, which correlate with increased local 
transcriptional activity at these sites. The closest vertebrate homologues of Eip75B are 
members of the NR1D/Rev-Erb family. These mammalian nuclear receptors include Rev-
Erbα (Rev-ErbA-α, THRAL, EAR-1; NR1D1) and Rev-erbβ (Rev-ErbB-β, RVR, EAR-
1R, BD-73; NR1D2) respectively173. The percentage amino acid identity in DBD/LBD of 
Eip75B to REV-ERB is 80/25 which ranks both NRs amongst the most highly conserved 
proteins during evolution127. Similar to REV-ERB, Eip75B tightly binds heme in its 
LBD. However unlike REV-ERB, heme is essential for Eip75B protein folding and 
accumulation. Both proteins undergo redox-dependent ligand switching and CO- and 
 
 
41 
NO-induced ligand displacement raising the possibility of their functions as redox 
sensors174. Indeed, cellular levels of Eip75B are proportional to heme amounts available 
in the cell suggesting that Eip75B acts as a heme sensor175. Generally, REV-ERBs and 
Eip75B function as repressors of transcription173,176-178. Accordingly, Eip75B and REV-
ERB have overlapping functions in regulating circadian rhythm and metabolism in both 
Drosophila179,180 and mammals181,182. Eip75B has at least seven protein isoform Eip75B-
RC (E75A), RA (E75B), RF, RD, RG, RB and RE (Flybase Apr 14, 2020 release), 3 of 
which are characterized in the literature183. Alternative splicing gives rise to protein 
isoforms that differ in their N-terminal sequences but share a common LBD in the C-
terminus. During development, Eip75B functions in development to regulate molting, 
pupal development, metamorphosis and adult viability183. Interestingly, Eip75B also acts 
as upstream of ecdysone as a regulator of ecdysone production in the prothoracic 
gland184.  
 
Drosophila Hormone Receptor 3 (Hr3) is orthologous to the vertebrate retinoid-related 
orphan receptor (ROR) and together they share a percentage amino acid identity in 
DBD/LBD of 76/35 127. Consistent with its similarity to ROR, Hr3 binds as a monomer to 
its response element on its target genes acting as a transcriptional activator. All Eip75B 
isoforms are reported to be able to bind Hr3 both in vivo and in vitro 175,177,184. 
Classically, Eip75B binds Hr3 blocking its transcriptional activities on target genes. This 
Eip75BHr3 interaction is regulated by NO binding, which disrupts the interaction of 
Eip75B with Hr3. The function of this nuclear receptor cascade has been validated across 
development in various contexts. Eip75BHr3 regulates behavior, fat deposition and 
developmental timing177,185-187. 
 
 Drosophila Hormone Receptor 51 or unfulfilled (unf/Hr51) is orthologous to the 
vertebrate PNR (photoreceptor-specific nuclear receptor) and together they share a 
percentage amino acid identity in DBD/LBD of 70/47127. Although not much is known 
about Hr51, it is reported to function together with Eip75B to regulate circadian rhythm 
in the pacemaker neurons 188 and direct developmental axon regrowth 189in a-NO 
dependent fashion. However, it is unclear whether Hr51 is an ecdysone-inducible target. 
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1.10. Broad as an ecdysone target: 
The Broad-Complex (BR-C) or broad is a complex gene that encodes a family of zinc 
finger transcription factors mapping to the 2B5 early puff. The broad complex contains up 
to four classical complementation groups (broad, reduced bristles on palpus (rbp), 
l(1)2Bc and l(1)2Bd), as well as a group of non-pupariating (npr1) alleles. Through 
alternative splicing, at least 14 transcript isoforms form from a single pre-messenger 
RNA transcript. The broad family consists of a common core N-terminal region with a 
protein–protein interaction domain BTB/POZ that they use to interact with other 
transcription factors or with chromatin and a pair of cysteine (C2) and histidine (H2) zinc 
fingers that bind to DNA of its target genes. 190. BR-C functions as an early ecdysone 
target to coordinate the stage-specificity of the ecdysone response during growth of 
imaginal discs, neuronal development, metamorphosis191. In adults, BR-C functions in 
regulating oogenesis192 and modulating innate immune responses193.  
1.11. Sex determination in mammals and Drosophila:  
As shortly presented in the introduction and discussed further, the steroid NRs bind 
steroid hormones and the active hormone receptor complex binds its hormone response 
elements to control target gene expression. The gonadal sex steroids are a subclass of the 
steroid NRs that are mainly synthesized from the gonads to act on many target tissues. 
Accordingly, sex hormones act as chemical mediators of gonadal sex that are involved in 
sex differentiation too. Sex hormones interact with the intrinsic genetic sex at different 
levels and, synchronously work to regulate the organismal homeostatic needs. Under 
certain conditions: predisposition to genetic diseases or exposure to external 
environmental cues result in disturbance of this interaction, posing a significant risk on 
the organism’s general and reproductive health or survival. Studies on how the two sex 
components: genetic and gonadal sex interact to control mechanisms that lead to sex 
differences would expand the knowledge of the fundamental biology of sex differences in 
physiology and disease processes, facilitating therapeutic outcomes of sporadic and 
genetic diseases. The interplay between gonadal sex, psychological sex and the intrinsic 
sex chromosome constitution of individual cells is likely to determine several behavioral 
aspects of organ physiology and disease as shown in examples (194-196). Hence, it remains 
interesting to study how the non-cell autonomous sex-determining mechanisms and the 
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sex hormones cross talk with the cell-autonomous cellular composition of the sex 
chromosomes to regulate tissue homeostasis. 
 
Figure 1.9: Factors contributing to phenotypic sex differences in physiology and 
disease. A multitude of factors contribute to the disease and non- disease human traits 
including the intrinsic genetic makeup of the cells (genetic components that lead to 
genetic variation in an individual’s genome represented in (a) single- nucleotide 
polymorphisms (SNPs) and copy number variants (CNVs)) and de novo mutations, (b) 
epigenetic differences in DNA accessibility and methylation status such that 
hypomethylation associates with accessibility of transcription factor (TF) binding to 
promote transcription and hypermethylation associates with compact chromatin. (c) the 
genotype imparted differences in gene expression vary between males and females. 
Genetic variants that affect RNA splicing are termed sQTLs, splicing quantitative trait 
loci. Genetic variants that differ in their regulatory mechanisms i.e. they can act in one 
sex and not the other, or with different effect sizes or even allelic direction in males and 
females are termed eQTLs, expression quantitative trait loci. (d) exogenous factors such 
as environmental exposures, lifestyle choices and occupation- related hazards (e) 
endogenous factors such as sex hormones and reproductive status all function together to 
regulate sex-biased gene expression and formation of sex- specific regulatory networks. 
Adopted from: Khramtsova et al,2019. 
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In mammals, our current understanding is that there are distinct levels of sex 
determination and identity. There is the environmental sex determination (ESD) whereby 
external factors such as temperature, toxicants, population density, nutrients and 
hormones regulate the sex of the organism. There is also the genetic sex determination 
(GSD), which is driven by mechanisms regulating gonadal sex determination as well as 
the chromosomal differences between the sexes.  
Gonadal sex determination is dominant over most sexually dimorphic characteristics. 
There is also the much-less understood psychological sex determination, which acts in the 
brain to determine gender identity and partner preference197. Sex chromosomes (XY) 
have evolved as morphologically distinct from autosomes. The Y chromosome carries the 
sex determining region Y (Sry) gene, which translates into a transcription factor that 
initiates testicular development in a gonad with the potential to be of male or female fates 
equally198-200. Expression of SRY in the somatic supporting cell lineage (i.e Sertoli cells 
in testis) causes the activation of its downstream target Sox9, which acts in a feed-forward 
loop with fibroblast growth factor 9 (FGF9), to suppress Wnt 4 and the female signature 
and instead, amplify the male biased signature of desert hedgehog (Dhh)201, prostaglandin 
D2 synthase (Ptgds) 202and platelet-derived growth factor (PDGF)203. In many egg-laying 
species including birds and turtles, despite the presence of a strong genetic sex 
determination system, they can be sex-reversed to female by the application of estrogen 
during the critical period of gonad formation and commitment to testis or ovarian fate, 
thereby reverting a testis into an ovarian fate204. In a similar context, in mammals that 
develop within a uterus (eutherian mammals), XX individuals can be fully sex-reversed 
to phenotypic males if Sry initiates testicular development, suggesting that gonadal sex 
determination non-cell autonomously exert control over the sex chromosome constitution 
of individual cells200. In Drosophila however, cells know their sex by their sex 
chromosome constitution, independent of their neighbors. An elegant demonstration of 
this concept is the existence of Gynandromorphs, which are animals that possess male 
regions and female regions in their body. This can happen when an X chromosome is lost 
from one embryonic nucleus. As a result, the cells that descend from this particular cell, 
instead of being XX (female), are XO (male)205,206.  
Fly sex determination is achieved through a combination of dosage compensation and sex 
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chromosome sensing mechanisms207, where X/X is female and X/Y is male. The bigger 
ratio of X chromosomes to autosomes (In females, the X:A ratio is 1) leads to activation 
of the expression of the master X-linked regulatory gene cascade starting with sex-lethal 
(sxl) that becomes activated in a positive-feedback loop to maintain its own alternative 
splicing, and also the splicing of transformer (tra) and female-specific isoforms of the 
transcription factor genes doublesex (dsx) and fruitless (fru) resulting in expression of a 
“female” transcriptional regulatory complex and a female sexual development genetic 
landscape i.e. female “ON” state207. At the same time, Sxl expression regulates dosage 
compensation through inhibiting male specific lethal-2 (msl-2) expression. Conversely, 
when msl-2 protein is expressed, it causes the formation of the male-specific MSL 
complex which is targeted to the single male X chromosome to activate 2-fold 
upregulation of the male chromosome (dosage compensation)208. In parallel, msl-2 
promotes the expression of male-specific doublesex (dsx) and fruitless (fru) isoforms, all 
of which work in synchrony to instruct male specific traits. So far, the majority of the 
sexual differentiation in Drosophila sex traits are reported to largely depend on the on/off 
state of Sxl209. Although, recent studies reveal the existence in Drosophila of sex-biased 
expression of tissue specific miRNAs that contribute in maintaining the sex identity of 
various tissues, through rather complex mechanisms that are still not fully understood. 30 
miRNAs are enriched at least fivefold in the male body suggesting distinct somatic 
functions. Whereas in females, 45 miRNAs are enriched in female somatic tissues, 28 of 
which are almost exclusively detected in the somatic tissues rather than the ovaries. As an 
example, miRNA let-7 expression is sexually dimorphic and regulated by the sex-biased 
hormone ecdysone. Ecdysone-regulated let-7 modulates the sex-determination hierarchy. 
During the late-larval to late pupal developmental stages, Let-7 levels are important to 
specify male and female sexual identity. While, during adulthood, let-7 helps establish 
and sustain gonadal differentiation and sexual identity in males and females210. This 
growing evidence demonstrates that sex-hormonal control of cellular sexual identity 
exists in Drosophila, similar to vertebrates211. 
Mammalian sexual differentiation is related to Drosophila sexual differentiation in a 
number of ways. First, females are X/X and males are X/Y. Second, in mammals females 
have two copies of a large, gene-rich X chromosome, whereas males have one X and a 
small, gene-poor Y chromosome. Hence, to avoid imbalance of genes and proteins and 
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drastic phenotypic effects, dosage compensation mechanisms have evolved that 
equilibrate the level of X-linked gene products between the sexes. Accordingly, twofold 
up-regulation in the expression of X-linked gene in males212 exists as well as the almost 
complete (but not all) inactivation of the genes on one of the two X chromosomes in 
females213. Third, Drosophila dsx, which is expressed in a male-specific pattern and is 
required for male differentiation, shares a high degree of homology to Mab3214, which is 
present in C.elegans, and Doublesex and Mab3 Related Transcription factor 1 (DMRT1) 
in reptiles, zebrafish215 and mammals216. It remains striking that the sex determination 
mechanisms is highly conserved across species from C.elegans to Drosophila and 
mammals and argues that future studies will reveal even more similarities in the global 
regulation of sex traits.  
Environmental cues also influence sex determination. One example is the regulation of 
sex identity by estrogen through the differential expression of an epigenetic histone 
modifier in reptiles. It has been shown that temperature or estrogen levels affect the sex 
determination pathway in reptiles by modulating the expression of the histone 
demethylase KDM6B in a sexually dimorphic manner. Expression of the chromatin 
modifier: KDM6B is high at male- producing temperatures (26°C) and low at warmer, 
female producing temperatures (32°C). KDM6B demethylates the trimethylated histone 
H3 lysine 27 (H3K27me3) which activates gene expression at the highly conserved key 
sex-determining gene locus, Dmrt1217. This leads to the expression of the testicular 
Sertoli cell markers Sox9 and Amh and the inhibition of ovarian markers Cyp19a1 and 
Foxl2. In contrast, high temperature or the presence of estrogen at low temperatures is 
sufficient to down-regulate relative expression levels of KDM6B, which gives rise to 
females217.  
Hence there is a strong interaction across species218 between the cell-autonomous sex 
determination whereby cells know their sex by their sex chromosome constitution, and 
non-cell autonomous gonadal sex whereby the gonadal sex elements primarily creates a 
system that is responsive to the sex-specific endocrine milieu characteristic of the stage of 
development, as well as the specific male and female environments, controling at least in 
part some aspects of the cellular sex as well as secondary sex characteristics211,219 .  
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1.12. Effect of sex hormones on sex and non-sex organs: 
Sex hormones are the chief systemic mediators of the sex differences imparted by the 
gonadal sex. They are responsible for many aspects of the sexual maturation and 
appearance of secondary sex characteristics. Nevertheless, there is accumulating evidence 
linking sex hormones to the physiology of non-sex organs as well. Sex steroids are 
steroid hormones that are cholesterol-derived220, and synthesized by Cytochrome P450 
enzymes mainly in the gonads of the animal but also to much lesser extents in the kidney, 
adipose tissue, skin, and brain220. In mammals, sex steroids include: estrogen, 
progesterone and testosterone. Sex hormones are involved in many processes including 
stem cell division221,222, renewal of reproductive223,224 and non-reproductive organs225,226, 
central regulation of systemic metabolism227 and stimulating appetite and food 
intake228.Similarly, sex steroids are known for their pro-229,230or anti-inflammatory231,232, 
immune-modulatory233,234, angiogenic235,236 roles as well as for the recruitment of stromal 
cells in the tumour microenvironment during cancer development237,238. Even 
development of severe body-wasting syndrome called cachexia shows a strong sex 
preference with higher prevalence in males than females possibly due to the protective 
effects of estrogen on the muscle mass239,240. Since the 20HE hormone I studied is of high 
resemblance to estrogen in both its structure and function123, I focus on the roles of 
estrogen and to a lesser extent progesterone (collectively termed female sex steroids) in 
the next paragraph. There are four naturally occurring steroid estrogens: estrone (E1), 
17β-estradiol (E2), estriol (E3) and the pregnancy-specific estetrol (E4). All estrogens are 
derived from cholesterol. E2 is the major product during the premenopausal period in a 
woman's life, whereas E1 is synthesized from the adipose tissue241 and plays a larger role 
after menopause. E3 is the least potent estrogen and together with E4 they are secreted by 
the placenta and remodel the organs during pregnancy. Estrogens are interconverted to 
each other through CYP450 enzymes in a process named metabolism. Metabolism is the 
enzymatic modification of exogenous or endogenous compounds, which either alters their 
metabolic stability or detoxifies them for clearance outside the body242. Similarly, 
endogenous hormones are metabolized into less active forms such as estrogen 
inactivation of E2 involves its conversion to a lesser active form E1 or E3 or addition of 
sulfation adducts by estrogen sulfotransferases which inactivate the estrogens243,244. 
Estrogens bind to at least three different estrogen receptors (ERs), ESR1 (ERalpha, or 
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ERα), ESR2 (ERbeta or ERβ) and a membrane G-protein coupled receptor, GPR30 (or 
GPER1). ERα and ERβ are well-identified nuclear receptors and are products of distinct 
genes located on different chromosomes. The actions of ERβ seem to be opposing to 
ERα-mediated transcriptional responses245,246. 17β-estradiol binds equally to ERα and 
ERβ, hence the genomic response in the target tissue depends on the ratio between ERα 
and ERβ247. Stimulation of target gene expression in response to estrogen-bound ERs 
occurs through (i) ‘direct binding’ to estrogen response elements (EREs) in the target 
genes and interacting directly with coactivator proteins and components of the RNA 
polymerase II transcription initiation complex resulting in enhanced transcription or (ii) 
‘tethering’ of liganded ER to another DNA-bound transcription factor such as RARα, 
Sp1, AP-1, and NFκB in a way that stabilizes the DNA binding of that transcription 
factor and/or recruits coactivators to the complex246. The latter mode of ER 
transactivation extends the ER influence to genes that do not contain ERE sequences in 
their promoter regions adding yet more complexity to the transcriptional regulation. 
Similarly, both ERα and ERβ interact with receptor tyrosine kinases, scaffolding proteins, 
guanine nucleotide exchange (G)-proteins, as well as other intracellular signaling 
proteins, to activate a wide array of cytoplasmic signaling pathways, independent of their 
transcriptional effects248. Alternatively, the transmembrane or endoplasmic reticulum-
bound GPR30 was shown to bind endogenous E2 as a ligand and to activate Erk and 
PI3K–Akt signaling in breast cancer cell lines249,250. 
Generally, female sex steroids regulate the growth, development and physiology of the 
reproductive organs during puberty, the estrus cycle and pregnancy 224,251-254 as well as 
their carcinogenesis255,256. Moreover, the female sex steroids are required in a paracrine 
or intracrine fashion to regulate the physiology and tissue-specific functions of the 
brain257,258, bone259 or adipose tissue260 with or without dependency on circulating levels 
of ovary-derived sex hormones. Surprisingly, estrogen-synthesizing aromatase and 
estrogen receptors are also expressed in diverse sites of the male gonads. E2 is required 
for spermiogenesis, sperm maturation and sperm motility 261,262. Additionally, estrogen is 
required for neuronal functions and aromatase-knockout mice, which are unable to 
synthesize estrogen, are impaired in many behaviors including sexual, aggressive, and 
locomotive behaviors263. Hence, there’s a tight balance between estrogen synthesis and 
deactivation to regulate organ-wide homeostasis and its deregulation leads to many 
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pathologies264.  
 
1.13. Impact of exogenous sex hormones on health.  
In the more recent years, exogenous exposure to sex steroid hormones has proven to have 
harmful effects on the reproductive health of many organisms in the ecosystem, including 
humans. As an example, estrogen will be discussed below as nearly all body tissues 
develop a response to estrogens265. Exogenous sources of estrogen may include exposure 
from environmental sources, dietary sources or through use of oral contraceptives and 
hormone replacement therapies. Estrogen can leak into the environment through the 
wastewater or manure of livestock as well as urine of women on oral contraceptives or 
hormone replacement therapy266,267. Of note, all food of animal origin contains detectable 
estrogen and its metabolites at variable concentrations. 17β-estradiol is the most potent 
estrogen, but even the least potent naturally occurring or synthetic estrogens have drastic 
effects that warrant for concern267. The relative potency of 17β-estradiol is 104 to 106 
times compared to some xenoestrogens in-vitro268. Elevated levels of 17β-estradiol in the 
environment266,269-271 are responsible for a plethora of endocrine disturbances including 
predisposition to obesity272, increased occurrence of genital abnormalities among new 
born boys and precocious puberty in girls273,274, disturbances in male spermatogenesis 
and fertility 262as well as sex reversal in fish275,276. As dietary or environmental exposure 
to steroid hormones and their metabolites is inevitable, it is therefore of prime importance 
to investigate if there is an impact of environment loading267 or dietary exposure of 
steroid hormones on the physiology of mammalian organs and health. Indeed, as an 
example dietary exposure to milk products supplies about 60-80% of ingested female sex 
steroids, that come from the animal’s endogenous stores even without the animals being 
raised on estradiol277,278. As early as 1-2 hours after cow milk consumption, both serum 
and urine concentrations of estrogen and progesterone metabolites were significantly 
increased in all men, women and children277,279. Milk consumption from pregnant cows 
also caused suppression of gonadotropin hormone secretion concurrent with the 
absorption of exogenous estrogens279. Elevated sex hormones are known to result in a 
negative feedback loop on the hypothalamic-pituitary-gonadal axis, which suppress 
gonadotropin hormone secretion. Gonadotropin hormone secretion is essential for the 
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regulation of the menstrual cycle and its disturbances is associated with some 
reproductive endocrine disorders including anovulatory amenorrhea and 
hypoestrogenemia280. In congruence with the hypothesis that dietary intake of estrogen-
rich foods interferes with the normal reproductive functions, dairy food intake is 
associated with twice higher risk of sporadic anovulation281, reproductive senescence and 
diminished ovarian reserve (accelerated ovarian aging)282. Similarly, suggestive evidence 
shows that exogenous dietary hormone intake, through milk consumption is associated 
with significantly higher risk of endometrial cancer progression, especially in post-
menopausal women283. Collectively, the current evidence associating sex hormone intake 
with reproductive health suggests that indeed the hormones in the food get absorbed to 
the blood, which are associated with detrimental long-term consequences on the 
reproductive health. Accordingly, the effect of dietary intake of naturally occurring 
sources of high sex steroids on the organismal health deserves more detailed study.
1.14. Fly genetics. 
Most of the experiments done in this thesis were based on the GAL4-UASts binary 
expression system, a P element based system –that allows patterns of an enhancer-driven 
expression to reflect the expression of any gene of interest. P elements are transposable 
DNA elements that hop and insert themselves into the genomic DNA, preferentially into 
sequences that regulate gene expression (i.e. enhancers). A GAL4-UAS is designed by 
replacing an "enhancer trap" P construct with the yeast transcription factor, Gal4 
followed by the introduction of the gene of interest in a second P element.  
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Figure 1.10 Genetic modifications of the GAL4 system to obtain spatiotemporal 
control of gene expression. (a) Ubiquitously expression of temperature- sensitive allele 
of GAL80 (tubGAL80ts ) will inhibit GAL4 activity at the permissive temperature of 18 
°C. At the restrictive temperature of 29 °C GAL80ts cannot bind GAL4 to inhibit it, 
therefore allowing GAL4-dependent transgene expression. (b) The GeneSwitch system is 
an example of ligand- inducible GAL4. Fusion of the GAL4 DNA binding domain to the 
ligand-binding domain of the progesterone receptor results in GAL4 activity only in the 
presence of the drug RU486/Mifprestone. Illustrations adopted from: Caygill and Brand, 
2016. DOI 10.1007/978-1-4939-6371-3_2 
 
Hence, the promoter will be activated by Gal4 binding and the candidate gene of interest 
will be expressed wherever Gal4 is expressed. Then, the GAL4-UAS system has another 
modification which is the introduction of a temperature sensitive version of the Gal4 
repressor a Gal80 protein that represses Gal4 at permissive temperature (18oC) but allows 
Gal4 expression upon shift to a higher temperature (25-29oC). This method allows for 
spatiotemporal control of gene expression such that other tissues where the gene of 
interest is expressed are not affected and the phenotype results from the specific 
manipulation of gene expression where the Gal4 is expressed. This system can be 
extended for clonal analysis by the introduction of UAS-flp Act>CD2>Gal4). This 
introduction of a sequence encoding for flippase enzyme flips a stop codon cassette 
spaced between the Act and Gal4 sequence, allowing the ubiquitous expression of actin-
driven genes thereafter8. Enhancers used for the Gal4 conditional systems include esg 
expressed in progenitor cells, esgts Su(H)Gal80 expressed in ISCs, Su(H) expressed in 
enreroblasts, Myo1A expressed in enterocytes, pros expressed in enteroendocrine cells 
and how expressed in visceral muscle. A different modification of the Gal4 system 
includes GeneSwitch GAL4 system which replaces the traditional Gal4 with chimeric 
 
 
52 
Gal4 protein, that it is activated only in response to feeding with the hormone analog 
mifepristone/RU486284.  
 
Figure 1.11 Mosaic Analysis with a Repressible Cell Marker (MARCM) uses 
FLP/FRT system to generate loss-of- function clones. Both GAL4 and GAL80 are 
ubiquitously expressed from the tubulin promoter, which causes the repression of the 
GAL4-inducible marker. Heat shock at 37°C induces expression of FLP recombinase that 
catalyzes recombination between FRTs on homologous chromosomes carrying either the 
mutation of interest or a tubGAL80 construct. GAL80 segregates from the mutation into 
different daughter cells, one that inherits two copies of the tubGAL80 and remains 
wildtype and the other that carries the mutation on the two chromosome arms i.e. 
homozygous mutant cell. GAL4 labels these mutant clones. Illustrations adopted from: 
Caygill and Brand, 2016. DOI 10.1007/978-1-4939-6371-3_2 
 
 
Alternatively, to analyze the function of impaired a small subset of cells in otherwise 
phenotypically wild-type organism, A MARCM (mosaic analysis with a repressible cell 
marker) system can be used to label homozygous mutant cells uniquely in mosaic tissues, 
In MARCM, initially, all cells are heterozygous for transgene encoding Gal80, which 
keeps the Gal4 activity inhibited. Then, FLP/FRT-mediated mitotic recombination takes 
place as the cells receive the stimulus to divide resulting in one daughter cell that 
expresses 2 copies of Gal80,and another cell that is devoid of Gal80, instead allowing the 
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expression of a Gal4-driven membrane-targeted green fluorescent protein (GFP) (mCD8-
GFP). Usually, a mutation is located on the chromosome arm in-trans to the chromosome 
arm containing the Gal80 transgene, the uniquely labeled Gal80-negative (Gal80−) cells 
should be homozygous for this mutation. Hence, homozygous mutant cells become 
labeled in a mosaic tissue285. 
Results 
The text of the following section (Results) has been taken and strongly modified from 
(Ahmed et al., 2020) and has been originally written by myself: 
2.1. 20HE induces ISC proliferation in male and female guts. 
To study the effects of steroid hormones on the gut, I first hypothesized that exogenous 
exposure of flies to steroids will be absorbed by the fly gut, similar to the human 
studies265,277.  Therefore, I added 20HE to high sucrose, low yeast food or standard fly 
food and I fed the flies overnight between 16hrs to 22hrs, then I assayed actively dividing 
ISCs/midgut by phospho-Ser10-histone 3 staining. I used enteric infection with 
Pseudomonas entomophila (P.e.) as a positive control that is known to cause strong ISC 
proliferation in mated females but not in males118 (Fig 2.1.1a). In contrast, I discovered 
that exogenous overnight feeding of 20HE induces ISC division in midguts of males or 
mated females regardless of the nutrient composition (Fig 2.1.1a,c).  Next, I used the 
intestinal lineage-tracing system esg-FlipOut (esgts-FO) that marks ISCs and their 
resulting progeny by GFP41. Feeding 5mM 20HE overnight resulted in ISC division 
accompanied by clonal expansion and growth in the midgut of both sexes, though the 
clonal expansion was more prominent in females (Fig 2.1.1b).  
20HE is known to act through the EcRUsp complex, whereby 20HE binds the EcRUsp 
complex, activating it to modulate target gene expression. To test if 20HE acts through 
EcRUsp complex in the midgut and whether this effect is strictly ISC-autonomous or 
not, I used temperature sensitive esgGal4 tub-Gal80ts (esgts) driver to deplete either EcR 
or Usp specifically in progenitors. The robust 20HE induced ISC divisions in control flies 
were efficiently blocked when EcR or Usp was knocked-down in either males or females 
indicating that 20HE acts cell-autonomously through midgut progenitors (Fig 2.1.1c,d). I 
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validated the results by an independent/isoform specific RNAi line (Fig 2.1.1e-f) or  
ectopic misexpression of dominant negative EcR isoform (Fig 2.1.1g-h). 
In both cases, I have used P.e. as a positive control but I will explain and refer to these 
results in a later section. Additionally, I used the MARCM system to generate GFP-
marked ISC clones homozygous for depleted EcR levels285. Consistent with the RNAi 
results, MARCM EcR depleted ISC clones failed to divide under basal conditions and 
after 20HE-feeding. In both cases, they mostly remained less than 10 small cells/clone 
(Fig 2.1.2c-d). 
EcR has 3 prominent isoforms: EcR A, EcR B1 and EcR B2 that are reported to regulate 
target gene expression differently159,286,287. In an attempt to figure out which isoform is 
functional in ISCs of the gut, I used dominant negative (DN) isoforms to mis-express 
EcR A or B1. Ectopic expression of DN EcR A in progenitors competes with endogenous 
EcR A and blocks 20HE induced mitoses (Fig 2.1.1g-h). Additionally, I used isoform 
specific UAS-RNAi constructs to deplete EcR A or EcR B in progenitors and fed the flies 
overnight with 5mM 20HE then I scored ISC-mitoses. I found that EcR A depletion 
blocks the 20HE-induced mitoses while EcR B depleted progenitors show a minor defect 
in their division rates relative to control ISCs (Fig 2.1.1f). 
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Figure 2.1.1: 20HE promotes ISC division through EcR A/Usp cell autonomously in 
male and female progenitors. Text and images have been taken and modified from 
(Ahmed et al., 2020) and have been originally written and made by myself: (a) Midguts 
from adult wildtype animals were treated for 20 hrs with enteric infection with 
Pseudomonas entomophila (P.e.) bacteria or 5mM 20HE exogenous feeding on low yeast 
diet overnight. Midguts were scored for phospho-histone3+ mitotic ISCs per time point. 
Males ISCs modestly divide while female ISCs divide strongly in response to P.e. 
infection. Both males and females had strong mitotic counts upon exogenous 5mM 20HE 
feeding. I have produced the female data of this panel during my master’s study and I 
used it in my master’s thesis as well, Sara Ahmed,2015464.  
(b) Using ISC lineage tracing tool, esgFOts. clonal growth was assessed such that GFP 
labels ISCs as well as their progeny. Upon 18-20 hrs 20HE feeding, females had a vast 
turnover in their epithelium whereas males had a slightly moderate turnover in their 
epithelium reflected by the mild increase in the GFP+ cells. This result shows that 
exogenous 20-HE boosts ISC mitoses and ISC clonal growth. 
(c-d) EcR and Usp are cell-autonomously required in progenitors for 20HE-induced 
mitoses c) Mitotic counts of EcRRNAi  and UspRNAi male and females progenitors fed with 
20HE overnight. d) EcR is not required for P.e.-induced ISC mitoses unlike Usp. 
Representative confocal images of the R4 region in the posterior midgut of mated 
females. Mated females were fed with exogenous 20HE, infected with P.e. for 20-22 hrs. 
I have produced the female data of this panel during my master’s study and I used it in 
my master’s thesis as well Sara Ahmed,2015464. 
(e) Mitotic counts of 20HE-fed EcRRNAi, UspRNAi, Eip75BRNAi (EcR-downstream target) 
male and females progenitors. Results are shown for an alternative independent RNAi 
line. 
(f) 20HE through isoform EcR-A but not EcR-B mediates ISC division. Progenitor 
specific depletion of EcR-ARNAi and EcR-BRNAi shows that EcR-A mainly, and to a much 
lesser extent EcR-B is required in progenitors for their 20HE-induced ISC response 18 
hrs after feeding. Depletion of EcR-A or EcR-B did not affect the strength of P.e.-
induced ISC mitoses relative to age-matched controls. 
(g-h) (g) Expression of EcR A dominant negative isoform inhibits the ISC proliferative 
response to 20HE but not to enteric infection 18-20 hrs after feeding. (h) Representative 
images of progenitors expansion following 20HE feeding indicative of ISC proliferation 
in control mated females, which is restricted by expression of EcR A DN in progenitors.  
Progenitors of control mated females or with EcR A DN misexpression expand across the 
epithelium to replace lost cells after infection. 
 
To check the requirement of EcR-specific isoform in basal ISC mitoses, I induced ISC 
clones with EcR A or B DN expression and I let the clones form under non-stressed basal 
conditions. ISC clones with EcR A DN expression have impeded growth. While, ISC 
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clones with EcR B DN induces a full epithelial turnover accompanied with mild 
hyperplasia of the gut at 3 days after clonal formation (Fig 2.1.2a-b). Hence, my results 
indicate that EcR isoform A is the main functioning receptor partner that forms a 
complex with Usp in the ISCs of the midgut to regulate target gene transcription. 
To further validate my findings, I checked the pattern of 20HE activation. I used 
EcR.LBD >GFP ligand trap reporter flies 186,288 that express GFP in cells with active 
20HE signaling. The ‘‘ligand/sensor trap’’ system consists of the DNA-binding domain 
of yeast GAL4 (hs-Gal4>) fused to the nuclear receptor ligand-binding domain (LBD) 
under control of a heat-shock inducible promoter.  
The expression of the fusion protein binds a UAS-controlled GFP reporter gene. Heat 
shock in these transgenic flies will drive ubiquitous expression of the transgenic fusion 
proteins only when the ligand is present, it will bind to the Gal4 fusion protein and 
activate the UAS-GFP reporter expression. As the active protein binds a UAS-linked 
GFP, nuclear GFP expression is induced186. Additionally, I labeled delta (ISC marker) 
positive cells or Su(H) (EB marker) positive cells. After 20HE feeding, I detected active 
20HE signaling in many ISC singlets, ISC doublets and in fewer enteroblasts of both 
males and females (Fig 2.2e-h). Remarkably, 20HE feeding activated EcR signaling in 
delta+ ISC pairs in the midguts of both males and females, suggestive of symmetric ISC 
division12. This finding is particularly intriguing because most instances of reported ISC 
mitoses in the Drosophila midgut occur in the asymmetric mode of division5,93. 
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Fig 2.1.2 20HE feeding to male and female flies require EcR and Eip75B to activate 
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EcR LBD reporters in symmetrically and asymmetrically dividing ISCs. 
Text and images have been taken and modified from (Ahmed et al., 2020) and have been 
originally written and made by myself: (a) EcR isoform A but not B is required for 
driving intestinal hyperplasia in mated females as shown by representative images of the 
posterior midgut of mated females expressing EcR A DN or EcR B DN. EcR isoform A 
but not isoform B is required for ISC-derived epithelial turnover. 
(b) ISC-derived clones with low levels of EcR A have impaired basal ISC mitoses. ISC 
mitotic counts were quantified after expressing different EcR dominant negative isoforms 
in mated female midguts.  
(c-d) (c) EcR depleted and the ecdysone-inducible target Eip75B mutant clones fail to 
divide after 20HE feeding. Eip75B mutant clones fail to regenerate the epithelium after 
enteric infection. Representative images of MARCM ISC clones that were generated 
through heat shock induction and the R4 region of the posterior midgut was examined 12 
days after clonal induction. Vehicle-fed control clones were multicellular and spread 
throughout the epithelium but, EcR depleted clones were considerably small, mostly 
between 2-4 cells and rarely up to 10 small cells/clone and Eip75B mutant ISC clones 
mostly remained single-celled clones. After 16hrs of 20-HE feeding, the epithelium is 
populated with newly formed cells within the control clones however, Eip75B mutant and 
EcR depleted ISC clones failed to promote ISC division. Upon enteric infection, Eip75B 
mutant clones minimally divide to give rise to clones with ≤10 cells in contrast to control 
clones. (d) Quantification of panel k by a macro designed to assess clonal sizes/maximum 
Z projection. (see methods).  
(e-h) 5mM 20-HE feeding caused a strong increase in the activity of EcR reporter 
indicated by increased GFP expression in the posterior midgut Males or mated females of 
the genotypes Gal4.DBD-EcR.LBD>GFP (Gal4-EcR>GFP) were heat shocked for 30 
min, infected with P.e., fed with 5mM 20HE or vehicle and dissected 18-20hrs later. 
These GFP ligand traps express GFP under the control of heat-inducible promoter and 
mark cells with active 20HE signaling. When fed with vehicle, Gal4-EcR>GFP is 
expressed in few cells in the R4 region posterior midgut (image shown) and in a lot more 
in the anterior midgut (image not shown). White arrows indicate cells that are double 
positive for delta or Su(H) lacZ markers. GFP was expressed in many delta+ cells (panels 
m,n) and much fewer Su(H)+ (panels o,p) of both males and females upon 5mM 20-HE 
feeding. The majority of the remaining positive cells are enterocytes. Upon 20 hrs of P.e. 
infection, GFP signal disappears from males and females guts indicating that EcR does 
not play a role in infection-induced stress response (panels m,n). 
 
2.2. 20HE acts independent of the sex-determination pathway.  
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In Drosophila, the cell-intrinsic sex determination pathway controls growth and 
metabolism through differential sex-biased expression of splicing factors118. Accordingly, 
females express sex lethal (sxl) and transformer (tra), the master regulators of both sexual 
development and dosage compensation. Presence of sxl and tra activates a “feminized” 
epi-/genetic landscape in the ISC that cell-autonomously controls ISC division118. When 
virgin females are challenged with SDS or enteric infection with P.e.. ISC proliferation 
increases in control virgin females, and this is blunted when ISCs are masculinized 
through sxl or tra depletion (Fig 2.2a)118, partly explaining the difference in the ISC 
behavior between males and females. I then hypothesized that the hormonal differences 
in 20HE titers between males and females would act as an additional non-cell 
autonomous signal that influences ISC proliferation, independent of the sex identity. To 
test the former, I fed tra-depleted virgin female flies with 5mM 20HE overnight and 
found that it strongly induced ISC divisions at similar rates to control virgins (Fig 2.2a) 
accompanied by a fast epithelial turnover represented by the numerous GFP+ progenitors 
populating the posterior midgut (Fig 2.2b). These results indicate that masculinized 
female progenitors remain competent to respond to the 20HE mitotic stimulus, partly 
simulating the competence of male ISCs to divide in response to 20HE. In turn, this 
evidence suggests that 20HE functions independently of the sex identity of the ISCs. 
Thus, a combination of ISC-autonomous and non-autonomous hormonal factors affect 
ISC proliferation.  
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Fig 2.2 20HE induces ISC mitoses independent of the ISC-intrinsic sex 
determination pathway. Text and images have been taken and modified from (Ahmed et 
al., 2020) and have been originally written and made by myself: (a-b) Masculinized 
progenitors (ISC+EB) exhibit impaired mitoses in response to P.e. or SDS, but not to 
exogenous 20HE. (a) Mitotic counts of traRNAi treated virgin progenitors after 16-18 hrs 
P.e. infection, 5mM 20HE or SDS feeding. (b) Representative images of expanding GFP-
marked traRNAi-treated progenitors upon feeding with exogenous 5mM 20HE. 
 
2.3. EBs provide pro-mitotic factors that non-cell autonomously regulate 20HE-
induced mitoses. 
In an attempt to figure out whether other midgut cell types besides the ISCs require EcR 
to signal for the ISCs to divide after 20HE feeding, I targeted the different midgut cell 
types using conditional, cell type-specific Gal4 drivers and multiple independent UAS-
RNAi lines or dominant negative expression to check which cells require EcR for the 
20HE-induced ISC mitoses. Mitotic counts revealed that ISCs cell autonomously require 
EcR and Usp for the 20HE-induced ISC mitoses (Fig 2.3a). Surprisingly, EcR depletion 
in enteroblasts also completely blunted the 20HE-induced ISC mitoses (Fig 2.3b). In 
contrast, the ISC divisions were only mildly compromised when EcR was depleted in 
enterocytes with RNAi or dominant negative expression (Fig 2.3c). Similarly, 
requirement of EcR in enteroendocrine cells for the 20HE-induced ISC mitoses was 
rather marginal (Fig 2.3d). As some cells of the nervous system also express esg289, I 
validated if EcR is required in those cells for the intestinal 20HE-induced mitoses. 
Expression of a pan-neuronal driver elavts 290 did not alter the mitotic counts of dividing 
ISCs to 20HE feeding in EcR depleted neurons relative to control neurons (Fig 2.3e).  
Hence, cell-specific analysis of EcR function in the different cells revealed that EcR is 
unexpectedly important in enteroblasts as well as ISCs for 20HE’s proliferative actions in 
the midgut, suggestive of cell-autonomous and non-autonomous roles of EcR.  
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Fig 2.3 The mitotic wave of 20HE feeding at 16-18 hrs requires EcR and Usp in 
enteroblasts. Text and images have been taken and modified from (Ahmed et al., 2020) 
and have been originally written and made by myself: (a) Both EcR and Usp are required 
by the ISCs for the 20HE induced-mitoses. Scored mitotic counts after 16-18hrs of 20HE 
feeding show diminished ISC mitoses upon 5mM 20-HE feeding in males and mated 
females midguts with ISC-specific EcRRNAi or UspRNAi. Results shown are for 2 different 
RNAi lines.  
(b) EcR is required by the enteroblasts for promoting the mitoses induced by 16hrs of 
20HE feeding. ISCs cannot divide after 20HE feeding when enteroblasts lack EcR in 
males and mated females. Results shown are for 2 different RNAi lines. This experiment 
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indicates that EcR is required non-cell autonomously in EBs for 20HE induced ISC 
divisions.  
(c) EcR is marginally required in enterocytes for peak induction of ISC mitoses 16 hrs 
after 20HE feeding. ISC mitoses to 20HE are slightly compromised relative to controls 
when EcR levels are reduced in enterocytes. Results shown are for 2 different RNAi lines 
for both males and females, and dominant negative isoform of EcR in females. This 
indicates a non-cell autonomous requirement of EcR in ECs to induce optimal ISC 
mitoses in response to 20-HE. 
(d) EcR in enteroendocrine cells plays a minimal role in 20HE-induced ISC mitoses of 
the male and female midguts. Enteroendocrine cells-specific EcRRNAi slightly 
compromises 20HE-induced ISC mitoses indicating that EcR in enteroendocrine cells is 
rather dispensable to 20HE-induced ISC mitoses. Results are shown for 2 different RNAi 
lines. 
(e) EcR in the central nervous system neurons is not required for 20HE-induced ISC 
mitoses of the midgut. Elavts ; that is a pan-neuronal driver for the adult central nervous 
system was used to induce EcRRNAi. Mitotic counts show that EcR depletion in the CNS 
did not alter the ISC division rates relative to control females. The period of RNAi 
induction is indicated above every panel. Results are from 3 or more pooled independent 
experiments. N≥10, for each genotype in the scatter plot. Error bars represent ± SD. 
Statistical analysis was performed using unpaired non-parametric two-tailed Mann-
Whitney test (*p≤ 0.05,**p≤0.01,***p≤0.001, ****p<0.0001). The overnight standard 
period of feeding the flies was 16-20 hours. ♂ refers to males and ♀ refers to mated 
females. 
 
2.4. 20HE induces ISC mitoses in 2 distinct waves, ISC autonomous then ISC non-
cell autonomous wave. 
 
The intriguing observation that EcR in EBs contributes to the 20HE-induced mitoses had 
led us to question the cell-autonomous role of ISCs after 20HE feeding and I attempted to 
examine if there is a period of the proliferative response where EcR is exclusively and 
initially required only in ISCs. If EcR is always required in the EBs to signal to the ISCs 
to divide then it means that the only ISCs with intact EcR would never divide to the 
mitotic stimulus of 20HE feeding. It also would suggest that the 20HE-induced mitoses 
are not a direct consequence of 20HE feeding but rather a secondary effect of the EBs 
sensing increased levels of 20HE in the midgut. So, I tried a time course feeding of 20HE 
to mated female flies and I scored the mitoses/midgut at 5 different time points. 
Strikingly, I discovered an early peak of 20HE-induced ISC mitoses that starts at 6hrs and 
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it blunts already by 9hrs then ISC division peaks again by 16hrs until 22hrs after feeding 
(Fig 2.4a), (compare to Fig 2.1a). Strikingly, when males were fed with 20HE for 6hrs 
their ISCs barely divided, whereas female ISCs had been dividing already albeit at 
slightly lower levels relative to 16hrs (Fig 2.4b). This could be due to biological 
variability in the potency of 20HE to induce ISC mitoses or that those flies particularly 
did not eat so much 20HE by 6hrs relative to ones in Fig2.4a. This is quite spectacular 
because the male ISCs seem to either have delayed or skipped initial ISC mitoses at 6hrs 
but then they become equally competent to female ISCs in their divisions after 20HE 
feeding. This finding goes in line with the evidence suggesting sex specific differences in 
the proportions of ISCs in the different cell cycle phases118.  
After revealing the earlier peak of 20HE-induced ISCs mitoses in females, I tried to 
figure out if EcR in enteroblasts contribute to that phase as well. Hence, I depleted EcR 
specifically in the progenitors (ISCs+EBs) or enteroblasts and then fed mated females 
with 20HE for 6 hrs (first mitotic peak) or 16 hrs (second mitotic peak). Progenitor-
specific reduction of endogenous EcR suppressed ISC mitoses at both time points, 
because the ISCs have reduced EcR levels. In contrast, depletion of EcR in enteroblasts 
had no effect on the ISC mitoses during the 1st mitotic peak but it blocked ISCs from 
dividing again at 16 hrs (Fig 2.4c). Hence, I was able to conclude that in females 20HE 
through EcR induces an ISC autonomous mitotic phase early after exposure, and then 
induces an ISC-non-cell autonomous mitotic phase that requires signals from 
enteroblasts.  
Next, I wanted to check whether the kinetics of ISC response is similar to other pro-
mitotic stimuli in the intestine (supplementary fig 1c in 291), (supplementary fig 4292). 
Thus, I did a time course of SDS feeding and I scored the mitoses at 3 different time 
points (compare to Fig 2.2c). Mitotic count analyses revealed that SDS-induced mitoses 
are detected by 6hrs of feeding however, unlike 20HE, the mitoses are extended over the 
assayed different time points (Fig 2.4d) (compare to Fig 2.2c). Upon provoking the 
midgut with different mitotic stimuli i.e. P.e. infection, detergent-induced stress that 
cause ISC divisions, the dynamics of the ISC mitoses are relatively extended over a time 
period ranging from 6 hrs to 48 hrs. Unlike, 20HE feeding, which causes at least a 
biphasic response of ISC mitoses, a unique behavior of 20HE-fed ISCs.  
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Fig 2.4 20HE induces ISC mitoses in a bi-phasic manner. Text and images have been 
taken and modified from (Ahmed et al., 2020) and have been originally written and made 
by myself: (a) 20HE induces 2 successive waves of ISC division, the first at 6hrs and the 
second at 16hrs. ISC mitotic counts of control mated females fed with 5mM 20HE for 
different durations.  
(b) At 6hrs, male ISCs unlike female ISCs fail to divide upon 20HE feeding, however, at 
16hrs, both male and female ISCs are equally competent to divide in response to 20HE 
feeding. ISC mitotic counts of control males or mated females fed with 5mM 20HE for 
6hrs or 16hrs.  
(c) EcR is required in ISCs but not EBs during the 1st mitotic wave at 6hrs. However, 
EcR is required in both ISCs and EBs for the 2nd mitotic wave. ISC mitoses in midguts 
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expressing EcR
RNAi in progenitors (left) or enteroblasts (right) after 6 or 16hrs of 
exogenous 20HE feeding. RNAi was induced for 3 days before 20HE feeding. ISCs of 
control and EcR depleted enteroblasts divide at equal rates at 6 hrs. Midguts with EcR 
depleted enteroblasts have diminished ISC mitoses by 16hrs.  
(d) ISCs start dividing by 6 hrs and the ISC mitoses extend over a period of at least 12hrs. 
ISC mitotic counts of control mated females fed with 0.1% SDS feeding.  
(e) 20HE induces ISC mitoses briefly then mitoses return to basal levels, quantified by 
mitotic indices of male and female wildtype flies subjected to 2-day treatment regimes. 
ISC proliferation was restored to basal levels after 5mM 20HE was withdrawn, 
suggesting that 20HE’s actions are not detrimental. Male and female flies were fed 
vehicle or 20HE in different successions such that flies were exposed for 20hrs to the first 
treatment, then for another 24hrs to the second treatment. ISC mitoses returned to basal 
levels after 16-20hrs treatments with 20HE then vehicle.  
(f) 20HE-induced mitoses returns back to basal levels within 40hrs of feeding. Virgin 
females were fed with 5mM 20HE and ISC mitoses were scored after 40hrs. ISC mitoses 
stimulated at 16hrs of feeding (refer to Fig 2.14) subside to basal mitoses by 40hrs. 
Statistical tests performed by unpaired non-parametric two-tailed Mann-Whitney test (ns 
p>0.05, **p≤0.01,***p<0.001, ****p<0.0001). ♂: males. ♀: mated females.  
 
Stress stimuli such as bleomycin feeding or P.e. enteric infection are known to cause 
massive ISC divisions for at least 48hrs8,293. Injury stimulated expansion of ISCs such as 
combined bleomycin and heatshock treatments can recover back to basal levels, although 
not entirely after 72 hrs of recovery292. Hence, I asked whether 20HE similarly ISC 
mitoses. So, I fed the flies overnight with 20HE then removed it for another 16-18hrs 
after which I scored mitotic counts. The 20HE induced ISC mitoses quickly subsided and 
returned to basal levels similar to mock-fed males and females (Fig 2.4e). In a separate 
set of experiments, I subjected female virgins to 20HE for 40hrs (Fig 2.4f) during which 
the flies were constantly feeding on 20HE, yet the 20HE-induced ISC mitoses were very 
low and almost comparable to basal ISC mitoses. The former finding indicates that the 
20HE-mitotic effect is readily reversible while the latter finding supports the biphasic 
manner of 20HE-induced mitoses observed in Fig 2.4a. 
 
2.5.1-3 20HE induces ISC mitoses cell autonomously through EGF signaling and 
unpaired cytokines in the first peak then unpaired cytokines are required in EBs or 
ECs non-cell autonomously to induce ISCs mitoses in the second peak. 
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To find out how 20HE causes ISCs to divide, I first asked which targets are being 
transcriptionally upregulated after 20HE, then I tested several reporters of some critical 
pathways involved in stress-inducible ISC mitoses8,41. Finally, I continued to functionally 
deplete the targets via RNAi or whole body mutants when available. According to 
previous reports, stress-induced damage to the epithelium causes EGF ligands and  
unpaireds 2,3 (Jak-Stat) ligands production mainly from the ECs and to a lesser extent 
from the EBs that in a positive feedback loop stimulate compensatory ISC division294. In 
contrast, what I found is that the 20HE-induced ISC mitoses in the 1st wave at 6hrs 
initially require EGFR signaling and maybe upd2 from the ISCs. Then, 20HE feeding 
requires and regulates both upd2 in EBs and ECs and to a lesser extent upd3 in the 
progenitors for the 2nd wave of mitoses at 16-18hrs to occur (Fig 2.5.3c). When the cell 
cycle and the initial mitoses are halted, upd2 and upd3-transcriptional upregulation does 
not occur in response to 20HE feeding. The novelty of these described results is in that 
they support a model295 in which 20HE-induced ISC divisions is a primary not a 
secondary consequence of 20HE feeding.  
To obtain the findings described above, I started by measuring endogenous induction of 
some of the well-studied signaling pathway components of Egfr and Jak-Stat signaling at 
an early time point after 20HE feeding (coincides with the first mitotic phase) and I used 
enteric infection as a positive control. I found that while P.e. infection caused mild 
upregulation of vein, keren Egf ligands, rho the protease cleaving them, it caused a 
drastic upregulation of upd2, upd3 and Socs36E in infected whole midguts (Fig 2.5.1a)8. 
In contrast, 20HE caused a mild increase of keren, spi, rho, very slightly upd2 but, 
unchanged upd3 and Socs36E mRNA levels (Fig 2.5.1a). Thus, I deduced that 20HE at 
its first mitotic phase of 6 hrs-post feeding regulates Egf signaling. Next, I noticed a very 
mild induction of upd2 at 6hrs and I wondered how is Jak-Stat signaling regulated by 
EcR in response to 20HE feeding.  
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Fig 2.5.1 2nd mitotic wave of 20HE feeding regulates EGF and JAK-STAT signaling. 
Text and images have been taken and modified from (Ahmed et al., 2020) and have been 
originally written and made by myself: (a) 20HE transcriptionally induces rho and spi or 
krn EGF ligands, but very mildly induces unpaired ligands relative to infected controls. 
Mated females were fed with 20HE or P.e. bacteria for 6 hrs. Midguts were extracted and 
the mRNA levels were analyzed by qRT-PCR, normalized to β-tubulin. Expression is 
indicated as mean fold change relative to vehicle-treated midguts ± SD (n≥3).  
(b) Expression of rho, upd2 and STAT target Socs36E is transcriptionally upregulated 
through EcR in progenitors 16-18 hrs after 20HE feeding. Midguts were extracted and 
mRNA levels were analyzed by qRT-PCR, normalized to β-tubulin. Expression is 
indicated as mean fold change relative to vehicle-treated midguts ± SD (n≥3).  
(c) Expression of rho, upd2 and STAT target Socs36E is transcriptionally upregulated 
through EcR in enteroblasts 16-18 hrs after 20HE feeding. Midguts were extracted and 
mRNA levels were analyzed by qRT-PCR, normalized to β-tubulin. Expression is 
indicated as mean fold change relative to vehicle-treated midguts ± SD (n≥3).  
(d) EcRRNAi in enterocytes does not control the 20HE-induced transcriptional upregulation 
of rho, upd2 and Socs36E. Midguts were extracted and mRNA levels were analyzed by 
qRT-PCR, normalized to β-tubulin. Expression is indicated as mean fold change relative 
to vehicle-treated midguts ± SD (n≥3).  
(e) Reduced EGF signaling through EgfrRNAi in progenitors or cell cycle arrest via 
stringRNAi in progenitors blocks the 20HE-induced transcriptional upregulation of rho, 
upd2 and Socs36E. EFG signaling and cell cycle cell-autonomously control the 
subsequent induction of JAK-STAT signaling. Expression is indicated as mean fold 
change relative to vehicle-treated midguts ± SD (n≥3).  
(f) Representative images of the STAT92E-GFP reporter phenotypes on chromosome II 
or III. Reporter activation is grouped into 3 different categories. Category: GFP in ISCs 
only has GFP expression in single ISCs and is labeled dark green. Category: brighter GFP 
in progenitors has GFP expression in doublets and is labeled bright green. Category: GFP 
in many cells has GFP expression diffuse throughout most cells. GFP, in green; DAPI, in 
blue. Scale bar, 100 μm. 
 
The following experiments were all done at the time point that coincides with the 2nd 
mitotic phase of ISCs to 20HE feeding and it is the time point where I observed the most 
transcriptional induction of upd2. To investigate how EcR regulates Egf and Jak-Stat 
signaling components, I proceeded with cell-specific depletion of EcR (in progenitors, 
enteroblasts or enterocytes) and I measured transcriptional induction of the same targets I 
used earlier. 16 hours post feeding, 20HE caused rho, upd2, modest upd3 and Socs36E 
induction, which is dependent on EcR in progenitors (Fig 2.5.1b). Although, there was a 
mild increase in spi and keren ligands, it did not seem to be regulated through EcR in 
 
 
70 
progenitors. Enteroblast-specific EcRRNAi blocked the 20HE-induction of rho, upd2, upd3 
and Socs36E (Fig 2.5.1c). In contrast, enterocyte-specific EcRRNAi did not affect the 
20HE-induction of rho, upd3 at all, though there was a marginal decrease in upd2 and 
Socs36E. Moreover, it slightly impaired the modest increase of spi and keren transcripts 
(Fig 2.5.1d). In summary, EcR seems to regulate rho, upd2 upd3 and Socs36E in 
progenitors, partly through enteroblasts while EcR in enterocytes seems to regulate Egf 
ligands after 16-18 hrs of 20HE feeding. Next to investigate whether EC- or EB-
dependent upregulation of upd2 was a secondary consequence of ISC division. To test 
this hypothesis, I first blocked ISC mitoses using an RNAi against String (stg), a Cdc25 
homolog required for all somatic cell mitoses in Drosophila296. Alternatively, I blocked 
ISC reception of EGF ligand by EgfrRNAi in progenitors. Progenitor-specific EgfrRNAi or 
stringRNAi almost completely blocks the inductive peaks of rho, upd2, upd3 and Socs36E 
caused by EBs and ECs. This result argues that the ISC autonomous division is what 
consequently drives the non-cell autonomous inductive peaks of rho and upd2 (Fig 
2.5.1e). Afterwards, I proceeded to validate the qPCR results by examining the 
expression of Jak-Stat pathway activation reporter after 20HE feeding in the different cell 
types of the posterior midgut. 10×Stat92E-GFP is a GFP reporter with 10 copies of 
STAT-binding sites at the promoter, which serves as a reliable marker for STAT92E 
activation in vivo297. Fig 2.5.1f shows example images of the categories of Jak-Stat 
activity, with GFP signal localized in mostly single cells (basal), in many pairs 
(moderate) or in all cells (strong). Under basal conditions, I found the Stat92E reporter to 
be active in mostly single cells and to a lesser extent in doublets. After 6 hrs of 20HE 
feeding, activity of the reporter was more diffuse, in doublets or small clusters (Fig 
2.5.2a). In contrast, 18 hrs after 20HE feeding, Stat92E activity varied from moderate to 
strong depending on the reporter’s genetic background. However, the 20HE-induced 
reporter’s activity was much weaker in comparison to the strong reporter activity induced 
by P.e., observed in all infected guts (Fig 2.5.2b).  
I also tested the upd3-lacZ reporter, a lacZ enhancer trap of upd3, which shows 
expression of β-galactosidase in the epithelial cells producing upd3298. I found the upd3-
lacZ reporter to be unchanged after 20HE feeding relative to its strong activity in cell  
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Fig 2.5.2 Upd2, rho and Egfr are required in progenitors for 20HE-induced mitoses. 
Text and images have been taken and modified from (Ahmed et al., 2020) and have been 
originally written and made by myself: (a) Under homeostatic conditions, the reporter 
expresses GFP mostly in ISCs alone (dark green bar). By 6 hrs of 20HE feeding, GFP is 
localized in midgut progenitors all over the gut (bright green bar). 18% of the guts that 
express the reporter on chromosome II show a slight accumulation of GFP in other cells 
upon 20HE feeding, but the GFP signal was not as strong as in the category “GFP in 
many cells”. Phenotypes were scored in the R4 region. Bright green bars denote a milder 
activation pattern while dark green bars denote no activation of the reporter. 5-7 days old 
mated females were used for the experiment. 
(b) 20HE feeding induces STAT92E-GFP reporter activity much slighter than does P.e. 
infection. Frequency of phenotype occurrence is analyzed based on the categories of 
activity in panel f. Under homeostatic conditions, the reporter expresses GFP only in 
ISCs (dark green bar). 16 hrs after 20HE feeding, most midguts of the reporter on 
chromosome II have GFP localized in many midgut cells including polyploid enterocytes 
(purple bar). However, most midguts of the reporter on chromosome III have GFP 
localized in the midgut progenitors (bright green bar). In contrast, P.e. infected midguts 
of the reporters on either chromosome exhibited a strong uniform activation pattern in all 
midgut cells of the R4 region. % Frequency of phenotype was plotted in reference to 
phenotypes observed in the R4 region. Purple bars denote the strongest activation pattern; 
bright green bars denote a milder activation pattern while dark green bars denote no 
activation of the reporter. 5-7 days old mated females were used for the experiment. 
(c) Upd3-lacZ reporter is not activated by 20HE feeding. Images of the R4 region of the 
midgut showing basal expression of the upd3 reporter in vehicle fed flies relative to 
strong activation of the reporter upon P.e. infection. In contrast, 16hrs of 20HE feeding 
did not appreciably activate the upd3 reporter. This data indicates that 20HE does not 
primarily activate upd3 to promote ISC mitoses in the midgut. 5-7 days old mated 
females were used for the experiment. All images were acquired at the same settings and 
the intensities of activation are accurately represented.  
(d) Number of mitoses in control and progenitor-specific downregulation of upd2, upd2, 
upd3, Egfr or rho for 8 days. Flies were exposed to exogenous 20HE feeding for 16 hrs. 
upd2, upd3, Egfr and rho from progenitors are required for the 20HE-induced ISC 
mitoses. 
(e) Number of mitoses in control and enteroblast-specific downregulation of upd2, upd2, 
upd3 or rho for 8 days. Flies were exposed to exogenous 20HE feeding for 16 hrs. upd2, 
upd3 and rho from enteroblasts are required for the 20HE-induced ISC mitoses. 
(f) Number of mitoses in control and enterocyte-specific downregulation of upd2, upd2, 
upd3 or rho for 8 days. Flies were exposed to exogenous 20HE feeding for 16 hrs. upd2 
but not upd3, rho from enterocytes are required for the 20HE-induced ISC mitoses. 
(g) Midgut mitotic counts of upd2Δ, upd3Δ, upd2,3Δ whole body mutants and control 
flies after 6 or 16hrs of 20HE feeding and 16hrs of P.e. infection. ISCs of upd2Δ and 
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upd2,3Δ mutants can divide yet, to a weaker extent relative to controls in response to the 
1st wave of ISC mitoses at 6 hrs. ISCs of upd3Δ mutants show a minimal defect in ISC 
division at the 2nd wave of 20HE induced mitoses however ISCs of upd2Δ and upd2,3Δ 
are unable to divide at the 2nd mitotic wave of 20HE feeding. upd2Δ and upd2,3Δ cannot 
divide after P.e. infection. Thus, chiefly upd2 and marginally upd3 are required for ISC 
activation the 2nd mitotic wave of 20HE-mitoses while both are additively required for 
P.e. infection.  
(h) Number of mitoses in control and progenitor-specific downregulation of Egfr or rho 
for 8 days. Flies were exposed to exogenous 20HE feeding for 6 hrs. Egfr and rho from 
progenitors are required for the 20HE-induced ISC mitoses. 
(i) Number of mitoses in control and enteroblast-specific downregulation of rho for 8 
days. Flies were exposed to exogenous 20HE feeding for 6 hrs. rho from enteroblasts is 
required to a lesser extent for the 20HE-induced ISC mitoses. Error bars represent ± SD. 
Statistical analysis was performed using unpaired non-parametric two-tailed Mann-
Whitney test (ns p>0.05, **p≤0.01,****p<0.0001). LacZ, in red; DAPI, in blue. Scale 
bar, 100 μm. 
 
clusters after P.e. infection (Fig 2.5.2c). These reporter data are consistent with the qPCR 
data, which suggest the mild activation of upd3-Jak-Stat signaling induced by 20HE 
feeding.  
To validate the functional involvement of the pathway components I tested above, I 
proceeded with depleting them with the cell-specific drivers and scored 20HE-induced 
mitoses. Consistent with the qPCR results, RNAi-mediated progenitor specific depletion 
of upd2 alone, upd2 upd3, rho or EGFR suppresses the 20HE-mediated mitotic response 
(Fig 2.5.2d). 
As I observed earlier that EcR in progenitors and to a lesser extent in ECs regulate Jak-
Stat and EGF signaling components, I sought to deplete upd2, upd3 and rho in 
progenitors to examine if they are required for 20HE-induced ISC mitoses. EB-specific 
depletion of upd2 alone, upd2 upd3 or rho severely compromised the mitotic response to 
20HE feeding (Fig 2.5.2e). Consistent with the qPCR data, upd3 and rho were not 
required in ECs for 20HE-mediated ISC divisions. However, EC-specific depletion of 
upd2 or upd2,upd3 prevented the ISCs from dividing after 20HE feeding (Fig 2.5.2f). 
This effect could be due to the RNAi perduring to the young newly born ECs as a result 
of the rapid 20HE-mediated divisions.  
 
 
74 
By now, I had identified that mainly upd2 is required in progenitors including EBs as 
well as ECs for the 20HE-induced ISC mitoses. To further corroborate the role of 20HE-
induced upd2-Jak-Stat signaling in the midgut, I used single whole body mutants for 
upd2, upd3 or the double mutant upd2,3 which I fed with 20HE for 6hrs (1st peak), 16hrs 
(2nd peak) and I used enteric P.e. infection as a positive control that absolutely requires 
upd2 and upd3 in an additive manner for the regenerative P.e.–induced ISC mitoses299. 
At the 1st mitotic peak after 20HE feeding, ISCs of the mutant backgrounds upd2Δ or 
upd2,3Δ were competently dividing in response to 20HE feeding, albeit at lower levels 
relative to control midguts. However, at the 2nd mitotic wave, ISCs of upd2Δ or upd2,3Δ 
flies barely divided (Fig 2.5.2g). upd3Δ ISCs showed some defect in their response to 
20HE feeding, indicating the marginal significance of upd3 in 20HE-induced mitoses. 
Relative to 20HE mitotic stimulus, ISCs of upd2Δ are moderately impaired in their P.e.-
induced mitoses (Fig 2.5.2g), which shows the specificity of the differential requirement 
of upd2 for 20HE divisions.  
Then owing to the transcriptional peak of EGF ligands I observed 6 hrs after 20HE 
feeding, I hypothesized that active EGF signaling in progenitors would contribute to the 
latter effect. To examine this, I depleted EGF signaling in progenitors through Egfr-RNAi 
or rho-RNAi, which caused a complete suppression of ISC mitoses after 20HE feeding 
(Fig 2.5.2h). Nevertheless, active EGF signaling was marginally required from EBs 
specifically to provide active EGF ligands, suggesting that majorly ISC cell-autonomous 
EGF is sufficient to sustain 20HE-induced mitoses at 6 hrs (Fig 2.5.2i). The EGFR 
activity readout, diphospho-ERK (dpERK), was also mildly activated by 20HE after 
16hrs, mostly in progenitors but occasionally in ECs19. Consistent with this result, EGF 
signaling through EGFR or rho from progenitors and mainly ISCs, but not ECs is 
indispensible to the 20HE-induced mitoses. Furthermore, Erk activation in response to 
the 20HE-induced mitoses requires upd2 in the midgut cells (Fig 2.5.3a,b). Collectively, 
mostly upd2 and to a lesser extent upd3 are required for 20HE-induced mitoses possibly 
relaying signals for EGFR activation. 
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Fig 2.5.3 20HE feeding activates dpErk in an-upd2 dependent fashion. Text and 
images have been taken and modified from (Ahmed et al., 2020) and have been originally 
written and made by myself: (a-b) 20HE feeding increases dpErk activity in progenitors. 
(a) Representative images of Erk activity showing the most prevalent phenotype for each 
condition, assayed as (diphospho-Erk) dpErk after 20HE feeding or enteric infection. (b) 
Quantifications of dpErk staining. Under non-stressed conditions, dpErk is present either 
in very few ECs per gut, or in progenitor cells and very few ECs. Upon enteric infection, 
dpErk is substantially increased mainly in ECs. Although 20HE feeding also induces 
dpErk in midguts, the pattern is distinct from the one caused by enteric infection. Upon 
20HE feeding, dpErk in mainly visible in progenitors and young ECs, and the signal is 
often localized to small patches of cells. In contrast, P.e. infection induces strong dpErk 
broadly throughout the gut. dpErk is absent in non-stressed upd2 or upd2,3 mutants. 
Enteric infection induces dpErk also in upd2 or upd2,3 mutants, albeit to a lower level 
than wildtype flies. In contrast, upd2 or upd2,3 mutants show very little or no dpErk upon 
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20HE feeding. 5-8 days old mated females were used for the experiment. Representative 
images are shown. dpErk, in red. Scale bar, 100 μm. 
(c) A model summarizing the cell-type specific supply of Jak-Stat and EGF ligands after 
20HE feeding. ON denotes cells with active 20HE EcR signaling. ISCs and to a lesser 
extent EBs have active rho signaling. ISCs produce their EGF ligands to stimulate cell-
autonomous divisions. EBs and ECs produce mainly upd2, and EBs only produce much 
less upd3 ligands that are required for 20HE induced mitoses. ECs do not seem to require 
active rho signaling though some EGF ligand induction is regulated by the ECs. Whether 
ISCs cell-autonomously produce upd2 and upd3 or not remains an open question, 
although the data presented in Fig 2.7.1e supports this possibility.  
 
2.6. Sexually dimorphic 20HE levels lead to increased ISC divisions and midgut 
growth in males or virgins. 
 
Male ISCs divide less strongly than female ISCs in response to any mitotic stimulus118. 
This coincides with the females having more abundant expression of transcripts related to 
cell cycle processes in the midgut and more female ISCs in G2/S-phase, suggestive of 
sex-biased differences in ISC mitoses, that are partly dependent on the intrinsic ISC 
identity118. Consistent with this idea, feminizing the male ISCs by expressing a 
feminizing variant of transformer, traF, in male progenitors increased stress-induced ISC 
mitoses118. However, under non-stressed conditions, feminized male ISCs did not divide 
any more than control male ISCs118. In parallel, mated females produce more ecdysone 
than virgin females or males300-302. Thus, I was intrigued to examine whether the 
dimorphic circulating ecdysone levels between males and mated females regulates sex-
specific differences in the intestinal stem cell divisions. Congruous with this notion, 
raising males on 1mM 20HE-laced food for 2 weeks increased male ISC mitoses, 
accelerated epithelial turnover, and increased midgut size (Fig 2.6a-b, c-d). 20HE also 
promoted male ISC proliferation on a low protein diet (Fig 2.6e), implying that it 
enhances ISC proliferation independently of protein or nutrient availability. Of note, no 
other stimulus is reported to similarly affect male ISC mitoses or illicit gut growth8,118,303. 
In order to figure out if the 20HE-dependent gut growth acts in part via the sex 
determination pathway, I overexpressed a feminizing variant of transformer, traF, in male 
progenitors (Fig 2.6d), which failed to drive midgut growth.  
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Fig 2.6: Prolonged 20HE feeding abrogates the sex differences in ISC division. Text 
and images have been taken and modified from (Ahmed et al., 2020) and have been 
originally written and made by myself: (a-b) (a) Representative images of the ISC lineage 
tracing: esgF/Ots in both sexes after 14 days of feeding with low 20HE doses. 20HE 
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feeding promotes ISC clonal growth and gut epithelial renewal. 1mM 20HE feeding 
stimulates epithelial turnover more rapidly in males than females.  
(b) 20HE induces an atypical boost in male ISC mitoses. Mitotic counts of control flies 
fed on 20HE-laced food relative to age-matched controls. At homeostatic conditions, 
vehicle-fed females divide at much-elevated rates than vehicle-fed males. However, 
dietary supplementation of 1mM 20HE in fly food caused male ISCs to divide 
dramatically, matching basal ISC mitoses in females. 
(c-d) Male midguts with traF-feminized progenitors are unable to grow. Similarly, male 
midguts overexpressing secreted spitz (Sspi) in progenitors are unable to grow. (c) 
Representative brightfield images of vehicle-fed or 20HE-fed males, 14 days after 
feeding showing that 20HE-fed males grow in length and area. (d) Long term 20HE 
feeding causes male-specific midgut growth, a unique phenotype to males. Midgut areas 
of vehicle-fed or 20HE-fed males relative to genetically manipulated males.  
 (e) 20HE causes a strong increase in male ISC divisions on a nutrient-deprived diet. 
Mitoses of control flies fed on 20HE-laced low yeast high sugar diet relative to age-
matched controls. At homeostatic conditions, more vehicle-fed female ISCs divide than 
ISCs of vehicle-fed males. However, 20HE-fed males had a strong increase in their 
mitotic index compared to vehicle-fed males. 
(f) 20HE triggers midgut growth independent of EcR in ECs. Raising males on prolonged 
20HE-laced diet causes 20HE-dependent midgut growth in midguts with EcR depleted 
ECs. This suggests that EcR in ECs is not required for the 20HE-induced midgut growth 
and implies that EcR in progenitors is sufficient to elicit 20HE-dependent midgut growth. 
(g) 20HE promotes ISC mitoses in P.e. infected males, altering their behavior to resemble 
P.e.-induced ISC division in females, as assayed by mitotic counts of males and females. 
Flies were raised on 20HE or vehicle-supplemented food for 12 days then the treatment 
was withdrawn overnight followed by P.e. infection for 20hrs. Male ISCs that were 
20HE-fed were able to respond to P.e. infection at similar rates to the age-controlled 
females fed on 20HE or vehicle. 
(h-i) Long-term 20HE-supplemented virgins have an accelerated midgut turnover in 
comparison to age-controlled virgins. Age-controlled virgins have infrequently dividing 
ISCs. (h) Representative images of control progenitors in virgins raised on vehicle or 
20HE-laced food for 14 days. 20HE-fed virgins have accumulated GFP+ progenitors 
across the intestinal epithelium. (i) ISC mitotic counts show increased ISC mitoses of 
20HE fed virgins relative to vehicle-fed virgins. 20HE fed virgins resemble the basal 
mitotic behavior of aged mated females. 
(j) Midgut lengths of control males, vehicle and 20HE-fed or virgins with ecdysone-
depleted ovaries via dibRNAi or control virgins showing the plasticity of male and female 
midgut growth to circulating 20HE levels. Virgins with dibRNAi have much shorter gut 
length than control virgins. 20HE-fed males have a longer gut length than vehicle-fed 
males. Error bars represent ± SD. Statistical analysis was performed using one-way 
ANOVA, followed by Bonferroni’s multiple comparisons test and unpaired non-
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parametric two-tailed Mann-Whitney test (ns p>0.05, *** p≤ 0.001, ****p<0.0001). ♀ 
refers to mated females. ☿ refers to virgins. ♂: males. Representative images are shown.  
 
Similarly, if a boost in pro-mitotic factors are sufficient to induce midgut growth, then 
expression of sSpi, a potent ISC mitogen19 would be sufficient to enlarge the male 
midgut. However, sSpi-overexpressing progenitors had no difference in their gut sizes 
similar to control males (Fig 2.6d). This result implied that 20HE does more than simply 
triggering ISC mitoses.  
Finally, since the gut’s densest populations (numbers/total cells) are enterocytes followed 
by progenitors (ISCs+enteroblasts)291, I asked whether enterocytes contribute to the 
20HE-induced male midgut growth. Hence, I induced enterocyte-specific depletion of 
EcR in males and fed the males with 1mM 20HE for 14 days only to find that the 20HE-
fed midguts were still able to grow. This result indicates that progenitors are sufficient to 
elicit 20HE-induced midgut growth (Fig 2.6f). Another sex difference between males and 
females is that female ISCs proliferate more strongly upon enteric infection than male 
ISCs41,118 (Fig 2.1.1a). Hence, I sought to test whether 20HE feeding would sensitize 
more male ISCs to divide in response to stress. Indeed, pre-feeding males with 20HE 
potentiated their ISC proliferative response to levels similar to those in females (Fig 
2.6g). Likewise, long-term 20HE feeding caused virgin female ISCs to proliferate under 
basal conditions similar to basal counts of ISCs mitoses in mated females (Fig 2.6h,i). In 
contrast, reduced ovarian-ecdysteroids (Fig 2.6j) or intestinal EcR signaling in midgut 
progenitors led to reduced midgut sizes (Fig 2.6j). In summary, my results show that 
sexually dimorphic aspects of ISC proliferative behavior as well as gut sizing are 
determined in part by 20HE levels. 
 
2.7 1-6 Prolonged 20HE feeding in males causes a change in the ISC metabolic 
signature. 
 
Since there are no preceding reports of sex steroid feeding causing non-sex organ growth, 
I was intrigued to figure out how in this case ecdysone elicits the male-specific intestinal 
growth. To answer this question, I focused on the genetic changes that could be attributed 
to the gain-of-function phenotype, caused by exogenous 20HE feeding in males. Hence, I 
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fed both control males and females with 20HE or vehicle for 14 days in the background 
of mira-GFP (which marks only the ISCs) then I FACS-sorted the ISCs and sequenced 
the transcriptome of the sorted ISCs and aligned the single reads with STAR aligner (Fig 
2.7.1a-d). I have aligned the reads using the Drosophila transcriptome as a reference and 
with built-in gene model with splice junction information, to detect isoform abundance. 
Firstly, the abundance of normalized transcript reads/sample shows that Oatp74D: the 
ecdysone transporter was indeed expressed in the ISCs304 and it is slightly higher 
expressed in males than females. Moreover, EcR variant A and the Eip75B variant C 
(used for overexpression in later sections of this thesis) are indeed the major variants 
expressed in the ISCs of the midgut (Fig 2.7.1a-b). It is interesting to note that there are 
several Eip75B isoforms expressed in the ISCs, all of which are ecdysone-inducible in 
males (Fig 2.7.1b). Br isoforms are much less abundant than Eip75B (Fig 2.7.1c). One 
predominant isoform variant B is normally expressed at higher levels in males and is 
induced after 20HE feeding. Components of Egf signaling such as rho, the ligands-
cleaving protease, Spitz, Keren and Vein are also present in sorted ISCs of both males 
and females though do not appear to be significantly changed after 20HE feeding 
consistent with the result in (Fig 2.6d) which showed that enforced spi expression is 
insufficient to elicit the 20HE-induced midgut growth (Fig 2.7.1d). Similarly, my results 
confirmed that upd2 and upd3 are expressed in the sorted ISCs, though at lower levels in 
males (Fig 2.7.1e) and Stat92E, the transcriptional activator of the Jak/Stat pathway was 
expressed at slightly higher levels in males relative to females consistent with the higher 
reporter activity also observed in males305. 20HE caused upd2 and upd3 transcriptional 
upregulation in ISCs, better seen in the male samples. Alternatively, a negative regulator 
of Jak/Stat signaling Heix, a tumor suppressor gene306, with unexplored functions in the 
midgut is transcriptionally inhibited by 20HE feeding in both males and females (Fig 
2.7.1e).  
As previously reported, genes with sex differences in expression are enriched for distinct 
biological processes; genes assigned to cell cycle-related processes, lipid and fatty acid 
metabolism were upregulated in females (Table 2.1b,c,d), whereas genes coding for 
proteins that function in MAPK, Wnt pathways, carbohydrate metabolism and 
glutathione oxidoreductive processes are preferentially expressed in males ISCs (Table 
2.2a,e,f), (Fig 2.7.2a-b)118. 
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Fig 2.7.1: 20HE feeding transcriptionally upregulates ecdysone-inducible genes, 
Jak/Stat and EGF ligands. (a) EcR A and Oatp74D are expressed in Drosophila ISCs. 
Normalized transcript reads of the ecdysone transporter Oatp74D and EcR variants 
outputted after STAR alignment to reflect transcript abundance in GFP sorted ISCs of 
both females and males +/- exogenous 20HE feeding.  
(b) Eip75B variant D is predominantly expressed in Drosophila ISCs yet, all Eip75B 
variants are induced in 20HE-fed males. Normalized transcript reads of the ecdysone-
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inducible Eip75B outputted after STAR alignment to reflect transcript abundance in GFP 
sorted ISCs of both females and males +/- exogenous 20HE feeding.  
(c) Br variant B is predominantly expressed in male Drosophila ISCs yet, br variants 
B,L,O,I are mildly induced in 20HE-fed males. Normalized transcript reads of the 
ecdysone-inducible br outputted after STAR alignment to reflect transcript abundance in 
GFP sorted ISCs of both females and males +/- exogenous 20HE feeding.  
(d) Egf signaling pathway components are relatively unchanged by long term 20HE 
feeding. Normalized transcript reads of rho variants, spi, krn and vn (latter are 3 EFG 
ligands) outputted after STAR alignment to reflect transcript abundance in GFP sorted 
ISCs of both females and males +/- exogenous 20HE feeding.  
(e) Upd2 and upd3 are expressed at higher levels in females relative to males. 
Downstream target Stat92E is expressed at slightly higher levels in males relative to 
females. Normalized transcript reads of Jak/Stat signaling pathway components outputted 
after STAR alignment to reflect transcript abundance in GFP sorted ISCs of both females 
and males +/- exogenous 20HE feeding.  
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Fig 2.7.2 Sex-biased differential gene expression between vehicle fed males and 
females. (a) Volcano plot of differentially expressed genes between vehicle-fed female to 
vehicle-fed male sorted ISCs with some annotated hits to complement Table 2.1 
(b) An interactive map outputted by Gorilla tool of GO terms that are enriched between 
vehicle-fed females/vehicle-fed males at p-value threshold of 10-3. Yellow-colored terms 
are presented by p-value 10-3 to 10-5 and orange-colored terms are presented by p value: 
10-5 to 10-7. A short table is presented below with the 'FDR q-value' , which is the 
correction of the above p-value for multiple testing using the Benjamini and Hochberg 
method. 
 
Males exposed to 20HE for a longtime have elevated string and png (positive regulators 
of the mitotic cell cycle) levels as well as a highly abundant metabolic signature 
associated with starch, aminoacid derivatives and lipid metabolism in their ISCs (Fig 
2.7.3a,d). This enrichment in metabolic hits reflects an upgrade in the metabolic capacity 
of the 20HE-fed males, possibly to satisfy increasing tissue homeostatic needs (Fig 
2.7.3a,d), (Table 2.2ab,d-g). Positively enriched metabolic signature of lipid and 
carbohydrate processing in 20HE-fed males is also consistent with the sexually dimorphic 
role of 20HE in promoting triglyceride and glycogen uptake in fertilized females123.  
Next, a previous report determined the presence of sex-biased expression of different 
genes in the Drosophila midgut118. Those genes were inherently different in their 
expression levels between males and females such that it is highly expressed in one sex 
and is inversely expressed in the other sex. Interestingly, differential analysis of the 
sorted 20HE-fed male ISCs showed an enhanced expression of a subset of those sexually 
dimorphic genes (75 hits in the ISCs from 826 hits detected in the ISC transcriptome or 
1305 hits from all cell types in whole midguts) (Fig 2.7.3b,c), (Table 2.2c). Those genes 
showed a striking upregulation in their expression relative to control males. The colored 
genes in the volcano plot were hits with identified metabolic function, yet the functions of 
the rest remain uncharacterized (Fig 2.7.3b,c).  
Next, as a control for the male effects, I examined how 20HE affects females. Despite not 
having obvious differences on ISC proliferation in females (refer to Fig 2.6a-b), 20HE 
feeding still affected several aspects of the transcriptome of the sorted female ISCs. 20HE 
caused a strong positive enrichment for regulation of immune response modulators, 
antimicrobial peptide production consistent with previous reports of how ecdysone- 
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inducible transcriptional networks controls the IMD immune response in Drosophila307,308 
(Fig 2.7.4a). 
20HE feeding also correlated with positive histone acetylation of H2 and H4 but a 
strongly downregulated enrichment in carbohydrate metabolizing genes (Fig 2.7.4a) 
(Table 2.3,a,b,d-g).  
 
 
86 
 
 
Fig 2.7.3 20HE feeding alters the metabolic transcriptome of males.  
(a) Volcano plot of differentially expressed genes between 20HE-fed males to vehicle-fed 
male sorted ISCs with some annotated hits to complement Table 2.2. 
(b) Volcano plot of genes that are the sexually dimorphic between males and females but 
are revealed to be regulated by 20HE feeding in males. The annotated hits in purple are 
hits of known metabolic function. These hits complement Table 2.2c. 
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(c) An interactive map outputted by Gorilla tool of GO terms that sexually dimorphic 
between males and females yet, are upregulated between ecdysone-fed males/vehicle-fed 
males at p-value threshold of 10-3. Yellow-colored terms are presented by p-value 10-3 to 
10-5 A short table is presented below with the 'FDR q-value' , which is the correction of 
the above p-value for multiple testing using the Benjamini and Hochberg method. 
 
(d) An interactive map outputted by Gorilla tool of GO terms that are upregulated 
between ecdysone-fed males/vehicle-fed males at p-value threshold of 10-3. Yellow-
colored terms are presented by p-value 10-3 to 10-5 A short table is presented below with 
the 'FDR q-value' , which is the correction of the above p-value for multiple testing using 
the Benjamini and Hochberg method. 
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Strikingly, another subset of the aforementioned sexually dimorphic genes118 were 
downregulated (n=62) and upregulated (n=9) in vehicle-fed females relative to 20HE-fed 
females (Table 2.3c), suggesting the high plasticity of the ISCs to adapt to increased 
levels of 20HE, though the number of replicates (n=2 vs 3 for females vs male samples) 
was quite low and the statistical significance was not as robust as in the male samples. 
This data suggests the presence of a subset of sexually dimorphic genes within ISCs that 
are regulated by 20HE feeding, implying that in part the circulating levels of the sex 
hormones could function to maintain the identity of the intrinsic sex of the cells, partly 
through metabolic changes. 
 
RNA seq analyses showed an increased abundance of fatty acid metabolic, carboxylic 
acid genes and DNA replication/cell cycle related processes in vehicle fed females 
relative to 20HE-fed males (Table 2.4a,f-g,i). 20HE-fed males have upregulated hits 
associated with improved carbohydrate metabolism, increased receptor tyrosine kinase, 
insulin receptor signaling, formation of piwi RNAs and notch processing (Fig 2.7.5a-c) 
(Table 2.4b,d,e). Intriguingly, among the gene candidates that is highly expressed in 
20HE-fed males relative to vehicle-fed females is lin-28. Lin-28 is highly enriched in the 
ISCs and it positively regulates insulin signaling, promotes symmetric ISC divisions and 
mediates gut growth in response to nutrients309. This candidate provides an interesting 
link between ISC symmetric divisions and insulin signaling that could explain the 
underlying boost of metabolic functions and subsequent gut growth. 
 Since it is known that the levels of 20HE are sexually dimorphic, I asked if this would 
also affect the underlying gene regulation between males and females. Fig 2.7.6a shows a 
correlation plot of normalized reads to ecdysone feeding between males and females that 
shows an inverse correlation between the presence of ecdysone and the abundance of the 
transcript. Transcripts skewed to the right bottom are enriched in females and diminished 
in males and are dependent on 20HE. While transcripts skewed to the upper left quadrant 
are highly abundant in males but lack in females and are 20HE dependent. Similarly, Fig 
2.7.6b (left) shows a correlation plot of normalized reads to ecdysone feeding in males 
relative to normalized reads between vehicle-fed males and females. Transcripts skewed 
to the upper left are of higher levels in 20HE-fed males relative to vehicle-fed males and 
are also higher in vehicle-fed females relative to vehicle-fed males.  
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Fig 2.7.4 20HE feeding alters the metabolic transcriptome of females.  
(a) Volcano plot of differentially expressed genes between 20HE-fed females to vehicle-
fed female sorted ISCs with some annotated hits to complement Table 2.3. 
 
While transcripts skewed to right bottom of the plot are more abundant in vehicle-fed 
males relative to vehicle-fed females but, downregulated by 20HE feeding in males. This 
distribution is strongly dependent on 20HE, hence revealing a sexually dimorphic pattern 
in the gene expression between males and females.   
Then, I explored if and which subsets of genes would be similar between females with 
physiological levels of 20HE and males with supra-physiological levels of exogenous 
20HE. I reasoned that the subset of genes that would be equalized by exogenous 20HE 
feeding in males would be one of the underlying reasons for the unique sexually 
dimorphic 20HE-induced ISC mitoses and subsequent midgut growth. Accordingly, I 
searched for the list of hits that satisfy the criteria of being sex-biased differentially 
expressed between control males and females yet at the same time were equalized to or 
surpassed female levels by 20HE feeding (Fig 2.6.b (right)).   
Table 2.4ci-ii,h shows the list of these hits and their GO or pathway enrichment terms. 
20HE availability seems to correlate with many metabolic aspects as well as regulation of 
the cell cycle (Fig 2.7.6c-d). 
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Fig 2.7.5: 20HE feeding upregulates metabolic hits in the ISC transcriptome of 
20HE-fed males relative to control females. (a) Volcano plot of differentially expressed 
genes between vehicle-fed female to 20HE-fed male sorted ISCs with some annotated 
hits to complement Table 2.4. 
(b) An interactive map outputted by Gorilla tool of GO terms that are enriched between 
20HE-fed males/vehicle-fed females at p-value threshold of 10-3. Yellow-colored terms 
are presented by p-value 10-3 to 10-5 and orange-colored terms are presented by p value: 
10-5 to 10-7. A short table is presented below with the 'FDR q-value', which is the 
correction of the above p-value for multiple testing using the Benjamini and Hochberg 
method. 
(c) An interactive map outputted by Gorilla tool of GO terms that are enriched between 
vehicle-fed females /20HE-fed males at p-value threshold of 10-3. Yellow-colored terms 
are presented by p-value 10-3 to 10-5 and orange-colored terms are presented by p value: 
10-5 to 10-7. A short table is presented below with the 'FDR q-value', which is the 
correction of the above p-value for multiple testing using the Benjamini and Hochberg 
method. 
 
Collectively, this experiment reveals the novelty of a sex steroid maybe partly adjusting 
the metabolism and cell cycle independent of the intrinsic genetic landscape of cells 
within non-sex organs, a hypothesis that remains highly unexplored and should prove 
interesting for future studies. As shortly presented in the introduction and discussed 
further, understanding how sex steroids act as signaling relays from sex organs to other 
non-sex organs would help us understand the physiological effects of sex hormones and 
evaluate their outcome on disease risk, prognosis and treatment efficacy310. 
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Fig 2.7.6: 20HE feeding normalizes metabolic and cell cycle hits in the ISC 
transcriptome of 20HE-fed males. (a) LC scatter plot showing the correlation between 2 
variables: ecdysone and the fly sex. Females or males were normalized as follows: log 
values of 20HE-fed samples/ vehicle-fed samples for each gender. Ratio higher than 1 are 
genes that are transcriptionally induced by 20HE feeding. The left upper quadrant shows 
the proportion of genes that are inversely correlated between “being male” and 20HE 
feeding. Highly abundant transcripts in this quadrant are specific to 20HE-fed males and 
are extremely low in 20HE-fed females. The lower right quadrant shows that the majority 
of the genes cluster together which suggests that the exogenous 20HE feeding does not 
correlate with “being female”. This negative correlation between the “male” sex and 
20HE presence suggests that a decrease of 20HE was correlated with an increase in the 
abundance of male-specific genes. 
(b) (left) LC scatter plot showing the correlation between 2 variables: ecdysone feeding in 
males and genes that are different between the females and males. Females or males were 
normalized as follows: ratio of normalized reads of 20HE-fed samples/ vehicle-fed samples 
relative to ratio of normalized reads of vehicle-fed male/ vehicle-fed female. Axes are in 
log scale. The left upper quadrant shows the proportion of genes that are regulated by 
20HE feeding in males and are low expressed in females. The lower right quadrant shows 
genes that are highly abundant in males but downregulated by 20HE feeding. (right) The 
log2 values from EdgeR are shown for the subset of genes from Table 2.4cii. R2 is 
0.6402. 
(c) An interactive map outputted by Gorilla tool of GO terms that are differentially 
expressed between males and females but are rather unchanged between vehicle-fed 
females and 20HE-fed males at p-value threshold of 10-3. Yellow-colored terms are 
presented by p-value 10-3 to 10-5, orange-colored terms are presented by p value: 10-5 to 
10-7 and red-colored terms are presented by p value:10-7 to 10-9. A short table is presented 
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below with the 'FDR q-value', which is the correction of the above p-value for multiple 
testing using the Benjamini and Hochberg method. 
(d) An interactive map outputted by Gorilla tool of GO terms that are differentially 
expressed between males and females but are rather unchanged between vehicle-fed 
females and 20HE-fed males at p-value threshold of 10-3. Yellow-colored terms are 
presented by p-value 10-3 to 10-5 and orange-colored terms are presented by p value: 10-5 
to 10-7. A short table is presented below with the 'FDR q-value', which is the correction of 
the above p-value for multiple testing using the Benjamini and Hochberg method. 
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2.8.1-2 Intestinal EcR signaling regulates post-mating ISC mitoses in the female 
midguts. 
The consequence of 20HE feeding on ISC divisions and gut growth begged the question 
of whether those exogenous feeding effects could have any physiological relevance? 
Mated females have much higher ecdysteroid levels than virgin females or males301 and 
the endogenous ecdysone is mainly produced by the ovaries153. Total ecdysteroid levels 
almost doubles only 24 hours after mating302. Thus, I sought to mate the flies for different 
durations and assay the actively dividing ISC divisions as a consequence of mating. It has 
been reported that 3 days post mating, flies experience an increase in the number and 
diameter of their enterocytes accompanied with a very modest increase in ISC 
divisions311. Hence, I mated female virgins and checked the ISC mitoses 2 and 3 days 
post-mating. Indeed, mating induced a transient, yet, massive increase in ISC 
proliferation (Fig 2.8.1a), expansion of gut progenitors and consequently an enlarged gut 
size across the whole midgut (Fig 2.8.2a-c), and not only growth restricted to the most 
posterior gut region as reported earlier311. This GFP progenitor expansion was also 
transient and 5 days after mating, the GFP signal was restricted to many doublets unlike 
the initial post-mating expansion (Fig 2.8.1b,c). Next, I asked if intestinal ecdysone 
signaling in progenitors was responsible for these ISC divisions and resulting midgut 
growth. EcR depletion in progenitors or ISCs impaired both the expansion of GFP-
expressing progenitors (Fig 2.8.1d) or ISC clones (Fig 2.8.1e) as well as ISC mitoses (Fig 
2.8.1f,g) and in both cases the resulting gut growth was repressed (Fig 2.8.2a-e). 
Similarly, Usp, EcR’s receptor partner was required for mating-induced ISC mitoses (Fig 
2.8.1f) and mating-dependent gut sizing (Fig 2.8.2d). 
In further tests, I examined the role of non-cell autonomous role of EcR signaling in EBs 
or ECs on the mating-induced ISC mitoses and the mating-dependent gut sizing.  Similar 
to 20HE feeding, mating-induced ISC mitoses absolutely necessitated EcR in EBs at later 
time points by 72 hrs but, EcR was dispensable to the initial ISC mitoses by 48 hrs (Fig 
2.8.1h). Interestingly, in addition to the cell-autonomous roles of EcR in ISCs to drive 
mitoses and midgut sizing, ecdysone/EcR-dependent midgut resizing marginally required 
EcR in enteroblasts for the optimal gut resizing after mating (Fig 2. 8.2h). In contrast, 
EcR in ECs was not required for the mating induced ISC mitoses (Fig 28.1i).  
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Fig 2.8.1: Mating induces a burst of EcR-dependent ISC mitoses. Text and images 
have been taken and modified from (Ahmed et al., 2020) and have been originally written 
and made by myself: (a) Mating leads to an increase in the number of ISC mitoses/gut. 
Mitotic counts of control virgin females 48hrs and 72hrs post mating.  
(b) Representative confocal images of transient progenitor expansion seen in control 
females after mating and upon progenitors-specific downregulation of EcR in the R4 
region of the posterior midgut of females (below). Females were mated to males with no 
genetic manipulations. Equal number of males and females were allowed to mate (a ratio 
of 1:1) and females were allowed to mate for the indicated times above the panels. GFP, 
in green; DAPI, in blue. Scale bar, 100 μm. 
(c) Representative images of the progenitor distribution in females that were mated for 5 
days. This shows how the GFP expression is restricted in progenitor doublets after their 
transient dense coverage at earlier time points (compare to panel b) suggesting that the 
mating effects are transient. GFP, in green; DAPI, in blue. Scale bar, 100 μm. 
(d) Progenitors expand shortly after mating and EcR regulates this progenitor expansion 
as shown in (b). Percentage of cells positive for the intestinal progenitor marker (esg+ 
GFP+/gut area) in controls and females with progenitor-restricted downregulation of 
EcR. Quantifications are done through a macro that calculates the area of GFP+ cells 
relative to the gut area (see methods) 
(e) ISC clones require EcR to expand after mating. Percentage of ISC clones covering the 
posterior midguts with EcR-depleted ISC clones relative to control midguts. 
Quantifications are done through a macro that calculates the area of GFP+ cells relative 
to the gut area (see methods)  
(f) Usp, Eip75B, EcR in progenitors are required for the mating-induced ISC mitoses. 
Number of mitoses in control and progenitor-specific depletion of Usp, Eip75B, EcR for 
8 days. Virgins were allowed to mate for 48 hrs. Results are shown for 2 independent 
RNAi lines for Usp . 
 (g) EcR in ISCs are required for the mating-induced ISC mitoses. Number of mitoses in 
control and ISC-specific downregulation of EcR for 8 days. Virgins were allowed to mate 
for 48 hrs and 72 hrs. Results are shown for 2 independent RNAi lines. 
(h) EcR in enteroblasts is not required at an earlier time point but, is rather required at the 
later 72 hour time point for the mating-induced ISC mitoses. Number of mitoses in 
control and enteroblast-specific downregulation of EcR for 8 days. Virgins were allowed 
to mate for 48 hrs and 72 hrs. Results are shown for 2 independent RNAi lines. 
 (i) EcR in enterocytes is not required at either time points for the mating-induced ISC 
mitoses. Number of mitoses in control and enterocyte-specific downregulation of EcR for 
8 days. Virgins were allowed to mate for 48 hrs and 72 hrs. All panels: Error bars 
represent ± SD. Statistical analysis was performed using unpaired non-parametric two-
tailed Mann-Whitney test (ns p>0.05, **p≤0.01,****p<0.0001). ♀ refers to mated 
females. ☿ refers to virgins. Representative images are shown. 
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Fig 2.8.2: Mating induces EcR-dependent gut growth. Text and images have been 
taken and modified from (Ahmed et al., 2020) and have been originally written and made 
by myself: (a) Midguts with EcR- or Eip75B-depleted progenitors do not grow post 
mating. Midgut size measurements of virgin and mated females, with and without 
EcRRNAi or Eip75BRNAi expressed in progenitors. Quantifications are done through a 
macro that calculates aspects of midgut morphology (see methods). Midgut areas are 
outputted and plotted in prism.  
(b) Midguts with EcR- or Eip75B-depleted progenitors fail to increase the midgut width 
after mating. Midgut width at R4 of virgin and mated females, with and without EcRRNAi 
or Eip75BRNAi expressed in progenitors. Quantifications are done through a macro that 
calculates aspects of midgut morphology (see methods). 
(c) Mating causes EcR-dependent gut growth. Representative bright-field images of a 
virgin, control or EcR-depleted mated female.  
(d) Midguts with Usp-depleted progenitors do not grow post-mating Midgut areas of 
virgin and mated females, with and without UspRNAi expressed in progenitors.. 
(e) Control females reveal a mating-dependent increase in gut size that is regulated by 
EcR in ISCs. Midgut size measurements of virgin and mated females, with and without 
EcRRNAi expressed in ISCs. Females were allowed to mate for 72 hrs only or raised mated.  
(f) Ovary production of ecdysone is essential for mating-dependent midgut growth. 
Representative bright field images of whole body spo mutants that are heterozygous and 
hence, viable with no growth or egg laying defects (1st upper panels) and survivor sterile 
homozygous spo mutants that are rescued to adulthood by a pulse of 20HE given to 
dechorionated embryos (2nd lower panels), quantified in (g). Scale bar 1mm.  
(g) spo mutants fail to undergo mating-dependent gut growth. Midgut areas from whole-
body homozygous spo mutants (spoZ339/Df) rescued to adulthood by an exogenous 20HE 
pulse given to embryos, and heterozygous controls (spoZ339/+).  
(h) EcR is needed in enteroblasts for an optimal full-grown gut post-mating. Midgut areas 
of virgin and mated females, with and without EcRRNAi expressed in enteroblasts.  
Error bars represent ± SD. Statistical analysis was performed using one-way ANOVA, 
followed by Bonferroni’s multiple comparisons test (ns p>0.05, *p≤ 0.05, **p≤ 0.01, *** 
p≤ 0.001, ****p<0.0001). ♀ refers to mated females. ☿ refers to virgins. Representative 
images are shown. 
 
Whether EcR in ECs is required for the mating-dependent midgut resizing remains 
unexplored. Additionally, to validate the RNAi results, I used whole body spo mutant 
animals, that are ecdysone-deficient and embryonic lethal, but can be rescued to 
adulthood by exogenous 20HE given during embryogenesis312. Remarkably, surviving 
adult mated spo mutant females were sterile and failed to resize their midguts (Fig 2. 
8.2g-h), suggesting that ovary-to-gut signaling is essential for mating-adaptive gut 
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resizing.  
2.9. Ovary-derived ecdysone signaling regulates post-mating gut growth in the 
female midguts. 
The main source of 20HE production is the ovaries153,301. So, in a next step I investigated 
if they are the source of 20HE that affects the midgut. Hence, I depleted 2 different 
ecdysone biosynthetic cytochrome P450 enzymes disembodied (dib) or spook (spo) with 
ovary-specific drivers (C587-Gal4ts, tj-Gal4)123,302,313,314, then I examined the effects on 
the gut post-mating. 
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 Fig 2.9: Ovary-derived 20HE production regulates mating-induced ISC mitoses. 
Text and images have been taken and modified from (Ahmed et al., 2020) and have been 
originally written and made by myself: (a) Ovarian ecdysone controls mating-induced 
ISC mitoses. Ecdysone production was suppressed in adult females by expressing spoRNAi 
or dibRNAi under the control of the ovarian somatic cell-specific Gal4 driver c587ts. 
Midguts were scored for mitotic cells 3 days after mating. Mated females with reduced 
ecdysteroidogenic enzymes in the ovaries have impairment in their mating-induced ISC 
mitoses. Results are shown for 2 independent RNAi lines for spo. 
(b) Ovarian ecdysone controls mating-induced ISC mitoses. Ecdysone production was 
suppressed in adult females by expressing spoRNAi under the control of the ovarian 
somatic cell-specific Gal4 driver traffic jam (tj). Midguts were scored for mitotic cells 3 
days after mating. Mated females with reduced spo in the ovaries have impairment in 
their mating-induced ISC mitoses. 
(c) Ovarian ecdysone from early stage follicles contributes to most of the mating-induced 
ISC mitoses. Ecdysone production was suppressed in adult females by expressing spoRNAi 
under the control of the ovarian late follicle cell-specific Gal4 driver (T155). Midguts 
were scored for mitotic cells 3 days after mating. Mated females with reduced spo in their 
late follicle have a slight non-significant impairment in their mating-induced ISC mitoses. 
(d) Knock down efficiency of spo was confirmed by qPCR on adult ovaries constitutively 
expressing the RNAi construct under the control of tubts.  
(e) Ecdysone production was suppressed in adult females by expressing dibRNAi under the 
control c587ts. Midgut sizes of mated females defective in ecdysteroidogenic enzymes are 
significantly smaller than age-matched controls. This gut size defect was rescued by 
raising the females on 20HE-supplemented food.  
(f) Maintenance of ovarian somatic cells does not affect mating ISC-induced mitoses of 
the gut. EcRRNAi was expressed under the control of the ovarian somatic cell-specific 
Gal4 driver c587ts. Midguts were scored for mitotic cells 3 days after mating. Mated 
females with reduced EcR signaling in the ovaries do not impact mating-induced 
intestinal EcR signaling in the gut. All panels: Error bars represent ± SD. Statistical 
analysis in e was performed by one-way ANOVA, followed by Bonferroni’s multiple 
comparisons test otherwise unpaired non-parametric two-tailed Mann-Whitney test was 
used (ns p>0.05, *** p≤ 0.001, ****p<0.0001). ♀ refers to mated females. ☿ refers to 
virgins. 
 
Ecdysone production is reported to occur in the early follicles and escort cells of the 
ovaries and the drivers I used C587-Gal4ts, tj-Gal4 are also reported to act in those 
cells313,314. As predicted, reduced ecdysone levels abolished the mating-induced ISC 
proliferation (Fig 2.9a-b) and midgut re-sizing, which could be restored by raising the 
flies on exogenous 20HE in their diet (Fig 2.9e). The suppressed gut effects were specific 
to the depletion of the ecdysone-synthesizing enzymes because EcRRNAi in the early 
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ovarian follicles, which is vital for the follicle formation315, was uncoupled from its 
actions on the mating-induced ISC mitoses of the midgut (Fig 2.9f). In contrast, depleting 
spo with a late ovarian-follicle specific driver (T155-Gal4) did not completely diminish 
the mating-induced ISC mitoses indicating that the late ovarian follicles are not the 
predominant source of endogenous ecdysone (Fig 2.9c). These results complement the 
whole body mutant results and prove that ovary-derived ecdysone regulate intestinal stem 
cell division and gut size.  
2.10 Masculinized female progenitors are able to resize their midguts after mating. 
My results so far have suggested that there are 2 non-overlapping pathways controlling 
ISC mitoses: 1st is the cell-autonomous sex determination pathway and 2nd is the non-cell 
autonomous ovary to gut 20HE signaling. Thus, I asked whether the consequences of 
ovary-derived 20HE after mating diverge from the effects of the sex determination 
pathway on ISC behavior. So, I induced progenitor-specific traRNAi in virgin females, 
then I mated them for 3 days, and found that virgins with traRNAi progenitors remain 
competent to expand their gut size post-mating (Fig 2.10a). Consequently, control virgin 
midguts or masculinized virgin midguts with traRNAi progenitors grow similarly after 
mating. When control females or females with masculinized progenitors were raised 
mated, the sizes of their midguts were comparable (Fig 2.10a).  
Fig 2.10: Females with progenitors masculinized by traRNAi are able to resize their 
midguts after mating. Text and images have been taken and modified from (Ahmed et 
al., 2020) and have been originally written and made by myself: (a) Both control and 
traRNAi progenitors female midguts exhibit a mating-dependent increase in gut size. Gut 
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growth is unaffected by masculinizing the identity of the progenitors. Midgut size 
measurements of virgin and mated females, with masculinized progenitors by tra-
depletion. Females were only allowed to mate for 72 hrs or raised mated.  
(b) Progenitors expand shortly after mating and this expansion is independent of tra.  
Percentage of progenitors positive for the GFP+/gut area in controls and females with 
progenitor-restricted downregulation of tra. Error bars represent ± SD. Statistical analysis 
in a was performed by one-way ANOVA, followed by Bonferroni’s multiple 
comparisons test otherwise unpaired non-parametric two-tailed Mann-Whitney test was 
used (ns p>0.05, ** p≤ 0.01, ****p<0.0001). ♀ refers to mated females. ☿ refers to 
virgins. 
 
Similarly, quantification of the GFP signal, reflective of progenitor expansion in 
masculinized progenitors reveals that the progenitors are competent to expand after 
mating similar to control progenitors (Fig 2.10b). The absence of an intestinal resizing 
defect in masculinized progenitors after mating is consistent with the hypothesis that the 
intestinal growth is non-cell autonomously controlled by the ovaries of mated females, 
independent of the cell-intrinsic mechanisms regulating ISC behavior.  
2.11. Mating leads to an additive advantage on female ISC proliferation. 
Next, I asked whether endogenous hormonal differences between virgin females 
(physiological low 20HE levels) relative to mated ones (physiological high 20HE 
level)301 would impart any differences on the ISC proliferation under stress or during 
homeostasis. To test this hypothesis, I induced masculinization of virgin or mated ISCs 
by repressing the sex-determination genes sex lethal or transformer in ISC clones. I raised 
some flies are virgins and others were left to mate with males until dissection then I let 
the flies feed on SDS detergent,16-18hrs before dissection118. ISC mitotic counts show 
that indeed ISCs of wildtype mated females are more efficient in dividing after detergent-
induced stress relative to wildtype virgin females. Furthermore, as previously shown ISC 
mitoses in virgin sxl-/tra- depleted ISC clones were completely suppressed (Fig 2.11a)118. 
In contrast, ISCs of mated females with sxlRNAi or traRNAi in their ISC clones are 
somewhat proficient in their regenerative mitoses. Alternately, I sought to suppress 
intestinal EcR signaling via EcR or its downstream target Eip75B-depletion in ISCs and 
assayed their mitotic responses to detergent-induced stress (Fig 2.11b). ISCs in EcRRNAi 
or Eip75BRNAi ISC clones shown significant defects in replenishing the midguts upon 
detergent-induced stress. This suggests that the mating status relays a stimulatory signal 
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via intestinal EcR signaling to improve the response of the midguts to stress-induced 
midgut mitoses. Additionally, mating also regulates basal ISC mitoses under non-stressed 
conditions. Aging ISCs of virgin traRNAi or sxlRNAi ISC clones barely divide, nonetheless 
ISCs of mated traRNAi or sxlRNAi ISC clones divide 11-76 times more frequent than virgin 
clones (Fig 2.11c).  
Fig 2.11: Mating cross talks with the cell-autonomous sex determination pathway to 
regulate ISC mitoses basally and under stress. Text and images have been taken and 
modified from (Ahmed et al., 2020) and have been originally written and made by 
myself: (a) Mating boosts the mitotic divisions of ISCs. Feeding 0.1% SDS for 16 hrs to 
 
 
107 
virgin females induces ISCs mitoses while male ISCs divide minimally to the stress. 
Mitoses are suppressed by masculinizing ISC clones using sxlRNAi or traRNAi. Mating 
increases the ISC mitotic responses to SDS feeding and somewhat restores the ability to 
masculinized ISCs to divide to detergent-stress. 
(b) Ecdysone signaling via EcR and Eip75B is required in ISC clones of mated females 
for optimal regenerative SDS-induced ISC mitoses. ISC mitotic counts of virgin females 
are minimal under basal conditions. Basal mitoses are increased in mated females. Upon 
SDS feeding, control mated ISC clones divide to regenerate the epithelium but EcR or 
Eip75B depleted ISC clones are significantly impaired in their ability to divide. RNAi 
was induced in ISC clones for 8 days before 16-18 hrs of 0.1%SDS feeding.  
(c) Mating causes an additive increase in homeostatic divisions independent of the sex 
identity. ISC counts of masculinized ISC clones using sxlRNAi or traRNAi show that 
masculinized midguts can still adapt to the increased basal ISC mitoses in mated relative 
to virgin females. Error bars represent ± SD. Statistical analysis was performed using 
unpaired non-parametric two-tailed Mann-Whitney test. (ns 
p>0.05,**p≤0.01,***p≤0.001,****p<0.0001). ♂ refers to males, ☿ refers to virgins and 
♀ refers to mated females. 
 
These results indicate that the mating status per se transduces additional hormonal non-
cell autonomous signals to the gut that promote the ISC mitoses upon detergent-induced 
ISC response and during aging. Highly competent ISCs have the advantage and the 
benefit of meeting the homeostatic tissue needs and high reproductive demand of the 
females, however, if this comes at the expense of faster deterioration of the gut or not is 
something I will explore in later sections. Hence, both ISC-autonomous and non-
autonomous hormonal factors alter ISC proliferation. 
 
 
 
2.12. rho and upd2 induction are a physiological consequence of mating 
As I discovered that 20HE exogenous feeding up-regulates rho and upd2, I wondered if 
mating induces the midgut expression of upd2 and rho to a similar degree as 20HE 
feeding  (Fig 2.12a) (Compare to Fig 2.5b). Indeed, whole gut qPCRs show that upd2 and 
rho induction also occur in response to mating suggesting that they are a part of the 
normal physiological mating response. This is particularly intriguing because these 
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targets were only previously described as a part of the gut epithelial damage or stress 
responses in Drosophila8,41,291.  
 
Fig 2.12: Mating prompts rho and upd2 upregulation. Text and images have been 
taken and modified from (Ahmed et al., 2020) and have been originally written and made 
by myself: (a) Mating-induced rho and upd2 induction is physiological and not stress-
related. mRNA expression was measured by qPCR of control midguts that are virgins or 
mated for  24 hrs or 72 hrs. Relative to virgins, a moderate increase in mRNA expression 
levels of rho and upd2 is detected as a consequence of mating.  
 
2.13. 20HE feeding is not supra physiological and induces target genes similar to 
mated females. 
 
Since in earlier sections I described mitotic effects and midgut growth that occurs in male 
and virgin Drosophila in response to different 20HE feedings, which hasn’t been 
unparalleled in previous reports, I wondered if this 20HE I was giving the flies was 
within the physiological range or not.  
Thus, I fed virgin females with various doses of 20HE and I compared the strength of the 
20HE-target gene induction to virgin flies that I mated for 24hrs or 48hrs (Fig 2.13a). I 
picked 2 of the well-known early 20HE-inducible targets the nuclear receptor Eip75B and 
the transcription factor Broad that I will refer to again in later chapters of this thesis. In 
parallel, I fed the flies with the same doses of 20HE and assayed the ISC mitoses 16-18 
hrs after feeding and compared it to basal mitoses in young mated female guts (Fig 
2.13b). Firstly, mating induced target genes 2-2.5 fold higher than virgin females, 
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consistent with the increased ecdysone levels produced by the ovaries. Similarly, ranges 
of 20HE doses between 0.5-5mM 20HE induced target genes 2-2.5 fold higher than that 
of mated females, while 10mM 20HE induced target genes almost 3 fold higher than that 
of mated females. Secondly, mitotic counts of 0.25-1mM 20HE-fed virgin flies were not 
significantly changed compared to mitotic counts of mated non-stressed females. Only 
2mM 20HE modestly increased ISC mitoses, but consistent with previous data, 5mM 
20HE boosted mitotic counts. These experiments indicate that the 20HE-dependent target 
gene induction did not reach its highest levels with the doses of 20HE that I have used in 
my studies. Also, a mild induction of 20HE target genes caused by exogenous feeding 
was not sufficient to induce a transient boost of ISC mitoses unlike mating where target 
genes were induced ≈2 fold accompanied by many transient ISC mitoses (compare to Fig 
2.8.1a). Probably, mating results in different kinetics of 20HE-target gene induction, in 
parallel with an organism-wide activation of metabolic processes that work in synchrony 
to direct ISC mitoses and gut growth311. These experiments also implied that 1mM 20HE 
that I have used for my long-term feeding experiments was well tolerated by the flies.  
Fig 2.13: 20HE causes a dose-dependent induction in target genes and subsequent 
ISC mitoses. 
 (a) Midguts of 24-48 hrs post-mated flies have upregulated levels of their ecdysone 
targets, similar to exogenous 20HE feeding. qRT-PCR measurements from whole 
midguts show that expression levels of Eip75B and broad mRNA are induced in a dose-
dependent manner after 20HE feeding relative to vehicle-fed virgins.  
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(b) 20HE feeding causes 20HE causes ISC divisions in a dose-dependent manner in ISCs 
of virgin females. Virgins were fed different concentrations of 20HE and their mitotic 
indexes were assessed after 16- 18hrs of feeding. At 0.25-1mM 20HE, ISCs divide 
similar to basal levels in mated females. At 2mM 20HE feeding, ISCs mildly divide (3-4x 
higher than divisions induced by 1mM 20HE). At 5mM 20HE, ISCs divide at 10-11x 
higher that divisions induced by 1mM 20HE. Error bars represent ± SD. Statistical 
analysis was performed by unpaired non-parametric two-tailed Mann-Whitney test (ns 
p>0.05,*p≤ 0.05,**p≤0.01,***p≤0.001, ****p<0.0001). ♀ refers to mated females. ☿ 
refers to virgins. 
2.14. Mating induces symmetric ISC divisions and ISC expansion. 
As the gut size is enlarged post-mating, it could be a consequence of increased cell 
number, size or both. As, I have discovered that there is a massive transient increase in 
ISC divisions, I wondered if the mode of most of those divisions was asymmetric or 
symmetric as previously described during regeneration316 or homeostatic adaptive gut 
growth12. If ISCs divide symmetrically, they give rise to two competent ISCs. 
Asymmetric ISC division however, gives rise to one ISC and a short-lived enteroblast316. 
To figure this out, I have used virgin female midguts with GFP-marked enteroblasts and 
LacZ-marked delta+ ISCs. Then, I mated them for 24, 40 hrs and 7 days. 24hrs-post 
mating, LacZ+ ISCs remained singlets, similar to virgins (Fig 2.14a-b). However, 40 hrs-
post mating, LacZ+ ISCs had mostly become doublets or triplets, indicating that those 
young ISCs are partly a result of symmetric ISC divisions. 7 days post mating, regardless 
of whether the flies have mated once/night or co-housed with males for the whole 
duration, there was an irreversible increase in the number of LacZ+ ISCs across the 
epithelial layer, with occasional doublets or triplets as a result of mating. However, the 
number of enteroblasts remained relatively low. This observation supports the view of an 
asymmetric division signature (Fig 2.14a-b). All in all, mating causes an ovarian 
ecdysone-dependent-(Fig 2.1.2m, Fig 2.14d) and EcR-dependent (Fig 2.8a,b,f, Fig 2.14c) 
increase in ISC numbers after mating. The claim that the increase in the progenitor 
population drives mating-dependent gut growth was supported by the quantification of 
EC size between EcR-depleted ECs of mated females versus ECs of control mated 
females (Fig 2.14e,f), and the quantification of EC numbers between flies that were 
raised as virgins or mated respectively (Fig 2.14g,h).  
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Fig 2.14: Mating induced 20HE regulates symmetric ISC divisions, ISC cell number, 
EC size and numbers. Text and images have been taken and modified from (Ahmed et 
al., 2020) and have been originally written and made by myself: (a-b) (a) Mating induces 
a symmetric increase in delta+ cells shortly after mating. Representative images of the R4 
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region of the midgut in virgin females shortly after mating or 7 days after mating. ISCs 
are marked with delta+ (red) and EBs are marked with GFP (green) Su(H)+ cells. At 24 
hrs post mating, most delta+ cells remain singlets, similar to virgins. At 40 hrs post 
mating, most delta+ cells expand to become doublets or triplets.  At 7 days after the 1st 
mating, most delta positive cells are again singlets, however their numbers are 
irreversibly increased relative to virgins. Females were mated to males with no genetic 
manipulations. Equal number of males and females were allowed to mate (a ratio of 1:1) 
and females were allowed to mate for 18-20 hrs after which males were removed, except 
for the condition “raised mated for 7 days” whereby males were always in the vial with 
the females. Images are acquired in the R4 region. delta, in red; GFP, in green; DAPI, in 
blue. Scale bar, 100 μm. (b) Quantification of (a). Each dot represents a gut, and % of 
delta+ or Su(H)+ cells are derived from absolute number of positive cells relative to total 
DAPI+ cells (see Methods). 
(c) Intestinal EcR signaling regulates progenitor cell number in the R4 region. 
Quantification of GFP+ progenitors/area of the midgut stack shows that EcRADN 
progenitors are reduced relative to control progenitors of mated females.  
(d) Ovarian ecdysone signaling regulates delta+ cell numbers in the R4 region. 
Quantification of delta+ cells/area of the midgut stack shows that dibRNAi ovaries have 
intestines with drastically reduced numbers of delta+ cells relative to delta+ cells of 
control mated females. 
 (e) R4 midgut enterocytes expressing EcRRNAi in young mated flies causes a non-
significant accumulation of smaller-sized cell populations relative to age controlled 
mated females. Shown is a frequency distribution of the different cell sizes. EcR depleted 
enterocytes have a very slight bigger proportion of cells sized 75-175 μm2 than control 
midguts (also observed in other contexts). However, the differences in distribution of the 
cell sizes are statistically non-significant.  
(f) Depletion of EcR in midgut enterocytes of old mated flies causes an accumulation of 
smaller-sized cell populations relative to age controlled mated females. Cells of the 
midgut were stained with a cytoplasmic stain and a macro was designed to segment the 
cells according to their sizes (see Methods). Shown is a frequency distribution of the 
different cell sizes. Control flies have a bigger proportion of cells sized 200-825 μm2 than 
midguts with EcRRNAi enterocytes. Images are taken in the R4 region.  
Collectively, data in panels e and f indicate that EcR regulates cell size of enterocytes that 
may consequently alter nutrient absorption from the gut. Data are from n≤5 stacks of 
midguts taken at the R4 region. 
(g) EcR is required for optimal increase of ECs number irrespective of mating. Midguts 
with EcR depleted ECs have a defect in the number of their ECs of the R4 region. Each 
dot represents the number of ECs/midgut quantified from R4 stitches (see Methods). 
While mating does not cause an increase in the number of ECs per se, EcR depleted ECs 
have a defect in their numbers that is not compensated by the “mating” process. 
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(h) Mating causes an increase in the ratio of other midgut cell types/ECs. Virgins have a 
higher number of ECs/total DAPI+ cells as quantified from R4 stitches. Mating causes a 
drop in this ratio indicative of a relative increase in the number of total EC-DAPI+ cells. 
Conversely, virgins with EcR depleted ECs have a defect in sustaining a high ratio of 
ECs/total DAPI+ cells suggesting that these midguts have a higher ratio of EC-DAPI+ 
cell types. This ratio is not altered after mating. Statistical analysis was performed using 
one-way ANOVA, followed by Bonferroni’s multiple comparisons test panels: g,h or 
unpaired non-parametric two-tailed Mann-Whitney test (ns p>0.05,*p≤ 0.05,**p≤0.01, 
****p<0.0001). ♀ refers to mated females. ☿ refers to virgins.  
 
To figure out the size distribution of cells in the R4 region, I stained the gut with a plasma 
membrane stain, then I imaged cells in the R4 region and counted them and generated a 
frequency distribution histogram of the percentage of cells versus cell size. EcR depletion 
in ECs of young guts did not show a measurable or significant difference in their 
distribution relative to control guts (Fig 2.14e). However, EcR depletion in ECs of old 
mated females caused a significant reduction in EC size (fractions higher than 176μm2) 
relative to control guts indicating that intestinal EcR signaling affects EC size (Fig 2.14f). 
Secondly, mated females did not show a striking increase in EC numbers in R4 region as 
a consequence of mating per se (Fig 2.13g,h) but there were specific effects of EcR on 
ECs on aspects of cell number, which I re-allude to in later sections of this thesis. This 
comes slightly in contrast to what a previous report finds311 though the differences could 
be attributed to two factors: Reiff et al focuses on R5 region which is the most posterior 
region of the midgut and it is a much smaller and functionally distinct than R42,3. 
Moreover, the differences they observe are slight, and they quantify the enterocytes 
across the whole gut, while I only took stitches focusing on the R4 region. Thus, I 
conclude that gut growth is highly dependent on the action of ovary-derived ecdysone on 
the midgut progenitors.  
 
2.15. 20HE is involved in the regulation of enteroblast differentiation into 
enterocytes as well as maintaining proper EC number. 
Several results I had from my experiments pointed towards a possible role of ecdysone 
signaling in differentiation, .in this section I will gather all the evidence I obtained during 
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the course of my thesis to support the role of intestinal EcR signaling in differentiating 
EBs or differentiated ECs. 
Enteroblasts are the cell type that differentiates to give rise to either absorptive 
enterocytes (ECs) or secretory entero-endocrine cells (ees)5,93,317. This fate specification 
step depends on the level of Notch signalling in the enteroblasts: High level of notch 
activates a transcriptional program in the enteroblasts that leads to its differentiation into 
an EC 317-319. ECs can be marked by nubbin (Pdm1) expression, a POU‐domain 
transcription factor specifically expressed in mature ECs320. Firstly, EcR depleted ISC 
clones of mated females leads to formation of clones with smaller cell sizes, which 
mostly fail to give rise to the large polyploid enterocytes (Fig 2.1.2k,l and Fig 2.23d,e). 
Then, as I investigated earlier which cell types are required for the 20HE-induced 
mitoses, I noticed that EcR depleted enteroblasts by SuHts leads to accumulation of many 
enteroblasts (Fig 2.15.1a). Conversely, overexpression of the ecdysone-inducible target 
Eip75B I characterize in later sections of the thesis (Fig 2.17-19) led to the accumulation 
of Pdm1+, GFP+ polyploid big-sized cells (Fig 2.15.1b), or large enteroblasts (Fig 2.17f) 
suggestive of Eip75B pushing cells through differentiation. As a matter of fact, every 
time the ISCs expressed high levels of Eip75B but were not triggered to divide, the ISCs 
start developing abnormal morphology and misdifferentiate. This adverse effect was 
rescued by sensitizing the ISCs to proliferate with a brief heatshock prior to ectopically 
increasing the Eip75B levels by shifting to 29oC (Fig 2.17e). So primary evidence 
suggests that intestinal EcR signaling, through Eip75B regulates EB differentiation.  
To determine whether EcR plays a role in establishing the cell number/size of both 
enteroblasts or ECs, I conducted a series of experiments to measure the number of EBs or 
ECs from microscope stitches taken in the R4 region of the midgut of males and females. 
This allowed me to count the number of cells from the respective driver background to 
examine the effects of EcR depletion in EBs or ECs upon exogenous 20HE feeding or 
mating. For this experiment, I fed males and females with vehicle or 20HE for 14 days 
that was replaced every 1-2 days. Fig 2.15.1c shows the total number of cells of male or 
female guts from different genetic backgrounds SuHts or Myo1Ats to reflect the robustness 
of the quantification. Indeed, the technique I used for getting the automated stitches and 
counting them is quite robust, reflected by the narrow standard deviation. Remarkably, 
20HE supplementation for 14 days causes a significant increase in the cellularity of the 
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midguts relative to vehicle-fed flies (Fig 2.15.1d). Nevertheless, 20HE feeding to control 
flies for 15 days does not increase the number of EBs relative to vehicle-fed control flies. 
This is not the case with transient overnight 20HE feeding, whereby there is an increase 
in the number of enteroblasts (data not shown), probably consistent with the state of 
increased transient ISC mitoses. 
Then, I examined the effect of reduced EcR levels in the EB population of the male and 
female midguts. When EcR was depleted in EBs of either male or female flies, there was 
a substantial accumulation of the enteroblast population in the posterior midgut 
suggesting that differentiation to ECs is blocked (Fig 2.15.1e,f). Strikingly, 20HE 
supplementation in the food releases this block and the number of EBs return to similar 
levels relative to control animals (Fig 2.15.1e,f). It remains unclear how 20HE would 
function to rescue this prominent EB defect of EcR depleted EBs in both sexes. It could 
be that the remaining EcR would be enough to transduce 20HE signalling to the EBs 
though highly unlikely as EcR depleted EBs suppress 20HE- or mating-induced ISC 
mitoses (Fig 2.3b and Fig 2.8.1h). Alternatively, EcR depletion with the co-increase of 
20HE availability could cause a compensatory changes such as upregulation of EcR 
expression or slowed trafficking or recycling of EcR in response to its hypofunction 
similar to a paradigm described for dopaminergic or seretonergic receptors321,322.  
Since there is hyperplasia of the midguts of 20HE-fed flies, I attributed it to increased 
number of the remaining midgut populations: ECs, ISCs or EECs (Fig 2.15.1d). 
Consistent with this idea, midguts with EcR depleted EBs that are raised on exogenous 
20HE have bigger midguts, though the effect is more pronounced in females (Fig 
2.15.1g). Thus, 20HE feeding causes hyperplasia which results in some gut growth and it 
is required also required for EB differentiation. 
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Fig 2.15.1: Intestinal EcR signaling functions in fine-tuning the balance between 
proliferation and differentiation.  
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(a) Mated female midguts with EcRRNAi expressing EBs accumulate numerous EBs 
relative to age-matched mated control females. Representative confocal images of midgut 
with EcR depleted EBs.  
(b) Eip75B overexpression leads to the appearance of GFP+ /Pdm1+ cells, suggestive of 
aberrant cell growth or precocious differentiation. Representative confocal images of 
midguts overexpressing Eip75B in the progenitors co-stained with the EC differentiation 
marker Pdm1+.  
(c) Total cell number of DAPI+ cells/gut side/midgut stitch in the R4 region from the 
different driver backgrounds: Su(H)ts Gal4 or MyoIAts Gal4 of male and female midguts 
+/- prolonged 20HE feeding. Females have more than double the number of cells relative 
to males. 20HE feeding in both males and females causes a significant increase in the 
total number of cells/midgut R4 region as quantified from automated stitches/R4 gut 
region (refer to methods section).  Each dot represents a midgut. The same stitches are 
used for analyses in panels d-f. 
(d) 20HE feeding causes an increase in the total number of DAPI+ cells/gut side/midgut 
stitch in the R4 region of Su(H)ts Gal4 male and female midguts.  
(e) EcR depletion in EBs causes a significant sturdy accumulation in EBs that is relieved 
by 20HE feeding in both males and females. Quantification of the EB number from 
midgut stitches from the genetic background Su(H)ts Gal4 +/- EcR depletion shows that 
the loss of EcR in EBs leads to tripling the amounts of the EBs in male midguts and 4 
times increase in the number of EBs in females. Such massive increase in EBs is 
stabilized back to basal levels when the flies are raised on 20HE for 14 days, suggesting 
that 20HE promotes the differentiation of the depleted EcR EBs. 
(f) Ratios of EB numbers/total DAPI+ cells in midgut stitches of males and females in the 
background of Su(H)ts Gal4 shows the relative increase in EB number upon EcR 
depletion and its drop back to basal levels relative to vehicle-fed animals after raising the 
animals on exogenous 20HE.  
(g) A rescue in the area of midguts with EcR depleted EBs, particularly that of females 
after 20HE feeding suggest that 20HE feeding is capable of rescuing the EcR depleted 
EB defects directly or indirectly. Midgut areas of animals raised on exogenous 20HE for 
14 days in the background of Su(H)ts Gal4.  
(f) 20HE feeding causes an increase in the total number of DAPI+ cells/gut side/midgut 
stitch in the R4 region of MyoIAts Gal4 male and female midguts. Cells/midgut R4 region 
are quantified from automated stitches/R4 gut region (refer to methods section).  Each dot 
represents a midgut. The same stitches are used for analyses in panels 1f and 2a-b.All 
panels: Error bars represent ± SD. Statistical analysis was performed using one-way 
ANOVA, followed by Bonferroni’s multiple comparisons test for panel g or unpaired 
parametric t-test with Welch’s correction. Unless specified, p values are (ns p>0.05,*p≤ 
0.05,**p≤0.01,***p≤0.001, ****p<0.0001). ♂ refers to males, ♀ refers to mated 
females. 
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Initially, I aimed to investigate the effects of EcR RNAi depletion on the transcriptome of 
progenitor cells that are virgins or mated. For that reason, I raised female flies as virgins 
then I mated them for 37hrs prior to the dissection of their midguts and FACS-sorting 
their progenitors to extract RNA from and sequence afterwards. I never managed to 
sequence the RNA from this experiment yet, I observed an interesting phenotype that 
complements the data I show in Fig 2.15a to support the requirement of EcR for 
differentiating EBs. FACS-sorted female GFP+ progenitors have 3 different GFP+ 
expressing populations (GFPlow P6, GFPmedium P7, GFPhigh P8). They are seemingly 
different in the intensities of their GFP+ expression. Mated control flies have 
predominantly a uniform population of GFPmedium expressing progenitors, with not so 
obvious changes in distribution of the GFP population between the virgins and the mated 
flies (Fig 2.15.2a,b). However, EcR depleted progenitors of female virgins show an 
accumulation of the GFPlow P6 and GFPmedium P7 (compare Fig 2.15.2a,b). This 
accumulation is quickly relieved when the females were mated, as early as 37hrs after 
mating (Fig 2.15.2b,d). This phenotype was replicated thrice with similar distribution of 
the GFP population, indicating an accumulation of cells that gets relieved after mating. 
Thus, both the FACS data and the microscope stitches suggest that non-cell autonomous 
mating that release endogenous 20HE or feeding exogenous 20HE affects the process of 
differentiating enteroblasts.  
Afterwards, I examined the effects of intestinal EcR signaling on EC numbers. 20HE 
feeding to control flies causes a slight increase in the number of ECs though I couldn’t 
conclude that with a lot of confidence due to the small (n) numbers and the missing 
control female guts. 
When EcR was depleted from ECs of females; there was a significant reduction in the 
number of ECs (Fig 2.15.2e). 20HE-feeding to female guts with EcR depleted ECs 
increases the number of ECs albeit non-significantly, possibly due to the high variability 
between the midguts and the small (n) numbers. 20HE seems to rescue the EC numbers 
in guts with EcR depleted ECs to similar numbers in the control flies (Fig 2.15.2e-f).  
. 
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Fig 2.15.2: Intestinal EcR signaling regulates EB differentiation to ECs.  
 (a) Histogram distribution of FACS sorted GFP+ cells isolated from progenitors of 14 
days old control virgins. 3 different GFP+ populations exist and the same gating strategy 
is applied for panels l-o (GFPlow P6, GFPmedium P7, GFPhigh P8).  GFPlow and GFPhigh are 
less than 250 counts, GFPmedium are around 750 counts.  
(b) Histogram distribution of FACS sorted GFP+ cells isolated from EcR-depleted 
progenitors of 14 days old virgins. GFPlow are 1500 counts, GFPmedium are 1800 counts 
and GFPhigh are less than 250 counts. 
(c) Histogram distribution of FACS sorted GFP+ cells isolated from progenitors of 14 
days old mated controls. Mating commenced 37 hours prior to dissection. . GFPlow and 
GFPhigh are less than 100 counts, GFPmedium are around 300 counts. 
(d) Histogram distribution of FACS sorted GFP+ cells isolated from EcR-depleted 
progenitors of 14 days old mated females. Mating commenced 37 hours prior to 
dissection. GFPlow are around 500 counts, GFPmedium are around 700 counts and GFPhigh 
are around 100 counts. Accumulation of GFP+ progenitors is more observed when EcR is 
depleted and mating relieves this effect. All panels: Error bars represent ± SD. Statistical 
analysis was performed using one-way ANOVA, followed by Bonferroni’s multiple 
comparisons test for panel k or unpaired parametric t-test with Welch’s correction. Unless 
specified, p values are (ns p>0.05,*p≤ 0.05,**p≤0.01). ♂ refers to males, ♀ refers to 
mated females. 
(e) EcR depletion in ECs causes a pronounced drop in the number of ECs/R4 midgut 
region in females that is fully rescued by exogenous 20HE feeding for 14 days. A similar 
increase of EC number in male midguts is also detected after 20HE feeding though a 
reduction of EC number is not observed in males possibly because of the low n number.  
(f) Ratios of EC numbers/total DAPI+ cells in midgut stitches of males and females in the 
background of Myo1Ats Gal4 shows the relative drop of EC ratio in control males after 
20HE feeding. This complements the result in Fig 2.6f and suggests that there is an 
increase in other EC- cell types upon prolonged 20HE feeding. Conversely, EcR depleted 
ECs have an inherent defect in their numbers that is fully rescued by exogenous 20HE 
feeding. EcR depleted female ECs do not seem to be rescued by exogenous 20HE. 
(g) Midgut areas of females raised on exogenous 20HE for 14 days in the background of 
Myo1Ats Gal4. There seems to be an initial increase in the midgut areas with EcR-
depleted ECs but no additional increase in the midgut area occurs after exogenous 20HE 
feeding. 
 
20HE feeding recovers the deficit in the number of ECs so that their numbers/R4 region 
matches vehicle-fed control midguts. Yet, the experiment’s results were not so robust due 
to the small n numbers. However, preliminary results suggest that EcR depletion in ECs 
causes a reduction in their number that is rescued by raising the flies on 20HE (Fig 
2.15.2e-f). Nevertheless, the 20HE-mediated increase in the number of ECs is not so 
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pronounced to explain the hyper-cellularity phenotype observed in 20HE-fed guts (Fig 
2.15.2a). Although there are differences in the number of EcR depleted ECs with 20HE 
feeding, it does not seem to exert much difference on midgut areas (Fig 2.15.2g). Midguts 
with EcRRNAi-enterocytes are initially slightly bigger than vehicle-fed control females. 
20HE-fed midguts with EcRRNAi-enterocytes have slightly higher but insignificant 
increase in their overall midgut area relative to vehicle fed midguts with EcRRNAi-
enterocytes. Hence, there seems to be an effect of intestinal 20HE signaling on EC size 
and number in the posterior region of the midgut. Altogether, my data suggest that 
intestinal EcR is involved in the epithelial differentiation of EB to ECs, possibly also 
regulate EC number to supply the gut with optimal number of nutrient-absorbing 
enterocytes. This preliminary evidence suggests that investigating the role of EcR in 
differentiating EBs or differentiated ECs should prove relevant and interesting in the 
future. 
2.16.1-2 Intestinal EcR is required for optimal reproductive capacity. 
Reproduction is a costly process and it is crucial for the females that conduct most of the 
reproductive burden to devise mechanisms that maximize their reproductive fitness323. 
Accordingly, ovary-induced steroid signaling causes both behavioral and metabolic 
changes that lead to maximal reproductive output 158,252,253,301,302,123,324,325. 
A female fly at its reproductive peak lays up to 5 times its weight per day in its fertilized 
eggs 326,327, which is limited by nutrient availability to the ovaries328,329. Thus, I wondered 
if intestinal EcR is involved in remodeling the gut size to maximize the reproductive 
output.  
This would be in line with the hypothesis that mating-induced gut growth increases the 
nutrients absorbed by the intestine and, thereby, nutrient availability to the fly’s other 
organs such as the ovary. For that, I expressed EcRRNAi in midgut progenitors or ISCs 
under the control of the esgts-Gal4 driver, or the esgts -Gal4 Su(H)-Gal80 driver 
respectively. Then, I monitored the amount of eggs deposited by females over a long 
period of time. Both approaches to reduce intestinal EcR signaling diminished egg 
production by up to ~40% (Fig. 2.16.1a-b).  
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Fig 2.16.1: Intestinal EcR signaling is required to maintain reproductive demand of 
females. Text and images have been taken and modified from (Ahmed et al., 2020) and 
have been originally written and made by myself: (a) Mated females expressing EcRRNAi 
or Eip75BRNAi in their midgut progenitors have reduced reproductive output. Flies with 
control, EcR- or Eip75B-depleted midgut progenitors were raised as virgins for 1-2 days 
then were shifted to the permissive temperature and mated to males with no genetic 
manipulations at a ratio of 1:1 in populations of 5-7 females/cage. Eggs were collected 
from the fly vials every day for up to 40 days and the cumulative sums (upper graph) or 
average total eggs/fly every 3 days (lower graph) are plotted. Control females lay more 
eggs than midguts expressing EcRRNAi or Eip75BRNAi in progenitors. Replicates from 3 
independent experiments are shown. Error bars represent S.D. and p-values are calculated 
by general linear mixed model (GLM).  
(b) Mated females expressing EcRRNAi or Eip75BRNAi in their midgut ISCs have reduced 
reproductive output. Flies with control, EcR- or Eip75B-depleted midgut ISCs were 
raised at 18oC for 2 days maximum then were shifted to 29oC and allowed to mate to 
males with no genetic manipulations at a ratio of 1:1. Flies were pooled together the first 
night of mating to ensure mating then on the next day, a single female was housed with a 
control male in a single vial. Eggs were collected from the fly vials every 48hrs for up to 
14 days and the first graph on top shows the cumulative eggs laid across 14 days while 
the graph below shows the same data as a function of the average total eggs/fly every 3 
days plotted across 14 days. Control females lay more eggs than midguts with EcRRNAi or 
Eip75BRNAi in ISCs. Error bars represent S.D. and p-values are calculated by GLM.  
(c) Egg laying assay with an independent alternative 2nd RNAi against EcR and Eip75B is 
shown to complement results in a-b. Females were raised as virgins from 8 days at 29oC 
then they were allowed to mate to males with no genetic manipulations at a ratio of 1:1 
and their eggs were scored for up to 11 days post mating. 3 days averages are plotted, 
error bars represent S.D. and p-values are calculated by two-tailed t-test with Welch’s 
correction. 
(d left) The number of GFP+ cells per germarium for both midgut drivers: esgts or esgts 
Su(H)gal80 which is expressed in midgut progenitors and ISCs respectively.  
Examination of esgts driver shows that it is expressed in around 4 escort cells while esgts 
Su(H)gal80 driver shows expression in around 14 escort cells.  n of germaria analyzed is 
indicated above each driver. Control germaria typically have 45-70 escort cells330. This 
quantification was done by Dr. Clothilde Pénalva in the Edgar Lab. (d right) Most midgut 
drivers express GFP in their germaria. The frequency of germaria expressing GFP is 
displayed in a bar graph. Ovaries of the esgts driver have some escapers that have no GFP 
in their germarium while almost all ovaries of the esgts Su(H)gal80 driver have no 
escapers and all ovaries express GFP. This quantification was done by Dr. Clothilde 
Pénalva in the Edgar Lab. 
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Fig 2.16.2: Drosophila midgut drivers express GFP at different stages of the 
developing egg chambers. Text and images have been taken and modified from (Ahmed 
et al., 2020) and have been originally written and made by Dr. Pénalva. e-q) Drosophila 
ovaries are composed of 16 ovarioles. At the anterior tip of every ovariole the germarium 
contains the germline stem cells and the somatic stem cells that constantly produce 
follicles or egg chambers. As the follicles progress to the posterior end of the ovariole 
they develop to lead to the formation of a mature egg. Follicle development is divided 
into 14 stages. In the most anterior part of the germarium (Region I) the cap cells and the 
escort cells constitute the niche required for the maintenance of the GSCs and the proper 
differentiation of the early germline cyst. expression of the esg-Gal4ts and the esgts 
Su(H)-Gal80 drivers was detected within the germarium in a subset of escort cells. e-h) 
Confocal sections of follicles from stage 2-7 (e), stage 9 (h) and germaria (f,g) isolated 
from esg-Gal4ts  flies and stained for GFP (green), Coracle (red) and DNA (DAPI, gray). 
No GFP signal was detected in follicles from stage 2 to 9 (e,h)or in later stages (not 
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shown). However, 96% of germaria showed GFP in a subset of cells in the anterior region 
I (f,g). The GFP expressing cells were located in between the germline cysts and 
exhibited a triangular shape indicating that they were the escort cells. i-l) Similarly, all 
germaria from esgtsSu(H)-Gal80 flies presented GFP expression in escort cells (a,j,k,l) 
and no GFP expression was detected from stage 2 to 9 (i,j) or in later stages (not shown). 
m-q) The expression of the Switch GS5961-Gal4 driver was detected within the posterior 
follicular cells of the ovaries from stage 8 of oogenesis. Confocal section of follicles 
isolated from GS5961/UAS-GFP flies kept 4 days on yeast paste only (RU-) or yeast 
paste supplemented with RU486 (RU+) for 4 days and stained for GFP (green), actin 
(phalloidin, gray) or DNA (DAPI, gray). In absence of RU induction no GFP was 
detected in the ovary (m,n). After RU feeding no expression was detected in germaria or 
follicles prior to stage 7 (p,q). At stage 7 a subset of the most posterior follicular cells 
started to express weakly the GFP, this expression was then stronger and spreading to 
more follicular cells in a posterior to anterior gradient during stage 8 of oogenesis (q - 
most posterior follicle)and maintained later on in most of the posterior follicular cells that 
cover the oocyte (o -stage10).  
*All pictures are presented with the anterior on the left and the posterior on the right. 
 
I have validated the fecundity result by using an independent alternative RNAi (Fig. 
2.16.1c). Thus, I concluded that midgut resizing affects the female fecundity to optimize 
their reproductive output.  
However, these drivers were reported to express in some cells of the ovary311. I have 
asked an expert in Drosophila ovary stainings in the Edgar lab of Utah to stain the 
ovaries of both drivers and check which ovarian cells express GFP. Dr. Pénalva (Edgar 
lab) found that GFP is expressed in a subset of escort cells in the germarium of the ovary. 
esgts-Gal4 has an average of 4 GFP+ cells, while esgts -Gal4 Su(H)-Gal80 has an average 
of 14 GFP+ cells (Fig. 2.16d-l)330. It remains unexplored if EcR might be required in these 
ovarian escort cells and would in turn contribute to the optimal fecundity. Notably, 
control germaria typically have 45-70 escort cells330. Thus only 8.3%-24% would be 
affected by genetic manipulations with both midgut drivers esgts-Gal4 and esgts -Gal4 
Su(H)-Gal80 respectively. Collectively, my results reveal a post-mating organ cross-talk 
between the gut to deliver nutrients to the ovaries to maximize nutrient deposition in their 
fertilized eggs. 
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2.17 Functional bifurcation of the canonical heterodimeric EcRUsp during 
regenerative ISC mitoses. 
 
As EcR was required for detergent-induced ISC mitoses, I next wondered if intestinal 
ecdysone signaling is required for regenerative compensatory ISC proliferation following 
infection with pathogenic bacteria. To answer that, I induced progenitor-specific 
depletion of EcR, then infected the flies overnight, and scored their mitotic indexes (Fig 
2.1d,f 2.17.1a). Reduced EcR levels did not affect the P.e.-induced ISC mitoses relative 
to control flies. Strikingly, Usp depletion abolished the regenerative response (Fig 
2.17.1a). The result was confirmed using an independent alternative RNAi line to Usp 
and EcR (Fig 2.17.1a). This result is surprising because most of ecdysone’s functions 
described during development and throughout this thesis too (20HE feeding or mating), 
act through the EcR/Usp heterodimer331. 
Yet, a number of results support that reduced levels of EcR is not necessary for P.e.-
induced ISC mitoses. The efficacy of the EcR RNAi was validated by its ability to 
suppress 20HE- or mating-induced mitoses (Fig 2.1.1c). Likewise, the expression of 
isoform specific RNAi against EcR A or B as well as EcR A DN did not compromise the 
ISC mitoses to P.e. infection (Fig 2.1.1f-h). Next, I sought to identify which cell type 
specifically require EcR or Usp. I used ISC- or EB-specific drivers to deplete EcR or Usp 
and then I scored mitoses after P.e. infection. EcRRNAi in either ISCs or EBs did not cause 
any significant change in the mitotic response to P.e. infection (Fig 2.17.1b,c). However, 
UspRNAi in ISCs but not in EBs strongly compromised the ISCs to divide after infection 
(Fig 2.17.1b-c). This indicates a cell autonomous requirement of Usp only by ISCs to 
control their proliferation in a context where EcR is dispensable to ISCs. To check 
whether EcR in ECs would also contribute to the non-cell autonomous P.e.-induced ISC 
mitoses, I depleted EcR from ECs (Fig 2.17.1d). EcR-depleted enterocytes cause the ISCs 
to remain competent to the P.e. regenerative responses, even at slightly higher rates 
relative to controls. Consistently, when constitutive tubts driver was used to deplete EcR 
or Usp, the same phenotypes described above were recapitulated (Fig 2.17.1e). To 
confirm Usp activity in vivo during P.e. infection or 20HE feeding, I used the Usp Gal4-
LBD ‘ligand trap’186,288. 20hrs after heat shock induction, at basal conditions, Usp is 
mildly active in a few small cells in the posterior midgut of control flies. 20HE feeding 
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activates ecdysone signaling in midgut cell clusters containing singlets, neighboring cell 
pairs and big polyploid cells (Fig 2.17.1f). After P.e. infection though, the Usp reporter 
was still detected in most cells (Fig 2.17.1f), though contrastingly, EcR reporter activity 
was absent from all cells (Fig 2.1.2 m-p). Altogether, my results show that unlike 
detergent-induced ISC mitoses, EcR in all epithelial cells is dispensable to the P.e.-
induced ISC mitoses. More importantly, this is the first report of a functional bifurcation 
between EcR and Usp in the adult Drosophila332. 
 
Fig 2.17: Only Usp but not EcR is required in ISCs during P.e. infection. Text and 
images have been taken and modified from (Ahmed et al., 2020) and have been originally 
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written and made by myself: (a) Usp is essential while EcR is dispensable to the 
regenerative response after infection. Progenitor-specific expression of UspRNAi after 
enteric infection strongly ablates P.e.-induced ISC mitoses however; progenitor-specific 
expression of EcRRNAi did not deplete P.e.-induced ISC mitoses. Hence, Usp but not EcR 
is indispensable regenerative infection-induced ISC mitoses. Results are shown for 2 
independent RNAi lines. I have produced half of this panel during my master’s study and 
I used it in my master’s thesis as well, Sara Ahmed,2015464.  
(b) Usp is essential while EcR is dispensable to the regenerative response after infection. 
ISC-specific expression of UspRNAi after enteric infection strongly ablates P.e.-induced 
ISC mitoses however; ISC-specific expression of EcRRNAi did not deplete P.e.-induced 
ISC mitoses. Hence, Usp but not EcR is indispensable regenerative infection-induced ISC 
mitoses. 
(c) EcR and Usp are dispensable to the enteroblasts during the regenerative response after 
infection. Enteroblast-specific expression of EcRRNAi and UspRNAi after enteric infection 
does not inhibit P.e.-induced ISC mitoses. Hence, depletion of EcR and Usp from the 
enteroblasts is not important to regenerative infection-induced ISC mitoses.  
(d) EcR is dispensable to the enterocytes during the regenerative response after infection. 
Enterocyte-specific expression of EcRRNAi after enteric infection does not inhibit P.e.-
induced ISC mitoses. Hence, depletion of EcR from the enterocytes is not important to 
regenerative infection-induced ISC mitoses. 
(e) Usp is essential while EcR is dispensable to the regenerative response after infection. 
Ubiquitous expression of UspRNAi with tubts driver after enteric infection causes a strong 
suppression of P.e.-induced ISC mitoses however; expression of EcRRNAi did not deplete 
P.e.-induced ISC mitoses. Hence, constitutive depletion of EcR from the different cell 
types is not important to regenerative infection-induced ISC mitoses. 
(f) Usp activity is present after P.e. infection and 20HE feeding. Representative images of 
the heat-shock inducible Gal4.DBD-Usp.LBD>GFP reporter. Mated female flies were 
heat shocked for 30 mins then exposed to vehicle, P.e. infection or 5mM 20HE for 20 
hrs. Gal4-Usp activity was detected in few cells under basal conditions. However, 
following P.e. infection, low levels of the Usp reporter were detected in most cells of the 
midgut. 20HE feeding induces the Gal4-Usp activity restricted in distinct doublets or 
large polyploid cells. GFP, in green; DAPI, in blue. Scale bar, 100 μm. 
Statistical analysis was performed using unpaired non-parametric two-tailed Mann-
Whitney test (*p≤0.05,**p≤0.01, ****p<0.0001).  
 
2.18 Usp may function with Hr38 to regulate ISC mitoses. 
 
My interesting observations about Usp functions raised the possibility that a nuclear 
receptor other than EcR might interact with Usp in ISCs, modulating the P.e.-induced 
regenerative ISC mitoses. Hence, I tested a panel of hormone receptors (e.g. Hr38, Hr96, 
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Hr83 and Hr51) known to heterodimerize with the Usp mammalian homologue 
RXR333,334.  
Progenitor-specific depletion of receptor partners (Hr96, Hr51) (data not shown for Hr83 
RNAi +P.e.) was not required for P.e. infection. Nevertheless, Hr51 and Hr83 were 
required for 20HE-induced mitoses. In contrast, Progenitor-specific depletion of Hr38 
strongly suppressed the ISC divisions in response to P.e. infection or 20HE feeding (Fig 
2.18a). Moreover, Hr38 reduction also causes a drastic loss in the number of GFP+ 
progenitors, which suggests that Hr38 functions in progenitors survival (Fig 2.18b). I 
validated these results using an alternative independent RNAi line against Hr38 (Fig 
2.18a). Conversely, P.e.-induced ISC mitoses do not require Hr51 or Hr96 and Hr83 
(data not shown for Hr83 RNAi +P.e.). Next, I examined the function of the same 
receptor partners during homeostatic epithelial renewal. ISC with reduced levels of Hr96 
either did not form clones or completely renewed the midgut epithelia (prevalence of the 
phenotype was assessed and a representative picture is shown) (Fig 2.18d). Similarly, ISC 
clones with depleted Hr51; Hr83 did not exhibit a recognizable perturbation in their basal 
ISC clonal formation (data not shown). However, only Hr38-depleted ISC clones 
exhibited a striking defect in their renewal functions (Fig 2.18d). Considerably, a 
significant number of ISCs were absent or remained a single cell. Nevertheless when the 
ISCs divided they gave rise to multicellular clones as depicted in the representative 
picture (Fig 2.18d) (compare to Fig 2.23e for Usp). Hence, my results strongly suggest 
that loss of Hr38 phenocopies the loss of Usp function. Consequently, I hypothesized that 
Usp and Hr38 interact together in vivo to regulate ISC mitoses. To determine the validity 
of this hypothesis, I used heterozygous whole body mutants for Usp or Hr38 then, I 
combined both mutations in trans to generate Usp Hr38 double mutant animals. Either 
heterozygous mutant displayed a defect in their P.e. or 20HE-induced ISC mitoses (Fig 
2.18e). Trans-heterozygotes Usp Δ/xHr38Δ/2 showed a synergistic defect in their ISC 
response to P.e. infection or 20HE feeding suggesting that they both interact together to 
modulate ISC division (Fig 2.18e). Jointly, these results all solidify the hypothesis that 
indeed Hr38 and Usp interact in a heterodimeric complex to regulate aspects of ISC 
division, maintenance or both. Notably, Hr38 is the only other Drosophila nuclear 
receptor known to heterodimerize with Usp to regulate cuticle formation335-337 
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Fig 2.18: Hr38 loss of function phenocopies Usp depletion in ISCs. (a-b) (a) Depletion 
of Hr38 ablates P.e.- or 20HE- induced mitoses. Progenitors-specific depletion of some 
hormone receptor candidates: Hr38, Hr96 and Hr51 thought to partner with Usp after 
enteric infection or 20HE feeding. Progenitor-specific depletion of Hr83 was also tested 
and was not found to phenocopy Usp depletion (data not shown for P.e. infection). ISCs 
of Hr96RNAi progenitors divide at similar extents relative to control midguts after P.e.- or 
20HE-feeding. ISCs of Hr51RNAi progenitors divide at similar extents relative to control 
midguts after P.e.-feeding. Conversely, 20HE-induced mitoses are strongly impaired in 
ISCs of midguts with Hr51RNAi progenitors while Hr96 is dispensable to 20HE-induced 
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mitoses. ISCs of Hr38RNAi progenitors are unable to divide to neither pro-mitotic stimuli. 
Hence, Hr38 depletion resembles Usp depletion in midgut progenitors.  
(b) Representative images of Hr38-depleted progenitors after 20HE feeding or enteric 
infection. A strong reduction in the number of GFP+ progeniitors was noticed after Hr38 
is depleted, implicating Hr38 in the viability as well as proliferation of the progenitors. 
(c) Representative images of Hr51RNAi or Hr96RNAi progenitors after P.e.-feeding shows 
that GFP progenitors expand after infection at similar extents to control midguts. 
(d) Hr38RNAi or Hr96RNAi and control ISC clones in the midgut 16 days after clonal 
induction under homeostatic conditions. Epithelia in control midguts are almost 
completely turned over. In midguts with Hr38 depleted ISC clones, ISCs are occasionally 
lost, however when the ISCs divided, they gave rise to big well-differentiated 
multicellular clones. Hr96 depleted ISC clones divide at normal rates relative to control 
midguts, marked by the complete epithelial renewal observed in most guts. 
(e) Hr38 and Usp may partner together in ISCs of the midgut. Genetic interaction 
between heterozygous whole body Hr38, Usp mutants or Hr38 Usp whole body double 
mutants in trans-heterozygosis. After 20HE- or P.e.-infection, there is an additive defect 
in ISC mitoses of trans-heterozygote double mutants. Representative images are shown. 
GFP, in green; DAPI, in blue. Scale bars, 100 μm. Statistical analysis was performed 
using unpaired non-parametric two-tailed Mann-Whitney test (*p≤0.05, **p≤0.01, 
***p≤0.001, ****p<0.0001).  
 
Fig 2.19 Eip75B and Broad are downstream effectors of midgut ecdysone signaling. 
 
The nuclear receptor Eip75B and the zinc finger transcription factor Broad are well-
characterized as early ecdysone effector genes during embryogenesis 338, 
339metamorphosis177,191and oogenesis340,341. I have demonstrated earlier that Broad and 
Eip75B are transcriptionally regulated by 20HE feeding (Fig 2.13a). Then, I sought to 
examine if either or both relays the ecdysone signals to ISCs of the midgut and how does 
the more relevant effector then act to regulate ISC functions, with a deeper focus on ISC 
mitoses. Firstly, I asked whether Broad and Eip75B are more generally regulated by other 
pro-mitotic stimuli or not. I checked their mRNA regulation after P.e. infection. Indeed, 
they were transcriptionally induced after P.e. infection suggesting that they function 
independently of the ecdysone hierarchy and not only explicitly ecdysone targets (Fig 
2.19a). Next, to determine if Broad and Eip75B are required for 20HE or P.e.-induced 
mitoses, I specifically depleted Broad or Eip75B from progenitors (Fig 2.19b). Consistent 
with the PCR data, both Broad and Eip75B were essential to the 20HE or P.e.-induced 
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mitoses (Fig 2.19b). To examine the role of Broad and Eip75B in the homeostatic 
epithelial renewal, I induced ISC clones with reduced levels of Eip75B and broad over 
time. Clonal analyses revealed that Broad was dispensable for the basal ISC divisions that 
sustain the midgut during homeostasis. However, Eip75B was essential for the ISC clonal 
growth (Fig 2.19d). Conversely, overexpression of Eip75B causes massive clonal over-
growth and increased mitotic indexes supporting the hypothesis that Eip75B is sufficient 
to cause ISC division (Fig 2.19c). When I tried validating this result in the background of 
the progenitor-specific esgts, I found that increased levels of Eip75B in progenitors only 
did not increase the PH3 counts per-se (Fig 2.19g). Nevertheless, the GFP signal that 
should only be restricted to progenitor doublets was widely spread to include many 
polyploid cells (Fig 2.19g). The same results were obtained with the ISC-specific driver 
that supposedly only mark single or doublet cells. Similarly, overexpression of Eip75B 
with the EB-specific driver gives rise to increased numbers of enteroblasts with aberrant 
morphology (Fig 2.19f-g). This has led me to propose several ideas about the discrepancy 
in the phenotype observed in UAS-Eip75B-expressing ISC clones relative to UAS-
Eip75B-expressing progenitors or ISCs. Firstly, despite not detecting ISC mitoses, ISCs 
appear to have divided, evident by the strong GFP signal that extends to the polyploid 
enterocytes and the formation of what appears to be a clone of ISC progeny. Secondly, 
there were definitively always changes in the cellular morphology of cells overexpressing 
Eip75B. UAS-Eip75B-expressing cells look bigger relative to control cells (Fig 2.19g). 
Lastly, despite repeating each experiment many times, the esgtsFO driver was the only 
background in which Eip75B overexpression resulted in increased ISC mitoses.  
Interestingly. This effect was not likely due to damage to ECs, since driving Eip75B with 
the EC-specific MyoIAts driver did not trigger ISC mitoses (data not shown). This 
ambiguous result has led me to think that either the highly expressing Eip75B ISCs 
divide too fast or they mis-differentiate and ISC pool is somewhat severely 
depleted316,342. Consistent with the latter hypothesis, overexpression of Eip75B for 9 days 
caused a prominent loss in regionalization of the midgut (Fig 2.21f).  
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Fig 2.19: Eip75B and broad are downstream 20HE-inducible targets in the 
Drosophila midgut. Text and images have been taken and modified from (Ahmed et al., 
2020) and have been originally written and made by myself: (a) 20HE feeding or P.e. 
infection transcriptionally upregulate the ecdysone-inducible targets Eip75B and broad. 
qRT-PCR measurements from whole midguts show that expression levels of Eip75B and 
broad mRNA are induced by P.e. infection or 20HE feeding 6 hrs after treatment. 
Expression is indicated as mean fold change relative to vehicle-treated midguts ± SD 
(n≥3). 
(b) 20HE and P.e.-induced ISC mitoses require Eip75B and broad. Midguts with RNAi-
mediated depletion of Eip75B or broad in progenitors had suppressed ISC mitoses 
relative to control midguts18 hrs after 20HE feeding or enteric infection.  
(c) Overexpression of Eip75B in ISC clones is sufficient to promote ISC mitoses. ISC 
clones ectopically expressing Eip75B show that Eip75B is pro-proliferative and sufficient 
to induce clonal growth (left). Mitotic counts show that clonal Eip75B overexpression 
activates ISC proliferation (right). I have produced this data during my master’s study 
and I used it in my master’s thesis as well, Sara Ahmed,2015464. 
(d) Eip75B but not broad is required for epithelial renewal. ISC-GFP marked clones are 
generated by the esgF/O system showing that control mated females have constantly 
renewed epithelium, with full replacement taking 1-2 weeks. The size of ISC clones with 
Eip75BRNAi was dramatically reduced but, the size of BroadRNAi ISC clones was seemingly 
unaffected. 
(e) Heatshock-sensitized midguts with progenitor-specific Eip75B overexpression 
vigorously triggers ISCs mitoses. Midgut mitotic figures were quantified after 
overexpressing Eip75B under the control of the progenitor-specific driver esgts for 3 days. 
Prior to inducing Eip75B overexpression via temperature shift, flies were subjected to 
heat-shock for 30 mins or left untreated. Heat-shock alone causes a mild increase in ISC 
mitoses. Eip75B overexpression in progenitors was insufficient to increase ISC divisions. 
Heat-shock of Eip75B overexpressing progenitors resulted in a synergistic effect on ISC 
mitoses. 
(f) Overexpression of E75A in enteroblasts induces a slight expansion in their number as 
shown by the counts of enteroblasts/midgut stack at the R4 region. I have produced this 
data during my master’s study and I used it in my master’s thesis as well, Sara 
Ahmed,2015464. 
(g) Eip75B overexpression results in aberrant enlargement of the cell size and precocious 
differentiation. Eip75B was induced by different cell-specific drivers in progenitors 
(esgts), ISCs (esgts Su(H)gal80) or enteroblasts (Su(H)ts) respectively. In all cases, the 
numbers of GFP+ cells were much higher than in age-controlled midguts without genetic 
manipulation. When misexpressed in progenitors or only in ISCs, many cells with large 
nuclei, typically enterocytes also accumulated. Eip75B misexpression in EBs resulted in 
more cells with abnormal morphology. Hence, Eip75B is maybe involved in both 
proliferation and differentiation. 
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 (i) Eip75B is downstream of EcR and Usp receptors. Mitotic indexes of ISCs reflecting 
the epistatic relationship between EcR/Usp depletion and Eip75B misexpression under 
homeostatic conditions or after 20HE feeding. Under both conditions, Eip75B partially 
rescues the proliferative defect of clonal EcR or Usp depletion which suggest that Eip75B 
relays at least part of the intestinal EcRUsp in the ISCs. Representative images are 
shown. GFP, in green; DAPI, in blue. Scale bars, 100 μm. Statistical analysis was 
performed using unpaired non-parametric two-tailed Mann-Whitney test (ns p>0.05, 
*p≤0.05, ****p<0.0001).  
 
Given this massive disturbance in the dynamic of dividing ISCs, I sought to prompt 
immediate activation of ISC divisions from the moment I induced Eip75B expression. 
Hence, I sensitized the flies with a brief heat shock (15 min, 37 degrees) prior to shifting 
them to 29°C to activate UAS-Eip75B in progenitors. 3 days later, Eip75B over 
expressing ISCs were markedly pro-mitotic (Fig 2.19e). Similar results were obtained 
with Hr3 depletion in ISC clones, as will be shown in a later section (Fig 2.20j). Next to 
determine whether Eip75B acts as a downstream effector of the intestinal ecdysone 
signaling pathway, I examined the effect of Eip75B depletion on the mating-induced 
midgut mitoses (Fig 2.8.1i) and subsequent midgut growth (Fig 2.8.2a-b). In both 
contexts, Eip75B was required to transduce the ovary-derived ecdysone signaling in ISCs 
of the midgut post-mating. Similarly, reduced Eip75B levels in progenitors suppressed 
the reproductive output of mated females (Fig 2.16.1a-c). Next, I performed epistatic tests 
between the loss of function of EcR/Usp together with the overexpression of Eip75B (Fig 
2.19h). Usp-depleted ISC clones had dramatically impaired ISC divisions. However, 
when Eip75B was co-overexpressed with UspRNAi, ISC mitoses were partially rescued. 
Importantly, this mitotic rescue was not observed only under basal homeostatic 
conditions but also after 20HE feeding yet, much less after P.e.-infection. Similarly, loss 
of function of EcR after 20HE feeding was rescued by Eip75B co-overexpression (Fig 
2.19h). These results indicate that Eip75B functions downstream of the EcRUsp 
receptor complex.  
 
Fig 2.20 Eip75B interacts with Hr3 to modulate ISC divisions. 
 
I have figured out that Eip75B is the more relevant 20HE target in the general context of 
basal and regenerative ISC mitoses. I next aimed to investigate how Eip75B functions to 
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regulate ISCs. Traditionally, Eip75B binds Hr3 and block its ability to regulate target 
genes during development175,185,189. In a less traditional model, Hr51 was also shown to 
interact with Eip75B in the Drosophila circadian pacemaker neurons and axon 
regeneration189,343. 
To control the proper balance between stem cell division, self-renewal and differentiated 
progeny, the ISCs must be maintained that they are not lost from the tissue over time. So, 
first, I determined whether Eip75B is involved in maintenance of the ISCs within the ISC 
pool, prolonged loss of Eip75B in progenitors was induced and 23 days later, the cell 
numbers were counted by Dr. Gabi de Silva in the Edgar lab. There was only a 30% 
decrease of intestinal stem cell number, suggesting that Eip75B is non-essential for ISC 
maintenance (Fig 2.20a). To investigate the role of Eip75B in proliferation, I suppressed 
Eip75B in ISC clones and fed the flies with various stresses that are known to cause 
compensatory ISC proliferation and midgut epithelial regeneration30.  When Eip75B 
signaling was suppressed in ISC clones by Eip75B RNAi, midgut regeneration was 
completely inhibited in response to ROS-induced stress or P.e. infection as well as 20HE 
feeding (Fig 2.20b,c). The mild mitotic response of heme feeding also requires the 
presence of Eip75B in the ISCs (Fig 2.20b,c) consistent with the fact that heme is the 
obligate ligand for Eip75B and is required for the Eip75B stability and accumulation175. 
Hence, Eip75B plays an essential role in ISC proliferation. To further explore whether 
Eip75B is required for ISC mitoses in a ISC-autonomous or non-autonomous manner, I 
depleted Eip75B from ISCs or EBs with the cell-type specific drivers, then I fed the flies 
with P.e. or 20HE to stimulate ISC mitoses. Eip75B was not required in EBs for either 
the P.e. or 20HE-induced ISC mitoses (Fig 2.20e), but the ISCs failed to divide when 
they had suppressed levels of Eip75B (Fig 2.20d) revealing the ISC-autonomous 
requirement of Eip75B for ISC mitoses.  
To validate the phenotype of Eip75B in ISCs, I generated mosaic ISC clones 
homozygous for Eip75B∆51, a null allele for all Eip75B isoforms 184 via the MARCMs 
system285 (Fig 2.20f, Fig 2.1.2k). I used two different recombinants and for one I 
quantified the size of generated ISC clones after clone induction then overnight 20HE 
feeding or P.e. infection.  
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Fig 2.20: Eip75B stimulates ISC proliferation through inhibiting Hr3. Text and 
images have been taken and modified from (Ahmed et al., 2020) and have been originally 
written and made by myself: (a) Basal levels of Eip75B are required for ISC 
maintenance. Quantification of the number of GFP+ progenitor cells 23 days after RNAi-
mediated depletion showed a small reduction (~25%) in the GFP+ progenitor pool size 
implying that Eip75B does not critically function in ISC survival. This quantification was 
done by Dr. Gabriela Da Silva from the Edgar Lab. I have used it in my master’s thesis as 
well, Sara Ahmed,2015464. 
(b-c) Eip75B depletion in ISC clones completely represses any stress-induced or 
stimulatory ISC proliferative responses. (b) Representative images of ISC clones in 
mated females after 20HE, heme, paraquat and P.e. infection. While control mated 
females were able to replace almost the entire epithelium 18 hrs after feeding. (c) Mitotic 
counts of Eip75B-depleted clones were strongly suppressed after being subjected to 
different promitotic stimuli. Results for P.e.-induced mitoses are shown for 2 independent 
Eip75B RNAi lines. 
(d) Eip75B is cell-autonomously required by ISCs for proliferation caused by P.e.-or 
20HE feeding. Mitotic indexes of midguts with ISC-specific depletion of Eip75B ablated 
both the P.e.-or 20HE induced ISC mitoses  
(e) Eip75B in EBs is dispensable to ISC mitoses as shown by mitotic indexes of midguts 
with EB-specific depletion of Eip75B. Eip75B-depleted EBs did not affect the P.e.-or 
20HE induced ISC mitoses.  
(f) Eip75B mutant clones fail to divide and grow after P.e. infection. MARCM ISC 
Eip75B null mutant or control clones were induced in female adult midgut epithelia. 
Vehicle-fed control clones were multicellular but, Eip75B null mutant clones remained as 
single ISC clones. After P.e. infection, progeny expanded in control clones yet, Eip75B 
null mutant clones were incapable of replenishing the lost epithelial cells. I have 
produced this data during my master’s study and I used it in my master’s thesis as well, 
Sara Ahmed,2015464. 
(g-h) ISC clones overexpressing Hr3 are unable to divide and maintain the homeostatic 
tissue demands of the epithelium. (g) Representative images of the gut epithelial turnover 
upon Hr3 misexpression using the esgF/O system. ISC clones in control female guts give 
rise to newborn progeny and self-replenish the whole epithelium in contrast to Hr3 
overexpressing clones, (h) Mitotic counts of accumulating ISC divisions in control 
epithelia as the flies age, however increased levels of Hr3 prevent basal ISC divisions. I 
have produced this data during my master’s study and I used it in my master’s thesis as 
well, Sara Ahmed,2015464.  
(i) Hr3 inhibits ISC proliferation. Mitotic counts of midguts misexpressing Hr3 in ISC 
clones strongly inhibited P.e.-induced ISC mitoses relative to control infected females.  
(j) Hr3 depletion is insufficient to induce ISC proliferation. Mitotic indexes of midguts 
with ISC clonal induction of Hr3RNAi after 18-20 hrs of enteric infection. No significant 
difference was observed relative to control infected flies. Results are shown for 2 
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independent RNAi lines. Dr.Gabriela Da Silva from the Edgar Lab did this experiment. I 
have used this data in my master’s thesis as well, Sara Ahmed,2015464.   
(k) After being sensitized with heatshock, midguts with Hr3RNAi ISC clones have elevated 
ISCs mitoses. Midgut mitotic figures were quantified after heatshock in Hr3RNAi ISC 
clones relative to control or Hr3-overexpressing flies. Prior to inducing Hr3 depletion via 
temperature shift, flies were subjected to heat-shock for 30 mins or left untreated. Heat-
shock alone caused a mild increase in ISC mitoses. When Hr3 was depleted in ISC clones 
without heatshock, basal ISC mitoses were minimal similar to guts with Hr3 
overexpressing ISC clones. Representative images are shown. GFP, in green; DAPI, in 
blue. Scale bars, 100 μm. Statistical analysis was performed using unpaired non-
parametric two-tailed Mann-Whitney test (ns p>0.05, *p≤0.05, ****p<0.0001).  
 
The clonal size of Eip75B mutant clones was severely compromised and most cells 
remained singlets or each clone consisted of very few cells (Fig 2.1.2k). Then, based on 
both models of Eip75B’s action described above, I sought to investigate which binding 
partner does Eip75B have in the gut. Hr51 depletion in progenitors was insufficient to 
block the P.e.-induced ISC mitoses despite being required for the 20HE-induced ISC 
mitoses excluding the possibility that Eip75B binds Hr51 (Fig 2.18a,c). Afterwards, I was 
prompted to test if Hr3 is the binding partner of Eip75B. Therefore, I hypothesized that 
overexpressing UAS-Hr3 would mimic the loss of Eip75. To validate that, I induced ISC 
clones with increased levels of Hr3, and then I traced the clonal sizes at intervals after 
clone induction under homeostatic conditions as well as the mitotic activity of ISCs. By 
26 days, the whole epithelium was renewed in mated control females accordant with the 
elevated ISC mitoses; however, Hr3-overexpressing ISC clones had barely divided. (Fig 
2.20g,h). Consistently, ISC clones ectopically expressing Hr3 had ablated ISC mitoses 
after being subjected to P.e. infection (Fig 2.20i).  
Hence, I concluded that the loss of Eip75B phenocopies overexpression of Hr3. As Hr3 
overexpression modulated the ISC mitoses, I expected that Hr3 depletion could potentiate 
the ISC mitoses, so ISC clones with suppressed Hr3 levels were generated and upon 
infection, ISC mitoses were scored. Nevertheless, control and Hr3-depleted ISC clones 
divided at similar rates implying that the increased Eip75B availability in the cell per se is 
not sufficient to promote ISC mitoses or that additional 20HE-dependent targets may be 
required downstream of Eip75B (Fig 2.20j). In an alternative approach to sensitize those 
ISCs to a promitotic stimulus prior to the RNAi-mediated depletion of Hr3, flies were 
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heatshocked prior to shifting to 29oC. 6 days later, the quantification of the basal mitotic 
indexes of the sensitized Hr3 depleted flies revealed that they were mitotically even more 
active than “heat-shock” sensitized control flies (Fig 2.20k). 
 
Fig 2.21 NO regulates Eip75B to Hr3 to modulate ISC divisions. 
To validate the interaction between Eip75B and Hr3, I used a Gal4-LBD ‘ligand sensor’ 
system to monitor the transcriptional activity of Eip75B and Hr3186. Due to the 
transcriptional repressive function of Eip75B, I could not use the GFP reporter to monitor 
the interaction in the reversible manner186. No GFP signal was detected in guts expressing 
the Gal4-Eip75B fusion protein (data not shown). After heatshock, the Gal4-Hr3 sensor 
showed a strong GFP signal in most midgut cells (progenitors and enterocytes, but not 
pros+ enteroendocrine cells; Fig 2.21a), reflective of Hr3 activity in those cells. Gal4-Hr3 
activity was significantly repressed by co-expression of Eip75B or by stimuli that are 
shown to induce Eip75B activity or transcriptional levels i.e.: heme feeding, P.e. 
infection or 20HE feeding (Fig 2.21a). Furthermore, NO interacts with the heme moiety 
of Eip75B, thereby restraining its ability to interact with Hr3176,185. Accordingly, I 
proposed that increased NO levels would stabilize Hr3 reporter activity. To prove that, I 
fed the reporter flies with NO donor (±)- S-Nitroso-N-acetylpenicillamine (SNAP) in 
combination with enteric infection, which effectively reversed the P.e.-suppressed Hr3 
reporter activity (Fig 2.21a). Interestingly, heat-shocked reporter flies were more 
sensitized to heme feeding (Fig 2.21b) relative to flies that are not subjected to this 
treatment (compared to Fig 2.20c), in agreement with the idea that heatshock would stress 
the midgut and induce upregulation of Eip75B in ISCs which is further stabilized by 
heme addition, resulting in a more pronounced mitotic effect (Fig 2.21b). Consistently, 
P.e.-induced ISC division was also significantly repressed by SNAP feeding (Fig 2.21b). 
Conversely, feeding the flies with NO inhibitor, Nω-Nitro-L-arginine methyl ester (L-
NAME) rescued the GFP expansion and mitotic defects shown in ISCs ectopically 
expressing Hr3 (Fig 2.21c,d). Finally, my findings were corroborated by epistasis 
experiments showing that the Eip75-mediation repression of ISC mitoses was  
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Fig 2.21: NO regulates Eip75B/Hr3 to adjust ISC mitoses. Text and images have been 
taken and modified from (Ahmed et al., 2020) and have been originally written and made 
by myself: (a-b) (a) Eip75B activity is regulated by heme. Representative images of 
heatshock inducible Hr3 reporter (hs-Gal4.DBD-Hr3.LBD>GFP) activity in the posterior 
midgut of mated flies after different treatments. Eip75B interacts with the heat-shock 
inducible GAL4-Hr3 fusion protein, blocking its ability to activate GFP expression. Upon 
heat shock for 30 mins, flies were exposed for 20 hrs to vehicle, hs-Eip75B, hs-Eip75B 
+10mM SNAP feeding (NO donor compound), 0.5mM Heme, P.e., P.e. +10mM SNAP 
or 5mM 20HE. Upon vehicle feeding, Gal4-Hr3 fusion protein was active and induced 
strong GFP expression in most cells. The Hr3-mediated GFP expression was repressed by 
the co-expression of Eip75B, 20HE or heme feeding, P.e. infection. Increasing NO levels 
by SNAP feeding in hs-Eip75B transgenic flies or during P.e. infection relieved the 
repressive action on GFP expression. I have produced half of the panel (a) during my 
master’s study and I used it in my master’s thesis as well, Sara Ahmed,2015464. 
(b) SNAP feeding acts as Nitric Oxide (NO) donor and increased NO binding prevents 
Eip75B interaction with Hr3. The Gal4-Hr3 reporter repression upon exposure to heme 
and P.e caused a significant increase in ISC proliferation. SNAP feeding inhibited P.e-
induced ISC division. Mitotic counts of the Hr3 reporter after different pro-mitotic 
treatments. Heme or P.e feeding stimulates ISC division.  
(c-d) NO inhibition rescues the repressive effects of Hr3 misexpression on ISC mitoses. 
(c) Representative images (d) mitotic counts of progenitors with ectopic Hr3 expression 
after treatment with L-NAME (NO inhibitor) +/- enteric infection. Increased Hr3 levels in 
progenitors suppress P.e.-induced ISC mitoses. NO interferes with the ability of the 
Eip75B protein to interact with Hr3 protein thereby, allowing Hr3’s transcriptional 
regulation of its targets. Treatment with L-NAME rescued the Hr3-repressed ISC mitoses 
and progenitor expansion after enteric infection. I have produced this data during my 
master’s study and I used it in my master’s thesis as well, Sara Ahmed,2015464.  
(e) Hr3 is epistatic to Eip75B. Mitotic counts of midguts examining the epistatic 
relationship between Hr3 and Eip75B during homeostasis, after 20HE feeding or P.e. 
infection. Eip75BRNAi, Hr3RNAi was induced in ISC clones of the epithelial midgut.  
Eip75BRNAi in ISC clones prevents ISC mitoses basally or to any of the treatments. 
Hr3RNAi in ISC clones does not have an obvious phenotype. However, repressed ISC 
mitoses in Eip75B depleted ISC clones are entirely rescued by Hr3 depletion under all 
conditions.  
(f) Overexpression of Eip75B causes a significant loss of gut regionalization.   
Representative confocal stitches of guts with Eip75B-overexpressing ISCs relative to 
aged-matched controls.  
(g) A model summarizing my findings. Representative images are shown. GFP, in green; 
DAPI, in blue. Scale bars, 100 μm. Error bars represent ± SD. Statistical analysis was 
performed using two-tailed Mann-Whitney test (ns p>0.05, *p≤0.05, ****p<0.0001).  
reversed by co-depletion of Hr3 under homeostatic conditions, 20HE feeding or P.e. 
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infection (Fig 2.21e). Altogether these results suggest a model in which 20HE-activated 
EcR regulates the expression of Eip75B and broad. Nevertheless, both genes seem to be 
regulated also independently from EcR during P.e. regenerative responses. In all cases, 
Eip75B binds its ligand heme and negatively regulates Hr3’s action on its target genes. 
Hr3 presumably promotes expression of anti-mitotic genes in ISCs, and Eip75B interfere 
with this function, thereby promoting ISC division (Fig 2.21g). 
 
Fig 2.22 Endogenous JH is required for infection-induced ISC mitoses while 
exogenous JH feeding has suppressive effects on ISC mitoses. 
Since I figured out in a very detailed manner how 20HE and its downstream pathway 
affect ISC mitoses, I further inquired how 20HE interacts with the other sesquiterpenoid 
hormone named JH. In the midgut, JH was reported to promote mating-dependent gut 
growth311 and its feeding to virgins had a slight pro-mitotic effect on ISC mitoses311. 
Hence, I started with feeding virgins with several hormone treatments alone or in 
combination for different durations of time (Fig2.22a). Feeding the virgins with 1mM JH 
overnight caused no effect on dividing ISCs and feeding the flies constantly for 3 days 
actually seemed to inhibit ISC mitoses, yet it definitively did not exert a promitotic effect 
on ISCs (Fig2.22a). 
On the other hand, feeding virgins with the JH agonist, methoprene overnight or 
continually for 3 days caused a slight but significant promitotic effect on dividing ISCs 
(Fig2.22a). Alternatively, overnight feeding of 2mM like 5mM 20HE stimulates ISC 
mitoses albeit at lower levels (Fig2.22a). As shown earlier however, 3-day feeding of 
5mM 20HE causes most ISC mitoses to return to almost basal levels. Surprisingly, 
synergistic effect of 20HE and methoprene feeding causes the ISC mitoses to significant 
drop to close to basal levels (compare the magnitude of the drop vehicle vs 20HE vs 
20HE+M or JH). This antagonistic effect of combined hormone feeding on ISC mitoses 
is observed after overnight or 3 days feeding (Fig2.22a). Hence, the relationship between 
the 20HE and JH signaling seems antagonistic rather than synergistic. Next, I asked how 
20HE-induced ISC mitoses interact with the endogenous JH receptors. Thus, I depleted 
the JH receptors Methoprene-tolerant (met) or germ cell-expressed bHLH-PAS (gce)  
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Fig 2.22: JH and methoprene act as mild pro-mitotic stimuli. Text and images have 
been taken and modified from (Ahmed et al., 2020) and have been originally written and 
made by myself: (a) 20HE acts as a strong promitotic stimulus that peaks transiently at 
16-18 hrs then ISC mitoses revert to basal levels by 3 days. JH or methoprene is a mild 
ISC-inducing agent that causes few but enduring ISC mitoses, which lasts after 3 days of 
feeding. Combination feeding of 20HE and methoprene or JH has an inhibitory effect on 
20HE-induced ISC mitoses. Different feeding regimes single or in a combination (JH, 
methoprene and 20HE) were given to virgin females overnight or for 3 days then mitotic 
counts were assayed.  
(b) JH receptors met or gce are required for 20HE-induced ISC mitoses. Progenitor-
specific depletion of gce or met suppresses the ISC mitoses induced by 20HE or 
methoprene feeding to virgin females, as shown by ISC counts. 
(c-d) Progenitor-specific depletion of met completely ablates P.e.-induced ISC mitoses 
while reduced levels of gce strongly inhibited P.e.-induced ISC mitoses but, ISCs still 
slightly divided following infection. (c) Representative images of gce or met depleted 
progenitors after P.e.-infection relative to the control female midguts. Gce-depleted 
progenitors show mild expansion after enteric infection. (d) Met and gce in progenitors 
are required for P.e.-induced ISC mitoses.  
(e) Methoprene requires ovarian ecdysone for its mild proliferative effect on ISCs. Virgin 
guts with depleted ovaries have impaired ISC mitotic response to methoprene feeding, as 
shown by ISC counts. 
(f) 1mM or 5mM methoprene feeding insignificantly affect ISC mitoses after 16hrs 
feeding to mated females. Similar to feedings of virgin females, JH or methoprene alone 
did not induce ISC mitoses. 20HE feeding induced strong ISC mitoses but combined JH 
and 20HE feeding inhibit the 20HE induced ISC mitoses, as shown by ISC counts. 
(g) Exogenous JH feeding inhibits the mitotic response to any ISC stimulus. Combined 
feeding of JH and enteric bacteria strongly inhibit P.e.-induced ISC mitoses. Similarly, 
heat shock causes mild ISC mitoses that are suppressed by exogenous feeding of JH after 
the heat shock, as shown by ISC counts. Duration of treatment or feeding is 16 to 18hrs. 
Representative images are shown. GFP, in green; DAPI, in blue. Scale bars, 100 μm. 
Statistical analysis was performed using unpaired non-parametric two-tailed Mann-
Whitney test (ns p>0.05, *p≤0.05, ***p<0.001, ****p<0.0001). 
 
then, I fed the flies with methoprene, 20HE or both (Fig2.22b). As previously reported, 
met or gce depleted progenitors could not divide in response to the methoprene-induced 
mitoses consistent with the hypothesis that met or gce are redundant JH receptors311. 
Surprisingly, feeding 20HE to midguts with met or gce depleted progenitors completely 
represses the 20HE-induced mitoses (Fig2.22b). Additionally, reduction of met or gce in 
the progenitors of mated females completely ablated the P.e.-induced ISC mitoses 
 
 
146 
(Fig2.22c,d). Both latter data indicate that endogenous JH signaling is required for the 
ecdysone- or P.e.-stimulated ISC mitoses. Additionally, this also suggests that the effect 
of endogenous JH signaling pathway components is permissive to ISC divisions yet, the 
exogenous JH feeding has an inhibitory effect on ISC mitoses. Next I examined the 
epistatic relationship between methoprene and ecdysone. Feeding ecdysone-depleted 
ovary-mediated dibRNAi virgin flies with methoprene impaired their mild stimulatory 
effect on ISC division indicating that intact ecdysone signaling is also required for the 
methoprene-induced ISC mitoses to occur (Fig2.22e). The various magnitudes of effects 
the different treatments had on stimulating ISC mitoses had intrigued me to examine 
whether the same effects apply to mated females (Fig2.22f). Intriguingly, feeding mated 
flies with JH or methorprene at the same or much higher concentrations did not cause ISC 
mitoses in mated females, indicating that the methoprene-promitotic effects are context 
specific to virgin females. Similar to virgins, combined ecdysone and JH hormone 
treatments blocked the ecdysone-induced ISC mitoses (Fig2.22f). I then asked, if this 
inhibitory effect of exogenous JH is specific to 20HE or general to other stimuli. Hence, I 
stressed mated flies with different mitotic stimuli such as P.e. infection or heat shock 
(Fig2.22g). All in all, my results reveal an interplay between 20HE and JH, yet further 
work is required to elucidate the discrepancy in the effect between endogenous and 
exogenous JH feeding on dividing ISCs, and their physiological relevance. 
 
Fig 2.23 Intestinal EcR signaling drives dysplasia and epithelial aging. 
As females age, they experience progressive gut dysplasia, wherein ISCs over-proliferate 
and fail to differentiate properly, leading to intestinal barrier breakdown, and a decrease 
in lifespan 8,62,68,118,120,124,311,344. I thereby asked how the ecdysone/EcR signaling axis 
affects the gut as the flies age. Consistent with previous reports62,120, I observed that aged 
fly guts accumulate many actively dividing ISCs as well as GFP+ve progenitors that are 
positive for enterocyte differentiation marker Pdm-1. Occasionally, these cells are also 
double positive for Ph3 (Fig 2.23.1a-c). Remarkably, progenitor-specific reduction of 
EcR signaling components at the receptor complex level or downstream target Eip75B in 
the gut significantly inhibited the hallmarks of gut aging, whether it is accumulation of 
progenitors or mis-differentiated progenitors or elevated ISC mitoses (Fig 2.23.1a-c).  
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Fig 2.23.1: Ovary derived ecdysone to intestinal EcR signaling regulates age-
dependent gut dysplasia. Text and images have been taken and modified from (Ahmed 
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et al., 2020) and have been originally written and made by myself: (a-c) (a) Aging 
progenitors of the control mated female midguts start accumulating aberrantly 
misdifferentiated dividing GFP+ progenitors. (Shown by representative images: compare 
7 days, 10 days and 35 days old control flies. Thick white arrows point to Pdm-1+, GFP+ 
progenitors. The small arrow points to a dividing Pdm-1+, GFP+ progenitor cell. The 
occurrence of this process across the midgut I refer to hereafter as dysplasia. Gut 
dysplasia is strongly dependent on intestinal EcR signaling through Eip75B. Progenitor-
specific reduction of EcR, Usp Eip75B levels strongly hinders the gut from becoming 
dysplastic. Quantification of dysplastic guts is shown in (b). If at least 10 cells 
accumulate pdm-1+ GFP+ signal in the R4 region, it is classified as dysplastic, otherwise 
the gut is termed non-dysplastic. (c) Mitotic counts of midguts with progenitor-specific 
depletion of EcR, Usp, Eip75B or EcR A dominant negative expression. 
(d-e) (d) Mitotic counts of the ISC clones using the esgF/O system with EcR or Usp 
depletion at different ages. (e) Representative images of EcR or Usp depleted ISC clones 
relative to age-matched controls at 2 different time points. Female gut turnover is slowed 
down upon reduced 20HE intestinal signaling. I have produced this data during my 
master’s study and I used it in my master’s thesis as well, Sara Ahmed,2015464.  
(f) Ecdysone-depleted ovaries have midguts with impaired ISC mitoses. Ecdysone 
production was suppressed in mated female flies by expressing spoRNAi or dibRNAi under 
the control of the ovarian somatic cell-specific C587ts-Gal4 driver. Mitotic counts show 
diminished ISC mitoses of ovary-depleted guts as the flies age (20 and 42 days old) and 
their mitotic indexes remain low relative to aged control midguts. The mitotic defect of 
spoRNAi or dibRNAi midguts was fully rescued when the adult flies were raised on 20HE-
supplemented food. 
(g) Ovarian-specific depletion of spo inhibits ISC mitoses and is fully rescued by 20HE 
feeding. A second alternative RNAi was used against spoRNAi to complement results in 
panel f. Representative images are shown. GFP, in green; DAPI, in blue. Scale bars, 100 
μm. Error bars represent ± SD. Statistical analysis was performed using two-tailed Mann-
Whitney test (ns p>0.05, **p≤0.01, ****p<0.0001). 
 
The phenotype was also replicated with esgts-FO driver to assess the clonal growth and 
ISC divisions. As expected, the whole midgut epithelium was renewed by day 16 and this 
clonal growth was severely suppressed by EcR or Usp depletion in aging flies (Fig 
2.23.1d-e). Similarly, I found that depleting ecdysteroigenic-synthesizing enzymes (dib, 
spo) from the ovary follicles (Fig 2.23.1f,g) or ubiquitously by a tubts driver (Fig 
2.23.2h), also significantly inhibited the age-dependent elevation of mitotic counts. This 
impaired ISC function was completely rescued when the females were reared on 
exogenous 20HE implicating the ovaries as a main organ to drive and potentiate gut 
dysplasia (Fig 2.23.1f-g).  Intestinal dysplasia is accompanied by a decrease in the midgut 
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size and a subsequent loss of regionalization (Fig 2.23.2i) (compare to Fig 2.8.2a). 
Nevertheless, midguts of EcR and Eip75B-depleted progenitors were detectably more 
shrunken than aged control midguts, reflective of the idea that they cannot sustain the 
homeostatic tissue needs (Fig 2.23.2i) 
 
Fig 2.23.2: Ovary ecdysone to EcR in the intestine signaling regulates the hallmarks 
of aging. Text and images have been taken and modified from (Ahmed et al., 2020) and 
have been originally written and made by myself: (a) Ubiquitous expression of dibRNAi 
under the control of the tubts driver in mated females significantly impaired ISC mitosis 
at 22 and 47 days old. 
(b) Reduced intestinal EcR signaling in progenitors accelerates the loss of midgut size. 
Midgut sizes of EcR/Eip75B depleted progenitors show that Eip75 and EcR are required 
to maintain midgut cellularity and morphology, without which it deteriorates somewhat 
faster than control epithelia. Error bars represent ± SD. Statistical analysis was performed 
using two-tailed Mann-Whitney test (**p≤0.01, ****p<0.0001). 
 
Fig 2.24 Intestinal EcR signaling possibly shortens the female lifespan. 
The gastrointestinal tract, due to its role as a digestive organ and function as a barrier 
between the exterior and interior milieu, is critically impacted by dietary, environmental, 
and inflammatory conditions that influence the organismal health and lifespan105. Indeed, 
both gut dysplasia and tumorigenesis shorten lifespan 62,95,107,345,346.  
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Fig 2.24: Reduction of intestinal EcR signaling may extend the lifespan of 
Drosophila females. Text and images have been taken and modified from (Ahmed et al., 
2020) and have been originally written and made by myself: Progeny of the genotype 
GS5961-Gal4 UAS-EcRF645A were mated for 48 hrs. The populations followed up were 
segregated based on their sex and separated into groups of 25 flies/vial. Approximately 
half of the flies were fed with 0.2 mg/ml RU486 to induce RNAi depletion in progenitors 
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and the other half were fed with vehicle. RU486 or vehicle (ethanol) were deposited on 
the food vials 4-6 hrs before flipping the flies into the vials at 48 hr intervals. Dead flies 
were visually identified and recorded. Life span assays were performed in two replicates 
and for each replicate days elapsed after the start of the assay were plotted as a function 
of percentage survival. (a) shows the 2 independent replicates performed on male subjects 
whereas (b) shows the 2 independent replicates performed on female subjects. Statistical 
analysis was performed using log rank test. x2 represents chi-squared value and is present 
below the plots. (c) displays the analyses of the experimental male or female replicates. 
 
As I have confirmed that mating-induced ecdysone is pro-mitotic and accordingly pro-
dysplastic, my findings suggested that ecdysone might also have an adverse effect on 
lifespan. 
Consistent with this idea, whole-body suppression of ecdysone signaling is reported to 
extend Drosophila lifespan166. To figure out whether this life span extension is in part due 
to suppression of age-dependent gut dysplasia, I conducted a lifespan assay with EcR 
dominant negative misexpression via the RU-inducible gut driver GS596162 in both males 
and females, in 2 independent replicates. EcR misexpression in male intestines had no 
apparent advantage on the lifespan (Fig 2.24a,c). In contrast, EcR misexpression in 
female intestines ameliorated their survival fitness relative to controls (Fig 2.24b,c). 
Despite being a highly significant effect, the magnitude of the lifespan extension effect 
was not so drastic (Fig 2.24c). Unfortunately, in figuring out in whether the GS5961 is 
highly specific to the gut, Dr. Pénalva in the Edgar lab detected GFP expression in the 
posterior follicular cells from stage 8 of oogenesis (Fig 2.16.2m-q). This result confounds 
with the lifespan extension effect I observed during my experiments, as reduced fecundity 
was also reported to extend lifespan in Drosophila 347. Thus, the effect of the driver on 
the gut could be explained as a result of slower gut aging or lesser eggs laid due to a 
smaller gut. And the effect of the driver on the ovary could be through an off-target 
indirect effect from the damaged ovarian follicles since EcR functions in migration, 
differentiation, and production of the egg shell 348. Nevertheless, misexpression of the 
same EcR allele I used in my assay was found to cause female sterility when expressed in 
late stage follicle cells 348, (the stages where Dr. Pénalva detected the driver expression in 
the ovary) but, the flies I used for the assay were perfectly fertile across their lifespan. 
This indicates and suggests that the magnitude of the GS5961 driver effect in the ovary is 
relatively minor. Crucially, the careful examination of all the midgut drivers by Dr. 
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Pénalva indicated that the same caveat applies to all the commonly used midgut drivers 
(esg-Gal4, MyoIA-Gal4, Mex-Gal4, Su(H)-Gal4), each of which had some expression in 
the ovary (Fig 2.16 and data not shown). Hence, it remains currently imprecise whether 
the lifespan advantage in all lifespan reports come from gene effects on the gut, in the 
ovary or both and it remains of prime importance to find highly tissue specific gut or 
ovary drivers for future studies. 
 
Fig 2.25 Elevated ecdysone levels pre-disposes flies to intestinal tumorigenesis. 
It is well known that females are more susceptible to forming ISC-derived tumors than 
males 95,345,346. There are several models to induce intestinal tumorigenesis in Drosophila 
346,349,350 among which is depletion of Notch receptor required for EB differentiation 
which leads to accumulation of constantly dividing undifferentiated tumor masses along 
the midgut (Fig 2.25a-h). NotchRNAi in mated females resulted in tumor induction in 100% 
of the flies (Fig 2.25a,b). Notably, NotchRNAi in virgin females was far less tumorigenic. 
Similarly, males display lower tumor burden despite being more prone to develop 
spontaneous neoplasias303 (Fig 2.25c,g,h). I thereby proposed that the tumorigenic 
potential was dependent on 20HE-EcR signaling. To test that, I blocked EcR signaling in 
mated females in the NotchRNAi expressing progenitors with dominant negative expression 
of EcR A, which drastically repressed the tumor growth and progression (Fig 2.25a-c). 
Conversely, I used NotchRNAi virgin females, which were unable to form tumors, and I fed 
them with 20HE prior to NotchRNAi induction. This treatment augmented the tumor 
initiation frequencies (Fig 2.25 b,d,e). 
Moreover, to test the tumorigenicity of ecdysone in males, I reared them on 20HE-laced 
food, which led to increased tumor burden (Fig 2.25c,g,h). 
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Fig 2.25: 20HE signaling predisposes intestinal tumorigenesis. Text and images have 
been taken and modified from (Ahmed et al., 2020) and have been originally written and 
made by myself: (a-b) Intestinal tumor progression is dependent on intestinal EcR 
signaling in progenitors and Notch depleted tumors fail to initiate in virgin females. (a) 
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Representative images of midguts with tumor induction in virgins, mated females or EcR 
A DN misexpressing progenitors. (b) Mitotic counts of Notch depleted adult virgin or 
mated females.  
(c) Quantification of the phenotypes of the intestinal tumors in mated females +/- reduced 
20HE signaling scored as categorized in (f) (first half of the panel). 2nd half of the panel is 
the phenotypes scored in male intestines raised on 1mM 20HE supplemented food as 
categorized in (g). 
(d) Tumors initiate in virgins fed on 20HE for 1 week prior to induction of Notch 
depletion. Quantification of the phenotypes of the intestinal tumors scored as categorized 
in (e). 
(e) Representative images of virgins fed on 20HE-laced food with initiated tumors 
relative to vehicle-fed virgins without tumor clusters. 
(f) Representative images of the 3 categories scored in female tumors: strong tumors are 
denoted in red, moderate are depicted in brown while non-tumorous are depicted in grey. 
(g-h) Representative images of 20-HE-fed notch depleted males that develop and 
progress tumors faster than in intestines that are vehicle-fed. (h) Quantifications are 
shown by deriving ratios between GFP+/DAPI+ areas of 20-HE or vehicle-fed NotchRNAi 
males. Tumor induction commenced few days prior to 20-HE feeding. GFP, in green; 
DAPI, in blue. Scale bars, 100 μm. Statistical analysis was performed using unpaired 
non-parametric two-tailed Mann-Whitney test (****p<0.0001). 
(i) Model summarizing my conclusions. Ovary-derived ecdysone is released after mating, 
whereby it resizes the midgut expanding its area through partly symmetric ISC mitoses. 
Subsequently, this gut resizing allows better nutrient uptake to satisfy the high 
reproductive demands of the mated female. This progressive midgut growth comes at the 
expense of increased predisposition to dysplasia and tumors, hence shortening the 
lifespan.  
 
 
 
To sum up, my experiments showed that steroid hormone signaling robustly stimulated 
ISC division in the midgut of both sexes independently of the sex identity of the ISCs, 
possibly through exerting metabolic effects. Moreover, I also revealed a cross-talk 
between the ovary and the gut whereby, mating-induced release of ovary-derived 
ecdysone stimulates phasic ISC mitoses, conceivably EB differentiation and increased gut 
cellularity, that leads to gut growth. Gut growth occurs to expand the gut’s capacity to 
absorb nutrients thereby, meeting the female’s reproductive demand. However, this gut 
re-sizing process comes at the cost of promoting age-dependent gut dysplasia, increased 
tumor burden and shortened lifespan (Fig 2.25i).  
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Discussion 
 
I reveal an organ-organ communication signal through which the release of an ovary-
derived sex specific signal directs intestinal stem cells of the gut to divide and initiate 
intiestinal growth. This depends on the actions of the highly conserved EcR signaling and 
its downstream target Eip75B. Below I provide a brief overview of the resemblances 
between Drosophila and mammals in the context of their female sex hormones ecdysone 
and estrogen: their actions on the gut and their similarities in the sexual maintenance 
mechanisms as well as similarities in the phenotypes they regulate. This goes along a 
number of implications and connections to existing data, which are worth discussing 
further and could present possible avenues for future research. 
 
3.1 Parallels between the mechanisms of action of ecdysone and estrogen:  
Both estrogen and ecdysone are cholesterol-derived sex-specific steroid hormones that 
are known to control aspects of sexual behavior and reproductive function in mammals264 
and Drosophila300. They are both being produced by the ovaries302,351. Estrogen release is 
directed by luteinizing hormone (LH), follicle-stimulating hormone (FSH) and 
gonadotropin-releasing hormone (GNRH) in mammals while ecdysone release is 
modulated by PTTH (prothoracicotropic hormone) in Drosophila during development but 
a similar brain axis is not described yet in adult Drosophila352. The similarity in their 
structure, site of synthesis, regulated secretion and actions on the reproductive system 
implies that they could have resemblances in their actions in other organs too. 
Although there is still a lot more to be discovered, there are interesting parallels in our 
current knowledge on how estrogen and ecdysone works.  
Liganded ERα, which is most highest expressed in intestinal crypts has been implicated 
in several cell cycle regulatory events. First, estrogen-activated ERα shortens the cell 
cycle significantly by altering the cell cycle duration in the S and G2/M phases. Notably, 
cyclins A and B and well as ERα protein levels display a synchronous behavior in their 
kinetics as the cells progress through the cell cycle after release from G1 arrest. These 
cell-cycle dependent changes in ERα protein expression are likely not mediated via 
transcriptional changes in gene expression, rather via a post-transcriptional 
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mechanism353,354. Secondly, ERα also interacts with cyclins A, B, D1 and E and it too 
directly interferes with the nuclear accumulation of CDK inhibitors including p27, 
CCNG2, p21CIP1 (CDKN1A), GADD45 to promote cell cycle progression355,356 both in-
vitro and in-vivo. Thirdly, distinct patterns of gene regulation are identified after estrogen 
administration most prominently between 4-8 hrs and 24-48 hrs, most of which are genes 
involved in cell cycle and nucleotide processing357.  
Short term pulses of 20HE or estrogen lead to upregulation of EGF and Jak/Stat signaling 
components. I have not had the chance to study the ecdysone-induced genetic profiles 
with such detail. However, remarkably, I find interesting similarities in the pathways they 
activate such as transcriptional induction of Egfr/MAPK and Jak/Stat pathways after 
overnight 20HE feeding consistent with their requirement for cell division to occur357,358. 
This suggests that 20HE and estrogen impinge to some extent on similar pathways, 
sharing at least a degree of conservation in their actions to direct cellular proliferation.   
All these mechanistic details that underlie the rhythmicity of the response to female sex 
hormones are very relevant to study and understand because they probably direct most 
growth in a female’s lifetime (in the sex organs to satisfy the reproductive demand but, 
also now I show that the effects extend to non-sex organs too). Indeed, the biphasic 
response of ISC mitotic stimulation was unique to 20HE feeding in females. Notably, as I 
have observed rhythmicity in the pattern of ISC divisions after mating or 20HE feeding in 
the intestine, the female reproductive tissues similarly undergo cyclical changes of 
growth and degeneration in-vivo directed by gonadal sex hormones. For example: the 
rodent uterine tissues are highly responsive to estrogen, and it causes cell division in a 
biphasic manner similar to what I have observed with 20HE feeding on ISCs of the 
midgut. A single dose of estradiol (most bioactive estrogen) causes early and late tissue 
responses to estrogen. The strength of the response is dependent on the bioavailability of 
the estrogen and the duration of interaction with its receptor. The early response usually 
occurs during the first 6 hrs after estrogen administration and it corresponds to increases 
in RNA and protein synthesis, stimulation of proliferative genes such as MYC and fos as 
well as water retention. This is followed by late estrogen responses include cycles of 
DNA synthesis and epithelial cell mitosis, which begin 10–16 hrs after estrogen 
administration. Two waves of mitoses occur: one wave after ∼16 hrs and the other after 
∼24 hrs356.  
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Accordingly, it would be interesting to profile ecdysone’s response on ISC divisions of 
the gut in-vivo in further detail. I propose repeating the ecdysone feeding and the mating 
experiments in an extended time course from 0-72 hrs (feeding), 0-5 days (mating) to 
define whether: 1. The phasic response observed in 20HE-fed flies extends over time or 
there are only 2 distinct proliferative peaks as I have described. 2. Using RNA seq, 
identifying different patterns of gene regulation to identify early only, late only and early 
and late 20HE regulated genes that correspond to 20HE-induced ISC mitoses. 3.Similar 
rhythmicity of ISC mitoses occurs in response to mating and if they correlate with 
changes in the female uterus to maximize nutrient deposition in fertilized eggs. 
 
3.2. Physiological functions of estrogen and ecdysone signaling in the intestine 
Estrogens and ecdysone contribute to the physiological function of the intestine. Not only 
do ecdysone and female mammalian sex hormones share a strong resemblance in 
reproductive actions in Drosophila 123,158,359 and mammals 323,360, evidence emerged 
suggesting that they have similar actions in other organs. Prior to this report, functions of 
sex-specific steroids on the intestine remain uncharacterized in flies and controversial in 
humans. ERα and ERβ are present in the stomach and intestine of both males and 
females247,361-363. ERα is mainly expressed at the base of the intestinal and colonic crypts 
of males and females, where the ISCs lie and can stimulate c-fos in an estrogen-
dependent manner361,364. ERβ expression is predominantly restricted to the differentiated 
epithelial cells of the intestine365. To date, ER functions in the maintenance of the 
epithelial integrity through the sexually dimorphic estrogen levels, that regulates mucosal 
bicarbonate secretion in the duodenum in mice and humans366,367. Estrogen signaling 
deregulation correlates with prevalence of duodenal ulcers366. Moreover, female sex 
hormones also function to regulate of smooth muscle contractility and motility of the GI 
tract, inhibit pro-inflammatory cytokine production, stimulate wound healing, and 
increase barrier function of the intestinal epithelial cells362,368. The data I gathered during 
my work suggests that EcR functions in the ISCs to regulate mitotic responses during 
epithelial renewal and detergent-induced regeneration. Moreover, my RNA sequencing 
data suggests that ecdysone is associated with increased abundance of digestive enzymes, 
lipid and starch metabolic enzymes. EcR also functions in the enteroblasts to regulate 
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their differentiation in enterocytes. EcR seems to also be required for maintenance of the 
epithelial cells in the midgut raising the possibility that it could function in maintaining 
the epithelial integrity or barrier function, similar to ER functions in the mammalian GI 
tract. To date, the function of the sex hormones regulating digestive functions or 
metabolic enzymes in the gut is not well-characterized which should not be peculiar 
given the conserved roles of sex steroids as central regulators of systemic metabolism in 
mammals acting at CNS, adipose tissue and skeletal muscle369 and in Drosophila acting 
at CNS167, ovaries123 and fat body370. However, the novel notion revealed by my 
experiments here is that at least some aspects of metabolism in a non-sex organ are 
controlled in a sexually dimorphic manner through the sex-specific hormone, 20HE. 
 
3.3. Pathophysiological implications of sex steroids in GI tumors 
Increased levels of estrogen correlate with tumorigenesis in the GI tract of males and 
females. Similarly, I show that tumor initiation and progression in the Drosophila males 
and females depend on ecdysone levels and the extent of active EcR signaling. Ecdysone 
feeding promotes tumor initiation in virgin females and increases tumor aggressiveness 
presented in the males. Reduced EcR levels in progenitors drastically slow tumor 
progression. In line with these results, accumulating biological evidence from 
mammalian studies strongly suggest a link between gastrointestinal adenomas and 
malignant tumors arising from different GI tissues and higher estrogen levels in both 
males and females371-382. Moreover, the rather conflicting long-held view that higher 
estrogens lower the risk of CRC has been debunked by recent studies383. In fact, 
increased circulating endogenous female hormones are linked to promoting CRC tumor 
progression in postmenopausal women384-386. 
Precisely, metabolism and inactivation of endogenous estrogens is suppressed in the 
vicinity of the GI tumors. Hence, the bioavailability of estrogen is higher in the tumor 
microenvironment relative to the surrounding tissues380,387,388. Moreover, in-vivo and in-
vitro studies show that estrogen acts a pro-mitotic stimulus to colorectal cells and it 
drives its tumorigenic effects through induction of c-fos. C-src and activation of the 
mitogen-activated protein kinase (MAPK) cascades389,390. Interestingly, estrogen also 
increases DNA replication activity and mediates alkalinization of colonic crypts isolated 
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from human distal colon and colorectal cancer cell lines through activation of calcium-
dependent protein kinase C (PKC) that alters pH in human colonic cells391. Similarly, 
increased expression of ERα is shown after DSS-induced intestinal inflammation122 and 
GI tumors such as, duodenal familial adenomatous polyposis392. In ERα and ERβ 
negative cell lines, GPER is also alternatively upregulated to transduce estrogen’s 
proliferative and pro-angiogenic actions. In CRC, GPER expression is significantly 
associated with poor survival393. Collectively, tumor progression is potentiated by 
estrogen actions on its receptors. The fact that estrogen increases DNA replication is 
interesting and it coincides with several observations from my RNA seq experiments. 
Males and females are intrinsically different in the expression of DNA-replication and 
cell cycle related genes such that females express higher levels of DNA polymerases and 
other helicases involved in DNA replication initiation. There are also more ISCs in the 
S/G2-phase in females than males in the adult midgut118. These differences could be in 
part explained by the differences in 20HE levels, as 20HE-fed males become more 
similar to females in genes associated with DNA replication.  
 
3.4. Exogenous exposure to steroids has detrimental consequences: 
As briefly introduced in the first chapter, many estrogens from oral contraceptives or 
hormone replacement therapy, dietary sources, livestock production and manure persist in 
the environment posing serious risks on the individuals health and ecosystem. Indeed, 
recent studies show that ethinyl estradiol (EE2, the active component of many birth 
control formulations) initiate rapid non-genomic (i.e. without modulation of target gene 
expression) activation of MAPK, ERK, and JNK pathways in pituitary tumor cells394. 
Moreover, environmental estrogen modulates hepatic insulin sensitivity, energy 
expenditure and distribution of body fat and adipose tissue369. This suggests that 
exogenous exposure to bioactive steroids or endocrine disruptors can mimic endogenous 
estrogens, exacerbating cell proliferation, altering their metabolic profile and increasing 
tumor predisposition. In light of the above and my findings on the actions of exogenous 
20HE feeding promoting ISC mitoses at the expense of faster aging of the gut, I suggest 
that exogenous steroids exposure may represent a real risk factor in the development of 
the metabolic syndrome and their actions should be studied in more detail. 
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3.5. JH signaling is dually required for stimulation or inhibition of ISC 
proliferation: 
My epistasis and feeding experiments led me to a series of conclusions regarding the 
regulation of the cross-talk between the highly complex JH and 20HE signaling networks. 
Exogenous feeding of JH agonist methoprene, but not JH stimulates ISC proliferation in 
virgin females311. Endogenous JH receptors Gce and met are required for the mating-
induced ISC division311, as well as homeostatic maintenance of progenitors. Additionally, 
they are also required for tumor growth 395, 20HE-induced ISC mitoses and stress-
induced mitoses (i.e. in response to paraquat 311 or P.e. infection) in both virgins and 
mated females. Collectively, these findings rather argue that met and partly gce are 
generally required for basal ISC divisions. JH production from at least two different 
sources influences the midgut ISC mitoses. After mating, ovary-derived ecdysone causes 
JH production from the corpora allata, to trigger ISC mitoses324. Additionally, midgut 
progenitors also locally synthesize JH, which is required for their maintainence395. The 
required level of JH signaling in mated females but not virgin females seems sufficient 
because exogenous JH or methoprene cause ISC division in virgin females, not in 
fertilized females.  
Interestingly, the epistasis experiments between 20HE and JH signaling propose a model 
whereby JH signaling components act downstream of 20HE and it is accordingly also 
differentially expressed between males and females. First, in adult flies, reproductive 
success in both males and females is achieved through ecdysone-mediated release of 
JH324. Accordingly, JH is also produced in the corpora allata of males and its release is a 
consequential effect of ecdysone324. Congruent to this model324, my results also suggest 
that JH signaling require ovary-derived ecdysone to trigger methoprene-induced ISC 
mitoses. Hence, I propose that at least partly, ecdysone and JH follow a similar hierarchy 
through which the 20HE regulates JH, partly through converging on similar targets such 
as: Eip75B 396,397 and Krh-1311,398. Consistent with the sexual dimorphism in 20HE, there 
is a sex-biased expression of both met and gce between female and male midguts118. This 
argues that 20HE levels may regulate the extent of activation of JH signaling. 
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Additionally, JH signaling needs to be tightly controlled for ISCs to divide. Exogenous 
JH or methoprene feeding suppressed any stimulus-induced ISC mitoses in either virgin 
or mated females. The stimuli tested included: heatshock, P.e. infection 20HE-feeding. 
 
3.6. Mating causes symmetric ISC mitoses: 
In response to feeding, ISCs remodel the gut by expanding the ISC pool via symmetric 
divisions, and by increasing their proliferation rate10. This causes a feeding-induced gut 
growth that is highly adaptable to nutritional cues.  Subsequent rounds of feeding, fasting, 
and re-feeding cause an adjustable change in gut sizes leading to growth, shrinkage then 
growth10. My experiments suggest that mating-dependent 20HE release from the ovary 
causes an increase in the number of ISCs, possibly via symmetric stem cell divisions as 
shown by EcR reporter activation in delta LacZ+ doublets. In contrast to nutrient-
dependent gut resizing, overnight mating during which females presumably copulate with 
males once appears to cause an irreversible increase in the ISC numbers, which fail to 
regress back to a “virgin-state”. Hence, Mating in flies irreversibly alter the physiology, 
and perhaps the life history, of female flies. I propose these changes to be analogous to 
morphological changes in different organs accompanied with the state of parity in 
mammals (termed as: the number of pregnancies in mammals)399,400. In an analogous 
manner, one could argue that a primigravida state (that is referring to a female pregnant  
once) may be sufficient to similarly alter the mammalian gut physiology. This is likely to 
be an important distinction that is mostly unaccounted for in mammalian studies. 
 
3.7. Functional bifurcation of EcR and Usp 
EcR and Usp function together to modulate gene expression in response to 20HE feeding 
or mating. However, I discovered the first evidence of functional bifurcation between 
EcR and Usp upon P.e. infection in adult Drosophila. EcR was dispensable to the ISCs or 
other midgut cell types for the P.e.-induced ISC mitoses, while Usp depletion completely 
suppressed P.e.-induced ISC mitoses. This is one of the non-overlapping functions 
described for Usp that fit with literature reports suggesting that Usp interacts with other 
nuclear receptor partners across the developmental stages of Drosophila 332. During 
embryogenesis, mutation in DBD/LBD of EcR results in embryonic lethality but, 
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mutation in the DBD of Usp causes lethality only in larval stages: during the first to 
second larval molt159,401. Ecdysone-dependent induction of larval glue genes, a behavioral 
event prior to pupal commitment is also mediated by EcR but, not through Usp402. 
Additionally, Usp forms a complex with Hr38 that is indirectly activated by ecdysteroids 
to function in cuticle formation 336,337, carbohydrate metabolism403, or regulating 20-HE-
dependent transcription335,337. Intriguingly, this interaction is also mediated by the 
mammalian counterparts and is conserved across the vertebrate species333. In the 
Drosophila midgut ISCs, loss of Hr38 phenocopies depleted Usp functions suggesting 
that they function in ISC maintenance. While depletion of other possible Usp partners 
such as Hr96, Hr51, and Hr83 did not suppress P.e.-induced mitoses. Moreover, genetic 
interaction tests validated the interaction between Usp and Hr38 mutants to mediate P.e.-
or 20HE-induced ISC mitoses. Hence, Usp seems to interact with Hr38 in midgut ISCs, 
similar to other contexts335-337,404,405.  
 
3.8. Role of Eip75B in ISC proliferation 
Downstream of 20HE feeding, I identified Eip75B as a critical regulator of ISC mitoses. 
Eip75B is highly homologous to the mammalian REV-ERB127. They are both heme-
bound182, structurally conserved and function in regulating proliferative and metabolic 
genes181,185,406,407. Eip75B functions as a transcriptional repressor, functioning directly at 
promoters of target genes176,184 or through repressing the activatory functions of Hr3175,177 
or Hr51189,408. Genetic epistasis data imply that Eip75B does not function with Hr51 in 
the Drosophila midgut ISCs. Rather, Eip75B represses the transcriptional functions of 
Hr3 not Hr51 to regulate ISC proliferation. Expression of many Eip75B isoforms were 
detected in the transcriptome of the sorted ISCs, not ruling out the likelihood that Eip75B 
can regulate transcriptional targets through direct binding to DNA. Furthermore, I 
showed that Eip75B actions in ISCs are modulated in-vivo through nitric oxide (NO) 
availability in the midgut. NO binds the heme moiety of Eip75B interfering with its 
ability to inhibit Hr3’s activity or recruit co-repressors176,185,189. This implicates Eip75B 
as a redox sensor in the ISCs of the midgut175,182. Indeed, Eip75B was required for 
Paraquat-induced (ROS-producing agent that leads to oxidative stress) and age-dependent 
elevation of ISC mitoses that also occurs as a result of increased oxidative stress106. 
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Accordingly, it becomes particularly interesting to address the role of Eip75B in redox 
homeostasis to control regenerative and self-renewal ISC mitoses, or age-related changes 
in redox state which result in the age-related stem cell dysfunction of ISCs and intestinal 
dysplasia. 
Similarly, heme is required for Eip75B stability and heme availability determines Eip75B 
levels175. Indeed, exogenous heme feeding induces ISC mitoses in an Eip75B dependent 
manner suggesting that Eip75B might act as a heme sensor in the gut. Heme is essentially 
required by metabolic, free radical detoxifying enzymes, hormone synthesizing CYP450 
and energy utilizing enzymes175,409. If indeed Eip75B is sensing heme, it would function 
to regulate a balance between heme availability and enzyme biogenesis175,409-413. This 
notion is supported by the evidence that steroidogenesis in Drosophila require both 
ferredoxins for Fe-S cluster biosynthesis and Eip75B isoform A (now called variant D) 
184,414-416. Notably, the requirement of ferredoxins for steroidogenesis is conserved across 
mammals416. How Eip75B would similarly function in tightly regulating redox or 
metabolic enzymes in the midgut remains an open question. 
In summary, my findings are consistent with the previous reports that established the 
function and validated the interaction of this Eip75B•Hr3 complex in other contexts 
during Drosophila development175,185,189. As Eip75B is highly expressed basally in all 
midgut cell types (Flygutseq database) but also in ISCs of 20HE-fed animals (my 
sequencing data), it should be interesting to identify which genes it actually regulates. 
Given that Eip75B and REV-ERB have overlapping functions in regulating circadian 
rhythm and metabolism in both Drosophila 179,180 and mammals 181,182 and the fact that 
REV-ERB is highly expressed across the GI tract (human Protein Atlas database), further 
studies on the impact of REV-ERB in the context of intestinal stem cell biology should 
prove interesting. 
3.9.The influence of hormones on sex traits: parallels from fly to humans  
Sex is a fundamental biological characteristic that influences nearly all-organismal traits 
from health to disease to mortality. According to the classical textbook definition traits 
can refer to an observable phenotype (termed phenotypic trait) or the underlying genetic 
loci that cause the phenotype (termed genotypic trait). Often traits are termed complex 
because they are multi-factorial. There is increasing evidence from model organisms to 
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genome-wide association studies (GWAS) in humans that suggest that sexually 
differentiated traits are the result of a coalescence of genetic, epigenetic, gonadal 
hormone and external environmental cues. As an example I discuss evidence I obtained 
which supports the contribution of hormonal signaling: 20HE regulation and its parallel 
in humans to the phenotypic and underlying genotypic sex differences in ISC mitoses, 
determined by 20HE levels.  
 
The central dogma is that sex maintenance arises from the primary sex-determining genes 
i.e. sex chromosomes in and outside of the gonads and gonadal sex-biased downstream 
products, such as gonadal hormones, which interact together to impart female and male 
specific sex traits, thereby defining and maintaining the sex of the individual, as 
discussed further. 
a) Sexually dimorphic ecdysone levels regulate ISC mitoses in males versus females 
My results identify circulating ecdysone levels as a sex-specific non-cell autonomous 
systemic signal that acts in concert with the intrinsic sex determination pathway to 
strongly regulate the mitotic ISC behavior in both males and females. Exposure to 
increased levels of exogenous 20HE for varying durations caused striking different 
phenotypes in both sexes. Firstly I begin with the phenotypes observed after short 
exposure to 20HE. 20HE feeding for 6 hrs stimulated 20HE only in females but not in 
males. Then, by 18 hrs, 20HE feeding promoted ISC mitoses rather equally in both sexes. 
Several open questions remain. How can the male ISCs miss the 1st mitotic wave but, 
remain competent to divide at the 2nd wave? Considering that the male gut area is only 
one third that of a young mated female, does this mean that males have less ISCs/gut? It 
could generally be implied that they have less ISCs/midgut because males do not to have 
a significantly higher density of ISCs than male ISCs/area118,316, hence it remains quite 
possible that the total number of available ISCs to divide/time point across the gut is 
different between a male and a female. Males and females do not have differences in the 
ratio of symmetric versus asymmetric divisions but, females have higher proportion of 
their ISCs at the G2/S transition indicating that they have shorter cell cycles118. 
Interestingly, the ratio of ISCs in the G2/S phase relative to the G1 phase is an aspect 
regulated by the intrinsic sex determination pathway118. It is interesting to note that the 
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EcR reporter was active in many delta LacZ+ doublets in the posterior midgut, linking 
20HE activity to symmetric ISC mitoses. So does 20HE exposure boost symmetric ISC 
division in male midguts that suddenly the guts are filled with unusual numbers of 
dividing ISCs? Does 20HE synchronously push the male ISCs through shorter cell cycles 
thereby, bypassing the male-specific trait of the “slower cell cycle” dictated by the 
intrinsic sex of the ISCs? However 20HE is acting, it surely acts differently between 
males and females, which begs further investigation of the sex-specific underlying 
mechanisms that stimulate ISC mitoses.  
Remarkably, short-term 20HE effects on the ISC mitoses remain transient because 
overnight withdrawal of 20HE was sufficient to regress ISC mitoses to basal levels in 
either sex. That is not typical of other pro-mitotic stimuli in the midgut that cause 
persistent ISC mitoses. Interestingly also, 20HE-induced mitoses plummet by 16-20 hrs 
after 20HE feeding but by 40 hrs of continuous exogenous feeding on 20HE, the ISC 
mitoses fall back to basal levels. Does that mean that females have developed the 
capacity to adapt to increased 20HE levels, thus protecting the ISCs from exhausting their 
ecdysone-responsive proliferative transcriptional network to limit over-proliferation? 
Indeed, suggestive of the previous idea, long term exogenous 20HE feeding in mated 
females does not give an obvious advantage to dividing ISCs, and they divide at similar 
rates relative to age-matched controls. Consistent with this, ecdysone targets are known 
to autoregulate their expression, hence limiting the activation of their target genes151. 
Suggestive evidence to support this idea is the fact that 14 days 20HE-fed females do not 
have a transcriptional upregulation of their ecdysone-inducible targets in contrast to the 
transcriptional upregulation of the same targets observed as early as 6 hrs of 20HE 
feeding. In other earlier experiments I did, I observed that the transcriptional induction of 
the ecdysone-inducible targets was not as strong by 20 hrs of 20HE feeding (data not 
shown). Hence, 20HE appear to transiently upregulate its targets to cause ISC divisions in 
mated females.  
Do males possess the same machinery to adapt and downsize the effects of prolonged 
20HE exposure on ISC mitoses? Augmented ISC divisions accompanied by a strong 
induction of the ecdysone-inducible targets after 14 days of feeding males on exogenous 
20HE dispute that males deploy the identical “20HE-female specific” mechanisms to 
limit over division of the ISCs. It is possible that such discrepancy occurs because male 
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ISCs do not have an evolutionary benefit in experiencing such high ecdysone levels. 
Indeed, this notion coincides with the male ISCs being quite resistant to stress 
responses8,118,303. 
Collectively, my findings identify the relevance of non-cell autonomous sex steroid 
signaling as a critical determinant of the mitotic ISC behavior, possibly acting through 
different effectors.  
 
b) Factors influencing sex genotypic traits and how could sex hormones possibly 
regulate them: 
There are several mechanisms with which the sexually different traits could be explained 
including the gonadal or sex-biased hormones. Hence, below, I concisely mention each 
mechanism and discuss the sex hormones factor more in depth since it is most relevant to 
my work. There are generally 4 mechanisms recently proposed to best explain the sex 
differences in the transcriptome and epigenome417. First is the sex biased gene expression 
between males and females in different tissues and across different developmental or 
environmental changes. This difference can be attributed to the difference in the sex 
chromosomes (X in males versus XX in females). Indeed, the X chromosome is enriched 
for sexually dimorphic genes. Of note, the relative change between female and male 
expression levels in sexually dimorphic genes is rather small310. The sex bias in 
differential gene expression often results in a higher predisposition to a certain disease, 
depending on the affected tissue. For example females have higher predisposition to 
autoimmune diseases, consistent with gene ontology enrichment for female-biased genes 
regulated by estrogen or linked to inflammation in gene expression data from the 
blood418,419. The study of 2,500 samples from 15 different human tissues and 9 different 
organs revealed differential expression between males and females in several tissues, 
including anterior cortex in the brain (1,818 genes), heart (375 genes), kidney (224 
genes), colon (163 genes) and thyroid (163 genes). Most sexually dimorphic genes had a 
magnitude fold change <1 between males and females420. In Drosophila, sex differences 
in intestinal physiology and predisposition to tumors exist between males and females. 
Accordingly, sex biased gene expression between males and females exist too. 8.3% of 
all genes in the midgut display significant sexual dimorphism in gene expression118. Not 
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surprisingly, the genes cluster into distinct biological processes118. I also observed similar 
sex biased gene expression in ISCs of the midgut. In total (around 800 in ISCs from the 
1305 genes detected from the whole midgut) genes are also differentially expressed 
between male and female ISCs. 
Additionally, sex- biased splicing also contributes to sex differences in gene expression 
levels421,422. This adds a powerful layer of transcriptional complexity because nearly all 
genes in the genome undergo alternative splicing. 95% of the sex-biased spliced genes in 
the human genome reside on the autosomes and 50% of sex- biased spliced genes are 
associated with genetic diseases423. Importantly, even though hormones are known to 
regulate differential gene expression for example in the context of immunity424, only 32% 
of the sexually dimorphic autosomal genes contain androgen or estrogen hormone 
response elements, suggesting that around two- thirds of the rest of the sexually 
dimorphic genes are not directly regulated by sex hormones420. Additionally, sex 
hormone receptors do not show sex-biased expression in most tissues, suggesting that the 
downstream sex-biased gene regulation is not solely explained by differences in mRNA 
levels of these receptors. Indeed, network analyses of gene regulation revealed extensive 
regulation by the sex hormone receptors and other non-steroid transcription factors, that 
drive the underlying sex differences in the gene regulatory networks425. Similarly, in the 
Drosophila ISC transcriptome, I do not find differences in the abundance of EcR mRNA 
between males and females, instead the differences are in some ecdysone pathway 
components that determine the amounts of 20HE within the cells118 such as controlled 
transport by Oatp74D transporter304 and activation by Shade enzyme155. This suggests 
that 20HE is tightly regulated systemically via its controlled production from the sex 
organs300 and also locally within the midgut. 
It remains an open question if the difference in 20HE levels between males and females 
contribute to the sex-biased differences in gene splicing. Of note, approximately 5.6% of 
the whole midgut transcriptome shows sex-biased isoform gene expression among which 
is Shade enzyme, that transforms ecdysone to its more active form 20HE118,155.   
The second mechanism, which could explain sex-biased gene expression, is the presence 
of genetically inherited variants that either influence RNA splicing and are termed 
splicing quantitative trait loci (sQTLs), or genetic variants that exert their effects through 
gene regulatory mechanisms and are termed expression quantitative trait loci 
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(eQTLs)426,427. Sexually-biased eQTLs may act in one sex but not the other or could be 
shared by both sexes but with larger effect in one sex over the other. Sex-biased eQTLs 
and sQTLs have not received so much attention in Drosophila or mammals yet, however, 
it is hypothesized that predisposition to sex-biased genetic disease could be due to 
accumulation of small effects across a broad range of variants417. The third mechanism is 
the underlying sex differences in the epigenome which include differentially methylated 
autosomal CpG sites428,429. Sex differences in chromatin accessibility result in sex-biased 
expression of genes. Sites with sex- specific chromatin accessibility are enriched for 
genes with sex- biased expression and eQTL genetic variants427. 20HE feeding may affect 
positive regulation of histone acetylation through the upregulation of the evolutionarily 
conserved histone acetyltransferase Atac2430, which is involved in nucleosome 
remodeling431. Notably, the pattern of Atac2 expression displays a sex antagonistic 
relationship in males and females, that is, 20HE-feeding results in higher levels of Atac2 
transcript in females but appears to show an opposite effect in males. Another histone 
acetylase Hcf is not detected in vehicle-fed control males yet it is increased in males after 
20HE feeding432. This could suggest that 20HE exerts some of its actions indirectly 
through the modulation of chromatin accessibility of its target genes. It is known that 
Atac2 activity regulates ISC identity; its high levels cause the ISCs to directly 
differentiate without interfering with lineage specification and its low levels cause 
expansion of ISCs clusters430. Atac2 is also involved in coordinating cellular responses to 
stress through interactions with several kinases such as MAPKs, Msn, JNK433,434. What 
are Atac2 targets in the ISCs? Whether 20HE indeed regulates their functions or not is 
interesting to figure out. It would support the growing body of evidence that steroid 
hormones affect the epigenome through regulating histone deacetylases (HDACs)139 and 
histone methyltransferases141. 
The fourth mechanism is the underlying sex differences in the gonadal sex hormones and 
its direct interaction with gene regulation. Growing evidence suggests that sexually 
dimorphic gene expression could be explained in part due to the interaction of hormone-
regulated transcription factors such as FOXA and STAT5 with sex-biased histone 
modifications that lead to differential responsiveness to ligand-activated nuclear receptor 
signaling and distinct enrichments for functional gene categories between males and 
females435,436. This is in part caused by differences in hormone receptor binding, for 
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example: the effect of growth hormone (GH) signaling on the liver. GH is secreted by the 
pituitary gland in a highly pulsatile manner in males, while in females GH secretion is 
continual and it is considered as a major hormonal determinant of liver sex 
differences436,438. Accordingly, continuous growth hormone infusion causes feminization 
of the male-specific patterns of gene expression and inhibition of a vast majority of male-
specific transcript patterns in the liver437. This is very interesting because it identifies the 
role of growth hormone, an extra-gonadal hormone that exhibits a sex-biased secretory 
pattern from the pituitary gland. Such example for hormonal regulation suggests that 
sexual dimorphism is not only limited to gonadal hormones but may also be determined 
by extra-gonadal hormones.   
As intestinal ecdysone/EcR signaling is causing both male and female ISCs to divide and 
EcR is a nuclear receptor, which exerts its effects mainly through transcriptional 
regulation of target genes. I reasoned that the different circulating 20HE levels would 
lead to differential gene expression between males and females, partly through 20HE. 
Indeed, my primary analyses of the RNA seq dataset revealed the presence of sexually 
dimorphic genes in the transcriptome of the ISCs of the Drosophila midgut, a subset of 
which are regulated by 20HE feeding (75 genes/826 genes at p-value cut off of 0.05 and 
103 genes at a p-value cut off of 0.1) (discussed more below). Notably, this is the first 
report of sexually dimorphic subset of genes in a specific cell type within a tissue in 
Drosophila (ISCs of the midgut) and also reporting changes upon 20HE feeding. The 
elegance of Drosophila genetics is that it gives us the ability to investigate particular 
subtypes of cells within a tissue in a way that is not yet possible in humans. Functional 
in-depth validation of the gene signatures I define as possibly regulated by 20HE will 
provide a mechanistic insight on the hormonal control of the genotypic sex trait that 
would, in part explain the underlying differences in ISC mitoses. 
Steroid-mediated regulation of metabolic function 
Differential gene expression between 20HE –fed and vehicle-fed males revealed that at 
least 20 of the 75 sexually dimorphic ISC transcripts regulated by 20HE are associated 
with metabolic functions118. Yet, the functions of many remain uncharacterized. 
Additionally, 20HE feeding in males resulted in upregulation of lipid and carbohydrate 
transcriptional signatures including digestive enzymes, transporters and metabolizing 
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enzymes in ISCs, all correlating with the amplified ISC divisions, possibly enhanced 
nutrient absorption that would result in the midgut growth. It is worth noting that 
increased 20HE levels in females are similarly reported to regulate glycogen and 
triglyceride levels through EcR signaling in the ovaries of mated flies, to maximize 
nutrient deposition in their fertilized eggs123. 20HE-fed males also have transcriptional 
upregulation of the insulin pathway components. Along this line of evidence, mammalian 
estrogen also increases the expression of insulin receptors in adipocytes and skeletal 
muscle via regulating the expression and translocation of glucose transporters. This 
increases glucose utilization, decreases lipid deposition preventing the development of 
obesity or insulin resistance439,440. Interestingly, from my RNA seq data, Lin-28, a highly 
expressed candidate of this insulin signature is involved in positively regulating 
symmetric ISC mitoses and nutrient-driven adaptive gut growth309. Similarly, the highly 
conserved mammalian Lin-28 is required for symmetric divisions in many stem cell and 
progenitor populations441-443. It does so partly through promoting sensitization to insulin, 
stimulating glucose uptake and metabolism, and oxidative phosphorylation444,445. Thus, it 
is defined as a central regulator of mammalian glucose metabolism. This implies that 
ecdysone might regulate insulin signaling, in part to satisfy the increased intestinal 
metabolic demands of the 20HE-fed males. Additionally, my results suggested that upd2 
is preferentially regulated by 20HE in EBs, ECs and possibly in ISCs. Intriguingly, upd2 
is known be a growth promoting factor and to have metabolic functions in the adult fly. 
Upd2 is secreted from the fat body to regulate insulin-like peptide secretion from the 
insulin-producing cells in the brain, to promote systemic growth and fat storage446. Upd2 
is homologous to mammalian Leptin hormone, which is also secreted by adipose tissue, 
to act on its receptors in the brain to regulate energy homeostasis447. The differential 
regulation of upd2 by 20HE in the midgut signals could signal for a preferential nutrient 
uptake of more carbohydrate and lipids Does that also indirectly contribute to the “fed-
state” of a fly? 
Future studies on how 20HE affects metabolism in the midgut should prove very 
insightful.  
3.10. Fecundity versus lifespan 
Often fecundity and longevity appear to anti-correlate in females, and a common belief is 
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that this is due to limited resources, that need to be allocated either towards egg laying or 
towards repairing one’s own tissues. However, it has been shown that fecundity and 
longevity can be uncoupled166,448. Furthermore, it has been shown that this balance in 
resource allocation does not fit with tracer experiments using stable isotope-labeled 
food449. This work argued that reproductive costs are not caused by resource allocation, 
but rather by indirect damage to the soma when reproduction is activated. Indeed, there is 
a growing body of evidence that suggests that gonadal steroid signaling activates lipid 
metabolism in the gut to regulate aging. Adult Drosophila flies lacking germline stem 
cells (GSCs) live 50 % longer than the controls450. The underlying mechanism suggesting 
that gonadal inputs could regulate aging and determine longevity may well be conserved. 
Also in mice, ovary transplantation from young females increases the life expectancy of 
the older female recipients451. Additionally, arrested germ cell proliferation also promotes 
longevity in C.elegans452. The underlying longevity effects require gonadal steroids from 
the somatic gonad that signal to the intestine and the nervous system of C.elegans453,454. 
In C.elegans, ecdysone equivalents, dafachronic acids (DA), are synthesized in the 
somatic gland via DAF-9/cytochrome P450 and other hydroxysteroid dehydrogenase 
enzymes, similar to the steroid-synthesizing enzymatic cascade in the Drosophila ovary. 
In the intestine, the DA receptor DAF-12, EcR paralog in C.elegans increases longevity 
in germline-ablated animals via regulating downstream target lipolytic genes 
expression455, activating nuclear receptors to regulate the expression of stearoyl-CoA-Δ 
9-desaturases and via promoting FOXO/DAF-16 nuclear localization in the intestine456. 
Notably, DA supplementation can restore longevity of the whole gonad-deficient worms 
lacking both germline and somatic gonad, which requires the presence of intestinal 
receptor DAF- 12457. In parallel, my results show that the activation of reproduction 
comes at the cost of increased dysplasia and tumor risk so also, strengthening this 
gonadal-gut axis regulation that determines the organism’s lifespan. Intriguingly, human 
FOXO3 variants are also associated with longevity again suggesting that the regulatory 
mechanism is evolutionarily conserved 458,459. 
 
My findings within this work thus contribute to the growing insight of the hormonal 
regulation on the intestine. I propose that active gonadal sex hormones render the gut 
more responsive to increased reproductive demands thereby, creating a trade-off between 
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satisfying reproductive demands and longevity in flies. This may be reminiscent of a 
conserved strategy in mammals where estrogens might have an initial advantage to the 
female gut functions, but over time accumulation of more estrogen metabolites 
contributes to inflammation and tumorigenesis of the GI tract. Given the evidence, I 
propose that the possible contribution of sex hormones to intestinal physiology deserves 
further investigation.  
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Materials and Methods: 
The text of the following section (Materials and Methods) has been taken from (Ahmed 
et al., 2020) and has been originally written by myself: 
 
Fly stocks and cultures 
Drosophila melanogaster were raised on standard media and maintained in incubators 
with controlled temperature and humidity on a 12 h light/dark cycle. Flies were 
transferred to fresh vials every 2 days. Male and female Drosophila were raised mated for 
all experiments, unless indicated otherwise. w1118 (VDRC #60000) flies were typically 
used as wild-type controls and y w[1118];P{attP,y[+],w[3`]  (VDRC #60100) were used 
as wild-type controls for KK RNAi lines. 
Gal4 driver lines:  
esgts: y,w; esg-Gal4/Cyo; tub-Gal80ts UAS-GFP/TM6B 5 
esgts F/O: w; esg-Gal4 tub-Gal80ts UAS-GFP/Cyo; UAS-flp, act>CD2>Gal4/TM6B 41 
esgts Su(H)-Gal80: esg-Gal4, UAS-2XEYFP; Su(H)GBE-Gal80 tub-Gal80ts (Gift from 
Steven Hou)  
Su(H)‐GBEts: Su(H)GBE‐Gal4,UAS‐CD8‐GFP/CyO; tub-Gal80ts/TM6B  
MyoIAts: w; Myo1A‐Gal4NP0001/CyO; tub‐Gal80ts, UAS‐GFP/TM6B 
prosts: w;tub-Gal80ts,UAS-GFP/CyO,wglacZ;Prosv1-Gal4 
tubts: tub-Gal4; tubGal80ts/TM3, ser (Gift from Valeria Cavaliere’s lab) 
howts: how-Gal4; tubGal80ts 
elavts: Elav-Gal4, UAS-GFP/FM7C;+; Tub-Gal80TS/TM2Ubx 
C587ts: c587-Gal4; tubGAL80ts 
UAS transgenes: 
UAS-Eip75B on II (kindly provided by Henry Krause, University of Toronto, Canada) 
UAS-Hr3 on III (kindly provided by Henry Krause, University of Toronto, Canada) 
UAS-EcR.A.F645A (BDSC 9452) 
UAS-EcR.A.W650A (BDSC 9451) 
UAS-EcR.B1-ΔC655.W650A (BDSC 6872)  
UAS-TraF (kindly provided by Irene Miguel-Aliaga) 
RNAi stocks:  
 
 
174 
UAS-EcR RNAi (VDRC GD 37059, BDSC 29374 TRiP JF02538) 
UAS-UspRNAi (VDRC GD 16893 and BDSC 27258) 
UAS-traRNAi (BL:2851 kindly provided by Irene Miguel-Aliaga) 
UAS-Eip75BRNAi  (VDRC GD 44851 and BDSC 35780, TRiP.HMS01530) 
UAS-Hr3RNAi (VDRC GD 12044, BDSC 27253, TRiP.JF02542, and NIG 12208R-2)  
UAS-SpoRNAi (BDSC 51496, spok RNAi 2A2;2A3 kindly provided by Michael 
O’Connor) 
UAS-DibRNAi (v101117 kindly provided by Michael O’Connor) 
UAS-BrRNAi (KK 104648) 
UAS-NotchRNAi (VDRC GD 27228) 
UAS-Upd2RNAi (TRIP 33988, HMS00948) 
UAS-Upd3RNAi 460 
UAS-RhoRNAi (TRIP 41699) 
UAS-stringRNAi  (NIG 1395R-1) 
UAS-EgfrRNAi (TRIP 31183) 
UAS-metRNAi (KK100638, TRIP 26205) 
UAS-gceRNAi (TRIP 26323) 
MARCM stocks: 
MARCM 80B yw hs-flp1.22 tub-Gal4 UAS-GFP(NLS); +; tub-Gal80 FRT80B/TM6B 
FRT 80B: W; [neoFRT]80B/TM6B,sb1 
Eip75BΔ51 FRT 80B: Eip75BΔ51P[neoFRT]80B ry506 (recombinant #1)/TM3.sb in Fig 
ED 3b,c (kindly provided by, Elizabeth T.Ables  East Carolina University School of 
Biology, North Carolina, USA). 
Eip75BΔ51 FRT 80B: Eip75BΔ51P[neoFRT]80B/TM3.sb in ED Fig 16c (kindly provided 
by Yijie Li, Johns Hopkins University School of Medicine, Baltimore, USA) 
 
Reporter lines:  
w1118; hs-GAL4-DHR3.LBD.HA; UAS-Stinger (BDSC 28868)  
w1118; UAS-Stinger; hs-GAL4-EcR.LBD (BDSC 28863) 
w1118; UAS-Stinger; hs-GAL4-Usp.LBD (BDSC 28864) 
w1118; P{10XStat92E-GFP}1 (BDSC 26197) 
w1118; P{10XStat92E-GFP}1 (BDSC 26198) 
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IF/CyO; Upd3.1 LacZ/TM6B 
Gbet Su(H)-lacZ/x 
Delta05151/tm3.sb 
 
Mutant stocks:  
w* upd2Δ (BDSC 55727) 
w* upd2Δ upd3Δ (BDSC 55729) 
w* upd3Δ (BDSC 55728) 
DmspoZ339 (Kindly provided by Michael O’Connor) 
spo1 st1 e1/TM3, Sb1 (BDSC 3276) 
 
Deficiency stocks: 
w[1118]; Df(3L)Exel6105, P{w[+mC]=XP-U}yorkExel6105/TM6B, Tb[1] Bloomington 
#7584 
w[1118]; Df(3L)BSC387/TM6C, Sb[1] cu[1] ] Bloomington #24411 
 
Drosophila husbandry 
For transgene expression using the Gal4/Gal80ts system, experimental crosses were 
maintained at 18°C (permissive temperature for GAL80ts) in standard medium. Animals 
of the desired sex and genotype were collected within 48h of eclosion and aged for an 
average of 5 days before shifting to 29°C (restrictive temperature for GAL80ts) to induce 
UAS transgene expression. Adult midguts were dissected after different periods of time 
as indicated in on top of each figure panel. The esg-Flip-Out system (esgF/Ots)41 and the 
MARCM system285 were used to generate ISC-derived clones. Flies were aged for 3-6 
days after eclosion before clonal induction by temperature shift to 29°C for esg‐FO 
clones or heat-shock for MARCM clones. Additional details on transgene expression 
times are indicated in the corresponding figure legends. MARCM 80B flies were heat 
shocked for 45-60 min in a 37°C water bath, and then aged for 12 days at 29°C before 
overnight treatment with vehicle, 5mM 20HE or Psuedomonas entomophila (P.e.). 
 
Mating experiments 
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At least 10-15 virgin females for each genotype were collected at 18oC as they emerged. 
They were aged for ~5 days and then shifted to 29oC until the time points indicated in 
each figure panel. At the start of mating, females were transferred to fresh vials and 
allowed to mate with equal numbers of adult 3-7 days old wild type w1118 males, devoid 
of any transgenes, at 25oC, for optimal fecundity. Time when males were introduced to 
females in the same vial is denoted as t0. If indicated as mated once, then after 18-20 
hours, the males were removed and the females were flipped into fresh vials every 48 
hours until the indicated time in the respective figure panels.  Otherwise, males were left 
together with the females for the following time points: 24 hours, 37-40 hours, 46-48 
hours or 72-74 hours.  
 
GAL4-LBD ‘ligand sensor’ system 
Adult flies with bipartite detection system consisting of the LBD of the Drosophila 
nuclear receptor (NR) fused to the DNA-binding domain of yeast GAL4, along with a 
GAL4 UAS-controlled GFP reporter gene were used as previously described186,288. Flies 
were raised and maintained at 25°C. For visualization of ligand sensor patterns, 5-7 day-
old mated females were starved for 2-4h, heat-treated for 30 min in a 37°C water bath 
only once for EcR, Usp and Hr3 reporters, and allowed to recover at room temperature 
for 15 minutes. Then, flies were transferred to vials containing a fresh feeding vial (see 
Feeding Experiments) and kept at 25 °C for 16-18 hrs until dissection. 
 
In vivo 10XSTAT92E-GFP reporter system: 
Adult mated female flies of the genetic background 10XSTAT92E-GFP that have 10 
Stat92E binding sites driving GFP expression were aged for 5-7 days and treated for 6hrs 
with 5mM 20HE and for 16-18 hrs with 5mM 20HE or P.e. infection.  
 
In vivo Upd3 lacZ reporter:  
Adult mated female flies of the genetic background Upd3.1 LacZ/TM6B were aged for 5-
7 days and treated for 16-18 hrs with 5mM 20HE or P.e. infection.  
 
Overnight Feeding Experiments 
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For all experiments except 20HE/SDS feeding (as indicated in the fig panel), flies were 
fed for 16-20 hrs, then dissected to remove the intestines, which were analyzed using 
immunofluorescence and confocal imaging. For 20HE feeding, flies were fed as early as 
4 hrs , then 6, 9, 12, 16 hrs and as late as 22 hrs. We observed a window of strong mitotic 
response at 6 hrs and again at 16-18 hrs that persisted to 22 hrs after exposing the flies to 
the 20HE feeding solution. 
For 20HE removal experiments, flies were fed overnight (O/N) for 16-18hrs with 5mM 
20HE, and then transferred to a fresh vial for another O/N treatment after which the 
midguts were dissected and stained. 
20-hydroxy-ecdysone (20HE) feeding: 10-15 adult male, mated female, or virgin female 
flies were used for the ecdysone feeding experiments, as indicated. 20HE was weighed 
out of the supplier’s vial and was first dissolved in 100% ethanol. Water was then added 
to make up a 25mM stock solution in 10% ethanol. 25mM 20HE stocks were stored at -
20oC. A final concentration of 0.25-10 mM ecdysone or 2% ethanol (as control) was used 
for the feeding experiments as indicated. 200μL of 5% sucrose solution, 5 mg/ 1mL dry 
yeast + 5mM 20HE (Sigma-Aldrich H5142) mix was deposited on top of a standard food 
vial to which flies were transferred. If the experiment required P.e. infection, then 400 μL 
of the same yeast/sucrose mix (described above) was deposited on filter-paper discs 
(Whatmann) to which flies were being transferred. The sucrose yeast mix with 2% 
ethanol was used as vehicle treatment. 
Detergent treatment: flies were left to feed on yeast sucrose solution (described above) 
with 0.1% or 1% SDS for 18-20h or at the times indicated. 
Enteric P.e. infection: A 25 mL pre-culture was started the first day by inoculating 
Pseudomonas entomophila (P.e.) bacteria from glycerol stocks (stored at -80°C) in 
Rifampicin-supplemented Luria Broth (LB; final antibiotic concentration: 100 μg /mL). 
The pre-culture was grown overnight at 29°C, shaking at 130 rpm. Next day, the pre-
culture was diluted in 175 mL Rifampicin supplemented LB and the culture was again 
grown overnight at 29°C, shaking at 130 rpm. After the growth of the bacterial culture 
reached optical density (O.D) ≈ 0.5, the culture was spun down at 2500 g for 25 min at 
4°C and the pellet was re-suspended in 3 mL of 5% sucrose + 150 μL yeast. Prior to 
infection, flies were starved for 2 hrs (optional step), and then placed in vials with 500 μL 
of this P.e. solution or 5% sucrose with yeast as the control vehicle.  
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Other treatments include feeding with 2.5mM Paraquat , Nω-Nitro-L-arginine methyl 
ester hydrochloride (Sigma-Aldrich, N5751) (200 mM L-NAME stock solution in 
distilled water; final 10mM concentration was used), (±)-S-Nitroso-N-
acetylpenicillamine (Sigma-Aldrich, N3398) (500 mM SNAP stock solution in 10% 
ethanol and 10mM SNAP final solution was used), Hemin (Frontier Scientific, H651-9) 
(2 mM stock solution dissolved in 0.1M NaOH, pH adjusted to 7 with sodium phosphate 
buffer and 0.5 mM final solution was immediately used) and their corresponding vehicle. 
Treatments were diluted in 400 μL total volume of 5% sucrose and 5 mg/1 mL yeast then 
added vials containing a fresh feeding paper. 
 
Long term ecdysone feeding 
At least 10-15 adult male and/or female flies were transferred to standard fresh food vials 
(2.5 cm diameter) containing circa 3 mL of food. To prepare ecdysone treated food, the 
food in the vial was scraped on the surface and 200 μL 1mM 20HE, 22 mg/mL yeast in 
5% sucrose solution was added. After 15 minutes, this solution diffused into the food. 
Flies were added to these vials and flipped into fresh 20HE containing vials every 48 hrs 
for 14 days unless otherwise indicated. As vehicle, vials with fly media containing 200 
μL 0.43% ethanol in sucrose/yeast solution were used. Flies were dissected to remove the 
intestines, which were analyzed using immunofluorescence and confocal imaging. For 
the flies raised on low nutrient food, flies were fed with 1mM 20HE, 5 mg/mL yeast in 
5% sucrose solution that was deposited on filter-paper discs (Whatmann) and exchanged 
every 24-30 hrs. For P.e. infection after long-term 20HE feeding, I discontinued feeding 
the flies on ecdysone-containing food for one day before the flies were fed with the P.e. 
bacterial solution.  
 
Fecundity assays 
At max 10-15 virgin females for each genotype/replicate were collected at 18oC as they 
eclosed, and pooled in one vial. For each genotype 3-4 replicates were performed. 
Virgins were aged one day and then shifted to 29oC to activate Gal4. Females were then 
transferred to fresh cages and allowed to mate with equal numbers of w1118 males. 
Females were housed in groups of 7-10 with equal number of males for this experiment. 
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Standard Drosophila media was poured in 5 cm plates and stored at 4oC. Flies in each egg 
collection cage were flipped onto fresh food plates every 24-48 hours for the indicated 
number of days, the number of eggs/replicate were scored and averaged over the number 
of flies in each cage. 3-4 replicates were pooled for each genotype.  
Virgins were aged 8 days at shifted 29oC to activate Gal4 first before mating to equal 
number of males. Females were housed in groups of 7-10 with equal number of males for 
this experiment. Flies in each egg collection cage were flipped onto fresh food plates 
every 24-48 hours for the indicated number of days, the number of eggs/replicate were 
scored and averaged over the number of flies in each cage. 
Virgins were aged one day and then shifted to 29oC to activate Gal4. Females were then 
transferred to fresh vials and allowed to mate with equal numbers of w1118 males. All 
subjects were housed overnight in the same vial to ensure mating success and numbers of 
eggs were counted and averaged for the number of females/vial. Next day, every 
female/male pair was separated and individual female/vial were followed up for 14 days. 
Vials were exchanged every 24-48 hours in this experiment and total number of eggs 
laid/2 days was counted for every female fly. 
A 3 day sum was calculated from the average number of eggs/fly laid every day, then an 
average sum of eggs laid/fly/3 days across the replicates was plotted with error bars ± 
confidence intervals (c.i.). Alternatively, the average/individual cumulative numbers of 
eggs were summed up and mean values were plotted with error bars ± standard deviation 
(s.d.). To test statistical significance for each day (source data), Two-sample unequal 
variance t-test were performed, with a two-tailed distribution assuming unequal variance 
for test genotype relative to control at every time point. Alternatively, general linear 
models (GLMs) with binomial errors were used to examine the effect of the genotype on 
the average cumulative number of eggs. 
 
spo mutant rescue experiment 
Males of either deficiency backgrounds BM#7584 or BM#24411 were crossed to 
heterozygous spo mutant virgins and allowed to lay eggs on apple plates for several days 
prior to the experiment. 2 deficiency genotypes were used to increase the likelihood to 
getting rescued homozygous spo mutant flies. On the day of the experiment, the parents 
were left to lay eggs for 4 hours then, were removed. The eggs were allowed to age 4-6 
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hours at 25oC then, were all pooled in a sieve and de-chorionated by bleach. After 
washing in PBS-T, the de-chorionated embryos were incubated in PBS-T supplemented 
with 100 μM 20E for 3 hours.  The embryos were covered with Halocarbon 27 Oil and 
incubated at 18oC overnight. Over the next 2 days, homozygous spo embryos were 
selected under a fluorescent stereoscope by the lack of GFP expression in the hatched 
larvae. The phenotypically correct larvae were collected in fresh food vials at the density 
of 40-60 larvae/vial and allowed to develop at 25oC until eclosion and selection of virgin 
or mated homozygous spo mutant flies. 
 
Lifespan assays 
Males and females of the genotype 5961GS EcR A DN were allowed to mate for 48hrs 
then were isolated in groups of 25 flies of the same sex/vial. For RU486 food 
supplementation, 100 μl of a 5 mg/ml solution of RU486 or vehicle (ethanol 80%) were 
deposited on top of a food vial and dried for at least 4-6 hours, resulting in a 0.2 mg/ml 
concentration of RU486 in the food accessible to flies. Flies were flipped every 48hrs into 
a fresh vial. Dead flies were visually identified (flies not moving, not responding to 
mechanical stimulation and laying on their side or back were deemed dead), and the 
number of dead flies was recorded. Oasis software was used for data analysis461. Logrank 
non-parametric test was performed by the software and the p values were derived from 
pairwise comparison with Bonferroni correction as displayed in ED 10 g-h.  
 
FACS sorting of ISCs: 
C587ts mira-GFP on chromosome II progeny were collected and aged 7-9 days at 18 
degrees then shifted at 29 degrees in groups of 60. (so, 30 males and 30 females/vial). 
350 μL of 1mM ecdysone or 10% ethanol are supplied to the flies daily for 15 days till 
sequencing date. 
FACS sorting protocol is adopted from Dutta et al, 2015.  
Midguts were dissected in in nuclease/RNAse free 1xPBS (80-100 midguts per sample) 
then transferred to 1.5 ml eppis with 450 µl nuclease/RNAse free 1xPBS on ice. 100uL 
elastase (0.4% w/v stock solution kept at -20°C) was added. This was incubated for 1.5 
hour at 27°C (300 rpm only the last 30 minutes) and the tube flicked every 10 mins. 
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Then,centrifuged at 2500 rpm for 12 mins. The supernatant was discarded without letting 
the pellet dry and fresh 500 µl nuclease/RNAse free 1xPBS was added. Propidium Iodide 
(PI) 1:1000 to stain dead cells. Then,cell suspension was pipetted onto blue cap of FACS 
tubes and gently tapped to help flow through. (RNAse free) 1.5 ml eppis with 250 µl 
Extraction Buffer was prepared for FACS sorting and RNA was extracted and sent for 
sequencing. The kit for RNA extraction used was Arcturus PicoPure RNA isolation kit 
(Applied Biosystems) according to the manufacturer’s instructions. 
Sequencing:  
Library prep (done by DKFZ core facility) using SMARTer® Ultra® Low Input RNA 
Kit for Sequencing  (Clontech Laboratories, Inc.) and Low Input Library Prep Kit 
(Clontech Laboratories, Inc. ) . Ultra Low RNA Seq was carried out using HiSeq V4 
SR50 sequencer. Total RNA was sequenced.  
 
Sequencing analysis: The FASTA files were aligned to the Drosophila transcriptome as 
follows: Adaptor-trimmed reads were mapped to a file containing coding sequences of 
combined Dmel transcripts and filtered for only uniquely mapping reads . Unique Dmel 
reads were re-mapped to the transcriptome Dmel release 6.02 genome using STAR 
(Spliced Transcripts Alignment to a Reference) Aligner on the galaxy.org server with the 
following settings: single-end reads. The mapped.bam alignment files were then assessed 
for their strandedness and counted with featurecounts on the Galaxy server. Single 
alignment was ensured and the percentage of reads mapped to multiple loci for every 
sample was 0%. The percentage of uniquely mapped reads for each sample was around 
80%. All hits were filtered for >10 reads and normalized for the total number of reads 
aligned. Afterwards, differentially expressed genes were determined using edgeR on the 
count data files. 
edgeR differential expression: count files were imported into the compaRNA function of 
the Husar Platform with the following parameters: P-Value Threshold for EdgeR 5.0e-2. 
The results were imported to excel, 0.05 p value was set as a cut-off for enriched hits in 
any sample, then -log10(p values) were calculated. The enriched hits were imported to 
Flymine v49 2020. Gene Ontology Enrichment or Pathway Enrichment widgets were 
used to compare hits against the background of my aligned reads filtered for reads>10, 
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max p-value was set to 0.05. Homologues were retrieved from Mouse or Human Mines 
and similarly Gene Ontology Enrichment or Pathway Enrichment widgets were used. 
The sexually dimorphic hits were determined in reference to the supplementary table of 
Hudry et al,2016 list of sexually dimorphic genes.  
The set of similar hits between 20HE fed males and vehicle fed females were determined 
by comparing the lists of genes that are differentially expressed between males and 
females and the list of genes that are differentially expressed between 20HE fed males 
and females (a p-value cut off of 0.05 or 0.1) and have more than 10 total reads. Through 
a series of vlookup functions, the list of genes that are different between males and 
females but are no longer different between 20HE fed males and females are the list of 
genes presented in 2.7.6 and table 2.4. Those hits reflect genes that are becoming “more 
similar to vehicle females” after 20HE feeding. 
 
Immunohistochemistry and microscopy 
Drosophila adult midguts were dissected in 1x phosphate-buffered saline (PBS) and fixed 
with 4% paraformaldehyde for 30 min at room temperature (RT). For all immune-
stainings except anti-dpErk, samples were washed with 0.015% Triton-X in PBS thrice at 
RT, then permeabilized with 0.15% Triton-X in PBS for 15 min at RT with shaking. 
Then, samples were re-washed and blocked in PBS with 2.5% BSA, 10% normal goat 
serum and 0.1% Tween-20 (blocking solution) for at least 1hr at RT. Midguts were 
incubated with primary antibody at 4 °C overnight at the following dilutions: chicken 
anti-GFP (Life Technologies/Molecular probes, 1:500); rabbit anti-phospho-Histone 3 
(Merck Millipore 1:1000); mouse anti-phospho-Histone 3 (Cell Signaling, 1:1000); 
guinea pig anti-GFP (Teleman Lab, 1:1000); chicken anti- -galactosidase (Abcam, 
1:1000). 
For the dpErk detection, samples were fixed in 4% paraformaldehyde, dehydrated for 5 
min in 50%, 75%, 87.5%, and 100% methanol, and rehydrated for 5 min in 50%, 25%, 
and 12.5% methanol in PBST (0.1% Triton X-100 in 1×PBS). After washing in 1×PBST, 
midguts were blocked in PBS with 2.5% BSA, 10% normal goat serum and 0.1% Tween-
20 (Blocking solution) for at least 1hr at RT then incubated with rabbit phospho-p44/42 
MAPK (Erk1/2) (Thr202/Tyr204) #9101 (Cell Signaling, 1:400) at 4 °C overnight.  
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After washing, all samples were incubated with secondary antibodies (Alexa 488, 568 or 
633, Invitrogen) >2 hours at RT at a dilution of 1:1000. All antibody incubations were 
performed in blocking solution. DNA was stained with 0.5 μg/mL DAPI (Sigma). 
For the plasma membrane cell stain: Freshly dissected midguts were stained with 
CellMaskTM deep red plasma membrane stain, Thermofisher® in 1x PBS at a 
concentration of 1:1000 then fixed in 4% formaldehyde and stained with 1x PBS/DAPI 
according to the manufacturer’s instructions. 
Ovary staining: One day old mated females have been place on active yeast paste for 4-5 
days at 29°c. Ovary have been dissected in dPBS, transfer in PBS, PFA8% and fixed for 
10min at room temperature under mixing. After washes in PBS triton 0.15% the ovaries 
have been blocked for 1 hour in PBST0.15%, BSA 2,5%. The primary antibodies 
incubated at 4°c overnight in blocking buffer: chicken anti-GFP 1/500, mouse anti-
coracle 1/500 (http://dshb.biology.uiowa.edu/C566-9_2). Then the ovaries have been 
washed 5 times 5 minutes in PBS T0.15% and incubated 1h30 with the secondary 
antibodies +dyes in blocking buffer at room temperature: Goat anti-chicken488 1/1000, 
Goat anti- Mouse568 1/1000, Hoechst 1/1000, phalloidine633 1/10000 . After two 
washes of 10min in PBST0.15%, the ovaries have been mounted between slide and 
coverslip in Vectashield. Images have been acquired using a Leica Sp8 confocal 
microscope and the figures made using Fiji with the ScientiFig plugin. 
Imaging: Midguts were mounted on glass slides in VectaShield (Linaris®). All midgut 
images were acquired on a Leica TCS SP5II inverted confocal microscope, equipped with 
HCX Plan APO 20x/1.30 glycerol-immersion (for quantifications) or 40x/1.30 oil-
immersion objectives (for representative images/ quantifications), using Leica 
Application Suite (LAS) AF software and processed with Fiji/ImageJ software462. 
Representative images are shown. GFP, in green (native GFP for all genotypes except for 
the reporter midguts and Su(H)+ cells marked with Su(H)ts  driver that were additionally 
stained with GFP for better visualization of the signal); DNA: DAPI, in blue. For 
displaying images in the figure panels, a Z-stack of defined steps for control and test 
genotypes in a single field was acquired in the R4 region (a region which is bounded by 
the apex of the midgut tube’s most distal 180° turn) as described in463. Images represent 
maximal intensity projections of the acquired Z-Stacks. Scale bars are 100 μm in all 
images, unless otherwise indicated.  
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Quantifications and statistics 
ISC proliferation: Mitotic indices were determined by manually counting all PH3 positive 
cells in entire midguts using Leica DM5000B or Zeiss Axiophot fluorescence 
microscopes through a 40x objective. Statistical analysis of all the mitotic counts was 
performed using two-tailed Mann-Whitney test (ns p> 0.05,*p≤ 0.05,**p≤ 0.01,***p≤ 
0.001,****p ≤ 0.0001). All dot plot graphs indicating mitoses are showing mean values ± 
s.d. Exact p values are provided in a table in the supplemental material. Data were plotted 
from at least 3 independent experiments.  
 
Quantification of the GFP+/delta+ cells: Z-stacks of both epithelial sides in R4a/b region 
were imaged at steps of 5.0 μm at 40x then the total number of GFP+ or delta+ cells were 
analyzed after limiting the particle size to 10-250 μm, circularity 0.00-1.00 and excluding 
holes after maximal Z-projects have been applied.  
 
Quantification of the delta+ and Su(H)+ cells: Z-stacks of both epithelial sides in the 
R4a/b region were imaged by confocal Zeiss LSM 780 Spinning Disc. The total number 
of DAPI+, Su(H)+ and delta+ cells were automatically segmented and counted by a 
designed Image J/FIJI macro. Su(H)+ and delta+ cells were manually recounted and 
verified and the numbers of each cell type were recorded to derive %cell type to total cell 
number/stack. 
 
Quantification of cell size: Midguts were mounted as previously described and Z-stacks 
of both epithelial sides in the R4a/b were imaged at steps 5.0 μm at 40x then an Image 
J/FIJI macro was created to segment the cytoplasm in reference to DAPI nuclear stain 
and internuclear distances. Area of the cells in μm2 were outputted to Microsoft Excel and 
a mixed effects 2-way ANOVA statistical model was computed to calculate the 
significance between the different conditions. 
 
Quantification of clonal size: Z-stacks of both epithelial sides in the R4a/b were imaged 
at steps 5.0 μm at 40x then an Image J/FIJI macro was designed to semi-automatically 
segment and determine the location and size of the GFP+ clones then the sizes in μm2 
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were outputted to Microsoft Excel and a mixed effects 2-way ANOVA statistical model 
was computed to calculate the significance between the different conditions. 
 
Quantification of the GFP+ areas: For analysis of the mating effects, Z-stacks of both 
epithelial sides in R4a/b region were imaged at steps 5.0 μm either at 40x or at 20xs. For 
analysis, the quantification of the area occupied by GFP+ cells was performed 
automatically using an ImageJ / FIJI macro. The macro created maximum Z-Projection of 
image stacks, median and gaussian filtering, automatic thresholding and measurement of 
GFP+ and gut occupying area. The measurements were exported to Microsoft Excel and 
the GFP+ / gut area ratio was derived from these values for at least 10 midguts for most 
experiments. 
 
Quantification of the GFP+ area/ DAPI+ cells: For analysis of the tumor effects (ED 10e), 
a fixed median filter was created for each stack, a fixed gaussian blur value was applied 
then the midgut was thresholded for the DAPI+ cells and GFP+ cells then areas for both 
have been calculated and a ratio was derived. An Image J/FIJI macro was used. 
 
Data are displayed in scatter plots with the mean values ± standard deviation (s.d.) for 
each series of experiments. Data shown are representative of at least 2-3 independent 
repeated experiments with similar results. Statistical significance was calculated either by 
two-tailed Mann-Whitney test without a multiple comparison test. Results were 
considered to be significantly different at p<0.05. All calculations were performed using 
the Prism 7.0 software (GraphPad Software, La Jolla, CA, USA). 
 
Gut measurements: After immunofluorescence staining and prior to mounting, midguts 
were put on a glass slide and imaged using a Leica M205 FA Stereo Microscope or 
Stereo Discovery.V8, unmounted guts were imaged at a defined magnification and these 
images were exported to Fiji for further analysis. An Image J/FIJI macro was designed to 
threshold each image then measure the area of every midgut and with the distance 
mapping technique, the midgut length was derived. For the width measurements, a line 
was drawn. Before quantifying any midgut dimensions, the genotype of each sample was 
concealed. Samples were randomly analyzed then the genotype was revealed only after 
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completing analysis. For statistical analyses of gut sizes, normality test was performed 
with Shaprio-Wilk normality test and the gut sizes showed normal Gaussian distribution. 
Thus, statistical significance of gut size measurements was calculated by ordinary 
ANOVA test, followed by Bonferroni’s multiple comparisons test. P values were 
calculated as follows: (ns p> 0.05,*p≤ 0.05,**p≤ 0.01,***p≤ 0.001,****p ≤ 0.0001). 
Data are displayed in scatter plots with the mean values ± standard deviation (s.d.). Data 
were plotted from at least 3 independent repeated experiments with similar results. 
 
All Image J/FIJI macros are available as supplementary online source material, or upon 
request from the authors. 
 
Sample sizes, Randomization, and Blinding 
No statistical method was used to predetermine sample sizes, but typically between 5 and 
20 flies were used per replicate per genotype in each experiment. Exact n values for each 
experiment can be found in the online source data. When selecting animals for an 
experiment, the parental genotype was not concealed because it was required to select 
pertinent progeny. Animals were first selected by genotype and then randomly chosen for 
experimental analysis. For measurements of mitoses/gut, gut sizes and tumor 
frequencies, the genotype of each sample was concealed during analysis. Samples were 
then randomly scored and genotypes were revealed only after completing the analysis. 
 
RT-qPCR 
10–12 female intestines per genotype were dissected and RNA isolated using the 
RNAeasy kit (QIAGEN). 750 ng of total RNA was used for cDNA synthesis reactions 
using the QuantiTect reverse transcription kit (QIAGEN). RT-qPCR was performed on a 
Light Cycler 480 II (Roche) using SYBR Green I (Roche). Experiments were performed 
in at least biological triplicates. Relative fold differences in expression level of target 
genes were calculated as ratios to the mean of the reference genes rp49 and tubulin using 
the ΔΔCt method. A series of 10-fold dilutions of an external standard was used in each 
run to produce a standard curve. Primer sequences are listed in the online Supplementary 
Information. 
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ΔΔCt method: ΔΔCt (or log2 fold change) is the difference in threshold cycles for the test 
and control sample normalized to the threshold cycles for the reference gene. 
ΔΔCt = ΔCt (test)− ΔCt (control) 
ΔCt (test) or ΔCt (control) = Ct target gene − Ct reference gene 
All data are presented as mean fold change (log2 ) with s.d. 
 
RT-qPCR primers 
Rp49 –Forward:TCGATATGCTAAGCTGTC 
Rp49–Reverse:GGCATCAGATACTGTCCCTTG  
β-tubulin-Forward: ACATCCCGCCCCGTGGTC  
β-tubulin-Reverse: AGAAAGCCTTGCGCCTGAACATAG  
Actin5C-Forward: CTCGCCACTTGCGTTTACAGT 
Actin5C- Reverse:  TCCATATCGTCCCAGTTGGTC 
Rho-Forward: ATCGGCTTTCTGGTGCTAAA 
Rho-Reverse: GTGCAACAGATGCTGGGTAA 
Eip75-Forward: AACTGCACCACCACTTGACA 
Eip75-Reverse: TTCTTCTCGTTGCCCGACTC 
spi- Forward: CCTTCTATTTGCGCTTCGAG 
spi- Reverse: CGCATGTGGTAGGGTAGCTT 
krn- Forward: CGTGTTTGGCAACAACAAGT 
krn- Reverse: TGTGGCAATGCAGTTTAAGG 
Upd2- Forward: CACAAGTGCGGTGAAGCTAA 
Upd2- Reverse: GGCTCTTCTGCTGATCCTTG  
Upd3- Forward: CCACAGTGAGCACCAAGACT 
Upd3- Reverse: GCGAAGGTTCAACTGTTTGCT 
Socs36E- Forward: CAGTCAGCAATATGTTGTCG 
Socs36E- Reverse: ACTTGCAGCATCGTCGCTTC 
Spo-Forward: TCCGCGAGGTGCTCAATCAA 
Spo-Reverse: CGCTCGCCACCAAATAGTTT 
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Tables 
Table 2.1a: list of genes differentially upregulated in control males relative to control females 
list of hits>10 raw reads log2FC edgeR p-value edgeR -log10(pvalue) 
roX2 10.3968 3.43E-20 19.46470588 
CR43961 9.6857 1.36E-15 14.86646109 
hbs 5.2622 4.35E-14 13.36151074 
CG12721 6.8849 3.43E-12 11.46470588 
CG3703 2.7943 2.13E-11 10.6716204 
CG43101 5.0713 1.47E-10 9.832682665 
lin-28 2.2286 1.67E-08 7.777283529 
CG42854 5.3013 7.13E-08 7.14691047 
CG31436 2.7205 1.17E-07 6.931814138 
CR44748 2.8154 5.16E-07 6.287350298 
CG34323 7.2681 1.17E-06 5.931814138 
rha 7.2782 1.21E-06 5.91721463 
Dcp-1 2.1891 1.63E-06 5.787812396 
RNaseMRP:RNA 1.9841 1.99E-06 5.701146924 
mam 2.4681 3.22E-06 5.492144128 
CG3568 2.4859 3.38E-06 5.4710833 
Sik2 2.0738 4.07E-06 5.390405591 
brk 1.8637 4.50E-06 5.346787486 
CG32638 1.9232 5.64E-06 5.248720896 
vilya 7.1651 1.29E-05 4.88941029 
CG44006 2.0812 1.78E-05 4.749579998 
CG15263 5.8997 2.07E-05 4.684029655 
Cyp6a20 2.3502 2.15E-05 4.66756154 
CG10337 1.8802 2.66E-05 4.575118363 
olf413 3.2921 4.47E-05 4.349692477 
CG13917 1.8386 4.51E-05 4.345823458 
CG12643 1.5994 4.57E-05 4.3400838 
CG44329 6.9175 6.44E-05 4.191114133 
CR43257 2.0949 8.21E-05 4.085656843 
CR45522 6.833 8.31E-05 4.080398976 
Sirt6 1.8338 9.85E-05 4.00656377 
CG6040 1.4772 0.0001 4 
CR43973 1.7045 0.0001 4 
Faa 2.0159 0.0001 4 
pirk 1.9361 0.0001 4 
CG32599 3.9445 0.0001 4 
CG11656 3.7341 0.0001 4 
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HP1D3csd 2.9281 0.0002 3.698970004 
CG8468 2.0774 0.0002 3.698970004 
CG13894 6.1784 0.0002 3.698970004 
cv-2 1.3604 0.0003 3.522878745 
Vti1a 1.605 0.0003 3.522878745 
CG14626 1.6102 0.0003 3.522878745 
CG34401 1.9702 0.0003 3.522878745 
CG14367 3.9078 0.0003 3.522878745 
CG44405 6.4872 0.0004 3.397940009 
SIFa 6.4242 0.0004 3.397940009 
CG3739 2.7317 0.0004 3.397940009 
CG11374 1.9882 0.0004 3.397940009 
CG30356 2.1258 0.0004 3.397940009 
CG13659 2.3504 0.0004 3.397940009 
CG18599 6.1882 0.0005 3.301029996 
Hexo2 2.096 0.0005 3.301029996 
Arc1 1.4615 0.0005 3.301029996 
laccase2 1.7841 0.0005 3.301029996 
Ir41a 3.6464 0.0005 3.301029996 
CR44547 1.5763 0.0006 3.22184875 
Rcd2 1.9022 0.0006 3.22184875 
Arc2 1.4441 0.0006 3.22184875 
CG13658 2.5539 0.0006 3.22184875 
snoRNA:Psi18S-1275 4.2518 0.0006 3.22184875 
CR44608 1.4873 0.0007 3.15490196 
daw 3.3024 0.0007 3.15490196 
CG9422 2.9673 0.0007 3.15490196 
geko 4.6444 0.0007 3.15490196 
CR46095 1.7289 0.0008 3.096910013 
CG12868 2.2823 0.0008 3.096910013 
CR44984 2.4553 0.0009 3.045757491 
Tie 1.3156 0.001 3 
CG13893 2.1632 0.001 3 
CG31510 1.144 0.0011 2.958607315 
CG11275 1.3763 0.0011 2.958607315 
Mal-A8 2.9946 0.0011 2.958607315 
laza 1.5465 0.0012 2.920818754 
CG18467 2.8655 0.0012 2.920818754 
AOX2 4.1932 0.0013 2.886056648 
Tab2 2.6302 0.0013 2.886056648 
 
 
222 
bou 1.6098 0.0015 2.823908741 
CR45820 1.5134 0.0016 2.795880017 
CG5644 2.3154 0.0016 2.795880017 
Paip2 1.2104 0.0017 2.769551079 
CG42393 2.0341 0.0017 2.769551079 
Gbeta5 3.2562 0.0017 2.769551079 
CG6405 2.6438 0.0018 2.744727495 
CG8072 3.1698 0.0018 2.744727495 
ed 1.3308 0.0019 2.721246399 
CG42364 3.0074 0.0019 2.721246399 
CG17265 1.1532 0.002 2.698970004 
comm2 2.207 0.002 2.698970004 
fs(1)Yb 5.9694 0.0021 2.677780705 
CG31627 3.5992 0.0021 2.677780705 
CG8343 2.6626 0.0021 2.677780705 
CG17111 2.2656 0.0022 2.657577319 
CG43968 6.6815 0.0022 2.657577319 
sinu 1.3859 0.0024 2.619788758 
CR44566 1.5582 0.0024 2.619788758 
CR46093 1.6771 0.0024 2.619788758 
CR45922 3.6394 0.0024 2.619788758 
CG4404 1.2706 0.0025 2.602059991 
tut 2.3639 0.0025 2.602059991 
swa 5.8367 0.0026 2.585026652 
CG6628 4.2165 0.0027 2.568636236 
Mnn1 1.2723 0.0028 2.552841969 
CR41257 2.6619 0.0028 2.552841969 
CG10376 1.1156 0.0029 2.537602002 
CR44445 2.1109 0.0029 2.537602002 
GstD4 1.4306 0.0031 2.508638306 
CG15515 3.8202 0.0034 2.468521083 
PGRP-SD 1.4328 0.0034 2.468521083 
pan 2.0604 0.0035 2.455931956 
CR41620 5.893 0.0036 2.443697499 
GstD5 1.7283 0.0036 2.443697499 
kirre 3.789 0.0037 2.431798276 
grim 2.2474 0.0037 2.431798276 
CG31808 2.0769 0.0038 2.420216403 
ppk27 2.2913 0.0038 2.420216403 
CR41583 2.6348 0.0038 2.420216403 
 
 
223 
CHKov2 1.1893 0.0039 2.408935393 
Pzl 5.6772 0.004 2.397940009 
E(spl)malpha-BFM 0.9859 0.0041 2.387216143 
CG15084 1.3227 0.0042 2.37675071 
Lac 1.7848 0.0044 2.356547324 
CG18745 0.9955 0.0045 2.346787486 
CG4297 1.2786 0.0045 2.346787486 
CR46249 2.6149 0.0045 2.346787486 
Ugt86Dd 2.012 0.0046 2.337242168 
CG42365 1.6352 0.0047 2.327902142 
sima 1.3636 0.0048 2.318758763 
Tsp42Ej 1.2016 0.005 2.301029996 
CR44538 2.5992 0.005 2.301029996 
NC2alpha 1.0801 0.0051 2.292429824 
CG32040 1.5381 0.0051 2.292429824 
Ir85a 6.991 0.0052 2.283996656 
Lcch3 1.6661 0.0054 2.26760624 
CG13436 1.9279 0.0055 2.259637311 
CG7966 1.1856 0.0056 2.251811973 
CG3556 3.7323 0.0057 2.244125144 
CR43242 1.2398 0.0057 2.244125144 
Eip75B 1.4818 0.0057 2.244125144 
CR45625 1.8807 0.0057 2.244125144 
CR44862 6.7535 0.0057 2.244125144 
CG42553 1.5631 0.0059 2.229147988 
PDZ-GEF 1.2065 0.006 2.22184875 
CG31370 1.4272 0.0061 2.214670165 
CG18368 3.4388 0.0061 2.214670165 
CR45028 2.0076 0.0061 2.214670165 
Or45a 1.8044 0.0062 2.207608311 
CG3262 1.1419 0.0065 2.187086643 
CG30047 1.5275 0.0065 2.187086643 
ssx 1.7262 0.0065 2.187086643 
CG3982 2.1697 0.0065 2.187086643 
CG6683 1.2906 0.0066 2.180456064 
sprt 1.7393 0.0067 2.173925197 
E(spl)m7-HLH 1.2983 0.0068 2.167491087 
Gld 3.7078 0.0069 2.161150909 
CG14196 2.3556 0.0069 2.161150909 
CR45824 3.7784 0.007 2.15490196 
 
 
224 
sing 1.7179 0.0072 2.142667504 
CR44138 2.9391 0.0074 2.13076828 
CG14837 3.0839 0.0075 2.124938737 
ebd1 1.1263 0.0075 2.124938737 
CG4462 1.534 0.0075 2.124938737 
CR43974 1.5003 0.0077 2.113509275 
CG30440 3.1719 0.0078 2.107905397 
CR45745 2.6296 0.008 2.096910013 
CR45171 1.6826 0.0081 2.091514981 
CG8319 1.1084 0.0082 2.086186148 
a 1.4025 0.0082 2.086186148 
CG3008 1.0991 0.0084 2.075720714 
CG34040 1.843 0.0084 2.075720714 
CG2064 1.0013 0.0085 2.070581074 
CG9328 1.3172 0.0087 2.060480747 
bnl 3.9421 0.0089 2.050609993 
TTLL3B 4.5217 0.0089 2.050609993 
shams 1.2587 0.009 2.045757491 
CR45166 3.8602 0.0091 2.040958608 
mir-4968 1.903 0.0093 2.031517051 
CG11000 2.0193 0.0095 2.022276395 
sstn 1.1359 0.01 2 
Hsromega 0.9131 0.0103 1.987162775 
Spn85F 5.7881 0.0105 1.978810701 
PlexA 1.6684 0.0106 1.974694135 
CG4723 5.4225 0.0108 1.966576245 
CG32845 1.1811 0.011 1.958607315 
Tsp42El 0.8762 0.0112 1.950781977 
CG14443 1.1166 0.0118 1.928117993 
Pig1 2.6019 0.0118 1.928117993 
Ptip 0.9546 0.0119 1.924453039 
ect 1.9081 0.012 1.920818754 
snoRNA:Me18S-U1356b 2.9272 0.012 1.920818754 
Hsc70-3 1.6867 0.0122 1.913640169 
CG6602 1.5814 0.0122 1.913640169 
CG33928 5.854 0.0123 1.910094889 
CG6330 1.4688 0.0124 1.906578315 
CG34348 0.9579 0.0126 1.899629455 
CG10559 1.9955 0.0127 1.896196279 
MYPT-75D 1.284 0.0128 1.89279003 
 
 
225 
CG6465 1.085 0.0131 1.882728704 
CG32486 0.8503 0.0132 1.879426069 
Sox102F 2.5682 0.0133 1.876148359 
ITP 1.0552 0.0137 1.863279433 
NFAT 1.0928 0.0138 1.860120914 
dpr1 2.6599 0.0139 1.8569852 
CG33267 1.7543 0.014 1.853871964 
CG12398 1.4175 0.0141 1.850780887 
Smurf 1.4153 0.0144 1.841637508 
Muc14A 2.6604 0.0146 1.835647144 
CG10730 2.0963 0.0146 1.835647144 
CG13088 1.7539 0.0147 1.832682665 
Gk2 1.9101 0.0147 1.832682665 
CR44276 1.7043 0.015 1.823908741 
Xpac 1.1253 0.0152 1.818156412 
CG32795 1.1811 0.0153 1.815308569 
Cyp6d5 1.2239 0.0153 1.815308569 
Ugt86Dc 2.1373 0.0154 1.812479279 
vn 1.3266 0.0154 1.812479279 
Atac1 1.0038 0.0161 1.793174124 
bigmax 0.8526 0.0162 1.790484985 
CR46015 1.6168 0.0165 1.782516056 
hog 2.7888 0.0166 1.779891912 
CG8492 6.582 0.0167 1.777283529 
CG32450 5.904 0.0167 1.777283529 
InR 1.0259 0.0167 1.777283529 
St3 5.4924 0.0168 1.774690718 
Csk 0.975 0.0169 1.772113295 
Fhos 2.1468 0.017 1.769551079 
Cad96Ca 2.1732 0.0171 1.76700389 
Cad87A 1.0345 0.0176 1.754487332 
Cpr64Ad 3.7841 0.0177 1.752026734 
CG8281 0.9718 0.0179 1.747146969 
Dat 0.9879 0.0179 1.747146969 
CG6791 1.1082 0.018 1.744727495 
Atf6 1.7831 0.0181 1.742321425 
CG17687 2.9685 0.0182 1.739928612 
Ppt2 1.0215 0.0185 1.732828272 
CG5059 0.9555 0.019 1.721246399 
CG30484 1.9182 0.019 1.721246399 
 
 
226 
CG8369 5.3843 0.0192 1.716698771 
CG30441 2.0064 0.0192 1.716698771 
CG5114 2.7561 0.0196 1.707743929 
CG14074 1.0616 0.0198 1.70333481 
l(1)G0193 1.1074 0.0199 1.701146924 
mst 1.2879 0.02 1.698970004 
Ir40a 5.3376 0.0205 1.688246139 
CG4586 1.0314 0.0205 1.688246139 
Naam 1.1167 0.0212 1.673664139 
Ac3 1.4742 0.0214 1.669586227 
CG30324 5.8996 0.0216 1.665546249 
snoRNA:Psi18S-1086 1.3938 0.0217 1.663540266 
CG14838 4.1728 0.0219 1.659555885 
lt 1.8493 0.0219 1.659555885 
CR45939 1.3041 0.0222 1.653647026 
CG3838 2.0134 0.0226 1.645891561 
mdy 1.37 0.0228 1.642065153 
CG9676 1.7505 0.0229 1.640164518 
snoRNA:Me28S-C437 2.023 0.023 1.638272164 
ric8a 1.1698 0.0236 1.627087997 
Pih1D1 0.8711 0.0237 1.625251654 
stas 1.5531 0.024 1.619788758 
Mal-A4 1.9423 0.0243 1.614393726 
CG8273 3.2718 0.0244 1.612610174 
GstD3 0.8419 0.0244 1.612610174 
CG3709 1.0353 0.0246 1.609064893 
row 1.1986 0.0246 1.609064893 
CG6013 0.9282 0.0247 1.607303047 
CG11486 0.9139 0.025 1.602059991 
CR32636 2.1814 0.0252 1.598599459 
TSG101 0.7575 0.0253 1.596879479 
CG3995 0.9071 0.0253 1.596879479 
Obp18a 1.0706 0.0258 1.588380294 
ttm2 1.0203 0.0258 1.588380294 
CR45549 1.7662 0.0258 1.588380294 
lbm 0.9544 0.0259 1.586700236 
GstE8 1.8313 0.0259 1.586700236 
CG43925 5.2682 0.026 1.585026652 
CG11655 1.1625 0.026 1.585026652 
CR44440 3.0132 0.0262 1.581698709 
 
 
227 
CG33640 1.3798 0.0265 1.576754126 
CG31111 0.9597 0.0267 1.573488739 
rost 1.4463 0.0273 1.563837353 
sty 0.7423 0.0276 1.559090918 
CG15760 3.1645 0.0278 1.555955204 
CG9945 2.1893 0.0278 1.555955204 
CG33463 2.5122 0.0279 1.554395797 
CG31347 1.1841 0.028 1.552841969 
CG32855 3.9694 0.0281 1.55129368 
CG11893 2.7618 0.0283 1.548213564 
CG17786 1.1182 0.0286 1.543633967 
CG17929 2.3807 0.0287 1.542118103 
CG34160 1.3319 0.0288 1.540607512 
Krn 0.9228 0.0289 1.539102157 
CG10638 1.1155 0.029 1.537602002 
MFS3 1.2377 0.0294 1.53165267 
Elp1 1.2653 0.0295 1.530177984 
CR45082 1.2995 0.0295 1.530177984 
CkIIalpha-i1 1.019 0.0296 1.528708289 
CG32371 2.9078 0.0301 1.521433504 
mir-967 1.2742 0.0302 1.519993057 
CG4676 4.2871 0.0303 1.518557371 
AhcyL2 2.0109 0.0303 1.518557371 
ntc 1.2166 0.0304 1.517126416 
CG31431 2.3541 0.0305 1.515700161 
Rbcn-3B 0.9687 0.0306 1.514278574 
fs(1)Ya 5.5434 0.0307 1.512861625 
CG11226 2.2606 0.0308 1.511449283 
CG3876 0.9948 0.0309 1.510041521 
MFS14 2.365 0.0312 1.505845406 
CG33710 1.6746 0.0315 1.501689446 
Rab2 0.839 0.0319 1.496209317 
CR45280 3.1041 0.032 1.494850022 
Drep4 1.0395 0.0322 1.492144128 
CG34231 1.2231 0.0322 1.492144128 
Snap24 0.903 0.0323 1.490797478 
ppk 2.3817 0.0323 1.490797478 
Kif3C 1.6404 0.0324 1.48945499 
Eaf6 0.8476 0.0326 1.4867824 
CR45128 2.8805 0.0327 1.485452247 
 
 
228 
CG45782 1.7442 0.0327 1.485452247 
CG30022 0.9609 0.0329 1.482804102 
l(3)02640 1.2891 0.0329 1.482804102 
CG7194 1.1992 0.0332 1.478861916 
CG14252 1.007 0.0339 1.469800302 
PGRP-LF 0.8559 0.0341 1.467245621 
CG18635 0.9945 0.0342 1.465973894 
CG7564 1.4161 0.0342 1.465973894 
Tsp42Ef 0.8197 0.0346 1.460923901 
dsx-c73A 1.6027 0.0348 1.458420756 
CG31817 1.1168 0.0349 1.457174573 
bun 0.8356 0.035 1.455931956 
CG5282 5.0661 0.0353 1.452225295 
CR41544 0.9233 0.0354 1.450996738 
CG7706 0.9693 0.0354 1.450996738 
14-3-3zeta 2.6466 0.0355 1.449771647 
Cyp4p3 2.5236 0.0358 1.446116973 
CG30197 1.2278 0.0358 1.446116973 
CG14227 1.469 0.036 1.443697499 
Ugt37b1 1.4352 0.036 1.443697499 
CG32444 2.4488 0.0362 1.441291429 
cwo 1.1985 0.0368 1.434152181 
SmydA-5 1.839 0.0369 1.432973634 
swi2 1.6533 0.0373 1.428291168 
CR44404 5.0069 0.0375 1.425968732 
CG14352 0.9396 0.0375 1.425968732 
CG16898 1.2699 0.0377 1.42365865 
baz 0.8178 0.0379 1.42136079 
bip1 3.4011 0.0381 1.419075024 
CG30099 1.9384 0.0381 1.419075024 
Tbc1d15-17 2.6204 0.0382 1.417936637 
GstE1 0.7994 0.0382 1.417936637 
nmo 1.5664 0.0382 1.417936637 
CG8223 5.0496 0.0384 1.415668776 
CrebA 0.8864 0.0385 1.41453927 
CG9821 0.7877 0.0385 1.41453927 
bowl 3.076 0.0387 1.412289035 
mthl14 0.7281 0.0387 1.412289035 
CG16833 1.646 0.0389 1.410050399 
GluRIIE 1.2433 0.0391 1.407823243 
 
 
229 
CG14965 1.2148 0.0393 1.40560745 
Rbp1 0.8507 0.0394 1.404503778 
CR46094 1.8881 0.0395 1.403402904 
lace 0.8839 0.0399 1.399027104 
Mrp4 0.9631 0.0399 1.399027104 
fidipidine 0.8277 0.04 1.397940009 
CG43672 3.1657 0.0401 1.396855627 
CG17684 2.164 0.0401 1.396855627 
CR32218 0.8255 0.0401 1.396855627 
CR43405 1.4843 0.0401 1.396855627 
CG45428 2.3132 0.0404 1.393618635 
Taf11 0.8644 0.0407 1.390405591 
JhI-26 1.2491 0.0409 1.388276692 
CR44817 0.9615 0.0413 1.384049948 
CG9684 0.7183 0.0414 1.382999659 
CR43653 1.5591 0.0416 1.380906669 
CR43849 1.8358 0.0417 1.379863945 
flfl 0.7277 0.0419 1.377785977 
CR45915 1.0206 0.0421 1.375717904 
GstE7 1.4537 0.0421 1.375717904 
CG42818 3.3062 0.0422 1.374687549 
CR45054 0.8759 0.0431 1.36552273 
Cyp311a1 1.0462 0.0432 1.364516253 
CG14770 3.9382 0.0439 1.35753548 
CR46204 1.264 0.0443 1.353596274 
CR43909 2.1516 0.0445 1.351639989 
CG43646 1.4886 0.0447 1.349692477 
Axs 0.9161 0.045 1.346787486 
CG14877 1.8853 0.0456 1.341035157 
pkaap 0.9219 0.0457 1.3400838 
CR45148 1.3193 0.0458 1.339134522 
shg 0.6812 0.046 1.337242168 
CG30456 3.1243 0.0468 1.329754147 
glec 0.6871 0.0468 1.329754147 
CR45224 1.5462 0.0468 1.329754147 
mrt 4.9315 0.0475 1.32330639 
CG17018 3.0817 0.0478 1.320572103 
foi 3.0088 0.0479 1.319664487 
CG33160 4.9219 0.0479 1.319664487 
yuri 2.7061 0.0482 1.316952962 
 
 
230 
wts 0.74 0.0489 1.310691141 
Tgi 1.1551 0.0492 1.308034897 
Ir51b 1.6574 0.0494 1.306273051 
CG9505 1.0175 0.0498 1.302770657 
CG33468 1.4953 0.0498 1.302770657 
Lap1 1.068 0.0499 1.301899454 
CG16716 2.2466 0.0501 1.300162274 
CG4660 2.3861 0.0504 1.297569464 
CR44145 1.1697 0.0505 1.296708622 
RhoGAP71E 1.1517 0.0506 1.295849483 
dgt1 0.89 0.0508 1.294136288 
kune 0.8278 0.0509 1.293282218 
CR45102 0.8436 0.051 1.292429824 
CG4455 0.7209 0.0512 1.290730039 
CR45256 2.5225 0.0514 1.289036881 
CG9425 1.4977 0.0514 1.289036881 
CG16711 0.9123 0.0515 1.288192771 
CG3163 0.8182 0.0518 1.28567024 
CR44348 2.2763 0.0521 1.283162277 
qkr58E-1 1.1166 0.0525 1.279840697 
Src42A 0.9192 0.0528 1.277366077 
CR46064 0.6989 0.0531 1.274905479 
CG5642 0.6598 0.0531 1.274905479 
Atac2 1.024 0.0531 1.274905479 
mir-4964 1.4584 0.0532 1.274088368 
CR43399 0.8411 0.0533 1.273272791 
AttD 1.3997 0.0533 1.273272791 
CG6843 0.8012 0.0534 1.272458743 
CG42816 5.3067 0.0535 1.271646218 
CG43192 1.3107 0.0538 1.269217724 
CG15563 2.6022 0.0541 1.266802735 
snoRNA:Psi18S-841b 1.6456 0.0544 1.2644011 
 
Table 2.1b: list of genes differentially upregulated in control females relative to control males 
list of hits>10 raw reads log2FC edgeR p-value edgeR -log10(pvalue) 
Pebp1 -4.8196 9.78E-26 25.00966115 
CG6295 -4.6944 8.94E-25 24.04866248 
pre-rRNA:CR45845 -5.6419 1.58E-22 21.80134291 
yip7 -3.3174 3.17E-22 21.49894074 
CG6296 -9.1509 3.41E-17 16.46724562 
Jon65Aiii -2.9835 9.12E-17 16.04000516 
 
 
231 
Jon65Aiv -3.4131 3.28E-16 15.48412616 
CG4563 -6.6562 9.45E-15 14.02456819 
Jon25Biii -4.3475 8.47E-14 13.07211659 
PGRP-SC2 -4.1219 5.33E-13 12.27327279 
thetaTry -3.8188 1.34E-12 11.8728952 
CG10182 -8.576 2.52E-12 11.59859946 
CG11241 -3.2885 4.75E-12 11.32330639 
CG5506 -4.8881 4.93E-12 11.30715308 
CG42747 -2.9459 4.37E-11 10.35951856 
CG18180 -2.9197 6.50E-11 10.18708664 
CG13813 -9.5056 1.63E-10 9.787812396 
CG12374 -5.3231 2.19E-10 9.659555885 
CG30090 -2.4048 2.37E-10 9.625251654 
RpS28b -2.5891 3.10E-10 9.508638306 
Jon66Ci -6.1965 5.52E-10 9.258060922 
CG8661 -3.4006 6.89E-10 9.161780778 
CG8952 -2.8699 8.09E-10 9.092051478 
CG8299 -9.4315 1.13E-09 8.946921557 
CG17192 -5.8606 1.37E-09 8.863279433 
CR42767 -6.4065 1.52E-09 8.818156412 
CG6891 -4.1601 3.26E-09 8.4867824 
CG8745 -5.0092 3.71E-09 8.43062609 
Jon99Cii -3.438 4.30E-09 8.366531544 
CR43264 -5.3834 9.43E-09 8.025488307 
tej -4.838 2.72E-08 7.565431096 
epsilonTry -3.9521 5.15E-08 7.288192771 
pyd3 -2.136 8.60E-08 7.065501549 
Muc68E -4.0152 8.96E-08 7.04769199 
Cyp6d2 -3.0961 1.00E-07 7 
alphaTry -2.723 1.10E-07 6.958607315 
O-fut2 -1.9538 2.12E-07 6.673664139 
CG9686 -7.7017 3.80E-07 6.420216403 
CG12170 -2.2561 4.19E-07 6.377785977 
CG4830 -3.326 4.20E-07 6.37675071 
CG5804 -3.0577 4.42E-07 6.354577731 
CG13690 -3.2136 4.80E-07 6.318758763 
CR45714 -7.1849 5.66E-07 6.247183569 
CG16775 -6.2695 5.72E-07 6.242603971 
CG15605 -4.3396 7.14E-07 6.146301788 
dgt3 -2.3691 8.38E-07 6.076755981 
 
 
232 
Jon25Bi -4.2436 1.43E-06 5.844663963 
gt -4.7392 2.43E-06 5.614393726 
CG3344 -3.6964 3.00E-06 5.522878745 
CG14526 -3.0884 4.91E-06 5.308918508 
Jon99Fii -4.5286 5.05E-06 5.296708622 
RfC3 -2.7579 5.88E-06 5.230622674 
Jon65Aii -4.4725 5.97E-06 5.224025669 
CG33127 -2.2061 6.15E-06 5.211124884 
CDC45L -1.7469 8.65E-06 5.062983893 
Lrpprc2 -1.6397 9.02E-06 5.044793462 
CG30411 -5.8252 1.09E-05 4.962573502 
Pen -2.4468 1.12E-05 4.950781977 
Npc2a -1.5065 1.25E-05 4.903089987 
CG8460 -1.5604 1.27E-05 4.896196279 
nrv3 -3.465 1.38E-05 4.860120914 
CG15630 -6.7702 1.58E-05 4.801342913 
bora -3.5976 1.86E-05 4.730487056 
CG9825 -4.7276 1.93E-05 4.714442691 
CG31041 -4.2934 1.94E-05 4.71219827 
CG17633 -4.4683 1.97E-05 4.705533774 
CG7280 -2.0548 2.01E-05 4.696803943 
CG14205 -3.132 2.54E-05 4.595166283 
CG34010 -1.9096 2.76E-05 4.559090918 
Fmo-2 -1.5026 3.08E-05 4.511449283 
Jon99Fi -4.6745 3.09E-05 4.510041521 
alphaTub84D -1.523 3.20E-05 4.494850022 
Meltrin -2.2999 3.67E-05 4.435333936 
Cht9 -3.9465 3.95E-05 4.403402904 
fa2h -4.6489 4.07E-05 4.390405591 
mms4 -2.0956 4.24E-05 4.372634143 
Mcm6 -1.9351 4.64E-05 4.333482019 
CG6733 -4.0288 5.09E-05 4.293282218 
Jon66Cii -7.2419 5.45E-05 4.263603498 
CG31266 -6.7755 5.83E-05 4.234331445 
LysX -4.1949 5.99E-05 4.222573178 
RnrL -1.7067 6.37E-05 4.195860568 
CG11700 -1.7091 6.74E-05 4.171340103 
Zwilch -2.0546 6.79E-05 4.168130226 
CG7298 -4.3337 7.30E-05 4.13667714 
stv -2.4853 7.42E-05 4.129596095 
 
 
233 
Ag5r2 -3.7558 7.42E-05 4.129596095 
CG7458 -1.9279 7.61E-05 4.118615343 
Ntf-2 -1.9192 7.64E-05 4.116906641 
Est-Q -3.064 8.45E-05 4.073143291 
Amy-d -1.716 9.15E-05 4.038578906 
Snm1 -1.7708 9.87E-05 4.005682847 
Jon99Ciii -3.1431 9.99E-05 4.000434512 
CG34026 -6.1937 0.0001 4 
CG5590 -1.3111 0.0001 4 
CG8834 -1.5794 0.0001 4 
Arc42 -1.5688 0.0001 4 
CG44475 -2.5543 0.0001 4 
Fit2 -2.1947 0.0001 4 
GILT3 -4.6563 0.0001 4 
CG15044 -3.599 0.0001 4 
CG5107 -2.6941 0.0001 4 
CR44830 -4.0446 0.0002 3.698970004 
amn -1.2833 0.0002 3.698970004 
blw -1.1524 0.0002 3.698970004 
CG6028 -1.4401 0.0002 3.698970004 
CG33966 -2.9453 0.0002 3.698970004 
Cht4 -4.1867 0.0002 3.698970004 
MFS1 -7.9437 0.0002 3.698970004 
CG8642 -4.5985 0.0003 3.522878745 
LysE -6.0438 0.0003 3.522878745 
CG3663 -1.468 0.0003 3.522878745 
CG7246 -1.4757 0.0003 3.522878745 
RnrS -1.4527 0.0003 3.522878745 
CG5254 -1.5475 0.0003 3.522878745 
GILT2 -1.7271 0.0003 3.522878745 
CG5770 -3.8369 0.0003 3.522878745 
CG10505 -2.9852 0.0003 3.522878745 
CG11068 -1.4338 0.0004 3.397940009 
Lim1 -3.954 0.0005 3.301029996 
Fdh -1.1835 0.0005 3.301029996 
psidin -1.2624 0.0005 3.301029996 
CG14798 -1.6379 0.0005 3.301029996 
CG18179 -2.6814 0.0005 3.301029996 
CG14820 -2.7741 0.0005 3.301029996 
CG6067 -2.306 0.0005 3.301029996 
 
 
234 
DNApol-alpha60 -2.0268 0.0005 3.301029996 
ppk3 -4.0899 0.0006 3.22184875 
CG32212 -1.3523 0.0006 3.22184875 
CG33514 -1.7575 0.0006 3.22184875 
Acox57D-d -1.751 0.0006 3.22184875 
spd-2 -1.9026 0.0006 3.22184875 
CG32698 -1.8154 0.0007 3.15490196 
CG5767 -3.2492 0.0007 3.15490196 
Sirt2 -3.7083 0.0008 3.096910013 
CG31345 -4.3575 0.0008 3.096910013 
CG30049 -1.2043 0.0008 3.096910013 
CG6126 -1.4303 0.0008 3.096910013 
CR42491 -1.2842 0.0008 3.096910013 
Fpps -1.2116 0.0009 3.045757491 
Debcl -1.3602 0.0009 3.045757491 
CG13151 -1.5259 0.0009 3.045757491 
CG3011 -1.5287 0.0009 3.045757491 
CG33109 -4.2282 0.0009 3.045757491 
CG43207 -2.8238 0.0009 3.045757491 
Jheh3 -1.5069 0.001 3 
Peritrophin-15a -2.2241 0.001 3 
CG18404 -3.0291 0.001 3 
Art7 -1.2619 0.0011 2.958607315 
l(3)mbt -1.4972 0.0011 2.958607315 
upd2 -1.4017 0.0011 2.958607315 
CR43989 -5.8887 0.0012 2.920818754 
CG11752 -1.1346 0.0012 2.920818754 
CG31076 -1.7577 0.0012 2.920818754 
Jon99Ci -1.6693 0.0012 2.920818754 
CG45080 -4.0419 0.0012 2.920818754 
dome -1.0767 0.0013 2.886056648 
pav -1.6301 0.0013 2.886056648 
Mesh1 -1.4387 0.0013 2.886056648 
CG45061 -1.4532 0.0013 2.886056648 
Rbf2 -1.7261 0.0013 2.886056648 
alpha-Est7 -2.1577 0.0013 2.886056648 
CG5724 -3.9339 0.0013 2.886056648 
CG31198 -2.3491 0.0013 2.886056648 
LysD -4.1733 0.0014 2.853871964 
CG1827 -1.1237 0.0014 2.853871964 
 
 
235 
CG16734 -1.4096 0.0014 2.853871964 
CG15127 -2.2699 0.0014 2.853871964 
CG32750 -3.5019 0.0014 2.853871964 
CG32641 -1.2955 0.0015 2.823908741 
CG42327 -2.9296 0.0015 2.823908741 
CG10869 -3.1761 0.0015 2.823908741 
CG6180 -1.1227 0.0016 2.795880017 
Irp-1B -1.3168 0.0016 2.795880017 
w -1.1467 0.0016 2.795880017 
Tina-1 -1.6139 0.0016 2.795880017 
CG15414 -1.5644 0.0016 2.795880017 
CG42397 -2.9139 0.0016 2.795880017 
CG9577 -1.2377 0.0017 2.769551079 
CG42825 -2.6209 0.0017 2.769551079 
Syx4 -1.9948 0.0017 2.769551079 
CG34288 -1.8548 0.0018 2.744727495 
DNaseII -2.5348 0.0018 2.744727495 
CG10000 -6.2936 0.002 2.698970004 
CG9581 -1.2346 0.002 2.698970004 
RecQ4 -1.8007 0.002 2.698970004 
msd1 -1.7031 0.002 2.698970004 
CG3625 -5.6614 0.0022 2.657577319 
CG34132 -1.0549 0.0022 2.657577319 
Gfat2 -1.1256 0.0023 2.638272164 
ATPsyndelta -1.462 0.0023 2.638272164 
CG4053 -6.5793 0.0025 2.602059991 
bsf -1.0145 0.0025 2.602059991 
CG42826 -3.237 0.003 2.522878745 
CG10912 -1.8515 0.003 2.522878745 
CG5892 -6.5945 0.0032 2.494850022 
Vha36-1 -0.9724 0.0032 2.494850022 
CG10911 -1.731 0.0032 2.494850022 
CG2681 -1.47 0.0033 2.48148606 
Tps1 -5.4786 0.0034 2.468521083 
Rif1 -1.3765 0.0034 2.468521083 
Osbp -1.1662 0.0035 2.455931956 
dgt6 -1.3624 0.0035 2.455931956 
upd3 -1.2787 0.0035 2.455931956 
CG15617 -2.6728 0.0035 2.455931956 
E(spl)m8-HLH -1.4124 0.0036 2.443697499 
 
 
236 
mag -2.6766 0.0037 2.431798276 
CCHa2 -3.9725 0.0038 2.420216403 
CR44692 -1.5844 0.0038 2.420216403 
CG42714 -2.3019 0.0038 2.420216403 
CG16700 -5.8742 0.0039 2.408935393 
CG16749 -2.0923 0.0039 2.408935393 
CG7630 -0.947 0.004 2.397940009 
Muc68Ca -2.1575 0.004 2.397940009 
CG6310 -1.1733 0.0042 2.37675071 
CG7593 -1.3492 0.0042 2.37675071 
CG13300 -2.1127 0.0042 2.37675071 
asp -1.5967 0.0042 2.37675071 
CG1946 -2.8083 0.0043 2.366531544 
CG14629 -1.1207 0.0044 2.356547324 
Hex-C -1.6447 0.0044 2.356547324 
l(2)10685 -1.4056 0.0045 2.346787486 
CG8562 -2.4317 0.0046 2.337242168 
E(spl)m2-BFM -1.508 0.0046 2.337242168 
CG31915 -1.1234 0.0048 2.318758763 
CG33116 -1.1036 0.0049 2.30980392 
CG31918 -1.1841 0.0049 2.30980392 
Orc1 -1.9861 0.0051 2.292429824 
SPH93 -2.6705 0.0052 2.283996656 
CG13082 -2.9375 0.0052 2.283996656 
DNApol-alpha180 -1.5868 0.0053 2.27572413 
CG12512 -1.842 0.0053 2.27572413 
CG12237 -0.9133 0.0054 2.26760624 
Ctf4 -1.7625 0.0054 2.26760624 
phyl -3.076 0.0054 2.26760624 
lectin-46Ca -2.2805 0.0054 2.26760624 
Oatp33Eb -2.7066 0.0055 2.259637311 
AP-1-2beta -0.9117 0.0056 2.251811973 
CG3906 -2.1752 0.0056 2.251811973 
Pmm45A -0.9843 0.0058 2.236572006 
CG12171 -1.084 0.0059 2.229147988 
CG1287 -1.2043 0.0059 2.229147988 
dmGlut -2.2373 0.0059 2.229147988 
CG11899 -1.8165 0.006 2.22184875 
CG32091 -1.075 0.0061 2.214670165 
CG3430 -1.143 0.0063 2.200659451 
 
 
237 
Nup107 -0.9609 0.0064 2.193820026 
CG7470 -1.573 0.0065 2.187086643 
ecd -1.2147 0.0066 2.180456064 
CG9663 -1.1279 0.0069 2.161150909 
AIMP1 -0.9664 0.007 2.15490196 
CG8773 -1.1429 0.007 2.15490196 
CG4194 -2.9168 0.0071 2.148741651 
CG6745 -1.2721 0.0072 2.142667504 
Glo1 -0.9258 0.0074 2.13076828 
CG4839 -3.365 0.0075 2.124938737 
Gip -0.9008 0.0076 2.119186408 
Ssb-c31a -0.975 0.0077 2.113509275 
caix -2.0302 0.0079 2.102372909 
rev7 -1.159 0.0081 2.091514981 
CG10592 -1.448 0.0081 2.091514981 
CG12926 -1.5003 0.0081 2.091514981 
CR44478 -1.5281 0.0081 2.091514981 
SLC22A -1.4758 0.0082 2.086186148 
CG17855 -1.021 0.0083 2.080921908 
CG7277 -1.0007 0.0084 2.075720714 
CR43253 -3.3622 0.0085 2.070581074 
CG17660 -0.9807 0.0085 2.070581074 
CG10584 -1.1102 0.0085 2.070581074 
CG43295 -1.4949 0.0086 2.065501549 
ox -0.9341 0.0087 2.060480747 
CG6178 -0.9505 0.0087 2.060480747 
CR44724 -1.5208 0.0087 2.060480747 
CG11911 -2.3515 0.0087 2.060480747 
CG1942 -3.0977 0.0088 2.055517328 
CR15061 -1.1414 0.0089 2.050609993 
Npc2f -1.511 0.0089 2.050609993 
CG10939 -1.4819 0.0089 2.050609993 
LysP -4.802 0.009 2.045757491 
Ndc1 -1.073 0.009 2.045757491 
spdo -1.4527 0.0091 2.040958608 
CG30339 -1.1875 0.0092 2.036212173 
CG7379 -0.9279 0.0093 2.031517051 
Tsr1 -0.9652 0.0093 2.031517051 
Cbs -2.6174 0.0094 2.026872146 
PRAS40 -0.8926 0.0095 2.022276395 
 
 
238 
CG9344 -0.9773 0.0096 2.017728767 
CG10470 -0.9783 0.0099 2.004364805 
ATPsynO -0.8388 0.01 2 
CG31344 -1.3962 0.01 2 
Vha14-1 -0.8828 0.0101 1.995678626 
CG11403 -1.0944 0.0104 1.982966661 
kappaTry -1.5835 0.0105 1.978810701 
DNApol-epsilon58 -1.5802 0.0108 1.966576245 
CG14120 -1.9513 0.0111 1.954677021 
CR44704 -1.6696 0.0111 1.954677021 
CG13364 -0.9317 0.0112 1.950781977 
CG3021 -0.9642 0.0115 1.93930216 
alpha-Est1 -1.352 0.0115 1.93930216 
CG12288 -1.6251 0.0117 1.931814138 
Mcm2 -1.2083 0.0118 1.928117993 
CG14104 -1.1868 0.0118 1.928117993 
Zw10 -0.9916 0.0119 1.924453039 
msd5 -1.3071 0.0121 1.91721463 
CG17278 -1.3087 0.0123 1.910094889 
Mdr50 -1.9491 0.0123 1.910094889 
CG1907 -1.0513 0.0126 1.899629455 
CG6454 -2.3263 0.0126 1.899629455 
Spindly -1.059 0.0127 1.896196279 
Mur29B -2.8587 0.0127 1.896196279 
CG8419 -2.694 0.0128 1.89279003 
pont -0.9701 0.0128 1.89279003 
Pex13 -0.9569 0.0134 1.872895202 
schuy -1.3296 0.0135 1.869666232 
CR44868 -1.1198 0.0136 1.866461092 
cN-IIIB -0.9915 0.0138 1.860120914 
CG12129 -0.8985 0.0139 1.8569852 
CG32483 -2.1871 0.0139 1.8569852 
CG1236 -0.9315 0.014 1.853871964 
snoRNA:Psi18S-531 -0.9388 0.014 1.853871964 
CG5958 -2.2533 0.0142 1.847711656 
mRpS11 -0.9011 0.0143 1.844663963 
ATPsynE -2.7804 0.0147 1.832682665 
CG2781 -1.7457 0.0149 1.826813732 
aurB -1.1795 0.015 1.823908741 
CG14543 -0.9749 0.0152 1.818156412 
 
 
239 
CG7889 -0.9004 0.0156 1.806875402 
CG5214 -0.8173 0.016 1.795880017 
CG18765 -1.6818 0.016 1.795880017 
Hsp70Bbb -1.374 0.0162 1.790484985 
cry -0.8161 0.0163 1.787812396 
Klp61F -1.1187 0.0163 1.787812396 
Mcm5 -1.1862 0.0164 1.785156152 
CG30283 -1.0092 0.0165 1.782516056 
Sdhaf3 -1.4575 0.0169 1.772113295 
Thiolase -0.7639 0.0172 1.764471553 
CG15210 -1.7408 0.0172 1.764471553 
ND-B15 -0.8083 0.0174 1.759450752 
Ote -1.0235 0.0174 1.759450752 
Gr94a -1.4248 0.0174 1.759450752 
xit -0.9028 0.0177 1.752026734 
CR45037 -2.0532 0.0179 1.747146969 
CG12825 -0.9348 0.0179 1.747146969 
CG31469 -1.3156 0.0179 1.747146969 
beta'COP -0.8089 0.0181 1.742321425 
sqa -2.2568 0.0182 1.739928612 
CG13324 -1.9554 0.0183 1.73754891 
Eip63F-1 -4.8873 0.0184 1.735182177 
Hydr1 -4.8873 0.0184 1.735182177 
msb1l -1.06 0.0187 1.728158393 
Taldo -0.7726 0.0189 1.723538196 
CG31126 -0.9685 0.019 1.721246399 
CG5010 -1.3646 0.019 1.721246399 
CG10184 -0.8636 0.0192 1.716698771 
SdhB -0.8379 0.0192 1.716698771 
CG14270 -0.8766 0.0194 1.71219827 
CG34200 -1.0483 0.0195 1.709965389 
CG30345 -0.8749 0.0195 1.709965389 
Bap60 -0.7654 0.0198 1.70333481 
CycE -4.8498 0.02 1.698970004 
CG13008 -2.2695 0.02 1.698970004 
ico -1.0794 0.02 1.698970004 
Orc5 -1.2574 0.0202 1.694648631 
CG32669 -1.7431 0.0203 1.692503962 
Cpr73D -1.2152 0.0204 1.690369833 
CG10472 -1.8595 0.0204 1.690369833 
 
 
240 
Ssrp -0.8088 0.0206 1.68613278 
Mdh2 -0.7414 0.0208 1.681936665 
rasp -0.9329 0.0208 1.681936665 
CG5569 -0.855 0.0213 1.671620397 
CG31550 -1.6585 0.0213 1.671620397 
CG14079 -2.1857 0.0214 1.669586227 
Cyp1 -0.7485 0.0215 1.66756154 
CG34198 -1.0695 0.0218 1.661543506 
Irp-1A -0.7889 0.0219 1.659555885 
DNApol-alpha50 -1.1517 0.0219 1.659555885 
CG8818 -0.8412 0.0224 1.649751982 
CCHa1-R -5.4678 0.0227 1.643974143 
Gr8a -5.4678 0.0227 1.643974143 
Mms19 -1.2029 0.0227 1.643974143 
Gycalpha99B -5.4678 0.0228 1.642065153 
CG13704 -1.6407 0.0235 1.628932138 
toy -1.2875 0.0237 1.625251654 
CG8607 -1.1266 0.0241 1.617982957 
CG32201 -2.2022 0.0241 1.617982957 
CG7567 -2.4586 0.0244 1.612610174 
CG11912 -3.0418 0.0244 1.612610174 
IntS4 -0.8836 0.0247 1.607303047 
Sc2 -0.7491 0.0247 1.607303047 
Egm -0.8233 0.0248 1.605548319 
CG4743 -0.9078 0.0249 1.603800653 
Tgt -0.7701 0.025 1.602059991 
RtcB -0.884 0.025 1.602059991 
CG7837 -1.0392 0.0252 1.598599459 
dnd -2.1773 0.0257 1.590066877 
CG33080 -2.8231 0.0258 1.588380294 
ida -1.0191 0.0258 1.588380294 
CG2254 -1.7202 0.0258 1.588380294 
Takl1 -2.3563 0.0258 1.588380294 
CG5167 -0.8917 0.0259 1.586700236 
beta4GalT7 -0.9063 0.026 1.585026652 
Pcl -1.2837 0.026 1.585026652 
Cisd2 -0.8436 0.0262 1.581698709 
CG8258 -0.8155 0.0262 1.581698709 
CG11878 -1.5233 0.0262 1.581698709 
hdm -3.6925 0.0263 1.580044252 
 
 
241 
CG34404 -1.6497 0.0263 1.580044252 
CG4627 -0.9998 0.0267 1.573488739 
CG8728 -0.8683 0.0267 1.573488739 
CG8891 -0.815 0.0268 1.571865206 
CG12321 -0.9057 0.0269 1.57024772 
mRpL36 -0.8362 0.0271 1.567030709 
CG14499 -3.3853 0.0274 1.562249437 
CG4557 -0.8553 0.0279 1.554395797 
CG11777 -1.035 0.0281 1.55129368 
Lgr3 -1.6167 0.0281 1.55129368 
CG10910 -1.4877 0.0284 1.54668166 
Gs1l -0.9892 0.0287 1.542118103 
CG2144 -1.0058 0.0291 1.536107011 
CG32284 -2.498 0.0295 1.530177984 
mRpL12 -0.7659 0.0296 1.528708289 
TBC1D5 -0.9011 0.0297 1.527243551 
mRpL47 -0.7491 0.0298 1.525783736 
CR45474 -2.142 0.0301 1.521433504 
Vha100-4 -2.4277 0.0302 1.519993057 
CG17841 -0.7886 0.0304 1.517126416 
Pi3K59F -0.8379 0.0305 1.515700161 
CG9568 -1.335 0.0306 1.514278574 
Nsun2 -0.8112 0.0313 1.504455662 
r-l -0.8568 0.0314 1.503070352 
CG3868 -1.14 0.0314 1.503070352 
mRpL20 -0.9376 0.0315 1.501689446 
arx -1.1859 0.0315 1.501689446 
CG11562 -0.8511 0.0317 1.498940738 
mRpL34 -0.867 0.0318 1.49757288 
CG30493 -0.8443 0.0319 1.496209317 
GlcT-1 -0.7685 0.0319 1.496209317 
CG31251 -1.2222 0.0319 1.496209317 
CR45973 -2.675 0.032 1.494850022 
CG15362 -1.0852 0.0323 1.490797478 
CG18577 -1.87 0.0324 1.48945499 
AsnRS-m -0.9829 0.0332 1.478861916 
mRpL10 -0.7908 0.0333 1.477555766 
CG7542 -1.9263 0.0333 1.477555766 
CG9752 -1.3752 0.0334 1.476253533 
Sld5 -1.1048 0.0335 1.474955193 
 
 
242 
CG1671 -0.8347 0.0339 1.469800302 
Caf1-180 -0.8242 0.034 1.468521083 
Rrp42 -0.8999 0.034 1.468521083 
tam -0.9897 0.0342 1.465973894 
CPT2 -0.8034 0.0343 1.46470588 
CG17570 -1.8716 0.0346 1.460923901 
Spp -0.7317 0.0349 1.457174573 
p47 -0.7331 0.0351 1.454692884 
CG12173 -0.8793 0.0351 1.454692884 
CG12279 -0.8807 0.0351 1.454692884 
CG13492 -1.3371 0.0357 1.447331784 
vanin-like -2.3264 0.0357 1.447331784 
CG9360 -1.1292 0.0359 1.444905551 
lectin-46Cb -1.3304 0.036 1.443697499 
Nrk -0.9285 0.0367 1.435333936 
beg -0.8028 0.0368 1.434152181 
Rrp46 -0.9698 0.037 1.431798276 
CG16979 -0.8644 0.0371 1.43062609 
mRpS35 -0.8175 0.0372 1.42945706 
Adgf-C -3.9081 0.0375 1.425968732 
mRpL18 -0.7157 0.0376 1.424812155 
CstF-50 -0.9761 0.0376 1.424812155 
TyrRS-m -0.8269 0.0377 1.42365865 
AdSL -0.7638 0.0378 1.4225082 
CG3909 -0.878 0.0378 1.4225082 
CG4278 -0.7921 0.0379 1.42136079 
Xpd -0.8764 0.0387 1.412289035 
CG17145 -1.3064 0.0391 1.407823243 
CG11964 -0.7555 0.0393 1.40560745 
CG3706 -2.3299 0.0394 1.404503778 
RpS14a -0.9624 0.0395 1.403402904 
mRpL44 -0.7429 0.0397 1.401209493 
CG17068 -0.8435 0.0397 1.401209493 
CG12204 -0.7785 0.0398 1.400116928 
Ing3 -0.8467 0.0398 1.400116928 
CG11590 -0.8507 0.0402 1.395773947 
Pdxk -0.779 0.0405 1.392544977 
vls -0.7659 0.0405 1.392544977 
CG7560 -4.9788 0.0417 1.379863945 
Mgstl -0.8917 0.042 1.37675071 
 
 
243 
CG30371 -3.6713 0.0424 1.372634143 
CG11164 -2.283 0.043 1.366531544 
Gk1 -1.0721 0.043 1.366531544 
Pgm -0.7341 0.0434 1.36251027 
Surf4 -0.7551 0.0436 1.360513511 
Fadd -0.8332 0.0439 1.35753548 
tex -0.7888 0.0442 1.354577731 
Acp53Ea -1.2018 0.0442 1.354577731 
beta-PheRS -0.7443 0.0445 1.351639989 
ATPsynB -0.6863 0.0453 1.343901798 
mRpL54 -0.7493 0.0456 1.341035157 
nht -1.9533 0.0458 1.339134522 
Ibf2 -1.198 0.0459 1.338187314 
NK7.1 -0.8137 0.046 1.337242168 
Ptp52F -0.9791 0.0461 1.336299075 
CG11858 -0.8994 0.0464 1.333482019 
CG8323 -0.8838 0.0466 1.331614083 
glu -0.9794 0.0468 1.329754147 
IP3K2 -1.0778 0.0468 1.329754147 
CG30287 -0.8938 0.0469 1.328827157 
Sym -0.7792 0.0471 1.326979093 
stg -1.288 0.0472 1.326058001 
CG5255 -1.9321 0.0482 1.316952962 
Mcm7 -1.5807 0.049 1.30980392 
CG33178 -1.6823 0.0494 1.306273051 
l(2)dtl -0.8239 0.0496 1.304518324 
RpS15Ab -0.7814 0.0497 1.303643611 
CG14424 -2.1247 0.0499 1.301899454 
CG8311 -0.7509 0.0499 1.301899454 
CG30001 -0.9443 0.0499 1.301899454 
mRpL30 -0.7406 0.0502 1.299296283 
Sas-4 -0.962 0.0502 1.299296283 
GckIII -0.7637 0.0503 1.298432015 
COX7A -0.8646 0.0505 1.296708622 
CG34220 -1.0087 0.0508 1.294136288 
CR32194 -1.1546 0.051 1.292429824 
SelG -0.8175 0.0515 1.288192771 
l(1)G0045 -0.8147 0.0525 1.279840697 
CCHa1 -1.822 0.0526 1.279014256 
SPE -1.9281 0.0527 1.278189385 
 
 
244 
CG15247 -3.1939 0.053 1.27572413 
AGBE -0.7303 0.053 1.27572413 
CG43120 -1.1863 0.053 1.27572413 
Ddx1 -0.8651 0.0531 1.274905479 
Gr66a -2.2459 0.0533 1.273272791 
Tfb4 -0.7257 0.0535 1.271646218 
cue -0.7187 0.0546 1.262807357 
Oga -0.7987 0.0549 1.260427656 
 
 
   
 
 
 
Table 2.1c: GO enrichment for hits differentially upregulated in control females relative to control 
males   
GO 
enrichment 
p-
value 
Hits Gene 
matche
s 
GO ID 
organic 
substance 
metabolic 
process 
0.0020
691 
FBgn0000078,FBgn0000477,FBgn0000543,FBgn0000
591,FBgn0001150,FBgn0001187,FBgn0002441,FBgn0
003044,FBgn0003076,FBgn0003257,FBgn0003356,FB
gn0003357,FBgn0003358,FBgn0003525,FBgn0003863
,FBgn0003996,FBgn0004403,FBgn0004406,FBgn0004
432,FBgn0010278,FBgn0010382,FBgn0010425,FBgn0
011211,FBgn0011555,FBgn0011703,FBgn0011704,FB
gn0011762,FBgn0011768,FBgn0011770,FBgn0011787
,FBgn0013725,FBgn0013972,FBgn0014023,FBgn0014
427,FBgn0014861,FBgn0015075,FBgn0015271,FBgn0
015277,FBgn0015299,FBgn0016691,FBgn0017577,FB
gn0019644,FBgn0019650,FBgn0020391,FBgn0020633
,FBgn0020906,FBgn0022700,FBgn0023477,FBgn0024
194,FBgn0024227,FBgn0024321,FBgn0024957,FBgn0
024958,FBgn0024997,FBgn0025352,FBgn0025373,FB
gn0025463,FBgn0025592,FBgn0025680,FBgn0025814
,FBgn0025815,FBgn0026079,FBgn0026143,FBgn0026
411,FBgn0026679,FBgn0026702,FBgn0026741,FBgn0
026876,FBgn0026879,FBgn0027560,FBgn0027578,FB
gn0027791,FBgn0027794,FBgn0027868,FBgn0028342
,FBgn0029718,FBgn0029823,FBgn0029828,FBgn0029
856,FBgn0029906,FBgn0029977,FBgn0030054,FBgn0
030081,FBgn0030136,FBgn0030507,FBgn0030688,FB
gn0030945,FBgn0030966,FBgn0031003,FBgn0031092
,FBgn0031145,FBgn0031231,FBgn0031248,FBgn0031
249,FBgn0031252,FBgn0031260,FBgn0031309,FBgn0
031321,FBgn0031381,FBgn0031653,FBgn0031663,FB
gn0031678,FBgn0031703,FBgn0031713,FBgn0031875
,FBgn0031996,FBgn0031999,FBgn0032144,FBgn0032
187,FBgn0032244,FBgn0032638,FBgn0032781,FBgn0
033179,FBgn0033187,FBgn0033235,FBgn0033377,FB
gn0033382,FBgn0033431,FBgn0033454,FBgn0033527
,FBgn0033549,FBgn0033555,FBgn0033733,FBgn0033
774,FBgn0033890,FBgn0033921,FBgn0034052,FBgn0
034065,FBgn0034085,FBgn0034141,FBgn0034177,FB
gn0034564,FBgn0034579,FBgn0034582,FBgn0034614
160 GO:0071
704 
 
 
245 
,FBgn0034629,FBgn0034817,FBgn0034988,FBgn0035
006,FBgn0035064,FBgn0035154,FBgn0035374,FBgn0
035383,FBgn0035471,FBgn0035644,FBgn0035665,FB
gn0035666,FBgn0035670,FBgn0035718,FBgn0035779
,FBgn0035886,FBgn0035887,FBgn0035901,FBgn0036
023,FBgn0036024,FBgn0036157,FBgn0036321,FBgn0
036335,FBgn0036512,FBgn0036691,FBgn0036738,FB
gn0036826,FBgn0036948,FBgn0036953,FBgn0036996
,FBgn0037045,FBgn0037073,FBgn0037146,FBgn0037
301,FBgn0037305,FBgn0037330,FBgn0037338,FBgn0
037345,FBgn0037356,FBgn0037371,FBgn0037513,FB
gn0037534,FBgn0037569,FBgn0037669,FBgn0037678
,FBgn0037815,FBgn0037996,FBgn0038038,FBgn0038
135,FBgn0038173,FBgn0038224,FBgn0038390,FBgn0
038437,FBgn0038467,FBgn0038474,FBgn0038482,FB
gn0038485,FBgn0038546,FBgn0038742,FBgn0038788
,FBgn0038928,FBgn0039052,FBgn0039094,FBgn0039
102,FBgn0039156,FBgn0039175,FBgn0039258,FBgn0
039403,FBgn0039404,FBgn0039470,FBgn0039471,FB
gn0039472,FBgn0039580,FBgn0039596,FBgn0039650
,FBgn0039687,FBgn0039777,FBgn0039778,FBgn0040
060,FBgn0040078,FBgn0040290,FBgn0040337,FBgn0
040959,FBgn0041103,FBgn0041147,FBgn0042112,FB
gn0043471,FBgn0043575,FBgn0046689,FBgn0050049
,FBgn0050085,FBgn0050090,FBgn0050287,FBgn0050
371,FBgn0050493,FBgn0050502,FBgn0051126,FBgn0
051198,FBgn0051266,FBgn0051469,FBgn0051550,FB
gn0052201,FBgn0052284,FBgn0052483,FBgn0053080
,FBgn0053116,FBgn0053127,FBgn0053138,FBgn0053
178,FBgn0053265,FBgn0067102,FBgn0083983,FBgn0
085249,FBgn0085484,FBgn0086708,FBgn0086712,FB
gn0243511,FBgn0250815,FBgn0259113,FBgn0259227
,FBgn0259676,FBgn0259678,FBgn0259748,FBgn0259
791,FBgn0260477,FBgn0261850,FBgn0262559,FBgn0
263133,FBgn0265140,FBgn0266420,FBgn0266465,FB
gn0267824,FBgn0283525,FBgn0283680,FBgn0284256
,FBgn0286788 
primary 
metabolic 
process 
0.0050
247 
FBgn0000078,FBgn0000477,FBgn0000543,FBgn0000
591,FBgn0001150,FBgn0001187,FBgn0002441,FBgn0
003044,FBgn0003076,FBgn0003257,FBgn0003356,FB
gn0003357,FBgn0003358,FBgn0003525,FBgn0003863
,FBgn0004403,FBgn0004406,FBgn0004432,FBgn0010
278,FBgn0010382,FBgn0010425,FBgn0011211,FBgn0
011555,FBgn0011703,FBgn0011704,FBgn0011762,FB
gn0011768,FBgn0011787,FBgn0013725,FBgn0013972
,FBgn0014023,FBgn0014028,FBgn0014427,FBgn0014
861,FBgn0015075,FBgn0015271,FBgn0015277,FBgn0
015299,FBgn0016691,FBgn0017577,FBgn0019644,FB
gn0019650,FBgn0020391,FBgn0020633,FBgn0020906
,FBgn0022700,FBgn0023477,FBgn0024194,FBgn0024
227,FBgn0024321,FBgn0024957,FBgn0024958,FBgn0
024997,FBgn0025352,FBgn0025373,FBgn0025463,FB
gn0025592,FBgn0025680,FBgn0025814,FBgn0025815
,FBgn0026079,FBgn0026143,FBgn0026411,FBgn0026
679,FBgn0026702,FBgn0026741,FBgn0026876,FBgn0
026879,FBgn0027560,FBgn0027578,FBgn0027791,FB
gn0027794,FBgn0027868,FBgn0028342,FBgn0029718
160 GO:0044
238 
 
 
246 
,FBgn0029823,FBgn0029828,FBgn0029856,FBgn0029
906,FBgn0029977,FBgn0030054,FBgn0030081,FBgn0
030136,FBgn0030507,FBgn0030688,FBgn0030945,FB
gn0031003,FBgn0031092,FBgn0031231,FBgn0031248
,FBgn0031249,FBgn0031252,FBgn0031260,FBgn0031
309,FBgn0031321,FBgn0031381,FBgn0031653,FBgn0
031663,FBgn0031678,FBgn0031703,FBgn0031996,FB
gn0031999,FBgn0032144,FBgn0032187,FBgn0032244
,FBgn0032638,FBgn0032781,FBgn0033179,FBgn0033
187,FBgn0033235,FBgn0033377,FBgn0033382,FBgn0
033431,FBgn0033454,FBgn0033527,FBgn0033549,FB
gn0033555,FBgn0033733,FBgn0033774,FBgn0033890
,FBgn0033921,FBgn0034052,FBgn0034065,FBgn0034
085,FBgn0034141,FBgn0034177,FBgn0034564,FBgn0
034579,FBgn0034582,FBgn0034614,FBgn0034629,FB
gn0034817,FBgn0034988,FBgn0035006,FBgn0035064
,FBgn0035154,FBgn0035374,FBgn0035383,FBgn0035
471,FBgn0035644,FBgn0035665,FBgn0035666,FBgn0
035670,FBgn0035718,FBgn0035779,FBgn0035886,FB
gn0035887,FBgn0035901,FBgn0036023,FBgn0036024
,FBgn0036157,FBgn0036321,FBgn0036335,FBgn0036
512,FBgn0036691,FBgn0036738,FBgn0036826,FBgn0
036996,FBgn0037045,FBgn0037073,FBgn0037146,FB
gn0037301,FBgn0037305,FBgn0037330,FBgn0037338
,FBgn0037345,FBgn0037356,FBgn0037371,FBgn0037
513,FBgn0037534,FBgn0037669,FBgn0037678,FBgn0
037815,FBgn0037891,FBgn0037996,FBgn0038038,FB
gn0038135,FBgn0038173,FBgn0038224,FBgn0038390
,FBgn0038467,FBgn0038474,FBgn0038482,FBgn0038
485,FBgn0038546,FBgn0038742,FBgn0038788,FBgn0
038928,FBgn0039052,FBgn0039094,FBgn0039102,FB
gn0039156,FBgn0039175,FBgn0039258,FBgn0039403
,FBgn0039404,FBgn0039470,FBgn0039471,FBgn0039
472,FBgn0039580,FBgn0039596,FBgn0039650,FBgn0
039687,FBgn0039777,FBgn0039778,FBgn0040060,FB
gn0040078,FBgn0040290,FBgn0040337,FBgn0041103
,FBgn0041147,FBgn0042112,FBgn0043471,FBgn0046
689,FBgn0050049,FBgn0050085,FBgn0050090,FBgn0
050287,FBgn0050371,FBgn0050502,FBgn0051126,FB
gn0051198,FBgn0051266,FBgn0051469,FBgn0051550
,FBgn0052201,FBgn0052483,FBgn0053080,FBgn0053
116,FBgn0053127,FBgn0053138,FBgn0053178,FBgn0
067102,FBgn0083983,FBgn0086708,FBgn0086712,FB
gn0243511,FBgn0250815,FBgn0259113,FBgn0259227
,FBgn0259676,FBgn0259678,FBgn0259791,FBgn0260
477,FBgn0261850,FBgn0262559,FBgn0263133,FBgn0
265140,FBgn0266420,FBgn0266465,FBgn0267824,FB
gn0283525,FBgn0284256,FBgn0286788 
metabolic 
process 
0.0058
731 
FBgn0000078,FBgn0000477,FBgn0000543,FBgn0000
591,FBgn0001150,FBgn0001187,FBgn0002441,FBgn0
003044,FBgn0003076,FBgn0003257,FBgn0003356,FB
gn0003357,FBgn0003358,FBgn0003525,FBgn0003863
,FBgn0003996,FBgn0004403,FBgn0004406,FBgn0004
432,FBgn0010278,FBgn0010380,FBgn0010382,FBgn0
010425,FBgn0011211,FBgn0011227,FBgn0011555,FB
gn0011703,FBgn0011704,FBgn0011762,FBgn0011768
,FBgn0011770,FBgn0011787,FBgn0013725,FBgn0013
160 GO:0008
152 
 
 
247 
972,FBgn0014023,FBgn0014028,FBgn0014427,FBgn0
014861,FBgn0015075,FBgn0015271,FBgn0015277,FB
gn0015299,FBgn0016691,FBgn0017577,FBgn0019644
,FBgn0019650,FBgn0020391,FBgn0020633,FBgn0020
906,FBgn0022700,FBgn0023477,FBgn0024194,FBgn0
024227,FBgn0024321,FBgn0024957,FBgn0024958,FB
gn0024997,FBgn0025352,FBgn0025373,FBgn0025463
,FBgn0025592,FBgn0025680,FBgn0025814,FBgn0025
815,FBgn0026079,FBgn0026143,FBgn0026411,FBgn0
026679,FBgn0026702,FBgn0026741,FBgn0026876,FB
gn0026879,FBgn0027560,FBgn0027578,FBgn0027791
,FBgn0027794,FBgn0027868,FBgn0028342,FBgn0029
131,FBgn0029718,FBgn0029823,FBgn0029828,FBgn0
029856,FBgn0029906,FBgn0029977,FBgn0030054,FB
gn0030081,FBgn0030136,FBgn0030507,FBgn0030688
,FBgn0030945,FBgn0030966,FBgn0031003,FBgn0031
092,FBgn0031145,FBgn0031231,FBgn0031248,FBgn0
031249,FBgn0031252,FBgn0031260,FBgn0031309,FB
gn0031321,FBgn0031381,FBgn0031653,FBgn0031663
,FBgn0031678,FBgn0031703,FBgn0031713,FBgn0031
875,FBgn0031996,FBgn0031999,FBgn0032144,FBgn0
032187,FBgn0032244,FBgn0032638,FBgn0032781,FB
gn0033079,FBgn0033179,FBgn0033187,FBgn0033235
,FBgn0033377,FBgn0033382,FBgn0033431,FBgn0033
454,FBgn0033527,FBgn0033549,FBgn0033555,FBgn0
033733,FBgn0033774,FBgn0033890,FBgn0033921,FB
gn0033961,FBgn0034052,FBgn0034065,FBgn0034085
,FBgn0034141,FBgn0034177,FBgn0034564,FBgn0034
579,FBgn0034582,FBgn0034614,FBgn0034629,FBgn0
034756,FBgn0034817,FBgn0034988,FBgn0035006,FB
gn0035064,FBgn0035154,FBgn0035374,FBgn0035383
,FBgn0035471,FBgn0035619,FBgn0035644,FBgn0035
665,FBgn0035666,FBgn0035670,FBgn0035718,FBgn0
035779,FBgn0035886,FBgn0035887,FBgn0035901,FB
gn0036023,FBgn0036024,FBgn0036157,FBgn0036321
,FBgn0036335,FBgn0036512,FBgn0036691,FBgn0036
738,FBgn0036826,FBgn0036948,FBgn0036953,FBgn0
036996,FBgn0037045,FBgn0037073,FBgn0037146,FB
gn0037301,FBgn0037305,FBgn0037330,FBgn0037338
,FBgn0037345,FBgn0037356,FBgn0037370,FBgn0037
371,FBgn0037513,FBgn0037534,FBgn0037569,FBgn0
037669,FBgn0037678,FBgn0037815,FBgn0037891,FB
gn0037996,FBgn0038038,FBgn0038135,FBgn0038173
,FBgn0038224,FBgn0038390,FBgn0038437,FBgn0038
467,FBgn0038474,FBgn0038482,FBgn0038485,FBgn0
038546,FBgn0038742,FBgn0038788,FBgn0038928,FB
gn0039052,FBgn0039094,FBgn0039099,FBgn0039102
,FBgn0039156,FBgn0039175,FBgn0039258,FBgn0039
403,FBgn0039404,FBgn0039470,FBgn0039471,FBgn0
039472,FBgn0039580,FBgn0039596,FBgn0039650,FB
gn0039687,FBgn0039777,FBgn0039778,FBgn0040060
,FBgn0040069,FBgn0040078,FBgn0040290,FBgn0040
337,FBgn0040529,FBgn0040959,FBgn0041103,FBgn0
041147,FBgn0042112,FBgn0043471,FBgn0043575,FB
gn0046689,FBgn0050049,FBgn0050085,FBgn0050090
,FBgn0050287,FBgn0050371,FBgn0050493,FBgn0050
502,FBgn0051126,FBgn0051198,FBgn0051266,FBgn0
 
 
248 
051469,FBgn0051550,FBgn0052201,FBgn0052284,FB
gn0052483,FBgn0052750,FBgn0053080,FBgn0053116
,FBgn0053127,FBgn0053138,FBgn0053178,FBgn0053
265,FBgn0067102,FBgn0083983,FBgn0085249,FBgn0
085484,FBgn0086708,FBgn0086712,FBgn0243511,FB
gn0250815,FBgn0259113,FBgn0259227,FBgn0259676
,FBgn0259678,FBgn0259748,FBgn0259791,FBgn0260
477,FBgn0261850,FBgn0262559,FBgn0263133,FBgn0
265140,FBgn0266420,FBgn0266465,FBgn0267824,FB
gn0283525,FBgn0283680,FBgn0284256,FBgn0286788 
organonitroge
n compound 
metabolic 
process 
0.0167
065 
FBgn0001187,FBgn0003257,FBgn0003356,FBgn0003
357,FBgn0003358,FBgn0003525,FBgn0003863,FBgn0
003996,FBgn0004403,FBgn0004432,FBgn0010278,FB
gn0010382,FBgn0010425,FBgn0011211,FBgn0011555
,FBgn0011703,FBgn0011704,FBgn0011768,FBgn0011
787,FBgn0013725,FBgn0013972,FBgn0014023,FBgn0
014427,FBgn0016691,FBgn0019644,FBgn0020391,FB
gn0020906,FBgn0022700,FBgn0024194,FBgn0024227
,FBgn0024997,FBgn0026741,FBgn0026879,FBgn0027
578,FBgn0027791,FBgn0027794,FBgn0028342,FBgn0
029718,FBgn0029823,FBgn0029828,FBgn0029856,FB
gn0029906,FBgn0030136,FBgn0030688,FBgn0030945
,FBgn0031003,FBgn0031145,FBgn0031231,FBgn0031
248,FBgn0031249,FBgn0031260,FBgn0031309,FBgn0
031653,FBgn0031678,FBgn0031999,FBgn0032144,FB
gn0032187,FBgn0032638,FBgn0033179,FBgn0033187
,FBgn0033235,FBgn0033431,FBgn0033527,FBgn0033
555,FBgn0033774,FBgn0034052,FBgn0034085,FBgn0
034177,FBgn0034579,FBgn0034582,FBgn0034817,FB
gn0034988,FBgn0035064,FBgn0035154,FBgn0035374
,FBgn0035665,FBgn0035666,FBgn0035670,FBgn0035
718,FBgn0035779,FBgn0035886,FBgn0035887,FBgn0
036023,FBgn0036024,FBgn0036157,FBgn0036335,FB
gn0036512,FBgn0036738,FBgn0036948,FBgn0036953
,FBgn0037045,FBgn0037146,FBgn0037301,FBgn0037
305,FBgn0037330,FBgn0037513,FBgn0037534,FBgn0
037678,FBgn0038135,FBgn0038173,FBgn0038224,FB
gn0038467,FBgn0038474,FBgn0038482,FBgn0038485
,FBgn0038788,FBgn0038928,FBgn0039052,FBgn0039
094,FBgn0039102,FBgn0039156,FBgn0039175,FBgn0
039258,FBgn0039580,FBgn0039650,FBgn0039687,FB
gn0039777,FBgn0039778,FBgn0040060,FBgn0040078
,FBgn0040959,FBgn0041147,FBgn0042112,FBgn0043
471,FBgn0043575,FBgn0046689,FBgn0050049,FBgn0
050090,FBgn0050287,FBgn0050371,FBgn0051198,FB
gn0051266,FBgn0051469,FBgn0052201,FBgn0052284
,FBgn0052483,FBgn0053127,FBgn0053178,FBgn0053
265,FBgn0067102,FBgn0083983,FBgn0085249,FBgn0
085484,FBgn0086708,FBgn0243511,FBgn0250815,FB
gn0259227,FBgn0259678,FBgn0259748,FBgn0259791
,FBgn0260477,FBgn0262559,FBgn0263133,FBgn0265
140,FBgn0266465,FBgn0267824,FBgn0284256 
157 GO:1901
564 
small 
molecule 
metabolic 
process 
4.43E-
07 
FBgn0000543,FBgn0001187,FBgn0003076,FBgn0003
257,FBgn0011211,FBgn0011703,FBgn0011704,FBgn0
011768,FBgn0011770,FBgn0013972,FBgn0014427,FB
gn0016691,FBgn0019644,FBgn0024957,FBgn0024958
,FBgn0025352,FBgn0025592,FBgn0025814,FBgn0028
62 GO:0044
281 
 
 
249 
342,FBgn0029823,FBgn0030507,FBgn0030966,FBgn0
031092,FBgn0031381,FBgn0031663,FBgn0031703,FB
gn0031713,FBgn0033733,FBgn0034177,FBgn0034629
,FBgn0034988,FBgn0035006,FBgn0035064,FBgn0035
383,FBgn0035471,FBgn0036157,FBgn0036691,FBgn0
037146,FBgn0037305,FBgn0037356,FBgn0037513,FB
gn0037534,FBgn0037996,FBgn0038173,FBgn0038224
,FBgn0038437,FBgn0038467,FBgn0038742,FBgn0039
052,FBgn0039094,FBgn0039156,FBgn0039175,FBgn0
039258,FBgn0039580,FBgn0039650,FBgn0050493,FB
gn0050502,FBgn0053178,FBgn0085484,FBgn0086712
,FBgn0262559,FBgn0283680 
proteolysis 9.114
E-06 
FBgn0003356,FBgn0003357,FBgn0003358,FBgn0003
863,FBgn0010425,FBgn0011555,FBgn0011703,FBgn0
011704,FBgn0013725,FBgn0020906,FBgn0024997,FB
gn0027578,FBgn0029828,FBgn0029856,FBgn0030688
,FBgn0031248,FBgn0031249,FBgn0031260,FBgn0031
653,FBgn0031678,FBgn0032144,FBgn0032638,FBgn0
033179,FBgn0033235,FBgn0033774,FBgn0034052,FB
gn0035154,FBgn0035665,FBgn0035666,FBgn0035670
,FBgn0035718,FBgn0035779,FBgn0035886,FBgn0035
887,FBgn0036023,FBgn0036024,FBgn0036512,FBgn0
036738,FBgn0037678,FBgn0038135,FBgn0038482,FB
gn0038485,FBgn0038928,FBgn0039102,FBgn0039777
,FBgn0039778,FBgn0040060,FBgn0041147,FBgn0043
471,FBgn0050049,FBgn0050090,FBgn0050287,FBgn0
050371,FBgn0051198,FBgn0051266,FBgn0052483,FB
gn0053127,FBgn0250815,FBgn0260477,FBgn0262559
,FBgn0265140 
61 GO:0006
508 
cell cycle 
process 
0.0318
894 
FBgn0000140,FBgn0003525,FBgn0003885,FBgn0004
378,FBgn0004643,FBgn0010382,FBgn0011020,FBgn0
011692,FBgn0014861,FBgn0015271,FBgn0015391,FB
gn0017577,FBgn0020633,FBgn0024227,FBgn0025815
,FBgn0026143,FBgn0026876,FBgn0027500,FBgn0027
868,FBgn0029977,FBgn0030054,FBgn0031549,FBgn0
032244,FBgn0033549,FBgn0033890,FBgn0033921,FB
gn0034569,FBgn0035644,FBgn0038390,FBgn0039403
,FBgn0039638,FBgn0040078,FBgn0040290,FBgn0041
147,FBgn0050085,FBgn0061476,FBgn0259113,FBgn0
259791,FBgn0261850,FBgn0286788 
40 GO:0022
402 
organic acid 
metabolic 
process 
4.282
E-06 
FBgn0001187,FBgn0011770,FBgn0014427,FBgn0024
957,FBgn0024958,FBgn0025352,FBgn0025814,FBgn0
029823,FBgn0030966,FBgn0031092,FBgn0031703,FB
gn0033733,FBgn0034177,FBgn0034629,FBgn0035006
,FBgn0035064,FBgn0035383,FBgn0035471,FBgn0036
157,FBgn0036691,FBgn0037146,FBgn0037305,FBgn0
037356,FBgn0037513,FBgn0037534,FBgn0037996,FB
gn0038437,FBgn0038742,FBgn0039052,FBgn0039094
,FBgn0039156,FBgn0039175,FBgn0039258,FBgn0050
502,FBgn0053178,FBgn0086712,FBgn0262559 
37 GO:0006
082 
oxoacid 
metabolic 
process 
4.282
E-06 
FBgn0001187,FBgn0011770,FBgn0014427,FBgn0024
957,FBgn0024958,FBgn0025352,FBgn0025814,FBgn0
029823,FBgn0030966,FBgn0031092,FBgn0031703,FB
gn0033733,FBgn0034177,FBgn0034629,FBgn0035006
,FBgn0035064,FBgn0035383,FBgn0035471,FBgn0036
157,FBgn0036691,FBgn0037146,FBgn0037305,FBgn0
037356,FBgn0037513,FBgn0037534,FBgn0037996,FB
37 GO:0043
436 
 
 
250 
gn0038437,FBgn0038742,FBgn0039052,FBgn0039094
,FBgn0039156,FBgn0039175,FBgn0039258,FBgn0050
502,FBgn0053178,FBgn0086712,FBgn0262559 
carbohydrate 
derivative 
metabolic 
process 
0.0015
541 
FBgn0001187,FBgn0003257,FBgn0011211,FBgn0011
703,FBgn0011704,FBgn0013972,FBgn0016691,FBgn0
019644,FBgn0022700,FBgn0023477,FBgn0025592,FB
gn0027791,FBgn0028342,FBgn0029906,FBgn0030507
,FBgn0033187,FBgn0033431,FBgn0034582,FBgn0034
988,FBgn0036948,FBgn0036953,FBgn0038038,FBgn0
038173,FBgn0038224,FBgn0038467,FBgn0039156,FB
gn0039258,FBgn0039580,FBgn0039650,FBgn0040959
,FBgn0043575,FBgn0052284,FBgn0053265,FBgn0067
102,FBgn0085249,FBgn0259748 
36 GO:1901
135 
carboxylic 
acid metabolic 
process 
9.758
E-06 
FBgn0001187,FBgn0011770,FBgn0014427,FBgn0024
957,FBgn0024958,FBgn0025352,FBgn0025814,FBgn0
029823,FBgn0031092,FBgn0031703,FBgn0033733,FB
gn0034177,FBgn0034629,FBgn0035006,FBgn0035064
,FBgn0035383,FBgn0035471,FBgn0036157,FBgn0036
691,FBgn0037146,FBgn0037305,FBgn0037356,FBgn0
037513,FBgn0037534,FBgn0037996,FBgn0038437,FB
gn0038742,FBgn0039052,FBgn0039094,FBgn0039156
,FBgn0039175,FBgn0050502,FBgn0053178,FBgn0086
712,FBgn0262559 
35 GO:0019
752 
lipid 
metabolic 
process 
0.0031
557 
FBgn0000543,FBgn0015277,FBgn0025352,FBgn0025
373,FBgn0025592,FBgn0025814,FBgn0029906,FBgn0
031092,FBgn0031381,FBgn0031703,FBgn0033187,FB
gn0033382,FBgn0033733,FBgn0034141,FBgn0034629
,FBgn0035006,FBgn0035383,FBgn0035471,FBgn0036
691,FBgn0036996,FBgn0037356,FBgn0037534,FBgn0
037996,FBgn0038038,FBgn0038742,FBgn0039156,FB
gn0039470,FBgn0039471,FBgn0039472,FBgn0050502
,FBgn0053116,FBgn0053178,FBgn0067102,FBgn0086
712 
34 GO:0006
629 
oxidation-
reduction 
process 
0.0252
941 
FBgn0003076,FBgn0011211,FBgn0011227,FBgn0011
703,FBgn0011704,FBgn0011768,FBgn0014028,FBgn0
023477,FBgn0024957,FBgn0024958,FBgn0025352,FB
gn0025814,FBgn0030966,FBgn0031092,FBgn0031713
,FBgn0033079,FBgn0033961,FBgn0034629,FBgn0034
756,FBgn0035383,FBgn0036157,FBgn0037146,FBgn0
037370,FBgn0037891,FBgn0038038,FBgn0038742,FB
gn0039099,FBgn0040529,FBgn0050502,FBgn0052201
,FBgn0053138,FBgn0053178,FBgn0086712,FBgn0262
559 
34 GO:0055
114 
DNA 
metabolic 
process 
0.0001
931 
FBgn0000477,FBgn0004406,FBgn0010382,FBgn0011
762,FBgn0014861,FBgn0015075,FBgn0015271,FBgn0
017577,FBgn0020633,FBgn0025815,FBgn0026143,FB
gn0027868,FBgn0029977,FBgn0030054,FBgn0031252
,FBgn0031309,FBgn0032244,FBgn0033549,FBgn0033
890,FBgn0035644,FBgn0036321,FBgn0037301,FBgn0
037338,FBgn0037345,FBgn0039403,FBgn0040290,FB
gn0050085,FBgn0259113,FBgn0259676,FBgn0261850
,FBgn0286788 
31 GO:0006
259 
small 
molecule 
biosynthetic 
process 
1.60E-
07 
FBgn0000543,FBgn0014427,FBgn0025814,FBgn0029
823,FBgn0031381,FBgn0031663,FBgn0031703,FBgn0
031713,FBgn0033733,FBgn0034988,FBgn0035006,FB
gn0035383,FBgn0035471,FBgn0036157,FBgn0036691
,FBgn0037146,FBgn0037305,FBgn0037356,FBgn0037
29 GO:0044
283 
 
 
251 
513,FBgn0037534,FBgn0037996,FBgn0038173,FBgn0
039094,FBgn0039156,FBgn0039650,FBgn0050493,FB
gn0053178,FBgn0085484,FBgn0283680 
cellular lipid 
metabolic 
process 
0.0055
799 
FBgn0015277,FBgn0025352,FBgn0025373,FBgn0025
592,FBgn0025814,FBgn0029906,FBgn0031092,FBgn0
031703,FBgn0033187,FBgn0033382,FBgn0033733,FB
gn0034141,FBgn0034629,FBgn0035006,FBgn0035383
,FBgn0035471,FBgn0036691,FBgn0037356,FBgn0037
534,FBgn0037996,FBgn0038038,FBgn0038742,FBgn0
039156,FBgn0050502,FBgn0053116,FBgn0053178,FB
gn0067102,FBgn0086712 
28 GO:0044
255 
mitotic cell 
cycle process 
0.0134
237 
FBgn0000140,FBgn0003525,FBgn0003885,FBgn0004
378,FBgn0004643,FBgn0010382,FBgn0011692,FBgn0
014861,FBgn0015271,FBgn0015391,FBgn0024227,FB
gn0025815,FBgn0026143,FBgn0031549,FBgn0033549
,FBgn0034569,FBgn0035644,FBgn0038390,FBgn0039
403,FBgn0039638,FBgn0040078,FBgn0040290,FBgn0
041147,FBgn0061476,FBgn0259113,FBgn0259791,FB
gn0261850,FBgn0286788 
28 GO:1903
047 
organophosph
ate metabolic 
process 
0.0133
514 
FBgn0001187,FBgn0003257,FBgn0011211,FBgn0011
703,FBgn0011704,FBgn0013972,FBgn0015277,FBgn0
016691,FBgn0019644,FBgn0023477,FBgn0025373,FB
gn0025592,FBgn0028342,FBgn0030507,FBgn0031663
,FBgn0033187,FBgn0034141,FBgn0034988,FBgn0038
224,FBgn0038467,FBgn0039156,FBgn0039580,FBgn0
039650,FBgn0053116,FBgn0085484,FBgn0283680 
26 GO:0019
637 
drug 
metabolic 
process 
3.89E-
06 
FBgn0011211,FBgn0011768,FBgn0016691,FBgn0019
644,FBgn0022700,FBgn0024957,FBgn0024958,FBgn0
028342,FBgn0029823,FBgn0034582,FBgn0035383,FB
gn0036948,FBgn0036953,FBgn0037305,FBgn0038173
,FBgn0038224,FBgn0038437,FBgn0038467,FBgn0039
094,FBgn0040959,FBgn0052284,FBgn0053265,FBgn0
085249,FBgn0085484,FBgn0259748 
25 GO:0017
144 
cellular 
response to 
DNA damage 
stimulus 
0.0044
455 
FBgn0004406,FBgn0014861,FBgn0015075,FBgn0017
577,FBgn0020633,FBgn0025815,FBgn0026143,FBgn0
027868,FBgn0029131,FBgn0029588,FBgn0029977,FB
gn0030054,FBgn0031252,FBgn0031309,FBgn0032244
,FBgn0033549,FBgn0033890,FBgn0035644,FBgn0037
301,FBgn0037338,FBgn0039403,FBgn0040290,FBgn0
050085,FBgn0261850 
24 GO:0006
974 
DNA 
replication 
8.10E-
08 
FBgn0004406,FBgn0010382,FBgn0011703,FBgn0011
762,FBgn0014861,FBgn0015271,FBgn0017577,FBgn0
020633,FBgn0025815,FBgn0026143,FBgn0030054,FB
gn0031875,FBgn0032244,FBgn0033549,FBgn0033890
,FBgn0035644,FBgn0039403,FBgn0040290,FBgn0050
085,FBgn0259113,FBgn0259676,FBgn0286788 
22 GO:0006
260 
DNA repair 0.0008
795 
FBgn0004406,FBgn0014861,FBgn0015075,FBgn0017
577,FBgn0020633,FBgn0025815,FBgn0026143,FBgn0
027868,FBgn0029977,FBgn0030054,FBgn0031252,FB
gn0031309,FBgn0032244,FBgn0033549,FBgn0033890
,FBgn0035644,FBgn0037301,FBgn0037338,FBgn0039
403,FBgn0040290,FBgn0261850 
21 GO:0006
281 
lipid 
biosynthetic 
process 
0.0009
743 
FBgn0000543,FBgn0015277,FBgn0025373,FBgn0025
814,FBgn0031381,FBgn0031703,FBgn0033187,FBgn0
033733,FBgn0034141,FBgn0035006,FBgn0035471,FB
gn0036691,FBgn0037356,FBgn0037534,FBgn0037996
,FBgn0038038,FBgn0039156,FBgn0050502,FBgn0053
21 GO:0008
610 
 
 
252 
116,FBgn0053178,FBgn0067102 
DNA-
dependent 
DNA 
replication 
2.67E-
07 
FBgn0004406,FBgn0011762,FBgn0014861,FBgn0015
271,FBgn0017577,FBgn0020633,FBgn0025815,FBgn0
026143,FBgn0030054,FBgn0031875,FBgn0032244,FB
gn0033549,FBgn0033890,FBgn0035644,FBgn0039403
,FBgn0040290,FBgn0050085,FBgn0259113,FBgn0259
676,FBgn0286788 
20 GO:0006
261 
monocarboxyl
ic acid 
metabolic 
process 
0.0001
07 
FBgn0001187,FBgn0011770,FBgn0025352,FBgn0025
814,FBgn0031092,FBgn0031703,FBgn0033733,FBgn0
034629,FBgn0035006,FBgn0035383,FBgn0035471,FB
gn0036691,FBgn0037356,FBgn0037534,FBgn0037996
,FBgn0038742,FBgn0039156,FBgn0050502,FBgn0053
178,FBgn0086712 
20 GO:0032
787 
nucleobase-
containing 
small 
molecule 
metabolic 
process 
0.0076
182 
FBgn0001187,FBgn0003257,FBgn0011211,FBgn0011
703,FBgn0011704,FBgn0013972,FBgn0016691,FBgn0
019644,FBgn0028342,FBgn0029823,FBgn0030507,FB
gn0031663,FBgn0034988,FBgn0037513,FBgn0038173
,FBgn0038224,FBgn0038467,FBgn0039156,FBgn0039
580,FBgn0039650 
20 GO:0055
086 
carbohydrate 
derivative 
biosynthetic 
process 
0.0339
194 
FBgn0003257,FBgn0011211,FBgn0011703,FBgn0011
704,FBgn0013972,FBgn0016691,FBgn0019644,FBgn0
025592,FBgn0027791,FBgn0028342,FBgn0029906,FB
gn0033187,FBgn0038038,FBgn0038173,FBgn0038224
,FBgn0038467,FBgn0039156,FBgn0039258,FBgn0039
580,FBgn0067102 
20 GO:1901
137 
organophosph
ate 
biosynthetic 
process 
0.0049
102 
FBgn0003257,FBgn0011211,FBgn0011703,FBgn0011
704,FBgn0013972,FBgn0015277,FBgn0016691,FBgn0
019644,FBgn0025373,FBgn0025592,FBgn0028342,FB
gn0033187,FBgn0034141,FBgn0038224,FBgn0038467
,FBgn0039156,FBgn0053116,FBgn0085484,FBgn0283
680 
19 GO:0090
407 
regulation of 
mitotic cell 
cycle 
0.0108
642 
FBgn0002441,FBgn0003525,FBgn0004643,FBgn0010
382,FBgn0024227,FBgn0026143,FBgn0031549,FBgn0
033549,FBgn0034569,FBgn0038390,FBgn0039403,FB
gn0039638,FBgn0040290,FBgn0041147,FBgn0061476
,FBgn0259791,FBgn0261850,FBgn0266465,FBgn0286
788 
19 GO:0007
346 
organic acid 
biosynthetic 
process 
3.645
E-06 
FBgn0014427,FBgn0025814,FBgn0029823,FBgn0031
703,FBgn0033733,FBgn0035006,FBgn0035471,FBgn0
036157,FBgn0036691,FBgn0037146,FBgn0037305,FB
gn0037356,FBgn0037513,FBgn0037534,FBgn0037996
,FBgn0039094,FBgn0039156,FBgn0053178 
18 GO:0016
053 
carboxylic 
acid 
biosynthetic 
process 
3.645
E-06 
FBgn0014427,FBgn0025814,FBgn0029823,FBgn0031
703,FBgn0033733,FBgn0035006,FBgn0035471,FBgn0
036157,FBgn0036691,FBgn0037146,FBgn0037305,FB
gn0037356,FBgn0037513,FBgn0037534,FBgn0037996
,FBgn0039094,FBgn0039156,FBgn0053178 
18 GO:0046
394 
fatty acid 
metabolic 
process 
5.632
E-06 
FBgn0025352,FBgn0025814,FBgn0031092,FBgn0031
703,FBgn0033733,FBgn0034629,FBgn0035006,FBgn0
035383,FBgn0035471,FBgn0036691,FBgn0037356,FB
gn0037534,FBgn0037996,FBgn0038742,FBgn0039156
,FBgn0050502,FBgn0053178,FBgn0086712 
18 GO:0006
631 
generation of 
precursor 
metabolites 
and energy 
0.0071
37 
FBgn0001187,FBgn0003076,FBgn0011211,FBgn0011
227,FBgn0011768,FBgn0014028,FBgn0016691,FBgn0
023477,FBgn0024957,FBgn0024958,FBgn0027794,FB
gn0033961,FBgn0035383,FBgn0037891,FBgn0040529
18 GO:0006
091 
 
 
253 
,FBgn0053138,FBgn0262559,FBgn0284256 
regulation of 
cell cycle 
process 
0.0098
543 
FBgn0003525,FBgn0004643,FBgn0010382,FBgn0024
227,FBgn0026143,FBgn0031549,FBgn0034569,FBgn0
035644,FBgn0038390,FBgn0039403,FBgn0039638,FB
gn0040290,FBgn0041147,FBgn0050085,FBgn0061476
,FBgn0259791,FBgn0261850,FBgn0286788 
18 GO:0010
564 
mitochondrial 
translation 
0.0011
225 
FBgn0011787,FBgn0014023,FBgn0026741,FBgn0027
794,FBgn0029718,FBgn0031231,FBgn0034579,FBgn0
035064,FBgn0035374,FBgn0036335,FBgn0037330,FB
gn0038474,FBgn0042112,FBgn0083983,FBgn0263133
,FBgn0284256 
16 GO:0032
543 
mitochondrial 
gene 
expression 
0.0043
101 
FBgn0011787,FBgn0014023,FBgn0026741,FBgn0027
794,FBgn0029718,FBgn0031231,FBgn0034579,FBgn0
035064,FBgn0035374,FBgn0036335,FBgn0037330,FB
gn0038474,FBgn0042112,FBgn0083983,FBgn0263133
,FBgn0284256 
16 GO:0140
053 
nucleoside 
phosphate 
metabolic 
process 
0.0107
824 
FBgn0001187,FBgn0003257,FBgn0011211,FBgn0011
703,FBgn0011704,FBgn0013972,FBgn0016691,FBgn0
019644,FBgn0028342,FBgn0030507,FBgn0031663,FB
gn0034988,FBgn0038224,FBgn0038467,FBgn0039156
,FBgn0039650 
16 GO:0006
753 
mitotic 
nuclear 
division 
0.0169
61 
FBgn0004378,FBgn0004643,FBgn0010382,FBgn0011
692,FBgn0015271,FBgn0015391,FBgn0024227,FBgn0
031549,FBgn0034569,FBgn0039638,FBgn0040078,FB
gn0041147,FBgn0061476,FBgn0259791,FBgn0261850 
15 GO:0140
014 
double-strand 
break repair 
0.0004
804 
FBgn0014861,FBgn0015075,FBgn0017577,FBgn0020
633,FBgn0025815,FBgn0026143,FBgn0027868,FBgn0
029977,FBgn0030054,FBgn0033549,FBgn0037301,FB
gn0037338,FBgn0039403,FBgn0040290 
14 GO:0006
302 
regulation of 
cell cycle 
phase 
transition 
0.0025
978 
FBgn0003525,FBgn0004643,FBgn0010382,FBgn0024
227,FBgn0026143,FBgn0031549,FBgn0038390,FBgn0
039403,FBgn0040290,FBgn0041147,FBgn0050085,FB
gn0061476,FBgn0261850,FBgn0286788 
14 GO:1901
987 
cell cycle 
phase 
transition 
0.0177
676 
FBgn0003525,FBgn0004643,FBgn0010382,FBgn0024
227,FBgn0026143,FBgn0031549,FBgn0038390,FBgn0
039403,FBgn0040290,FBgn0041147,FBgn0050085,FB
gn0061476,FBgn0261850,FBgn0286788 
14 GO:0044
770 
nucleotide 
metabolic 
process 
0.0377
349 
FBgn0001187,FBgn0003257,FBgn0011211,FBgn0011
703,FBgn0011704,FBgn0013972,FBgn0016691,FBgn0
019644,FBgn0028342,FBgn0030507,FBgn0038224,FB
gn0038467,FBgn0039156,FBgn0039650 
14 GO:0009
117 
DNA 
recombination 
0.0023
796 
FBgn0014861,FBgn0017577,FBgn0020633,FBgn0025
815,FBgn0026143,FBgn0027868,FBgn0029977,FBgn0
030054,FBgn0033549,FBgn0037301,FBgn0039403,FB
gn0040290,FBgn0261850 
13 GO:0006
310 
regulation of 
mitotic cell 
cycle phase 
transition 
0.0044
564 
FBgn0003525,FBgn0004643,FBgn0010382,FBgn0024
227,FBgn0026143,FBgn0031549,FBgn0038390,FBgn0
039403,FBgn0040290,FBgn0041147,FBgn0061476,FB
gn0261850,FBgn0286788 
13 GO:1901
990 
DNA 
conformation 
change 
0.0086
556 
FBgn0014861,FBgn0015075,FBgn0015271,FBgn0015
391,FBgn0017577,FBgn0020633,FBgn0024227,FBgn0
025815,FBgn0026143,FBgn0026876,FBgn0030054,FB
gn0040290,FBgn0261850 
13 GO:0071
103 
small 
molecule 
catabolic 
0.0105
96 
FBgn0003076,FBgn0011768,FBgn0025352,FBgn0029
823,FBgn0031092,FBgn0034629,FBgn0034988,FBgn0
035383,FBgn0038173,FBgn0038742,FBgn0039094,FB
13 GO:0044
282 
 
 
254 
process gn0039650,FBgn0086712 
mitotic cell 
cycle phase 
transition 
0.0238
005 
FBgn0003525,FBgn0004643,FBgn0010382,FBgn0024
227,FBgn0026143,FBgn0031549,FBgn0038390,FBgn0
039403,FBgn0040290,FBgn0041147,FBgn0061476,FB
gn0261850,FBgn0286788 
13 GO:0044
772 
purine-
containing 
compound 
metabolic 
process 
0.0258
011 
FBgn0001187,FBgn0011211,FBgn0013972,FBgn0016
691,FBgn0019644,FBgn0028342,FBgn0029823,FBgn0
034988,FBgn0038173,FBgn0038224,FBgn0038467,FB
gn0039156,FBgn0039650 
13 GO:0072
521 
ribonucleotide 
metabolic 
process 
0.0270
761 
FBgn0001187,FBgn0003257,FBgn0011211,FBgn0013
972,FBgn0016691,FBgn0019644,FBgn0028342,FBgn0
030507,FBgn0038224,FBgn0038467,FBgn0039156,FB
gn0039650 
12 GO:0009
259 
ATP 
metabolic 
process 
0.0294
131 
FBgn0001187,FBgn0011211,FBgn0011227,FBgn0014
028,FBgn0016691,FBgn0019644,FBgn0027794,FBgn0
028342,FBgn0033961,FBgn0038224,FBgn0040529,FB
gn0284256 
12 GO:0046
034 
ribose 
phosphate 
metabolic 
process 
0.0345
188 
FBgn0001187,FBgn0003257,FBgn0011211,FBgn0013
972,FBgn0016691,FBgn0019644,FBgn0028342,FBgn0
030507,FBgn0038224,FBgn0038467,FBgn0039156,FB
gn0039650 
12 GO:0019
693 
fatty acid 
biosynthetic 
process 
7.03E-
05 
FBgn0025814,FBgn0031703,FBgn0033733,FBgn0035
006,FBgn0035471,FBgn0036691,FBgn0037356,FBgn0
037534,FBgn0037996,FBgn0039156,FBgn0053178 
11 GO:0006
633 
monocarboxyl
ic acid 
biosynthetic 
process 
0.0002
471 
FBgn0025814,FBgn0031703,FBgn0033733,FBgn0035
006,FBgn0035471,FBgn0036691,FBgn0037356,FBgn0
037534,FBgn0037996,FBgn0039156,FBgn0053178 
11 GO:0072
330 
aminoglycan 
metabolic 
process 
0.0007
067 
FBgn0022700,FBgn0034582,FBgn0036948,FBgn0036
953,FBgn0039258,FBgn0040959,FBgn0043575,FBgn0
052284,FBgn0053265,FBgn0085249,FBgn0259748 
11 GO:0006
022 
nucleotide 
biosynthetic 
process 
0.0175
982 
FBgn0003257,FBgn0011211,FBgn0011703,FBgn0011
704,FBgn0013972,FBgn0016691,FBgn0019644,FBgn0
028342,FBgn0038224,FBgn0038467,FBgn0039156 
11 GO:0009
165 
nucleoside 
phosphate 
biosynthetic 
process 
0.0194
314 
FBgn0003257,FBgn0011211,FBgn0011703,FBgn0011
704,FBgn0013972,FBgn0016691,FBgn0019644,FBgn0
028342,FBgn0038224,FBgn0038467,FBgn0039156 
11 GO:1901
293 
cell cycle 
DNA 
replication 
0.0003
947 
FBgn0014861,FBgn0017577,FBgn0020633,FBgn0025
815,FBgn0026143,FBgn0030054,FBgn0033890,FBgn0
035644,FBgn0259113,FBgn0286788 
10 GO:0044
786 
double-strand 
break repair 
via 
homologous 
recombination 
0.0005
684 
FBgn0014861,FBgn0017577,FBgn0020633,FBgn0025
815,FBgn0026143,FBgn0027868,FBgn0030054,FBgn0
037301,FBgn0039403,FBgn0040290 
10 GO:0000
724 
recombination
al repair 
0.0005
684 
FBgn0014861,FBgn0017577,FBgn0020633,FBgn0025
815,FBgn0026143,FBgn0027868,FBgn0030054,FBgn0
037301,FBgn0039403,FBgn0040290 
10 GO:0000
725 
amino sugar 
metabolic 
process 
0.0010
665 
FBgn0022700,FBgn0034582,FBgn0036948,FBgn0036
953,FBgn0039580,FBgn0040959,FBgn0052284,FBgn0
053265,FBgn0085249,FBgn0259748 
10 GO:0006
040 
regulation of 
mitotic 
nuclear 
0.0036
566 
FBgn0004643,FBgn0010382,FBgn0024227,FBgn0031
549,FBgn0034569,FBgn0039638,FBgn0041147,FBgn0
061476,FBgn0259791,FBgn0261850 
10 GO:0007
088 
 
 
255 
division 
regulation of 
nuclear 
division 
0.0065
731 
FBgn0004643,FBgn0010382,FBgn0024227,FBgn0031
549,FBgn0034569,FBgn0039638,FBgn0041147,FBgn0
061476,FBgn0259791,FBgn0261850 
10 GO:0051
783 
purine-
containing 
compound 
biosynthetic 
process 
0.0075
273 
FBgn0011211,FBgn0013972,FBgn0016691,FBgn0019
644,FBgn0028342,FBgn0029823,FBgn0038173,FBgn0
038224,FBgn0038467,FBgn0039156 
10 GO:0072
522 
DNA 
replication 
initiation 
7.091
E-06 
FBgn0014861,FBgn0015271,FBgn0017577,FBgn0020
633,FBgn0025815,FBgn0026143,FBgn0050085,FBgn0
259113,FBgn0286788 
9 GO:0006
270 
chitin 
metabolic 
process 
0.0005
122 
FBgn0022700,FBgn0034582,FBgn0036948,FBgn0036
953,FBgn0040959,FBgn0052284,FBgn0053265,FBgn0
085249,FBgn0259748 
9 GO:0006
030 
glucosamine-
containing 
compound 
metabolic 
process 
0.0023
822 
FBgn0022700,FBgn0034582,FBgn0036948,FBgn0036
953,FBgn0040959,FBgn0052284,FBgn0053265,FBgn0
085249,FBgn0259748 
9 GO:1901
071 
mitotic 
spindle 
organization 
0.0034
304 
FBgn0000140,FBgn0004378,FBgn0011692,FBgn0015
271,FBgn0024227,FBgn0034569,FBgn0039638,FBgn0
040078,FBgn0259791 
9 GO:0007
052 
chromosome 
separation 
0.0034
304 
FBgn0004643,FBgn0015391,FBgn0017577,FBgn0024
227,FBgn0029977,FBgn0031549,FBgn0033549,FBgn0
041147,FBgn0061476 
9 GO:0051
304 
ribonucleotide 
biosynthetic 
process 
0.0213
646 
FBgn0003257,FBgn0011211,FBgn0013972,FBgn0016
691,FBgn0019644,FBgn0028342,FBgn0038224,FBgn0
038467,FBgn0039156 
9 GO:0009
260 
ribose 
phosphate 
biosynthetic 
process 
0.0265
672 
FBgn0003257,FBgn0011211,FBgn0013972,FBgn0016
691,FBgn0019644,FBgn0028342,FBgn0038224,FBgn0
038467,FBgn0039156 
9 GO:0046
390 
microtubule 
cytoskeleton 
organization 
involved in 
mitosis 
0.0265
672 
FBgn0000140,FBgn0004378,FBgn0011692,FBgn0015
271,FBgn0024227,FBgn0034569,FBgn0039638,FBgn0
040078,FBgn0259791 
9 GO:1902
850 
positive 
regulation of 
cell cycle 
process 
0.0029
71 
FBgn0003525,FBgn0010382,FBgn0024227,FBgn0026
143,FBgn0035644,FBgn0039403,FBgn0040290,FBgn0
041147 
8 GO:0090
068 
maturation of 
SSU-rRNA 
0.0074
43 
FBgn0004403,FBgn0030081,FBgn0030136,FBgn0033
454,FBgn0034564,FBgn0037073,FBgn0038474,FBgn0
039404 
8 GO:0030
490 
proton 
transmembran
e transport 
0.0087
49 
FBgn0011211,FBgn0016691,FBgn0019644,FBgn0022
097,FBgn0028342,FBgn0038224,FBgn0038613,FBgn0
262512 
8 GO:1902
600 
positive 
regulation of 
cell cycle 
0.0204
304 
FBgn0003525,FBgn0010382,FBgn0024227,FBgn0026
143,FBgn0035644,FBgn0039403,FBgn0040290,FBgn0
041147 
8 GO:0045
787 
purine 
ribonucleotide 
biosynthetic 
process 
0.0260
53 
FBgn0011211,FBgn0013972,FBgn0016691,FBgn0019
644,FBgn0028342,FBgn0038224,FBgn0038467,FBgn0
039156 
8 GO:0009
152 
purine 0.0363 FBgn0011211,FBgn0013972,FBgn0016691,FBgn0019 8 GO:0006
 
 
256 
nucleotide 
biosynthetic 
process 
772 644,FBgn0028342,FBgn0038224,FBgn0038467,FBgn0
039156 
164 
ribosomal 
small subunit 
biogenesis 
0.0403
551 
FBgn0004403,FBgn0030081,FBgn0030136,FBgn0033
454,FBgn0034564,FBgn0037073,FBgn0038474,FBgn0
039404 
8 GO:0042
274 
DNA duplex 
unwinding 
3.362
E-05 
FBgn0014861,FBgn0015075,FBgn0020633,FBgn0025
815,FBgn0026876,FBgn0040290,FBgn0261850 
7 GO:0032
508 
DNA 
geometric 
change 
5.886
E-05 
FBgn0014861,FBgn0015075,FBgn0020633,FBgn0025
815,FBgn0026876,FBgn0040290,FBgn0261850 
7 GO:0032
392 
nuclear DNA 
replication 
9.773
E-05 
FBgn0014861,FBgn0017577,FBgn0020633,FBgn0025
815,FBgn0026143,FBgn0035644,FBgn0259113 
7 GO:0033
260 
cellular amino 
acid 
biosynthetic 
process 
0.0022
279 
FBgn0014427,FBgn0029823,FBgn0036157,FBgn0037
146,FBgn0037305,FBgn0037513,FBgn0039094 
7 GO:0008
652 
aerobic 
respiration 
0.0279
379 
FBgn0011227,FBgn0014028,FBgn0024957,FBgn0024
958,FBgn0037891,FBgn0040529,FBgn0262559 
7 GO:0009
060 
double-strand 
break repair 
via break-
induced 
replication 
1.359
E-06 
FBgn0014861,FBgn0017577,FBgn0020633,FBgn0025
815,FBgn0026143,FBgn0039403 
6 GO:0000
727 
positive 
regulation of 
mitotic cell 
cycle phase 
transition 
0.0012
276 
FBgn0003525,FBgn0010382,FBgn0026143,FBgn0039
403,FBgn0040290,FBgn0041147 
6 GO:1901
992 
positive 
regulation of 
cell cycle 
phase 
transition 
0.0023
561 
FBgn0003525,FBgn0010382,FBgn0026143,FBgn0039
403,FBgn0040290,FBgn0041147 
6 GO:1901
989 
alpha-amino 
acid 
biosynthetic 
process 
0.0067
269 
FBgn0014427,FBgn0029823,FBgn0036157,FBgn0037
146,FBgn0037305,FBgn0039094 
6 GO:1901
607 
maturation of 
SSU-rRNA 
from 
tricistronic 
rRNA 
transcript 
(SSU-rRNA, 
5.8S rRNA, 
LSU-rRNA) 
0.0103
453 
FBgn0004403,FBgn0030081,FBgn0033454,FBgn0037
073,FBgn0038474,FBgn0039404 
6 GO:0000
462 
positive 
regulation of 
mitotic cell 
cycle 
0.0103
453 
FBgn0003525,FBgn0010382,FBgn0026143,FBgn0039
403,FBgn0040290,FBgn0041147 
6 GO:0045
931 
fatty acid 
catabolic 
process 
0.0151
647 
FBgn0025352,FBgn0031092,FBgn0034629,FBgn0035
383,FBgn0038742,FBgn0086712 
6 GO:0009
062 
nucleoside 
triphosphate 
metabolic 
0.0151
647 
FBgn0011211,FBgn0016691,FBgn0019644,FBgn0028
342,FBgn0031663,FBgn0038224 
6 GO:0009
141 
 
 
257 
process 
carbohydrate 
derivative 
catabolic 
process 
0.0180
78 
FBgn0022700,FBgn0034582,FBgn0034988,FBgn0038
173,FBgn0039650,FBgn0043575 
6 GO:1901
136 
monocarboxyl
ic acid 
catabolic 
process 
0.0290
547 
FBgn0025352,FBgn0031092,FBgn0034629,FBgn0035
383,FBgn0038742,FBgn0086712 
6 GO:0072
329 
regulation of 
chromosome 
segregation 
0.0494
389 
FBgn0004643,FBgn0024227,FBgn0031549,FBgn0041
147,FBgn0061476,FBgn0261850 
6 GO:0051
983 
DNA 
biosynthetic 
process 
0.0494
389 
FBgn0010382,FBgn0025815,FBgn0026143,FBgn0035
644,FBgn0040290,FBgn0286788 
6 GO:0071
897 
mitotic DNA 
replication 
0.0002
631 
FBgn0014861,FBgn0025815,FBgn0026143,FBgn0035
644,FBgn0259113 
5 GO:1902
969 
DNA 
amplification 
0.0057
867 
FBgn0010382,FBgn0025815,FBgn0026143,FBgn0040
290,FBgn0286788 
5 GO:0006
277 
energy 
coupled 
proton 
transport, 
down 
electrochemic
al gradient 
0.0057
867 
FBgn0011211,FBgn0016691,FBgn0019644,FBgn0028
342,FBgn0038224 
5 GO:0015
985 
ATP synthesis 
coupled 
proton 
transport 
0.0057
867 
FBgn0011211,FBgn0016691,FBgn0019644,FBgn0028
342,FBgn0038224 
5 GO:0015
986 
ATP 
biosynthetic 
process 
0.0099
8 
FBgn0011211,FBgn0016691,FBgn0019644,FBgn0028
342,FBgn0038224 
5 GO:0006
754 
purine 
nucleoside 
triphosphate 
biosynthetic 
process 
0.0195
623 
FBgn0011211,FBgn0016691,FBgn0019644,FBgn0028
342,FBgn0038224 
5 GO:0009
145 
purine 
ribonucleoside 
triphosphate 
metabolic 
process 
0.0195
623 
FBgn0011211,FBgn0016691,FBgn0019644,FBgn0028
342,FBgn0038224 
5 GO:0009
205 
purine 
ribonucleoside 
triphosphate 
biosynthetic 
process 
0.0195
623 
FBgn0011211,FBgn0016691,FBgn0019644,FBgn0028
342,FBgn0038224 
5 GO:0009
206 
tricarboxylic 
acid cycle 
0.0237
538 
FBgn0014028,FBgn0024957,FBgn0024958,FBgn0037
891,FBgn0262559 
5 GO:0006
099 
fatty acid 
beta-oxidation 
0.0237
538 
FBgn0025352,FBgn0031092,FBgn0034629,FBgn0035
383,FBgn0086712 
5 GO:0006
635 
purine 
nucleoside 
triphosphate 
metabolic 
0.0237
538 
FBgn0011211,FBgn0016691,FBgn0019644,FBgn0028
342,FBgn0038224 
5 GO:0009
144 
 
 
258 
process 
regulation of 
mitotic 
metaphase/ana
phase 
transition 
0.0284
835 
FBgn0004643,FBgn0024227,FBgn0031549,FBgn0041
147,FBgn0061476 
5 GO:0030
071 
ribonucleoside 
triphosphate 
metabolic 
process 
0.0337
694 
FBgn0011211,FBgn0016691,FBgn0019644,FBgn0028
342,FBgn0038224 
5 GO:0009
199 
ribonucleoside 
triphosphate 
biosynthetic 
process 
0.0337
694 
FBgn0011211,FBgn0016691,FBgn0019644,FBgn0028
342,FBgn0038224 
5 GO:0009
201 
fatty acid 
oxidation 
0.0337
694 
FBgn0025352,FBgn0031092,FBgn0034629,FBgn0035
383,FBgn0086712 
5 GO:0019
395 
regulation of 
metaphase/ana
phase 
transition of 
cell cycle 
0.0337
694 
FBgn0004643,FBgn0024227,FBgn0031549,FBgn0041
147,FBgn0061476 
5 GO:1902
099 
nucleoside 
triphosphate 
biosynthetic 
process 
0.0396
254 
FBgn0011211,FBgn0016691,FBgn0019644,FBgn0028
342,FBgn0038224 
5 GO:0009
142 
lipid oxidation 0.0396
254 
FBgn0025352,FBgn0031092,FBgn0034629,FBgn0035
383,FBgn0086712 
5 GO:0034
440 
DNA 
endoreduplica
tion 
0.0453
913 
FBgn0017577,FBgn0030054,FBgn0033890,FBgn0035
644,FBgn0286788 
5 GO:0042
023 
pre-replicative 
complex 
assembly 
involved in 
nuclear cell 
cycle DNA 
replication 
3.541
E-05 
FBgn0014861,FBgn0017577,FBgn0020633,FBgn0025
815 
4 GO:0006
267 
pre-replicative 
complex 
assembly 
3.541
E-05 
FBgn0014861,FBgn0017577,FBgn0020633,FBgn0025
815 
4 GO:0036
388 
pre-replicative 
complex 
assembly 
involved in 
cell cycle 
DNA 
replication 
3.541
E-05 
FBgn0014861,FBgn0017577,FBgn0020633,FBgn0025
815 
4 GO:1902
299 
DNA 
unwinding 
involved in 
DNA 
replication 
0.0019
261 
FBgn0014861,FBgn0020633,FBgn0025815,FBgn0040
290 
4 GO:0006
268 
activation of 
cysteine-type 
endopeptidase 
activity 
0.0032
566 
FBgn0011703,FBgn0011704,FBgn0038928,FBgn0262
559 
4 GO:0006
919 
 
 
259 
involved in 
apoptotic 
process 
neuropeptide 
signaling 
pathway 
0.0050
992 
FBgn0038147,FBgn0038199,FBgn0050106,FBgn0086
782 
4 GO:0007
218 
fatty acid 
derivative 
biosynthetic 
process 
0.0050
992 
FBgn0025814,FBgn0035383,FBgn0039156,FBgn0053
178 
4 GO:1901
570 
DNA-
dependent 
DNA 
replication 
maintenance 
of fidelity 
0.0144
114 
FBgn0004406,FBgn0033549,FBgn0035644,FBgn0050
085 
4 GO:0045
005 
fatty acid 
derivative 
metabolic 
process 
0.0189
686 
FBgn0025814,FBgn0035383,FBgn0039156,FBgn0053
178 
4 GO:1901
568 
eggshell 
chorion gene 
amplification 
0.0243
231 
FBgn0010382,FBgn0025815,FBgn0040290,FBgn0286
788 
4 GO:0007
307 
neurotransmitt
er metabolic 
process 
0.0243
231 
FBgn0011768,FBgn0029823,FBgn0037513,FBgn0039
094 
4 GO:0042
133 
positive 
regulation of 
cysteine-type 
endopeptidase 
activity 
involved in 
apoptotic 
process 
0.0243
231 
FBgn0011703,FBgn0011704,FBgn0038928,FBgn0262
559 
4 GO:0043
280 
positive 
regulation of 
cysteine-type 
endopeptidase 
activity 
0.0375
221 
FBgn0011703,FBgn0011704,FBgn0038928,FBgn0262
559 
4 GO:2001
056 
nucleobase-
containing 
small 
molecule 
biosynthetic 
process 
0.0453
913 
FBgn0031663,FBgn0034988,FBgn0038173,FBgn0039
650 
4 GO:0034
404 
positive 
regulation of 
DNA 
metabolic 
process 
0.0040
921 
FBgn0037301,FBgn0037345,FBgn0261850 3 GO:0051
054 
insemination 0.0077
161 
FBgn0015584,FBgn0040092,FBgn0040093 3 GO:0007
320 
serine family 
amino acid 
biosynthetic 
process 
0.0077
161 
FBgn0014427,FBgn0029823,FBgn0039094 3 GO:0009
070 
 
 
260 
sperm 
competition 
0.0077
161 
FBgn0015584,FBgn0040092,FBgn0040093 3 GO:0046
692 
resolution of 
meiotic 
recombination 
intermediates 
0.0127
341 
FBgn0017577,FBgn0029977,FBgn0033549 3 GO:0000
712 
regulation of 
oxidative 
phosphorylati
on 
0.0127
341 
FBgn0027794,FBgn0040529,FBgn0284256 3 GO:0002
082 
purine 
nucleoside 
catabolic 
process 
0.0127
341 
FBgn0034988,FBgn0038173,FBgn0039650 3 GO:0006
152 
multi-
multicellular 
organism 
process 
0.0127
341 
FBgn0015584,FBgn0040092,FBgn0040093 3 GO:0044
706 
purine 
ribonucleoside 
catabolic 
process 
0.0127
341 
FBgn0034988,FBgn0038173,FBgn0039650 3 GO:0046
130 
nucleoside 
catabolic 
process 
0.0192
188 
FBgn0034988,FBgn0038173,FBgn0039650 3 GO:0009
164 
N-terminal 
protein amino 
acid 
modification 
0.0192
188 
FBgn0024194,FBgn0039687,FBgn0243511 3 GO:0031
365 
nucleobase-
containing 
small 
molecule 
catabolic 
process 
0.0192
188 
FBgn0034988,FBgn0038173,FBgn0039650 3 GO:0034
656 
ribonucleoside 
catabolic 
process 
0.0192
188 
FBgn0034988,FBgn0038173,FBgn0039650 3 GO:0042
454 
positive 
regulation of 
G1/S 
transition of 
mitotic cell 
cycle 
0.0192
188 
FBgn0010382,FBgn0026143,FBgn0039403 3 GO:1900
087 
mitochondrial 
transcription 
0.0271
999 
FBgn0011787,FBgn0027794,FBgn0284256 3 GO:0006
390 
serine family 
amino acid 
metabolic 
process 
0.0271
999 
FBgn0014427,FBgn0029823,FBgn0039094 3 GO:0009
069 
regulation of 
mitotic cell 
cycle, 
embryonic 
0.0271
999 
FBgn0002441,FBgn0003525,FBgn0261850 3 GO:0009
794 
neurotransmitt
er biosynthetic 
process 
0.0271
999 
FBgn0029823,FBgn0037513,FBgn0039094 3 GO:0042
136 
 
 
261 
nucleobase 
biosynthetic 
process 
0.0271
999 
FBgn0003257,FBgn0029823,FBgn0037513 3 GO:0046
112 
response to 
acid chemical 
0.0366
716 
FBgn0029823,FBgn0030108,FBgn0035870 3 GO:0001
101 
aminoglycan 
catabolic 
process 
0.0366
716 
FBgn0022700,FBgn0034582,FBgn0043575 3 GO:0006
026 
copulation 0.0366
716 
FBgn0015584,FBgn0040092,FBgn0040093 3 GO:0007
620 
meiotic 
chromosome 
separation 
0.0366
716 
FBgn0017577,FBgn0029977,FBgn0033549 3 GO:0051
307 
nucleoside 
phosphate 
catabolic 
process 
0.0366
716 
FBgn0031663,FBgn0034988,FBgn0039650 3 GO:1901
292 
positive 
regulation of 
cell cycle 
G1/S phase 
transition 
0.0366
716 
FBgn0010382,FBgn0026143,FBgn0039403 3 GO:1902
808 
DNA strand 
elongation 
involved in 
DNA 
replication 
0.0476 FBgn0020633,FBgn0032244,FBgn0259113 3 GO:0006
271 
DNA strand 
elongation 
0.0476 FBgn0020633,FBgn0032244,FBgn0259113 3 GO:0022
616 
glycosyl 
compound 
catabolic 
process 
0.0476 FBgn0034988,FBgn0038173,FBgn0039650 3 GO:1901
658 
regulation of 
ATP 
metabolic 
process 
0.0476 FBgn0027794,FBgn0040529,FBgn0284256 3 GO:1903
578 
DNA 
replication, 
synthesis of 
RNA primer 
0.0059
794 
FBgn0011762,FBgn0259676 2 GO:0006
269 
activation of 
adenylate 
cyclase 
activity 
0.0059
794 
FBgn0039354,FBgn0086782 2 GO:0007
190 
response to 
iron(II) ion 
0.0059
794 
FBgn0024957,FBgn0024958 2 GO:0010
040 
positive 
regulation of 
G2/M 
transition of 
mitotic cell 
cycle 
0.0059
794 
FBgn0003525,FBgn0040290 2 GO:0010
971 
nuclear 
envelope 
reassembly 
0.0059
794 
FBgn0033179,FBgn0266420 2 GO:0031
468 
 
 
262 
positive 
regulation of 
DNA 
recombination 
0.0059
794 
FBgn0037301,FBgn0261850 2 GO:0045
911 
guanosine-
containing 
compound 
catabolic 
process 
0.0059
794 
FBgn0034988,FBgn0039650 2 GO:1901
069 
response to L-
canavanine 
0.0059
794 
FBgn0030108,FBgn0035870 2 GO:1901
354 
cell cycle 
DNA 
replication 
initiation 
0.0059
794 
FBgn0014861,FBgn0259113 2 GO:1902
292 
nuclear cell 
cycle DNA 
replication 
initiation 
0.0059
794 
FBgn0014861,FBgn0259113 2 GO:1902
315 
positive 
regulation of 
cell cycle 
G2/M phase 
transition 
0.0059
794 
FBgn0003525,FBgn0040290 2 GO:1902
751 
mitotic DNA 
replication 
initiation 
0.0059
794 
FBgn0014861,FBgn0259113 2 GO:1902
975 
prostaglandin 
biosynthetic 
process 
0.0170
167 
FBgn0025814,FBgn0053178 2 GO:0001
516 
citrate 
metabolic 
process 
0.0170
167 
FBgn0024957,FBgn0024958 2 GO:0006
101 
glycine 
biosynthetic 
process 
0.0170
167 
FBgn0029823,FBgn0039094 2 GO:0006
545 
L-serine 
metabolic 
process 
0.0170
167 
FBgn0014427,FBgn0029823 2 GO:0006
563 
L-serine 
biosynthetic 
process 
0.0170
167 
FBgn0014427,FBgn0029823 2 GO:0006
564 
deoxyribonucl
eotide 
biosynthetic 
process 
0.0170
167 
FBgn0011703,FBgn0011704 2 GO:0009
263 
astral 
microtubule 
organization 
0.0170
167 
FBgn0000140,FBgn0027500 2 GO:0030
953 
endoplasmic 
reticulum 
calcium ion 
homeostasis 
0.0170
167 
FBgn0030350,FBgn0032746 2 GO:0032
469 
preblastoderm 
mitotic cell 
cycle 
0.0170
167 
FBgn0002441,FBgn0033890 2 GO:0035
185 
 
 
263 
regulation of 
mitochondrial 
mRNA 
stability 
0.0170
167 
FBgn0027794,FBgn0284256 2 GO:0044
528 
icosanoid 
biosynthetic 
process 
0.0170
167 
FBgn0025814,FBgn0053178 2 GO:0046
456 
prostanoid 
biosynthetic 
process 
0.0170
167 
FBgn0025814,FBgn0053178 2 GO:0046
457 
tRNA-guanine 
transglycosyla
tion 
0.0170
167 
FBgn0031321,FBgn0034614 2 GO:0101
030 
regulation of 
mitochondrial 
transcription 
0.0170
167 
FBgn0027794,FBgn0284256 2 GO:1903
108 
reactive 
nitrogen 
species 
metabolic 
process 
0.0170
167 
FBgn0011768,FBgn0030966 2 GO:2001
057 
prostanoid 
metabolic 
process 
0.0322
968 
FBgn0025814,FBgn0053178 2 GO:0006
692 
prostaglandin 
metabolic 
process 
0.0322
968 
FBgn0025814,FBgn0053178 2 GO:0006
693 
nuclear 
envelope 
organization 
0.0322
968 
FBgn0033179,FBgn0266420 2 GO:0006
998 
deoxyribonucl
eotide 
metabolic 
process 
0.0322
968 
FBgn0011703,FBgn0011704 2 GO:0009
262 
maintenance 
of 
gastrointestina
l epithelium 
0.0322
968 
FBgn0030904,FBgn0053542 2 GO:0030
277 
intracellular 
sterol 
transport 
0.0322
968 
FBgn0031381,FBgn0039154 2 GO:0032
366 
intracellular 
cholesterol 
transport 
0.0322
968 
FBgn0031381,FBgn0039154 2 GO:0032
367 
nuclear-
transcribed 
mRNA 
catabolic 
process, 
exonucleolytic
, 3'-5' 
0.0322
968 
FBgn0034065,FBgn0037815 2 GO:0034
427 
U4 snRNA 3'-
end 
processing 
0.0322
968 
FBgn0034065,FBgn0037815 2 GO:0034
475 
tetrahydrofola
te 
interconversio
0.0322
968 
FBgn0029823,FBgn0036157 2 GO:0035
999 
 
 
264 
n 
DNA 
replication 
proofreading 
0.0322
968 
FBgn0004406,FBgn0035644 2 GO:0045
004 
brain 
morphogenesi
s 
0.0322
968 
FBgn0000140,FBgn0019650 2 GO:0048
854 
intestinal 
epithelial 
structure 
maintenance 
0.0322
968 
FBgn0030904,FBgn0053542 2 GO:0060
729 
extrinsic 
apoptotic 
signaling 
pathway 
0.0322
968 
FBgn0029131,FBgn0038928 2 GO:0097
191 
 
Table 2.1d: Pathway enrichment for hits differentially upregulated in control females relative to 
control males   
Pathway 
enrichmen
t 
p-value Hits Gene 
matche
s 
Pathway ID 
Metabolis
m 
7.92553
E-05 
FBgn0001187,FBgn0003076,FBgn0003257,FBg
n0010241,FBgn0011211,FBgn0011227,FBgn00
11703,FBgn0011704,FBgn0011768,FBgn00140
28,FBgn0014427,FBgn0015277,FBgn0016691,F
Bgn0019644,FBgn0019982,FBgn0020626,FBgn
0023477,FBgn0025352,FBgn0025373,FBgn002
5463,FBgn0025592,FBgn0025814,FBgn002834
2,FBgn0029823,FBgn0029994,FBgn0030816,F
Bgn0030966,FBgn0031048,FBgn0031248,FBgn
0031663,FBgn0031703,FBgn0033215,FBgn003
3216,FBgn0033377,FBgn0033382,FBgn003396
1,FBgn0034629,FBgn0034919,FBgn0034988,F
Bgn0035383,FBgn0035471,FBgn0035619,FBgn
0036157,FBgn0036381,FBgn0036691,FBgn003
7146,FBgn0037186,FBgn0037305,FBgn003737
0,FBgn0037513,FBgn0037534,FBgn0037891,F
Bgn0038224,FBgn0038407,FBgn0038467,FBgn
0038742,FBgn0039258,FBgn0039470,FBgn003
9471,FBgn0039472,FBgn0039486,FBgn003967
4,FBgn0040069,FBgn0040383,FBgn0050345,F
Bgn0050502,FBgn0052669,FBgn0052750,FBgn
0053116,FBgn0053178,FBgn0067102,FBgn008
5484,FBgn0262559,FBgn0283450,FBgn028368
0 
75 R-DME-1430728 
Metabolic 
pathways 
1.38283
E-06 
FBgn0000078,FBgn0001187,FBgn0003076,FBg
n0003257,FBgn0004406,FBgn0011211,FBgn00
11227,FBgn0011703,FBgn0011704,FBgn00117
62,FBgn0011768,FBgn0011770,FBgn0014028,F
Bgn0014427,FBgn0015277,FBgn0015568,FBgn
0015575,FBgn0016691,FBgn0019644,FBgn002
2097,FBgn0023477,FBgn0024957,FBgn002495
8,FBgn0025352,FBgn0025373,FBgn0025592,F
Bgn0028342,FBgn0029823,FBgn0029906,FBgn
0031048,FBgn0031663,FBgn0031703,FBgn003
1713,FBgn0033377,FBgn0033961,FBgn003414
66 1100 
 
 
265 
1,FBgn0034629,FBgn0035619,FBgn0035644,F
Bgn0036157,FBgn0036691,FBgn0037146,FBgn
0037186,FBgn0037356,FBgn0037513,FBgn003
7891,FBgn0038080,FBgn0038224,FBgn003846
7,FBgn0038613,FBgn0038742,FBgn0039094,F
Bgn0039258,FBgn0039580,FBgn0039596,FBgn
0040069,FBgn0052201,FBgn0053116,FBgn005
3138,FBgn0067102,FBgn0085484,FBgn025911
3,FBgn0259676,FBgn0262512,FBgn0262559,F
Bgn0283680 
Metabolis
m of lipids 
0.00258
5092 
FBgn0010241,FBgn0015277,FBgn0020626,FBg
n0025352,FBgn0025373,FBgn0025463,FBgn00
25592,FBgn0025814,FBgn0029994,FBgn00310
48,FBgn0031703,FBgn0033215,FBgn0033216,F
Bgn0033382,FBgn0034629,FBgn0035383,FBgn
0035471,FBgn0035619,FBgn0036381,FBgn003
6691,FBgn0037534,FBgn0038407,FBgn003874
2,FBgn0039470,FBgn0039471,FBgn0039472,F
Bgn0050502,FBgn0053116,FBgn0053178,FBgn
0067102 
30 R-DME-556833 
Cell Cycle 0.00165
5286 
FBgn0003525,FBgn0010382,FBgn0011692,FBg
n0011762,FBgn0014861,FBgn0015271,FBgn00
15391,FBgn0017577,FBgn0020633,FBgn00242
27,FBgn0025463,FBgn0025815,FBgn0026143,F
Bgn0027868,FBgn0029856,FBgn0032244,FBgn
0035644,FBgn0038390,FBgn0039125,FBgn003
9403,FBgn0041147,FBgn0259113,FBgn025967
6,FBgn0259791,FBgn0286788 
25 R-DME-1640170 
Cell Cycle, 
Mitotic 
0.00092
757 
FBgn0003525,FBgn0010382,FBgn0011692,FBg
n0011762,FBgn0014861,FBgn0015271,FBgn00
15391,FBgn0017577,FBgn0020633,FBgn00242
27,FBgn0025815,FBgn0026143,FBgn0027868,F
Bgn0029856,FBgn0032244,FBgn0035644,FBgn
0038390,FBgn0039125,FBgn0039403,FBgn004
1147,FBgn0259113,FBgn0259676,FBgn025979
1,FBgn0286788 
24 R-DME-69278 
DNA 
Replication 
0.00028
0248 
FBgn0010382,FBgn0011762,FBgn0014861,FBg
n0015271,FBgn0017577,FBgn0020633,FBgn00
25815,FBgn0026143,FBgn0029856,FBgn00322
44,FBgn0035644,FBgn0039403,FBgn0041147,F
Bgn0259113,FBgn0259676,FBgn0286788 
16 R-DME-69306 
G1/S 
Transition 
0.00016
0573 
FBgn0003525,FBgn0010382,FBgn0011762,FBg
n0014861,FBgn0015271,FBgn0017577,FBgn00
20633,FBgn0025815,FBgn0026143,FBgn00298
56,FBgn0035644,FBgn0038390,FBgn0259113,F
Bgn0259676,FBgn0286788 
15 R-DME-69206 
Mitotic G1 
phase and 
G1/S 
transition 
0.00058
2619 
FBgn0003525,FBgn0010382,FBgn0011762,FBg
n0014861,FBgn0015271,FBgn0017577,FBgn00
20633,FBgn0025815,FBgn0026143,FBgn00298
56,FBgn0035644,FBgn0038390,FBgn0259113,F
Bgn0259676,FBgn0286788 
15 R-DME-453279 
Synthesis 
of DNA 
0.00077
2417 
FBgn0010382,FBgn0011762,FBgn0014861,FBg
n0017577,FBgn0020633,FBgn0025815,FBgn00
29856,FBgn0032244,FBgn0035644,FBgn00394
03,FBgn0041147,FBgn0259113,FBgn0259676,F
Bgn0286788 
14 R-DME-69239 
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S Phase 0.00232
4736 
FBgn0010382,FBgn0011762,FBgn0014861,FBg
n0017577,FBgn0020633,FBgn0025815,FBgn00
29856,FBgn0032244,FBgn0035644,FBgn00394
03,FBgn0041147,FBgn0259113,FBgn0259676,F
Bgn0286788 
14 R-DME-69242 
Fatty acid 
metabolis
m 
0.00087
2613 
FBgn0025352,FBgn0025814,FBgn0031703,FBg
n0033215,FBgn0033216,FBgn0034629,FBgn00
35383,FBgn0035471,FBgn0036691,FBgn00375
34,FBgn0038407,FBgn0038742,FBgn0053178 
13 R-DME-8978868 
DNA 
Replication 
Pre-
Initiation 
0.00057
0692 
FBgn0011762,FBgn0014861,FBgn0015271,FBg
n0017577,FBgn0020633,FBgn0025815,FBgn00
26143,FBgn0029856,FBgn0035644,FBgn02591
13,FBgn0259676,FBgn0286788 
12 R-DME-69002 
Oxidative 
phosphoryl
ation 
0.00480
4838 
FBgn0011211,FBgn0011227,FBgn0014028,FBg
n0016691,FBgn0019644,FBgn0022097,FBgn00
28342,FBgn0033961,FBgn0038224,FBgn00386
13,FBgn0040529,FBgn0262512 
12 190 
Mitochond
rial 
translation 
elongation 
0.00544
0535 
FBgn0011787,FBgn0014023,FBgn0026741,FBg
n0029718,FBgn0031231,FBgn0034579,FBgn00
35374,FBgn0037330,FBgn0038474,FBgn00421
12,FBgn0083983,FBgn0263133 
12 R-DME-5389840 
Mitochond
rial 
translation 
0.00691
2208 
FBgn0011787,FBgn0014023,FBgn0026741,FBg
n0029718,FBgn0031231,FBgn0034579,FBgn00
35374,FBgn0037330,FBgn0038474,FBgn00421
12,FBgn0083983,FBgn0263133 
12 R-DME-5368287 
Phospholip
id 
metabolis
m 
0.00968
982 
FBgn0015277,FBgn0025352,FBgn0031048,FBg
n0033215,FBgn0033216,FBgn0033382,FBgn00
35619,FBgn0036381,FBgn0039470,FBgn00394
71,FBgn0039472,FBgn0053116 
12 R-DME-1483257 
Cell Cycle 
Checkpoint
s 
0.01951
3066 
FBgn0003525,FBgn0014861,FBgn0015271,FBg
n0017577,FBgn0020633,FBgn0025463,FBgn00
25815,FBgn0026143,FBgn0029856,FBgn00322
44,FBgn0041147,FBgn0286788 
12 R-DME-69620 
The citric 
acid (TCA) 
cycle and 
respiratory 
electron 
transport 
0.03823
3499 
FBgn0011211,FBgn0011227,FBgn0014028,FBg
n0016691,FBgn0019644,FBgn0028342,FBgn00
33961,FBgn0034919,FBgn0037891,FBgn00382
24,FBgn0262559,FBgn0283450 
12 R-DME-1428517 
Activation 
of the pre-
replicative 
complex 
5.19E-
07 
FBgn0011762,FBgn0014861,FBgn0015271,FBg
n0017577,FBgn0020633,FBgn0025815,FBgn00
26143,FBgn0035644,FBgn0259113,FBgn02596
76,FBgn0286788 
11 R-DME-68962 
DNA 
replication 
1.39539
E-06 
FBgn0011762,FBgn0014861,FBgn0017577,FBg
n0020633,FBgn0025815,FBgn0030507,FBgn00
31252,FBgn0032244,FBgn0035644,FBgn02591
13,FBgn0259676 
11 3030 
Glyceroph
ospholipid 
biosynthesi
s 
0.00206
6775 
FBgn0025352,FBgn0031048,FBgn0033215,FBg
n0033216,FBgn0033382,FBgn0035619,FBgn00
36381,FBgn0039470,FBgn0039471,FBgn00394
72,FBgn0053116 
11 R-DME-1483206 
Mitochond
rial 
translation 
termination 
0.01627
0993 
FBgn0011787,FBgn0014023,FBgn0026741,FBg
n0029718,FBgn0031231,FBgn0034579,FBgn00
35374,FBgn0037330,FBgn0038474,FBgn00421
12,FBgn0083983 
11 R-DME-5419276 
Activation 
of ATR in 
6.18517
E-05 
FBgn0003525,FBgn0014861,FBgn0015271,FBg
n0017577,FBgn0020633,FBgn0025815,FBgn00
9 R-DME-176187 
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response to 
replication 
stress 
26143,FBgn0032244,FBgn0286788 
G2/M 
Checkpoint
s 
0.00132
9919 
FBgn0003525,FBgn0014861,FBgn0015271,FBg
n0017577,FBgn0020633,FBgn0025815,FBgn00
26143,FBgn0032244,FBgn0286788 
9 R-DME-69481 
Pyrimidine 
metabolis
m 
0.02721
9846 
FBgn0003257,FBgn0011703,FBgn0011704,FBg
n0011762,FBgn0031663,FBgn0035644,FBgn00
37513,FBgn0259113,FBgn0259676 
9 240 
Metabolis
m of 
nucleotides 
0.01046
1081 
FBgn0003257,FBgn0011703,FBgn0011704,FBg
n0019982,FBgn0031663,FBgn0034988,FBgn00
37513,FBgn0038467 
8 R-DME-15869 
Switching 
of origins 
to a post-
replicative 
state 
0.04133
7481 
FBgn0010382,FBgn0014861,FBgn0017577,FBg
n0020633,FBgn0025815,FBgn0029856,FBgn00
41147,FBgn0286788 
8 R-DME-69052 
Metabolis
m of 
water-
soluble 
vitamins 
and 
cofactors 
0.04569
9379 
FBgn0029823,FBgn0031248,FBgn0036157,FBg
n0040069,FBgn0050345,FBgn0052669,FBgn00
52750,FBgn0085484 
8 R-DME-196849 
Amino 
sugar and 
nucleotide 
sugar 
metabolis
m 
0.00291
5205 
FBgn0001187,FBgn0003076,FBgn0004427,FBg
n0022700,FBgn0033377,FBgn0034582,FBgn00
39580 
7 520 
Iron uptake 
and 
transport 
0.00997
0999 
FBgn0022097,FBgn0024957,FBgn0024958,FBg
n0029856,FBgn0038613,FBgn0050345,FBgn02
62512 
7 R-DME-917937 
Assembly 
of the pre-
replicative 
complex 
0.03244
4058 
FBgn0014861,FBgn0015271,FBgn0017577,FBg
n0020633,FBgn0025815,FBgn0029856,FBgn02
86788 
7 R-DME-68867 
Fatty acid 
metabolis
m 
0.00858
8522 
FBgn0011768,FBgn0025352,FBgn0031703,FBg
n0034629,FBgn0035383,FBgn0038742 
6 71 
Formation 
of ATP by 
chemiosmo
tic 
coupling 
0.00138
9367 
FBgn0011211,FBgn0016691,FBgn0019644,FBg
n0028342,FBgn0038224 
5 R-DME-163210 
Cristae 
formation 
0.00138
9367 
FBgn0011211,FBgn0016691,FBgn0019644,FBg
n0028342,FBgn0038224 
5 R-DME-8949613 
Mitochond
rial 
biogenesis 
0.00211
5626 
FBgn0011211,FBgn0016691,FBgn0019644,FBg
n0028342,FBgn0038224 
5 R-DME-1592230 
Telomere 
Maintenan
ce 
0.00433
63 
FBgn0011762,FBgn0032244,FBgn0035644,FBg
n0259113,FBgn0259676 
5 R-DME-157579 
Telomere 
C-strand 
(Lagging 
Strand) 
0.00433
63 
FBgn0011762,FBgn0032244,FBgn0035644,FBg
n0259113,FBgn0259676 
5 R-DME-174417 
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Synthesis 
Extension 
of 
Telomeres 
0.00433
63 
FBgn0011762,FBgn0032244,FBgn0035644,FBg
n0259113,FBgn0259676 
5 R-DME-180786 
Chromoso
me 
Maintenan
ce 
0.00433
63 
FBgn0011762,FBgn0032244,FBgn0035644,FBg
n0259113,FBgn0259676 
5 R-DME-73886 
DNA 
strand 
elongation 
0.00591
267 
FBgn0011762,FBgn0032244,FBgn0039403,FBg
n0259113,FBgn0259676 
5 R-DME-69190 
Citrate 
cycle TCA 
cycle 
0.02908
7828 
FBgn0014028,FBgn0024957,FBgn0024958,FBg
n0037891,FBgn0262559 
5 20 
Dual 
Incision in 
GG-NER 
0.02908
7828 
FBgn0029856,FBgn0031309,FBgn0032244,FBg
n0035644,FBgn0261850 
5 R-DME-5696400 
Polymeras
e switching 
on the C-
strand of 
the 
telomere 
0.00104
6392 
FBgn0011762,FBgn0032244,FBgn0259113,FBg
n0259676 
4 R-DME-174411 
Telomere 
C-strand 
synthesis 
initiation 
0.00104
6392 
FBgn0011762,FBgn0035644,FBgn0259113,FBg
n0259676 
4 R-DME-174430 
DNA 
replication 
initiation 
0.00104
6392 
FBgn0011762,FBgn0035644,FBgn0259113,FBg
n0259676 
4 R-DME-68952 
Polymeras
e switching 
0.00104
6392 
FBgn0011762,FBgn0032244,FBgn0259113,FBg
n0259676 
4 R-DME-69091 
Leading 
Strand 
Synthesis 
0.00104
6392 
FBgn0011762,FBgn0032244,FBgn0259113,FBg
n0259676 
4 R-DME-69109 
Inhibition 
of 
replication 
initiation 
of 
damaged 
DNA by 
RB1/E2F1 
0.00196
5216 
FBgn0011762,FBgn0038390,FBgn0259113,FBg
n0259676 
4 R-DME-113501 
E2F 
mediated 
regulation 
of DNA 
replication 
0.00196
5216 
FBgn0011762,FBgn0038390,FBgn0259113,FBg
n0259676 
4 R-DME-113510 
Glyoxylate 
and 
dicarboxyl
ate 
metabolis
m 
0.00520
1449 
FBgn0011770,FBgn0024957,FBgn0024958,FBg
n0262559 
4 630 
mRNA 
decay by 3' 
0.00520
1449 
FBgn0027524,FBgn0034065,FBgn0034988,FBg
n0037815 
4 R-DME-429958 
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to 5' 
exoribonuc
lease 
Mitochond
rial Fatty 
Acid Beta-
Oxidation 
0.00520
1449 
FBgn0025352,FBgn0031703,FBgn0036691,FBg
n0038742 
4 R-DME-77289 
Arachidoni
c acid 
metabolis
m 
0.00767
9416 
FBgn0025814,FBgn0033215,FBgn0033216,FBg
n0053178 
4 R-DME-2142753 
Neuroactiv
e ligand-
receptor 
interaction 
0.01469
5025 
FBgn0003863,FBgn0010425,FBgn0011555,FBg
n0039354 
4 4080 
Metabolis
m of 
Angiotensi
nogen to 
Angiotensi
ns 
0.01933
9339 
FBgn0031678,FBgn0032144,FBgn0033774,FBg
n0035718 
4 R-DME-2022377 
Lagging 
Strand 
Synthesis 
0.01933
9339 
FBgn0011762,FBgn0032244,FBgn0259113,FBg
n0259676 
4 R-DME-69186 
Glycine, 
serine and 
threonine 
metabolis
m 
0.04625
0778 
FBgn0014427,FBgn0029823,FBgn0037186,FBg
n0039094 
4 260 
Formation 
of the 
activated 
receptor 
complex 
0.00176
7154 
FBgn0030904,FBgn0043903,FBgn0053542 3 R-DME-209209 
Vitamin 
B6 
metabolis
m 
0.00416
3478 
FBgn0014427,FBgn0031048,FBgn0085484 3 750 
Formation 
of the 
activated 
STAT92E 
dimer and 
transport to 
the nucleus 
0.00416
3478 
FBgn0030904,FBgn0043903,FBgn0053542 3 R-DME-209228 
The 
retinoid 
cycle in 
cones 
(daylight 
vision) 
0.00416
3478 
FBgn0029994,FBgn0033215,FBgn0033216 3 R-DME-2187335 
Dephospho
rylation by 
PTP61F 
phosphatas
es 
0.00784
9313 
FBgn0030904,FBgn0043903,FBgn0053542 3 R-DME-210688 
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Synthesis 
of PE 
0.01295
1503 
FBgn0031048,FBgn0036381,FBgn0053116 3 R-DME-1483213 
JAK/STAT 
pathway 
0.01954
3275 
FBgn0030904,FBgn0043903,FBgn0053542 3 R-DME-209405 
Lysine 
catabolism 
0.01954
3275 
FBgn0036381,FBgn0037891,FBgn0040383 3 R-DME-71064 
Triglycerid
e 
biosynthesi
s 
0.01954
3275 
FBgn0025592,FBgn0033215,FBgn0033216 3 R-DME-75109 
Synthesis 
of bile 
acids and 
bile salts 
0.02765
3751 
FBgn0010241,FBgn0020626,FBgn0034629 3 R-DME-192105 
Vitamin 
B5 
(pantothen
ate) 
metabolis
m 
0.02765
3751 
FBgn0040069,FBgn0052669,FBgn0052750 3 R-DME-199220 
Removal 
of the Flap 
Intermediat
e 
0.03727
6166 
FBgn0011762,FBgn0259113,FBgn0259676 3 R-DME-69166 
Processive 
synthesis 
on the 
lagging 
strand 
0.04837
4947 
FBgn0011762,FBgn0259113,FBgn0259676 3 R-DME-69183 
Glycogen 
synthesis 
0.00605
94 
FBgn0003076,FBgn0033377 2 R-DME-3322077 
Beta 
oxidation 
of 
hexanoyl-
CoA to 
butanoyl-
CoA 
0.00605
94 
FBgn0025352,FBgn0038742 2 R-DME-77350 
Phosphoryl
ation of 
proteins 
involved in 
G1/S 
transition 
by active 
Cyclin 
E:Cdk2 
complexes 
0.01724
0412 
FBgn0010382,FBgn0038390 2 R-DME-69200 
Digestion 
of dietary 
carbohydra
te 
0.03271
3669 
FBgn0000078,FBgn0022700 2 R-DME-189085 
AKT 
phosphoryl
ates targets 
in the 
cytosol 
0.03271
3669 
FBgn0025463,FBgn0267824 2 R-DME-198323 
 
 
271 
mitochondr
ial fatty 
acid beta-
oxidation 
of 
saturated 
fatty acids 
0.03271
3669 
FBgn0025352,FBgn0038742 2 R-DME-77286 
Wax 
biosynthesi
s 
0.03271
3669 
FBgn0033215,FBgn0033216 2 R-DME-9640463 
 
Table 2.1e: GO enrichment for hits differentially upregulated in control males relative to control 
females   
GO 
enrichmen
t 
p-
value 
Hits Gene 
matche
s 
GO ID 
multicellul
ar 
organismal 
process 
0.0489
251 
FBgn0000008,FBgn0000152,FBgn0000163,FBgn00003
95,FBgn0000451,FBgn0000547,FBgn0000568,FBgn000
0928,FBgn0001112,FBgn0001218,FBgn0001234,FBgn0
002524,FBgn0002566,FBgn0002633,FBgn0002643,FBg
n0002732,FBgn0003391,FBgn0003655,FBgn0003984,F
Bgn0004396,FBgn0004797,FBgn0004893,FBgn000490
7,FBgn0010238,FBgn0010240,FBgn0010501,FBgn0010
651,FBgn0010894,FBgn0011739,FBgn0011817,FBgn00
14073,FBgn0014135,FBgn0014388,FBgn0015229,FBgn
0015946,FBgn0016032,FBgn0020258,FBgn0020300,FB
gn0022800,FBgn0023510,FBgn0024236,FBgn0024250,
FBgn0024555,FBgn0025741,FBgn0026263,FBgn00282
92,FBgn0028369,FBgn0028424,FBgn0029006,FBgn002
9082,FBgn0030596,FBgn0030985,FBgn0031461,FBgn0
031853,FBgn0031885,FBgn0032843,FBgn0033032,FBg
n0033127,FBgn0033404,FBgn0033926,FBgn0034136,F
Bgn0034262,FBgn0035461,FBgn0035513,FBgn003562
6,FBgn0035977,FBgn0036072,FBgn0036518,FBgn0036
666,FBgn0036801,FBgn0037802,FBgn0038592,FBgn00
39509,FBgn0039938,FBgn0040532,FBgn0040726,FBgn
0041160,FBgn0041629,FBgn0043900,FBgn0045842,FB
gn0050456,FBgn0051216,FBgn0052133,FBgn0052179,
FBgn0052364,FBgn0053527,FBgn0085430,FBgn00854
32,FBgn0259176,FBgn0259683,FBgn0259938,FBgn026
1284,FBgn0261799,FBgn0262081,FBgn0263316,FBgn0
264959,FBgn0265778,FBgn0266084,FBgn0266411,FBg
n0283499,FBgn0283545,FBgn0286203 
102 GO:003250
1 
anatomical 
structure 
developme
nt 
0.0470
289 
FBgn0000008,FBgn0000163,FBgn0000395,FBgn00004
51,FBgn0000547,FBgn0000568,FBgn0000928,FBgn000
1112,FBgn0001234,FBgn0002524,FBgn0002566,FBgn0
002633,FBgn0002643,FBgn0002732,FBgn0003391,FBg
n0003655,FBgn0003984,FBgn0004396,FBgn0004797,F
Bgn0004893,FBgn0004907,FBgn0010238,FBgn001050
1,FBgn0010651,FBgn0010894,FBgn0011705,FBgn0011
739,FBgn0011817,FBgn0014073,FBgn0014135,FBgn00
14388,FBgn0015229,FBgn0015946,FBgn0016032,FBgn
0022800,FBgn0023510,FBgn0024236,FBgn0024250,FB
gn0024555,FBgn0025741,FBgn0026263,FBgn0028292,
FBgn0028369,FBgn0029006,FBgn0029082,FBgn00305
96,FBgn0031461,FBgn0031853,FBgn0031885,FBgn003
3032,FBgn0033127,FBgn0034262,FBgn0034279,FBgn0
88 GO:004885
6 
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035153,FBgn0035461,FBgn0035513,FBgn0035626,FBg
n0035977,FBgn0036518,FBgn0036666,FBgn0036801,F
Bgn0037802,FBgn0038592,FBgn0039048,FBgn004053
2,FBgn0041160,FBgn0043900,FBgn0045842,FBgn0050
456,FBgn0051216,FBgn0052133,FBgn0052179,FBgn00
52364,FBgn0085430,FBgn0085432,FBgn0259176,FBgn
0259938,FBgn0261245,FBgn0261284,FBgn0261799,FB
gn0262081,FBgn0263316,FBgn0264959,FBgn0265778,
FBgn0266084,FBgn0266411,FBgn0283499,FBgn02862
03 
cell 
communic
ation 
0.0322
915 
FBgn0000395,FBgn0000547,FBgn0000568,FBgn00012
18,FBgn0001234,FBgn0002566,FBgn0002643,FBgn000
2732,FBgn0003984,FBgn0004907,FBgn0010240,FBgn0
010501,FBgn0011739,FBgn0011817,FBgn0014009,FBg
n0014073,FBgn0014135,FBgn0014388,FBgn0015946,F
Bgn0022800,FBgn0023416,FBgn0024250,FBgn002562
5,FBgn0025741,FBgn0028292,FBgn0029006,FBgn0029
082,FBgn0030011,FBgn0030505,FBgn0030850,FBgn00
31461,FBgn0031885,FBgn0033926,FBgn0034136,FBgn
0034262,FBgn0034647,FBgn0035023,FBgn0035153,FB
gn0035626,FBgn0035806,FBgn0035977,FBgn0036518,
FBgn0037007,FBgn0037163,FBgn0039273,FBgn00439
00,FBgn0050440,FBgn0050456,FBgn0051201,FBgn005
2179,FBgn0052476,FBgn0052638,FBgn0053527,FBgn0
085432,FBgn0086358,FBgn0262081,FBgn0264959,FBg
n0265778,FBgn0266411,FBgn0266720,FBgn0283499 
61 GO:000715
4 
signaling 0.0272
355 
FBgn0000395,FBgn0000547,FBgn0000568,FBgn00012
18,FBgn0001234,FBgn0002643,FBgn0002732,FBgn000
3984,FBgn0004907,FBgn0010240,FBgn0010501,FBgn0
011739,FBgn0011817,FBgn0014009,FBgn0014073,FBg
n0014135,FBgn0014388,FBgn0015946,FBgn0022800,F
Bgn0023416,FBgn0024250,FBgn0025625,FBgn002574
1,FBgn0028292,FBgn0029006,FBgn0029082,FBgn0030
011,FBgn0030505,FBgn0030850,FBgn0031461,FBgn00
31885,FBgn0033926,FBgn0034136,FBgn0034262,FBgn
0034647,FBgn0035023,FBgn0035153,FBgn0035626,FB
gn0035806,FBgn0035977,FBgn0036518,FBgn0037007,
FBgn0037163,FBgn0039273,FBgn0043900,FBgn00504
40,FBgn0050456,FBgn0051201,FBgn0052179,FBgn005
2476,FBgn0052638,FBgn0053527,FBgn0085432,FBgn0
086358,FBgn0262081,FBgn0264959,FBgn0265778,FBg
n0266411,FBgn0266720,FBgn0283499 
60 GO:002305
2 
signal 
transductio
n 
0.0281
688 
FBgn0000395,FBgn0000547,FBgn0000568,FBgn00012
18,FBgn0001234,FBgn0002643,FBgn0002732,FBgn000
3984,FBgn0004907,FBgn0010240,FBgn0011739,FBgn0
011817,FBgn0014009,FBgn0014073,FBgn0014135,FBg
n0014388,FBgn0015946,FBgn0022800,FBgn0023416,F
Bgn0024250,FBgn0025625,FBgn0025741,FBgn002829
2,FBgn0029006,FBgn0029082,FBgn0030011,FBgn0031
461,FBgn0031885,FBgn0034262,FBgn0034647,FBgn00
35023,FBgn0035153,FBgn0035626,FBgn0035806,FBgn
0035977,FBgn0036518,FBgn0037007,FBgn0037163,FB
gn0039273,FBgn0043900,FBgn0050440,FBgn0050456,
FBgn0052179,FBgn0052476,FBgn0052638,FBgn00535
27,FBgn0085432,FBgn0086358,FBgn0262081,FBgn026
4959,FBgn0265778,FBgn0266411,FBgn0283499 
53 GO:000716
5 
tube 0.0057 FBgn0000163,FBgn0000395,FBgn0000451,FBgn00005 34 GO:003529
 
 
273 
developme
nt 
055 47,FBgn0002524,FBgn0002643,FBgn0003391,FBgn000
3984,FBgn0004893,FBgn0010651,FBgn0011739,FBgn0
011817,FBgn0014135,FBgn0014388,FBgn0023510,FBg
n0024236,FBgn0024250,FBgn0029006,FBgn0029082,F
Bgn0031461,FBgn0031885,FBgn0036518,FBgn003666
6,FBgn0036801,FBgn0040532,FBgn0043900,FBgn0050
456,FBgn0052133,FBgn0085432,FBgn0263316,FBgn02
64959,FBgn0265778,FBgn0266084,FBgn0283499 
5 
morphogen
esis of an 
epithelium 
0.0424
701 
FBgn0000163,FBgn0000395,FBgn0000547,FBgn00026
43,FBgn0003391,FBgn0003984,FBgn0004893,FBgn001
0238,FBgn0010894,FBgn0011817,FBgn0014135,FBgn0
014388,FBgn0024236,FBgn0024250,FBgn0029082,FBg
n0031461,FBgn0031885,FBgn0036518,FBgn0036666,F
Bgn0036801,FBgn0043900,FBgn0050456,FBgn005217
9,FBgn0085432,FBgn0264959,FBgn0265778,FBgn0266
084 
27 GO:000200
9 
imaginal 
disc 
developme
nt 
0.0356
385 
FBgn0000395,FBgn0000547,FBgn0002524,FBgn00026
43,FBgn0003391,FBgn0003984,FBgn0004893,FBgn001
0651,FBgn0011739,FBgn0011817,FBgn0014135,FBgn0
024250,FBgn0031461,FBgn0031885,FBgn0036518,FBg
n0036801,FBgn0040532,FBgn0043900,FBgn0050456,F
Bgn0052133,FBgn0085432,FBgn0263316,FBgn026495
9,FBgn0265778,FBgn0266084,FBgn0283499 
26 GO:000744
4 
tube 
morphogen
esis 
0.0176
962 
FBgn0000163,FBgn0000395,FBgn0000547,FBgn00026
43,FBgn0003391,FBgn0003984,FBgn0004893,FBgn001
1817,FBgn0014135,FBgn0014388,FBgn0023510,FBgn0
024236,FBgn0024250,FBgn0029006,FBgn0031461,FBg
n0031885,FBgn0036518,FBgn0036666,FBgn0036801,F
Bgn0043900,FBgn0050456,FBgn0085432,FBgn026495
9,FBgn0265778,FBgn0266084 
25 GO:003523
9 
epithelial 
tube 
morphogen
esis 
0.0273
455 
FBgn0000163,FBgn0000395,FBgn0000547,FBgn00026
43,FBgn0003391,FBgn0003984,FBgn0004893,FBgn001
1817,FBgn0014135,FBgn0014388,FBgn0024236,FBgn0
024250,FBgn0031461,FBgn0031885,FBgn0036518,FBg
n0036666,FBgn0036801,FBgn0043900,FBgn0050456,F
Bgn0085432,FBgn0264959,FBgn0265778,FBgn026608
4 
23 GO:006056
2 
regulation 
of cell 
differentiat
ion 
0.0258
182 
FBgn0000547,FBgn0002633,FBgn0003391,FBgn00036
55,FBgn0003984,FBgn0004797,FBgn0011739,FBgn001
4073,FBgn0014388,FBgn0025741,FBgn0028369,FBgn0
031461,FBgn0052179,FBgn0085430,FBgn0259176,FBg
n0259938,FBgn0263353,FBgn0264959,FBgn0265778,F
Bgn0266084,FBgn0283499 
21 GO:004559
5 
response to 
abiotic 
stimulus 
0.0204
374 
FBgn0004832,FBgn0004907,FBgn0010651,FBgn00117
39,FBgn0011817,FBgn0014073,FBgn0015946,FBgn002
0258,FBgn0030505,FBgn0031885,FBgn0033132,FBgn0
034335,FBgn0037163,FBgn0038530,FBgn0039464,FBg
n0045842,FBgn0263316,FBgn0266411,FBgn0267430,F
Bgn0283499 
20 GO:000962
8 
regulation 
of cell 
developme
nt 
0.0210
157 
FBgn0000547,FBgn0002633,FBgn0003391,FBgn00036
55,FBgn0003984,FBgn0004797,FBgn0011739,FBgn001
4073,FBgn0014388,FBgn0025741,FBgn0031461,FBgn0
052179,FBgn0085430,FBgn0259176,FBgn0259938,FBg
n0264959,FBgn0265778,FBgn0266084,FBgn0283499 
19 GO:006028
4 
respiratory 
system 
developme
0.0002
383 
FBgn0000163,FBgn0000547,FBgn0003391,FBgn00102
38,FBgn0010894,FBgn0011739,FBgn0014135,FBgn001
4388,FBgn0023510,FBgn0024236,FBgn0033032,FBgn0
18 GO:006054
1 
 
 
274 
nt 036666,FBgn0085432,FBgn0261284,FBgn0264959,FBg
n0266084,FBgn0266411,FBgn0283499 
enzyme 
linked 
receptor 
protein 
signaling 
pathway 
0.0091
84 
FBgn0000395,FBgn0000547,FBgn0003984,FBgn00049
07,FBgn0014073,FBgn0014135,FBgn0014388,FBgn002
2800,FBgn0024250,FBgn0025625,FBgn0029006,FBgn0
031461,FBgn0035626,FBgn0052179,FBgn0264959,FBg
n0266411,FBgn0283499 
17 GO:000716
7 
post-
embryonic 
appendage 
morphogen
esis 
0.0436
033 
FBgn0000395,FBgn0000547,FBgn0002643,FBgn00033
91,FBgn0003984,FBgn0004893,FBgn0011817,FBgn002
4250,FBgn0031461,FBgn0036518,FBgn0036801,FBgn0
043900,FBgn0050456,FBgn0085432,FBgn0264959,FBg
n0265778,FBgn0266084 
17 GO:003512
0 
imaginal 
disc-
derived 
appendage 
morphogen
esis 
0.0486
28 
FBgn0000395,FBgn0000547,FBgn0002643,FBgn00033
91,FBgn0003984,FBgn0004893,FBgn0011817,FBgn002
4250,FBgn0031461,FBgn0036518,FBgn0036801,FBgn0
043900,FBgn0050456,FBgn0085432,FBgn0264959,FBg
n0265778,FBgn0266084 
17 GO:003511
4 
open 
tracheal 
system 
developme
nt 
0.0012
062 
FBgn0000163,FBgn0000547,FBgn0003391,FBgn00102
38,FBgn0010894,FBgn0011739,FBgn0014135,FBgn001
4388,FBgn0023510,FBgn0024236,FBgn0033032,FBgn0
036666,FBgn0085432,FBgn0261284,FBgn0264959,FBg
n0283499 
16 GO:000742
4 
cell 
adhesion 
0.0007
773 
FBgn0000163,FBgn0000547,FBgn0003391,FBgn00102
38,FBgn0010894,FBgn0015229,FBgn0022800,FBgn002
5741,FBgn0028369,FBgn0029082,FBgn0037963,FBgn0
043900,FBgn0264959,FBgn0266084 
14 GO:000715
5 
biological 
adhesion 
0.0008
548 
FBgn0000163,FBgn0000547,FBgn0003391,FBgn00102
38,FBgn0010894,FBgn0015229,FBgn0022800,FBgn002
5741,FBgn0028369,FBgn0029082,FBgn0037963,FBgn0
043900,FBgn0264959,FBgn0266084 
14 GO:002261
0 
embryonic 
morphogen
esis 
0.0163
682 
FBgn0000163,FBgn0000547,FBgn0002643,FBgn00033
91,FBgn0004893,FBgn0010238,FBgn0010894,FBgn002
8292,FBgn0029006,FBgn0036518,FBgn0085432,FBgn0
264959,FBgn0265778,FBgn0283499 
14 GO:004859
8 
transmemb
rane 
receptor 
protein 
tyrosine 
kinase 
signaling 
pathway 
0.0187
95 
FBgn0000547,FBgn0003984,FBgn0004907,FBgn00140
73,FBgn0014135,FBgn0014388,FBgn0022800,FBgn002
5625,FBgn0035626,FBgn0052179,FBgn0264959,FBgn0
266411,FBgn0283499 
13 GO:000716
9 
defense 
response to 
bacterium 
0.0160
245 
FBgn0024987,FBgn0033980,FBgn0034647,FBgn00358
06,FBgn0035813,FBgn0035977,FBgn0038530,FBgn004
0384,FBgn0052133,FBgn0086358,FBgn0264959,FBgn0
265052 
12 GO:004274
2 
response to 
bacterium 
0.0315
131 
FBgn0024987,FBgn0033980,FBgn0034647,FBgn00358
06,FBgn0035813,FBgn0035977,FBgn0038530,FBgn004
0384,FBgn0052133,FBgn0086358,FBgn0264959,FBgn0
265052 
12 GO:000961
7 
cell-cell 
adhesion 
0.0004
45 
FBgn0000163,FBgn0000547,FBgn0003391,FBgn00102
38,FBgn0015229,FBgn0022800,FBgn0028369,FBgn002
9082,FBgn0037963,FBgn0043900,FBgn0264959 
11 GO:009860
9 
determinati
on of adult 
0.0261
507 
FBgn0002566,FBgn0015946,FBgn0031461,FBgn00318
85,FBgn0033127,FBgn0035977,FBgn0037802,FBgn005
11 GO:000834
0 
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lifespan 1216,FBgn0259176,FBgn0263316,FBgn0283499 
multicellul
ar 
organism 
aging 
0.0276
998 
FBgn0002566,FBgn0015946,FBgn0031461,FBgn00318
85,FBgn0033127,FBgn0035977,FBgn0037802,FBgn005
1216,FBgn0259176,FBgn0263316,FBgn0283499 
11 GO:001025
9 
positive 
regulation 
of 
intracellula
r signal 
transductio
n 
0.0293
142 
FBgn0000547,FBgn0001234,FBgn0003984,FBgn00049
07,FBgn0014135,FBgn0031885,FBgn0050440,FBgn005
0456,FBgn0262081,FBgn0264959,FBgn0283499 
11 GO:190253
3 
aging 0.0327
437 
FBgn0002566,FBgn0015946,FBgn0031461,FBgn00318
85,FBgn0033127,FBgn0035977,FBgn0037802,FBgn005
1216,FBgn0259176,FBgn0263316,FBgn0283499 
11 GO:000756
8 
cell-cell 
junction 
organizatio
n 
0.0007
144 
FBgn0000163,FBgn0003391,FBgn0010238,FBgn00108
94,FBgn0028369,FBgn0033032,FBgn0261284,FBgn026
2081,FBgn0264959,FBgn0265778 
10 GO:004521
6 
cell 
junction 
organizatio
n 
0.0008
173 
FBgn0000163,FBgn0003391,FBgn0010238,FBgn00108
94,FBgn0028369,FBgn0033032,FBgn0261284,FBgn026
2081,FBgn0264959,FBgn0265778 
10 GO:003433
0 
sulfur 
compound 
metabolic 
process 
0.0204
494 
FBgn0010039,FBgn0010040,FBgn0010041,FBgn00150
11,FBgn0032986,FBgn0034335,FBgn0050022,FBgn006
3492,FBgn0063493,FBgn0265052 
10 GO:000679
0 
positive 
regulation 
of 
phosphorus 
metabolic 
process 
0.0204
494 
FBgn0001234,FBgn0003984,FBgn0014073,FBgn00141
35,FBgn0022800,FBgn0025741,FBgn0031461,FBgn003
1885,FBgn0264959,FBgn0283499 
10 GO:001056
2 
positive 
regulation 
of 
phosphate 
metabolic 
process 
0.0204
494 
FBgn0001234,FBgn0003984,FBgn0014073,FBgn00141
35,FBgn0022800,FBgn0025741,FBgn0031461,FBgn003
1885,FBgn0264959,FBgn0283499 
10 GO:004593
7 
cell-cell 
adhesion 
via 
plasma-
membrane 
adhesion 
molecules 
1.38E-
05 
FBgn0000163,FBgn0000547,FBgn0003391,FBgn00102
38,FBgn0015229,FBgn0022800,FBgn0028369,FBgn002
9082,FBgn0037963 
9 GO:009874
2 
regulation 
of 
locomotion 
0.0170
422 
FBgn0003391,FBgn0003984,FBgn0014073,FBgn00141
35,FBgn0025741,FBgn0052179,FBgn0085430,FBgn026
6084,FBgn0266411 
9 GO:004001
2 
regulation 
of cellular 
component 
movement 
0.0170
422 
FBgn0003391,FBgn0003984,FBgn0014073,FBgn00141
35,FBgn0025741,FBgn0052179,FBgn0085430,FBgn026
6084,FBgn0266411 
9 GO:005127
0 
positive 
regulation 
of 
0.0386
17 
FBgn0001234,FBgn0003984,FBgn0014073,FBgn00141
35,FBgn0022800,FBgn0031461,FBgn0031885,FBgn026
4959,FBgn0283499 
9 GO:004232
7 
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phosphoryl
ation 
MAPK 
cascade 
0.0487
412 
FBgn0001234,FBgn0003984,FBgn0014135,FBgn00143
88,FBgn0031885,FBgn0035977,FBgn0264959,FBgn026
5778,FBgn0283499 
9 GO:000016
5 
cell-cell 
junction 
assembly 
0.0008
342 
FBgn0000163,FBgn0003391,FBgn0010238,FBgn00108
94,FBgn0028369,FBgn0033032,FBgn0261284,FBgn026
5778 
8 GO:000704
3 
cell 
junction 
assembly 
0.0009
864 
FBgn0000163,FBgn0003391,FBgn0010238,FBgn00108
94,FBgn0028369,FBgn0033032,FBgn0261284,FBgn026
5778 
8 GO:003432
9 
cuticle 
developme
nt 
0.0045
878 
FBgn0000451,FBgn0001112,FBgn0004396,FBgn00355
13,FBgn0043900,FBgn0085432,FBgn0261799,FBgn028
6203 
8 GO:004233
5 
regulation 
of cell 
migration 
0.0071
917 
FBgn0003391,FBgn0003984,FBgn0014073,FBgn00141
35,FBgn0025741,FBgn0052179,FBgn0266084,FBgn026
6411 
8 GO:003033
4 
regulation 
of cell 
motility 
0.0097
811 
FBgn0003391,FBgn0003984,FBgn0014073,FBgn00141
35,FBgn0025741,FBgn0052179,FBgn0266084,FBgn026
6411 
8 GO:200014
5 
detection 
of stimulus 
0.0130
077 
FBgn0020258,FBgn0033404,FBgn0035806,FBgn00371
63,FBgn0037630,FBgn0040849,FBgn0050081,FBgn025
9683 
8 GO:005160
6 
stem cell 
proliferatio
n 
0.0216
965 
FBgn0000163,FBgn0011739,FBgn0024555,FBgn00282
92,FBgn0031461,FBgn0035626,FBgn0085432,FBgn025
9176 
8 GO:007208
9 
stem cell 
division 
0.0273
108 
FBgn0000163,FBgn0000928,FBgn0003391,FBgn00245
55,FBgn0028292,FBgn0035626,FBgn0052364,FBgn028
3499 
8 GO:001714
5 
homophilic 
cell 
adhesion 
via plasma 
membrane 
adhesion 
molecules 
6.751
E-05 
FBgn0000547,FBgn0003391,FBgn0010238,FBgn00228
00,FBgn0028369,FBgn0029082,FBgn0037963 
7 GO:000715
6 
glutathione 
metabolic 
process 
0.0021
294 
FBgn0010039,FBgn0010040,FBgn0010041,FBgn00343
35,FBgn0050022,FBgn0063492,FBgn0063493 
7 GO:000674
9 
chitin-
based 
cuticle 
developme
nt 
0.0025
003 
FBgn0001112,FBgn0004396,FBgn0035513,FBgn00439
00,FBgn0085432,FBgn0261799,FBgn0286203 
7 GO:004000
3 
morphogen
esis of a 
branching 
structure 
0.0033
893 
FBgn0000163,FBgn0000547,FBgn0003391,FBgn00141
35,FBgn0014388,FBgn0024236,FBgn0036666 
7 GO:000176
3 
branching 
morphogen
esis of an 
epithelial 
tube 
0.0033
893 
FBgn0000163,FBgn0000547,FBgn0003391,FBgn00141
35,FBgn0014388,FBgn0024236,FBgn0036666 
7 GO:004875
4 
branching 
involved in 
open 
tracheal 
0.0033
893 
FBgn0000163,FBgn0000547,FBgn0003391,FBgn00141
35,FBgn0014388,FBgn0024236,FBgn0036666 
7 GO:006044
6 
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system 
developme
nt 
morphogen
esis of a 
branching 
epithelium 
0.0033
893 
FBgn0000163,FBgn0000547,FBgn0003391,FBgn00141
35,FBgn0014388,FBgn0024236,FBgn0036666 
7 GO:006113
8 
cellular 
modified 
amino acid 
metabolic 
process 
0.0118
394 
FBgn0010039,FBgn0010040,FBgn0010041,FBgn00343
35,FBgn0050022,FBgn0063492,FBgn0063493 
7 GO:000657
5 
posttranscr
iptional 
gene 
silencing 
0.0145
638 
FBgn0001218,FBgn0011291,FBgn0024987,FBgn00314
88,FBgn0035626,FBgn0036451,FBgn0039972 
7 GO:001644
1 
modulation 
of 
chemical 
synaptic 
transmissio
n 
0.0324
448 
FBgn0010501,FBgn0030505,FBgn0030850,FBgn00339
26,FBgn0051201,FBgn0262081,FBgn0264959 
7 GO:005080
4 
regulation 
of trans-
synaptic 
signaling 
0.0324
448 
FBgn0010501,FBgn0030505,FBgn0030850,FBgn00339
26,FBgn0051201,FBgn0262081,FBgn0264959 
7 GO:009917
7 
establishm
ent of 
planar 
polarity 
0.0407
185 
FBgn0000163,FBgn0000547,FBgn0003391,FBgn00118
17,FBgn0014388,FBgn0029082,FBgn0052179 
7 GO:000173
6 
morphogen
esis of a 
polarized 
epithelium 
0.0407
185 
FBgn0000163,FBgn0000547,FBgn0003391,FBgn00118
17,FBgn0014388,FBgn0029082,FBgn0052179 
7 GO:000173
8 
establishm
ent of 
tissue 
polarity 
0.0407
185 
FBgn0000163,FBgn0000547,FBgn0003391,FBgn00118
17,FBgn0014388,FBgn0029082,FBgn0052179 
7 GO:000716
4 
detection 
of 
chemical 
stimulus 
0.0027
514 
FBgn0033404,FBgn0035806,FBgn0037630,FBgn00408
49,FBgn0050081,FBgn0259683 
6 GO:000959
3 
adherens 
junction 
organizatio
n 
0.0039
19 
FBgn0000163,FBgn0003391,FBgn0028369,FBgn02620
81,FBgn0264959,FBgn0265778 
6 GO:003433
2 
apical 
junction 
assembly 
0.0054
184 
FBgn0000163,FBgn0003391,FBgn0010238,FBgn00108
94,FBgn0033032,FBgn0261284 
6 GO:004329
7 
establishm
ent of 
ommatidial 
planar 
polarity 
0.0083
991 
FBgn0000547,FBgn0003391,FBgn0011817,FBgn00143
88,FBgn0029082,FBgn0052179 
6 GO:004206
7 
gastrulatio
n 
0.0217
839 
FBgn0000163,FBgn0002643,FBgn0003391,FBgn00282
92,FBgn0036518,FBgn0085432 
6 GO:000736
9 
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cell fate 
specificatio
n 
0.0320
726 
FBgn0000547,FBgn0002732,FBgn0003984,FBgn00117
39,FBgn0031461,FBgn0259176 
6 GO:000170
8 
positive 
regulation 
of cell 
population 
proliferatio
n 
0.0415
766 
FBgn0003984,FBgn0031461,FBgn0035626,FBgn00521
79,FBgn0259176,FBgn0283499 
6 GO:000828
4 
regulation 
of tube 
architectur
e, open 
tracheal 
system 
0.0451 FBgn0003391,FBgn0010238,FBgn0010894,FBgn00235
10,FBgn0033032,FBgn0261284 
6 GO:003515
2 
regulation 
of 
oogenesis 
0.0451 FBgn0003391,FBgn0003655,FBgn0003984,FBgn00047
97,FBgn0014073,FBgn0052179 
6 GO:190587
9 
ommatidial 
rotation 
0.0032
684 
FBgn0000547,FBgn0003391,FBgn0011817,FBgn00143
88,FBgn0052179 
5 GO:001631
8 
intestinal 
stem cell 
homeostasi
s 
0.0040
587 
FBgn0001218,FBgn0032691,FBgn0259176,FBgn02649
59,FBgn0283499 
5 GO:003633
5 
homeostasi
s of 
number of 
cells 
0.0040
587 
FBgn0001218,FBgn0032691,FBgn0259176,FBgn02649
59,FBgn0283499 
5 GO:004887
2 
hippo 
signaling 
0.0294
005 
FBgn0000547,FBgn0004907,FBgn0011739,FBgn00290
06,FBgn0262081 
5 GO:003532
9 
regulation 
of 
epithelial 
cell 
migration 
0.0327
878 
FBgn0003391,FBgn0003984,FBgn0014073,FBgn00141
35,FBgn0052179 
5 GO:001063
2 
positive 
regulation 
of cell 
migration 
0.0364
089 
FBgn0003391,FBgn0003984,FBgn0014073,FBgn00521
79,FBgn0266084 
5 GO:003033
5 
regulation 
of defense 
response to 
bacterium 
0.0364
089 
FBgn0034647,FBgn0035806,FBgn0035977,FBgn00521
33,FBgn0086358 
5 GO:190042
4 
molting 
cycle, 
chitin-
based 
cuticle 
0.0443
641 
FBgn0000568,FBgn0001112,FBgn0004396,FBgn00439
00,FBgn0085432 
5 GO:000759
1 
molting 
cycle 
0.0443
641 
FBgn0000568,FBgn0001112,FBgn0004396,FBgn00439
00,FBgn0085432 
5 GO:004230
3 
positive 
regulation 
of cell 
motility 
0.0487
023 
FBgn0003391,FBgn0003984,FBgn0014073,FBgn00521
79,FBgn0266084 
5 GO:200014
7 
cuticle 
developme
nt involved 
0.0031
394 
FBgn0001112,FBgn0004396,FBgn0043900,FBgn00854
32 
4 GO:004233
7 
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in chitin-
based 
cuticle 
molting 
cycle 
adherens 
junction 
assembly 
0.0055
339 
FBgn0000163,FBgn0003391,FBgn0028369,FBgn02657
78 
4 GO:003433
3 
execution 
phase of 
apoptosis 
0.0089
118 
FBgn0010501,FBgn0015946,FBgn0028406,FBgn00342
79 
4 GO:009719
4 
regulation 
of ERK1 
and ERK2 
cascade 
0.0191
338 
FBgn0003984,FBgn0014135,FBgn0014388,FBgn02649
59 
4 GO:007037
2 
circadian 
sleep/wake 
cycle 
0.0261
696 
FBgn0034136,FBgn0035023,FBgn0053527,FBgn02834
99 
4 GO:004274
5 
regulation 
of 
compound 
eye 
photorecep
tor cell 
differentiat
ion 
0.0261
696 
FBgn0000547,FBgn0014388,FBgn0264959,FBgn02657
78 
4 GO:011011
6 
feeding 
behavior 
0.0301
97 
FBgn0020258,FBgn0039509,FBgn0040726,FBgn02834
99 
4 GO:000763
1 
ERK1 and 
ERK2 
cascade 
0.0301
97 
FBgn0003984,FBgn0014135,FBgn0014388,FBgn02649
59 
4 GO:007037
1 
syncytium 
formation 
by plasma 
membrane 
fusion 
0.0345
704 
FBgn0011705,FBgn0028369,FBgn0029082,FBgn02612
45 
4 GO:000076
8 
syncytium 
formation 
0.0345
704 
FBgn0011705,FBgn0028369,FBgn0029082,FBgn02612
45 
4 GO:000694
9 
myoblast 
fusion 
0.0345
704 
FBgn0011705,FBgn0028369,FBgn0029082,FBgn02612
45 
4 GO:000752
0 
septate 
junction 
assembly 
0.0345
704 
FBgn0010238,FBgn0010894,FBgn0033032,FBgn02612
84 
4 GO:001999
1 
peptidogly
can 
recognition 
protein 
signaling 
pathway 
0.0345
704 
FBgn0034647,FBgn0035806,FBgn0035977,FBgn00863
58 
4 GO:006105
7 
cell-cell 
fusion 
0.0345
704 
FBgn0011705,FBgn0028369,FBgn0029082,FBgn02612
45 
4 GO:014025
3 
tight 
junction 
assembly 
0.0392
924 
FBgn0010238,FBgn0010894,FBgn0033032,FBgn02612
84 
4 GO:012019
2 
tight 
junction 
organizatio
0.0392
924 
FBgn0010238,FBgn0010894,FBgn0033032,FBgn02612
84 
4 GO:012019
3 
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n 
positive 
regulation 
of border 
follicle cell 
migration 
0.0443
641 
FBgn0003391,FBgn0003984,FBgn0014073,FBgn00521
79 
4 GO:190368
8 
positive 
regulation 
of 
epithelial 
cell 
migration 
0.0497
853 
FBgn0003391,FBgn0003984,FBgn0014073,FBgn00521
79 
4 GO:001063
4 
myotube 
differentiat
ion 
0.0497
853 
FBgn0011705,FBgn0028369,FBgn0029082,FBgn02612
45 
4 GO:001490
2 
positive 
regulation 
of 
epithelial 
cell 
differentiat
ion 
0.0497
853 
FBgn0003391,FBgn0003984,FBgn0014073,FBgn00521
79 
4 GO:003085
8 
regulation 
of border 
follicle cell 
migration 
0.0497
853 
FBgn0003391,FBgn0003984,FBgn0014073,FBgn00521
79 
4 GO:190368
4 
symmetric 
stem cell 
division 
0.0001
266 
FBgn0003391,FBgn0035626,FBgn0052364 3 GO:009872
4 
symmetric 
cell 
division 
0.0004
874 
FBgn0003391,FBgn0035626,FBgn0052364 3 GO:009872
5 
calcium-
dependent 
cell-cell 
adhesion 
via plasma 
membrane 
cell 
adhesion 
molecules 
0.0038
068 
FBgn0003391,FBgn0022800,FBgn0037963 3 GO:001633
9 
protein 
polyglycyl
ation 
0.0084
735 
FBgn0026147,FBgn0031853,FBgn0034459 3 GO:001809
4 
response to 
osmotic 
stress 
0.0116
594 
FBgn0015946,FBgn0030505,FBgn0031885 3 GO:000697
0 
negative 
regulation 
of cell 
adhesion 
0.0116
594 
FBgn0000163,FBgn0025741,FBgn0043900 3 GO:000716
2 
chitin-
based 
larval 
cuticle 
pattern 
0.0116
594 
FBgn0004396,FBgn0043900,FBgn0085432 3 GO:003529
3 
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formation 
negative 
regulation 
of 
secretion 
by cell 
0.0116
594 
FBgn0030505,FBgn0032428,FBgn0283499 3 GO:190353
1 
heterophili
c cell-cell 
adhesion 
via plasma 
membrane 
cell 
adhesion 
molecules 
0.0154
43 
FBgn0015229,FBgn0028369,FBgn0029082 3 GO:000715
7 
peptidyl-
glutamic 
acid 
modificatio
n 
0.0154
43 
FBgn0026147,FBgn0031853,FBgn0034459 3 GO:001820
0 
negative 
regulation 
of 
secretion 
0.0154
43 
FBgn0030505,FBgn0032428,FBgn0283499 3 GO:005104
8 
larval 
chitin-
based 
cuticle 
developme
nt 
0.0198
366 
FBgn0004396,FBgn0043900,FBgn0085432 3 GO:000836
3 
tube fusion 0.0198
366 
FBgn0000547,FBgn0003391,FBgn0024236 3 GO:003514
6 
branch 
fusion, 
open 
tracheal 
system 
0.0198
366 
FBgn0000547,FBgn0003391,FBgn0024236 3 GO:003514
7 
negative 
regulation 
of imaginal 
disc 
growth 
0.0248
458 
FBgn0011739,FBgn0036666,FBgn0262081 3 GO:004557
1 
positive 
regulation 
of hippo 
signaling 
0.0304
701 
FBgn0000547,FBgn0004907,FBgn0262081 3 GO:003533
2 
positive 
regulation 
of ERK1 
and ERK2 
cascade 
0.0304
701 
FBgn0003984,FBgn0014135,FBgn0264959 3 GO:007037
4 
female 
mating 
behavior 
0.0367
042 
FBgn0028424,FBgn0053527,FBgn0283499 3 GO:006018
0 
regulation 
of 
peptidogly
0.0367
042 
FBgn0034647,FBgn0035806,FBgn0035977 3 GO:006105
8 
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can 
recognition 
protein 
signaling 
pathway 
histone H4 
acetylation 
0.0435
38 
FBgn0031876,FBgn0032691,FBgn0035624 3 GO:004396
7 
R8 cell 
differentiat
ion 
0.0435
38 
FBgn0000547,FBgn0011739,FBgn0031461 3 GO:004546
5 
germline 
stem cell 
symmetric 
division 
0.0025
308 
FBgn0003391,FBgn0052364 2 GO:009872
9 
male 
germline 
stem cell 
symmetric 
division 
0.0025
308 
FBgn0003391,FBgn0052364 2 GO:009873
0 
mesoderma
l cell fate 
determinati
on 
0.0073
393 
FBgn0002643,FBgn0085432 2 GO:000750
0 
gonadal 
mesoderm 
developme
nt 
0.0073
393 
FBgn0003391,FBgn0024236 2 GO:000750
6 
phenol-
containing 
compound 
catabolic 
process 
0.0073
393 
FBgn0016013,FBgn0037153 2 GO:001933
6 
response to 
anoxia 
0.0073
393 
FBgn0263316,FBgn0283499 2 GO:003405
9 
response to 
light 
intensity 
0.0141
912 
FBgn0033132,FBgn0037163 2 GO:000964
2 
gonad 
morphogen
esis 
0.0141
912 
FBgn0003391,FBgn0024236 2 GO:003526
2 
histone 
H2A 
acetylation 
0.0141
912 
FBgn0032691,FBgn0035624 2 GO:004396
8 
CENP-A 
containing 
chromatin 
organizatio
n 
0.0141
912 
FBgn0002643,FBgn0037624 2 GO:006164
1 
negative 
regulation 
of feeding 
behavior 
0.0141
912 
FBgn0020258,FBgn0283499 2 GO:200025
2 
regulation 
of striated 
muscle 
tissue 
developme
0.0228
698 
FBgn0028369,FBgn0029082 2 GO:001620
2 
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nt 
chromatin 
remodeling 
at 
centromere 
0.0228
698 
FBgn0002643,FBgn0037624 2 GO:003105
5 
CENP-A 
containing 
nucleosom
e assembly 
0.0228
698 
FBgn0002643,FBgn0037624 2 GO:003408
0 
regulation 
of muscle 
tissue 
developme
nt 
0.0228
698 
FBgn0028369,FBgn0029082 2 GO:190186
1 
negative 
regulation 
of peptide 
secretion 
0.0331
752 
FBgn0032428,FBgn0283499 2 GO:000279
2 
cell-cell 
adhesion 
mediated 
by 
cadherin 
0.0331
752 
FBgn0003391,FBgn0037963 2 GO:004433
1 
delaminati
on 
0.0331
752 
FBgn0000163,FBgn0043900 2 GO:006023
2 
mesenchy
me 
developme
nt 
0.0331
752 
FBgn0003391,FBgn0024236 2 GO:006048
5 
mesoderma
l cell fate 
commitme
nt 
0.0449
226 
FBgn0002643,FBgn0085432 2 GO:000171
0 
DNA 
replication-
independen
t 
nucleosom
e assembly 
0.0449
226 
FBgn0002643,FBgn0037624 2 GO:000633
6 
mechanose
nsory 
behavior 
0.0449
226 
FBgn0020258,FBgn0267430 2 GO:000763
8 
response to 
salt stress 
0.0449
226 
FBgn0030505,FBgn0031885 2 GO:000965
1 
contractile 
actin 
filament 
bundle 
assembly 
0.0449
226 
FBgn0000547,FBgn0266084 2 GO:003003
8 
centromere 
complex 
assembly 
0.0449
226 
FBgn0002643,FBgn0037624 2 GO:003450
8 
mesoderma
l cell 
differentiat
ion 
0.0449
226 
FBgn0002643,FBgn0085432 2 GO:004833
3 
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negative 
regulation 
of behavior 
0.0449
226 
FBgn0020258,FBgn0283499 2 GO:004852
1 
 
Table 2.1f: Pathway enrichment for hits differentially upregulated in control males relative to control 
females   
p-value Hits Gene 
matches 
Pathway ID 
0.00288
7389 
FBgn0000163,FBgn0000568,FBgn0003984,FBgn0004907,F
Bgn0011739,FBgn0011817,FBgn0014135,FBgn0014388,FB
gn0022800,FBgn0022986,FBgn0023416,FBgn0025741,FBgn
0029006,FBgn0030011,FBgn0030505,FBgn0031461,FBgn00
31885,FBgn0033205,FBgn0033815,FBgn0034706,FBgn0036
290,FBgn0036518,FBgn0039938,FBgn0043900,FBgn005044
0,FBgn0050456,FBgn0085432,FBgn0262081,FBgn0264959,
FBgn0265778,FBgn0283499 
31 R-DME-
162582 
0.01914
754 
FBgn0004907,FBgn0011817,FBgn0029006,FBgn0030011,F
Bgn0030505,FBgn0031885,FBgn0039938,FBgn0043900,FB
gn0085432 
9 R-DME-
195721 
0.00038
3677 
FBgn0010039,FBgn0010040,FBgn0010041,FBgn0026755,F
Bgn0034335,FBgn0040256,FBgn0063493 
7 980 
0.00038
3677 
FBgn0010039,FBgn0010040,FBgn0010041,FBgn0026755,F
Bgn0034335,FBgn0040256,FBgn0063493 
7 982 
0.01355
4847 
FBgn0010240,FBgn0023416,FBgn0030011,FBgn0034136,F
Bgn0038752,FBgn0051201,FBgn0266720 
7 R-DME-
112315 
0.03531
5175 
FBgn0014135,FBgn0015011,FBgn0024236,FBgn0030638,F
Bgn0031002,FBgn0034136,FBgn0038752 
7 R-DME-
425407 
0.00464
45 
FBgn0003984,FBgn0004907,FBgn0014135,FBgn0022800,F
Bgn0262081,FBgn0265778 
6 R-DME-
5673001 
0.00524
8567 
FBgn0003984,FBgn0004907,FBgn0014135,FBgn0022800,F
Bgn0262081,FBgn0265778 
6 R-DME-
5684996 
0.00825
1417 
FBgn0003984,FBgn0004907,FBgn0014135,FBgn0022800,F
Bgn0262081,FBgn0265778 
6 R-DME-
5683057 
0.00825
1417 
FBgn0003984,FBgn0004907,FBgn0014135,FBgn0022800,F
Bgn0262081,FBgn0265778 
6 R-DME-
9607240 
0.03043
6918 
FBgn0004907,FBgn0029006,FBgn0031885,FBgn0039938,F
Bgn0043900,FBgn0085432 
6 R-DME-
201681 
0.00549
5592 
FBgn0010039,FBgn0010040,FBgn0010041,FBgn0034335,F
Bgn0063493 
5 480 
0.01509
0854 
FBgn0024236,FBgn0030638,FBgn0031002,FBgn0034136,F
Bgn0038752 
5 R-DME-
425366 
0.00946
1437 
FBgn0011817,FBgn0030011,FBgn0030505,FBgn0085432 4 R-DME-
4086398 
0.00946
1437 
FBgn0025741,FBgn0030011,FBgn0050440,FBgn0050456 4 R-DME-
416482 
0.03446
5988 
FBgn0026755,FBgn0033294,FBgn0033297,FBgn0040256 4 500 
0.03807
0252 
FBgn0010240,FBgn0023416,FBgn0030011,FBgn0051201 4 R-DME-
112314 
0.04188
3273 
FBgn0014135,FBgn0031461,FBgn0031885,FBgn0037772 4 R-DME-
381426 
0.04188
3273 
FBgn0014135,FBgn0031461,FBgn0031885,FBgn0037772 4 R-DME-
8957275 
0.00994
3728 
FBgn0031885,FBgn0043900,FBgn0085432 3 R-DME-
201722 
0.01256 FBgn0000163,FBgn0029006,FBgn0031461 3 R-DME-
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2316 2173791 
0.01256
2316 
FBgn0003984,FBgn0014135,FBgn0022800 3 R-DME-
6811558 
0.02258
2152 
FBgn0004797,FBgn0026755,FBgn0040256 3 830 
0.02258
2152 
FBgn0003984,FBgn0014135,FBgn0022800 3 R-DME-
199418 
0.02258
2152 
FBgn0004907,FBgn0039938,FBgn0085432 3 R-DME-
3769402 
0.03109
1166 
FBgn0026755,FBgn0039273,FBgn0040256 3 514 
0.04656
2625 
FBgn0030367,FBgn0033397,FBgn0036290 3 R-DME-
193144 
0.00866
5626 
FBgn0000547,FBgn0028369 2 R-DME-
373753 
0.00866
5626 
FBgn0036986,FBgn0037818 2 R-DME-
5423646 
0.01407
4039 
FBgn0043900,FBgn0085432 2 R-DME-
209421 
0.01407
4039 
FBgn0004907,FBgn0011739 2 R-DME-
390098 
0.02057
3844 
FBgn0030011,FBgn0051201 2 R-DME-
500657 
0.03648
3803 
FBgn0004907,FBgn0011739 2 R-DME-
2028269 
0.03648
3803 
FBgn0014135,FBgn0031461 2 R-DME-
3000170 
0.03648
3803 
FBgn0004797,FBgn0035266 2 R-DME-75109 
0.04572
5398 
FBgn0014135,FBgn0031461 2 R-DME-
3000171 
0.04572
5398 
FBgn0033205,FBgn0036290 2 R-DME-
975634 
0.03916
3624 
FBgn0014135 1 R-DME-
190241 
0.03916
3624 
FBgn0014135 1 R-DME-
190242 
0.03916
3624 
FBgn0014135 1 R-DME-
190370 
0.03916
3624 
FBgn0014135 1 R-DME-
190371 
0.03916
3624 
FBgn0014135 1 R-DME-
190373 
0.03916
3624 
FBgn0014135 1 R-DME-
190374 
0.03916
3624 
FBgn0014135 1 R-DME-
190375 
0.03916
3624 
FBgn0014135 1 R-DME-
190377 
0.03916
3624 
FBgn0034136 1 R-DME-
379401 
 
 
Table 2.2a: list of genes differentially upregulated in control males relative to 20HE males 
list of hits>10 raw reads log2FC edgeR p-value edgeR -log10(pvalue) 
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AOX2 -6.5067 7.42E-06 5.129596095 
CG43968 -6.6688 0.0002 3.698970004 
CG12446 -5.8271 0.0002 3.698970004 
Pig1 -3.1216 0.0003 3.522878745 
CG42818 -6.5236 0.0005 3.301029996 
CG3246 -3.0039 0.0014 2.853871964 
CG31391 -4.0215 0.0017 2.769551079 
CG14545 -2.9623 0.0024 2.619788758 
CG18003 -3.4764 0.0024 2.619788758 
CG1602 -1.161 0.0032 2.494850022 
CG14291 -2.0361 0.0036 2.443697499 
CG3709 -1.0501 0.0039 2.408935393 
CG31287 -2.1138 0.0039 2.408935393 
CG7406 -3.8103 0.0043 2.366531544 
Sr-CIII -5.6264 0.0057 2.244125144 
CG14837 -2.4124 0.0064 2.193820026 
Zip88E -1.4633 0.007 2.15490196 
CR44566 -1.093 0.0075 2.124938737 
snoRNA:Me28S-C3227b -1.8774 0.008 2.096910013 
CR43849 -1.596 0.0082 2.086186148 
CG4462 -1.0211 0.0084 2.075720714 
CG14238 -4.2035 0.0107 1.970616222 
CG14695 -2.7579 0.0125 1.903089987 
CG17681 -1.6223 0.0125 1.903089987 
CG42364 -1.5618 0.0132 1.879426069 
snoRNA:Psi28S-2648 -1.5208 0.0135 1.869666232 
CG14367 -1.5871 0.0138 1.860120914 
DptA -6.3191 0.0142 1.847711656 
RpL13A -1.7022 0.0147 1.832682665 
CG12868 -1.2714 0.016 1.795880017 
CG42672 -2.1561 0.0161 1.793174124 
heix -0.894 0.0162 1.790484985 
CG13843 -2.2947 0.0162 1.790484985 
CG3335 -0.8243 0.0163 1.787812396 
tos -1.4721 0.0165 1.782516056 
Fur2 -2.0955 0.0166 1.779891912 
CR44833 -2.7113 0.0167 1.777283529 
GluRS-m -0.9863 0.0173 1.761953897 
CG10581 -1.9571 0.0174 1.759450752 
CG6568 -2.1704 0.0177 1.752026734 
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CG17249 -0.9304 0.0179 1.747146969 
CG7137 -0.8816 0.021 1.677780705 
CG10933 -6.1121 0.021 1.677780705 
CR44611 -1.5672 0.0215 1.66756154 
snoRNA:Me18S-C419 -2.2584 0.0216 1.665546249 
snoRNA:Me28S-A982a -1.8086 0.0231 1.63638802 
Ser7 -1.24 0.0239 1.621602099 
CG44002 -0.9024 0.024 1.619788758 
CG8319 -0.806 0.0247 1.607303047 
CG6712 -0.7023 0.0249 1.603800653 
CG14252 -0.9 0.0254 1.595166283 
wor -1.6041 0.0255 1.59345982 
Tab2 -1.2721 0.0278 1.555955204 
CG6574 -1.18 0.0296 1.528708289 
mir-967 -0.9719 0.0296 1.528708289 
Cyp6a20 -0.8244 0.03 1.522878745 
CG42258 -2.6432 0.0303 1.518557371 
CG8072 -1.7811 0.0315 1.501689446 
CG14971 -0.7776 0.0316 1.500312917 
CR44138 -1.6638 0.0318 1.49757288 
snoRNA:Psi28S-2949 -1.0821 0.0321 1.493494968 
CG16833 -1.4088 0.0324 1.48945499 
SerRS-m -1.3166 0.0337 1.472370099 
CG13494 -1.157 0.0348 1.458420756 
CR44022 -2.0912 0.0354 1.450996738 
CG33331 -0.8178 0.0363 1.440093375 
snoRNA:Me28S-A992 -1.6987 0.0367 1.435333936 
snoRNA:Me28S-G764 -1.5829 0.0379 1.42136079 
snoRNA:Psi18S-1275 -1.5073 0.038 1.420216403 
CG10063 -2.3783 0.0411 1.386158178 
snoRNA:Me28S-G3255b -1.2316 0.0412 1.385102784 
fray -2.0595 0.0412 1.385102784 
Arc1 -0.6566 0.0419 1.377785977 
Kif19A -5.4692 0.0429 1.367542708 
CG6962 -0.8724 0.0441 1.355561411 
dsx-c73A -1.3142 0.0448 1.348721986 
CG34231 -0.9484 0.0449 1.347753659 
Atxn7 -1.8506 0.045 1.346787486 
CG31606 -1.6906 0.0455 1.341988603 
CG32396 -1.2616 0.0457 1.3400838 
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mthl10 -1.3117 0.0463 1.334419009 
CG8492 -3.0693 0.0479 1.319664487 
snoRNA:Psi18S-920 -1.3085 0.048 1.318758763 
CG12909 -0.6273 0.0481 1.317854924 
CG7857 -0.6874 0.0486 1.313363731 
CR46220 -1.6496 0.0491 1.308918508 
isoQC -1.074 0.0501 1.300162274 
CG1463 -4.4261 0.0502 1.299296283 
CG43101 -0.9784 0.0506 1.295849483 
snoRNA:nop5-x16-a -1.3274 0.0508 1.294136288 
CG13868 -1.1543 0.051 1.292429824 
CR46102 -2.2176 0.051 1.292429824 
SmydA-5 -1.4836 0.0511 1.2915791 
CR45823 -4.6824 0.0516 1.287350298 
CG11257 -0.7572 0.0517 1.286509457 
dpr18 -0.8827 0.0521 1.283162277 
CG17294 -0.7187 0.0527 1.278189385 
CG10730 -1.6359 0.0531 1.274905479 
Rbp4 -1.6379 0.0534 1.272458743 
Hexo2 -0.8738 0.0538 1.269217724 
CG43370 -0.9773 0.054 1.26760624 
TBC1D16 -0.9783 0.054 1.26760624 
 
 
Table 2.2b:  list of genes differentially upregulated in 20HE males relative to control males 
list of hits>10 raw reads log2FC edgeR p-value edgeR -log10(pvalue)2 
CG13813 15.064 6.06E-26 25.21752738 
CG11241 3.5682 5.70E-14 13.24412514 
alpha-Est7 3.0456 1.57E-08 7.804100348 
snoRNA:Me28S-A30 3.2883 7.11E-08 7.148130399 
CG5361 6.7608 7.45E-07 6.127843727 
CG18180 5.1105 1.86E-06 5.730487056 
CG6295 3.9842 1.45E-05 4.838631998 
tej 3.6374 1.54E-05 4.812479279 
CG3344 3.414 2.80E-05 4.552841969 
CG18179 4.6862 2.89E-05 4.539102157 
CG10910 4.6753 3.32E-05 4.478861916 
CG44286 4.1695 4.07E-05 4.390405591 
CG30411 6.0163 4.93E-05 4.307153081 
CG34026 7.9805 6.12E-05 4.213248578 
CR45127 3.6236 0.0001 4 
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CG10869 3.1314 0.0001 4 
CG32483 3.1875 0.0002 3.698970004 
CR45921 3.3383 0.0002 3.698970004 
png 1.6477 0.0003 3.522878745 
Amy-d 2.7046 0.0003 3.522878745 
CG8952 2.8574 0.0004 3.397940009 
CG31690 3.8478 0.0004 3.397940009 
Muc68E 4.0708 0.0006 3.22184875 
CG8299 8.1206 0.0007 3.15490196 
CG42825 2.9383 0.0007 3.15490196 
CG42846 2.8918 0.0009 3.045757491 
CG8568 2.3918 0.001 3 
Est-Q 3.0296 0.0011 2.958607315 
CG14694 2.3192 0.0011 2.958607315 
Jon99Cii 2.8035 0.0011 2.958607315 
Jon99Ci 2.0867 0.0012 2.920818754 
kappaTry 2.6034 0.0013 2.886056648 
CG33510 1.2647 0.0014 2.853871964 
CR44867 3.5541 0.0014 2.853871964 
CG15605 3.9996 0.0016 2.795880017 
stg 2.0629 0.0016 2.795880017 
CG10000 6.2272 0.0016 2.795880017 
CR46322 6.1148 0.0019 2.721246399 
E(spl)m6-BFM 1.5074 0.002 2.698970004 
E(spl)m8-HLH 1.4753 0.0021 2.677780705 
ninaD 2.811 0.0022 2.657577319 
CAH2 3.2068 0.0023 2.638272164 
CG31345 3.9613 0.0026 2.585026652 
CG2772 1.6162 0.0035 2.455931956 
CG42714 2.9918 0.0036 2.443697499 
Ucp4C 4.1052 0.004 2.397940009 
CG45080 4.909 0.0041 2.387216143 
CG5506 1.8863 0.0041 2.387216143 
CG7458 1.2286 0.0046 2.337242168 
CR44150 3.6154 0.0051 2.292429824 
CG4302 1.6118 0.0062 2.207608311 
thetaTry 2.8663 0.0064 2.193820026 
CG33109 6.191 0.0065 2.187086643 
Tps1 6.1082 0.0068 2.167491087 
CG30339 1.087 0.0077 2.113509275 
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Cpr73D 1.1698 0.0079 2.102372909 
gskt 2.0345 0.0082 2.086186148 
dgt3 1.1599 0.0084 2.075720714 
CG7470 1.3092 0.0089 2.050609993 
GstD7 2.3818 0.0091 2.040958608 
CG6067 1.6202 0.0099 2.004364805 
CG33127 1.112 0.01 2 
CG4835 5.4578 0.0117 1.931814138 
CG15695 3.4705 0.0119 1.924453039 
Jon99Ciii 3.2062 0.0124 1.906578315 
CR45272 3.1296 0.0137 1.863279433 
CG30371 5.1978 0.0138 1.860120914 
PGRP-SC2 2.1279 0.0139 1.8569852 
CR45908 1.5726 0.0145 1.838631998 
CG9396 1.6802 0.0145 1.838631998 
CG34347 0.9676 0.0146 1.835647144 
Eip78C 1.2406 0.0152 1.818156412 
CG33301 3.7144 0.0156 1.806875402 
fa2h 3.137 0.0159 1.798602876 
CG11192 1.4458 0.016 1.795880017 
Eip75B 0.9144 0.0161 1.793174124 
CG12780 1.2326 0.0172 1.764471553 
Mtp 0.9393 0.0173 1.761953897 
CG42327 2.7127 0.0183 1.73754891 
sut4 5.153 0.0184 1.735182177 
lcs 4.4828 0.0187 1.728158393 
Mdr50 1.7958 0.0211 1.675717545 
Gr8a 5.0115 0.0219 1.659555885 
LysP 4.9099 0.022 1.657577319 
CG11426 1.7413 0.0222 1.653647026 
CG6296 4.8824 0.023 1.638272164 
CG32054 2.0331 0.0232 1.634512015 
CR44429 0.938 0.0241 1.617982957 
CG12766 1.5593 0.0258 1.588380294 
CG12219 0.7943 0.0264 1.578396073 
CG8642 3.2986 0.0275 1.560667306 
CG5804 0.992 0.0279 1.554395797 
CG9498 2.4184 0.0279 1.554395797 
CR45045 2.4959 0.0294 1.53165267 
CR44868 0.9162 0.0296 1.528708289 
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CG5254 0.7791 0.0297 1.527243551 
CG3739 1.673 0.0332 1.478861916 
CG33346 2.0919 0.0337 1.472370099 
aay 0.993 0.0338 1.4710833 
CR45298 1.8549 0.034 1.468521083 
lin-28 0.7338 0.0353 1.452225295 
CG31300 1.5904 0.0356 1.448550002 
Nuf2 0.7842 0.0369 1.432973634 
upd2 0.8034 0.038 1.420216403 
CR45949 1.0705 0.038 1.420216403 
Amyrel 1.6441 0.0392 1.406713933 
CG14526 1.5213 0.0401 1.396855627 
etaTry 1.6679 0.0409 1.388276692 
CG15497 4.5702 0.0419 1.377785977 
Dtg 0.648 0.0426 1.370590401 
CG15263 2.4167 0.0494 1.306273051 
CCHa1-R 5.2994 0.0515 1.288192771 
CG2254 1.3734 0.0536 1.27083521 
 
Table 2.2c: list of sexually dimorphic hits in reference to Hudry et al,2016 Table S1  
alpha-Est7 
CG18180 
tobi 
CG6283 
CG11155 
CG3739 
CG33346 
aay 
CG31300 
CG13325 
Amyrel 
CG14160 
CG11407 
CG11899 
CG17681 
RpL13A 
CG12868 
CG6712 
fray 
CG16833 
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Arc1 
CG8368 
CG4462 
CG15263 
CG16965 
CG42846 
Jon99Cii 
Jon99Ci 
kappaTry 
CG33510 
CG8299 
CG42825 
Amy-d 
CG8952 
CG32483 
CG34026 
CG3344 
CG18179 
CG10910 
ninaD 
CAH2 
CG42714 
CG5506 
CG3699 
CG4363 
CG31104 
thetaTry 
CG11878 
CG4053 
CG7470 
GstD7 
CG17839 
CG13360 
Ser8 
CG4835 
Jon99Ciii 
CG9396 
CG6484 
CG33301 
Mal-A1 
 
 
293 
fa2h 
CG11898 
CG12780 
Mal-A4 
CG31463 
CG6296 
CG32054 
CG4377 
Mdr49 
CG10659 
CG12766 
CG17192 
CG17633 
CG9498 
CG10912 
 
Table 2.2d: Pathway enrichment for hits differentially upregulated in 20HE males relative to control 
males   
Pathway 
enrichmen
t 
 
p-value 
 
 
Hits 
 
 
Gene matches 
 
Pathway ID 
 
Starch and 
sucrose 
metabolis
m 
8.42E-07 FBgn0000078,FBgn0002570,FBg
n0020506,FBgn0027073,FBgn00
27560,FBgn0033294,FBgn02615
75 
7 500 
Metabolis
m of lipids 
9.2643E-05 FBgn0000568,FBgn0010241,FBg
n0029994,FBgn0035476,FBgn00
36381,FBgn0037166,FBgn00377
86,FBgn0039470,FBgn0039471,F
Bgn0039472,FBgn0039474,FBgn
0050502,FBgn0053177 
13 R-DME-556833 
Galactose 
metabolis
m 
0.00014491 FBgn0002570,FBgn0033294,FBg
n0035476,FBgn0261575 
4 52 
Synthesis 
of PA 
0.00021659 FBgn0037786,FBgn0039470,FBg
n0039471,FBgn0039472,FBgn00
39474 
5 R-DME-1483166 
Acyl chain 
remodellin
g of PS 
0.00027321 FBgn0039470,FBgn0039471,FBg
n0039472,FBgn0039474 
4 R-DME-1482801 
Glyceroph
ospholipid 
biosynthesi
s 
0.00042991 FBgn0036381,FBgn0037786,FBg
n0039470,FBgn0039471,FBgn00
39472,FBgn0039474 
6 R-DME-1483206 
Metabolic 
pathways 
0.00159037 FBgn0000078,FBgn0002570,FBg
n0015568,FBgn0015575,FBgn00
20506,FBgn0023129,FBgn00270
73,FBgn0033294,FBgn0035476,F
Bgn0037146,FBgn0037166,FBgn
0037186,FBgn0037786,FBgn003
17 1100 
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8070,FBgn0039596,FBgn005222
0,FBgn0261575 
Phospholip
id 
metabolis
m 
0.0017436 FBgn0036381,FBgn0037786,FBg
n0039470,FBgn0039471,FBgn00
39472,FBgn0039474 
6 R-DME-1483257 
Metabolis
m 
0.00278954 FBgn0000568,FBgn0010241,FBg
n0023129,FBgn0027843,FBgn00
29994,FBgn0034200,FBgn00354
76,FBgn0036381,FBgn0037146,F
Bgn0037166,FBgn0037186,FBgn
0037786,FBgn0037845,FBgn003
9470,FBgn0039471,FBgn003947
2,FBgn0039474,FBgn0040383,FB
gn0050502,FBgn0053177 
20 R-DME-1430728 
Lysine 
catabolism 
0.00381016 FBgn0036381,FBgn0040383 2 R-DME-71064 
Neuroactiv
e ligand-
receptor 
interaction 
0.00429203 FBgn0003863,FBgn0011554,FBg
n0011555 
3 4080 
SUMOylat
ion of 
intracellula
r receptors 
0.00462862 FBgn0000568,FBgn0004865 2 R-DME-4090294 
Digestion 0.00502788 FBgn0000078,FBgn0020506,FBg
n0037786 
3 R-DME-8935690 
Glycerolipi
d 
metabolis
m 
0.00767307 FBgn0035476,FBgn0037166,FBg
n0038070 
3 561 
Digestion 
and 
absorption 
0.00817995 FBgn0000078,FBgn0020506,FBg
n0037786 
3 R-DME-8963743 
Digestion 
of dietary 
carbohydra
te 
0.00862443 FBgn0000078,FBgn0020506 2 R-DME-189085 
Metabolis
m of amino 
acids and 
derivatives 
0.0094115 FBgn0023129,FBgn0034200,FBg
n0036381,FBgn0037146,FBgn00
37186,FBgn0040383 
6 R-DME-71291 
Drug 
metabolis
m - other 
enzymes 
0.0158108 FBgn0015568,FBgn0015575,FBg
n0027073 
3 983 
Nuclear 
Receptor 
transcriptio
n pathway 
0.01663373 FBgn0000568,FBgn0004865 2 R-DME-383280 
Transcripti
onal 
regulation 
of white 
adipocyte 
differentiat
ion 
0.01896242 FBgn0000568 1 R-DME-381340 
 
 
295 
Cellular 
hexose 
transport 
0.02146927 FBgn0028560,FBgn0034247 2 R-DME-189200 
Glycine, 
serine and 
threonine 
metabolis
m 
0.02319595 FBgn0023129,FBgn0037186 2 260 
Keratinizat
ion 
0.02319595 FBgn0031533,FBgn0038070 2 R-DME-6805567 
Formation 
of the 
cornified 
envelope 
0.02319595 FBgn0031533,FBgn0038070 2 R-DME-6809371 
Sphingolip
id de novo 
biosynthesi
s 
0.02681444 FBgn0037166,FBgn0050502 2 R-DME-1660661 
Signaling 
by 
Retinoic 
Acid 
0.02681444 FBgn0000568,FBgn0029994 2 R-DME-5362517 
Transcripti
onal 
regulation 
of 
granulopoi
esis 
0.03757247 FBgn0000568 1 R-DME-9616222 
Serine 
biosynthesi
s 
0.03757247 FBgn0023129 1 R-DME-977347 
Collagen 
degradatio
n 
0.04674736 FBgn0036381 1 R-DME-1442490 
Polo-like 
kinase 
mediated 
events 
0.04674736 FBgn0003525 1 R-DME-156711 
Vitamin 
B1 
(thiamin) 
metabolis
m 
0.04674736 FBgn0037845 1 R-DME-196819 
Formation 
of the 
activated 
receptor 
complex 
0.04674736 FBgn0030904 1 R-DME-209209 
Metabolis
m of 
steroids 
0.04929803 FBgn0010241,FBgn0029994,FBg
n0035476 
3 R-DME-8957322 
 
 
 
Table 2.2g: GO enrichment for hits differentially upregulated in 20HE males relative to control 
males   
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GO enrichment p-
value 
Hits Gene 
matche
s 
GO ID 
proteolysis 3.502
E-05 
FBgn0003356,FBgn0003357,FBgn0003358
,FBgn0003863,FBgn0011554,FBgn001155
5,FBgn0019928,FBgn0027578,FBgn00298
28,FBgn0030688,FBgn0032144,FBgn0034
052,FBgn0034507,FBgn0035154,FBgn003
6023,FBgn0036024,FBgn0038482,FBgn00
38702,FBgn0043471,FBgn0050371,FBgn0
051266,FBgn0052483,FBgn0053127 
23 GO:0006508 
positive regulation 
of mitotic cell 
cycle, embryonic 
0.000
5896
2 
FBgn0000826,FBgn0003525 2 GO:0045977 
positive regulation 
of embryonic 
development 
0.002
6803
3 
FBgn0000826,FBgn0003525 2 GO:0040019 
lipid metabolic 
process 
0.003
8512
1 
FBgn0000568,FBgn0031533,FBgn0037166
,FBgn0038070,FBgn0038733,FBgn003947
0,FBgn0039471,FBgn0039472,FBgn00394
74,FBgn0040349,FBgn0050502,FBgn0053
177 
12 GO:0006629 
carbohydrate 
metabolic process 
0.004
5203
3 
FBgn0000078,FBgn0002570,FBgn0020506
,FBgn0027560,FBgn0032387,FBgn003329
4,FBgn0039596,FBgn0261575 
8 GO:0005975 
lipid catabolic 
process 
0.006
3439
1 
FBgn0039470,FBgn0039471,FBgn0039472
,FBgn0039474,FBgn0040349 
5 GO:0016042 
regulation of 
mitotic cell cycle, 
embryonic 
0.008
3762
1 
FBgn0000826,FBgn0003525 2 GO:0009794 
tetraterpenoid 
transport 
0.010
0278 
FBgn0002939 1 GO:0046866 
carotenoid 
transport 
0.010
0278 
FBgn0002939 1 GO:0046867 
trehalose 
metabolism in 
response to stress 
0.010
0278 
FBgn0027560 1 GO:0070413 
negative regulation 
of extrinsic 
apoptotic signaling 
pathway via death 
domain receptors 
0.010
0278 
FBgn0033985 1 GO:1902042 
response to cold 0.010
9026
1 
FBgn0031757,FBgn0034296 2 GO:0009409 
glucose import 0.015
2361
7 
FBgn0028560,FBgn0034247 2 GO:0046323 
glucose 
transmembrane 
transport 
0.015
2361
7 
FBgn0028560,FBgn0034247 2 GO:1904659 
hexose 
transmembrane 
transport 
0.016
8195
6 
FBgn0028560,FBgn0034247 2 GO:0008645 
monosaccharide 0.016 FBgn0028560,FBgn0034247 2 GO:0015749 
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transmembrane 
transport 
8195
6 
carbohydrate 
transmembrane 
transport 
0.018
4698
7 
FBgn0028560,FBgn0034247 2 GO:0034219 
isoprenoid 
transport 
0.019
9560
3 
FBgn0002939 1 GO:0046864 
terpenoid transport 0.019
9560
3 
FBgn0002939 1 GO:0046865 
regulation of 
G2/MI transition 
of meiotic cell 
cycle 
0.019
9560
3 
FBgn0003525 1 GO:0110030 
positive regulation 
of G2/MI 
transition of 
meiotic cell cycle 
0.019
9560
3 
FBgn0003525 1 GO:0110032 
positive regulation 
of meiotic cell 
cycle phase 
transition 
0.019
9560
3 
FBgn0003525 1 GO:1901995 
regulation of 
extrinsic apoptotic 
signaling pathway 
via death domain 
receptors 
0.019
9560
3 
FBgn0033985 1 GO:1902041 
negative regulation 
of production of 
miRNAs involved 
in gene silencing 
by miRNA 
0.019
9560
3 
FBgn0035626 1 GO:1903799 
regulation of pre-
miRNA processing 
0.019
9560
3 
FBgn0035626 1 GO:2000631 
negative regulation 
of pre-miRNA 
processing 
0.019
9560
3 
FBgn0035626 1 GO:2000632 
negative regulation 
of extrinsic 
apoptotic signaling 
pathway 
0.019
9560
3 
FBgn0033985 1 GO:2001237 
carbohydrate 
transport 
0.021
9653
8 
FBgn0028560,FBgn0034247 2 GO:0008643 
response to 
insecticide 
0.023
8077 
FBgn0010241,FBgn0030108 2 GO:0017085 
oligosaccharide 
biosynthetic 
process 
0.025
7111
8 
FBgn0027560,FBgn0039596 2 GO:0009312 
trehalose 
biosynthetic 
process 
0.029
7856
7 
FBgn0027560 1 GO:0005992 
proline 
biosynthetic 
0.029
7856
FBgn0037146 1 GO:0006561 
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process 7 
L-serine 
biosynthetic 
process 
0.029
7856
7 
FBgn0023129 1 GO:0006564 
extrinsic apoptotic 
signaling pathway 
via death domain 
receptors 
0.029
7856
7 
FBgn0033985 1 GO:0008625 
negative regulation 
of 
posttranscriptional 
gene silencing 
0.029
7856
7 
FBgn0035626 1 GO:0060149 
negative regulation 
of gene silencing 
by miRNA 
0.029
7856
7 
FBgn0035626 1 GO:0060965 
response to L-
canavanine 
0.029
7856
7 
FBgn0030108 1 GO:1901354 
regulation of 
production of 
miRNAs involved 
in gene silencing 
by miRNA 
0.029
7856
7 
FBgn0035626 1 GO:1903798 
lipid localization 0.030
6695
7 
FBgn0002939,FBgn0015575,FBgn0030904
,FBgn0266369 
4 GO:0010876 
fatty acid 
metabolic process 
0.034
9513
3 
FBgn0038733,FBgn0040349,FBgn0050502
,FBgn0053177 
4 GO:0006631 
organic acid 
biosynthetic 
process 
0.036
7566
4 
FBgn0023129,FBgn0037146,FBgn0038733
,FBgn0053177 
4 GO:0016053 
carboxylic acid 
biosynthetic 
process 
0.036
7566
4 
FBgn0023129,FBgn0037146,FBgn0038733
,FBgn0053177 
4 GO:0046394 
prostaglandin 
biosynthetic 
process 
0.039
5176
8 
FBgn0053177 1 GO:0001516 
mitochondrial 
pyruvate 
transmembrane 
transport 
0.039
5176
8 
FBgn0037714 1 GO:0006850 
G2/MI transition 
of meiotic cell 
cycle 
0.039
5176
8 
FBgn0003525 1 GO:0008315 
positive regulation 
of G2/M transition 
of mitotic cell 
cycle 
0.039
5176
8 
FBgn0003525 1 GO:0010971 
disaccharide 
biosynthetic 
process 
0.039
5176
8 
FBgn0027560 1 GO:0046351 
icosanoid 
biosynthetic 
process 
0.039
5176
8 
FBgn0053177 1 GO:0046456 
prostanoid 0.039 FBgn0053177 1 GO:0046457 
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biosynthetic 
process 
5176
8 
regulation of 
meiotic cell cycle 
phase transition 
0.039
5176
8 
FBgn0003525 1 GO:1901993 
positive regulation 
of cell cycle G2/M 
phase transition 
0.039
5176
8 
FBgn0003525 1 GO:1902751 
regulation of 
extrinsic apoptotic 
signaling pathway 
0.039
5176
8 
FBgn0033985 1 GO:2001236 
oligosaccharide 
metabolic process 
0.047
8151
2 
FBgn0027560,FBgn0039596 2 GO:0009311 
dephosphorylation 0.047
8215
5 
FBgn0003525,FBgn0023129,FBgn0037166
,FBgn0037786,FBgn0259227 
5 GO:0016311 
L-serine metabolic 
process 
0.049
1530
3 
FBgn0023129 1 GO:0006563 
prostanoid 
metabolic process 
0.049
1530
3 
FBgn0053177 1 GO:0006692 
prostaglandin 
metabolic process 
0.049
1530
3 
FBgn0053177 1 GO:0006693 
phototransduction, 
UV 
0.049
1530
3 
FBgn0002939 1 GO:0007604 
detection of biotic 
stimulus 
0.049
1530
3 
FBgn0033301 1 GO:0009595 
response to 
symbiont 
0.049
1530
3 
FBgn0283451 1 GO:0009608 
xenobiotic 
transport 
0.049
1530
3 
FBgn0010241 1 GO:0042908 
symmetric stem 
cell division 
0.049
1530
3 
FBgn0035626 1 GO:0098724 
pyruvate 
transmembrane 
transport 
0.049
1530
3 
FBgn0037714 1 GO:1901475 
 
Table 2.2e: GO enrichment for hits differentially upregulated in control males relative to 20HE 
males 
GO enrichment p-value Hits Gene 
matches 
GO ID 
ï»¿menaquinone 
metabolic process 
0.0053614 FBgn0028375 1 GO:0009233 
menaquinone 
biosynthetic 
process 
0.0053614 FBgn0028375 1 GO:0009234 
lactate oxidation 0.0053614 FBgn0061356 1 GO:0019516 
proteoglycan 0.0053614 FBgn0038660 1 GO:0030167 
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catabolic process 
heparan sulfate 
proteoglycan 
catabolic process 
0.0053614 FBgn0038660 1 GO:0030200 
ubiquinone 
biosynthetic 
process via 3,4-
dihydroxy-5-
polyprenylbenzoat
e 
0.0053614 FBgn0028375 1 GO:0032194 
positive regulation 
of histone 
ubiquitination 
0.0053614 FBgn0031420 1 GO:0033184 
SAGA complex 
assembly 
0.0053614 FBgn0031420 1 GO:0036285 
cellular response to 
glucose starvation 
0.0053614 FBgn0034422 1 GO:0042149 
vitamin K 
biosynthetic 
process 
0.0053614 FBgn0028375 1 GO:0042371 
regulation of 
transcription by 
glucose 
0.0053614 FBgn0034422 1 GO:0046015 
mitochondrial 
seryl-tRNA 
aminoacylation 
0.0053614 FBgn0021750 1 GO:0070158 
vesicle-mediated 
intercellular 
transport 
0.0053614 FBgn0033926 1 GO:0110077 
positive regulation 
of histone H2B 
ubiquitination 
0.0053614 FBgn0031420 1 GO:2001168 
ncRNA metabolic 
process 
0.00734357 FBgn0021750,FBgn0030406,FBgn
0031227,FBgn0032408,FBgn00335
07,FBgn0036629 
6 GO:0034660 
defense response 
to bacterium 
0.00827174 FBgn0004240,FBgn0033980,FBgn
0034210,FBgn0035813,FBgn00863
58 
5 GO:0042742 
maturation of 
LSU-rRNA 
0.01044144 FBgn0030406,FBgn0032408 2 GO:0000470 
chromatin 
silencing at rDNA 
0.01069458 FBgn0034422 1 GO:0000183 
lactate metabolic 
process 
0.01069458 FBgn0061356 1 GO:0006089 
glutamyl-tRNA 
aminoacylation 
0.01069458 FBgn0036629 1 GO:0006424 
seryl-tRNA 
aminoacylation 
0.01069458 FBgn0021750 1 GO:0006434 
UDP-glucose 
transmembrane 
transport 
0.01069458 FBgn0035449 1 GO:0015786 
histone H2B 
ubiquitination 
0.01069458 FBgn0031420 1 GO:0033523 
fat-soluble vitamin 
biosynthetic 
process 
0.01069458 FBgn0028375 1 GO:0042362 
 
 
301 
vitamin K 
metabolic process 
0.01069458 FBgn0028375 1 GO:0042373 
snoRNA 
localization 
0.01069458 FBgn0030406 1 GO:0048254 
regulation of 
histone H2B 
ubiquitination 
0.01069458 FBgn0031420 1 GO:2001166 
response to 
bacterium 
0.01425925 FBgn0004240,FBgn0033980,FBgn
0034210,FBgn0035813,FBgn00863
58 
5 GO:0009617 
sphingomyelin 
catabolic process 
0.01599969 FBgn0037958 1 GO:0006685 
fat-soluble vitamin 
metabolic process 
0.01599969 FBgn0028375 1 GO:0006775 
tRNA 
aminoacylation for 
protein translation 
0.01753328 FBgn0021750,FBgn0036629 2 GO:0006418 
tRNA 
aminoacylation 
0.01932178 FBgn0021750,FBgn0036629 2 GO:0043039 
amino acid 
activation 
0.02024368 FBgn0021750,FBgn0036629 2 GO:0043038 
peptidyl-
pyroglutamic acid 
biosynthetic 
process, using 
glutaminyl-peptide 
cyclotransferase 
0.02127688 FBgn0036999 1 GO:0017186 
peptidyl-glutamine 
modification 
0.02127688 FBgn0036999 1 GO:0018199 
tRNA 
pseudouridine 
synthesis 
0.02127688 FBgn0031227 1 GO:0031119 
cardiolipin 
metabolic process 
0.02127688 FBgn0067628 1 GO:0032048 
cardiolipin 
biosynthetic 
process 
0.02127688 FBgn0067628 1 GO:0032049 
tRNA 
aminoacylation for 
mitochondrial 
protein translation 
0.02127688 FBgn0021750 1 GO:0070127 
defense response 
to Gram-negative 
bacterium 
0.02412875 FBgn0004240,FBgn0033980,FBgn
0035813 
3 GO:0050829 
glycoprotein 
catabolic process 
0.02652629 FBgn0038660 1 GO:0006516 
phosphatidylglycer
ol biosynthetic 
process 
0.02652629 FBgn0067628 1 GO:0006655 
 
 
Table 2.2f: Pathway enrichment for hits differentially upregulated in control males relative to 20HE 
males 
Pathway 
enrichment 
p-value Hits Gene 
matches 
Pathway ID 
Glycosaminoglyca 0.00114 FBgn0038660,FBgn0041629 2 531 
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n degradation 4691 
Metabolism of 
vitamin K 
0.00663
7902 
FBgn0028375 1 R-DME-
6806664 
Histidine 
catabolism 
0.00663
7902 
FBgn0061356 1 R-DME-
70921 
Kinesins 0.00669
1187 
FBgn0038205,FBgn0052396 2 R-DME-
983189 
Glycosphingolipid 
biosynthesis - 
globo series 
0.01323
3932 
FBgn0041629 1 603 
Thiamine 
metabolism 
0.01323
3932 
FBgn0037046 1 730 
Aminoacyl-tRNA 
biosynthesis 
0.01330
4972 
FBgn0021750,FBgn0036629 2 970 
Glycosphingolipid 
biosynthesis - 
ganglio series 
0.01978
834 
FBgn0041629 1 604 
Removal of 
aminoterminal 
propeptides from 
gamma-
carboxylated 
proteins 
0.01978
834 
FBgn0004598 1 R-DME-
159782 
Gamma-
carboxylation, 
transport, and 
amino-terminal 
cleavage of 
proteins 
0.01978
834 
FBgn0004598 1 R-DME-
159854 
Vitamin B1 
(thiamin) 
metabolism 
0.01978
834 
FBgn0037846 1 R-DME-
196819 
Transport of bile 
salts and organic 
acids, metal ions 
and amine 
compounds 
0.02551
1531 
FBgn0038312,FBgn0038752 2 R-DME-
425366 
Factors involved in 
megakaryocyte 
development and 
platelet production 
0.02551
1531 
FBgn0038205,FBgn0052396 2 R-DME-
983231 
COPI-dependent 
Golgi-to-ER 
retrograde traffic 
0.03212
8162 
FBgn0038205,FBgn0052396 2 R-DME-
6811434 
Activation of 
Matrix 
Metalloproteinases 
0.03277
3283 
FBgn0004598 1 R-DME-
1592389 
Zinc transporters 0.03277
3283 
FBgn0038312 1 R-DME-
435354 
Zinc influx into 
cells by the SLC39 
gene family 
0.03277
3283 
FBgn0038312 1 R-DME-
442380 
Lysosome 0.03639
1051 
FBgn0038660,FBgn0041629 2 4142 
SIRT1 negatively 
regulates rRNA 
0.04559
4705 
FBgn0034422 1 R-DME-
427359 
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expression 
Negative 
epigenetic 
regulation of 
rRNA expression 
0.04559
4705 
FBgn0034422 1 R-DME-
5250941 
Mismatch Repair 0.04559
4705 
FBgn0015553 1 R-DME-
5358508 
Mismatch repair 
(MMR) directed 
by MSH2:MSH6 
(MutSalpha) 
0.04559
4705 
FBgn0015553 1 R-DME-
5358565 
 
Table 2.3a:  list of genes differentially upregulated in 20HE females relative to control males 
list of hits>10 raw 
reads 
log2FC edgeR p-value edgeR -log10(pvalue) 
CR44748 2.1014 0.0007 3.15490196 
CR43405 2.4557 0.0008 3.096910013 
mAChR-C 6.736 0.001 3 
nvd 6.6191 0.0012 2.920818754 
CG33160 6.0842 0.0014 2.853871964 
CG11656 3.2921 0.0019 2.721246399 
CG13894 4.1039 0.002 2.698970004 
CG33928 6.0018 0.0021 2.677780705 
CG5361 7.8665 0.0023 2.638272164 
Tdc1 2.5141 0.0026 2.585026652 
CG44405 6.1148 0.0033 2.48148606 
CG10337 1.394 0.0037 2.431798276 
CG6405 2.3727 0.0044 2.356547324 
CR46249 2.5628 0.005 2.301029996 
CR44708 3.2341 0.006 2.22184875 
Gld 3.7396 0.0067 2.173925197 
AhcyL2 2.7617 0.0067 2.173925197 
CG32055 1.7764 0.0075 2.124938737 
Cad96Ca 2.112 0.008 2.096910013 
rha 5.7705 0.0083 2.080921908 
snoRNA:Psi18S-1275 4.0322 0.0084 2.075720714 
CG6465 1.2105 0.0093 2.031517051 
CG14367 3.1864 0.0095 2.022276395 
CG31436 1.2678 0.01 2 
CG8492 5.4687 0.0109 1.962573502 
CG11407 5.4687 0.0109 1.962573502 
Arc1 1.0416 0.0121 1.91721463 
CG8252 2.9416 0.016 1.795880017 
yuri 3.002 0.017 1.769551079 
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Arc2 0.9961 0.0173 1.761953897 
snoRNA:Me28S-
A2634b 
2.4565 0.0175 1.756961951 
ninaD 4.7921 0.0177 1.752026734 
CR45166 3.5683 0.0192 1.716698771 
E(spl)mdelta-HLH 5.5024 0.0202 1.694648631 
CG15865 2.8461 0.0215 1.66756154 
CG32040 1.5573 0.0217 1.663540266 
Tab2 2.1419 0.0218 1.661543506 
PGRP-LF 1.233 0.022 1.657577319 
CG33258 4.0752 0.0221 1.655607726 
CR45824 3.3435 0.0225 1.647817482 
CG7387 2.6304 0.0238 1.623423043 
cact 1.492 0.0248 1.605548319 
snoRNA:Me18S-
U1356a 
2.2627 0.0253 1.596879479 
CG4676 3.3425 0.0256 1.591760035 
CR43832 2.3318 0.0275 1.560667306 
Pig1 2.0741 0.0277 1.557520231 
CG14740 2.9134 0.0297 1.527243551 
CG43101 1.8727 0.0298 1.525783736 
BBS8 5.5167 0.0302 1.519993057 
CG34401 1.5229 0.0313 1.504455662 
CG15818 3.6395 0.0314 1.503070352 
bip1 3.2594 0.0318 1.49757288 
CR43411 5.2125 0.0323 1.490797478 
CR32636 2.2817 0.0333 1.477555766 
CG32450 5.0165 0.034 1.468521083 
CG43925 5.0044 0.0352 1.453457337 
CG5282 5.0288 0.0363 1.440093375 
Efhc1.1 2.194 0.0365 1.437707136 
Grd 1.8655 0.0376 1.424812155 
fig 1.1609 0.0381 1.419075024 
CG8468 1.3221 0.0384 1.415668776 
Cbp53E 2.6048 0.0391 1.407823243 
snoRNA:Me18S-
U1356b 
2.4191 0.0402 1.395773947 
Cyp4p3 2.4069 0.0407 1.390405591 
Spn42Dd 1.0623 0.0421 1.375717904 
Atac2 0.9165 0.0451 1.345823458 
CG44329 5.2286 0.0455 1.341988603 
CG18417 1.7246 0.0462 1.335358024 
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CG31897 1.7993 0.047 1.327902142 
mthl14 0.7291 0.0516 1.287350298 
CG14856 1.7005 0.0517 1.286509457 
CR41620 4.8367 0.0525 1.279840697 
CR46093 1.1195 0.0526 1.279014256 
CG4424 1.045 0.0532 1.274088368 
Dcp-1 0.9085 0.0534 1.272458743 
AOX2 3.9142 0.0541 1.266802735 
 
Table 2.3b: list of genes differentially upregulated in control females relative to 20HE females 
Gene name log2FC edgeR p-value edgeR -log10(pvalue) 
CG18180 -4.8605 6.61E-20 19.17979854 
tobi -5.3313 8.83E-10 9.054039296 
CG18179 -5.1045 4.87E-08 7.312471039 
CG43055 -4.4978 2.39E-07 6.621602099 
PGRP-SC2 -3.8534 2.89E-07 6.539102157 
Amy-d -2.3118 3.66E-07 6.436518915 
w -1.9389 8.10E-06 5.091514981 
Jon66Ci -4.0409 1.03E-05 4.987162775 
CG33109 -8.0444 2.33E-05 4.632644079 
Jon25Bi -2.0005 2.81E-05 4.55129368 
CG17633 -4.1914 2.85E-05 4.54515514 
nerfin-1 -4.0555 3.55E-05 4.449771647 
CG3739 -2.5789 3.81E-05 4.419075024 
Jon25Biii -3.6153 4.14E-05 4.382999659 
Jon65Aiv -1.4887 4.96E-05 4.304518324 
CG8299 -4.8541 5.47E-05 4.262012674 
CG6484 -2.1864 7.19E-05 4.14327111 
Jon65Aiii -1.461 8.74E-05 4.058488567 
CG18404 -4.1627 0.0001 4 
CG45080 -9.0884 0.0001 4 
CG17192 -1.4986 0.0002 3.698970004 
alphaTry -1.4007 0.0002 3.698970004 
CG3906 -4.0425 0.0002 3.698970004 
Cyp28a5 -3.1808 0.0002 3.698970004 
CG15630 -6.7813 0.0002 3.698970004 
CG31104 -2.9523 0.0003 3.522878745 
Jon65Aii -4.1788 0.0003 3.522878745 
CG5107 -1.7528 0.0004 3.397940009 
Jon99Ci -2.0447 0.0004 3.397940009 
CG6067 -2.4944 0.0004 3.397940009 
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lcs -9.2652 0.0004 3.397940009 
Jon99Cii -1.9279 0.0005 3.301029996 
CG10910 -2.4245 0.0005 3.301029996 
Jon99Fi -3.8571 0.0005 3.301029996 
CG8834 -1.791 0.0006 3.22184875 
CG13813 -3.5184 0.0006 3.22184875 
CG9896 -2.3041 0.0007 3.15490196 
CG12374 -1.6431 0.0008 3.096910013 
stv -1.9563 0.0008 3.096910013 
CG11878 -2.1455 0.0009 3.045757491 
CG7916 -4.9286 0.0009 3.045757491 
CG8745 -2.3306 0.001 3 
CG33346 -2.516 0.0011 2.958607315 
CG10869 -3.8835 0.0013 2.886056648 
CG7567 -6.3309 0.0014 2.853871964 
CG10659 -2.3237 0.0014 2.853871964 
CG18577 -2.0732 0.0015 2.823908741 
alpha-Est8 -3.1631 0.0015 2.823908741 
Jon99Fii -3.6303 0.0015 2.823908741 
Lrpprc2 -1.3609 0.0016 2.795880017 
CG4329 -1.907 0.0017 2.769551079 
CG31041 -3.2548 0.0019 2.721246399 
mag -2.6956 0.0022 2.657577319 
Meltrin -1.6346 0.0023 2.638272164 
Jon66Cii -4.9687 0.0023 2.638272164 
CG6295 -1.253 0.0024 2.619788758 
CG3699 -2.2543 0.0024 2.619788758 
CG3344 -2.4773 0.0026 2.585026652 
CG16965 -2.6821 0.0026 2.585026652 
CG3868 -1.8129 0.0027 2.568636236 
Ag5r2 -3.3454 0.0029 2.537602002 
CG10911 -1.1594 0.0033 2.48148606 
CG34345 -6.0006 0.0036 2.443697499 
Toll-7 -2.3863 0.0037 2.431798276 
CG5770 -3.2293 0.0039 2.408935393 
Hsp70Bbb -1.3497 0.0043 2.366531544 
Muc68E -2.1028 0.0043 2.366531544 
CG13315 -1.9901 0.0044 2.356547324 
CG42397 -2.2297 0.0052 2.283996656 
CG11912 -4.2693 0.0052 2.283996656 
 
 
307 
CG14780 -2.7606 0.0055 2.259637311 
CG10912 -1.4752 0.0056 2.251811973 
CG14688 -5.7389 0.0061 2.214670165 
epsilonTry -1.2405 0.0064 2.193820026 
Mur18B -3.8614 0.0068 2.167491087 
Mal-A3 -3.105 0.0072 2.142667504 
Listericin -2.8063 0.0077 2.113509275 
CG6454 -2.7844 0.0077 2.113509275 
CG6839 -3.4208 0.0078 2.107905397 
CG1946 -1.7025 0.0081 2.091514981 
Gr93b -5.6851 0.009 2.045757491 
CG9396 -1.4788 0.0093 2.031517051 
CG7024 -3.3823 0.0096 2.017728767 
CG7091 -2.566 0.01 2 
CG15605 -2.3932 0.0106 1.974694135 
CG2652 -5.5333 0.0107 1.970616222 
LysP -6.6646 0.0119 1.924453039 
Ing3 -1.2343 0.0119 1.924453039 
CG42714 -1.9435 0.0119 1.924453039 
Cyp28d1 -1.7643 0.0124 1.906578315 
CG13324 -2.686 0.0125 1.903089987 
CG31077 -6.4862 0.0128 1.89279003 
CG5892 -6.6007 0.0128 1.89279003 
Prx2540-1 -2.1171 0.0129 1.88941029 
CG42826 -2.733 0.0136 1.866461092 
Jon99Ciii -2.0618 0.0139 1.8569852 
CR44295 -2.1387 0.0145 1.838631998 
CG5639 -5.8025 0.0146 1.835647144 
CG31785 -1.4184 0.0148 1.829738285 
CG4563 -1.5862 0.0156 1.806875402 
CG9903 -1.7253 0.0162 1.790484985 
CG34220 -1.378 0.0171 1.76700389 
GstE9 -1.1892 0.0172 1.764471553 
CG43207 -1.9199 0.0172 1.764471553 
CG30357 -1.2529 0.0178 1.749579998 
CR45921 -3.2092 0.0184 1.735182177 
CG30371 -6.3129 0.0188 1.725842151 
CG10725 -5.4188 0.0194 1.71219827 
CG11671 -0.9715 0.0196 1.707743929 
CG42724 -1.4053 0.0198 1.70333481 
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Mal-A1 -1.2821 0.0199 1.701146924 
CG10505 -2.1447 0.0199 1.701146924 
CDC45L -1.0214 0.02 1.698970004 
CG12896 -2.0809 0.0214 1.669586227 
Gr64f -3.5044 0.022 1.657577319 
lectin-24A -3.955 0.0222 1.653647026 
CG10472 -1.9923 0.0222 1.653647026 
Inx7 -1.2924 0.0227 1.643974143 
CG5958 -1.4071 0.023 1.638272164 
prtp -2.7135 0.0234 1.630784143 
CG34431 -1.6441 0.0242 1.616184634 
Sytbeta -5.5891 0.0244 1.612610174 
CR45962 -1.169 0.0246 1.609064893 
Pebp1 -0.8804 0.0249 1.603800653 
CG4267 -1.7522 0.0259 1.586700236 
lectin-46Cb -1.7195 0.0284 1.54668166 
CG5767 -1.758 0.0288 1.540607512 
CG4734 -1.0377 0.0295 1.530177984 
CheB42b -3.3329 0.0301 1.521433504 
CG31265 -3.8124 0.0305 1.515700161 
CG8665 -2.2354 0.0306 1.514278574 
CG11029 -1.5351 0.0313 1.504455662 
CR45272 -3.3745 0.0314 1.503070352 
CG2681 -1.2706 0.0317 1.498940738 
Trxr-1 -1.8192 0.0318 1.49757288 
CG13074 -2.8025 0.0325 1.488116639 
Hsp70Bc -0.8509 0.0327 1.485452247 
CR43904 -2.2765 0.0329 1.482804102 
isoQC -1.5416 0.0329 1.482804102 
Npc1b -3.1448 0.0331 1.480172006 
AOX1 -0.8752 0.0335 1.474955193 
CG5010 -1.5782 0.0336 1.473660723 
CG8258 -0.8805 0.0353 1.452225295 
E(spl)m6-BFM -1.0904 0.0354 1.450996738 
bdl -1.7942 0.0358 1.446116973 
yip7 -0.814 0.0359 1.444905551 
CG44836 -3.8514 0.0374 1.427128398 
Pask -1.4019 0.0379 1.42136079 
Lim1 -2.0041 0.0401 1.396855627 
CG8952 -1.0905 0.0406 1.391473966 
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Actbeta -2.7354 0.0407 1.390405591 
Est-Q -1.2619 0.0412 1.385102784 
CR44299 -1.3272 0.0418 1.378823718 
CG9663 -0.9388 0.0427 1.369572125 
CG31848 -1.6486 0.043 1.366531544 
CG8642 -2.4511 0.0432 1.364516253 
CG15439 -0.9319 0.0433 1.363512104 
CR46214 -5.5692 0.0434 1.36251027 
CG5157 -1.9982 0.0441 1.355561411 
Ptpmeg -2.4651 0.0456 1.341035157 
CG17930 -1.3686 0.0458 1.339134522 
mus81 -1.6181 0.0458 1.339134522 
phyl -1.5518 0.0463 1.334419009 
CG7785 -0.8683 0.0467 1.330683119 
CCKLR-17D3 -1.9264 0.0469 1.328827157 
Nurf-38 -2.0135 0.0474 1.324221658 
CG16749 -1.4458 0.049 1.30980392 
CR44149 -2.0322 0.0496 1.304518324 
Vha100-4 -1.5016 0.0501 1.300162274 
CG7379 -0.7894 0.0506 1.295849483 
CG15414 -1.0432 0.051 1.292429824 
CG10592 -1.0868 0.0522 1.282329497 
CG14262 -3.2894 0.0528 1.277366077 
CG7458 -0.9456 0.0539 1.268411235 
 
Table 2.3c: list of sexually dimorphic hits that are regulated by 20HE feeding in females in reference 
to Hudry et al,2016 Table S1  
Amy-d 
Arc1 
CG10659 
CG10910 
CG10912 
CG11407 
CG11878 
CG16965 
CG17192 
CG17633 
CG18179 
CG18180 
CG31104 
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CG33346 
CG3344 
CG3699 
CG3739 
CG42714 
CG6484 
CG8299 
CG8952 
CG9396 
Jon99Ci 
Jon99Cii 
Jon99Ciii 
Mal-A1 
ninaD 
tobi 
Ag5r2 
alpha-Est8 
Arc2 
cact 
CG10505 
CG11912 
CG12374 
CG13315 
CG13324 
CG15818 
CG16749 
CG18577 
CG1946 
CG31041 
CG33258 
CG5157 
CG5770 
CG5958 
CG6465 
CG7916 
CG8258 
CG8834 
CG9663 
CG9896 
epsilonTry 
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GstE9 
Jon25Bi 
Jon25Biii 
Jon65Aii 
Jon65Aiii 
Jon66Ci 
Jon66Cii 
Jon99Fi 
Jon99Fii 
mag 
Mal-A3 
mthl14 
Prx2540-1 
Prx2540-2 
Ptpmeg 
Sytbeta 
w 
yip7 
 
Table 2.3d:Pathway enrichment for hits differentially upregulated in 20HE females relative to 
control females 
Pathway 
enrichment 
p-value Hits Gene matches Pathway ID 
ï»¿Aflatoxin 
activation and 
detoxification 
0.00020088 FBgn0036986,FBgn0037818 2 R-DME-5423646 
Biological 
oxidations 
0.00311735 FBgn0033397,FBgn0036986,
FBgn0037818 
3 R-DME-211859 
Synthesis of 
Leukotrienes 
(LT) and 
Eoxins (EX) 
0.01191451 FBgn0036986 1 R-DME-2142691 
Bicarbonate 
transporters 
0.01782136 FBgn0015011 1 R-DME-425381 
TAK1 
activates 
NFkB by 
phosphorylati
on and 
activation of 
IKKs complex 
0.01782136 FBgn0000250 1 R-DME-445989 
Insect 
hormone 
biosynthesis 
0.02369485 FBgn0287185 1 981 
BBSome-
mediated 
cargo-
targeting to 
cilium 
0.02369485 FBgn0031255 1 R-DME-5620922 
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Regulation of 
KIT signaling 
0.02953516 FBgn0022800 1 R-DME-1433559 
DL and DIF 
homodimers 
bind to TUB 
and 
phosphorylate
d PLL in the 
TL receptor 
'signalling 
complex' 
0.02953516 FBgn0000250 1 R-DME-214842 
DL and DIF 
homodimers 
complexed 
with CACT 
are all 
phosphorylate
d in the TL 
receptor 
'signalling 
complex' 
0.02953516 FBgn0000250 1 R-DME-214844 
Phosphorylate
d CACT, DL 
and DIF 
homodimers 
dissociate 
from the TL 
receptor 
'signalling 
complex' 
0.02953516 FBgn0000250 1 R-DME-214869 
Amine ligand-
binding 
receptors 
0.03534247 FBgn0029909 1 R-DME-375280 
p75NTR 
signals via 
NF-kB 
0.04111694 FBgn0000250 1 R-DME-193639 
NF-kB is 
activated and 
signals 
survival 
0.04111694 FBgn0000250 1 R-DME-209560 
Signaling by 
SCF-KIT 
0.04685875 FBgn0022800 1 R-DME-1433557 
Activation of 
the IkappaB 
kinase 
complex, 
KEY:IRD5 
dimer:KEY 
0.04685875 FBgn0086358 1 R-DME-209447 
 
Table 2.3e: GO enrichment for hits differentially upregulated in control females relative to 20HE 
males 
GO 
enrichment 
p-value Hits Gene 
matche
s 
GO ID 
ï»¿proteolysis 4.51E-
09 
FBgn0003356,FBgn0003357,FBgn0003358,FBgn0
003863,FBgn0010425,FBgn0013725,FBgn0020906
,FBgn0024997,FBgn0025383,FBgn0029828,FBgn0
33 GO:000650
8 
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030688,FBgn0031248,FBgn0031653,FBgn0032144
,FBgn0033774,FBgn0034052,FBgn0035154,FBgn0
035665,FBgn0035666,FBgn0035670,FBgn0035886
,FBgn0035887,FBgn0036023,FBgn0036024,FBgn0
037678,FBgn0038702,FBgn0039777,FBgn0039778
,FBgn0040060,FBgn0050371,FBgn0051265,FBgn0
250815,FBgn0265140 
cell redox 
homeostasis 
0.00026
64 
FBgn0020653,FBgn0030329,FBgn0033518,FBgn0
033520,FBgn0033521 
5 GO:004545
4 
aminoglycan 
metabolic 
process 
0.00175
486 
FBgn0030999,FBgn0036362,FBgn0043575,FBgn0
051077,FBgn0053265,FBgn0085249,FBgn0259748 
7 GO:000602
2 
cofactor 
catabolic 
process 
0.00183
107 
FBgn0032945,FBgn0033518,FBgn0033520 3 GO:005118
7 
chitin 
metabolic 
process 
0.00305
58 
FBgn0030999,FBgn0036362,FBgn0051077,FBgn0
053265,FBgn0085249,FBgn0259748 
6 GO:000603
0 
glucosamine-
containing 
compound 
metabolic 
process 
0.00451
867 
FBgn0030999,FBgn0036362,FBgn0051077,FBgn0
053265,FBgn0085249,FBgn0259748 
6 GO:190107
1 
heat shock-
mediated 
polytene 
chromosome 
puffing 
0.00472
029 
FBgn0013279,FBgn0051354 2 GO:003508
0 
drug 
metabolic 
process 
0.00510
05 
FBgn0030999,FBgn0033518,FBgn0033520,FBgn0
036362,FBgn0051077,FBgn0053265,FBgn0085249
,FBgn0259748,FBgn0267408 
9 GO:001714
4 
amino sugar 
metabolic 
process 
0.00522
897 
FBgn0030999,FBgn0036362,FBgn0051077,FBgn0
053265,FBgn0085249,FBgn0259748 
6 GO:000604
0 
polytene 
chromosome 
puffing 
0.00585
494 
FBgn0013279,FBgn0051354 2 GO:003507
9 
hydrogen 
peroxide 
catabolic 
process 
0.00585
494 
FBgn0033518,FBgn0033520 2 GO:004274
4 
double-strand 
break repair 
via break-
induced 
replication 
0.00845
576 
FBgn0026143,FBgn0040347 2 GO:000072
7 
hydrogen 
peroxide 
metabolic 
process 
0.00991
647 
FBgn0033518,FBgn0033520 2 GO:004274
3 
guanine 
nucleotide 
transport 
0.01181
493 
FBgn0003996 1 GO:000140
8 
innate 
immune 
response 
activating cell 
0.01181
493 
FBgn0034476 1 GO:000222
0 
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surface 
receptor 
signaling 
pathway 
immune 
response-
activating cell 
surface 
receptor 
signaling 
pathway 
0.01181
493 
FBgn0034476 1 GO:000242
9 
cell surface 
pattern 
recognition 
receptor 
signaling 
pathway 
0.01181
493 
FBgn0034476 1 GO:000275
2 
10-
formyltetrahy
drofolate 
catabolic 
process 
0.01181
493 
FBgn0032945 1 GO:000925
8 
folic acid-
containing 
compound 
catabolic 
process 
0.01181
493 
FBgn0032945 1 GO:000939
7 
intestinal 
cholesterol 
absorption 
0.01181
493 
FBgn0261675 1 GO:003029
9 
negative 
regulation of 
epithelial cell 
differentiation 
0.01181
493 
FBgn0261985 1 GO:003085
7 
pteridine-
containing 
compound 
catabolic 
process 
0.01181
493 
FBgn0032945 1 GO:004256
0 
pyridoxal 
metabolic 
process 
0.01181
493 
FBgn0267408 1 GO:004281
7 
lipid digestion 0.01181
493 
FBgn0261675 1 GO:004424
1 
negative 
regulation of 
glycogen 
biosynthetic 
process 
0.01181
493 
FBgn0034950 1 GO:004571
9 
intestinal 
absorption 
0.01181
493 
FBgn0261675 1 GO:005089
2 
histamine 
uptake 
0.01181
493 
FBgn0003996 1 GO:005161
5 
cyclic 
nucleotide 
transport 
0.01181
493 
FBgn0003996 1 GO:007072
9 
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cGMP 
transport 
0.01181
493 
FBgn0003996 1 GO:007073
1 
intestinal lipid 
absorption 
0.01181
493 
FBgn0261675 1 GO:009885
6 
mitotic DNA 
replication 
preinitiation 
complex 
assembly 
0.01181
493 
FBgn0026143 1 GO:190297
7 
negative 
regulation of 
border follicle 
cell migration 
0.01181
493 
FBgn0261985 1 GO:190368
7 
amine 
transport 
0.01314
524 
FBgn0003996,FBgn0261090 2 GO:001583
7 
antibiotic 
catabolic 
process 
0.01314
524 
FBgn0033518,FBgn0033520 2 GO:001700
1 
apoptotic 
DNA 
fragmentation 
0.01871
844 
FBgn0036831,FBgn0053346 2 GO:000630
9 
cellular 
component 
disassembly 
involved in 
execution 
phase of 
apoptosis 
0.01871
844 
FBgn0036831,FBgn0053346 2 GO:000692
1 
apoptotic 
nuclear 
changes 
0.01871
844 
FBgn0036831,FBgn0053346 2 GO:003026
2 
defense 
response to 
virus 
0.01997
379 
FBgn0033593,FBgn0034476,FBgn0037562 3 GO:005160
7 
organonitroge
n compound 
metabolic 
process 
0.02151
901 
FBgn0003356,FBgn0003357,FBgn0003358,FBgn0
003863,FBgn0003996,FBgn0010425,FBgn0013725
,FBgn0020906,FBgn0024913,FBgn0024997,FBgn0
025383,FBgn0027794,FBgn0029722,FBgn0029828
,FBgn0030688,FBgn0030945,FBgn0030999,FBgn0
031248,FBgn0031653,FBgn0032144,FBgn0032945
,FBgn0033774,FBgn0034052,FBgn0034950,FBgn0
035154,FBgn0035665,FBgn0035666,FBgn0035670
,FBgn0035886,FBgn0035887,FBgn0036023,FBgn0
036024,FBgn0036362,FBgn0036999,FBgn0037678
,FBgn0038702,FBgn0039777,FBgn0039778,FBgn0
040060,FBgn0043575,FBgn0050371,FBgn0051077
,FBgn0051265,FBgn0053265,FBgn0063491,FBgn0
085249,FBgn0085374,FBgn0086708,FBgn0250815
,FBgn0259748,FBgn0261985,FBgn0265140,FBgn0
267408 
53 GO:190156
4 
regulation of 
glycogen 
biosynthetic 
process 
0.02349
143 
FBgn0034950 1 GO:000597
9 
R1/R6 cell 
fate 
commitment 
0.02349
143 
FBgn0013725 1 GO:000746
2 
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coenzyme 
catabolic 
process 
0.02349
143 
FBgn0032945 1 GO:000910
9 
negative 
regulation of 
epithelial cell 
migration 
0.02349
143 
FBgn0261985 1 GO:001063
3 
regulation of 
glucan 
biosynthetic 
process 
0.02349
143 
FBgn0034950 1 GO:001096
2 
regulation of 
polysaccharid
e biosynthetic 
process 
0.02349
143 
FBgn0034950 1 GO:003288
5 
induction of 
bacterial 
agglutination 
0.02349
143 
FBgn0262357 1 GO:004315
2 
regulation of 
lipoprotein 
metabolic 
process 
0.02349
143 
FBgn0086708 1 GO:005074
6 
positive 
regulation of 
lipoprotein 
metabolic 
process 
0.02349
143 
FBgn0086708 1 GO:005074
7 
negative 
regulation of 
glycogen 
metabolic 
process 
0.02349
143 
FBgn0034950 1 GO:007087
4 
DNA 
replication 
preinitiation 
complex 
assembly 
0.02349
143 
FBgn0026143 1 GO:007116
3 
regulation of 
protein 
lipidation 
0.02349
143 
FBgn0086708 1 GO:190305
9 
positive 
regulation of 
protein 
lipidation 
0.02349
143 
FBgn0086708 1 GO:190306
1 
regulation of 
apoptotic cell 
clearance 
0.02349
143 
FBgn0030329 1 GO:200042
5 
positive 
regulation of 
apoptotic cell 
clearance 
0.02349
143 
FBgn0030329 1 GO:200042
7 
DNA 
catabolic 
process, 
endonucleolyti
c 
0.02510
873 
FBgn0036831,FBgn0053346 2 GO:000073
7 
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ammonium 
transport 
0.02510
873 
FBgn0003996,FBgn0261090 2 GO:001569
6 
response to 
virus 
0.02832
579 
FBgn0033593,FBgn0034476,FBgn0037562 3 GO:000961
5 
DNA 
catabolic 
process 
0.03225
301 
FBgn0036831,FBgn0053346 2 GO:000630
8 
10-
formyltetrahy
drofolate 
metabolic 
process 
0.03503
111 
FBgn0032945 1 GO:000925
6 
negative 
regulation of 
cellular 
carbohydrate 
metabolic 
process 
0.03503
111 
FBgn0034950 1 GO:001067
7 
regulation of 
chromatin 
silencing at 
telomere 
0.03503
111 
FBgn0026143 1 GO:003193
8 
negative 
regulation of 
carbohydrate 
metabolic 
process 
0.03503
111 
FBgn0034950 1 GO:004591
2 
histamine 
transport 
0.03503
111 
FBgn0003996 1 GO:005160
8 
regulation of 
mitochondrial 
transcription 
0.03503
111 
FBgn0027794 1 GO:190310
8 
response to 
hypoxia 
0.03674
316 
FBgn0013279,FBgn0020653,FBgn0051354 3 GO:000166
6 
antibiotic 
metabolic 
process 
0.03740
512 
FBgn0033518,FBgn0033520 2 GO:001699
9 
cofactor 
metabolic 
process 
0.03959
033 
FBgn0029722,FBgn0032945,FBgn0033518,FBgn0
033520,FBgn0063491,FBgn0267408 
6 GO:005118
6 
organic 
hydroxy 
compound 
transport 
0.04009
154 
FBgn0261090,FBgn0261675 2 GO:001585
0 
regulation of 
generation of 
precursor 
metabolites 
and energy 
0.04284
88 
FBgn0027794,FBgn0034950 2 GO:004346
7 
response to 
decreased 
oxygen levels 
0.04462
91 
FBgn0013279,FBgn0020653,FBgn0051354 3 GO:003629
3 
'de novo' 
posttranslation
al protein 
folding 
0.04567
487 
FBgn0013279,FBgn0051354 2 GO:005108
4 
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chaperone 
cofactor-
dependent 
protein 
refolding 
0.04567
487 
FBgn0013279,FBgn0051354 2 GO:005108
5 
immune 
response-
regulating cell 
surface 
receptor 
signaling 
pathway 
0.04643
555 
FBgn0034476 1 GO:000276
8 
acetyl-CoA 
biosynthetic 
process from 
pyruvate 
0.04643
555 
FBgn0029722 1 GO:000608
6 
mitochondrial 
pyruvate 
transmembran
e transport 
0.04643
555 
FBgn0037714 1 GO:000685
0 
eye pigment 
precursor 
transport 
0.04643
555 
FBgn0003996 1 GO:000685
6 
peptidyl-
pyroglutamic 
acid 
biosynthetic 
process, using 
glutaminyl-
peptide 
cyclotransfera
se 
0.04643
555 
FBgn0036999 1 GO:001718
6 
peptidyl-
glutamine 
modification 
0.04643
555 
FBgn0036999 1 GO:001819
9 
regulation of 
carbohydrate 
biosynthetic 
process 
0.04643
555 
FBgn0034950 1 GO:004325
5 
regulation of 
mitochondrial 
mRNA 
stability 
0.04643
555 
FBgn0027794 1 GO:004452
8 
negative 
regulation of 
oogenesis 
0.04643
555 
FBgn0261985 1 GO:190588
0 
metabolic 
process 
0.04784
699 
FBgn0000078,FBgn0002570,FBgn0002571,FBgn0
003356,FBgn0003357,FBgn0003358,FBgn0003863
,FBgn0003996,FBgn0010425,FBgn0013725,FBgn0
016687,FBgn0020653,FBgn0020906,FBgn0024913
,FBgn0024997,FBgn0025383,FBgn0025838,FBgn0
026143,FBgn0026411,FBgn0027794,FBgn0028940
,FBgn0028999,FBgn0029722,FBgn0029828,FBgn0
030688,FBgn0030945,FBgn0030999,FBgn0031248
,FBgn0031653,FBgn0031689,FBgn0031735,FBgn0
032144,FBgn0032387,FBgn0032945,FBgn0033518
,FBgn0033520,FBgn0033521,FBgn0033733,FBgn0
84 GO:000815
2 
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033774,FBgn0034052,FBgn0034476,FBgn0034950
,FBgn0035006,FBgn0035154,FBgn0035619,FBgn0
035665,FBgn0035666,FBgn0035670,FBgn0035886
,FBgn0035887,FBgn0036023,FBgn0036024,FBgn0
036362,FBgn0036831,FBgn0036996,FBgn0036999
,FBgn0037678,FBgn0038546,FBgn0038702,FBgn0
039471,FBgn0039472,FBgn0039777,FBgn0039778
,FBgn0040060,FBgn0040347,FBgn0040349,FBgn0
043575,FBgn0050371,FBgn0051077,FBgn0051265
,FBgn0053265,FBgn0053346,FBgn0063491,FBgn0
085249,FBgn0085374,FBgn0086708,FBgn0250815
,FBgn0259748,FBgn0261575,FBgn0261641,FBgn0
261985,FBgn0264979,FBgn0265140,FBgn0267408 
execution 
phase of 
apoptosis 
0.04856
777 
FBgn0036831,FBgn0053346 2 GO:009719
4 
lipid catabolic 
process 
0.04965
137 
FBgn0039471,FBgn0039472,FBgn0040349,FBgn0
264979 
4 GO:001604
2 
 
Table 2.3f: Pathway enrichment for hits differentially upregulated in control females relative to 
20HE females 
Pathway 
enrichment 
p-value Hits Gene 
matche
s 
Pathway ID 
ï»¿Glycerophosph
olipid biosynthesis 
1.9399E-
05 
FBgn0031735,FBgn0033216,FBgn003
5619,FBgn0036381,FBgn0039471,FB
gn0039472,FBgn0264979 
7 R-DME-1483206 
Phospholipid 
metabolism 
0.0001592
2 
FBgn0031735,FBgn0033216,FBgn003
5619,FBgn0036381,FBgn0039471,FB
gn0039472,FBgn0264979 
7 R-DME-1483257 
Synthesis of PA 0.0010249
8 
FBgn0035619,FBgn0039471,FBgn003
9472,FBgn0264979 
4 R-DME-1483166 
Neuroactive 
ligand-receptor 
interaction 
0.0010943
9 
FBgn0003863,FBgn0010425,FBgn003
0954 
3 4080 
Starch and sucrose 
metabolism 
0.0017142
7 
FBgn0000078,FBgn0002570,FBgn000
2571,FBgn0261575 
4 500 
Galactose 
metabolism 
0.0020688
9 
FBgn0002570,FBgn0002571,FBgn026
1575 
3 52 
Digestion and 
absorption 
0.0020688
9 
FBgn0000078,FBgn0035619,FBgn026
1675 
3 R-DME-8963743 
Acyl chain 
remodelling of PS 
0.0024830
1 
FBgn0039471,FBgn0039472,FBgn026
4979 
3 R-DME-1482801 
Phenylalanine 
metabolism 
0.0038803
7 
FBgn0033518,FBgn0033520 2 360 
Neutrophil 
degranulation 
0.0073557
7 
FBgn0013279,FBgn0020508,FBgn003
0329,FBgn0038613,FBgn0039527,FB
gn0040092,FBgn0051354,FBgn02623
57,FBgn0265140,FBgn0284436 
10 R-DME-6798695 
Degradation of the 
extracellular 
matrix 
0.0090207
1 
FBgn0036381,FBgn0265140 2 R-DME-1474228 
Digestion 0.0160208
5 
FBgn0000078,FBgn0035619 2 R-DME-8935690 
Cytosolic tRNA 
aminoacylation 
0.0165947
6 
FBgn0016687 1 R-DME-379716 
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tRNA 
Aminoacylation 
0.0165947
6 
FBgn0016687 1 R-DME-379724 
Mitochondrial 
tRNA 
aminoacylation 
0.0165947
6 
FBgn0016687 1 R-DME-379726 
Pyrophosphate 
hydrolysis 
0.0165947
6 
FBgn0016687 1 R-DME-71737 
GABA synthesis, 
release, reuptake 
and degradation 
0.0187347
6 
FBgn0013279,FBgn0051354 2 R-DME-888590 
Metabolism of 
Angiotensinogen 
to Angiotensins 
0.0216277
8 
FBgn0032144,FBgn0033774 2 R-DME-2022377 
HSF1-dependent 
transactivation 
0.0216277
8 
FBgn0013279,FBgn0051354 2 R-DME-3371571 
Innate Immune 
System 
0.0247681
5 
FBgn0013279,FBgn0020508,FBgn003
0329,FBgn0038613,FBgn0039527,FB
gn0040092,FBgn0051354,FBgn02619
85,FBgn0262357,FBgn0265140,FBgn
0284436 
11 R-DME-168249 
Regulation of 
HSF1-mediated 
heat shock 
response 
0.0276202
3 
FBgn0013279,FBgn0051354,FBgn008
6708 
3 R-DME-3371453 
Antagonism of 
Activin by 
Follistatin 
0.0329195
4 
FBgn0024913 1 R-DME-2473224 
Intestinal lipid 
absorption 
0.0329195
4 
FBgn0261675 1 R-DME-8963678 
Cellular response 
to heat stress 
0.0418232
3 
FBgn0013279,FBgn0051354,FBgn008
6708 
3 R-DME-3371556 
Peptide hormone 
metabolism 
0.0463723
7 
FBgn0032144,FBgn0033774 2 R-DME-2980736 
Selenocompound 
metabolism 
0.0489786
7 
FBgn0020653 1 450 
Collagen 
degradation 
0.0489786
7 
FBgn0036381 1 R-DME-1442490 
Cobalamin (Cbl, 
vitamin B12) 
transport and 
metabolism 
0.0489786
7 
FBgn0031248 1 R-DME-196741 
Resolution of D-
Loop Structures 
0.0489786
7 
FBgn0040347 1 R-DME-5693537 
Resolution of D-
loop Structures 
through Holliday 
Junction 
Intermediates 
0.0489786
7 
FBgn0040347 1 R-DME-5693568 
 
Table 2.3e: GO enrichment for hits differentially upregulated in 20HE females relative to control 
females 
GO enrichment p-value Hits Gene matches GO ID 
ï»¿antimicrobial 
humoral response 
0.00094857 FBgn0000250,FBg
n0028988,FBgn00
35977,FBgn00863
58 
4 GO:0019730 
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negative regulation 
of antimicrobial 
peptide production 
0.00111074 FBgn0000250,FBg
n0028988 
2 GO:0002785 
humoral immune 
response 
0.00120994 FBgn0000250,FBg
n0028988,FBgn00
35977,FBgn00863
58 
4 GO:0006959 
negative regulation 
of immune effector 
process 
0.00147404 FBgn0000250,FBg
n0028988 
2 GO:0002698 
negative regulation 
of production of 
molecular 
mediator of 
immune response 
0.00147404 FBgn0000250,FBg
n0028988 
2 GO:0002701 
regulation of 
defense response 
to fungus 
0.00147404 FBgn0000250,FBg
n0028988 
2 GO:1900150 
negative regulation 
of response to 
biotic stimulus 
0.00148786 FBgn0000250,FBg
n0028988,FBgn00
35977 
3 GO:0002832 
negative regulation 
of defense 
response 
0.00148786 FBgn0000250,FBg
n0028988,FBgn00
35977 
3 GO:0031348 
negative regulation 
of immune 
response 
0.00148786 FBgn0000250,FBg
n0028988,FBgn00
35977 
3 GO:0050777 
negative regulation 
of antimicrobial 
humoral response 
0.00188629 FBgn0000250,FBg
n0028988 
3 GO:0008348 
negative regulation 
of Toll signaling 
pathway 
0.0023468 FBgn0000250,FBg
n0028988 
2 GO:0045751 
regulation of 
response to stress 
0.00265316 FBgn0000250,FBg
n0004580,FBgn00
22800,FBgn00289
88,FBgn0035977,F
Bgn0086358 
6 GO:0080134 
negative regulation 
of multi-organism 
process 
0.00269392 FBgn0000250,FBg
n0028988,FBgn00
35977 
3 GO:0043901 
negative regulation 
of humoral 
immune response 
0.00285486 FBgn0000250,FBg
n0028988 
2 GO:0002921 
negative regulation 
of response to 
external stimulus 
0.00290351 FBgn0000250,FBg
n0028988,FBgn00
35977 
3 GO:0032102 
negative regulation 
of immune system 
process 
0.00312289 FBgn0000250,FBg
n0028988,FBgn00
35977 
3 GO:0002683 
antimicrobial 
peptide production 
0.00437188 FBgn0000250,FBg
n0028988,FBgn00
86358 
3 GO:0002775 
regulation of 
antimicrobial 
peptide production 
0.00437188 FBgn0000250,FBg
n0028988,FBgn00
86358 
3 GO:0002784 
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production of 
molecular 
mediator of 
immune response 
0.00465304 FBgn0000250,FBg
n0028988,FBgn00
86358 
3 GO:0002440 
regulation of 
production of 
molecular 
mediator of 
immune response 
0.00465304 FBgn0000250,FBg
n0028988,FBgn00
86358 
5 GO:0002700 
regulation of 
response to 
external stimulus 
0.00472177 FBgn0000250,FBg
n0028988,FBgn00
35977,FBgn00854
30,FBgn0086358 
5 GO:0032101 
regulation of 
antimicrobial 
humoral response 
0.0052477 FBgn0000250,FBg
n0028988,FBgn00
86358 
3 GO:0002759 
regulation of 
humoral immune 
response 
0.00588627 FBgn0000250,FBg
n0028988,FBgn00
86358 
3 GO:0002920 
regulation of 
defense response 
0.00661344 FBgn0000250,FBg
n0028988,FBgn00
35977,FBgn00863
58 
4 GO:0031347 
negative regulation 
of antifungal 
peptide production 
0.00745968 FBgn0000250 1 GO:0002789 
G protein-coupled 
acetylcholine 
receptor signaling 
pathway 
0.00745968 FBgn0029909 1 GO:0007213 
cytoplasmic 
sequestering of 
NF-kappaB 
0.00745968 FBgn0000250 1 GO:0007253 
phototransduction, 
UV 
0.00745968 FBgn0002939 1 GO:0007604 
pupal chitin-based 
cuticle 
development 
0.00745968 FBgn0001112 1 GO:0008364 
detection of UV 0.00745968 FBgn0002939 1 GO:0009589 
regulation of 
ubiquinone 
biosynthetic 
process 
0.00745968 FBgn0039694 1 GO:0010795 
negative regulation 
of nervous system 
process 
0.00745968 FBgn0001134 1 GO:0031645 
positive regulation 
of histone 
acetylation 
0.00745968 FBgn0032691 1 GO:0035066 
negative regulation 
of action potential 
0.00745968 FBgn0001134 1 GO:0045759 
isoprenoid 
transport 
0.00745968 FBgn0002939 1 GO:0046864 
terpenoid transport 0.00745968 FBgn0002939 1 GO:0046865 
tetraterpenoid 
transport 
0.00745968 FBgn0002939 1 GO:0046866 
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carotenoid 
transport 
0.00745968 FBgn0002939 1 GO:0046867 
regulation of 
coenzyme 
metabolic process 
0.00745968 FBgn0039694 21 GO:0051196 
regulation of 
transmission of 
nerve impulse 
0.00745968 FBgn0001134 1 GO:0051969 
negative regulation 
of transmission of 
nerve impulse 
0.00745968 FBgn0001134 1 GO:0051970 
synaptic 
transmission, 
glycinergic 
0.00745968 FBgn0001134 1 GO:0060012 
positive regulation 
of histone H4 
acetylation 
0.00745968 FBgn0032691 1 GO:0090240 
acetylcholine 
receptor signaling 
pathway 
0.00745968 FBgn0029909 1 GO:0095500 
regulation of 
action potential 
0.00745968 FBgn0001134 1 GO:0098900 
regulation of 
neuronal action 
potential 
0.00745968 FBgn0001134 1 GO:0098908 
postsynaptic signal 
transduction 
0.00745968 FBgn0029909 1 GO:0098926 
vesicle-mediated 
intercellular 
transport 
0.00745968 FBgn0033926 1 GO:0110077 
regulation of long-
term synaptic 
potentiation 
0.00745968 FBgn0004580 1 GO:1900271 
positive regulation 
of protein 
acetylation 
0.00745968 FBgn0032691 1 GO:1901985 
negative regulation 
of neuronal action 
potential 
0.00745968 FBgn0001134 1 GO:1904456 
response to 
acetylcholine 
0.00745968 FBgn0029909 1 GO:1905144 
cellular response to 
acetylcholine 
0.00745968 FBgn0029909 1 GO:1905145 
positive regulation 
of histone H4-K16 
acetylation 
0.00745968 FBgn0032691 1 GO:2000620 
positive regulation 
of peptidyl-lysine 
acetylation 
0.00745968 FBgn0032691 1 GO:2000758 
regulation of 
immune response 
0.00756881 FBgn0000250,FBg
n0028988,FBgn00
35977,FBgn00863
58 
4 GO:0050776 
regulation of 
immune effector 
process 
0.00847882 FBgn0000250,FBg
n0028988,FBgn00
86358 
3 GO:0002697 
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cilium 
organization 
0.00847882 FBgn0031255,FBg
n0038170,FBgn00
45842 
3 GO:0044782 
regulation of 
response to 
wounding 
0.00854911 FBgn0004580,FBg
n0022800 
2 GO:1903034 
regulation of 
response to biotic 
stimulus 
0.00916677 FBgn0000250,FBg
n0028988,FBgn00
35977,FBgn00863
58 
4 GO:0002831 
ketone 
biosynthetic 
process 
0.00945465 FBgn0039694,FBg
n0287185 
2 GO:0042181 
regulation of Toll 
signaling pathway 
0.0145835 FBgn0000250,FBg
n0028988 
2 GO:0008592 
regulation of 
synaptic plasticity 
0.0145835 FBgn0004580,FBg
n0033926 
2 GO:0048167 
peptidoglycan 
recognition protein 
signaling pathway 
0.0145835 FBgn0035977,FBg
n0086358 
2 GO:0061057 
negative regulation 
of NF-kappaB 
transcription factor 
activity 
0.0148652 FBgn0000250 1 GO:0032088 
sperm storage 0.0148652 FBgn0001112 1 GO:0046693 
regulation of 
cofactor metabolic 
process 
0.0148652 FBgn0039694 1 GO:0051193 
antifungal innate 
immune response 
0.0148652 FBgn0028988 1 GO:0061760 
regulation of 
antifungal innate 
immune response 
0.0148652 FBgn0028988 1 GO:1905034 
negative regulation 
of antifungal 
innate immune 
response 
0.0148652 FBgn0028988 1 GO:1905035 
regulation of 
histone H4-K16 
acetylation 
0.0148652 FBgn0032691 1 GO:2000618 
response to 
external stimulus 
0.01603822 FBgn0000250,FBg
n0002939,FBgn00
28988,FBgn00339
26,FBgn0035813,F
Bgn0035977,FBgn
0045842,FBgn008
5430,FBgn008635
8 
9 GO:0009605 
defense response 
to fungus 
0.01811977 FBgn0000250,FBg
n0028988 
2 GO:0050832 
Toll signaling 
pathway 
0.01937146 FBgn0000250,FBg
n0028988 
2 GO:0008063 
defense response 
to other organism 
0.02053956 FBgn0000250,FBg
n0028988,FBgn00
35813,FBgn00359
77,FBgn0086358 
5 GO:0098542 
 
 
325 
regulation of 
immune system 
process 
0.02140815 FBgn0000250,FBg
n0028988,FBgn00
35977,FBgn00863
58 
4 GO:0002682 
neuronal action 
potential 
0.02221695 FBgn0001134 1 GO:0019228 
negative regulation 
of protein secretion 
0.02221695 FBgn0032428 1 GO:0050709 
long-term synaptic 
potentiation 
0.02221695 FBgn0004580 1 GO:0060291 
regulation of 
histone H4 
acetylation 
0.02221695 FBgn0032691 1 GO:0090239 
regulation of 
presynaptic 
cytosolic calcium 
ion concentration 
0.02221695 FBgn0004580 1 GO:0099509 
chloride 
transmembrane 
transport 
0.02221695 FBgn0001134 52 GO:1902476 
negative regulation 
of response to 
wounding 
0.02221695 FBgn0004580 1 GO:1903035 
defense response 0.02245378 FBgn0000250,FBg
n0028988,FBgn00
35813,FBgn00359
77,FBgn0086358 
5 GO:0006952 
response to fungus 0.02333727 FBgn0000250,FBg
n0028988 
2 GO:0009620 
synaptic signaling 0.02834487 FBgn0001134,FBg
n0004580,FBgn00
29909,FBgn00339
26 
4 GO:0099536 
peptidoglycan 
metabolic process 
0.02951531 FBgn0035977 1 GO:0000270 
peptidoglycan 
catabolic process 
0.02951531 FBgn0035977 1 GO:0009253 
transmission of 
nerve impulse 
0.02951531 FBgn0001134 1 GO:0019226 
ciliary basal body 
organization 
0.02951531 FBgn0045842 1 GO:0032053 
S-
adenosylmethionin
e cycle 
0.02951531 FBgn0015011 1 GO:0033353 
cellular response to 
UV 
0.02951531 FBgn0002939 1 GO:0034644 
multicellular 
organismal 
signaling 
0.02951531 FBgn0001134 1 GO:0035637 
cytoplasmic 
sequestering of 
transcription factor 
0.02951531 FBgn0000250 1 GO:0042994 
histone H2A 
acetylation 
0.02951531 FBgn0032691 1 GO:0043968 
R1/R6 cell 
differentiation 
0.02951531 FBgn0002734 1 GO:0048052 
 
 
326 
cytoplasmic 
sequestering of 
protein 
0.02951531 FBgn0000250 1 GO:0051220 
regulation of 
defense response 
to bacterium 
0.030616 FBgn0035977,FBg
n0086358 
2 GO:1900424 
immune response 0.033856 FBgn0000250,FBg
n0028988,FBgn00
35977,FBgn00863
58 
4 GO:0006955 
response to biotic 
stimulus 
0.03481612 FBgn0000250,FBg
n0028988,FBgn00
35813,FBgn00359
77,FBgn0086358 
5 GO:0009607 
response to 
external biotic 
stimulus 
0.03481612 FBgn0000250,FBg
n0028988,FBgn00
35813,FBgn00359
77,FBgn0086358 
5 GO:0043207 
response to other 
organism 
0.03481612 FBgn0000250,FBg
n0028988,FBgn00
35813,FBgn00359
77,FBgn0086358 
5 GO:0051707 
cellular ketone 
metabolic process 
0.03536095 FBgn0039694,FBg
n0287185 
2 GO:0042180 
regulation of 
multi-organism 
process 
0.03649488 FBgn0000250,FBg
n0028988,FBgn00
35977,FBgn00863
58 
4 GO:0043900 
action potential 0.03676066 FBgn0001134 1 GO:0001508 
glycosaminoglycan 
catabolic process 
0.03676066 FBgn0035977 1 GO:0006027 
intercellular 
transport 
0.03676066 FBgn0033926 1 GO:0010496 
regulation of 
ketone 
biosynthetic 
process 
0.03676066 FBgn0039694 1 GO:0010566 
behavioral 
response to 
starvation 
0.03676066 FBgn0033926 1 GO:0042595 
negative regulation 
of hemocyte 
differentiation 
0.03676066 FBgn0000250 1 GO:0045611 
S-
adenosylmethionin
e metabolic 
process 
0.03676066 FBgn0015011 1 GO:0046500 
signal transduction 
involved in cellular 
response to 
ammonium ion 
0.03676066 FBgn0029909 1 GO:1903831 
immune system 
process 
0.04145909 FBgn0000250,FBg
n0026263,FBgn00
28988,FBgn00359
77,FBgn0086358 
5 GO:0002376 
immune effector 0.04257944 FBgn0000250,FBg 3 GO:0002252 
 
 
327 
process n0028988,FBgn00
86358 
antifungal peptide 
production 
0.04395336 FBgn0000250 1 GO:0002781 
regulation of 
antifungal peptide 
production 
0.04395336 FBgn0000250 1 GO:0002788 
negative regulation 
of peptide 
secretion 
0.04395336 FBgn0032428 1 GO:0002792 
insemination 0.04395336 FBgn0001112 1 GO:0007320 
rhodopsin 
biosynthetic 
process 
0.04395336 FBgn0002939 1 GO:0016063 
rhodopsin 
metabolic process 
0.04395336 FBgn0002939 1 GO:0046154 
sperm competition 0.04395336 FBgn0001112 1 GO:0046692 
inorganic anion 
transmembrane 
transport 
0.04395336 FBgn0001134 1 GO:0098661 
aminoglycan 
metabolic process 
0.04744436 FBgn0035977,FBg
n0053258 
2 GO:0006022 
 
Table 2.4a: list of genes differentially upregulated in control females relative to 20HE males 
list of hits>10 raw 
reads 
log2FC edgeR p-value edgeR -log10(pvalue) 
pre-rRNA:CR45845 -6.3651 3.96E-23 22.40230481 
Pebp1 -5.4311 2.77E-14 13.55752023 
CG5767 -6.8077 2.62E-13 12.58169871 
CG4563 -9.2771 7.73E-12 11.11182051 
CG8661 -4.0981 1.05E-10 9.978810701 
CG8773 -3.5478 5.76E-09 8.239577517 
Jon25Bi -4.6617 4.70E-08 7.327902142 
CG10182 -6.2323 5.44E-08 7.2644011 
CR42767 -8.2402 1.18E-07 6.928117993 
Jon66Ci -5.8805 2.20E-07 6.657577319 
CG1946 -3.1847 2.54E-07 6.595166283 
CG30090 -2.6413 2.59E-07 6.586700236 
Vha100-4 -5.4985 4.38E-07 6.358525889 
CG5770 -10.0087 5.40E-07 6.26760624 
CG14205 -4.1118 5.93E-07 6.226945307 
CG6296 -4.3183 6.03E-07 6.219682688 
CG42747 -2.5566 7.37E-07 6.132532512 
Jon25Biii -3.7039 1.15E-06 5.93930216 
CG6891 -4.1297 1.69E-06 5.772113295 
Cht4 -8.2014 1.69E-06 5.772113295 
CG16775 -7.5924 1.83E-06 5.73754891 
 
 
328 
CG7298 -8.1153 1.93E-06 5.714442691 
CG8299 -7.0528 3.77E-06 5.42365865 
CG8745 -3.7376 6.54E-06 5.184422252 
CG17192 -4.2785 7.69E-06 5.11407366 
thetaTry -3.8037 8.58E-06 5.066512712 
RpS28b -2.1765 9.49E-06 5.022733788 
CG6277 -3.8016 1.07E-05 4.970616222 
CG15044 -7.1295 2.01E-05 4.696803943 
CG18404 -4.7382 2.42E-05 4.616184634 
Peritrophin-15a -3.8604 3.14E-05 4.503070352 
CG9686 -7.6712 3.28E-05 4.484126156 
CG9825 -7.3528 3.45E-05 4.462180905 
CG33460 -7.109 3.57E-05 4.447331784 
CG4830 -3.6388 3.57E-05 4.447331784 
CR45714 -7.1573 4.03E-05 4.394694954 
pyd3 -1.9811 4.24E-05 4.372634143 
CG6733 -5.745 4.59E-05 4.338187314 
CG5958 -3.5698 4.61E-05 4.336299075 
vanin-like -2.3955 4.76E-05 4.322393047 
CG33109 -8.0038 4.91E-05 4.308918508 
Orc1 -2.3069 7.13E-05 4.14691047 
CG4558 -6.8057 0.0001 4 
CG32750 -6.9859 0.0001 4 
bora -3.8354 0.0001 4 
CG17658 -4.8365 0.0002 3.698970004 
CG7542 -4.1347 0.0002 3.698970004 
O-fut2 -1.7192 0.0002 3.698970004 
CG6839 -8.0134 0.0002 3.698970004 
yip7 -3.2953 0.0002 3.698970004 
Cht9 -4.3142 0.0003 3.522878745 
Fmo-2 -1.7394 0.0003 3.522878745 
SLC22A -2.6139 0.0003 3.522878745 
CG7912 -3.2177 0.0003 3.522878745 
CG15617 -3.6656 0.0003 3.522878745 
CG15630 -6.7416 0.0004 3.397940009 
CG5590 -1.537 0.0004 3.397940009 
CG10914 -1.9412 0.0004 3.397940009 
CG14820 -2.9238 0.0004 3.397940009 
CG11068 -1.7532 0.0005 3.301029996 
CG5804 -2.2227 0.0005 3.301029996 
 
 
329 
CG6048 -4.4566 0.0006 3.22184875 
CG8834 -1.8817 0.0006 3.22184875 
CG3011 -2.1125 0.0006 3.22184875 
Jon99Fi -4.2774 0.0006 3.22184875 
Debcl -1.6166 0.0007 3.15490196 
Mms19 -1.7071 0.0007 3.15490196 
Pen -2.009 0.0007 3.15490196 
CG45080 -6.6695 0.0007 3.15490196 
Fpps -1.5834 0.0008 3.096910013 
CR43264 -3.2388 0.0008 3.096910013 
CG10301 -6.4444 0.0009 3.045757491 
pav -1.7349 0.0009 3.045757491 
CG9360 -1.898 0.0009 3.045757491 
Jon66Cii -7.2096 0.001 3 
CG31266 -6.7559 0.001 3 
CG13151 -1.8735 0.001 3 
tos -2.1576 0.001 3 
CG34198 -1.6172 0.0011 2.958607315 
CG31344 -2.04 0.0011 2.958607315 
CG5506 -3.1168 0.0011 2.958607315 
CG8460 -1.4618 0.0013 2.886056648 
CG10505 -2.6599 0.0015 2.823908741 
CG15127 -2.2121 0.0016 2.795880017 
CG30049 -1.442 0.0017 2.769551079 
CR44830 -4.3288 0.0018 2.744727495 
Lrpprc2 -1.3919 0.0018 2.744727495 
mms4 -1.8952 0.0019 2.721246399 
CG6310 -1.5 0.002 2.698970004 
Npc1b -5.9448 0.002 2.698970004 
Meltrin -1.7936 0.002 2.698970004 
Mcm6 -1.7582 0.0021 2.677780705 
CG13300 -2.2013 0.0021 2.677780705 
CCHa1 -2.2786 0.0022 2.657577319 
CG18473 -3.0452 0.0022 2.657577319 
Arc42 -1.3485 0.0024 2.619788758 
MFS1 -7.9272 0.0024 2.619788758 
CG7567 -6.2889 0.0027 2.568636236 
Sr-CIII -6.0098 0.0027 2.568636236 
CG11700 -1.6033 0.0027 2.568636236 
Acox57D-d -2.1186 0.0027 2.568636236 
 
 
330 
CG12926 -1.859 0.0028 2.552841969 
CG44475 -2.0327 0.0028 2.552841969 
dmGlut -1.9304 0.0028 2.552841969 
CG12374 -3.618 0.0029 2.537602002 
CG7280 -1.5357 0.003 2.522878745 
CG42329 -4.1747 0.0031 2.508638306 
bsf -1.2427 0.0031 2.508638306 
CG12170 -1.7743 0.0032 2.494850022 
Npc2a -1.228 0.0034 2.468521083 
CG2781 -2.1675 0.0034 2.468521083 
CG15126 -1.7793 0.0035 2.455931956 
CDC45L -1.4594 0.0036 2.443697499 
Tina-1 -1.5577 0.0037 2.431798276 
nrv3 -2.4447 0.0037 2.431798276 
epsilonTry -3.2273 0.0037 2.431798276 
CG31041 -4.4018 0.0037 2.431798276 
TyrR -6.1434 0.0038 2.420216403 
Mst36Fa -5.9129 0.0038 2.420216403 
CG10137 -3.0528 0.0039 2.408935393 
CG1671 -1.3846 0.0041 2.387216143 
gt -3.0424 0.0043 2.366531544 
l(2)10685 -1.7053 0.0044 2.356547324 
CG34010 -1.4232 0.0045 2.346787486 
CG15423 -1.8733 0.0045 2.346787486 
GILT2 -1.6841 0.0046 2.337242168 
CG15210 -2.5549 0.0046 2.337242168 
Jon65Aii -3.1645 0.0046 2.337242168 
CG14079 -3.1461 0.0048 2.318758763 
Mcm10 -2.0607 0.0048 2.318758763 
QC -2.9766 0.0049 2.30980392 
CG8728 -1.1915 0.0049 2.30980392 
Ddx1 -1.7968 0.0049 2.30980392 
psidin -1.2737 0.0051 2.292429824 
Cbs -3.1907 0.0052 2.283996656 
CG31198 -1.8326 0.0052 2.283996656 
SPE -3.3508 0.0054 2.26760624 
Tsr1 -1.2907 0.0054 2.26760624 
Zip88E -1.9368 0.0056 2.251811973 
CG33966 -2.4914 0.0057 2.244125144 
Fdh -1.1425 0.0058 2.236572006 
 
 
331 
AdSL -1.2171 0.0061 2.214670165 
CG8064 -1.3141 0.0064 2.193820026 
ida -1.5447 0.0064 2.193820026 
Jon99Fii -3.32 0.0064 2.193820026 
Ntf-2 -1.5511 0.0065 2.187086643 
cN-IIIB -1.3606 0.0067 2.173925197 
CG9903 -2.1008 0.0068 2.167491087 
Gfat2 -1.2154 0.007 2.15490196 
CG14036 -5.7083 0.0073 2.13667714 
CG10184 -1.2204 0.0073 2.13667714 
Gr94a -2.9089 0.0073 2.13667714 
CR44873 -3.8832 0.0074 2.13076828 
CG6962 -1.4878 0.0075 2.124938737 
CG9568 -1.9648 0.0075 2.124938737 
Gnmt -5.8601 0.0078 2.107905397 
CR43989 -5.8601 0.0078 2.107905397 
CG1371 -1.189 0.0079 2.102372909 
Pmm45A -1.1531 0.0079 2.102372909 
CG33514 -1.4165 0.0079 2.102372909 
amn -1.1495 0.008 2.096910013 
lectin-24A -5.3089 0.008 2.096910013 
CG13912 -2.5162 0.0082 2.086186148 
RnrS -1.2507 0.0089 2.050609993 
CG3430 -1.3453 0.0089 2.050609993 
CG31265 -6.914 0.0095 2.022276395 
Scp2 -5.7512 0.0097 2.013228266 
AsnRS-m -1.5104 0.0098 2.008773924 
Jon65Aiv -2.7792 0.0098 2.008773924 
CG6178 -1.1543 0.0103 1.987162775 
CG32698 -1.4959 0.0103 1.987162775 
Oseg6 -3.0926 0.0105 1.978810701 
Rif1 -1.3933 0.0106 1.974694135 
CG42826 -3.0576 0.0107 1.970616222 
CG16736 -5.5882 0.011 1.958607315 
CG2144 -1.3111 0.0114 1.943095149 
CG8607 -1.3361 0.0115 1.93930216 
Ag5r2 -2.7881 0.0116 1.935542011 
alpha-Est8 -3.0311 0.0117 1.931814138 
CG6126 -1.2791 0.0119 1.924453039 
CG6028 -1.1787 0.012 1.920818754 
 
 
332 
CG3625 -5.6337 0.0123 1.910094889 
l(3)mbt -1.3612 0.0124 1.906578315 
Irp-1B -1.1844 0.0126 1.899629455 
CG7246 -1.325 0.0127 1.896196279 
PRAS40 -1.0695 0.0129 1.88941029 
CPT2 -1.19 0.013 1.886056648 
CG4743 -1.3586 0.013 1.886056648 
CG12512 -1.656 0.0131 1.882728704 
CG42728 -3.6264 0.0131 1.882728704 
CG11598 -5.4818 0.0138 1.860120914 
CG3520 -1.4398 0.0142 1.847711656 
Ser6 -2.1843 0.0142 1.847711656 
CG18765 -2.7293 0.0143 1.844663963 
CG11123 -1.3043 0.0144 1.841637508 
CR42491 -1.0555 0.0151 1.821023053 
CG9143 -1.1164 0.0152 1.818156412 
Lim1 -2.9122 0.0153 1.815308569 
xit -1.12 0.0158 1.801342913 
RecQ4 -1.8545 0.0158 1.801342913 
DNApol-alpha60 -1.5519 0.0158 1.801342913 
IP3K2 -1.6809 0.0158 1.801342913 
CG11103 -1.2545 0.0159 1.798602876 
CG4053 -6.5628 0.016 1.795880017 
CG14424 -3.6028 0.0161 1.793174124 
CG18788 -2.288 0.0161 1.793174124 
CG17726 -1.3977 0.0163 1.787812396 
CG12171 -1.1048 0.0164 1.785156152 
LysP -6.6245 0.0166 1.779891912 
RfC3 -1.6405 0.017 1.769551079 
CG7277 -1.1297 0.0171 1.76700389 
Snm1 -1.3059 0.0175 1.756961951 
CG31469 -1.7399 0.0175 1.756961951 
CG34301 -3.5871 0.0177 1.752026734 
Pex13 -1.1344 0.0178 1.749579998 
CG32641 -1.1683 0.0178 1.749579998 
Egm -1.0441 0.0179 1.747146969 
CG5157 -2.4948 0.0181 1.742321425 
fa2h -2.849 0.0183 1.73754891 
heix -1.218 0.0194 1.71219827 
CG6745 -1.262 0.0196 1.707743929 
 
 
333 
CG13690 -1.3186 0.0197 1.705533774 
CG14120 -1.9371 0.0198 1.70333481 
CG14545 -2.5358 0.0199 1.701146924 
CG8419 -3.0404 0.0205 1.688246139 
CR45037 -2.5396 0.0209 1.679853714 
CR43253 -3.6744 0.0217 1.663540266 
CG14629 -1.0631 0.0218 1.661543506 
RtcB -1.0482 0.0219 1.659555885 
CG10933 -5.7914 0.0226 1.645891561 
CG5639 -5.7603 0.0226 1.645891561 
CG7730 -5.7603 0.0226 1.645891561 
otk2 -1.6825 0.0235 1.628932138 
Nsun2 -1.0774 0.0236 1.627087997 
CG15362 -1.3813 0.0242 1.616184634 
CG31343 -1.4063 0.0245 1.610833916 
beta-PheRS -1.1583 0.0247 1.607303047 
Mcm7 -1.3406 0.0247 1.607303047 
CG10592 -1.2281 0.0249 1.603800653 
CG14798 -1.215 0.0252 1.598599459 
AGBE -1.0353 0.0254 1.595166283 
Ote -1.1858 0.0254 1.595166283 
Gk1 -1.2997 0.0254 1.595166283 
CG30371 -6.273 0.0255 1.59345982 
GILT3 -2.9457 0.026 1.585026652 
CR45938 -1.8857 0.026 1.585026652 
CG3663 -1.0822 0.0264 1.578396073 
CG9577 -1.0915 0.0266 1.575118363 
lcs -4.2892 0.0267 1.573488739 
MESK2 -1.5649 0.0269 1.57024772 
CG1827 -0.9419 0.027 1.568636236 
ico -1.1121 0.027 1.568636236 
CG3021 -1.0484 0.0272 1.565431096 
l(2)dtl -1.1823 0.0272 1.565431096 
Oatp33Eb -2.6721 0.0272 1.565431096 
Zip89B -3.4193 0.0278 1.555955204 
Ssrp -0.9484 0.0281 1.55129368 
CG7593 -1.1954 0.0282 1.549750892 
SdhB -0.9244 0.0287 1.542118103 
CG45061 -1.024 0.0287 1.542118103 
alpha-Est4 -5.1983 0.0288 1.540607512 
 
 
334 
CG33116 -1.0918 0.0291 1.536107011 
Takl1 -2.8719 0.0293 1.53313238 
CG33080 -3.0718 0.0298 1.525783736 
CG43207 -2.146 0.0298 1.525783736 
CG11911 -2.1631 0.0298 1.525783736 
blw -0.8956 0.0302 1.519993057 
r-l -0.9856 0.0307 1.512861625 
CG10470 -1.0115 0.0307 1.512861625 
Nup107 -0.961 0.031 1.508638306 
CG6180 -0.9581 0.0311 1.507239611 
Rrp46 -1.2152 0.0317 1.498940738 
Syx4 -1.7451 0.0318 1.49757288 
CG7406 -3.3421 0.0319 1.496209317 
CG31915 -1.0831 0.0323 1.490797478 
alphaTub84D -0.9969 0.0325 1.488116639 
rev7 -1.1847 0.0328 1.484126156 
Zwilch -1.2035 0.033 1.48148606 
Cyp6t1 -1.2044 0.0331 1.480172006 
TBC1D5 -1.1251 0.0336 1.473660723 
CG32572 -1.6695 0.0337 1.472370099 
CG9663 -1.0664 0.0339 1.469800302 
AlaRS-m -1.0702 0.0343 1.46470588 
CG7137 -1.1815 0.0344 1.463441557 
CG6271 -3.7069 0.0345 1.462180905 
cue -1.0029 0.0345 1.462180905 
upd3 -0.9525 0.0346 1.460923901 
Thiolase -0.8613 0.036 1.443697499 
CR44704 -1.4842 0.036 1.443697499 
CG13704 -1.5901 0.036 1.443697499 
CG6325 -1.0797 0.037 1.431798276 
asl -1.0366 0.0371 1.43062609 
CCKLR-17D3 -1.8066 0.0372 1.42945706 
spd-2 -1.2167 0.0372 1.42945706 
CG30377 -3.2566 0.0374 1.427128398 
CG31097 -2.7315 0.0376 1.424812155 
LysX -2.9429 0.0376 1.424812155 
Sytbeta -5.5508 0.0378 1.4225082 
CG18335 -1.9689 0.0383 1.416801226 
CG6574 -1.3936 0.0386 1.413412695 
CG33127 -1.3018 0.0389 1.410050399 
 
 
335 
CG31391 -3.3131 0.0393 1.40560745 
Art7 -0.9828 0.0397 1.401209493 
CR45158 -2.2982 0.0397 1.401209493 
Tcp-1zeta -0.9094 0.0401 1.396855627 
Sym -1.0556 0.0403 1.394694954 
Pi3K59F -0.992 0.0413 1.384049948 
CG11752 -0.8841 0.0414 1.382999659 
CG32212 -0.9485 0.0414 1.382999659 
CG18190 -1.4024 0.0416 1.380906669 
CR46102 -2.6128 0.0418 1.378823718 
pont -0.909 0.0418 1.378823718 
Tao -1.7571 0.0423 1.373659633 
CG16749 -1.4462 0.0423 1.373659633 
snoRNA:Me18S-G1189 -1.4086 0.0429 1.367542708 
NK7.1 -1.0172 0.0436 1.360513511 
stv -1.1939 0.0436 1.360513511 
Kif19A -5.8077 0.044 1.356547324 
RnrL -0.9965 0.0444 1.35261703 
CG18528 -1.153 0.0446 1.350665141 
Jon65Aiii -2.056 0.0463 1.334419009 
CG15629 -0.9041 0.0464 1.333482019 
Xpd -0.9409 0.0467 1.330683119 
CG14301 -3.5842 0.0476 1.322393047 
CG13843 -2.4964 0.0477 1.321481621 
CNT1 -1.6745 0.05 1.301029996 
AOX1 -0.8833 0.0502 1.299296283 
Surf4 -0.8341 0.0503 1.298432015 
CG12288 -1.3139 0.0503 1.298432015 
CG6287 -1.1329 0.0505 1.296708622 
CG17010 -5.6936 0.0507 1.294992041 
Listericin -1.9964 0.0508 1.294136288 
Jheh3 -1.146 0.0509 1.293282218 
fzr2 -1.3374 0.051 1.292429824 
CG5255 -1.5677 0.051 1.292429824 
nero -0.9047 0.0519 1.284832642 
CG17855 -0.8825 0.052 1.283996656 
snoRNA:Psi28S-1135b -2.3694 0.0527 1.278189385 
Trxr-1 -1.6965 0.0531 1.274905479 
CG3987 -1.0286 0.0531 1.274905479 
Fen1 -1.0301 0.0538 1.269217724 
 
 
336 
CG43774 -1.6751 0.0539 1.268411235 
CG7839 -0.9414 0.0549 1.260427656 
 
Table 2.4b:  list of genes differentially upregulated in 20HE males relative to control females 
list of hits>10 raw 
reads 
log2FC edgeR p-value edgeR -log10(pvalue) 
roX2 10.6073 1.76E-18 17.75448733 
CR43961 9.8493 2.07E-15 14.68402965 
CG12721 7.0139 6.61E-15 14.17979854 
hbs 4.5641 2.88E-10 9.540607512 
CG3739 4.9048 1.22E-09 8.913640169 
lin-28 2.9282 1.47E-09 8.832682665 
CG42854 5.9939 5.55E-09 8.255707017 
CG3703 2.6459 5.91E-08 7.228412519 
CG34323 8.0601 6.89E-08 7.161780778 
CG31436 2.7115 1.55E-07 6.809668302 
CG44006 2.8502 3.33E-07 6.477555766 
CG43101 3.8771 4.07E-07 6.390405591 
CG15263 8.8117 5.34E-07 6.272458743 
CG3568 2.8316 1.18E-06 5.928117993 
CR44748 3.1285 2.32E-06 5.634512015 
snoRNA:Me28S-A30 4.3504 6.35E-06 5.197226275 
Mal-A4 3.3322 1.12E-05 4.950781977 
CG13813 5.6432 1.17E-05 4.931814138 
CG14196 3.7162 2.28E-05 4.642065153 
CG42393 2.6649 2.46E-05 4.609064893 
CG11407 8.9582 2.67E-05 4.573488739 
Eip75B 2.441 4.18E-05 4.378823718 
ninaD 5.0995 4.72E-05 4.326058001 
vilya 7.0011 5.29E-05 4.276544328 
CG34401 2.4342 0.0001 4 
CG15695 7.9833 0.0001 4 
gskt 3.6281 0.0002 3.698970004 
Mal-A8 3.5256 0.0002 3.698970004 
CG44286 6.8248 0.0003 3.522878745 
CG6465 1.7598 0.0003 3.522878745 
CG32040 2.1534 0.0003 3.522878745 
sing 2.4851 0.0003 3.522878745 
CR45522 6.5808 0.0004 3.397940009 
E(spl)malpha-BFM 1.4602 0.0004 3.397940009 
CG12643 1.5203 0.0004 3.397940009 
 
 
337 
geko 4.6019 0.0005 3.301029996 
bip1 4.5666 0.0005 3.301029996 
CG5361 6.5239 0.0005 3.301029996 
brk 1.6085 0.0005 3.301029996 
Mal-A1 2.8683 0.0005 3.301029996 
CR45824 4.5159 0.0006 3.22184875 
Sik2 1.7774 0.0006 3.22184875 
mam 2.0317 0.0006 3.22184875 
Gbeta5 3.8145 0.0006 3.22184875 
CG32638 1.7381 0.0007 3.15490196 
CG9498 5.6766 0.0007 3.15490196 
CG32599 3.7467 0.0008 3.096910013 
CG13917 1.7188 0.0008 3.096910013 
CR43257 1.9416 0.0008 3.096910013 
CG32055 2.3407 0.0011 2.958607315 
tobi 3.9505 0.0011 2.958607315 
CG10257 6.2574 0.0012 2.920818754 
TTLL3B 4.4842 0.0012 2.920818754 
CG6040 1.4885 0.0013 2.886056648 
GstD5 1.964 0.0014 2.853871964 
CG31808 2.7052 0.0014 2.853871964 
Faa 1.8345 0.0015 2.823908741 
fs(1)Yb 6.4755 0.0016 2.795880017 
CG4363 3.1302 0.0016 2.795880017 
ed 1.4121 0.0018 2.744727495 
CG11192 2.3564 0.0019 2.721246399 
CG3699 2.9869 0.002 2.698970004 
Ir40a 6.1369 0.0022 2.657577319 
E(spl)m6-BFM 1.6686 0.0022 2.657577319 
CR44429 1.9689 0.0022 2.657577319 
tut 2.2542 0.0022 2.657577319 
br 6.0958 0.0023 2.638272164 
CG31510 1.2895 0.0023 2.638272164 
CR44445 2.2644 0.0023 2.638272164 
rha 7.1366 0.0024 2.619788758 
laccase2 1.8044 0.0024 2.619788758 
CG13658 1.849 0.0025 2.602059991 
CG30484 2.4471 0.0025 2.602059991 
Eip78C 2.3785 0.0026 2.585026652 
CG13659 1.6834 0.0027 2.568636236 
 
 
338 
Gld 4.2053 0.0028 2.552841969 
GstD8 3.9181 0.0028 2.552841969 
CG10559 2.1509 0.0028 2.552841969 
Hsromega 1.2852 0.0029 2.537602002 
CG30324 6.3372 0.003 2.522878745 
CG8468 1.9052 0.003 2.522878745 
CG8343 2.9287 0.0032 2.494850022 
RNaseMRP:RNA 1.4928 0.0032 2.494850022 
CR45922 3.5121 0.0033 2.48148606 
GstD4 1.5997 0.0033 2.48148606 
Gbp2 5.6621 0.0033 2.48148606 
Paip2 1.2468 0.0034 2.468521083 
CR44547 1.5687 0.0034 2.468521083 
CG3505 2.77 0.0038 2.420216403 
CG10337 1.5041 0.0039 2.408935393 
CG30356 2.1808 0.0039 2.408935393 
CG13894 4.3874 0.004 2.397940009 
Dcp-1 1.5625 0.004 2.397940009 
CG3764 1.493 0.004 2.397940009 
HP1D3csd 2.4688 0.0041 2.387216143 
Ect3 2.4384 0.0041 2.387216143 
cv-2 1.2455 0.0042 2.37675071 
CG32354 1.891 0.0042 2.37675071 
CG32523 2.8379 0.0047 2.327902142 
CG13893 1.9995 0.0047 2.327902142 
CG31370 1.4779 0.0048 2.318758763 
CR44380 3.1324 0.0049 2.30980392 
CG11275 1.4415 0.0049 2.30980392 
CG33160 5.9843 0.0051 2.292429824 
CG30197 1.5773 0.0051 2.292429824 
pirk 1.7012 0.0054 2.26760624 
Sirt6 1.5188 0.0055 2.259637311 
Ac3 2.0016 0.0056 2.251811973 
CR46095 1.6041 0.0058 2.236572006 
CG44329 6.2133 0.006 2.22184875 
CG11374 1.7808 0.006 2.22184875 
CG17111 2.046 0.0061 2.214670165 
CG14838 3.9156 0.0064 2.193820026 
Tsp42Ej 1.3247 0.0065 2.187086643 
CG43672 3.4032 0.0067 2.173925197 
 
 
339 
Rcd2 1.4405 0.0067 2.173925197 
Ir7g 5.7403 0.0069 2.161150909 
CG15515 3.9085 0.0072 2.142667504 
CG43647 2.9645 0.0073 2.13667714 
CG12728 1.1736 0.0073 2.13667714 
MYPT-75D 1.4028 0.0074 2.13076828 
CR44538 2.7403 0.0078 2.107905397 
alphagamma-
element:CR32865 
1.4048 0.0079 2.102372909 
Cyp6a20 1.6509 0.0079 2.102372909 
CR45280 3.3498 0.008 2.096910013 
Ir41a 3.0098 0.008 2.096910013 
CG18745 1.1206 0.0083 2.080921908 
CR46250 1.9422 0.0087 2.060480747 
CG9422 2.3003 0.0091 2.040958608 
CG14141 3.8201 0.0093 2.031517051 
Lac 1.8498 0.0093 2.031517051 
CG5059 1.1545 0.0096 2.017728767 
vn 1.3779 0.0096 2.017728767 
Obp18a 1.4386 0.01 2 
sprt 1.4795 0.01 2 
Drep4 1.3272 0.0101 1.995678626 
Ddr 2.1813 0.0101 1.995678626 
E(spl)m7-HLH 1.3505 0.0102 1.991399828 
CR44608 1.361 0.0103 1.987162775 
Vti1a 1.3318 0.0105 1.978810701 
SIFa 5.8133 0.0106 1.974694135 
Or45a 1.8002 0.0106 1.974694135 
kirre 3.9349 0.0107 1.970616222 
CG4377 2.414 0.0107 1.970616222 
mst 1.5371 0.0108 1.966576245 
CR45082 1.5962 0.0111 1.954677021 
Oatp74D 1.2807 0.0113 1.946921557 
Rad23 1.1065 0.0115 1.93930216 
CG43389 6.7413 0.0117 1.931814138 
CG4660 2.7839 0.0118 1.928117993 
CG17265 1.1251 0.0119 1.924453039 
ND-51L1 1.9582 0.0119 1.924453039 
snoRNA:Me28S-C437 2.0905 0.012 1.920818754 
CR45102 1.1325 0.0122 1.913640169 
CR44276 2.0229 0.0122 1.913640169 
 
 
340 
CG3262 1.2415 0.0123 1.910094889 
Xpac 1.3311 0.0123 1.910094889 
CG11226 2.2916 0.0126 1.899629455 
Cad96Ca 2.151 0.0127 1.896196279 
CG34040 4.4697 0.0128 1.89279003 
CR44784 1.3856 0.0129 1.88941029 
CR41257 2.4539 0.013 1.886056648 
CG11893 1.9762 0.013 1.886056648 
CR32636 2.7446 0.0133 1.876148359 
Mal-A2 1.8969 0.0133 1.876148359 
CG18467 2.581 0.0134 1.872895202 
Mos 2.8721 0.0136 1.866461092 
daw 2.6111 0.0136 1.866461092 
krimp 1.2256 0.0137 1.863279433 
Spn85F 5.7664 0.0138 1.860120914 
CR44145 1.622 0.0141 1.850780887 
CR9162 2.1438 0.0142 1.847711656 
CG6683 1.2553 0.0142 1.847711656 
Csk 1.1004 0.0143 1.844663963 
CR45793 1.7582 0.0144 1.841637508 
pan 1.6901 0.0145 1.838631998 
CR44984 2.0928 0.0146 1.835647144 
CG14227 1.4603 0.0146 1.835647144 
CG5644 1.9557 0.0146 1.835647144 
mGluR 2.8347 0.0147 1.832682665 
CR44564 2.6101 0.0149 1.826813732 
CG10910 3.3373 0.0153 1.815308569 
Gr47b 2.0142 0.0156 1.806875402 
Fhos 2.5471 0.0157 1.804100348 
CG33267 1.502 0.0163 1.787812396 
CG32706 1.7724 0.0169 1.772113295 
CG12483 5.6657 0.0171 1.76700389 
CG9821 0.9801 0.0171 1.76700389 
CG31104 2.8709 0.0172 1.764471553 
Ptip 1.0735 0.0177 1.752026734 
CG14626 1.0325 0.0177 1.752026734 
sty 0.9656 0.0192 1.716698771 
CG17186 1.2444 0.0192 1.716698771 
Cbp53E 3.0872 0.0194 1.71219827 
CR43973 1.2134 0.02 1.698970004 
 
 
341 
sqz 1.145 0.0201 1.696803943 
GATAd 1.1365 0.0203 1.692503962 
CG5281 1.6784 0.0204 1.690369833 
snoRNA:Me28S-
A3407a 
1.7987 0.0204 1.690369833 
CG34348 1.1264 0.0207 1.684029655 
Hsp67Bc 1.1376 0.0209 1.679853714 
Rbp1 1.0379 0.0212 1.673664139 
CHKov2 1.1208 0.0216 1.665546249 
noe 1.1162 0.0216 1.665546249 
CR45625 1.7592 0.0216 1.665546249 
CG18368 2.8286 0.0217 1.663540266 
CR44723 2.4509 0.0219 1.659555885 
VhaSFD 5.3989 0.022 1.657577319 
CR44404 5.3989 0.022 1.657577319 
snoRNA:Psi18S-1854a 1.97 0.0224 1.649751982 
CR45745 2.4539 0.0227 1.643974143 
CR45964 3.3242 0.0228 1.642065153 
l(1)G0193 1.3413 0.0233 1.632644079 
CR44862 6.216 0.0237 1.625251654 
CG12655 1.8331 0.0237 1.625251654 
CG14160 4.49 0.0237 1.625251654 
olf413 2.1822 0.0239 1.621602099 
CR46204 1.4381 0.024 1.619788758 
CG30099 2.0324 0.024 1.619788758 
Cad87A 1.1541 0.0241 1.617982957 
CR46093 1.4163 0.0241 1.617982957 
CG9328 1.2636 0.0242 1.616184634 
CG31300 2.0997 0.0242 1.616184634 
scaRNA:MeU5-C46 0.976 0.0245 1.610833916 
ntc 1.3526 0.0246 1.609064893 
laza 1.168 0.0251 1.600326279 
CG32368 1.0242 0.0253 1.596879479 
CG9684 0.9432 0.0254 1.595166283 
CG3281 1.0923 0.0254 1.595166283 
dos 1.4552 0.0259 1.586700236 
CG5282 6.2688 0.0261 1.583359493 
Traf4 1.2 0.0262 1.581698709 
CG10376 1.0088 0.0264 1.578396073 
Gycbeta100B 2.4884 0.0265 1.576754126 
TSG101 0.9168 0.0265 1.576754126 
 
 
342 
png 2.0923 0.0269 1.57024772 
CG13436 1.7852 0.0269 1.57024772 
Mnn1 1.0997 0.0271 1.567030709 
Ugt37b1 3.2953 0.0272 1.565431096 
CR46021 5.3113 0.0275 1.560667306 
CG4586 1.1636 0.0276 1.559090918 
BtbVII 2.2912 0.0277 1.557520231 
InR 1.068 0.028 1.552841969 
CR31451 2.9495 0.0282 1.549750892 
grim 1.9379 0.0286 1.543633967 
TwdlC 3.1165 0.0287 1.542118103 
CG31288 1.6415 0.0288 1.540607512 
Ugt86Dd 1.3672 0.0289 1.539102157 
CG13739 3.3503 0.0296 1.528708289 
CG42816 6.0676 0.0298 1.525783736 
kcc 5.2406 0.0298 1.525783736 
CG7747 1.0688 0.0299 1.524328812 
CG45782 1.92 0.0299 1.524328812 
CG32795 1.2035 0.03 1.522878745 
GstD3 0.9395 0.0303 1.518557371 
CG10514 3.3346 0.0304 1.517126416 
CR45549 1.8994 0.0307 1.512861625 
Eaf6 1.0492 0.0309 1.510041521 
cact 1.1734 0.031 1.508638306 
CG1657 1.0623 0.0311 1.507239611 
CR45187 1.5706 0.0312 1.505845406 
Sp212 3.4438 0.0316 1.500312917 
CR43242 1.1103 0.0317 1.498940738 
snoRNA:Me18S-
U1356b 
2.6828 0.032 1.494850022 
flfl 0.9242 0.0323 1.490797478 
CG32625 1.3806 0.0323 1.490797478 
CR45234 2.421 0.0328 1.484126156 
CG8281 1.0712 0.0331 1.480172006 
Arc2 0.9756 0.0332 1.478861916 
CR45166 3.6136 0.0338 1.4710833 
CR44892 1.2216 0.0339 1.469800302 
Gr32a 2.8891 0.0341 1.467245621 
yuri 2.8838 0.0343 1.46470588 
CG9425 1.5979 0.0343 1.46470588 
CG32444 2.0573 0.0345 1.462180905 
 
 
343 
CG9676 2.0843 0.0345 1.462180905 
CG33643 1.8114 0.0345 1.462180905 
CG11155 1.872 0.0354 1.450996738 
PDZ-GEF 1.0469 0.0361 1.442492798 
Axs 1.0648 0.0361 1.442492798 
Gr77a 1.3273 0.0361 1.442492798 
CR44720 1.7117 0.0364 1.438898616 
E(spl)m3-HLH 0.8409 0.0366 1.436518915 
Mal-A6 3.5228 0.0385 1.41453927 
CG34160 1.1947 0.039 1.408935393 
CG18128 2.1524 0.0392 1.406713933 
dop 1.3293 0.0392 1.406713933 
CG3876 1.0554 0.0393 1.40560745 
CG31245 3.4138 0.0401 1.396855627 
comm2 1.4001 0.0406 1.391473966 
CG7194 1.3092 0.0409 1.388276692 
Smyd4-2 2.4454 0.0411 1.386158178 
CR41620 5.0637 0.0413 1.384049948 
bigmax 0.8964 0.0413 1.384049948 
mir-4974 2.1807 0.0415 1.381951903 
CR45127 2.1552 0.0417 1.379863945 
CG8369 5.0393 0.0418 1.378823718 
ec 5.0393 0.0418 1.378823718 
CG4297 0.9686 0.0424 1.372634143 
CR43974 1.2848 0.0428 1.368556231 
NFAT 0.9721 0.043 1.366531544 
DJ-1alpha 2.3331 0.0434 1.36251027 
nvd 5.7154 0.0435 1.361510743 
CG12224 1.0328 0.0435 1.361510743 
fs(1)Ya 5.7154 0.0436 1.360513511 
omd 1.5098 0.0438 1.358525889 
insc 0.8159 0.044 1.356547324 
CR46094 2.0502 0.0442 1.354577731 
snoRNA:Psi18S-1854b 1.1552 0.0446 1.350665141 
CG8568 1.8494 0.0446 1.350665141 
swi2 1.8474 0.0447 1.349692477 
Ppt2 1.001 0.0449 1.347753659 
l(2)35Cc 2.8217 0.0451 1.345823458 
CG6013 0.9736 0.0452 1.344861565 
CG31111 1.015 0.0456 1.341035157 
 
 
344 
CG33463 2.4061 0.0461 1.336299075 
godzilla 2.2268 0.0463 1.334419009 
ect 1.6446 0.0463 1.334419009 
Ucp4C 2.4212 0.0464 1.333482019 
CR45028 1.6695 0.0468 1.329754147 
Vav 0.8683 0.047 1.327902142 
RhoGAP71E 1.1549 0.0472 1.326058001 
bowl 3.4322 0.0473 1.325138859 
Cpr51A 0.8572 0.0473 1.325138859 
CR46044 1.2346 0.0474 1.324221658 
Tsp42El 0.8205 0.0475 1.32330639 
CG17361 1.0572 0.0479 1.319664487 
CG34136 2.1762 0.0484 1.315154638 
CG32109 0.8844 0.0487 1.312471039 
Tie 0.9211 0.0488 1.311580178 
CG33510 1.3994 0.0488 1.311580178 
baz 0.9138 0.0492 1.308034897 
Cpr64Ad 3.4976 0.0493 1.307153081 
kek5 0.8218 0.0495 1.305394801 
CG42365 1.1459 0.0495 1.305394801 
FASN3 2.1101 0.0501 1.300162274 
CG18180 2.439 0.0504 1.297569464 
CG31463 1.5931 0.0506 1.295849483 
Krn 0.9266 0.0507 1.294992041 
CG16894 3.8045 0.0508 1.294136288 
BBS8 5.6118 0.0511 1.2915791 
Gbp1 5.7689 0.0515 1.288192771 
Rab2 0.8635 0.0525 1.279840697 
glec 0.806 0.0525 1.279840697 
CG11655 1.1328 0.053 1.27572413 
CG10638 1.1463 0.0532 1.274088368 
CAH2 1.9189 0.0535 1.271646218 
CR44867 2.7064 0.0538 1.269217724 
lt 1.4674 0.0541 1.266802735 
CR44809 1.6071 0.0546 1.262807357 
Table 2.4c:  
threshold p=0.1 in the male control versus male 
20HE fed list 
threshold p=0.05 in the male control versus female 
control list 
threshold p=0.05 in the male control versus male 
20HE fed list 
threshold p=0.05 in the male control versus female 
control list 
Genes that are 
upregulated in control 
males but were 
Genes that are 
downregulated in 
control males but were 
Genes that are 
upregulated in control 
males but were 
Genes that are 
downregulated in control 
males but were equalized 
 
 
345 
equalized to female 
levels by 20HE feeding 
equalized to female 
levels by 20HE feeding 
equalized to female 
levels by 20HE feeding 
to female levels by 20HE 
feeding 
ave mus101 a Acp53Ea 
CG6999 CG4653 AhcyL2 Adgf-C 
Stim l(2)05287 AOX2 AIMP1 
CG33107 mRpL51 Arc1 alpha-Est1 
snRNA:U7 rdgBbeta Atac1 alpha-Est7 
CG8578 Hsp67Ba Atf6 alphaTry 
FucTC CG32054 bnl Amy-d 
Pc CG5346 bou AP-1-2beta 
Ugt86Dj RfC4 bun arx 
Cyp4ac3 CG12736 CG10638 asp 
viaf Spc25 CG10730 ATPsynB 
CG32202 DNApol-alpha73 CG11000 ATPsyndelta 
crb Acf CG11486 ATPsynE 
Ugt36Ba mRpS33 CG11655 ATPsynO 
hebe CAH1 CG11656 aurB 
CR40611 CG30280 CG12398 Bap60 
CG3036 icln CG12868 beg 
crim CG30069 CG13088 beta'COP 
CG10324 Rpn11 CG14074 beta4GalT7 
CR45753 CR42874 CG14252 Caf1-180 
ZIPIC CG16941 CG14352 caix 
CR42746 DNA-ligI CG14367 CCHa1-R 
CG11638 betaggt-II CG14443 CCHa2 
CG9018 CG5728 CG14770 CG10000 
alphaTub67C FK506-bp2 CG14837 CG10472 
Mst36Fb BubR1 CG14877 CG10584 
ATP7 CG11060 CG14965 CG10869 
rgr CG16985 CG15084 CG10911 
CR46104 fng CG15760 CG10912 
CG5002 CG14969 CG16833 CG10939 
CG17977 m CG16898 CG11164 
CG6770 CG33679 CG17018 CG11241 
CG30385 CG32278 CG17684 CG11403 
CG3223 CG11788 CG17687 CG11562 
CG33645 Inx7 CG17786 CG11590 
CG17765 tank CG17929 CG11777 
Gmap DIP-iota CG18599 CG11858 
alpha-Man-Ia Tsp42Ec CG18635 CG11878 
Fcp3C mRpL45 CG2064 CG11899 
Ns2 Eps-15 CG30022 CG11912 
 
 
346 
CR45798 CG11851 CG30047 CG11964 
CG15461 babo CG3008 CG12129 
mbc GAPcenA CG30440 CG12173 
CG15879 ND-13B CG30441 CG12204 
CG7332 GstE9 CG30456 CG12237 
CG2641 CR44026 CG31347 CG12279 
nahoda l(1)G0004 CG31431 CG12288 
snoRNA:Psi28S-2566 Bap111 CG31627 CG12321 
Sin1 CG33301 CG31817 CG1236 
CG12025 Cyp305a1 CG32371 CG12825 
wake CG12093 CG32450 CG1287 
CR44992 btn CG32486 CG13008 
Cys pn CG32845 CG13082 
CG15611 CG14757 CG32855 CG13324 
Sry-delta crn CG33468 CG13364 
Aatf CG7992 CG33640 CG13492 
CG8713 CG4332 CG33710 CG14104 
AspRS-m CG2233 CG33928 CG14270 
CG13252 CG13928 CG34231 CG14499 
azot UQCR-C1 CG3556 CG14526 
CG15818 CG31546 CG3709 CG14543 
Ctr1A Trxr-1 CG3838 CG15414 
RIOK2 CG12608 CG3982 CG15605 
Pde6 wrapper CG3995 CG16700 
snoRNA:nop5-x16-a CG10194 CG42364 CG16734 
CR43241 CG13563 CG42553 CG16979 
zetaCOP Set CG42818 CG17068 
Cyp6a13 CAH2 CG43646 CG17145 
Grd CSN7 CG43925 CG17278 
btv sc CG43968 CG17570 
CG5567 CG16953 CG4404 CG17633 
CG8036 CG10425 CG44405 CG17660 
CG6138 CG16723 CG4462 CG17841 
Trim9 CG17760 CG45428 CG17855 
scaRNA:PsiU5-44 CG2533 CG4676 CG18179 
CG5810 CG10467 CG4723 CG18180 
CG1360 CG6462 CG5114 CG18577 
CR45979 Mip CG6330 CG1907 
CG5071 CG11880 CG6405 CG1942 
CG6443 CG2608 CG6602 CG2254 
prt CG8417 CG6628 CG2681 
CR45035 lab CG6791 CG30001 
 
 
347 
bin3 CG4045 CG7564 CG30283 
Sodh-2 Nup75 CG7706 CG30287 
CG12909 lds CG7966 CG30339 
CR32690 rin CG8072 CG30345 
CG32814 Ugt36Bb CG8223 CG30411 
Cul2 CR45607 CG8273 CG30493 
Lrch Cks30A CG8319 CG31076 
Gbp1 Tango4 CG8492 CG31126 
mir-2b-2 CG14694 CG9505 CG31251 
ex Cdk7 CG9945 CG31345 
Prx2540-1 Ube3a CkIIalpha-i1 CG31550 
da Fen1 CR32218 CG31918 
CG14353 CG11771 CR41544 CG32091 
Ak6 CG7156 CR41583 CG32201 
Su(H) OstStt3 CR43405 CG32284 
CG3335 l(2)35Bd CR43653 CG32483 
CR44758 sel CR43849 CG32669 
CG9951 Cdc6 CR43909 CG33178 
CG14562 ATPsynD CR44138 CG3344 
Stat92E rig CR44440 CG34026 
let-7-C CG8858 CR44566 CG34132 
Smr mus301 CR44817 CG34200 
noc Prosalpha4 CR45054 CG34288 
CG13339 CG15673 CR45128 CG34404 
CG11384 Mulk CR45148 CG3706 
su(r) CG6495 CR45171 CG3868 
CG42450 SWIP CR45224 CG3906 
CG3308 Dhc36C CR45820 CG3909 
CG10516 CG8192 CR45915 CG4194 
ZC3H3 CG5267 CR45939 CG42327 
CG5500 CG34150 CR46015 CG42397 
CG4022 CG42239 CR46249 CG42714 
cnir Gga CrebA CG4278 
CG32783 edl cwo CG42825 
CG7611 CR44512 Cyp311a1 CG43295 
cv-d CG30344 Cyp4p3 CG4557 
snoRNA:Me18S-
U1356a 
mRpS18A Cyp6d5 CG4627 
snoRNA:684 GCC88 Dat CG4839 
CR45188 ND-B14.5A dpr1 CG5010 
az2 Scox dsx-c73A CG5107 
CR44779 CG6227 ebd1 CG5167 
fand CG15536 Elp1 CG5214 
 
 
348 
sgl Prosalpha7 fidipidine CG5254 
CR45620 CG14407 foi CG5255 
CG6665 Cat Gk2 CG5569 
smg CG17059 glec CG5724 
CG10262 CG3803 GluRIIE CG5892 
Tdc2 CG9065 GstE1 CG6067 
Su(Tpl) Tcp-1eta GstE7 CG6295 
CG33137 CR46245 GstE8 CG6454 
CG12007 Drat Hexo2 CG7379 
CHKov1 Pms2 hog CG7458 
4EHP CG15422 Hsc70-3 CG7470 
Spn42Dd CG11034 Ir51b CG7560 
CG30414 CG34253 Ir85a CG7630 
scaf6 mRpS24 ITP CG7837 
CG17249 IleRS-m JhI-26 CG7889 
ymp CG10877 Kif3C CG8258 
egl CG4880 Krn CG8311 
mthl10 st l(3)02640 CG8323 
fs(1)K10 CG5721 lace CG8562 
CG32437 mtSSB Lap1 CG8642 
CG5705 CR45804 lbm CG8818 
CR43899 CG42763 Lcch3 CG8891 
CG13108 CG3902 lt CG8952 
CG31606 CR45921 mdy CG9344 
CG14855 mys MFS14 CG9581 
CG43188 CG31798 MFS3 CG9752 
Su(z)2 CG1598 mir-4968 Cisd2 
Efa6 GluProRS mir-967 Cpr73D 
fzo CG4406 Mrp4 CR15061 
p CG2680 mrt CR44478 
CG7794 CG17646 mthl14 CR44692 
CG8239 CG14683 Muc14A CR44724 
CR43644 FK506-bp1 Naam CR44868 
CG6340 CG10628 NC2alpha CR45474 
CG32095 CG12219 nmo CR45973 
tws Miro PGRP-LF cry 
Edc3 CG8132 PGRP-SD CstF-50 
CR44022 CG12375 Pig1 Ctf4 
Spt20 Amyrel Pih1D1 CycE 
RhoL CG13365 pkaap Cyp1 
CG15766 CG15653 PlexA Cyp6d2 
CG42258 CG5589 ppk dgt3 
 
 
349 
jumu Rpn1 ppk27 dgt6 
pwn CG6428 Pzl DNApol-alpha180 
CG12003 l(2)37Bb Rab2 DNApol-alpha50 
gkt Oga Rbcn-3B DNApol-epsilon58 
CG42266 Tfb4 ric8a DNaseII 
CR43436 Gr66a rost dnd 
wde CG43120 row dome 
DptA CG15247 shams E(spl)m2-BFM 
Eph l(1)G0045 shg E(spl)m8-HLH 
Or85f SelG sima ecd 
MED1 CR32194 sinu Eip63F-1 
Vps39 CG34220 Smurf Est-Q 
pcs COX7A SmydA-5 Fadd 
pygo GckIII Snap24 Fit2 
snoRNA:Psi18S-841b Sas-4 snoRNA:Psi18S-1086 Gip 
CG15563 mRpL30 snoRNA:Psi18S-1275 GlcT-1 
CG43192 CG8311 Sox102F Glo1 
CG6843 CG30001 sstn glu 
CR43399 RpS15Ab ssx Gr8a 
AttD CG33178 St3 Gs1l 
mir-4964 CG5255 stas Gycalpha99B 
CR46064 stg swa hdm 
CG5642 CG30287 Tab2 Hex-C 
Atac2 glu Taf11 Hsp70Bbb 
Src42A CG8323 Tbc1d15-17 Hydr1 
qkr58E-1 CG11858 Tgi Ibf2 
CR44348 Ptp52F Tsp42Ef Ing3 
CG3163 Ibf2 ttm2 IntS4 
CG16711 nht Ugt86Dc Irp-1A 
CR45256 mRpL54 wts Jheh3 
CG4455 ATPsynB 
 
Jon99Ci 
kune tex 
 
Jon99Cii 
dgt1 Acp53Ea 
 
Jon99Ciii 
CG16716 Fadd 
 
kappaTry 
Lap1 Pgm 
 
Klp61F 
CG9505 CG11164 
 
lectin-46Ca 
CG33468 Mgstl 
 
lectin-46Cb 
Ir51b CG7560 
 
Lgr3 
Tgi Pdxk 
 
LysD 
wts vls 
 
LysE 
foi CG11590 
 
mag 
CG17018 Ing3 
 
Mcm2 
 
 
350 
mrt CG12204 
 
Mcm5 
glec mRpL44 
 
Mdh2 
CR45224 CG17068 
 
Mdr50 
CG30456 RpS14a 
 
Mesh1 
shg CG3706 
 
Mgstl 
CR45148 CG11964 
 
mRpL10 
pkaap CG17145 
 
mRpL12 
CG14877 CG4278 
 
mRpL18 
CG43646 CG3909 
 
mRpL20 
CR43909 TyrRS-m 
 
mRpL34 
CG14770 mRpL18 
 
mRpL36 
Cyp311a1 CstF-50 
 
mRpL44 
CR45054 Adgf-C 
 
mRpL47 
CG42818 mRpS35 
 
mRpL54 
GstE7 CG16979 
 
mRpS11 
CR45915 beg 
 
mRpS35 
CR43849 Nrk 
 
msb1l 
CR43653 lectin-46Cb 
 
msd1 
CR44817 CG13492 
 
msd5 
JhI-26 p47 
 
Muc68Ca 
Taf11 CG12279 
 
Muc68E 
CG45428 CG12173 
 
Mur29B 
CR43405 Spp 
 
ND-B15 
CR32218 CG17570 
 
Ndc1 
CG17684 tam 
 
nht 
fidipidine Rrp42 
 
Npc2f 
Mrp4 Caf1-180 
 
Nrk 
lace Sld5 
 
Orc5 
CG14965 CG9752 
 
Osbp 
GluRIIE mRpL10 
 
ox 
CG16833 CG18577 
 
p47 
mthl14 CR45973 
 
pcl 
CrebA GlcT-1 
 
Pdxk 
CG8223 CG31251 
 
Pgm 
Tbc1d15-17 CG30493 
 
PGRP-SC2 
nmo mRpL34 
 
phyl 
GstE1 CG11562 
 
ppk3 
CG16898 arx 
 
Ptp52F 
CG14352 mRpL20 
 
rasp 
SmydA-5 CG3868 
 
Rbf2 
cwo CG17841 
 
RpS14a 
Cyp4p3 CR45474 
 
RpS15Ab 
 
 
351 
14-3-3zeta mRpL47 
 
Rrp42 
CR41544 mRpL12 
 
Sc2 
CG7706 CG32284 
 
schuy 
bun Gs1l 
 
Sdhaf3 
CG31817 Lgr3 
 
Sirt2 
dsx-c73A CG11777 
 
Sld5 
Tsp42Ef CG4557 
 
snoRNA:Psi18S-531 
CG7564 CG14499 
 
spdo 
CG18635 mRpL36 
 
SPH93 
PGRP-LF CG12321 
 
Spindly 
CG14252 CG8891 
 
Spp 
l(3)02640 CG4627 
 
sqa 
CG30022 CG34404 
 
Ssb-c31a 
CR45128 hdm 
 
stg 
Kif3C Cisd2 
 
Surf4 
Snap24 CG8258 
 
Taldo 
ppk CG11878 
 
tam 
CG34231 pcl 
 
tej 
Rab2 beta4GalT7 
 
tex 
CG33710 CG5167 
 
Tgt 
MFS14 CG2254 
 
toy 
Rbcn-3B dnd 
 
Tps1 
CG31431 CG7837 
 
TyrRS-m 
CG4676 Tgt 
 
upd2 
AhcyL2 IntS4 
 
Vha14-1 
mir-967 Sc2 
 
Vha36-1 
CG32371 CG11912 
 
vls 
CkIIalpha-i1 CG32201 
 
w 
Elp1 toy 
  
MFS3 Gycalpha99B 
 
CG10638 Gr8a 
  
CG17929 CCHa1-R 
  
CG17786 CG8818 
  
CG32855 DNApol-alpha50 
 
CG31347 Irp-1A 
  
CG9945 Cyp1 
  
CG15760 CG5569 
  
rost CG31550 
  
CG33640 rasp 
  
CR44440 Mdh2 
  
CG43925 Cpr73D 
  
CG11655 CG10472 
  
 
 
352 
GstE8 CG32669 
  
lbm Orc5 
  
ttm2 CycE 
  
CG3995 CG13008 
  
CG11486 Bap60 
  
CG3709 CG34200 
  
row CG30345 
  
CG8273 CG14270 
  
stas CG5010 
  
Pih1D1 CG31126 
  
ric8a Taldo 
  
mdy msb1l 
  
CG3838 Hydr1 
  
CR45939 Eip63F-1 
  
lt CG13324 
  
snoRNA:Psi18S-1086 sqa 
  
Naam beta'COP 
  
CG14074 CG12825 
  
CG5114 ND-B15 
  
CG30441 Sdhaf3 
  
CG17687 CG30283 
  
Atf6 Mcm5 
  
CG6791 Klp61F 
  
Dat cry 
  
St3 Hsp70Bbb 
  
CG8492 CG5214 
  
CG32450 CG7889 
  
hog CG14543 
  
CR46015 aurB 
  
Atac1 ATPsynE 
  
Ugt86Dc mRpS11 
  
Cyp6d5 snoRNA:Psi18S-531 
 
Gk2 CG1236 
  
CG13088 CG32483 
  
Muc14A CG12129 
  
CG10730 CR44868 
  
Smurf schuy 
  
CG12398 Spindly 
  
dpr1 Mur29B 
  
ITP CG6454 
  
Sox102F CG1907 
  
CG32486 Mdr50 
  
 
 
353 
CG6330 CG17278 
  
CG33928 msd5 
  
Hsc70-3 Zw10 
  
CG6602 Mcm2 
  
Pig1 CG14104 
  
CG14443 alpha-Est1 
  
CG32845 CG13364 
  
CG4723 DNApol-epsilon58 
 
PlexA kappaTry 
  
sstn CG11403 
  
CG11000 Vha14-1 
  
mir-4968 ATPsynO 
  
shams CG9344 
  
bnl CG7379 
  
CG2064 CG30339 
  
CG3008 spdo 
  
CG8319 Ndc1 
  
a Npc2f 
  
CR45171 CG10939 
  
CG30440 CR15061 
  
ebd1 CG1942 
  
CG4462 ox 
  
CG14837 CR44724 
  
CR44138 CG43295 
  
CG3982 CG17660 
  
CG30047 CG10584 
  
ssx CG17855 
  
CG42553 CR44478 
  
CG3556 caix 
  
CG7966 Ssb-c31a 
  
Lcch3 Gip 
  
Ir85a CG4839 
  
NC2alpha Glo1 
  
sima CG4194 
  
CR46249 AIMP1 
  
CG15084 ecd 
  
Pzl CG7470 
  
ppk27 CG32091 
  
CR41583 CG11899 
  
PGRP-SD CG1287 
  
CG6628 CG3906 
  
swa AP-1-2beta 
  
 
 
354 
CG4404 phyl 
  
sinu lectin-46Ca 
  
CR44566 Ctf4 
  
CG43968 CG12237 
  
CG31627 DNApol-alpha180 
 
CG42364 SPH93 
  
CG8072 CG13082 
  
CG6405 CG31918 
  
CR45820 E(spl)m2-BFM 
 
bou CG8562 
  
AOX2 Hex-C 
  
Tab2 asp 
  
CG12868 Muc68Ca 
  
snoRNA:Psi18S-1275 CG7630 
  
Arc1 CG16700 
  
Hexo2 CR44692 
  
CG18599 CG42714 
  
CG44405 CCHa2 
  
CG14367 mag 
  
CG11656 E(spl)m8-HLH 
 
 
 
Table 2.4d:  Pathway enrichment for hits differentially upregulated in 20HE males relative to control 
females 
Pathway 
enrichment 
p-value Hits Gene matches Pathway ID 
Galactose 
metabolism 
9.47362E-06 FBgn0002569,FBg
n0002570,FBgn00
33294,FBgn00332
97,FBgn0260746,F
Bgn0261575 
6 52 
Starch and sucrose 
metabolism 
5.93946E-05 FBgn0002569,FBg
n0002570,FBgn00
26755,FBgn00332
94,FBgn0033297,F
Bgn0040256,FBgn
0261575 
7 500 
PI5P, PP2A and 
IER3 Regulate 
PI3K/AKT 
Signaling 
0.000454317 FBgn0003984,FBg
n0016794,FBgn00
22800,FBgn00400
68 
4 R-DME-6811558 
Negative 
regulation of the 
PI3K/AKT 
network 
0.000774174 FBgn0003984,FBg
n0016794,FBgn00
22800,FBgn00400
68 
4 R-DME-199418 
Metabolism of 
xenobiotics by 
cytochrome P450 
0.003300173 FBgn0010039,FBg
n0010040,FBgn00
10041,FBgn00267
55,FBgn0040256 
5 980 
Drug metabolism - 0.003561307 FBgn0010039,FBg 5 982 
 
 
355 
cytochrome P450 n0010040,FBgn00
10041,FBgn00267
55,FBgn0040256 
PI3K events in 
ERBB2 signaling 
0.004529543 FBgn0003984,FBg
n0016794 
2 R-DME-1963642 
Nephrin family 
interactions 
0.004529543 FBgn0000547,FBg
n0028369 
2 R-DME-373753 
Signaling by 
Receptor Tyrosine 
Kinases 
0.005106565 FBgn0003984,FBg
n0014388,FBgn00
16794,FBgn00228
00,FBgn0027779,F
Bgn0040068,FBgn
0052055,FBgn026
2081,FBgn028349
9 
9 R-DME-9006934 
Signaling by 
Insulin receptor 
0.005853482 FBgn0016794,FBg
n0022800,FBgn00
27779,FBgn02834
99 
4 R-DME-74752 
FLT3 Signaling 0.009468478 FBgn0003984,FBg
n0016794,FBgn00
22800,FBgn02620
81,FBgn0265778 
5 R-DME-9607240 
Signaling by SCF-
KIT 
0.010497272 FBgn0022800,FBg
n0040068 
2 R-DME-1433557 
Signaling by 
ERBB2 
0.010688809 FBgn0003984,FBg
n0016794,FBgn02
62081 
3 R-DME-1227986 
Signaling by 
EGFR 
0.0118715 FBgn0014388,FBg
n0016794,FBgn00
52055 
3 R-DME-177929 
Aflatoxin 
activation and 
detoxification 
0.012969919 FBgn0036986,FBg
n0037818 
2 R-DME-5423646 
SUMOylation of 
intracellular 
receptors 
0.015669143 FBgn0000568,FBg
n0004865 
2 R-DME-4090294 
Signal 
Transduction 
0.017769782 FBgn0000163,FBg
n0000250,FBgn00
00568,FBgn00012
29,FBgn0003984,F
Bgn0014388,FBgn
0016794,FBgn001
9985,FBgn002280
0,FBgn0023416,F
Bgn0027779,FBgn
0030011,FBgn003
0505,FBgn003146
1,FBgn0031885,F
Bgn0034706,FBgn
0036290,FBgn003
6518,FBgn004006
8,FBgn0052055,F
Bgn0085432,FBgn
0262081,FBgn026
5778,FBgn028349
9 
24 R-DME-162582 
 
 
356 
Glutathione 
metabolism 
0.021811993 FBgn0010039,FBg
n0010040,FBgn00
10041,FBgn00100
44 
4 480 
Ca2+ pathway 0.022205774 FBgn0030011,FBg
n0030505,FBgn00
85432 
3 R-DME-4086398 
Downregulation of 
ERBB2 signaling 
0.025040297 FBgn0003984,FBg
n0262081 
2 R-DME-8863795 
PI3K Cascade 0.028560994 FBgn0016794,FBg
n0022800 
2 R-DME-109704 
Formation of the 
beta-catenin:TCF 
transactivating 
complex 
0.028560994 FBgn0031885,FBg
n0085432 
2 R-DME-201722 
RAF/MAP kinase 
cascade 
0.031215951 FBgn0003984,FBg
n0022800,FBgn02
62081,FBgn02657
78 
4 R-DME-5673001 
IRS-mediated 
signalling 
0.032266979 FBgn0016794,FBg
n0022800 
2 R-DME-112399 
IRS-related events 
triggered by 
IGF1R 
0.032266979 FBgn0016794,FBg
n0022800 
2 R-DME-2428928 
Surfactant 
metabolism 
0.032266979 FBgn0032223,FBg
n0263747 
2 R-DME-5683826 
MAPK1/MAPK3 
signaling 
0.032726615 FBgn0003984,FBg
n0022800,FBgn02
62081,FBgn02657
78 
4 R-DME-5684996 
Transcriptional 
regulation of white 
adipocyte 
differentiation 
0.035453374 FBgn0000568 1 R-DME-381340 
TGF-beta receptor 
signaling in EMT 
(epithelial to 
mesenchymal 
transition) 
0.03615065 FBgn0000163,FBg
n0031461 
2 R-DME-2173791 
Signaling by Type 
1 Insulin-like 
Growth Factor 1 
Receptor (IGF1R) 
0.03615065 FBgn0016794,FBg
n0022800 
2 R-DME-2404192 
IGF1R signaling 
cascade 
0.03615065 FBgn0016794,FBg
n0022800 
2 R-DME-2428924 
Non-integrin 
membrane-ECM 
interactions 
0.040204616 FBgn0031461,FBg
n0053531 
2 R-DME-3000171 
Insulin receptor 
signalling cascade 
0.040204616 FBgn0016794,FBg
n0022800 
2 R-DME-74751 
MAPK family 
signaling cascades 
0.042682581 FBgn0003984,FBg
n0022800,FBgn02
62081,FBgn02657
78 
4 R-DME-5683057 
Presynaptic 
function of Kainate 
0.044421685 FBgn0030011,FBg
n0039927 
2 R-DME-500657 
 
 
357 
receptors 
Signaling by 
FGFR4 
0.048794866 FBgn0014388,FBg
n0016794 
2 R-DME-5654743 
 
Table 2.4f: Pathway enrichment for hits differentially upregulated in control females relative to 
20HE males 
p-value Hits Gene 
matche
s 
Pathway 
ID 
0.00708
5029 
FBgn0003257,FBgn0011211,FBgn0011703,FBgn0011704,FBgn0011
768,FBgn0014028,FBgn0015277,FBgn0025352,FBgn0025373,FBgn
0025592,FBgn0028375,FBgn0029823,FBgn0030966,FBgn0031630,F
Bgn0031703,FBgn0032350,FBgn0033216,FBgn0033377,FBgn00346
29,FBgn0034988,FBgn0035383,FBgn0035619,FBgn0036381,FBgn0
036575,FBgn0037513,FBgn0037534,FBgn0037846,FBgn0037880,F
Bgn0037958,FBgn0038074,FBgn0038407,FBgn0038467,FBgn00385
42,FBgn0038742,FBgn0039470,FBgn0039472,FBgn0039475,FBgn0
039476,FBgn0040069,FBgn0050502,FBgn0052750,FBgn0053116,F
Bgn0283680 
43 R-DME-
1430728 
0.01592
2058 
FBgn0003257,FBgn0011211,FBgn0011703,FBgn0011704,FBgn0011
768,FBgn0014028,FBgn0015277,FBgn0015572,FBgn0024957,FBgn
0025352,FBgn0025373,FBgn0025592,FBgn0029823,FBgn0029906,F
Bgn0031703,FBgn0031713,FBgn0032350,FBgn0033377,FBgn00346
29,FBgn0035619,FBgn0037356,FBgn0037513,FBgn0037958,FBgn0
038467,FBgn0038613,FBgn0038742,FBgn0039094,FBgn0039580,F
Bgn0040069,FBgn0053116,FBgn0053138,FBgn0259676,FBgn02836
80 
33 1100 
0.00180
5804 
FBgn0015277,FBgn0025352,FBgn0025373,FBgn0025592,FBgn0031
630,FBgn0031703,FBgn0033216,FBgn0034629,FBgn0035383,FBgn
0035619,FBgn0036381,FBgn0037534,FBgn0037958,FBgn0038407,F
Bgn0038742,FBgn0039470,FBgn0039472,FBgn0039475,FBgn00394
76,FBgn0050502,FBgn0053116 
21 R-DME-
556833 
0.03059
6156 
FBgn0011692,FBgn0015553,FBgn0020633,FBgn0025815,FBgn0025
832,FBgn0026143,FBgn0027868,FBgn0029856,FBgn0032244,FBgn
0032929,FBgn0041147,FBgn0259676,FBgn0259791,FBgn0286788 
14 R-DME-
1640170 
0.03125
1957 
FBgn0011692,FBgn0020633,FBgn0025815,FBgn0025832,FBgn0026
143,FBgn0027868,FBgn0029856,FBgn0032244,FBgn0032929,FBgn
0041147,FBgn0259676,FBgn0259791,FBgn0286788 
13 R-DME-
69278 
0.00180
4544 
FBgn0015277,FBgn0025352,FBgn0033216,FBgn0035619,FBgn0036
381,FBgn0039470,FBgn0039472,FBgn0039475,FBgn0039476,FBgn
0053116 
10 R-DME-
1483257 
0.00328
9324 
FBgn0020633,FBgn0025815,FBgn0025832,FBgn0026143,FBgn0029
856,FBgn0032244,FBgn0032929,FBgn0041147,FBgn0259676,FBgn
0286788 
10 R-DME-
69306 
0.04482
8241 
FBgn0013548,FBgn0015553,FBgn0025832,FBgn0029856,FBgn0032
244,FBgn0033549,FBgn0037345,FBgn0040078,FBgn0261850,FBgn
0267727 
10 R-DME-
73894 
0.00063
4202 
FBgn0025352,FBgn0033216,FBgn0035619,FBgn0036381,FBgn0039
470,FBgn0039472,FBgn0039475,FBgn0039476,FBgn0053116 
9 R-DME-
1483206 
0.01131
9054 
FBgn0015553,FBgn0020633,FBgn0025815,FBgn0026143,FBgn0029
856,FBgn0032244,FBgn0032929,FBgn0041147,FBgn0286788 
9 R-DME-
69620 
0.00822
3325 
FBgn0025352,FBgn0031703,FBgn0033216,FBgn0034629,FBgn0035
383,FBgn0037534,FBgn0038407,FBgn0038742 
8 R-DME-
8978868 
0.01522
2878 
FBgn0020633,FBgn0025815,FBgn0025832,FBgn0029856,FBgn0032
244,FBgn0041147,FBgn0259676,FBgn0286788 
8 R-DME-
69239 
0.02764 FBgn0020633,FBgn0025815,FBgn0025832,FBgn0029856,FBgn0032 8 R-DME-
 
 
358 
311 244,FBgn0041147,FBgn0259676,FBgn0286788 69242 
0.00112
775 
FBgn0015553,FBgn0020633,FBgn0025815,FBgn0026143,FBgn0032
244,FBgn0032929,FBgn0286788 
7 R-DME-
69481 
0.01071
3028 
FBgn0020633,FBgn0025815,FBgn0026143,FBgn0029856,FBgn0032
929,FBgn0259676,FBgn0286788 
7 R-DME-
69002 
0.03771
378 
FBgn0020633,FBgn0025815,FBgn0026143,FBgn0029856,FBgn0032
929,FBgn0259676,FBgn0286788 
7 R-DME-
69206 
0.00063
1673 
FBgn0011768,FBgn0025352,FBgn0031703,FBgn0034629,FBgn0035
383,FBgn0038742 
6 71 
0.00063
1673 
FBgn0020633,FBgn0025815,FBgn0026143,FBgn0032929,FBgn0259
676,FBgn0286788 
6 R-DME-
68962 
0.00079
9516 
FBgn0020633,FBgn0025815,FBgn0026143,FBgn0032244,FBgn0032
929,FBgn0286788 
6 R-DME-
176187 
0.00099
984 
FBgn0020633,FBgn0025815,FBgn0025832,FBgn0031252,FBgn0032
244,FBgn0259676 
6 3030 
0.00971
6104 
FBgn0003257,FBgn0011703,FBgn0011704,FBgn0034988,FBgn0037
513,FBgn0038467 
6 R-DME-
15869 
0.04470
2805 
FBgn0003257,FBgn0011703,FBgn0011704,FBgn0020653,FBgn0037
513,FBgn0259676 
6 240 
0.00859
338 
FBgn0035619,FBgn0039470,FBgn0039472,FBgn0039475,FBgn0039
476 
5 R-DME-
1483166 
0.03020
9845 
FBgn0015553,FBgn0025832,FBgn0032244,FBgn0033549,FBgn0267
727 
5 R-DME-
5693532 
0.00679
1084 
FBgn0039470,FBgn0039472,FBgn0039475,FBgn0039476 4 R-DME-
1482801 
0.00841
9111 
FBgn0029823,FBgn0032350,FBgn0038074,FBgn0039094 4 260 
0.03080
024 
FBgn0022700,FBgn0033377,FBgn0034582,FBgn0039580 4 520 
0.03926
3616 
FBgn0013548,FBgn0029856,FBgn0032244,FBgn0037345 4 R-DME-
73893 
0.04394
5631 
FBgn0015553,FBgn0025832,FBgn0032244,FBgn0033549 4 R-DME-
5693538 
0.04394
5631 
FBgn0029856,FBgn0031092,FBgn0033812,FBgn0034629 4 R-DME-
9033241 
0.00944
7184 
FBgn0025352,FBgn0031703,FBgn0038742 3 R-DME-
77289 
0.02031
0018 
FBgn0010425,FBgn0011555,FBgn0030954 3 4080 
0.02031
0018 
FBgn0029856,FBgn0032244,FBgn0037345 3 R-DME-
110312 
0.02031
0018 
FBgn0029856,FBgn0032244,FBgn0037345 3 R-DME-
5655862 
0.02031
0018 
FBgn0029856,FBgn0032244,FBgn0037345 3 R-DME-
5656121 
0.02497
991 
FBgn0025832,FBgn0032244,FBgn0259676 3 R-DME-
69186 
0.03589
8487 
FBgn0025832,FBgn0032244,FBgn0259676 3 R-DME-
69190 
0.03589
8487 
FBgn0022700,FBgn0035619,FBgn0261675 3 R-DME-
8963743 
0.00217
5169 
FBgn0025352,FBgn0038742 2 R-DME-
77350 
0.01226
1509 
FBgn0025352,FBgn0038742 2 R-DME-
77286 
 
 
359 
0.01226
1509 
FBgn0038135,FBgn0051343 2 R-DME-
983170 
0.01981
1617 
FBgn0031630,FBgn0033216 2 R-DME-
2187335 
0.01981
1617 
FBgn0038312,FBgn0038412 2 R-DME-
435354 
0.01981
1617 
FBgn0038312,FBgn0038412 2 R-DME-
442380 
0.02881
3137 
FBgn0034988,FBgn0037513 2 R-DME-
73621 
0.03911
5641 
FBgn0036381,FBgn0053116 2 R-DME-
1483213 
0.03911
5641 
FBgn0032244,FBgn0259676 2 R-DME-
174411 
0.03911
5641 
FBgn0032244,FBgn0259676 2 R-DME-
69091 
0.03911
5641 
FBgn0032244,FBgn0259676 2 R-DME-
69109 
0.04679
7212 
FBgn0040069 1 780 
0.04679
7212 
FBgn0051915 1 R-DME-
1474290 
0.04679
7212 
FBgn0051915 1 R-DME-
1650814 
0.04679
7212 
FBgn0038542 1 R-DME-
392023 
0.04679
7212 
FBgn0028375 1 R-DME-
6806664 
0.04679
7212 
FBgn0029823 1 R-DME-
71262 
0.04679
7212 
FBgn0011768 1 R-DME-
71384 
0.04679
7212 
FBgn0025352 1 R-DME-
77285 
0.04679
7212 
FBgn0025352 1 R-DME-
77310 
0.04679
7212 
FBgn0038742 1 R-DME-
77352 
 
Table 2.4e: GO enrichment for hits differentially upregulated in 20HE males relative to control 
females 
GO enrichment p-value Hits Gene 
matches 
GO 
ID 
multicellular 
organismal process 
0.0032011 FBgn0000152,FBgn0000163,FBgn00
00250,FBgn0000395,FBgn0000451,
FBgn0000542,FBgn0000547,FBgn00
00568,FBgn0000826,FBgn0000928,
FBgn0001112,FBgn0001234,FBgn00
02566,FBgn0002609,FBgn0002632,
FBgn0002633,FBgn0002643,FBgn00
02732,FBgn0003984,FBgn0004893,
FBgn0010238,FBgn0010501,FBgn00
10768,FBgn0011674,FBgn0014073,
FBgn0014388,FBgn0015229,FBgn00
15946,FBgn0016794,FBgn0019985,
FBgn0020300,FBgn0022800,FBgn00
89 GO:00
32501 
 
 
360 
24250,FBgn0024555,FBgn0026263,
FBgn0026319,FBgn0027779,FBgn00
28369,FBgn0029082,FBgn0030985,
FBgn0031461,FBgn0031853,FBgn00
31885,FBgn0033404,FBgn0033773,
FBgn0033942,FBgn0033985,FBgn00
34098,FBgn0034199,FBgn0034262,
FBgn0035461,FBgn0035513,FBgn00
35626,FBgn0036282,FBgn0036518,
FBgn0036666,FBgn0036732,FBgn00
36801,FBgn0037802,FBgn0038168,
FBgn0038832,FBgn0039469,FBgn00
39509,FBgn0040068,FBgn0040532,
FBgn0041160,FBgn0041241,FBgn00
41246,FBgn0045474,FBgn0045842,
FBgn0046332,FBgn0052133,FBgn00
52179,FBgn0052354,FBgn0052364,
FBgn0053527,FBgn0053531,FBgn00
85430,FBgn0085432,FBgn0259683,
FBgn0262081,FBgn0265778,FBgn02
66084,FBgn0267390,FBgn0283451,
FBgn0283499,FBgn0283545,FBgn02
86203,FBgn0287185 
response to 
stimulus 
0.00265597 FBgn0000250,FBgn0000395,FBgn00
00547,FBgn0000568,FBgn0001229,
FBgn0001234,FBgn0002566,FBgn00
02632,FBgn0002643,FBgn0002732,
FBgn0002939,FBgn0003984,FBgn00
04580,FBgn0004832,FBgn0010501,
FBgn0010768,FBgn0011674,FBgn00
13973,FBgn0014009,FBgn0014073,
FBgn0014388,FBgn0015946,FBgn00
16794,FBgn0019985,FBgn0020300,
FBgn0022800,FBgn0023416,FBgn00
24250,FBgn0024555,FBgn0025625,
FBgn0026319,FBgn0026777,FBgn00
29082,FBgn0029825,FBgn0029968,
FBgn0030011,FBgn0030286,FBgn00
30505,FBgn0031016,FBgn0031461,
FBgn0031757,FBgn0031885,FBgn00
33132,FBgn0033404,FBgn0033773,
FBgn0033885,FBgn0033980,FBgn00
33985,FBgn0034199,FBgn0034200,
FBgn0034262,FBgn0034647,FBgn00
35626,FBgn0036518,FBgn0036732,
FBgn0037007,FBgn0037163,FBgn00
37442,FBgn0040068,FBgn0040384,
FBgn0040849,FBgn0041160,FBgn00
45842,FBgn0052133,FBgn0052179,
FBgn0052638,FBgn0052706,FBgn00
53329,FBgn0053527,FBgn0053531,
FBgn0085430,FBgn0085432,FBgn02
59683,FBgn0261794,FBgn0262081,
FBgn0265778,FBgn0266084,FBgn02
67390,FBgn0283451,FBgn0283499 
80 GO:00
50896 
developmental 
process 
0.01555884 FBgn0000163,FBgn0000250,FBgn00
00395,FBgn0000451,FBgn0000542,
78 GO:00
32502 
 
 
361 
FBgn0000547,FBgn0000568,FBgn00
00826,FBgn0000928,FBgn0001112,
FBgn0001234,FBgn0002566,FBgn00
02609,FBgn0002632,FBgn0002633,
FBgn0002643,FBgn0002732,FBgn00
03984,FBgn0004893,FBgn0010238,
FBgn0010501,FBgn0010768,FBgn00
11674,FBgn0014073,FBgn0014388,
FBgn0015229,FBgn0015946,FBgn00
16794,FBgn0022800,FBgn0024250,
FBgn0024555,FBgn0026263,FBgn00
26319,FBgn0027779,FBgn0028369,
FBgn0029082,FBgn0031461,FBgn00
31853,FBgn0031885,FBgn0032223,
FBgn0033773,FBgn0033942,FBgn00
33985,FBgn0034098,FBgn0034199,
FBgn0034262,FBgn0035461,FBgn00
35513,FBgn0035626,FBgn0036282,
FBgn0036518,FBgn0036666,FBgn00
36732,FBgn0036801,FBgn0037802,
FBgn0038168,FBgn0039048,FBgn00
39469,FBgn0040068,FBgn0040532,
FBgn0041160,FBgn0045842,FBgn00
52133,FBgn0052179,FBgn0052354,
FBgn0052364,FBgn0053531,FBgn00
85430,FBgn0085432,FBgn0261245,
FBgn0262081,FBgn0265778,FBgn02
66084,FBgn0267390,FBgn0283451,
FBgn0283499,FBgn0286203,FBgn02
87185 
anatomical 
structure 
development 
0.00650427 FBgn0000163,FBgn0000250,FBgn00
00395,FBgn0000451,FBgn0000542,
FBgn0000547,FBgn0000568,FBgn00
00826,FBgn0000928,FBgn0001112,
FBgn0001234,FBgn0002566,FBgn00
02609,FBgn0002632,FBgn0002633,
FBgn0002643,FBgn0002732,FBgn00
03984,FBgn0004893,FBgn0010238,
FBgn0010501,FBgn0010768,FBgn00
11674,FBgn0014073,FBgn0014388,
FBgn0015229,FBgn0015946,FBgn00
16794,FBgn0022800,FBgn0024250,
FBgn0024555,FBgn0026263,FBgn00
26319,FBgn0027779,FBgn0028369,
FBgn0029082,FBgn0031461,FBgn00
31853,FBgn0031885,FBgn0033773,
FBgn0033942,FBgn0033985,FBgn00
34098,FBgn0034262,FBgn0035461,
FBgn0035513,FBgn0035626,FBgn00
36282,FBgn0036518,FBgn0036666,
FBgn0036732,FBgn0036801,FBgn00
37802,FBgn0038168,FBgn0039048,
FBgn0039469,FBgn0040068,FBgn00
40532,FBgn0041160,FBgn0045842,
FBgn0052133,FBgn0052179,FBgn00
52354,FBgn0052364,FBgn0053531,
FBgn0085430,FBgn0085432,FBgn02
76 GO:00
48856 
 
 
362 
61245,FBgn0262081,FBgn0265778,
FBgn0266084,FBgn0267390,FBgn02
83451,FBgn0283499,FBgn0286203,
FBgn0287185 
multicellular 
organism 
development 
0.00675677 FBgn0000163,FBgn0000250,FBgn00
00395,FBgn0000451,FBgn0000542,
FBgn0000547,FBgn0000568,FBgn00
00826,FBgn0001112,FBgn0002566,
FBgn0002609,FBgn0002632,FBgn00
02633,FBgn0002643,FBgn0002732,
FBgn0003984,FBgn0004893,FBgn00
10238,FBgn0010501,FBgn0010768,
FBgn0011674,FBgn0014073,FBgn00
14388,FBgn0015229,FBgn0015946,
FBgn0016794,FBgn0022800,FBgn00
24250,FBgn0024555,FBgn0026263,
FBgn0026319,FBgn0027779,FBgn00
28369,FBgn0029082,FBgn0031461,
FBgn0031853,FBgn0031885,FBgn00
33942,FBgn0033985,FBgn0034098,
FBgn0034262,FBgn0035461,FBgn00
35513,FBgn0036282,FBgn0036518,
FBgn0036666,FBgn0036732,FBgn00
36801,FBgn0037802,FBgn0038168,
FBgn0039469,FBgn0040068,FBgn00
40532,FBgn0041160,FBgn0045842,
FBgn0052133,FBgn0052179,FBgn00
52354,FBgn0053531,FBgn0085430,
FBgn0085432,FBgn0262081,FBgn02
65778,FBgn0266084,FBgn0267390,
FBgn0283451,FBgn0283499,FBgn02
86203,FBgn0287185 
69 GO:00
07275 
cell communication 0.00251377 FBgn0000250,FBgn0000395,FBgn00
00547,FBgn0000568,FBgn0001234,
FBgn0002566,FBgn0002632,FBgn00
02643,FBgn0002732,FBgn0002939,
FBgn0003984,FBgn0004580,FBgn00
10501,FBgn0013973,FBgn0014009,
FBgn0014073,FBgn0014388,FBgn00
15946,FBgn0016794,FBgn0019985,
FBgn0022800,FBgn0023416,FBgn00
24250,FBgn0025625,FBgn0026319,
FBgn0029082,FBgn0030011,FBgn00
30286,FBgn0030505,FBgn0031016,
FBgn0031461,FBgn0031885,FBgn00
33773,FBgn0033885,FBgn0033985,
FBgn0034199,FBgn0034200,FBgn00
34262,FBgn0034647,FBgn0035626,
FBgn0036518,FBgn0036732,FBgn00
37007,FBgn0037163,FBgn0039927,
FBgn0040068,FBgn0052179,FBgn00
52638,FBgn0053527,FBgn0053531,
FBgn0085432,FBgn0262081,FBgn02
65778,FBgn0267390,FBgn0283499 
55 GO:00
07154 
signaling 0.00223074 FBgn0000250,FBgn0000395,FBgn00
00547,FBgn0000568,FBgn0001234,
FBgn0002632,FBgn0002643,FBgn00
54 GO:00
23052 
 
 
363 
02732,FBgn0002939,FBgn0003984,
FBgn0004580,FBgn0010501,FBgn00
13973,FBgn0014009,FBgn0014073,
FBgn0014388,FBgn0015946,FBgn00
16794,FBgn0019985,FBgn0022800,
FBgn0023416,FBgn0024250,FBgn00
25625,FBgn0026319,FBgn0029082,
FBgn0030011,FBgn0030286,FBgn00
30505,FBgn0031016,FBgn0031461,
FBgn0031885,FBgn0033773,FBgn00
33885,FBgn0033985,FBgn0034199,
FBgn0034200,FBgn0034262,FBgn00
34647,FBgn0035626,FBgn0036518,
FBgn0036732,FBgn0037007,FBgn00
37163,FBgn0039927,FBgn0040068,
FBgn0052179,FBgn0052638,FBgn00
53527,FBgn0053531,FBgn0085432,
FBgn0262081,FBgn0265778,FBgn02
67390,FBgn0283499 
cellular response to 
stimulus 
0.00087659 FBgn0000250,FBgn0000395,FBgn00
00568,FBgn0001229,FBgn0001234,
FBgn0002566,FBgn0002643,FBgn00
02939,FBgn0003984,FBgn0004832,
FBgn0010501,FBgn0013973,FBgn00
14009,FBgn0014073,FBgn0014388,
FBgn0015946,FBgn0016794,FBgn00
19985,FBgn0022800,FBgn0023416,
FBgn0024250,FBgn0024555,FBgn00
25625,FBgn0026319,FBgn0026777,
FBgn0029825,FBgn0030011,FBgn00
30286,FBgn0031016,FBgn0031461,
FBgn0031885,FBgn0033132,FBgn00
33885,FBgn0033985,FBgn0034199,
FBgn0034200,FBgn0034262,FBgn00
35626,FBgn0036518,FBgn0036732,
FBgn0037007,FBgn0037163,FBgn00
40068,FBgn0052179,FBgn0052638,
FBgn0053527,FBgn0053531,FBgn00
85432,FBgn0261794,FBgn0265778,
FBgn0267390,FBgn0283451,FBgn02
83499 
53 GO:00
51716 
cellular 
developmental 
process 
0.01542028 FBgn0000163,FBgn0000250,FBgn00
00542,FBgn0000547,FBgn0000568,
FBgn0000928,FBgn0001234,FBgn00
02609,FBgn0002632,FBgn0002633,
FBgn0002643,FBgn0002732,FBgn00
03984,FBgn0010501,FBgn0010768,
FBgn0011674,FBgn0014073,FBgn00
14388,FBgn0015946,FBgn0016794,
FBgn0024555,FBgn0026319,FBgn00
28369,FBgn0029082,FBgn0031461,
FBgn0031853,FBgn0032223,FBgn00
33773,FBgn0033985,FBgn0034098,
FBgn0035461,FBgn0035626,FBgn00
36282,FBgn0036518,FBgn0036666,
FBgn0038168,FBgn0039048,FBgn00
40068,FBgn0041160,FBgn0045842,
52 GO:00
48869 
 
 
364 
FBgn0052179,FBgn0052354,FBgn00
52364,FBgn0085430,FBgn0085432,
FBgn0261245,FBgn0262081,FBgn02
65778,FBgn0266084,FBgn0267390,
FBgn0283451,FBgn0283499 
cell differentiation 0.01475489 FBgn0000163,FBgn0000250,FBgn00
00542,FBgn0000547,FBgn0000568,
FBgn0000928,FBgn0001234,FBgn00
02609,FBgn0002632,FBgn0002633,
FBgn0002643,FBgn0002732,FBgn00
03984,FBgn0010501,FBgn0010768,
FBgn0011674,FBgn0014073,FBgn00
14388,FBgn0015946,FBgn0016794,
FBgn0024555,FBgn0026319,FBgn00
28369,FBgn0029082,FBgn0031461,
FBgn0031853,FBgn0032223,FBgn00
33773,FBgn0033985,FBgn0034098,
FBgn0035461,FBgn0035626,FBgn00
36282,FBgn0036518,FBgn0036666,
FBgn0038168,FBgn0040068,FBgn00
41160,FBgn0045842,FBgn0052179,
FBgn0052354,FBgn0052364,FBgn00
85430,FBgn0085432,FBgn0261245,
FBgn0262081,FBgn0265778,FBgn02
66084,FBgn0267390,FBgn0283451,
FBgn0283499 
51 GO:00
30154 
signal transduction 0.00080948 FBgn0000250,FBgn0000395,FBgn00
00547,FBgn0000568,FBgn0001234,
FBgn0002632,FBgn0002643,FBgn00
02732,FBgn0002939,FBgn0003984,
FBgn0013973,FBgn0014009,FBgn00
14073,FBgn0014388,FBgn0015946,
FBgn0016794,FBgn0019985,FBgn00
22800,FBgn0023416,FBgn0024250,
FBgn0025625,FBgn0026319,FBgn00
29082,FBgn0030011,FBgn0030286,
FBgn0031016,FBgn0031461,FBgn00
31885,FBgn0033773,FBgn0033885,
FBgn0033985,FBgn0034199,FBgn00
34200,FBgn0034262,FBgn0034647,
FBgn0035626,FBgn0036518,FBgn00
36732,FBgn0037007,FBgn0037163,
FBgn0040068,FBgn0052179,FBgn00
52638,FBgn0053527,FBgn0053531,
FBgn0085432,FBgn0262081,FBgn02
65778,FBgn0267390,FBgn0283499 
50 GO:00
07165 
multi-organism 
process 
0.02079769 FBgn0000152,FBgn0000163,FBgn00
00250,FBgn0000547,FBgn0000568,
FBgn0000826,FBgn0000927,FBgn00
00928,FBgn0001112,FBgn0001234,
FBgn0002643,FBgn0003984,FBgn00
10501,FBgn0011674,FBgn0014073,
FBgn0014388,FBgn0015946,FBgn00
19985,FBgn0026319,FBgn0031853,
FBgn0033773,FBgn0033980,FBgn00
34098,FBgn0034199,FBgn0034647,
FBgn0035461,FBgn0035626,FBgn00
44 GO:00
51704 
 
 
365 
40068,FBgn0040384,FBgn0041246,
FBgn0045842,FBgn0046332,FBgn00
52133,FBgn0052179,FBgn0052364,
FBgn0052706,FBgn0053329,FBgn00
53527,FBgn0262081,FBgn0265778,
FBgn0267390,FBgn0283451,FBgn02
83499,FBgn0283545 
regulation of cell 
communication 
0.01419327 FBgn0000250,FBgn0000395,FBgn00
00547,FBgn0001234,FBgn0002632,
FBgn0002732,FBgn0003984,FBgn00
04580,FBgn0010501,FBgn0013973,
FBgn0014388,FBgn0016794,FBgn00
19985,FBgn0024250,FBgn0026319,
FBgn0029082,FBgn0030286,FBgn00
30505,FBgn0031016,FBgn0031461,
FBgn0031885,FBgn0033773,FBgn00
33885,FBgn0033985,FBgn0034199,
FBgn0034647,FBgn0035626,FBgn00
39927,FBgn0040068,FBgn0262081,
FBgn0283499 
31 GO:00
10646 
regulation of 
signaling 
0.01419327 FBgn0000250,FBgn0000395,FBgn00
00547,FBgn0001234,FBgn0002632,
FBgn0002732,FBgn0003984,FBgn00
04580,FBgn0010501,FBgn0013973,
FBgn0014388,FBgn0016794,FBgn00
19985,FBgn0024250,FBgn0026319,
FBgn0029082,FBgn0030286,FBgn00
30505,FBgn0031016,FBgn0031461,
FBgn0031885,FBgn0033773,FBgn00
33885,FBgn0033985,FBgn0034199,
FBgn0034647,FBgn0035626,FBgn00
39927,FBgn0040068,FBgn0262081,
FBgn0283499 
31 GO:00
23051 
cell surface 
receptor signaling 
pathway 
0.0125462 FBgn0000250,FBgn0000395,FBgn00
00547,FBgn0002632,FBgn0002643,
FBgn0002732,FBgn0003984,FBgn00
14073,FBgn0014388,FBgn0016794,
FBgn0019985,FBgn0022800,FBgn00
24250,FBgn0025625,FBgn0026319,
FBgn0029082,FBgn0031016,FBgn00
31461,FBgn0033985,FBgn0035626,
FBgn0040068,FBgn0052179,FBgn00
53531,FBgn0085432,FBgn0283499 
25 GO:00
07166 
intracellular signal 
transduction 
0.01656247 FBgn0000547,FBgn0001234,FBgn00
03984,FBgn0013973,FBgn0014009,
FBgn0014388,FBgn0015946,FBgn00
16794,FBgn0023416,FBgn0025625,
FBgn0026319,FBgn0030286,FBgn00
31885,FBgn0033773,FBgn0033885,
FBgn0033985,FBgn0034199,FBgn00
34262,FBgn0036518,FBgn0040068,
FBgn0262081,FBgn0265778,FBgn02
67390,FBgn0283499 
24 GO:00
35556 
post-embryonic 
development 
0.02584292 FBgn0000395,FBgn0000547,FBgn00
00568,FBgn0001112,FBgn0002643,
FBgn0003984,FBgn0004893,FBgn00
14388,FBgn0015946,FBgn0024250,
24 GO:00
09791 
 
 
366 
FBgn0026263,FBgn0026319,FBgn00
28369,FBgn0031461,FBgn0031885,
FBgn0034262,FBgn0036518,FBgn00
36732,FBgn0036801,FBgn0085432,
FBgn0265778,FBgn0266084,FBgn02
83451,FBgn0287185 
phosphorylation 0.02714477 FBgn0000826,FBgn0001229,FBgn00
01234,FBgn0003984,FBgn0014073,
FBgn0014388,FBgn0022800,FBgn00
25625,FBgn0026319,FBgn0031461,
FBgn0031885,FBgn0032702,FBgn00
33773,FBgn0033885,FBgn0034199,
FBgn0034251,FBgn0040068,FBgn00
46332,FBgn0053531,FBgn0262081,
FBgn0265778,FBgn0267390,FBgn02
83499 
23 GO:00
16310 
morphogenesis of 
an epithelium 
0.04646577 FBgn0000163,FBgn0000395,FBgn00
00542,FBgn0000547,FBgn0002643,
FBgn0003984,FBgn0004893,FBgn00
10238,FBgn0014388,FBgn0024250,
FBgn0026319,FBgn0029082,FBgn00
31461,FBgn0031885,FBgn0036518,
FBgn0036666,FBgn0036801,FBgn00
40068,FBgn0052179,FBgn0085432,
FBgn0265778,FBgn0266084 
22 GO:00
02009 
protein 
phosphorylation 
0.0038016 FBgn0000826,FBgn0001229,FBgn00
01234,FBgn0003984,FBgn0014073,
FBgn0014388,FBgn0022800,FBgn00
25625,FBgn0026319,FBgn0031461,
FBgn0031885,FBgn0032702,FBgn00
33773,FBgn0034199,FBgn0040068,
FBgn0046332,FBgn0053531,FBgn02
62081,FBgn0265778,FBgn0267390,
FBgn0283499 
21 GO:00
06468 
epithelial cell 
differentiation 
0.027283 FBgn0000163,FBgn0000250,FBgn00
00547,FBgn0000928,FBgn0002643,
FBgn0003984,FBgn0014073,FBgn00
14388,FBgn0026319,FBgn0029082,
FBgn0031461,FBgn0036518,FBgn00
40068,FBgn0052179,FBgn0267390,
FBgn0283451,FBgn0283499 
17 GO:00
30855 
regulation of cell 
differentiation 
0.03410763 FBgn0000250,FBgn0000542,FBgn00
00547,FBgn0002609,FBgn0002633,
FBgn0003984,FBgn0014073,FBgn00
14388,FBgn0028369,FBgn0031461,
FBgn0033985,FBgn0038168,FBgn00
52179,FBgn0085430,FBgn0265778,
FBgn0266084,FBgn0283499 
17 GO:00
45595 
enzyme linked 
receptor protein 
signaling pathway 
0.00203711 FBgn0000395,FBgn0000547,FBgn00
03984,FBgn0014073,FBgn0014388,
FBgn0016794,FBgn0022800,FBgn00
24250,FBgn0025625,FBgn0031016,
FBgn0031461,FBgn0035626,FBgn00
40068,FBgn0052179,FBgn0053531,
FBgn0283499 
16 GO:00
07167 
regulation of 
catalytic activity 
0.02438309 FBgn0014073,FBgn0014388,FBgn00
15946,FBgn0022800,FBgn0026319,
16 GO:00
50790 
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FBgn0029082,FBgn0030286,FBgn00
32702,FBgn0035461,FBgn0037772,
FBgn0040068,FBgn0040348,FBgn00
53531,FBgn0265778,FBgn0267390,
FBgn0283499 
regulation of cell 
development 
0.03754967 FBgn0000542,FBgn0000547,FBgn00
02609,FBgn0002633,FBgn0003984,
FBgn0014073,FBgn0014388,FBgn00
31461,FBgn0033985,FBgn0038168,
FBgn0052179,FBgn0085430,FBgn02
65778,FBgn0266084,FBgn0283499 
15 GO:00
60284 
regulation of 
phosphorylation 
0.00721047 FBgn0001234,FBgn0003984,FBgn00
14073,FBgn0014388,FBgn0022800,
FBgn0026319,FBgn0031461,FBgn00
31885,FBgn0032702,FBgn0033773,
FBgn0034199,FBgn0040068,FBgn00
53531,FBgn0283499 
14 GO:00
42325 
regulation of 
phosphate 
metabolic process 
0.01338992 FBgn0001234,FBgn0003984,FBgn00
14073,FBgn0014388,FBgn0022800,
FBgn0026319,FBgn0031461,FBgn00
31885,FBgn0032702,FBgn0033773,
FBgn0034199,FBgn0040068,FBgn00
53531,FBgn0283499 
14 GO:00
19220 
regulation of 
phosphorus 
metabolic process 
0.01338992 FBgn0001234,FBgn0003984,FBgn00
14073,FBgn0014388,FBgn0022800,
FBgn0026319,FBgn0031461,FBgn00
31885,FBgn0032702,FBgn0033773,
FBgn0034199,FBgn0040068,FBgn00
53531,FBgn0283499 
14 GO:00
51174 
cell fate 
commitment 
0.01527561 FBgn0000163,FBgn0000547,FBgn00
02632,FBgn0002643,FBgn0002732,
FBgn0003984,FBgn0011674,FBgn00
16794,FBgn0024555,FBgn0026319,
FBgn0031461,FBgn0032223,FBgn00
85432,FBgn0283451 
14 GO:00
45165 
cellular response to 
organic substance 
0.04264694 FBgn0000395,FBgn0000568,FBgn00
14388,FBgn0024250,FBgn0025625,
FBgn0026319,FBgn0031016,FBgn00
31461,FBgn0034199,FBgn0035626,
FBgn0036732,FBgn0052638,FBgn02
83451,FBgn0283499 
14 GO:00
71310 
transmembrane 
receptor protein 
tyrosine kinase 
signaling pathway 
0.00738567 FBgn0000547,FBgn0003984,FBgn00
14073,FBgn0014388,FBgn0016794,
FBgn0022800,FBgn0025625,FBgn00
31016,FBgn0035626,FBgn0040068,
FBgn0052179,FBgn0053531,FBgn02
83499 
13 GO:00
07169 
positive regulation 
of cellular protein 
metabolic process 
0.02486577 FBgn0001229,FBgn0001234,FBgn00
03984,FBgn0015946,FBgn0026319,
FBgn0029082,FBgn0031461,FBgn00
31885,FBgn0033773,FBgn0034199,
FBgn0035461,FBgn0040068,FBgn02
83499 
13 GO:00
32270 
positive regulation 
of protein 
metabolic process 
0.03793025 FBgn0001229,FBgn0001234,FBgn00
03984,FBgn0015946,FBgn0026319,
FBgn0029082,FBgn0031461,FBgn00
31885,FBgn0033773,FBgn0034199,
13 GO:00
51247 
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FBgn0035461,FBgn0040068,FBgn02
83499 
positive regulation 
of phosphorylation 
0.00021974 FBgn0001234,FBgn0003984,FBgn00
14073,FBgn0022800,FBgn0026319,
FBgn0031461,FBgn0031885,FBgn00
33773,FBgn0034199,FBgn0040068,
FBgn0053531,FBgn0283499 
12 GO:00
42327 
positive regulation 
of phosphorus 
metabolic process 
0.00033108 FBgn0001234,FBgn0003984,FBgn00
14073,FBgn0022800,FBgn0026319,
FBgn0031461,FBgn0031885,FBgn00
33773,FBgn0034199,FBgn0040068,
FBgn0053531,FBgn0283499 
12 GO:00
10562 
positive regulation 
of phosphate 
metabolic process 
0.00033108 FBgn0001234,FBgn0003984,FBgn00
14073,FBgn0022800,FBgn0026319,
FBgn0031461,FBgn0031885,FBgn00
33773,FBgn0034199,FBgn0040068,
FBgn0053531,FBgn0283499 
12 GO:00
45937 
positive regulation 
of catalytic activity 
0.00738567 FBgn0014073,FBgn0015946,FBgn00
22800,FBgn0026319,FBgn0029082,
FBgn0035461,FBgn0040068,FBgn00
40348,FBgn0053531,FBgn0265778,
FBgn0267390,FBgn0283499 
12 GO:00
43085 
positive regulation 
of molecular 
function 
0.0266796 FBgn0014073,FBgn0015946,FBgn00
22800,FBgn0026319,FBgn0029082,
FBgn0035461,FBgn0040068,FBgn00
40348,FBgn0053531,FBgn0265778,
FBgn0267390,FBgn0283499 
12 GO:00
44093 
embryonic 
morphogenesis 
0.03242536 FBgn0000163,FBgn0000547,FBgn00
02643,FBgn0004893,FBgn0010238,
FBgn0026319,FBgn0036518,FBgn00
40068,FBgn0085432,FBgn0265778,
FBgn0283499 
11 GO:00
48598 
regulation of 
protein 
phosphorylation 
0.035288 FBgn0001234,FBgn0003984,FBgn00
14388,FBgn0026319,FBgn0031461,
FBgn0031885,FBgn0032702,FBgn00
33773,FBgn0034199,FBgn0040068,
FBgn0283499 
11 GO:00
01932 
MAPK cascade 0.00413587 FBgn0001234,FBgn0003984,FBgn00
14388,FBgn0026319,FBgn0031885,
FBgn0033773,FBgn0034199,FBgn00
40068,FBgn0265778,FBgn0283499 
10 GO:00
00165 
signal transduction 
by protein 
phosphorylation 
0.00640013 FBgn0001234,FBgn0003984,FBgn00
14388,FBgn0026319,FBgn0031885,
FBgn0033773,FBgn0034199,FBgn00
40068,FBgn0265778,FBgn0283499 
10 GO:00
23014 
cell adhesion 0.00894071 FBgn0000163,FBgn0000547,FBgn00
10238,FBgn0015229,FBgn0022800,
FBgn0028369,FBgn0029082,FBgn00
34199,FBgn0037963,FBgn0266084 
10 GO:00
07155 
biological adhesion 0.00953063 FBgn0000163,FBgn0000547,FBgn00
10238,FBgn0015229,FBgn0022800,
FBgn0028369,FBgn0029082,FBgn00
34199,FBgn0037963,FBgn0266084 
10 GO:00
22610 
positive regulation 
of protein 
modification 
process 
0.01219293 FBgn0001229,FBgn0001234,FBgn00
03984,FBgn0026319,FBgn0031461,
FBgn0031885,FBgn0033773,FBgn00
34199,FBgn0040068,FBgn0283499 
10 GO:00
31401 
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positive regulation 
of intracellular 
signal transduction 
0.01538287 FBgn0000547,FBgn0001234,FBgn00
03984,FBgn0026319,FBgn0031885,
FBgn0033773,FBgn0034199,FBgn00
40068,FBgn0262081,FBgn0283499 
10 GO:19
02533 
positive regulation 
of cell 
development 
0.0224073 FBgn0000542,FBgn0002609,FBgn00
03984,FBgn0014073,FBgn0031461,
FBgn0033985,FBgn0038168,FBgn00
52179,FBgn0266084,FBgn0283499 
10 GO:00
10720 
positive regulation 
of cell 
differentiation 
0.02604027 FBgn0000542,FBgn0002609,FBgn00
03984,FBgn0014073,FBgn0031461,
FBgn0033985,FBgn0038168,FBgn00
52179,FBgn0266084,FBgn0283499 
10 GO:00
45597 
cell-cell adhesion 0.00118625 FBgn0000163,FBgn0000547,FBgn00
10238,FBgn0015229,FBgn0022800,
FBgn0028369,FBgn0029082,FBgn00
34199,FBgn0037963 
9 GO:00
98609 
positive regulation 
of protein 
phosphorylation 
0.00412466 FBgn0001234,FBgn0003984,FBgn00
26319,FBgn0031461,FBgn0031885,
FBgn0033773,FBgn0034199,FBgn00
40068,FBgn0283499 
9 GO:00
01934 
regulation of 
MAPK cascade 
0.00666673 FBgn0001234,FBgn0003984,FBgn00
14388,FBgn0026319,FBgn0031885,
FBgn0033773,FBgn0034199,FBgn00
40068,FBgn0283499 
9 GO:00
43408 
cell-cell adhesion 
via plasma-
membrane 
adhesion molecules 
1.9281E-05 FBgn0000163,FBgn0000547,FBgn00
10238,FBgn0015229,FBgn0022800,
FBgn0028369,FBgn0029082,FBgn00
37963 
8 GO:00
98742 
positive regulation 
of MAPK cascade 
0.00115956 FBgn0001234,FBgn0003984,FBgn00
26319,FBgn0031885,FBgn0033773,
FBgn0034199,FBgn0040068,FBgn02
83499 
8 GO:00
43410 
positive regulation 
of programmed cell 
death 
0.00387376 FBgn0000542,FBgn0001234,FBgn00
15946,FBgn0026319,FBgn0035461,
FBgn0037007,FBgn0262081,FBgn02
83451 
8 GO:00
43068 
positive regulation 
of cell death 
0.00611912 FBgn0000542,FBgn0001234,FBgn00
15946,FBgn0026319,FBgn0035461,
FBgn0037007,FBgn0262081,FBgn02
83451 
8 GO:00
10942 
response to 
hormone 
0.03226562 FBgn0000568,FBgn0025625,FBgn00
34262,FBgn0035626,FBgn0036732,
FBgn0052638,FBgn0283451,FBgn02
83499 
8 GO:00
09725 
sensory perception 
of chemical 
stimulus 
0.0045763 FBgn0020300,FBgn0030985,FBgn00
33404,FBgn0041241,FBgn0041246,
FBgn0045474,FBgn0259683 
7 GO:00
07606 
cuticle 
development 
0.0045763 FBgn0000451,FBgn0001112,FBgn00
33942,FBgn0035513,FBgn0039469,
FBgn0085432,FBgn0286203 
7 GO:00
42335 
cell-cell junction 
organization 
0.00907956 FBgn0000163,FBgn0010238,FBgn00
26319,FBgn0028369,FBgn0040068,
FBgn0262081,FBgn0265778 
7 GO:00
45216 
cell junction 
organization 
0.00992108 FBgn0000163,FBgn0010238,FBgn00
26319,FBgn0028369,FBgn0040068,
FBgn0262081,FBgn0265778 
7 GO:00
34330 
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modulation of 
chemical synaptic 
transmission 
0.00992108 FBgn0004580,FBgn0010501,FBgn00
13973,FBgn0019985,FBgn0030505,
FBgn0039927,FBgn0262081 
7 GO:00
50804 
regulation of trans-
synaptic signaling 
0.00992108 FBgn0004580,FBgn0010501,FBgn00
13973,FBgn0019985,FBgn0030505,
FBgn0039927,FBgn0262081 
7 GO:00
99177 
stem cell 
proliferation 
0.01881843 FBgn0000163,FBgn0002609,FBgn00
11674,FBgn0024555,FBgn0031461,
FBgn0035626,FBgn0085432 
7 GO:00
72089 
stem cell division 0.02327013 FBgn0000163,FBgn0000928,FBgn00
11674,FBgn0024555,FBgn0035626,
FBgn0052364,FBgn0283499 
7 GO:00
17145 
cellular response to 
hormone stimulus 
0.02490298 FBgn0000568,FBgn0025625,FBgn00
35626,FBgn0036732,FBgn0052638,
FBgn0283451,FBgn0283499 
7 GO:00
32870 
positive regulation 
of hydrolase 
activity 
0.02490298 FBgn0015946,FBgn0029082,FBgn00
35461,FBgn0040068,FBgn0040348,
FBgn0265778,FBgn0267390 
7 GO:00
51345 
regulation of 
proteolysis 
0.04322665 FBgn0001234,FBgn0015946,FBgn00
26777,FBgn0029082,FBgn0034706,
FBgn0035461,FBgn0037772 
7 GO:00
30162 
regulation of 
kinase activity 
0.04568728 FBgn0014073,FBgn0014388,FBgn00
22800,FBgn0026319,FBgn0032702,
FBgn0053531,FBgn0283499 
7 GO:00
43549 
homophilic cell 
adhesion via 
plasma membrane 
adhesion molecules 
0.00015927 FBgn0000547,FBgn0010238,FBgn00
22800,FBgn0028369,FBgn0029082,
FBgn0037963 
6 GO:00
07156 
adherens junction 
organization 
0.0011657 FBgn0000163,FBgn0026319,FBgn00
28369,FBgn0040068,FBgn0262081,
FBgn0265778 
6 GO:00
34332 
chitin-based cuticle 
development 
0.00346874 FBgn0001112,FBgn0033942,FBgn00
35513,FBgn0039469,FBgn0085432,
FBgn0286203 
6 GO:00
40003 
cellular response to 
abiotic stimulus 
0.00577872 FBgn0002939,FBgn0004832,FBgn00
14073,FBgn0015946,FBgn0033132,
FBgn0261794 
6 GO:00
71214 
cellular response to 
environmental 
stimulus 
0.00577872 FBgn0002939,FBgn0004832,FBgn00
14073,FBgn0015946,FBgn0033132,
FBgn0261794 
6 GO:01
04004 
positive regulation 
of cell population 
proliferation 
0.014778 FBgn0002609,FBgn0003984,FBgn00
31461,FBgn0035626,FBgn0052179,
FBgn0283499 
6 GO:00
08284 
striated muscle cell 
differentiation 
0.014778 FBgn0014388,FBgn0028369,FBgn00
29082,FBgn0040068,FBgn0261245,
FBgn0283451 
6 GO:00
51146 
muscle cell 
differentiation 
0.02088399 FBgn0014388,FBgn0028369,FBgn00
29082,FBgn0040068,FBgn0261245,
FBgn0283451 
6 GO:00
42692 
detection of 
stimulus 
0.0377774 FBgn0002939,FBgn0029968,FBgn00
33404,FBgn0037163,FBgn0040849,
FBgn0259683 
6 GO:00
51606 
establishment of 
planar polarity 
0.04036259 FBgn0000163,FBgn0000542,FBgn00
00547,FBgn0014388,FBgn0029082,
FBgn0052179 
6 GO:00
01736 
morphogenesis of a 0.04036259 FBgn0000163,FBgn0000542,FBgn00 6 GO:00
 
 
371 
polarized 
epithelium 
00547,FBgn0014388,FBgn0029082,
FBgn0052179 
01738 
establishment of 
tissue polarity 
0.04036259 FBgn0000163,FBgn0000542,FBgn00
00547,FBgn0014388,FBgn0029082,
FBgn0052179 
6 GO:00
07164 
establishment of 
ommatidial planar 
polarity 
0.01299446 FBgn0000542,FBgn0000547,FBgn00
14388,FBgn0029082,FBgn0052179 
5 GO:00
42067 
phenol-containing 
compound 
metabolic process 
0.0180364 FBgn0015946,FBgn0016013,FBgn00
33885,FBgn0037153,FBgn0040068 
5 GO:00
18958 
urogenital system 
development 
0.02422652 FBgn0000163,FBgn0011674,FBgn00
24250,FBgn0028369,FBgn0029082 
5 GO:00
01655 
renal system 
development 
0.02422652 FBgn0000163,FBgn0011674,FBgn00
24250,FBgn0028369,FBgn0029082 
5 GO:00
72001 
gastrulation 0.0290305 FBgn0000163,FBgn0002643,FBgn00
26319,FBgn0036518,FBgn0085432 
5 GO:00
07369 
cell fate 
specification 
0.04034337 FBgn0000547,FBgn0002632,FBgn00
02732,FBgn0003984,FBgn0031461 
5 GO:00
01708 
positive regulation 
of apoptotic 
process 
0.04353597 FBgn0001234,FBgn0015946,FBgn00
26319,FBgn0035461,FBgn0037007 
5 GO:00
43065 
response to 
osmotic stress 
0.00041991 FBgn0015946,FBgn0030505,FBgn00
31885,FBgn0261794 
4 GO:00
06970 
ommatidial 
rotation 
0.00848941 FBgn0000542,FBgn0000547,FBgn00
14388,FBgn0052179 
4 GO:00
16318 
syncytium 
formation by 
plasma membrane 
fusion 
0.01585731 FBgn0028369,FBgn0029082,FBgn00
40068,FBgn0261245 
4 GO:00
00768 
syncytium 
formation 
0.01585731 FBgn0028369,FBgn0029082,FBgn00
40068,FBgn0261245 
4 GO:00
06949 
myoblast fusion 0.01585731 FBgn0028369,FBgn0029082,FBgn00
40068,FBgn0261245 
4 GO:00
07520 
positive regulation 
of JNK cascade 
0.01585731 FBgn0001234,FBgn0026319,FBgn00
31885,FBgn0034199 
4 GO:00
46330 
cell-cell fusion 0.01585731 FBgn0028369,FBgn0029082,FBgn00
40068,FBgn0261245 
4 GO:01
40253 
positive regulation 
of stress-activated 
MAPK cascade 
0.01817229 FBgn0001234,FBgn0026319,FBgn00
31885,FBgn0034199 
4 GO:00
32874 
positive regulation 
of stress-activated 
protein kinase 
signaling cascade 
0.01817229 FBgn0001234,FBgn0026319,FBgn00
31885,FBgn0034199 
4 GO:00
70304 
myotube 
differentiation 
0.02340506 FBgn0028369,FBgn0029082,FBgn00
40068,FBgn0261245 
4 GO:00
14902 
detection of 
chemical stimulus 
0.02633032 FBgn0029968,FBgn0033404,FBgn00
40849,FBgn0259683 
4 GO:00
09593 
response to 
ecdysone 
0.03637304 FBgn0000568,FBgn0034262,FBgn00
36732,FBgn0283451 
4 GO:00
35075 
response to sterol 0.03637304 FBgn0000568,FBgn0034262,FBgn00
36732,FBgn0283451 
4 GO:00
36314 
response to ketone 0.04014807 FBgn0000568,FBgn0034262,FBgn00
36732,FBgn0283451 
4 GO:19
01654 
regulation of stem 0.04413795 FBgn0002609,FBgn0031461,FBgn00 4 GO:00
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cell proliferation 35626,FBgn0085432 72091 
response to salt 
stress 
0.00191883 FBgn0030505,FBgn0031885,FBgn02
61794 
3 GO:00
09651 
basal protein 
localization 
0.00298069 FBgn0000163,FBgn0011674,FBgn00
24555 
3 GO:00
45175 
heterophilic cell-
cell adhesion via 
plasma membrane 
cell adhesion 
molecules 
0.00803979 FBgn0015229,FBgn0028369,FBgn00
29082 
3 GO:00
07157 
asymmetric protein 
localization 
involved in cell 
fate determination 
0.01314246 FBgn0000163,FBgn0011674,FBgn00
26319 
3 GO:00
45167 
adherens junction 
assembly 
0.01972316 FBgn0000163,FBgn0028369,FBgn02
65778 
3 GO:00
34333 
execution phase of 
apoptosis 
0.02781216 FBgn0010501,FBgn0015946,FBgn00
28406 
3 GO:00
97194 
positive regulation 
of stem cell 
proliferation 
0.02781216 FBgn0002609,FBgn0031461,FBgn00
35626 
3 GO:20
00648 
positive regulation 
of endopeptidase 
activity 
0.03740398 FBgn0015946,FBgn0029082,FBgn00
35461 
3 GO:00
10950 
positive regulation 
of peptidase 
activity 
0.03740398 FBgn0015946,FBgn0029082,FBgn00
35461 
3 GO:00
10952 
sensory perception 
of taste 
0.04275372 FBgn0041241,FBgn0041246,FBgn00
45474 
3 GO:00
50909 
nucleotide-excision 
repair, DNA 
damage recognition 
0.00156981 FBgn0004832,FBgn0026777 2 GO:00
00715 
mesodermal cell 
fate determination 
0.00458594 FBgn0002643,FBgn0085432 2 GO:00
07500 
phenol-containing 
compound 
catabolic process 
0.00458594 FBgn0016013,FBgn0037153 2 GO:00
19336 
symmetric stem 
cell division 
0.00458594 FBgn0035626,FBgn0052364 2 GO:00
98724 
response to light 
intensity 
0.00893217 FBgn0033132,FBgn0037163 2 GO:00
09642 
cellular response to 
UV 
0.00893217 FBgn0002939,FBgn0004832 2 GO:00
34644 
symmetric cell 
division 
0.00893217 FBgn0035626,FBgn0052364 2 GO:00
98725 
regulation of 
striated muscle 
tissue development 
0.01449913 FBgn0028369,FBgn0029082 2 GO:00
16202 
cellular response to 
osmotic stress 
0.01449913 FBgn0015946,FBgn0261794 2 GO:00
71470 
regulation of 
muscle tissue 
development 
0.01449913 FBgn0028369,FBgn0029082 2 GO:19
01861 
mesodermal cell 
fate commitment 
0.02889002 FBgn0002643,FBgn0085432 2 GO:00
01710 
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I-kappaB 
kinase/NF-kappaB 
signaling 
0.02889002 FBgn0026319,FBgn0033985 2 GO:00
07249 
calcium-dependent 
cell-cell adhesion 
via plasma 
membrane cell 
adhesion molecules 
0.02889002 FBgn0022800,FBgn0037963 2 GO:00
16339 
contractile actin 
filament bundle 
assembly 
0.02889002 FBgn0000547,FBgn0266084 2 GO:00
30038 
dopamine 
metabolic process 
0.02889002 FBgn0033885,FBgn0037153 2 GO:00
42417 
mesodermal cell 
differentiation 
0.02889002 FBgn0002643,FBgn0085432 2 GO:00
48333 
cyclic purine 
nucleotide 
metabolic process 
0.02889002 FBgn0013973,FBgn0023416 2 GO:00
52652 
RNA 5'-end 
processing 
0.03752647 FBgn0033092,FBgn0052706 2 GO:00
00966 
epithelial cell 
morphogenesis 
involved in 
gastrulation 
0.03752647 FBgn0026319,FBgn0036518 2 GO:00
03381 
catecholamine 
metabolic process 
0.03752647 FBgn0033885,FBgn0037153 2 GO:00
06584 
cyclic nucleotide 
biosynthetic 
process 
0.03752647 FBgn0013973,FBgn0023416 2 GO:00
09190 
catechol-containing 
compound 
metabolic process 
0.03752647 FBgn0033885,FBgn0037153 2 GO:00
09712 
peptide hormone 
secretion 
0.03752647 FBgn0034199,FBgn0283499 2 GO:00
30072 
ncRNA 5'-end 
processing 
0.03752647 FBgn0033092,FBgn0052706 2 GO:00
34471 
regulation of 
peptide hormone 
secretion 
0.03752647 FBgn0034199,FBgn0283499 2 GO:00
90276 
apical constriction 
involved in 
gastrulation 
0.04700803 FBgn0026319,FBgn0036518 2 GO:00
03384 
endosome 
organization 
0.04700803 FBgn0036666,FBgn0267390 2 GO:00
07032 
regulation of 
muscle organ 
development 
0.04700803 FBgn0028369,FBgn0029082 2 GO:00
48634 
endonucleolytic 
cleavage of 
tetracistronic rRNA 
transcript (SSU-
rRNA, 5.8S rRNA, 
2S rRNA, LSU-
rRNA) 
0.03971774 FBgn0065098 1 GO:00
00483 
negative regulation 
of antifungal 
0.03971774 FBgn0000250 1 GO:00
02789 
 
 
374 
peptide production 
tyrosine catabolic 
process 
0.03971774 FBgn0016013 1 GO:00
06572 
hypotonic response 0.03971774 FBgn0261794 1 GO:00
06971 
activation of NF-
kappaB-inducing 
kinase activity 
0.03971774 FBgn0026319 1 GO:00
07250 
cytoplasmic 
sequestering of 
NF-kappaB 
0.03971774 FBgn0000250 1 GO:00
07253 
phototransduction, 
UV 
0.03971774 FBgn0002939 1 GO:00
07604 
pupal chitin-based 
cuticle 
development 
0.03971774 FBgn0001112 1 GO:00
08364 
detection of UV 0.03971774 FBgn0002939 1 GO:00
09589 
response to high 
light intensity 
0.03971774 FBgn0033132 1 GO:00
09644 
regulation of 
translational 
initiation by eIF2 
alpha 
phosphorylation 
0.03971774 FBgn0001229 1 GO:00
10998 
keratinocyte 
differentiation 
0.03971774 FBgn0031461 1 GO:00
30216 
positive regulation 
of homotypic cell-
cell adhesion 
0.03971774 FBgn0034199 1 GO:00
34112 
nuclear speck 
organization 
0.03971774 FBgn0001234 1 GO:00
35063 
negative regulation 
of fusion cell fate 
specification 
0.03971774 FBgn0000547 1 GO:00
35157 
angiotensin-
activated signaling 
pathway 
0.03971774 FBgn0052638 1 GO:00
38166 
hypotonic salinity 
response 
0.03971774 FBgn0261794 1 GO:00
42539 
regulation of 
translational 
initiation in 
response to stress 
0.03971774 FBgn0001229 1 GO:00
43558 
skin development 0.03971774 FBgn0031461 1 GO:00
43588 
histone H4-K5 
acetylation 
0.03971774 FBgn0035624 1 GO:00
43981 
histone H3-K14 
acetylation 
0.03971774 FBgn0035624 1 GO:00
44154 
metaphase/anaphas
e transition of 
meiotic cell cycle 
0.03971774 FBgn0033773 1 GO:00
44785 
regulation of R8 
cell differentiation 
0.03971774 FBgn0000547 1 GO:00
45679 
 
 
375 
negative regulation 
of R8 cell 
differentiation 
0.03971774 FBgn0000547 1 GO:00
45680 
isoprenoid 
transport 
0.03971774 FBgn0002939 1 GO:00
46864 
terpenoid transport 0.03971774 FBgn0002939 1 GO:00
46865 
tetraterpenoid 
transport 
0.03971774 FBgn0002939 1 GO:00
46866 
carotenoid 
transport 
0.03971774 FBgn0002939 1 GO:00
46867 
protein 
heterotetramerizati
on 
0.03971774 FBgn0283499 1 GO:00
51290 
protein 
heterooligomerizati
on 
0.03971774 FBgn0283499 1 GO:00
51291 
establishment of 
centrosome 
localization 
0.03971774 FBgn0000163 1 GO:00
51660 
garland nephrocyte 
differentiation 
0.03971774 FBgn0028369 1 GO:00
61321 
positive regulation 
of fat cell 
proliferation 
0.03971774 FBgn0283499 1 GO:00
70346 
cellular hypotonic 
response 
0.03971774 FBgn0261794 1 GO:00
71476 
cellular hypotonic 
salinity response 
0.03971774 FBgn0261794 1 GO:00
71477 
cellular response to 
high light intensity 
0.03971774 FBgn0033132 1 GO:00
71486 
regulation of actin 
cytoskeleton 
organization by 
cell-cell adhesion 
0.03971774 FBgn0000547 1 GO:00
90138 
cell-cell adhesion 
involved in 
establishment of 
planar polarity 
0.03971774 FBgn0000163 1 GO:00
90250 
synaptic signaling 
by nitric oxide 
0.03971774 FBgn0013973 1 GO:00
99163 
trans-synaptic 
signaling by 
soluble gas 
0.03971774 FBgn0013973 1 GO:00
99543 
trans-synaptic 
signaling by nitric 
oxide 
0.03971774 FBgn0013973 1 GO:00
99548 
trans-synaptic 
signaling, 
modulating 
synaptic 
transmission 
0.03971774 FBgn0013973 1 GO:00
99550 
trans-synaptic 
signaling by 
soluble gas, 
modulating 
0.03971774 FBgn0013973 1 GO:00
99554 
 
 
376 
synaptic 
transmission 
trans-synaptic 
signaling by nitric 
oxide, modulating 
synaptic 
transmission 
0.03971774 FBgn0013973 1 GO:00
99555 
regulation of 
glutamate receptor 
clustering 
0.03971774 FBgn0014009 1 GO:01
06104 
negative regulation 
of imaginal disc-
derived wing vein 
specification 
0.03971774 FBgn0014388 1 GO:01
10109 
regulation of long-
term synaptic 
potentiation 
0.03971774 FBgn0004580 1 GO:19
00271 
positive regulation 
of NIK/NF-kappaB 
signaling 
0.03971774 FBgn0026319 1 GO:19
01224 
negative regulation 
of meiotic cell 
cycle phase 
transition 
0.03971774 FBgn0033773 1 GO:19
01994 
homogentisate 
metabolic process 
0.03971774 FBgn0016013 1 GO:19
01999 
homogentisate 
catabolic process 
0.03971774 FBgn0016013 1 GO:19
02000 
regulation of 
extrinsic apoptotic 
signaling pathway 
via death domain 
receptors 
0.03971774 FBgn0033985 1 GO:19
02041 
negative regulation 
of extrinsic 
apoptotic signaling 
pathway via death 
domain receptors 
0.03971774 FBgn0033985 1 GO:19
02042 
regulation of 
metaphase/anaphas
e transition of 
meiotic cell cycle 
0.03971774 FBgn0033773 1 GO:19
02102 
negative regulation 
of 
metaphase/anaphas
e transition of 
meiotic cell cycle 
0.03971774 FBgn0033773 1 GO:19
02103 
regulation of 
receptor clustering 
0.03971774 FBgn0014009 1 GO:19
03909 
cellular response to 
angiotensin 
0.03971774 FBgn0052638 1 GO:19
04385 
regulation of 
meiotic 
chromosome 
separation 
0.03971774 FBgn0033773 1 GO:19
05132 
negative regulation 0.03971774 FBgn0033773 1 GO:19
 
 
377 
of meiotic 
chromosome 
separation 
05133 
negative regulation 
of morphogenesis 
of an epithelium 
0.03971774 FBgn0014388 1 GO:19
05331 
response to 
angiotensin 
0.03971774 FBgn0052638 1 GO:19
90776 
regulation of ATP-
dependent 
microtubule motor 
activity, minus-
end-directed 
0.03971774 FBgn0267390 1 GO:20
00577 
positive regulation 
of ATP-dependent 
microtubule motor 
activity, minus-
end-directed 
0.03971774 FBgn0267390 1 GO:20
00579 
negative regulation 
of extrinsic 
apoptotic signaling 
pathway 
0.03971774 FBgn0033985 1 GO:20
01237 
muscle fiber 
development 
0.04700803 FBgn0014388,FBgn0283451 GO:0048747 
negative regulation 
of synaptic 
transmission 
0.04700803 FBgn0010501,FBgn0030505 GO:0050805 
cellular response to 
endogenous 
stimulus 
0.04807654 FBgn0000568,FBgn0025625,FBgn00
31461,FBgn0034199,FBgn0035626,
FBgn0036732,FBgn0052638,FBgn02
83451,FBgn0283499 
GO:0071495 
regulation of 
endopeptidase 
activity 
0.04834249 FBgn0015946,FBgn0029082,FBgn00
35461,FBgn0037772 
GO:0052548 
cell population 
proliferation 
0.04844707 FBgn0000163,FBgn0002609,FBgn00
03984,FBgn0011674,FBgn0024555,
FBgn0031461,FBgn0031885,FBgn00
35626,FBgn0051111,FBgn0052179,
FBgn0085432,FBgn0262081,FBgn02
83499 
GO:0008283 
negative regulation 
of epidermal 
growth factor 
receptor signaling 
pathway 
0.04846444 FBgn0000547,FBgn0014388,FBgn00
31016,FBgn0040068 
GO:0042059 
regulation of ERK1 
and ERK2 cascade 
0.04846444 FBgn0003984,FBgn0014388,FBgn00
40068 
GO:0070372 
cellular response to 
light stimulus 
0.04846444 FBgn0002939,FBgn0004832,FBgn00
33132 
GO:0071482 
negative regulation 
of ERBB signaling 
pathway 
0.04846444 FBgn0000547,FBgn0014388,FBgn00
31016,FBgn0040068 
GO:1901185 
 
Table 2.4g: GO enrichment for hits differentially upregulated in control females relative to 20HE 
males 
GO p- Hits Gene GO ID 
 
 
378 
enrichmen
t 
value matches 
metabolic 
process 
0.0309
9917 
FBgn0001150,FBgn0002441,FBgn0003257,FBgn0010278
,FBgn0010425,FBgn0011211,FBgn0011555,FBgn001170
3,FBgn0011704,FBgn0011768,FBgn0011834,FBgn00140
28,FBgn0015075,FBgn0015277,FBgn0015553,FBgn0020
633,FBgn0020653,FBgn0020906,FBgn0022700,FBgn002
4321,FBgn0024957,FBgn0025352,FBgn0025373,FBgn00
25592,FBgn0025815,FBgn0025832,FBgn0026079,FBgn0
026143,FBgn0026411,FBgn0027791,FBgn0027794,FBgn
0027868,FBgn0028375,FBgn0028962,FBgn0029131,FBg
n0029823,FBgn0029827,FBgn0029856,FBgn0029906,FB
gn0030081,FBgn0030136,FBgn0030966,FBgn0031030,F
Bgn0031092,FBgn0031145,FBgn0031182,FBgn0031249,
FBgn0031252,FBgn0031381,FBgn0031653,FBgn0031703
,FBgn0031713,FBgn0031875,FBgn0031996,FBgn003199
9,FBgn0032244,FBgn0032350,FBgn0032424,FBgn00327
81,FBgn0032929,FBgn0033079,FBgn0033187,FBgn0033
235,FBgn0033377,FBgn0033431,FBgn0033454,FBgn003
3549,FBgn0033733,FBgn0033774,FBgn0034052,FBgn00
34177,FBgn0034422,FBgn0034582,FBgn0034629,FBgn0
034817,FBgn0034937,FBgn0034988,FBgn0035006,FBgn
0035383,FBgn0035619,FBgn0035665,FBgn0035666,FBg
n0035718,FBgn0035886,FBgn0035887,FBgn0035901,FB
gn0036321,FBgn0036738,FBgn0036831,FBgn0036948,F
Bgn0037073,FBgn0037301,FBgn0037338,FBgn0037345,
FBgn0037356,FBgn0037371,FBgn0037513,FBgn0037534
,FBgn0037678,FBgn0037683,FBgn0037814,FBgn003781
5,FBgn0037958,FBgn0037996,FBgn0038067,FBgn00380
74,FBgn0038135,FBgn0038467,FBgn0038482,FBgn0038
485,FBgn0038597,FBgn0038632,FBgn0038742,FBgn003
9052,FBgn0039094,FBgn0039099,FBgn0039102,FBgn00
39156,FBgn0039175,FBgn0039189,FBgn0039470,FBgn0
039472,FBgn0039475,FBgn0039476,FBgn0039580,FBgn
0039687,FBgn0039777,FBgn0039778,FBgn0040060,FBg
n0040069,FBgn0040078,FBgn0040290,FBgn0040337,FB
gn0040959,FBgn0041147,FBgn0046689,FBgn0050049,F
Bgn0050085,FBgn0050090,FBgn0050371,FBgn0050502,
FBgn0051198,FBgn0051265,FBgn0051266,FBgn0051343
,FBgn0051391,FBgn0051469,FBgn0052412,FBgn005275
0,FBgn0053080,FBgn0053116,FBgn0053127,FBgn00531
38,FBgn0053460,FBgn0086708,FBgn0086712,FBgn0243
511,FBgn0250815,FBgn0259676,FBgn0259791,FBgn026
1479,FBgn0261681,FBgn0261850,FBgn0263133,FBgn02
65140,FBgn0266420,FBgn0267408,FBgn0267824,FBgn0
283525,FBgn0283680,FBgn0284256,FBgn0286788 
172 GO:0008
152 
organic 
substance 
metabolic 
process 
0.0383
5981 
FBgn0001150,FBgn0002441,FBgn0003257,FBgn0010278
,FBgn0010425,FBgn0011211,FBgn0011555,FBgn001170
3,FBgn0011704,FBgn0011768,FBgn0011834,FBgn00150
75,FBgn0015277,FBgn0015553,FBgn0020633,FBgn0020
906,FBgn0022700,FBgn0024321,FBgn0024957,FBgn002
5352,FBgn0025373,FBgn0025592,FBgn0025815,FBgn00
25832,FBgn0026079,FBgn0026143,FBgn0026411,FBgn0
027791,FBgn0027794,FBgn0027868,FBgn0028375,FBgn
0028962,FBgn0029823,FBgn0029827,FBgn0029856,FBg
n0029906,FBgn0030081,FBgn0030136,FBgn0030966,FB
gn0031030,FBgn0031092,FBgn0031145,FBgn0031249,F
161 GO:0071
704 
 
 
379 
Bgn0031252,FBgn0031381,FBgn0031653,FBgn0031703,
FBgn0031713,FBgn0031875,FBgn0031996,FBgn0031999
,FBgn0032244,FBgn0032350,FBgn0032424,FBgn003278
1,FBgn0032929,FBgn0033187,FBgn0033235,FBgn00333
77,FBgn0033431,FBgn0033454,FBgn0033549,FBgn0033
733,FBgn0033774,FBgn0034052,FBgn0034177,FBgn003
4422,FBgn0034582,FBgn0034629,FBgn0034817,FBgn00
34937,FBgn0034988,FBgn0035006,FBgn0035383,FBgn0
035665,FBgn0035666,FBgn0035718,FBgn0035886,FBgn
0035887,FBgn0035901,FBgn0036321,FBgn0036738,FBg
n0036831,FBgn0036948,FBgn0037073,FBgn0037301,FB
gn0037338,FBgn0037345,FBgn0037356,FBgn0037371,F
Bgn0037513,FBgn0037534,FBgn0037678,FBgn0037814,
FBgn0037815,FBgn0037958,FBgn0037996,FBgn0038067
,FBgn0038074,FBgn0038135,FBgn0038467,FBgn003848
2,FBgn0038485,FBgn0038597,FBgn0038632,FBgn00387
42,FBgn0039052,FBgn0039094,FBgn0039102,FBgn0039
156,FBgn0039175,FBgn0039189,FBgn0039470,FBgn003
9472,FBgn0039475,FBgn0039476,FBgn0039580,FBgn00
39687,FBgn0039777,FBgn0039778,FBgn0040060,FBgn0
040078,FBgn0040290,FBgn0040337,FBgn0040959,FBgn
0041147,FBgn0046689,FBgn0050049,FBgn0050085,FBg
n0050090,FBgn0050371,FBgn0050502,FBgn0051198,FB
gn0051265,FBgn0051266,FBgn0051343,FBgn0051469,F
Bgn0052412,FBgn0053080,FBgn0053116,FBgn0053127,
FBgn0053138,FBgn0053460,FBgn0086708,FBgn0086712
,FBgn0243511,FBgn0250815,FBgn0259676,FBgn025979
1,FBgn0261479,FBgn0261681,FBgn0261850,FBgn02631
33,FBgn0265140,FBgn0266420,FBgn0267408,FBgn0267
824,FBgn0283525,FBgn0283680,FBgn0284256,FBgn028
6788 
small 
molecule 
metabolic 
process 
1.2133
E-05 
FBgn0003257,FBgn0011211,FBgn0011703,FBgn0011704
,FBgn0011768,FBgn0024957,FBgn0025352,FBgn002559
2,FBgn0028375,FBgn0028962,FBgn0029823,FBgn00309
66,FBgn0031092,FBgn0031381,FBgn0031703,FBgn0031
713,FBgn0032350,FBgn0032424,FBgn0033733,FBgn003
4177,FBgn0034629,FBgn0034988,FBgn0035006,FBgn00
35383,FBgn0037356,FBgn0037513,FBgn0037534,FBgn0
037996,FBgn0038074,FBgn0038467,FBgn0038742,FBgn
0039052,FBgn0039094,FBgn0039156,FBgn0039175,FBg
n0039580,FBgn0050502,FBgn0086712,FBgn0267408,FB
gn0283680 
40 GO:0044
281 
proteolysis 5.6745
E-05 
FBgn0010425,FBgn0011555,FBgn0011703,FBgn0011704
,FBgn0011834,FBgn0020906,FBgn0029827,FBgn002985
6,FBgn0031249,FBgn0031653,FBgn0033235,FBgn00337
74,FBgn0034052,FBgn0034937,FBgn0035665,FBgn0035
666,FBgn0035718,FBgn0035886,FBgn0035887,FBgn003
6738,FBgn0037678,FBgn0038135,FBgn0038482,FBgn00
38485,FBgn0039102,FBgn0039777,FBgn0039778,FBgn0
040060,FBgn0041147,FBgn0050049,FBgn0050090,FBgn
0050371,FBgn0051198,FBgn0051265,FBgn0051266,FBg
n0051343,FBgn0053127,FBgn0053460,FBgn0250815,FB
gn0265140 
40 GO:0006
508 
organic 
substance 
catabolic 
process 
0.0388
2098 
FBgn0011768,FBgn0022700,FBgn0025352,FBgn0027794
,FBgn0029823,FBgn0029856,FBgn0031092,FBgn003125
2,FBgn0034582,FBgn0034629,FBgn0034937,FBgn00349
88,FBgn0035383,FBgn0036321,FBgn0036831,FBgn0037
31 GO:1901
575 
 
 
380 
513,FBgn0037815,FBgn0037958,FBgn0038074,FBgn003
8135,FBgn0038742,FBgn0039094,FBgn0039470,FBgn00
39472,FBgn0039475,FBgn0039476,FBgn0041147,FBgn0
051198,FBgn0051343,FBgn0086712,FBgn0284256 
lipid 
metabolic 
process 
0.0001
3624 
FBgn0015277,FBgn0025352,FBgn0025373,FBgn0025592
,FBgn0029906,FBgn0031092,FBgn0031381,FBgn003170
3,FBgn0033187,FBgn0033733,FBgn0034629,FBgn00350
06,FBgn0035383,FBgn0037356,FBgn0037534,FBgn0037
958,FBgn0037996,FBgn0038067,FBgn0038742,FBgn003
9156,FBgn0039470,FBgn0039472,FBgn0039475,FBgn00
39476,FBgn0050502,FBgn0053116,FBgn0086712 
27 GO:0006
629 
organic 
acid 
metabolic 
process 
2.8548
E-05 
FBgn0024957,FBgn0025352,FBgn0028962,FBgn0029823
,FBgn0030966,FBgn0031092,FBgn0031703,FBgn003235
0,FBgn0033733,FBgn0034177,FBgn0034629,FBgn00350
06,FBgn0035383,FBgn0037356,FBgn0037513,FBgn0037
534,FBgn0037996,FBgn0038074,FBgn0038742,FBgn003
9052,FBgn0039094,FBgn0039156,FBgn0039175,FBgn00
50502,FBgn0086712 
25 GO:0006
082 
oxoacid 
metabolic 
process 
2.8548
E-05 
FBgn0024957,FBgn0025352,FBgn0028962,FBgn0029823
,FBgn0030966,FBgn0031092,FBgn0031703,FBgn003235
0,FBgn0033733,FBgn0034177,FBgn0034629,FBgn00350
06,FBgn0035383,FBgn0037356,FBgn0037513,FBgn0037
534,FBgn0037996,FBgn0038074,FBgn0038742,FBgn003
9052,FBgn0039094,FBgn0039156,FBgn0039175,FBgn00
50502,FBgn0086712 
25 GO:0043
436 
carboxylic 
acid 
metabolic 
process 
3.8053
E-05 
FBgn0024957,FBgn0025352,FBgn0028962,FBgn0029823
,FBgn0031092,FBgn0031703,FBgn0032350,FBgn003373
3,FBgn0034177,FBgn0034629,FBgn0035006,FBgn00353
83,FBgn0037356,FBgn0037513,FBgn0037534,FBgn0037
996,FBgn0038074,FBgn0038742,FBgn0039052,FBgn003
9094,FBgn0039156,FBgn0039175,FBgn0050502,FBgn00
86712 
24 GO:0019
752 
oxidation-
reduction 
process 
0.0343
3962 
FBgn0011211,FBgn0011703,FBgn0011704,FBgn0011768
,FBgn0014028,FBgn0020653,FBgn0024957,FBgn002535
2,FBgn0030966,FBgn0031092,FBgn0031182,FBgn00317
13,FBgn0032350,FBgn0033079,FBgn0034629,FBgn0035
383,FBgn0038742,FBgn0039099,FBgn0050502,FBgn005
3138,FBgn0086712,FBgn0267408 
22 GO:0055
114 
DNA 
metabolic 
process 
0.0005
1279 
FBgn0015075,FBgn0015553,FBgn0020633,FBgn0025815
,FBgn0025832,FBgn0026143,FBgn0027868,FBgn003125
2,FBgn0032244,FBgn0032929,FBgn0033549,FBgn00363
21,FBgn0036831,FBgn0037301,FBgn0037338,FBgn0037
345,FBgn0040290,FBgn0050085,FBgn0259676,FBgn026
1850,FBgn0286788 
21 GO:0006
259 
cellular 
lipid 
metabolic 
process 
0.0012
9471 
FBgn0015277,FBgn0025352,FBgn0025373,FBgn0025592
,FBgn0029906,FBgn0031092,FBgn0031703,FBgn003318
7,FBgn0033733,FBgn0034629,FBgn0035006,FBgn00353
83,FBgn0037356,FBgn0037534,FBgn0037958,FBgn0037
996,FBgn0038742,FBgn0039156,FBgn0050502,FBgn005
3116,FBgn0086712 
21 GO:0044
255 
transmemb
rane 
transport 
0.0252
2501 
FBgn0010497,FBgn0011211,FBgn0031516,FBgn0032435
,FBgn0032946,FBgn0033371,FBgn0033812,FBgn003461
2,FBgn0034783,FBgn0037140,FBgn0037668,FBgn00378
46,FBgn0038312,FBgn0038407,FBgn0038412,FBgn0038
613,FBgn0039357,FBgn0039736,FBgn0042126,FBgn005
0272,FBgn0262008 
21 GO:0055
085 
 
 
381 
homeostati
c process 
0.0380
6386 
FBgn0011204,FBgn0015277,FBgn0020653,FBgn0024957
,FBgn0029131,FBgn0031030,FBgn0031381,FBgn003167
7,FBgn0032746,FBgn0032946,FBgn0034629,FBgn00353
83,FBgn0037338,FBgn0038074,FBgn0038613,FBgn0050
085,FBgn0050377,FBgn0053542,FBgn0086712,FBgn026
6420 
20 GO:0042
592 
carbohydra
te 
derivative 
metabolic 
process 
0.0380
6386 
FBgn0003257,FBgn0011211,FBgn0011703,FBgn0011704
,FBgn0022700,FBgn0025592,FBgn0027791,FBgn002990
6,FBgn0033187,FBgn0033431,FBgn0034582,FBgn00349
88,FBgn0036948,FBgn0038074,FBgn0038467,FBgn0038
632,FBgn0039156,FBgn0039580,FBgn0040959,FBgn026
1681 
20 GO:1901
135 
cellular 
response to 
DNA 
damage 
stimulus 
0.0018
7823 
FBgn0015075,FBgn0015553,FBgn0020633,FBgn0025815
,FBgn0025832,FBgn0026143,FBgn0027868,FBgn002913
1,FBgn0029588,FBgn0031030,FBgn0031252,FBgn00322
44,FBgn0033549,FBgn0037301,FBgn0037338,FBgn0040
290,FBgn0050085,FBgn0261850 
18 GO:0006
974 
small 
molecule 
biosyntheti
c process 
0.0001
1852 
FBgn0028375,FBgn0029823,FBgn0031381,FBgn0031703
,FBgn0031713,FBgn0033733,FBgn0034988,FBgn003500
6,FBgn0035383,FBgn0037356,FBgn0037513,FBgn00375
34,FBgn0037996,FBgn0038074,FBgn0039094,FBgn0039
156,FBgn0283680 
17 GO:0044
283 
drug 
metabolic 
process 
0.0004
5547 
FBgn0011211,FBgn0011768,FBgn0022700,FBgn0024957
,FBgn0029823,FBgn0034582,FBgn0035383,FBgn003694
8,FBgn0038074,FBgn0038467,FBgn0038632,FBgn00390
94,FBgn0040959,FBgn0261681,FBgn0267408 
15 GO:0017
144 
fatty acid 
metabolic 
process 
4.2887
E-06 
FBgn0025352,FBgn0031092,FBgn0031703,FBgn0033733
,FBgn0034629,FBgn0035006,FBgn0035383,FBgn003735
6,FBgn0037534,FBgn0037996,FBgn0038742,FBgn00391
56,FBgn0050502,FBgn0086712 
14 GO:0006
631 
monocarbo
xylic acid 
metabolic 
process 
0.0002
9901 
FBgn0025352,FBgn0031092,FBgn0031703,FBgn0033733
,FBgn0034629,FBgn0035006,FBgn0035383,FBgn003735
6,FBgn0037534,FBgn0037996,FBgn0038742,FBgn00391
56,FBgn0050502,FBgn0086712 
14 GO:0032
787 
DNA 
repair 
0.0027
8036 
FBgn0015075,FBgn0015553,FBgn0020633,FBgn0025815
,FBgn0025832,FBgn0026143,FBgn0027868,FBgn003125
2,FBgn0032244,FBgn0033549,FBgn0037301,FBgn00373
38,FBgn0040290,FBgn0261850 
14 GO:0006
281 
lipid 
biosyntheti
c process 
0.0029
862 
FBgn0015277,FBgn0025373,FBgn0031381,FBgn0031703
,FBgn0033187,FBgn0033733,FBgn0035006,FBgn003735
6,FBgn0037534,FBgn0037958,FBgn0037996,FBgn00391
56,FBgn0050502,FBgn0053116 
14 GO:0008
610 
DNA 
replication 
0.0002
9309 
FBgn0011703,FBgn0020633,FBgn0025815,FBgn0026143
,FBgn0031875,FBgn0032244,FBgn0032929,FBgn003354
9,FBgn0040290,FBgn0050085,FBgn0259676,FBgn02867
88 
12 GO:0006
260 
organopho
sphate 
biosyntheti
c process 
0.0178
0335 
FBgn0003257,FBgn0011211,FBgn0011703,FBgn0011704
,FBgn0015277,FBgn0025373,FBgn0025592,FBgn003318
7,FBgn0038467,FBgn0039156,FBgn0053116,FBgn02836
80 
12 GO:0090
407 
chemical 
homeostasi
s 
0.0451
3263 
FBgn0011204,FBgn0024957,FBgn0031381,FBgn0031677
,FBgn0032746,FBgn0032946,FBgn0034629,FBgn003538
3,FBgn0038074,FBgn0038613,FBgn0050377,FBgn00867
12 
12 GO:0048
878 
lipid 
catabolic 
process 
0.0003
4632 
FBgn0025352,FBgn0031092,FBgn0034629,FBgn0035383
,FBgn0037958,FBgn0038742,FBgn0039470,FBgn003947
2,FBgn0039475,FBgn0039476,FBgn0086712 
11 GO:0016
042 
 
 
382 
organic 
acid 
biosyntheti
c process 
0.0003
4632 
FBgn0029823,FBgn0031703,FBgn0033733,FBgn0035006
,FBgn0037356,FBgn0037513,FBgn0037534,FBgn003799
6,FBgn0038074,FBgn0039094,FBgn0039156 
11 GO:0016
053 
carboxylic 
acid 
biosyntheti
c process 
0.0003
4632 
FBgn0029823,FBgn0031703,FBgn0033733,FBgn0035006
,FBgn0037356,FBgn0037513,FBgn0037534,FBgn003799
6,FBgn0038074,FBgn0039094,FBgn0039156 
11 GO:0046
394 
DNA-
dependent 
DNA 
replication 
0.0004
4532 
FBgn0020633,FBgn0025815,FBgn0026143,FBgn0031875
,FBgn0032244,FBgn0032929,FBgn0033549,FBgn004029
0,FBgn0050085,FBgn0259676,FBgn0286788 
11 GO:0006
261 
small 
molecule 
catabolic 
process 
0.0049
6955 
FBgn0011768,FBgn0025352,FBgn0029823,FBgn0031092
,FBgn0034629,FBgn0034988,FBgn0035383,FBgn003874
2,FBgn0039094,FBgn0086712 
10 GO:0044
282 
response to 
drug 
0.0287
0394 
FBgn0010497,FBgn0029823,FBgn0031030,FBgn0031182
,FBgn0036381,FBgn0037140,FBgn0037668,FBgn003935
7,FBgn0086782,FBgn0261090 
10 GO:0042
493 
double-
strand 
break 
repair 
0.0036
555 
FBgn0015075,FBgn0020633,FBgn0025815,FBgn0026143
,FBgn0027868,FBgn0033549,FBgn0037301,FBgn003733
8,FBgn0040290 
9 GO:0006
302 
DNA 
recombinat
ion 
0.0049
2357 
FBgn0015553,FBgn0020633,FBgn0025815,FBgn0026143
,FBgn0027868,FBgn0033549,FBgn0037301,FBgn004029
0,FBgn0261850 
9 GO:0006
310 
cellular 
amino acid 
metabolic 
process 
0.0195
7051 
FBgn0028962,FBgn0029823,FBgn0032350,FBgn0034177
,FBgn0037513,FBgn0038074,FBgn0039052,FBgn003909
4,FBgn0039175 
9 GO:0006
520 
organic 
acid 
catabolic 
process 
0.0051
3011 
FBgn0025352,FBgn0029823,FBgn0031092,FBgn0034629
,FBgn0035383,FBgn0038742,FBgn0039094,FBgn008671
2 
8 GO:0016
054 
carboxylic 
acid 
catabolic 
process 
0.0051
3011 
FBgn0025352,FBgn0029823,FBgn0031092,FBgn0034629
,FBgn0035383,FBgn0038742,FBgn0039094,FBgn008671
2 
8 GO:0046
395 
fatty acid 
biosyntheti
c process 
0.0013
821 
FBgn0031703,FBgn0033733,FBgn0035006,FBgn0037356
,FBgn0037534,FBgn0037996,FBgn0039156 
7 GO:0006
633 
amino 
sugar 
metabolic 
process 
0.0029
6798 
FBgn0022700,FBgn0034582,FBgn0036948,FBgn0038632
,FBgn0039580,FBgn0040959,FBgn0261681 
7 GO:0006
040 
monocarbo
xylic acid 
biosyntheti
c process 
0.0029
6798 
FBgn0031703,FBgn0033733,FBgn0035006,FBgn0037356
,FBgn0037534,FBgn0037996,FBgn0039156 
7 GO:0072
330 
cellular 
lipid 
catabolic 
process 
0.0089
1742 
FBgn0025352,FBgn0031092,FBgn0034629,FBgn0035383
,FBgn0037958,FBgn0038742,FBgn0086712 
7 GO:0044
242 
DNA 
replication 
initiation 
0.0002
188 
FBgn0020633,FBgn0025815,FBgn0026143,FBgn0032929
,FBgn0050085,FBgn0286788 
6 GO:0006
270 
 
 
383 
fatty acid 
catabolic 
process 
0.0012
6835 
FBgn0025352,FBgn0031092,FBgn0034629,FBgn0035383
,FBgn0038742,FBgn0086712 
6 GO:0009
062 
monocarbo
xylic acid 
catabolic 
process 
0.0026
97 
FBgn0025352,FBgn0031092,FBgn0034629,FBgn0035383
,FBgn0038742,FBgn0086712 
6 GO:0072
329 
chitin 
metabolic 
process 
0.0031
9207 
FBgn0022700,FBgn0034582,FBgn0036948,FBgn0038632
,FBgn0040959,FBgn0261681 
6 GO:0006
030 
double-
strand 
break 
repair via 
homologou
s 
recombinat
ion 
0.0087
4888 
FBgn0020633,FBgn0025815,FBgn0026143,FBgn0027868
,FBgn0037301,FBgn0040290 
6 GO:0000
724 
recombinat
ional repair 
0.0087
4888 
FBgn0020633,FBgn0025815,FBgn0026143,FBgn0027868
,FBgn0037301,FBgn0040290 
6 GO:0000
725 
glucosamin
e-
containing 
compound 
metabolic 
process 
0.0087
4888 
FBgn0022700,FBgn0034582,FBgn0036948,FBgn0038632
,FBgn0040959,FBgn0261681 
6 GO:1901
071 
lipid 
homeostasi
s 
0.0191
5643 
FBgn0011204,FBgn0031381,FBgn0034629,FBgn0035383
,FBgn0038074,FBgn0086712 
6 GO:0055
088 
aminoglyc
an 
metabolic 
process 
0.0211
2945 
FBgn0022700,FBgn0034582,FBgn0036948,FBgn0038632
,FBgn0040959,FBgn0261681 
6 GO:0006
022 
lipid 
modificatio
n 
0.0388
4904 
FBgn0015277,FBgn0025352,FBgn0031092,FBgn0034629
,FBgn0035383,FBgn0086712 
6 GO:0030
258 
DNA 
duplex 
unwinding 
0.0003
0339 
FBgn0015075,FBgn0020633,FBgn0025815,FBgn0040290
,FBgn0261850 
5 GO:0032
508 
DNA 
geometric 
change 
0.0004
3786 
FBgn0015075,FBgn0020633,FBgn0025815,FBgn0040290
,FBgn0261850 
5 GO:0032
392 
drug 
transport 
0.0023
5624 
FBgn0010497,FBgn0037140,FBgn0037668,FBgn0039357
,FBgn0261090 
5 GO:0015
893 
fatty acid 
beta-
oxidation 
0.0029
3478 
FBgn0025352,FBgn0031092,FBgn0034629,FBgn0035383
,FBgn0086712 
5 GO:0006
635 
fatty acid 
oxidation 
0.0043
8844 
FBgn0025352,FBgn0031092,FBgn0034629,FBgn0035383
,FBgn0086712 
5 GO:0019
395 
lipid 
oxidation 
0.0052
8033 
FBgn0025352,FBgn0031092,FBgn0034629,FBgn0035383
,FBgn0086712 
5 GO:0034
440 
maturation 
of SSU-
rRNA 
0.0305
2081 
FBgn0030081,FBgn0030136,FBgn0033454,FBgn0037073
,FBgn0038597 
5 GO:0030
490 
neurotrans
mitter 
0.0042
325 
FBgn0011768,FBgn0029823,FBgn0037513,FBgn0039094 4 GO:0042
133 
 
 
384 
metabolic 
process 
DNA 
amplificati
on 
0.0054
3906 
FBgn0025815,FBgn0026143,FBgn0040290,FBgn0286788 4 GO:0006
277 
cellular 
amino acid 
biosyntheti
c process 
0.0272
0496 
FBgn0029823,FBgn0037513,FBgn0038074,FBgn0039094 4 GO:0008
652 
positive 
regulation 
of mitotic 
cell cycle 
0.0272
0496 
FBgn0026143,FBgn0032929,FBgn0040290,FBgn0041147 4 GO:0045
931 
regulation 
of DNA 
metabolic 
process 
0.0395
0524 
FBgn0037301,FBgn0037345,FBgn0050085,FBgn0261850 4 GO:0051
052 
positive 
regulation 
of DNA 
metabolic 
process 
0.0009
42 
FBgn0037301,FBgn0037345,FBgn0261850 3 GO:0051
054 
double-
strand 
break 
repair via 
break-
induced 
replication 
0.0030
7374 
FBgn0020633,FBgn0025815,FBgn0026143 3 GO:0000
727 
DNA 
unwinding 
involved in 
DNA 
replication 
0.0047
4912 
FBgn0020633,FBgn0025815,FBgn0040290 3 GO:0006
268 
vitamin 
metabolic 
process 
0.0068
7967 
FBgn0028375,FBgn0029823,FBgn0267408 3 GO:0006
766 
neurotrans
mitter 
biosyntheti
c process 
0.0068
7967 
FBgn0029823,FBgn0037513,FBgn0039094 3 GO:0042
136 
nucleobase 
biosyntheti
c process 
0.0068
7967 
FBgn0003257,FBgn0029823,FBgn0037513 3 GO:0046
112 
sulfur 
compound 
transport 
0.0068
7967 
FBgn0037668,FBgn0039357,FBgn0039736 3 GO:0072
348 
peptide 
catabolic 
process 
0.0162
3751 
FBgn0038135,FBgn0051198,FBgn0051343 3 GO:0043
171 
organic 
hydroxy 
compound 
transport 
0.0203
9263 
FBgn0031381,FBgn0261090,FBgn0261675 3 GO:0015
850 
nucleobase 
metabolic 
process 
0.0250
7592 
FBgn0003257,FBgn0029823,FBgn0037513 3 GO:0009
112 
 
 
385 
ribonucleo
side 
monophos
phate 
metabolic 
process 
0.0250
7592 
FBgn0003257,FBgn0034988,FBgn0038467 3 GO:0009
161 
eggshell 
chorion 
gene 
amplificati
on 
0.0302
8677 
FBgn0025815,FBgn0040290,FBgn0286788 3 GO:0007
307 
nucleoside 
monophos
phate 
metabolic 
process 
0.0302
8677 
FBgn0003257,FBgn0034988,FBgn0038467 3 GO:0009
123 
defense 
response to 
Gram-
positive 
bacterium 
0.0302
8677 
FBgn0033593,FBgn0038973,FBgn0039102 3 GO:0050
830 
acylglycer
ol 
homeostasi
s 
0.0302
8677 
FBgn0011204,FBgn0035383,FBgn0038074 3 GO:0055
090 
triglyceride 
homeostasi
s 
0.0302
8677 
FBgn0011204,FBgn0035383,FBgn0038074 3 GO:0070
328 
inorganic 
anion 
transport 
0.0360
2086 
FBgn0010497,FBgn0037668,FBgn0039736 3 GO:0015
698 
nuclear 
DNA 
replication 
0.0360
2086 
FBgn0020633,FBgn0025815,FBgn0026143 3 GO:0033
260 
positive 
regulation 
of mitotic 
cell cycle 
phase 
transition 
0.0422
7057 
FBgn0026143,FBgn0040290,FBgn0041147 3 GO:1901
992 
detoxificati
on 
0.0490
2542 
FBgn0011768,FBgn0031182,FBgn0038412 3 GO:0098
754 
chromatin 
silencing at 
rDNA 
0.0021
7883 
FBgn0034422,FBgn0039687 2 GO:0000
183 
positive 
regulation 
of DNA 
recombinat
ion 
0.0021
7883 
FBgn0037301,FBgn0261850 2 GO:0045
911 
glycine 
biosyntheti
c process 
0.0063
3435 
FBgn0029823,FBgn0039094 2 GO:0006
545 
deoxyribon
ucleotide 
biosyntheti
c process 
0.0063
3435 
FBgn0011703,FBgn0011704 2 GO:0009
263 
 
 
386 
response to 
nicotine 
0.0063
3435 
FBgn0031030,FBgn0036381 2 GO:0035
094 
regulation 
of 
mitochondr
ial mRNA 
stability 
0.0063
3435 
FBgn0027794,FBgn0284256 2 GO:0044
528 
protein 
homotetra
merization 
0.0063
3435 
FBgn0029823,FBgn0038074 2 GO:0051
289 
regulation 
of 
mitochondr
ial 
transcriptio
n 
0.0063
3435 
FBgn0027794,FBgn0284256 2 GO:1903
108 
reactive 
nitrogen 
species 
metabolic 
process 
0.0063
3435 
FBgn0011768,FBgn0030966 2 GO:2001
057 
pre-
replicative 
complex 
assembly 
involved in 
nuclear cell 
cycle DNA 
replication 
0.0122
7841 
FBgn0020633,FBgn0025815 2 GO:0006
267 
deoxyribon
ucleotide 
metabolic 
process 
0.0122
7841 
FBgn0011703,FBgn0011704 2 GO:0009
262 
pre-
replicative 
complex 
assembly 
0.0122
7841 
FBgn0020633,FBgn0025815 2 GO:0036
388 
pre-
replicative 
complex 
assembly 
involved in 
cell cycle 
DNA 
replication 
0.0122
7841 
FBgn0020633,FBgn0025815 2 GO:1902
299 
chitin 
catabolic 
process 
0.0198
3602 
FBgn0022700,FBgn0034582 2 GO:0006
032 
N-terminal 
protein 
amino acid 
acetylation 
0.0198
3602 
FBgn0039687,FBgn0243511 2 GO:0006
474 
sulfate 
transport 
0.0198
3602 
FBgn0037668,FBgn0039736 2 GO:0008
272 
regulation 
of 
mitochondr
0.0198
3602 
FBgn0029131,FBgn0029588 2 GO:0046
902 
 
 
387 
ial 
membrane 
permeabilit
y 
protein 
tetrameriza
tion 
0.0198
3602 
FBgn0029823,FBgn0038074 2 GO:0051
262 
necrotic 
cell death 
0.0198
3602 
FBgn0029131,FBgn0029588 2 GO:0070
265 
regulation 
of 
membrane 
permeabilit
y 
0.0198
3602 
FBgn0029131,FBgn0029588 2 GO:0090
559 
'de novo' 
pyrimidine 
nucleobase 
biosyntheti
c process 
0.0288
4451 
FBgn0003257,FBgn0037513 2 GO:0006
207 
glycine 
metabolic 
process 
0.0288
4451 
FBgn0029823,FBgn0039094 2 GO:0006
544 
phosphate 
ion 
transport 
0.0288
4451 
FBgn0010497,FBgn0037668 2 GO:0006
817 
serine 
family 
amino acid 
biosyntheti
c process 
0.0288
4451 
FBgn0029823,FBgn0039094 2 GO:0009
070 
cholesterol 
transport 
0.0288
4451 
FBgn0031381,FBgn0261675 2 GO:0030
301 
amino 
sugar 
catabolic 
process 
0.0288
4451 
FBgn0022700,FBgn0034582 2 GO:0046
348 
glucosamin
e-
containing 
compound 
catabolic 
process 
0.0288
4451 
FBgn0022700,FBgn0034582 2 GO:1901
072 
regulation 
of 
oxidative 
phosphoryl
ation 
0.0391
5282 
FBgn0027794,FBgn0284256 2 GO:0002
082 
digestion 0.0391
5282 
FBgn0053542,FBgn0261675 2 GO:0007
586 
sterol 
transport 
0.0391
5282 
FBgn0031381,FBgn0261675 2 GO:0015
918 
pyrimidine 
nucleobase 
biosyntheti
c process 
0.0391
5282 
FBgn0003257,FBgn0037513 2 GO:0019
856 
RNA exon 
ligation 
0.0467
7419 
FBgn0032781 1 GO:0000
378 
 
 
388 
nucleotide-
excision 
repair, 
DNA 
duplex 
unwinding 
0.0467
7419 
FBgn0261850 1 GO:0000
717 
tRNA exon 
ligation 
0.0467
7419 
FBgn0032781 1 GO:0000
968 
tRNA exon 
ligation 
utilizing 
2',3' cyclic 
phosphate 
of 5'-exon 
as source 
of linkage 
phosphate 
0.0467
7419 
FBgn0032781 1 GO:0000
971 
biosyntheti
c process 
of 
antibacteri
al peptides 
active 
against 
Gram-
positive 
bacteria 
0.0467
7419 
FBgn0039102 1 GO:0002
815 
regulation 
of 
biosyntheti
c process 
of 
antibacteri
al peptides 
active 
against 
Gram-
positive 
bacteria 
0.0467
7419 
FBgn0039102 1 GO:0002
816 
L-serine 
catabolic 
process 
0.0467
7419 
FBgn0029823 1 GO:0006
565 
fat-soluble 
vitamin 
metabolic 
process 
0.0467
7419 
FBgn0028375 1 GO:0006
775 
positive 
regulation 
of 
biosyntheti
c process 
of 
antibacteri
al peptides 
active 
against 
Gram-
0.0467
7419 
FBgn0039102 1 GO:0006
965 
 
 
389 
positive 
bacteria 
regulation 
of 
preblastode
rm mitotic 
cell cycle 
0.0467
7419 
FBgn0002441 1 GO:0007
347 
specificatio
n of 
segmental 
identity, 
labial 
segment 
0.0467
7419 
FBgn0001150 1 GO:0007
381 
peptidyl-
lysine 
modificatio
n to 
peptidyl-
hypusine 
0.0467
7419 
FBgn0261479 1 GO:0008
612 
menaquino
ne 
metabolic 
process 
0.0467
7419 
FBgn0028375 1 GO:0009
233 
menaquino
ne 
biosyntheti
c process 
0.0467
7419 
FBgn0028375 1 GO:0009
234 
response to 
amine 
0.0467
7419 
FBgn0038542 1 GO:0014
075 
S-
adenosyl-
L-
methionine 
transport 
0.0467
7419 
FBgn0039357 1 GO:0015
805 
nucleoside 
transport 
0.0467
7419 
FBgn0033371 1 GO:0015
858 
acetylcholi
ne 
transport 
0.0467
7419 
FBgn0037140 1 GO:0015
870 
protein 
nitrosylatio
n 
0.0467
7419 
FBgn0011768 1 GO:0017
014 
peptidyl-
cysteine S-
nitrosylatio
n 
0.0467
7419 
FBgn0011768 1 GO:0018
119 
glycine 
biosyntheti
c process 
from serine 
0.0467
7419 
FBgn0029823 1 GO:0019
264 
intestinal 
cholesterol 
absorption 
0.0467
7419 
FBgn0261675 1 GO:0030
299 
protection 
from non-
homologou
s end 
0.0467
7419 
FBgn0037338 1 GO:0031
848 
 
 
390 
joining at 
telomere 
regulation 
of 
deoxyribon
uclease 
activity 
0.0467
7419 
FBgn0037345 1 GO:0032
070 
positive 
regulation 
of nuclease 
activity 
0.0467
7419 
FBgn0037345 1 GO:0032
075 
positive 
regulation 
of 
deoxyribon
uclease 
activity 
0.0467
7419 
FBgn0037345 1 GO:0032
077 
ubiquinone 
biosyntheti
c process 
via 3,4-
dihydroxy-
5-
polyprenyl
benzoate 
0.0467
7419 
FBgn0028375 1 GO:0032
194 
negative 
regulation 
of synaptic 
transmissio
n, 
cholinergic 
0.0467
7419 
FBgn0037140 1 GO:0032
223 
geranyl 
diphosphat
e metabolic 
process 
0.0467
7419 
FBgn0025373 1 GO:0033
383 
geranyl 
diphosphat
e 
biosyntheti
c process 
0.0467
7419 
FBgn0025373 1 GO:0033
384 
beta-
alanine 
biosyntheti
c process 
via 3-
ureidoprop
ionate 
0.0467
7419 
FBgn0037513 1 GO:0033
396 
internal 
genitalia 
morphogen
esis 
0.0467
7419 
FBgn0267728 1 GO:0035
260 
neurotroph
in 
signaling 
pathway 
0.0467
7419 
FBgn0267824 1 GO:0038
179 
nitrate 
metabolic 
0.0467
7419 
FBgn0030966 1 GO:0042
126 
 
 
391 
process 
nitrate 
assimilatio
n 
0.0467
7419 
FBgn0030966 1 GO:0042
128 
cellular 
response to 
glucose 
starvation 
0.0467
7419 
FBgn0034422 1 GO:0042
149 
fat-soluble 
vitamin 
biosyntheti
c process 
0.0467
7419 
FBgn0028375 1 GO:0042
362 
vitamin K 
biosyntheti
c process 
0.0467
7419 
FBgn0028375 1 GO:0042
371 
vitamin K 
metabolic 
process 
0.0467
7419 
FBgn0028375 1 GO:0042
373 
pyridoxal 
metabolic 
process 
0.0467
7419 
FBgn0267408 1 GO:0042
817 
telomere 
maintenanc
e in 
response to 
DNA 
damage 
0.0467
7419 
FBgn0037338 1 GO:0043
247 
'de novo' 
UMP 
biosyntheti
c process 
0.0467
7419 
FBgn0003257 1 GO:0044
205 
lipid 
digestion 
0.0467
7419 
FBgn0261675 1 GO:0044
241 
regulation 
of 
transcriptio
n involved 
in 
anterior/po
sterior axis 
specificatio
n 
0.0467
7419 
FBgn0001150 1 GO:0044
324 
sodium-
dependent 
phosphate 
transport 
0.0467
7419 
FBgn0010497 1 GO:0044
341 
positive 
regulation 
of mitotic 
recombinat
ion 
0.0467
7419 
FBgn0261850 1 GO:0045
951 
regulation 
of 
transcriptio
n by 
glucose 
0.0467
7419 
FBgn0034422 1 GO:0046
015 
 
 
392 
formaldehy
de 
metabolic 
process 
0.0467
7419 
FBgn0011768 1 GO:0046
292 
formaldehy
de 
catabolic 
process 
0.0467
7419 
FBgn0011768 1 GO:0046
294 
folic acid 
metabolic 
process 
0.0467
7419 
FBgn0029823 1 GO:0046
655 
ketone 
body 
biosyntheti
c process 
0.0467
7419 
FBgn0035383 1 GO:0046
951 
neurotroph
in TRK 
receptor 
signaling 
pathway 
0.0467
7419 
FBgn0267824 1 GO:0048
011 
S-
adenosylm
ethionine 
catabolic 
process 
0.0467
7419 
FBgn0038074 1 GO:0050
843 
intestinal 
absorption 
0.0467
7419 
FBgn0261675 1 GO:0050
892 
coenzyme 
transport 
0.0467
7419 
FBgn0039357 1 GO:0051
182 
L-
glutamate 
import 
0.0467
7419 
FBgn0010497 1 GO:0051
938 
apoptotic 
process 
involved in 
morphogen
esis 
0.0467
7419 
FBgn0029131 1 GO:0060
561 
regulation 
of 
chromatin 
silencing at 
rDNA 
0.0467
7419 
FBgn0039687 1 GO:0061
187 
cellular 
response to 
amine 
stimulus 
0.0467
7419 
FBgn0038542 1 GO:0071
418 
replication 
fork arrest 
involved in 
DNA 
replication 
termination 
0.0467
7419 
FBgn0050085 1 GO:0071
807 
tyramine 
signaling 
pathway 
0.0467
7419 
FBgn0038542 1 GO:0071
928 
nitrogen 
cycle 
0.0467
7419 
FBgn0030966 1 GO:0071
941 
 
 
393 
metabolic 
process 
regulation 
of nitric 
oxide 
metabolic 
process 
0.0467
7419 
FBgn0011768 1 GO:0080
164 
peptidyl-
N-
phospho-
arginine 
dephospho
rylation 
0.0467
7419 
FBgn0051469 1 GO:0098
628 
intestinal 
lipid 
absorption 
0.0467
7419 
FBgn0261675 1 GO:0098
856 
cellular 
detoxificati
on of 
aldehyde 
0.0467
7419 
FBgn0011768 1 GO:0110
095 
cellular 
response to 
aldehyde 
0.0467
7419 
FBgn0011768 1 GO:0110
096 
regulation 
of 
phospholip
ase C-
activating 
G protein-
coupled 
receptor 
signaling 
pathway 
0.0467
7419 
FBgn0038542 1 GO:1900
736 
positive 
regulation 
of 
phospholip
ase C-
activating 
G protein-
coupled 
receptor 
signaling 
pathway 
0.0467
7419 
FBgn0038542 1 GO:1900
738 
sarcosine 
metabolic 
process 
0.0467
7419 
FBgn0038074 1 GO:1901
052 
sarcosine 
biosyntheti
c process 
0.0467
7419 
FBgn0038074 1 GO:1901
054 
acetate 
ester 
transport 
0.0467
7419 
FBgn0037140 1 GO:1901
374 
nucleoside 
transmemb
rane 
transport 
0.0467
7419 
FBgn0033371 1 GO:1901
642 
 
 
394 
negative 
regulation 
of 
compound 
eye retinal 
cell 
apoptotic 
process 
0.0467
7419 
FBgn0032929 1 GO:1901
693 
regulation 
of 
exodeoxyri
bonuclease 
activity 
0.0467
7419 
FBgn0037345 1 GO:1902
392 
positive 
regulation 
of 
exodeoxyri
bonuclease 
activity 
0.0467
7419 
FBgn0037345 1 GO:1902
394 
mitotic 
DNA 
replication 
preinitiatio
n complex 
assembly 
0.0467
7419 
FBgn0026143 1 GO:1902
977 
regulation 
of tRNA 
metabolic 
process 
0.0467
7419 
FBgn0032781 1 GO:1903
326 
positive 
regulation 
of tRNA 
metabolic 
process 
0.0467
7419 
FBgn0032781 1 GO:1903
328 
microtubul
e bundle 
formation 
involved in 
mitotic 
spindle 
midzone 
assembly 
0.0467
7419 
FBgn0011692 1 GO:1903
562 
regulation 
of 
cytoplasmi
c transport 
0.0467
7419 
FBgn0015277 1 GO:1903
649 
response to 
tetrahydrof
olate 
0.0467
7419 
FBgn0029823 1 GO:1904
481 
cellular 
response to 
tetrahydrof
olate 
0.0467
7419 
FBgn0029823 1 GO:1904
482 
positive 
regulation 
of double-
strand 
0.0467
7419 
FBgn0037301 1 GO:1905
168 
 
 
395 
break 
repair via 
homologou
s 
recombinat
ion 
regulation 
of 
exonucleas
e activity 
0.0467
7419 
FBgn0037345 1 GO:1905
777 
positive 
regulation 
of 
exonucleas
e activity 
0.0467
7419 
FBgn0037345 1 GO:1905
779 
regulation 
of 
peptidyl-
cysteine S-
nitrosylatio
n 
0.0467
7419 
FBgn0011768 1 GO:2000
169 
regulation 
of tRNA 
processing 
0.0467
7419 
FBgn0032781 1 GO:2000
235 
positive 
regulation 
of tRNA 
processing 
0.0467
7419 
FBgn0032781 1 GO:2000
237 
regulation 
of early 
endosome 
to late 
endosome 
transport 
0.0467
7419 
FBgn0015277 1 GO:2000
641 
positive 
regulation 
of double-
strand 
break 
repair 
0.0467
7419 
FBgn0037301 1 GO:2000
781 
 
Table 2.4h: GO enrichment for hits equalized in control females relative to 20HE males 
GO 
enrichmen
t 
p-value Hits Gene 
matche
s 
GO ID 
ï»¿mitocho
ndrial 
translation 
4.82E-
07 
FBgn0011787,FBgn0014023,FBgn0026741,FBgn00297
18,FBgn0031231,FBgn0032053,FBgn0032486,FBgn003
3184,FBgn0034579,FBgn0035064,FBgn0035374,FBgn0
036335,FBgn0036569,FBgn0037330,FBgn0038426,FBg
n0038474,FBgn0039159,FBgn0042112,FBgn0051450,F
Bgn0083983,FBgn0263863 
21 GO:0032
543 
DNA-
dependent 
DNA 
replication 
1.2254E
-06 
FBgn0002878,FBgn0003116,FBgn0004406,FBgn00056
96,FBgn0010438,FBgn0011762,FBgn0014861,FBgn001
5271,FBgn0017577,FBgn0030054,FBgn0032290,FBgn0
032813,FBgn0033890,FBgn0035644,FBgn0035918,FBg
n0039403,FBgn0259113,FBgn0260985,FBgn0262619 
19 GO:0006
261 
 
 
396 
DNA 
replication 
1.2492E
-06 
FBgn0002878,FBgn0003116,FBgn0004406,FBgn00056
96,FBgn0010382,FBgn0010438,FBgn0011762,FBgn001
4861,FBgn0015271,FBgn0017577,FBgn0030054,FBgn0
032290,FBgn0032813,FBgn0033890,FBgn0034495,FBg
n0035644,FBgn0035918,FBgn0039403,FBgn0259113,F
Bgn0260985,FBgn0262619 
21 GO:0006
260 
mitochondr
ial gene 
expression 
7.7436E
-06 
FBgn0011787,FBgn0014023,FBgn0026741,FBgn00297
18,FBgn0031231,FBgn0032053,FBgn0032486,FBgn003
3184,FBgn0034579,FBgn0035064,FBgn0035374,FBgn0
036335,FBgn0036569,FBgn0037330,FBgn0038426,FBg
n0038474,FBgn0039159,FBgn0042112,FBgn0051450,F
Bgn0083983,FBgn0263863 
21 GO:0140
053 
DNA 
replication 
initiation 
0.00029
005 
FBgn0002878,FBgn0005696,FBgn0014861,FBgn00152
71,FBgn0017577,FBgn0035918,FBgn0259113 
7 GO:0006
270 
heterocycle 
metabolic 
process 
0.00052
487 
FBgn0000377,FBgn0000477,FBgn0000543,FBgn00005
62,FBgn0000591,FBgn0001187,FBgn0002522,FBgn000
2542,FBgn0002566,FBgn0002878,FBgn0002899,FBgn0
003042,FBgn0003044,FBgn0003116,FBgn0003512,FBg
n0003515,FBgn0003996,FBgn0004170,FBgn0004396,F
Bgn0004403,FBgn0004406,FBgn0004837,FBgn000490
7,FBgn0005674,FBgn0005696,FBgn0005771,FBgn0010
382,FBgn0010786,FBgn0011291,FBgn0011660,FBgn00
11762,FBgn0011787,FBgn0013972,FBgn0014037,FBgn
0014861,FBgn0014949,FBgn0015271,FBgn0015299,FB
gn0015396,FBgn0015778,FBgn0016070,FBgn0016120,
FBgn0016691,FBgn0016917,FBgn0017577,FBgn00196
44,FBgn0019650,FBgn0022986,FBgn0023214,FBgn002
4987,FBgn0025185,FBgn0025463,FBgn0025629,FBgn0
025680,FBgn0025741,FBgn0025832,FBgn0026679,FBg
n0026702,FBgn0026876,FBgn0027499,FBgn0027620,F
Bgn0028342,FBgn0029006,FBgn0029079,FBgn002997
7,FBgn0030054,FBgn0030085,FBgn0030093,FBgn0030
365,FBgn0030432,FBgn0030507,FBgn0030631,FBgn00
30683,FBgn0030699,FBgn0031227,FBgn0031309,FBgn
0031321,FBgn0031643,FBgn0031663,FBgn0031851,FB
gn0032130,FBgn0032290,FBgn0032400,FBgn0032813,
FBgn0032956,FBgn0033010,FBgn0033507,FBgn00338
59,FBgn0033890,FBgn0033921,FBgn0033998,FBgn003
4065,FBgn0034310,FBgn0034564,FBgn0034614,FBgn0
034650,FBgn0034938,FBgn0035064,FBgn0035153,FBg
n0035246,FBgn0035318,FBgn0035397,FBgn0035644,F
Bgn0035900,FBgn0035918,FBgn0035986,FBgn003601
8,FBgn0036157,FBgn0036373,FBgn0036374,FBgn0036
569,FBgn0036734,FBgn0036735,FBgn0036754,FBgn00
36771,FBgn0036826,FBgn0036827,FBgn0037109,FBgn
0037146,FBgn0037330,FBgn0037607,FBgn0037669,FB
gn0037716,FBgn0037722,FBgn0037822,FBgn0037918,
FBgn0037926,FBgn0038173,FBgn0038224,FBgn00382
37,FBgn0038390,FBgn0038474,FBgn0038546,FBgn003
8592,FBgn0039182,FBgn0039306,FBgn0039403,FBgn0
039404,FBgn0039462,FBgn0039464,FBgn0039650,FBg
n0039740,FBgn0039938,FBgn0039972,FBgn0041103,F
Bgn0043796,FBgn0043900,FBgn0051126,FBgn005155
0,FBgn0051739,FBgn0053504,FBgn0061469,FBgn0085
484,FBgn0086450,FBgn0086679,FBgn0250850,FBgn02
59113,FBgn0259176,FBgn0259938,FBgn0260817,FBgn
177 GO:0046
483 
 
 
397 
0260985,FBgn0261287,FBgn0261872,FBgn0262467,FB
gn0262619,FBgn0263144,FBgn0263237,FBgn0263855,
FBgn0265048,FBgn0265523,FBgn0265623,FBgn02664
11,FBgn0266917,FBgn0267792,FBgn0267821,FBgn028
6027,FBgn0286506 
mitotic 
DNA 
replication 
0.00053
522 
FBgn0014861,FBgn0032290,FBgn0035644,FBgn02591
13,FBgn0262619 
5 GO:1902
969 
cellular 
aromatic 
compound 
metabolic 
process 
0.00101
431 
FBgn0000377,FBgn0000477,FBgn0000543,FBgn00005
62,FBgn0000591,FBgn0001187,FBgn0002522,FBgn000
2542,FBgn0002566,FBgn0002878,FBgn0002899,FBgn0
003042,FBgn0003044,FBgn0003116,FBgn0003512,FBg
n0003515,FBgn0003996,FBgn0004170,FBgn0004396,F
Bgn0004403,FBgn0004406,FBgn0004837,FBgn000490
7,FBgn0005674,FBgn0005696,FBgn0005771,FBgn0010
382,FBgn0010786,FBgn0011291,FBgn0011660,FBgn00
11762,FBgn0011787,FBgn0013972,FBgn0014037,FBgn
0014380,FBgn0014861,FBgn0014949,FBgn0015271,FB
gn0015299,FBgn0015396,FBgn0015778,FBgn0016070,
FBgn0016120,FBgn0016691,FBgn0016917,FBgn00175
77,FBgn0019644,FBgn0019650,FBgn0022986,FBgn002
3214,FBgn0024987,FBgn0025185,FBgn0025463,FBgn0
025629,FBgn0025680,FBgn0025741,FBgn0025832,FBg
n0025936,FBgn0026679,FBgn0026702,FBgn0026876,F
Bgn0027499,FBgn0027620,FBgn0028342,FBgn002900
6,FBgn0029079,FBgn0029977,FBgn0030054,FBgn0030
085,FBgn0030093,FBgn0030365,FBgn0030432,FBgn00
30507,FBgn0030631,FBgn0030683,FBgn0030699,FBgn
0031227,FBgn0031309,FBgn0031321,FBgn0031643,FB
gn0031663,FBgn0031851,FBgn0032130,FBgn0032290,
FBgn0032400,FBgn0032813,FBgn0032956,FBgn00330
10,FBgn0033507,FBgn0033859,FBgn0033890,FBgn003
3921,FBgn0033998,FBgn0034065,FBgn0034310,FBgn0
034564,FBgn0034614,FBgn0034650,FBgn0034938,FBg
n0035064,FBgn0035153,FBgn0035246,FBgn0035318,F
Bgn0035397,FBgn0035644,FBgn0035900,FBgn003591
8,FBgn0035986,FBgn0036018,FBgn0036157,FBgn0036
373,FBgn0036374,FBgn0036569,FBgn0036734,FBgn00
36735,FBgn0036754,FBgn0036771,FBgn0036826,FBgn
0036827,FBgn0037109,FBgn0037330,FBgn0037607,FB
gn0037669,FBgn0037716,FBgn0037722,FBgn0037822,
FBgn0037918,FBgn0037926,FBgn0038173,FBgn00382
24,FBgn0038237,FBgn0038390,FBgn0038474,FBgn003
8546,FBgn0038592,FBgn0039182,FBgn0039306,FBgn0
039403,FBgn0039404,FBgn0039462,FBgn0039464,FBg
n0039650,FBgn0039740,FBgn0039938,FBgn0039972,F
Bgn0041103,FBgn0043796,FBgn0043900,FBgn005112
6,FBgn0051550,FBgn0051739,FBgn0053504,FBgn0061
469,FBgn0085484,FBgn0086450,FBgn0086679,FBgn02
50850,FBgn0259113,FBgn0259176,FBgn0259938,FBgn
0260817,FBgn0260985,FBgn0261287,FBgn0261872,FB
gn0262467,FBgn0262619,FBgn0263144,FBgn0263237,
FBgn0263855,FBgn0265048,FBgn0265523,FBgn02656
23,FBgn0266411,FBgn0266917,FBgn0267792,FBgn026
7821,FBgn0286027,FBgn0286506 
178 GO:0006
725 
copper ion 
transport 
0.00107
248 
FBgn0030343,FBgn0030610,FBgn0062413,FBgn02624
67 
4 GO:0006
825 
 
 
398 
nuclear 
DNA 
replication 
0.00117
708 
FBgn0014861,FBgn0017577,FBgn0032290,FBgn00356
44,FBgn0259113,FBgn0262619 
6 GO:0033
260 
organic 
cyclic 
compound 
metabolic 
process 
0.00118
241 
FBgn0000377,FBgn0000477,FBgn0000543,FBgn00005
62,FBgn0000591,FBgn0001187,FBgn0002522,FBgn000
2542,FBgn0002566,FBgn0002878,FBgn0002899,FBgn0
003042,FBgn0003044,FBgn0003116,FBgn0003512,FBg
n0003515,FBgn0003996,FBgn0004170,FBgn0004396,F
Bgn0004403,FBgn0004406,FBgn0004837,FBgn000490
7,FBgn0005674,FBgn0005696,FBgn0005771,FBgn0010
382,FBgn0010786,FBgn0011291,FBgn0011660,FBgn00
11762,FBgn0011787,FBgn0013972,FBgn0014037,FBgn
0014380,FBgn0014861,FBgn0014949,FBgn0015271,FB
gn0015299,FBgn0015396,FBgn0015778,FBgn0016070,
FBgn0016120,FBgn0016691,FBgn0016917,FBgn00175
77,FBgn0019644,FBgn0019650,FBgn0022986,FBgn002
3214,FBgn0024987,FBgn0025185,FBgn0025463,FBgn0
025629,FBgn0025680,FBgn0025741,FBgn0025832,FBg
n0025936,FBgn0026679,FBgn0026702,FBgn0026876,F
Bgn0027499,FBgn0027620,FBgn0028342,FBgn002900
6,FBgn0029079,FBgn0029977,FBgn0030054,FBgn0030
085,FBgn0030093,FBgn0030365,FBgn0030432,FBgn00
30507,FBgn0030596,FBgn0030631,FBgn0030683,FBgn
0030699,FBgn0031227,FBgn0031309,FBgn0031321,FB
gn0031643,FBgn0031663,FBgn0031851,FBgn0032130,
FBgn0032290,FBgn0032400,FBgn0032813,FBgn00329
56,FBgn0033010,FBgn0033507,FBgn0033859,FBgn003
3890,FBgn0033921,FBgn0033998,FBgn0034065,FBgn0
034310,FBgn0034564,FBgn0034614,FBgn0034650,FBg
n0034938,FBgn0035064,FBgn0035153,FBgn0035246,F
Bgn0035318,FBgn0035397,FBgn0035644,FBgn003590
0,FBgn0035918,FBgn0035986,FBgn0036018,FBgn0036
157,FBgn0036373,FBgn0036374,FBgn0036569,FBgn00
36734,FBgn0036735,FBgn0036754,FBgn0036771,FBgn
0036826,FBgn0036827,FBgn0037109,FBgn0037146,FB
gn0037330,FBgn0037607,FBgn0037669,FBgn0037716,
FBgn0037722,FBgn0037822,FBgn0037918,FBgn00379
26,FBgn0038173,FBgn0038224,FBgn0038237,FBgn003
8390,FBgn0038474,FBgn0038546,FBgn0038592,FBgn0
039182,FBgn0039306,FBgn0039403,FBgn0039404,FBg
n0039462,FBgn0039464,FBgn0039650,FBgn0039740,F
Bgn0039938,FBgn0039972,FBgn0041103,FBgn004379
6,FBgn0043900,FBgn0051126,FBgn0051550,FBgn0051
739,FBgn0053100,FBgn0053504,FBgn0061469,FBgn00
85484,FBgn0086450,FBgn0086679,FBgn0250850,FBgn
0259113,FBgn0259176,FBgn0259938,FBgn0260817,FB
gn0260985,FBgn0261287,FBgn0261872,FBgn0262467,
FBgn0262619,FBgn0263144,FBgn0263237,FBgn02638
55,FBgn0265048,FBgn0265523,FBgn0265623,FBgn026
6411,FBgn0266917,FBgn0267792,FBgn0267821,FBgn0
286027,FBgn0286506 
181 GO:1901
360 
maturation 
of SSU-
rRNA 
0.00165
345 
FBgn0002899,FBgn0004403,FBgn0030085,FBgn00316
43,FBgn0034564,FBgn0036754,FBgn0038474,FBgn003
9306,FBgn0039404 
9 GO:0030
490 
mitochondr
ial DNA 
replication 
0.00172
323 
FBgn0003116,FBgn0004406,FBgn0010438 3 GO:0006
264 
 
 
399 
aminergic 
neurotrans
mitter 
loading 
into 
synaptic 
vesicle 
0.00172
323 
FBgn0003515,FBgn0003996,FBgn0043005 3 GO:0015
842 
cell cycle 
DNA 
replication 
0.00233
396 
FBgn0014861,FBgn0017577,FBgn0030054,FBgn00322
90,FBgn0033890,FBgn0035644,FBgn0259113,FBgn026
2619 
8 GO:0044
786 
nucleobase
-containing 
compound 
metabolic 
process 
0.00269
511 
FBgn0000377,FBgn0000477,FBgn0000543,FBgn00005
62,FBgn0000591,FBgn0001187,FBgn0002522,FBgn000
2542,FBgn0002878,FBgn0002899,FBgn0003042,FBgn0
003044,FBgn0003512,FBgn0004170,FBgn0004396,FBg
n0004403,FBgn0004406,FBgn0004837,FBgn0004907,F
Bgn0005674,FBgn0005696,FBgn0005771,FBgn001038
2,FBgn0011291,FBgn0011660,FBgn0011762,FBgn0011
787,FBgn0013972,FBgn0014037,FBgn0014861,FBgn00
14949,FBgn0015271,FBgn0015299,FBgn0015396,FBgn
0015778,FBgn0016070,FBgn0016120,FBgn0016691,FB
gn0016917,FBgn0017577,FBgn0019644,FBgn0019650,
FBgn0022986,FBgn0023214,FBgn0024987,FBgn00251
85,FBgn0025463,FBgn0025629,FBgn0025680,FBgn002
5741,FBgn0025832,FBgn0026679,FBgn0026702,FBgn0
026876,FBgn0027499,FBgn0027620,FBgn0028342,FBg
n0029006,FBgn0029079,FBgn0029977,FBgn0030054,F
Bgn0030085,FBgn0030093,FBgn0030365,FBgn003043
2,FBgn0030507,FBgn0030631,FBgn0030683,FBgn0030
699,FBgn0031227,FBgn0031309,FBgn0031321,FBgn00
31643,FBgn0031663,FBgn0031851,FBgn0032130,FBgn
0032290,FBgn0032400,FBgn0032813,FBgn0032956,FB
gn0033010,FBgn0033507,FBgn0033859,FBgn0033890,
FBgn0033921,FBgn0033998,FBgn0034065,FBgn00343
10,FBgn0034564,FBgn0034614,FBgn0034650,FBgn003
5064,FBgn0035153,FBgn0035246,FBgn0035318,FBgn0
035397,FBgn0035644,FBgn0035900,FBgn0035918,FBg
n0035986,FBgn0036018,FBgn0036373,FBgn0036374,F
Bgn0036569,FBgn0036734,FBgn0036735,FBgn003675
4,FBgn0036771,FBgn0036826,FBgn0036827,FBgn0037
109,FBgn0037330,FBgn0037607,FBgn0037669,FBgn00
37716,FBgn0037722,FBgn0037822,FBgn0037918,FBgn
0037926,FBgn0038173,FBgn0038224,FBgn0038237,FB
gn0038390,FBgn0038474,FBgn0038546,FBgn0038592,
FBgn0039182,FBgn0039306,FBgn0039403,FBgn00394
04,FBgn0039462,FBgn0039464,FBgn0039650,FBgn003
9740,FBgn0039938,FBgn0039972,FBgn0041103,FBgn0
043796,FBgn0043900,FBgn0051126,FBgn0051550,FBg
n0051739,FBgn0053504,FBgn0061469,FBgn0086450,F
Bgn0250850,FBgn0259113,FBgn0259176,FBgn025993
8,FBgn0260817,FBgn0260985,FBgn0261287,FBgn0261
872,FBgn0262467,FBgn0262619,FBgn0263144,FBgn02
63237,FBgn0263855,FBgn0265048,FBgn0265523,FBgn
0265623,FBgn0266411,FBgn0266917,FBgn0267792,FB
gn0267821,FBgn0286027,FBgn0286506 
167 GO:0006
139 
mitochondr
ial 
respiratory 
0.00316
855 
FBgn0002021,FBgn0011227,FBgn0030610,FBgn00312
47,FBgn0033274,FBgn0034919,FBgn0038437,FBgn026
2467 
8 GO:0033
108 
 
 
400 
chain 
complex 
assembly 
regulation 
of helicase 
activity 
0.00328
788 
FBgn0010438,FBgn0014861 2 GO:0051
095 
ATP 
biosyntheti
c process 
0.00365
611 
FBgn0016120,FBgn0016691,FBgn0019644,FBgn00283
42,FBgn0038224,FBgn0262467 
6 GO:0006
754 
mitotic cell 
cycle 
phase 
transition 
0.00413
304 
FBgn0002878,FBgn0003525,FBgn0004583,FBgn00046
43,FBgn0004837,FBgn0004889,FBgn0010382,FBgn001
1739,FBgn0024227,FBgn0031549,FBgn0032047,FBgn0
035918,FBgn0038390,FBgn0039403,FBgn0263855 
15 GO:0044
772 
mitotic cell 
cycle 
0.00437
591 
FBgn0000140,FBgn0002878,FBgn0003042,FBgn00035
25,FBgn0004170,FBgn0004378,FBgn0004583,FBgn000
4643,FBgn0004837,FBgn0004889,FBgn0004907,FBgn0
010314,FBgn0010382,FBgn0011020,FBgn0011739,FBg
n0014861,FBgn0015271,FBgn0015391,FBgn0024227,F
Bgn0028292,FBgn0031549,FBgn0032047,FBgn003229
0,FBgn0033890,FBgn0034495,FBgn0034569,FBgn0035
249,FBgn0035644,FBgn0035918,FBgn0038390,FBgn00
38565,FBgn0039403,FBgn0039638,FBgn0087021,FBgn
0087040,FBgn0259113,FBgn0262619,FBgn0263237,FB
gn0263855,FBgn0265523,FBgn0266418,FBgn0266465,
FBgn0266917 
43 GO:0000
278 
regulation 
of mitotic 
cell cycle 
phase 
transition 
0.00456
763 
FBgn0002878,FBgn0003525,FBgn0004583,FBgn00046
43,FBgn0004837,FBgn0004889,FBgn0010382,FBgn002
4227,FBgn0031549,FBgn0035918,FBgn0038390,FBgn0
039403,FBgn0263855 
13 GO:1901
990 
mitotic cell 
cycle 
process 
0.00484
144 
FBgn0000140,FBgn0002878,FBgn0003525,FBgn00043
78,FBgn0004583,FBgn0004643,FBgn0004837,FBgn000
4889,FBgn0010382,FBgn0011739,FBgn0014861,FBgn0
015271,FBgn0015391,FBgn0024227,FBgn0028292,FBg
n0031549,FBgn0032047,FBgn0032290,FBgn0034495,F
Bgn0034569,FBgn0035249,FBgn0035644,FBgn003591
8,FBgn0038390,FBgn0039403,FBgn0039638,FBgn0087
021,FBgn0087040,FBgn0259113,FBgn0262619,FBgn02
63855,FBgn0266418 
32 GO:1903
047 
cellular 
copper ion 
homeostasi
s 
0.00552
936 
FBgn0030343,FBgn0062413,FBgn0262467 3 GO:0006
878 
neurotrans
mitter 
loading 
into 
synaptic 
vesicle 
0.00552
936 
FBgn0003515,FBgn0003996,FBgn0043005 3 GO:0098
700 
peripheral 
nervous 
system 
developme
nt 
0.00607
998 
FBgn0004170,FBgn0010382,FBgn0025936,FBgn00517
21,FBgn0061469,FBgn0087040,FBgn0259938,FBgn026
0440,FBgn0267821 
9 GO:0007
422 
nucleic 
acid 
metabolic 
0.00625
836 
FBgn0000377,FBgn0000477,FBgn0000543,FBgn00005
91,FBgn0002522,FBgn0002542,FBgn0002878,FBgn000
2899,FBgn0003042,FBgn0003044,FBgn0003512,FBgn0
148 GO:0090
304 
 
 
401 
process 004170,FBgn0004396,FBgn0004403,FBgn0004406,FBg
n0004837,FBgn0004907,FBgn0005674,FBgn0005696,F
Bgn0005771,FBgn0010382,FBgn0011291,FBgn001166
0,FBgn0011762,FBgn0011787,FBgn0014037,FBgn0014
861,FBgn0014949,FBgn0015271,FBgn0015299,FBgn00
15396,FBgn0015778,FBgn0016070,FBgn0016917,FBgn
0017577,FBgn0019650,FBgn0022986,FBgn0023214,FB
gn0024987,FBgn0025185,FBgn0025463,FBgn0025629,
FBgn0025680,FBgn0025832,FBgn0026679,FBgn00267
02,FBgn0027499,FBgn0027620,FBgn0029006,FBgn002
9079,FBgn0029977,FBgn0030054,FBgn0030085,FBgn0
030093,FBgn0030365,FBgn0030432,FBgn0030507,FBg
n0030631,FBgn0030699,FBgn0031227,FBgn0031309,F
Bgn0031321,FBgn0031643,FBgn0031851,FBgn003213
0,FBgn0032290,FBgn0032400,FBgn0032813,FBgn0032
956,FBgn0033010,FBgn0033507,FBgn0033859,FBgn00
33890,FBgn0033921,FBgn0033998,FBgn0034065,FBgn
0034310,FBgn0034564,FBgn0034614,FBgn0034650,FB
gn0035064,FBgn0035153,FBgn0035246,FBgn0035318,
FBgn0035397,FBgn0035644,FBgn0035900,FBgn00359
18,FBgn0035986,FBgn0036018,FBgn0036373,FBgn003
6374,FBgn0036569,FBgn0036734,FBgn0036735,FBgn0
036754,FBgn0036771,FBgn0036826,FBgn0036827,FBg
n0037109,FBgn0037330,FBgn0037607,FBgn0037669,F
Bgn0037716,FBgn0037722,FBgn0037822,FBgn003791
8,FBgn0037926,FBgn0038390,FBgn0038474,FBgn0038
546,FBgn0038592,FBgn0039182,FBgn0039306,FBgn00
39403,FBgn0039404,FBgn0039462,FBgn0039740,FBgn
0039938,FBgn0039972,FBgn0041103,FBgn0043796,FB
gn0043900,FBgn0051126,FBgn0051550,FBgn0051739,
FBgn0053504,FBgn0061469,FBgn0250850,FBgn02591
13,FBgn0259176,FBgn0259938,FBgn0260817,FBgn026
0985,FBgn0261287,FBgn0261872,FBgn0262619,FBgn0
263144,FBgn0263237,FBgn0263855,FBgn0265048,FBg
n0265523,FBgn0265623,FBgn0266411,FBgn0266917,F
Bgn0267792,FBgn0267821,FBgn0286027 
regulation 
of cell 
cycle 
phase 
transition 
0.00691
18 
FBgn0002878,FBgn0003525,FBgn0004583,FBgn00046
43,FBgn0004837,FBgn0004889,FBgn0010382,FBgn002
4227,FBgn0031549,FBgn0035918,FBgn0038390,FBgn0
039403,FBgn0263855 
13 GO:1901
987 
nucleoside 
triphosphat
e 
metabolic 
process 
0.00703
878 
FBgn0016120,FBgn0016691,FBgn0019644,FBgn00283
42,FBgn0031663,FBgn0038224,FBgn0262467 
7 GO:0009
141 
cell cycle 
phase 
transition 
0.00745
462 
FBgn0002878,FBgn0003525,FBgn0004583,FBgn00046
43,FBgn0004837,FBgn0004889,FBgn0010382,FBgn001
1739,FBgn0024227,FBgn0031549,FBgn0032047,FBgn0
035918,FBgn0038390,FBgn0039403,FBgn0263855 
15 GO:0044
770 
purine 
nucleoside 
triphosphat
e 
biosyntheti
c process 
0.00748
54 
FBgn0016120,FBgn0016691,FBgn0019644,FBgn00283
42,FBgn0038224,FBgn0262467 
6 GO:0009
145 
purine 0.00748 FBgn0016120,FBgn0016691,FBgn0019644,FBgn00283 6 GO:0009
 
 
402 
ribonucleo
side 
triphosphat
e 
metabolic 
process 
54 42,FBgn0038224,FBgn0262467 205 
purine 
ribonucleo
side 
triphosphat
e 
biosyntheti
c process 
0.00748
54 
FBgn0016120,FBgn0016691,FBgn0019644,FBgn00283
42,FBgn0038224,FBgn0262467 
6 GO:0009
206 
negative 
regulation 
of Notch 
signaling 
pathway 
0.00807
882 
FBgn0004837,FBgn0013725,FBgn0035060,FBgn00392
73,FBgn0259685,FBgn0260440,FBgn0265523 
7 GO:0045
746 
metabolic 
process 
0.00812
459 
FBgn0000078,FBgn0000261,FBgn0000377,FBgn00004
77,FBgn0000543,FBgn0000562,FBgn0000591,FBgn000
0810,FBgn0001187,FBgn0001218,FBgn0002021,FBgn0
002522,FBgn0002524,FBgn0002542,FBgn0002566,FBg
n0002878,FBgn0002899,FBgn0003042,FBgn0003044,F
Bgn0003076,FBgn0003116,FBgn0003356,FBgn000335
7,FBgn0003358,FBgn0003512,FBgn0003515,FBgn0003
525,FBgn0003863,FBgn0003996,FBgn0004066,FBgn00
04170,FBgn0004396,FBgn0004403,FBgn0004406,FBgn
0004432,FBgn0004797,FBgn0004837,FBgn0004889,FB
gn0004907,FBgn0005674,FBgn0005696,FBgn0005771,
FBgn0010314,FBgn0010380,FBgn0010382,FBgn00104
38,FBgn0010786,FBgn0011227,FBgn0011291,FBgn001
1300,FBgn0011336,FBgn0011591,FBgn0011660,FBgn0
011739,FBgn0011762,FBgn0011770,FBgn0011787,FBg
n0011817,FBgn0013269,FBgn0013725,FBgn0013954,F
Bgn0013972,FBgn0014023,FBgn0014037,FBgn001413
5,FBgn0014380,FBgn0014427,FBgn0014861,FBgn0014
949,FBgn0015011,FBgn0015271,FBgn0015299,FBgn00
15396,FBgn0015513,FBgn0015778,FBgn0016070,FBgn
0016120,FBgn0016691,FBgn0016917,FBgn0017577,FB
gn0019644,FBgn0019650,FBgn0020391,FBgn0020506,
FBgn0020653,FBgn0022359,FBgn0022986,FBgn00231
75,FBgn0023214,FBgn0023477,FBgn0023545,FBgn002
4194,FBgn0024227,FBgn0024958,FBgn0024987,FBgn0
024995,FBgn0024997,FBgn0025185,FBgn0025463,FBg
n0025629,FBgn0025680,FBgn0025741,FBgn0025814,F
Bgn0025832,FBgn0025839,FBgn0025936,FBgn002614
7,FBgn0026679,FBgn0026702,FBgn0026741,FBgn0026
876,FBgn0026879,FBgn0027499,FBgn0027560,FBgn00
27578,FBgn0027620,FBgn0027843,FBgn0027844,FBgn
0028342,FBgn0028694,FBgn0028695,FBgn0028836,FB
gn0028970,FBgn0028988,FBgn0029006,FBgn0029079,
FBgn0029689,FBgn0029718,FBgn0029828,FBgn00299
77,FBgn0030054,FBgn0030085,FBgn0030093,FBgn003
0365,FBgn0030367,FBgn0030432,FBgn0030507,FBgn0
030596,FBgn0030631,FBgn0030683,FBgn0030688,FBg
n0030699,FBgn0030776,FBgn0030945,FBgn0031003,F
Bgn0031227,FBgn0031231,FBgn0031248,FBgn003126
283 GO:0008
152 
 
 
403 
0,FBgn0031309,FBgn0031321,FBgn0031635,FBgn0031
643,FBgn0031663,FBgn0031678,FBgn0031695,FBgn00
31741,FBgn0031805,FBgn0031851,FBgn0031876,FBgn
0032047,FBgn0032053,FBgn0032130,FBgn0032144,FB
gn0032187,FBgn0032290,FBgn0032400,FBgn0032486,
FBgn0032638,FBgn0032691,FBgn0032813,FBgn00329
56,FBgn0033010,FBgn0033061,FBgn0033179,FBgn003
3184,FBgn0033188,FBgn0033274,FBgn0033304,FBgn0
033382,FBgn0033397,FBgn0033507,FBgn0033520,FBg
n0033527,FBgn0033555,FBgn0033815,FBgn0033859,F
Bgn0033890,FBgn0033921,FBgn0033935,FBgn003396
1,FBgn0033988,FBgn0033998,FBgn0034030,FBgn0034
065,FBgn0034085,FBgn0034141,FBgn0034199,FBgn00
34310,FBgn0034335,FBgn0034459,FBgn0034495,FBgn
0034527,FBgn0034564,FBgn0034579,FBgn0034614,FB
gn0034650,FBgn0034756,FBgn0034938,FBgn0035064,
FBgn0035124,FBgn0035153,FBgn0035154,FBgn00352
46,FBgn0035266,FBgn0035318,FBgn0035374,FBgn003
5397,FBgn0035471,FBgn0035644,FBgn0035663,FBgn0
035670,FBgn0035679,FBgn0035779,FBgn0035806,FBg
n0035900,FBgn0035918,FBgn0035977,FBgn0035986,F
Bgn0036018,FBgn0036023,FBgn0036157,FBgn003623
7,FBgn0036258,FBgn0036290,FBgn0036335,FBgn0036
373,FBgn0036374,FBgn0036512,FBgn0036549,FBgn00
36569,FBgn0036671,FBgn0036691,FBgn0036713,FBgn
0036734,FBgn0036735,FBgn0036754,FBgn0036760,FB
gn0036771,FBgn0036824,FBgn0036826,FBgn0036827,
FBgn0036910,FBgn0036953,FBgn0036996,FBgn00370
45,FBgn0037109,FBgn0037146,FBgn0037293,FBgn003
7305,FBgn0037330,FBgn0037370,FBgn0037538,FBgn0
037569,FBgn0037607,FBgn0037669,FBgn0037687,FBg
n0037716,FBgn0037722,FBgn0037822,FBgn0037891,F
Bgn0037918,FBgn0037926,FBgn0038038,FBgn003817
3,FBgn0038194,FBgn0038224,FBgn0038237,FBgn0038
271,FBgn0038348,FBgn0038390,FBgn0038426,FBgn00
38437,FBgn0038474,FBgn0038485,FBgn0038546,FBgn
0038588,FBgn0038592,FBgn0038593,FBgn0038788,FB
gn0038870,FBgn0038928,FBgn0038981,FBgn0039023,
FBgn0039159,FBgn0039182,FBgn0039252,FBgn00392
58,FBgn0039273,FBgn0039304,FBgn0039306,FBgn003
9347,FBgn0039403,FBgn0039404,FBgn0039462,FBgn0
039464,FBgn0039471,FBgn0039507,FBgn0039596,FBg
n0039650,FBgn0039740,FBgn0039938,FBgn0039972,F
Bgn0040529,FBgn0040754,FBgn0041103,FBgn004162
9,FBgn0042112,FBgn0043471,FBgn0043575,FBgn0043
796,FBgn0043900,FBgn0044872,FBgn0047038,FBgn00
50022,FBgn0050047,FBgn0050287,FBgn0050414,FBgn
0050446,FBgn0050493,FBgn0051126,FBgn0051450,FB
gn0051550,FBgn0051721,FBgn0051739,FBgn0052201,
FBgn0052284,FBgn0052483,FBgn0053100,FBgn00531
78,FBgn0053265,FBgn0053504,FBgn0061469,FBgn006
3491,FBgn0063492,FBgn0063493,FBgn0067102,FBgn0
083983,FBgn0085249,FBgn0085484,FBgn0086358,FBg
n0086450,FBgn0086679,FBgn0250850,FBgn0259113,F
Bgn0259170,FBgn0259176,FBgn0259227,FBgn025967
8,FBgn0259685,FBgn0259748,FBgn0259938,FBgn0260
477,FBgn0260750,FBgn0260817,FBgn0260985,FBgn02
 
 
404 
61287,FBgn0261445,FBgn0261872,FBgn0262449,FBgn
0262467,FBgn0262559,FBgn0262619,FBgn0263144,FB
gn0263237,FBgn0263260,FBgn0263780,FBgn0263855,
FBgn0263863,FBgn0264494,FBgn0264959,FBgn02650
48,FBgn0265052,FBgn0265523,FBgn0265623,FBgn026
6411,FBgn0266465,FBgn0266917,FBgn0267792,FBgn0
267821,FBgn0286027,FBgn0286506 
leading 
strand 
elongation 
0.00847
253 
FBgn0032813,FBgn0259113,FBgn0260985 3 GO:0006
272 
purine 
nucleoside 
triphosphat
e 
metabolic 
process 
0.00877
658 
FBgn0016120,FBgn0016691,FBgn0019644,FBgn00283
42,FBgn0038224,FBgn0262467 
6 GO:0009
144 
tRNA-
guanine 
transglycos
ylation 
0.00948
75 
FBgn0031321,FBgn0034614 2 GO:0101
030 
response to 
L-
canavanine 
0.00948
75 
FBgn0030108,FBgn0035870 2 GO:1901
354 
regulation 
of mitotic 
cell cycle 
0.01028
673 
FBgn0002878,FBgn0003525,FBgn0004170,FBgn00045
83,FBgn0004643,FBgn0004837,FBgn0004889,FBgn001
0314,FBgn0010382,FBgn0024227,FBgn0031549,FBgn0
034569,FBgn0035249,FBgn0035918,FBgn0038390,FBg
n0039403,FBgn0039638,FBgn0263855,FBgn0265523,F
Bgn0266465 
20 GO:0007
346 
energy 
coupled 
proton 
transport, 
down 
electroche
mical 
gradient 
0.01046
341 
FBgn0016120,FBgn0016691,FBgn0019644,FBgn00283
42,FBgn0038224 
5 GO:0015
985 
ATP 
synthesis 
coupled 
proton 
transport 
0.01046
341 
FBgn0016120,FBgn0016691,FBgn0019644,FBgn00283
42,FBgn0038224 
5 GO:0015
986 
cellular 
transition 
metal ion 
homeostasi
s 
0.01046
341 
FBgn0024236,FBgn0024958,FBgn0030343,FBgn00624
13,FBgn0262467 
5 GO:0046
916 
ribonucleo
side 
triphosphat
e 
metabolic 
process 
0.01182
359 
FBgn0016120,FBgn0016691,FBgn0019644,FBgn00283
42,FBgn0038224,FBgn0262467 
6 GO:0009
199 
ribonucleo
side 
triphosphat
e 
0.01182
359 
FBgn0016120,FBgn0016691,FBgn0019644,FBgn00283
42,FBgn0038224,FBgn0262467 
6 GO:0009
201 
 
 
405 
biosyntheti
c process 
positive 
regulation 
of Ras 
protein 
signal 
transductio
n 
0.01187
745 
FBgn0004907,FBgn0015513,FBgn0034194,FBgn00504
40,FBgn0050456,FBgn0050476,FBgn0051158 
7 GO:0046
579 
positive 
regulation 
of small 
GTPase 
mediated 
signal 
transductio
n 
0.01187
745 
FBgn0004907,FBgn0015513,FBgn0034194,FBgn00504
40,FBgn0050456,FBgn0050476,FBgn0051158 
7 GO:0051
057 
one-carbon 
metabolic 
process 
0.01217
255 
FBgn0027843,FBgn0027844,FBgn0036157 3 GO:0006
730 
protein 
stabilizatio
n 
0.01359
687 
FBgn0004889,FBgn0004907,FBgn0028292,FBgn00288
36,FBgn0259685,FBgn0267821 
6 GO:0050
821 
ribosomal 
small 
subunit 
biogenesis 
0.01380
91 
FBgn0002899,FBgn0004403,FBgn0030085,FBgn00316
43,FBgn0034564,FBgn0036754,FBgn0038474,FBgn003
9306,FBgn0039404 
9 GO:0042
274 
DNA 
strand 
elongation 
involved in 
DNA 
replication 
0.01403
523 
FBgn0032813,FBgn0259113,FBgn0260985,FBgn02626
19 
4 GO:0006
271 
DNA 
strand 
elongation 
0.01403
523 
FBgn0032813,FBgn0259113,FBgn0260985,FBgn02626
19 
4 GO:0022
616 
determinati
on of adult 
lifespan 
0.01445
96 
FBgn0000261,FBgn0002566,FBgn0004657,FBgn00113
00,FBgn0015575,FBgn0016120,FBgn0020653,FBgn003
0350,FBgn0033127,FBgn0033448,FBgn0035132,FBgn0
035977,FBgn0038788,FBgn0051216,FBgn0259170,FBg
n0259176,FBgn0263316 
17 GO:0008
340 
apical 
junction 
assembly 
0.01503
664 
FBgn0003391,FBgn0010894,FBgn0033032,FBgn00361
98,FBgn0259685,FBgn0261284,FBgn0266465 
7 GO:0043
297 
chromoso
me 
separation 
0.01540
763 
FBgn0004643,FBgn0004889,FBgn0015391,FBgn00175
77,FBgn0024227,FBgn0029977,FBgn0031549,FBgn026
3855 
8 GO:0051
304 
positive 
regulation 
of G1/S 
transition 
of mitotic 
cell cycle 
0.01665
79 
FBgn0004837,FBgn0010382,FBgn0039403 3 GO:1900
087 
multicellul
ar 
organism 
aging 
0.01700
86 
FBgn0000261,FBgn0002566,FBgn0004657,FBgn00113
00,FBgn0015575,FBgn0016120,FBgn0020653,FBgn003
0350,FBgn0033127,FBgn0033448,FBgn0035132,FBgn0
035977,FBgn0038788,FBgn0051216,FBgn0259170,FBg
17 GO:0010
259 
 
 
406 
n0259176,FBgn0263316 
copper ion 
homeostasi
s 
0.01724
405 
FBgn0030343,FBgn0033274,FBgn0062413,FBgn02624
67 
4 GO:0055
070 
nucleoside 
triphosphat
e 
biosyntheti
c process 
0.01768
425 
FBgn0016120,FBgn0016691,FBgn0019644,FBgn00283
42,FBgn0038224,FBgn0262467 
6 GO:0009
142 
prostaglan
din 
biosyntheti
c process 
0.01825
495 
FBgn0025814,FBgn0053178 2 GO:0001
516 
lagging 
strand 
elongation 
0.01825
495 
FBgn0259113,FBgn0262619 2 GO:0006
273 
eye 
pigment 
precursor 
transport 
0.01825
495 
FBgn0003515,FBgn0003996 2 GO:0006
856 
ocellus 
developme
nt 
0.01825
495 
FBgn0005771,FBgn0019650 2 GO:0008
056 
regulation 
of 
nucleotide 
biosyntheti
c process 
0.01825
495 
FBgn0025741,FBgn0262467 2 GO:0030
808 
positive 
regulation 
of 
nucleotide 
biosyntheti
c process 
0.01825
495 
FBgn0025741,FBgn0262467 2 GO:0030
810 
copper ion 
transmemb
rane 
transport 
0.01825
495 
FBgn0030343,FBgn0062413 2 GO:0035
434 
DNA 
replication 
proofreadi
ng 
0.01825
495 
FBgn0004406,FBgn0035644 2 GO:0045
004 
positive 
regulation 
of 
nucleotide 
metabolic 
process 
0.01825
495 
FBgn0025741,FBgn0262467 2 GO:0045
981 
icosanoid 
biosyntheti
c process 
0.01825
495 
FBgn0025814,FBgn0053178 2 GO:0046
456 
prostanoid 
biosyntheti
c process 
0.01825
495 
FBgn0025814,FBgn0053178 2 GO:0046
457 
regulation 
of purine 
0.01825
495 
FBgn0025741,FBgn0262467 2 GO:1900
371 
 
 
407 
nucleotide 
biosyntheti
c process 
positive 
regulation 
of purine 
nucleotide 
biosyntheti
c process 
0.01825
495 
FBgn0025741,FBgn0262467 2 GO:1900
373 
positive 
regulation 
of purine 
nucleotide 
metabolic 
process 
0.01825
495 
FBgn0025741,FBgn0262467 2 GO:1900
544 
cell cycle 
DNA 
replication 
initiation 
0.01825
495 
FBgn0014861,FBgn0259113 2 GO:1902
292 
nuclear 
cell cycle 
DNA 
replication 
initiation 
0.01825
495 
FBgn0014861,FBgn0259113 2 GO:1902
315 
mitotic 
DNA 
replication 
initiation 
0.01825
495 
FBgn0014861,FBgn0259113 2 GO:1902
975 
positive 
regulation 
of 
chromatin 
organizatio
n 
0.02083
228 
FBgn0016917,FBgn0025463,FBgn0027499,FBgn00326
91,FBgn0037669,FBgn0263855,FBgn0265623 
7 GO:1905
269 
ommochro
me 
biosyntheti
c process 
0.02087
48 
FBgn0002566,FBgn0003515,FBgn0003996,FBgn00866
79 
4 GO:0006
727 
ocellus 
pigment 
biosyntheti
c process 
0.02087
48 
FBgn0002566,FBgn0003515,FBgn0003996,FBgn00866
79 
4 GO:0008
055 
ocellus 
pigmentati
on 
0.02087
48 
FBgn0002566,FBgn0003515,FBgn0003996,FBgn00866
79 
4 GO:0033
060 
ommochro
me 
metabolic 
process 
0.02087
48 
FBgn0002566,FBgn0003515,FBgn0003996,FBgn00866
79 
4 GO:0046
152 
ocellus 
pigment 
metabolic 
process 
0.02087
48 
FBgn0002566,FBgn0003515,FBgn0003996,FBgn00866
79 
4 GO:0046
158 
regulation 
of exit 
from 
mitosis 
0.02194
419 
FBgn0004583,FBgn0010382,FBgn0263855 3 GO:0007
096 
 
 
408 
intestinal 
stem cell 
homeostasi
s 
0.02310
798 
FBgn0000261,FBgn0001218,FBgn0032691,FBgn02591
76,FBgn0264959 
5 GO:0036
335 
aging 0.02313
687 
FBgn0000261,FBgn0002566,FBgn0004657,FBgn00113
00,FBgn0015575,FBgn0016120,FBgn0020653,FBgn003
0350,FBgn0033127,FBgn0033448,FBgn0035132,FBgn0
035977,FBgn0038788,FBgn0051216,FBgn0259170,FBg
n0259176,FBgn0263316 
17 GO:0007
568 
regulation 
of mitotic 
nuclear 
division 
0.02511
586 
FBgn0004583,FBgn0004643,FBgn0004889,FBgn00103
82,FBgn0024227,FBgn0031549,FBgn0034569,FBgn003
9638,FBgn0263855 
9 GO:0007
088 
organic 
substance 
metabolic 
process 
0.02523
394 
FBgn0000078,FBgn0000377,FBgn0000477,FBgn00005
43,FBgn0000562,FBgn0000591,FBgn0000810,FBgn000
1187,FBgn0001218,FBgn0002522,FBgn0002524,FBgn0
002542,FBgn0002566,FBgn0002878,FBgn0002899,FBg
n0003042,FBgn0003044,FBgn0003076,FBgn0003116,F
Bgn0003356,FBgn0003357,FBgn0003358,FBgn000351
2,FBgn0003515,FBgn0003525,FBgn0003863,FBgn0003
996,FBgn0004066,FBgn0004170,FBgn0004396,FBgn00
04403,FBgn0004406,FBgn0004432,FBgn0004797,FBgn
0004837,FBgn0004889,FBgn0004907,FBgn0005674,FB
gn0005696,FBgn0005771,FBgn0010314,FBgn0010382,
FBgn0010438,FBgn0010786,FBgn0011291,FBgn00113
00,FBgn0011336,FBgn0011591,FBgn0011660,FBgn001
1739,FBgn0011762,FBgn0011770,FBgn0011787,FBgn0
011817,FBgn0013725,FBgn0013954,FBgn0013972,FBg
n0014023,FBgn0014037,FBgn0014135,FBgn0014380,F
Bgn0014427,FBgn0014861,FBgn0014949,FBgn001501
1,FBgn0015271,FBgn0015299,FBgn0015396,FBgn0015
513,FBgn0015778,FBgn0016070,FBgn0016120,FBgn00
16691,FBgn0016917,FBgn0017577,FBgn0019644,FBgn
0019650,FBgn0020391,FBgn0020506,FBgn0022986,FB
gn0023175,FBgn0023214,FBgn0023477,FBgn0023545,
FBgn0024194,FBgn0024227,FBgn0024958,FBgn00249
87,FBgn0024995,FBgn0024997,FBgn0025185,FBgn002
5463,FBgn0025629,FBgn0025680,FBgn0025741,FBgn0
025814,FBgn0025832,FBgn0025936,FBgn0026147,FBg
n0026679,FBgn0026702,FBgn0026741,FBgn0026876,F
Bgn0026879,FBgn0027499,FBgn0027560,FBgn002757
8,FBgn0027620,FBgn0028342,FBgn0028694,FBgn0028
695,FBgn0028836,FBgn0028970,FBgn0028988,FBgn00
29006,FBgn0029079,FBgn0029689,FBgn0029718,FBgn
0029828,FBgn0029977,FBgn0030054,FBgn0030085,FB
gn0030093,FBgn0030365,FBgn0030432,FBgn0030507,
FBgn0030596,FBgn0030631,FBgn0030683,FBgn00306
88,FBgn0030699,FBgn0030776,FBgn0030945,FBgn003
1003,FBgn0031227,FBgn0031231,FBgn0031248,FBgn0
031260,FBgn0031309,FBgn0031321,FBgn0031643,FBg
n0031663,FBgn0031678,FBgn0031741,FBgn0031805,F
Bgn0031851,FBgn0031876,FBgn0032047,FBgn003205
3,FBgn0032130,FBgn0032144,FBgn0032187,FBgn0032
290,FBgn0032400,FBgn0032486,FBgn0032638,FBgn00
32691,FBgn0032813,FBgn0032956,FBgn0033010,FBgn
0033061,FBgn0033179,FBgn0033184,FBgn0033188,FB
gn0033274,FBgn0033382,FBgn0033507,FBgn0033527,
283 GO:0071
704 
 
 
409 
FBgn0033555,FBgn0033815,FBgn0033859,FBgn00338
90,FBgn0033921,FBgn0033935,FBgn0033988,FBgn003
3998,FBgn0034030,FBgn0034065,FBgn0034085,FBgn0
034141,FBgn0034199,FBgn0034310,FBgn0034335,FBg
n0034459,FBgn0034495,FBgn0034527,FBgn0034564,F
Bgn0034579,FBgn0034614,FBgn0034650,FBgn003493
8,FBgn0035064,FBgn0035124,FBgn0035153,FBgn0035
154,FBgn0035246,FBgn0035266,FBgn0035318,FBgn00
35374,FBgn0035397,FBgn0035471,FBgn0035644,FBgn
0035663,FBgn0035670,FBgn0035679,FBgn0035779,FB
gn0035806,FBgn0035900,FBgn0035918,FBgn0035977,
FBgn0035986,FBgn0036018,FBgn0036023,FBgn00361
57,FBgn0036237,FBgn0036258,FBgn0036335,FBgn003
6373,FBgn0036374,FBgn0036512,FBgn0036549,FBgn0
036569,FBgn0036671,FBgn0036691,FBgn0036713,FBg
n0036734,FBgn0036735,FBgn0036754,FBgn0036760,F
Bgn0036771,FBgn0036826,FBgn0036827,FBgn003695
3,FBgn0036996,FBgn0037045,FBgn0037109,FBgn0037
146,FBgn0037293,FBgn0037305,FBgn0037330,FBgn00
37538,FBgn0037569,FBgn0037607,FBgn0037669,FBgn
0037687,FBgn0037716,FBgn0037722,FBgn0037822,FB
gn0037918,FBgn0037926,FBgn0038038,FBgn0038173,
FBgn0038224,FBgn0038237,FBgn0038271,FBgn00383
48,FBgn0038390,FBgn0038426,FBgn0038437,FBgn003
8474,FBgn0038485,FBgn0038546,FBgn0038588,FBgn0
038592,FBgn0038788,FBgn0038870,FBgn0038928,FBg
n0039023,FBgn0039159,FBgn0039182,FBgn0039252,F
Bgn0039258,FBgn0039273,FBgn0039304,FBgn003930
6,FBgn0039347,FBgn0039403,FBgn0039404,FBgn0039
462,FBgn0039464,FBgn0039471,FBgn0039507,FBgn00
39596,FBgn0039650,FBgn0039740,FBgn0039938,FBgn
0039972,FBgn0040754,FBgn0041103,FBgn0041629,FB
gn0042112,FBgn0043471,FBgn0043575,FBgn0043796,
FBgn0043900,FBgn0044872,FBgn0050022,FBgn00500
47,FBgn0050287,FBgn0050414,FBgn0050446,FBgn005
0493,FBgn0051126,FBgn0051450,FBgn0051550,FBgn0
051721,FBgn0051739,FBgn0052201,FBgn0052284,FBg
n0052483,FBgn0053100,FBgn0053178,FBgn0053265,F
Bgn0053504,FBgn0061469,FBgn0063491,FBgn006349
2,FBgn0063493,FBgn0067102,FBgn0083983,FBgn0085
249,FBgn0085484,FBgn0086358,FBgn0086450,FBgn00
86679,FBgn0250850,FBgn0259113,FBgn0259170,FBgn
0259176,FBgn0259227,FBgn0259678,FBgn0259685,FB
gn0259748,FBgn0259938,FBgn0260477,FBgn0260750,
FBgn0260817,FBgn0260985,FBgn0261287,FBgn02614
45,FBgn0261872,FBgn0262449,FBgn0262467,FBgn026
2559,FBgn0262619,FBgn0263144,FBgn0263237,FBgn0
263260,FBgn0263780,FBgn0263855,FBgn0263863,FBg
n0264494,FBgn0264959,FBgn0265048,FBgn0265523,F
Bgn0265623,FBgn0266411,FBgn0266465,FBgn026691
7,FBgn0267792,FBgn0267821,FBgn0286027,FBgn0286
506 
nitrogen 
compound 
metabolic 
process 
0.02727
286 
FBgn0000377,FBgn0000477,FBgn0000543,FBgn00005
62,FBgn0000591,FBgn0000810,FBgn0001187,FBgn000
1218,FBgn0002522,FBgn0002524,FBgn0002542,FBgn0
002566,FBgn0002878,FBgn0002899,FBgn0003042,FBg
n0003044,FBgn0003116,FBgn0003356,FBgn0003357,F
283 GO:0006
807 
 
 
410 
Bgn0003358,FBgn0003512,FBgn0003525,FBgn000386
3,FBgn0003996,FBgn0004066,FBgn0004170,FBgn0004
396,FBgn0004403,FBgn0004406,FBgn0004432,FBgn00
04837,FBgn0004889,FBgn0004907,FBgn0005674,FBgn
0005696,FBgn0005771,FBgn0010314,FBgn0010382,FB
gn0010786,FBgn0011291,FBgn0011300,FBgn0011336,
FBgn0011591,FBgn0011660,FBgn0011739,FBgn00117
62,FBgn0011787,FBgn0011817,FBgn0013725,FBgn001
3954,FBgn0013972,FBgn0014023,FBgn0014037,FBgn0
014135,FBgn0014427,FBgn0014861,FBgn0014949,FBg
n0015271,FBgn0015299,FBgn0015396,FBgn0015513,F
Bgn0015778,FBgn0016070,FBgn0016120,FBgn001669
1,FBgn0016917,FBgn0017577,FBgn0019644,FBgn0019
650,FBgn0020391,FBgn0022986,FBgn0023175,FBgn00
23214,FBgn0023545,FBgn0024194,FBgn0024227,FBgn
0024987,FBgn0024995,FBgn0024997,FBgn0025185,FB
gn0025463,FBgn0025629,FBgn0025680,FBgn0025741,
FBgn0025832,FBgn0025936,FBgn0026147,FBgn00266
79,FBgn0026702,FBgn0026741,FBgn0026876,FBgn002
6879,FBgn0027499,FBgn0027578,FBgn0027620,FBgn0
028342,FBgn0028694,FBgn0028695,FBgn0028836,FBg
n0028970,FBgn0028988,FBgn0029006,FBgn0029079,F
Bgn0029689,FBgn0029718,FBgn0029828,FBgn002997
7,FBgn0030054,FBgn0030085,FBgn0030093,FBgn0030
365,FBgn0030432,FBgn0030507,FBgn0030631,FBgn00
30683,FBgn0030688,FBgn0030699,FBgn0030776,FBgn
0030945,FBgn0031003,FBgn0031227,FBgn0031231,FB
gn0031248,FBgn0031260,FBgn0031309,FBgn0031321,
FBgn0031643,FBgn0031663,FBgn0031678,FBgn00317
41,FBgn0031805,FBgn0031851,FBgn0031876,FBgn003
2047,FBgn0032053,FBgn0032130,FBgn0032144,FBgn0
032187,FBgn0032290,FBgn0032400,FBgn0032486,FBg
n0032638,FBgn0032691,FBgn0032813,FBgn0032956,F
Bgn0033010,FBgn0033179,FBgn0033184,FBgn003327
4,FBgn0033507,FBgn0033527,FBgn0033555,FBgn0033
815,FBgn0033859,FBgn0033890,FBgn0033921,FBgn00
33935,FBgn0033988,FBgn0033998,FBgn0034030,FBgn
0034065,FBgn0034085,FBgn0034199,FBgn0034310,FB
gn0034335,FBgn0034459,FBgn0034527,FBgn0034564,
FBgn0034579,FBgn0034614,FBgn0034650,FBgn00349
38,FBgn0035064,FBgn0035124,FBgn0035153,FBgn003
5154,FBgn0035246,FBgn0035318,FBgn0035374,FBgn0
035397,FBgn0035644,FBgn0035663,FBgn0035670,FBg
n0035779,FBgn0035806,FBgn0035900,FBgn0035918,F
Bgn0035977,FBgn0035986,FBgn0036018,FBgn003602
3,FBgn0036157,FBgn0036237,FBgn0036258,FBgn0036
335,FBgn0036373,FBgn0036374,FBgn0036512,FBgn00
36549,FBgn0036569,FBgn0036671,FBgn0036734,FBgn
0036735,FBgn0036754,FBgn0036760,FBgn0036771,FB
gn0036826,FBgn0036827,FBgn0036953,FBgn0037045,
FBgn0037109,FBgn0037146,FBgn0037293,FBgn00373
05,FBgn0037330,FBgn0037538,FBgn0037607,FBgn003
7669,FBgn0037687,FBgn0037716,FBgn0037722,FBgn0
037822,FBgn0037918,FBgn0037926,FBgn0038173,FBg
n0038224,FBgn0038237,FBgn0038271,FBgn0038390,F
Bgn0038426,FBgn0038474,FBgn0038485,FBgn003854
6,FBgn0038588,FBgn0038592,FBgn0038788,FBgn0038
 
 
411 
870,FBgn0038928,FBgn0039023,FBgn0039159,FBgn00
39182,FBgn0039252,FBgn0039258,FBgn0039273,FBgn
0039304,FBgn0039306,FBgn0039347,FBgn0039403,FB
gn0039404,FBgn0039462,FBgn0039464,FBgn0039650,
FBgn0039740,FBgn0039938,FBgn0039972,FBgn00407
54,FBgn0041103,FBgn0042112,FBgn0043471,FBgn004
3575,FBgn0043796,FBgn0043900,FBgn0044872,FBgn0
050022,FBgn0050047,FBgn0050287,FBgn0050414,FBg
n0050446,FBgn0051126,FBgn0051450,FBgn0051550,F
Bgn0051721,FBgn0051739,FBgn0052201,FBgn005228
4,FBgn0052483,FBgn0053100,FBgn0053178,FBgn0053
265,FBgn0053504,FBgn0061469,FBgn0063491,FBgn00
63492,FBgn0063493,FBgn0067102,FBgn0083983,FBgn
0085249,FBgn0085484,FBgn0086358,FBgn0086450,FB
gn0250850,FBgn0259113,FBgn0259170,FBgn0259176,
FBgn0259227,FBgn0259678,FBgn0259685,FBgn02597
48,FBgn0259938,FBgn0260477,FBgn0260750,FBgn026
0817,FBgn0260985,FBgn0261287,FBgn0261445,FBgn0
261872,FBgn0262449,FBgn0262467,FBgn0262559,FBg
n0262619,FBgn0263144,FBgn0263237,FBgn0263260,F
Bgn0263780,FBgn0263855,FBgn0263863,FBgn026495
9,FBgn0265048,FBgn0265523,FBgn0265623,FBgn0266
411,FBgn0266465,FBgn0266917,FBgn0267792,FBgn02
67821,FBgn0286027,FBgn0286506 
double-
strand 
break 
repair via 
break-
induced 
replication 
0.02803
595 
FBgn0014861,FBgn0017577,FBgn0039403 3 GO:0000
727 
positive 
regulation 
of defense 
response to 
virus by 
host 
0.02803
595 
FBgn0016917,FBgn0038928,FBgn0086358 3 GO:0002
230 
regulation 
of defense 
response to 
virus by 
host 
0.02803
595 
FBgn0016917,FBgn0038928,FBgn0086358 3 GO:0050
691 
prostanoid 
metabolic 
process 
0.02927
61 
FBgn0025814,FBgn0053178 2 GO:0006
692 
prostaglan
din 
metabolic 
process 
0.02927
61 
FBgn0025814,FBgn0053178 2 GO:0006
693 
protein-
cofactor 
linkage 
0.02927
61 
FBgn0010786,FBgn0033274 2 GO:0018
065 
respiratory 
chain 
complex II 
assembly 
0.02927
61 
FBgn0033274,FBgn0038437 2 GO:0034
552 
 
 
412 
mitochondr
ial 
respiratory 
chain 
complex II 
assembly 
0.02927
61 
FBgn0033274,FBgn0038437 2 GO:0034
553 
regulation 
of Notch 
signaling 
pathway 
0.02929
277 
FBgn0002592,FBgn0004837,FBgn0011591,FBgn00137
25,FBgn0035060,FBgn0039273,FBgn0259685,FBgn026
0440,FBgn0265523 
9 GO:0008
593 
nuclear-
transcribed 
mRNA 
poly(A) 
tail 
shortening 
0.02944
978 
FBgn0016070,FBgn0035246,FBgn0035397,FBgn00399
72 
4 GO:0000
289 
protein 
peptidyl-
prolyl 
isomerizati
on 
0.02944
978 
FBgn0004432,FBgn0013954,FBgn0033527,FBgn00393
47 
4 GO:0000
413 
sensory 
organ 
developme
nt 
0.02975
204 
FBgn0000008,FBgn0000543,FBgn0000591,FBgn00025
92,FBgn0003116,FBgn0003174,FBgn0003391,FBgn000
4170,FBgn0004583,FBgn0004837,FBgn0004889,FBgn0
005771,FBgn0010380,FBgn0010382,FBgn0011300,FBg
n0011591,FBgn0011739,FBgn0011817,FBgn0013725,F
Bgn0014135,FBgn0015396,FBgn0015778,FBgn001965
0,FBgn0020391,FBgn0023214,FBgn0033179,FBgn0034
243,FBgn0043903,FBgn0045073,FBgn0050476,FBgn00
51158,FBgn0051721,FBgn0259176,FBgn0259685,FBgn
0260440,FBgn0264959,FBgn0267821 
37 GO:0007
423 
regulation 
of mitotic 
metaphase/
anaphase 
transition 
0.03011
154 
FBgn0004643,FBgn0004889,FBgn0024227,FBgn00315
49,FBgn0263855 
5 GO:0030
071 
regulation 
of 
chromoso
me 
organizatio
n 
0.03081
074 
FBgn0004643,FBgn0004889,FBgn0014861,FBgn00169
17,FBgn0024227,FBgn0025463,FBgn0027499,FBgn002
7620,FBgn0031549,FBgn0032691,FBgn0037607,FBgn0
037669,FBgn0039507,FBgn0043796,FBgn0263855,FBg
n0265623,FBgn0267792 
17 GO:0033
044 
ncRNA 
metabolic 
process 
0.03139
418 
FBgn0002899,FBgn0004403,FBgn0005674,FBgn00256
29,FBgn0026679,FBgn0026702,FBgn0030085,FBgn003
1227,FBgn0031321,FBgn0031643,FBgn0033507,FBgn0
033921,FBgn0034065,FBgn0034564,FBgn0034614,FBg
n0035064,FBgn0035986,FBgn0036569,FBgn0036754,F
Bgn0037330,FBgn0037822,FBgn0037926,FBgn003847
4,FBgn0039306,FBgn0039404,FBgn0051739,FBgn0263
144 
27 GO:0034
660 
mitotic cell 
cycle, 
embryonic 
0.03139
468 
FBgn0003042,FBgn0003525,FBgn0004907,FBgn00103
14,FBgn0011020,FBgn0033890 
6 GO:0045
448 
cell cycle 
process 
0.03203
942 
FBgn0000140,FBgn0002542,FBgn0002878,FBgn00028
99,FBgn0003525,FBgn0004378,FBgn0004583,FBgn000
4643,FBgn0004837,FBgn0004889,FBgn0010314,FBgn0
010382,FBgn0011020,FBgn0011739,FBgn0014861,FBg
45 GO:0022
402 
 
 
413 
n0015271,FBgn0015391,FBgn0017577,FBgn0024227,F
Bgn0026876,FBgn0028292,FBgn0029977,FBgn003005
4,FBgn0031549,FBgn0032047,FBgn0032290,FBgn0033
890,FBgn0033921,FBgn0034495,FBgn0034569,FBgn00
35249,FBgn0035644,FBgn0035918,FBgn0038390,FBgn
0039403,FBgn0039638,FBgn0052371,FBgn0087021,FB
gn0087040,FBgn0259113,FBgn0259685,FBgn0260985,
FBgn0262619,FBgn0263855,FBgn0266418 
cellular 
metal ion 
homeostasi
s 
0.03297
3 
FBgn0024236,FBgn0024958,FBgn0030343,FBgn00303
50,FBgn0034136,FBgn0034199,FBgn0045073,FBgn006
2413,FBgn0261872,FBgn0262467 
10 GO:0006
875 
homeostasi
s of 
number of 
cells 
0.03406
246 
FBgn0000261,FBgn0001218,FBgn0032691,FBgn02591
76,FBgn0264959 
5 GO:0048
872 
regulation 
of 
metaphase/
anaphase 
transition 
of cell 
cycle 
0.03406
246 
FBgn0004643,FBgn0004889,FBgn0024227,FBgn00315
49,FBgn0263855 
5 GO:1902
099 
exit from 
mitosis 
0.03492
824 
FBgn0004583,FBgn0010382,FBgn0263855 3 GO:0010
458 
regulation 
of 
heterochro
matin 
assembly 
0.03492
824 
FBgn0016917,FBgn0025463,FBgn0027620 3 GO:0031
445 
bicoid 
mRNA 
localizatio
n 
0.03492
824 
FBgn0000562,FBgn0003512,FBgn0003655 3 GO:0045
450 
negative 
regulation 
of behavior 
0.03492
824 
FBgn0020258,FBgn0033257,FBgn0036713 3 GO:0048
521 
regulation 
of nuclear-
transcribed 
mRNA 
poly(A) 
tail 
shortening 
0.03492
824 
FBgn0016070,FBgn0035246,FBgn0039972 3 GO:0060
211 
positive 
regulation 
of nuclear-
transcribed 
mRNA 
poly(A) 
tail 
shortening 
0.03492
824 
FBgn0016070,FBgn0035246,FBgn0039972 3 GO:0060
213 
positive 
regulation 
of cell 
cycle G1/S 
phase 
0.03492
824 
FBgn0004837,FBgn0010382,FBgn0039403 3 GO:1902
808 
 
 
414 
transition 
cellular 
metabolic 
process 
0.03560
41 
FBgn0000261,FBgn0000377,FBgn0000477,FBgn00005
43,FBgn0000562,FBgn0000591,FBgn0000810,FBgn000
1187,FBgn0001218,FBgn0002522,FBgn0002524,FBgn0
002542,FBgn0002566,FBgn0002878,FBgn0002899,FBg
n0003042,FBgn0003044,FBgn0003076,FBgn0003116,F
Bgn0003512,FBgn0003515,FBgn0003525,FBgn000399
6,FBgn0004066,FBgn0004170,FBgn0004396,FBgn0004
403,FBgn0004406,FBgn0004432,FBgn0004797,FBgn00
04837,FBgn0004889,FBgn0004907,FBgn0005674,FBgn
0005696,FBgn0005771,FBgn0010314,FBgn0010380,FB
gn0010382,FBgn0010438,FBgn0010786,FBgn0011227,
FBgn0011291,FBgn0011300,FBgn0011336,FBgn00115
91,FBgn0011660,FBgn0011739,FBgn0011762,FBgn001
1770,FBgn0011787,FBgn0011817,FBgn0013269,FBgn0
013725,FBgn0013954,FBgn0013972,FBgn0014023,FBg
n0014037,FBgn0014135,FBgn0014380,FBgn0014427,F
Bgn0014861,FBgn0014949,FBgn0015011,FBgn001527
1,FBgn0015299,FBgn0015396,FBgn0015513,FBgn0015
778,FBgn0016070,FBgn0016120,FBgn0016691,FBgn00
16917,FBgn0017577,FBgn0019644,FBgn0019650,FBgn
0020391,FBgn0022986,FBgn0023175,FBgn0023214,FB
gn0023477,FBgn0023545,FBgn0024194,FBgn0024227,
FBgn0024958,FBgn0024987,FBgn0024995,FBgn00249
97,FBgn0025185,FBgn0025463,FBgn0025629,FBgn002
5680,FBgn0025741,FBgn0025814,FBgn0025832,FBgn0
025839,FBgn0025936,FBgn0026147,FBgn0026679,FBg
n0026702,FBgn0026741,FBgn0026876,FBgn0026879,F
Bgn0027499,FBgn0027560,FBgn0027620,FBgn002784
3,FBgn0027844,FBgn0028342,FBgn0028694,FBgn0028
695,FBgn0028836,FBgn0028970,FBgn0028988,FBgn00
29006,FBgn0029079,FBgn0029689,FBgn0029718,FBgn
0029977,FBgn0030054,FBgn0030085,FBgn0030093,FB
gn0030365,FBgn0030432,FBgn0030507,FBgn0030596,
FBgn0030631,FBgn0030683,FBgn0030699,FBgn00309
45,FBgn0031003,FBgn0031227,FBgn0031231,FBgn003
1260,FBgn0031309,FBgn0031321,FBgn0031635,FBgn0
031643,FBgn0031663,FBgn0031851,FBgn0031876,FBg
n0032047,FBgn0032053,FBgn0032130,FBgn0032187,F
Bgn0032290,FBgn0032400,FBgn0032486,FBgn003269
1,FBgn0032813,FBgn0032956,FBgn0033010,FBgn0033
179,FBgn0033184,FBgn0033274,FBgn0033382,FBgn00
33507,FBgn0033520,FBgn0033527,FBgn0033555,FBgn
0033815,FBgn0033859,FBgn0033890,FBgn0033921,FB
gn0033935,FBgn0033961,FBgn0033988,FBgn0033998,
FBgn0034030,FBgn0034065,FBgn0034085,FBgn00341
41,FBgn0034199,FBgn0034310,FBgn0034335,FBgn003
4459,FBgn0034495,FBgn0034527,FBgn0034564,FBgn0
034579,FBgn0034614,FBgn0034650,FBgn0034938,FBg
n0035064,FBgn0035124,FBgn0035153,FBgn0035154,F
Bgn0035246,FBgn0035266,FBgn0035318,FBgn003537
4,FBgn0035397,FBgn0035471,FBgn0035644,FBgn0035
900,FBgn0035918,FBgn0035977,FBgn0035986,FBgn00
36018,FBgn0036157,FBgn0036258,FBgn0036335,FBgn
0036373,FBgn0036374,FBgn0036549,FBgn0036569,FB
gn0036671,FBgn0036691,FBgn0036713,FBgn0036734,
FBgn0036735,FBgn0036754,FBgn0036760,FBgn00367
283 GO:0044
237 
 
 
415 
71,FBgn0036826,FBgn0036827,FBgn0036953,FBgn003
7045,FBgn0037109,FBgn0037146,FBgn0037293,FBgn0
037305,FBgn0037330,FBgn0037538,FBgn0037607,FBg
n0037669,FBgn0037687,FBgn0037716,FBgn0037722,F
Bgn0037822,FBgn0037891,FBgn0037918,FBgn003792
6,FBgn0038038,FBgn0038173,FBgn0038224,FBgn0038
237,FBgn0038271,FBgn0038348,FBgn0038390,FBgn00
38426,FBgn0038437,FBgn0038474,FBgn0038546,FBgn
0038588,FBgn0038592,FBgn0038593,FBgn0038788,FB
gn0038870,FBgn0038928,FBgn0039159,FBgn0039182,
FBgn0039252,FBgn0039258,FBgn0039273,FBgn00393
04,FBgn0039306,FBgn0039347,FBgn0039403,FBgn003
9404,FBgn0039462,FBgn0039464,FBgn0039650,FBgn0
039740,FBgn0039938,FBgn0039972,FBgn0040529,FBg
n0040754,FBgn0041103,FBgn0042112,FBgn0043575,F
Bgn0043796,FBgn0043900,FBgn0044872,FBgn004703
8,FBgn0050022,FBgn0050446,FBgn0050493,FBgn0051
126,FBgn0051450,FBgn0051550,FBgn0051721,FBgn00
51739,FBgn0052201,FBgn0052284,FBgn0052483,FBgn
0053100,FBgn0053178,FBgn0053265,FBgn0053504,FB
gn0061469,FBgn0063491,FBgn0063492,FBgn0063493,
FBgn0067102,FBgn0083983,FBgn0085249,FBgn00854
84,FBgn0086358,FBgn0086450,FBgn0086679,FBgn025
0850,FBgn0259113,FBgn0259170,FBgn0259176,FBgn0
259227,FBgn0259678,FBgn0259685,FBgn0259748,FBg
n0259938,FBgn0260750,FBgn0260817,FBgn0260985,F
Bgn0261287,FBgn0261445,FBgn0261872,FBgn026244
9,FBgn0262467,FBgn0262559,FBgn0262619,FBgn0263
144,FBgn0263237,FBgn0263855,FBgn0263863,FBgn02
64494,FBgn0264959,FBgn0265048,FBgn0265052,FBgn
0265523,FBgn0265623,FBgn0266411,FBgn0266465,FB
gn0266917,FBgn0267792,FBgn0267821,FBgn0286027,
FBgn0286506 
asymmetri
c cell 
division 
0.03580
441 
FBgn0000140,FBgn0003391,FBgn0004837,FBgn00048
89,FBgn0010382,FBgn0011020,FBgn0024227,FBgn002
8292,FBgn0028836,FBgn0260440,FBgn0266418 
11 GO:0008
356 
regulation 
of nuclear 
division 
0.03643
352 
FBgn0004583,FBgn0004643,FBgn0004889,FBgn00103
82,FBgn0024227,FBgn0031549,FBgn0034569,FBgn003
9638,FBgn0263855 
9 GO:0051
783 
wing disc 
dorsal/vent
ral pattern 
formation 
0.03673
362 
FBgn0004837,FBgn0010651,FBgn0011591,FBgn00118
17,FBgn0014037,FBgn0259685,FBgn0263316 
7 GO:0048
190 
rRNA 
processing 
0.03678
627 
FBgn0002899,FBgn0004403,FBgn0026702,FBgn00300
85,FBgn0031643,FBgn0033507,FBgn0034065,FBgn003
4564,FBgn0035986,FBgn0036754,FBgn0037822,FBgn0
038474,FBgn0039306,FBgn0039404 
14 GO:0006
364 
mRNA 
transport 
0.03840
119 
FBgn0000562,FBgn0033926,FBgn0034310,FBgn00359
00,FBgn0037569,FBgn0087040 
6 GO:0051
028 
transition 
metal ion 
homeostasi
s 
0.03840
119 
FBgn0024236,FBgn0024958,FBgn0030343,FBgn00332
74,FBgn0062413,FBgn0262467 
6 GO:0055
076 
response to 
oxygen 
levels 
0.03905
725 
FBgn0004240,FBgn0010651,FBgn0020653,FBgn00331
88,FBgn0038437,FBgn0038530,FBgn0051354,FBgn026
3316,FBgn0266411 
9 GO:0070
482 
 
 
416 
cell cycle 0.03946
61 
FBgn0000140,FBgn0002542,FBgn0002878,FBgn00028
99,FBgn0003042,FBgn0003525,FBgn0004170,FBgn000
4378,FBgn0004583,FBgn0004643,FBgn0004837,FBgn0
004889,FBgn0004907,FBgn0010314,FBgn0010382,FBg
n0011020,FBgn0011739,FBgn0014861,FBgn0015271,F
Bgn0015391,FBgn0017577,FBgn0024227,FBgn002687
6,FBgn0028292,FBgn0029977,FBgn0030054,FBgn0031
549,FBgn0032047,FBgn0032290,FBgn0032400,FBgn00
33890,FBgn0033921,FBgn0034495,FBgn0034569,FBgn
0035249,FBgn0035644,FBgn0035918,FBgn0037716,FB
gn0038390,FBgn0038565,FBgn0039403,FBgn0039638,
FBgn0052371,FBgn0087021,FBgn0087040,FBgn02591
13,FBgn0259685,FBgn0260985,FBgn0262619,FBgn026
3237,FBgn0263855,FBgn0265523,FBgn0266418,FBgn0
266465,FBgn0266917 
55 GO:0007
049 
cellular 
chemical 
homeostasi
s 
0.03951
186 
FBgn0001187,FBgn0011300,FBgn0023510,FBgn00242
36,FBgn0024958,FBgn0030343,FBgn0030350,FBgn003
4136,FBgn0034199,FBgn0045073,FBgn0062413,FBgn0
261872,FBgn0262467 
13 GO:0055
082 
DNA 
endoredupl
ication 
0.03982
656 
FBgn0017577,FBgn0030054,FBgn0033890,FBgn00356
44 
4 GO:0042
023 
cellular 
nitrogen 
compound 
metabolic 
process 
0.04215
74 
FBgn0000377,FBgn0000477,FBgn0000543,FBgn00005
62,FBgn0000591,FBgn0000810,FBgn0001187,FBgn000
2522,FBgn0002542,FBgn0002878,FBgn0002899,FBgn0
003042,FBgn0003044,FBgn0003512,FBgn0003996,FBg
n0004170,FBgn0004396,FBgn0004403,FBgn0004406,F
Bgn0004837,FBgn0004907,FBgn0005674,FBgn000569
6,FBgn0005771,FBgn0010382,FBgn0010786,FBgn0011
291,FBgn0011660,FBgn0011762,FBgn0011787,FBgn00
13972,FBgn0014023,FBgn0014037,FBgn0014861,FBgn
0014949,FBgn0015271,FBgn0015299,FBgn0015396,FB
gn0015778,FBgn0016070,FBgn0016120,FBgn0016691,
FBgn0016917,FBgn0017577,FBgn0019644,FBgn00196
50,FBgn0022986,FBgn0023214,FBgn0024987,FBgn002
5185,FBgn0025463,FBgn0025629,FBgn0025680,FBgn0
025741,FBgn0025832,FBgn0026679,FBgn0026702,FBg
n0026741,FBgn0026876,FBgn0026879,FBgn0027499,F
Bgn0027620,FBgn0028342,FBgn0029006,FBgn002907
9,FBgn0029689,FBgn0029718,FBgn0029977,FBgn0030
054,FBgn0030085,FBgn0030093,FBgn0030365,FBgn00
30432,FBgn0030507,FBgn0030631,FBgn0030683,FBgn
0030699,FBgn0031227,FBgn0031231,FBgn0031260,FB
gn0031309,FBgn0031321,FBgn0031643,FBgn0031663,
FBgn0031851,FBgn0032053,FBgn0032130,FBgn00322
90,FBgn0032400,FBgn0032486,FBgn0032813,FBgn003
2956,FBgn0033010,FBgn0033184,FBgn0033507,FBgn0
033555,FBgn0033859,FBgn0033890,FBgn0033921,FBg
n0033998,FBgn0034065,FBgn0034310,FBgn0034335,F
Bgn0034564,FBgn0034579,FBgn0034614,FBgn003465
0,FBgn0034938,FBgn0035064,FBgn0035153,FBgn0035
246,FBgn0035318,FBgn0035374,FBgn0035397,FBgn00
35644,FBgn0035900,FBgn0035918,FBgn0035986,FBgn
0036018,FBgn0036157,FBgn0036258,FBgn0036335,FB
gn0036373,FBgn0036374,FBgn0036569,FBgn0036734,
FBgn0036735,FBgn0036754,FBgn0036771,FBgn00368
26,FBgn0036827,FBgn0037109,FBgn0037330,FBgn003
209 GO:0034
641 
 
 
417 
7607,FBgn0037669,FBgn0037687,FBgn0037716,FBgn0
037722,FBgn0037822,FBgn0037918,FBgn0037926,FBg
n0038173,FBgn0038224,FBgn0038237,FBgn0038390,F
Bgn0038426,FBgn0038474,FBgn0038546,FBgn003859
2,FBgn0038928,FBgn0039159,FBgn0039182,FBgn0039
252,FBgn0039306,FBgn0039403,FBgn0039404,FBgn00
39462,FBgn0039464,FBgn0039650,FBgn0039740,FBgn
0039938,FBgn0039972,FBgn0041103,FBgn0042112,FB
gn0043575,FBgn0043796,FBgn0043900,FBgn0050022,
FBgn0051126,FBgn0051450,FBgn0051550,FBgn00517
39,FBgn0053100,FBgn0053178,FBgn0053504,FBgn006
1469,FBgn0063491,FBgn0063492,FBgn0063493,FBgn0
067102,FBgn0083983,FBgn0085484,FBgn0086358,FBg
n0086450,FBgn0250850,FBgn0259113,FBgn0259176,F
Bgn0259938,FBgn0260750,FBgn0260817,FBgn026098
5,FBgn0261287,FBgn0261872,FBgn0262449,FBgn0262
467,FBgn0262619,FBgn0263144,FBgn0263237,FBgn02
63855,FBgn0263863,FBgn0265048,FBgn0265523,FBgn
0265623,FBgn0266411,FBgn0266917,FBgn0267792,FB
gn0267821,FBgn0286027,FBgn0286506 
neurotrans
mitter 
uptake 
0.04226
429 
FBgn0003996,FBgn0034136 2 GO:0001
504 
regulation 
of 
nucleotide 
metabolic 
process 
0.04226
429 
FBgn0025741,FBgn0262467 2 GO:0006
140 
icosanoid 
metabolic 
process 
0.04226
429 
FBgn0025814,FBgn0053178 2 GO:0006
690 
polarity 
specificatio
n of 
dorsal/vent
ral axis 
0.04226
429 
FBgn0002899,FBgn0263260 2 GO:0009
951 
protein 
geranylger
anylation 
0.04226
429 
FBgn0028970,FBgn0037293 2 GO:0018
344 
translesion 
synthesis 
0.04226
429 
FBgn0032813,FBgn0035644 2 GO:0019
985 
regulation 
of purine 
nucleotide 
metabolic 
process 
0.04226
429 
FBgn0025741,FBgn0262467 2 GO:1900
542 
organic 
substance 
biosyntheti
c process 
0.04237
17 
FBgn0000543,FBgn0000562,FBgn0000591,FBgn00008
10,FBgn0002522,FBgn0002524,FBgn0002542,FBgn000
2566,FBgn0002878,FBgn0002899,FBgn0003042,FBgn0
003044,FBgn0003076,FBgn0003116,FBgn0003512,FBg
n0003515,FBgn0003996,FBgn0004170,FBgn0004396,F
Bgn0004403,FBgn0004406,FBgn0004797,FBgn000483
7,FBgn0004907,FBgn0005674,FBgn0005696,FBgn0005
771,FBgn0010382,FBgn0010438,FBgn0010786,FBgn00
11291,FBgn0011336,FBgn0011591,FBgn0011762,FBgn
0011787,FBgn0013972,FBgn0014023,FBgn0014037,FB
gn0014427,FBgn0014861,FBgn0014949,FBgn0015271,
182 GO:1901
576 
 
 
418 
FBgn0015299,FBgn0015396,FBgn0016070,FBgn00161
20,FBgn0016691,FBgn0016917,FBgn0017577,FBgn001
9644,FBgn0019650,FBgn0023214,FBgn0023545,FBgn0
024194,FBgn0025185,FBgn0025463,FBgn0025680,FBg
n0025741,FBgn0025814,FBgn0026741,FBgn0026879,F
Bgn0027499,FBgn0027560,FBgn0027620,FBgn002834
2,FBgn0029006,FBgn0029718,FBgn0030054,FBgn0030
093,FBgn0030432,FBgn0030683,FBgn0030699,FBgn00
31231,FBgn0031309,FBgn0031663,FBgn0031851,FBgn
0032053,FBgn0032130,FBgn0032290,FBgn0032400,FB
gn0032486,FBgn0032813,FBgn0032956,FBgn0033010,
FBgn0033184,FBgn0033507,FBgn0033555,FBgn00338
15,FBgn0033890,FBgn0033998,FBgn0034141,FBgn003
4310,FBgn0034495,FBgn0034579,FBgn0034650,FBgn0
034938,FBgn0035064,FBgn0035153,FBgn0035246,FBg
n0035266,FBgn0035374,FBgn0035471,FBgn0035644,F
Bgn0035918,FBgn0036157,FBgn0036258,FBgn003633
5,FBgn0036373,FBgn0036374,FBgn0036569,FBgn0036
691,FBgn0036713,FBgn0036771,FBgn0036826,FBgn00
36827,FBgn0037109,FBgn0037146,FBgn0037305,FBgn
0037330,FBgn0037607,FBgn0037669,FBgn0037722,FB
gn0037918,FBgn0038038,FBgn0038173,FBgn0038224,
FBgn0038390,FBgn0038426,FBgn0038474,FBgn00385
46,FBgn0038592,FBgn0038870,FBgn0038928,FBgn003
9159,FBgn0039258,FBgn0039273,FBgn0039304,FBgn0
039403,FBgn0039462,FBgn0039464,FBgn0039596,FBg
n0039650,FBgn0039740,FBgn0039938,FBgn0041103,F
Bgn0042112,FBgn0043575,FBgn0043796,FBgn004390
0,FBgn0044872,FBgn0050493,FBgn0051126,FBgn0051
450,FBgn0051739,FBgn0053100,FBgn0053178,FBgn00
61469,FBgn0067102,FBgn0083983,FBgn0085484,FBgn
0086358,FBgn0086450,FBgn0086679,FBgn0259113,FB
gn0259176,FBgn0259938,FBgn0260985,FBgn0261445,
FBgn0262449,FBgn0262467,FBgn0262619,FBgn02631
44,FBgn0263237,FBgn0263855,FBgn0263863,FBgn026
5048,FBgn0265523,FBgn0265623,FBgn0266411,FBgn0
267792,FBgn0267821,FBgn0286506 
mechanose
nsory 
behavior 
0.04260
806 
FBgn0020258,FBgn0023096,FBgn0267430 3 GO:0007
638 
response to 
amino acid 
0.04260
806 
FBgn0030108,FBgn0034199,FBgn0035870 3 GO:0043
200 
response to 
hyperoxia 
0.04260
806 
FBgn0004240,FBgn0038437,FBgn0038530 3 GO:0055
093 
positive 
regulation 
of small 
molecule 
metabolic 
process 
0.04260
806 
FBgn0025741,FBgn0053100,FBgn0262467 3 GO:0062
013 
regulation 
of nuclear-
transcribed 
mRNA 
catabolic 
process, 
deadenylati
0.04260
806 
FBgn0016070,FBgn0035246,FBgn0039972 3 GO:1900
151 
 
 
419 
on-
dependent 
decay 
positive 
regulation 
of nuclear-
transcribed 
mRNA 
catabolic 
process, 
deadenylati
on-
dependent 
decay 
0.04260
806 
FBgn0016070,FBgn0035246,FBgn0039972 3 GO:1900
153 
hindgut 
morphogen
esis 
0.04343
44 
FBgn0000377,FBgn0000543,FBgn0016917,FBgn00290
06,FBgn0033859,FBgn0043903,FBgn0259685 
7 GO:0007
442 
hindgut 
developme
nt 
0.04343
44 
FBgn0000377,FBgn0000543,FBgn0016917,FBgn00290
06,FBgn0033859,FBgn0043903,FBgn0259685 
7 GO:0061
525 
negative 
regulation 
of organ 
growth 
0.04569
919 
FBgn0004583,FBgn0011739,FBgn0015778,FBgn02596
85 
4 GO:0046
621 
RNA 
metabolic 
process 
0.04650
811 
FBgn0000377,FBgn0000543,FBgn0000591,FBgn00025
22,FBgn0002542,FBgn0002899,FBgn0003042,FBgn000
3044,FBgn0003512,FBgn0004170,FBgn0004396,FBgn0
004403,FBgn0004837,FBgn0004907,FBgn0005674,FBg
n0005771,FBgn0011291,FBgn0011762,FBgn0011787,F
Bgn0014037,FBgn0014949,FBgn0015299,FBgn001539
6,FBgn0015778,FBgn0016070,FBgn0016917,FBgn0019
650,FBgn0022986,FBgn0023214,FBgn0024987,FBgn00
25185,FBgn0025463,FBgn0025629,FBgn0025680,FBgn
0026679,FBgn0026702,FBgn0027499,FBgn0027620,FB
gn0029006,FBgn0029079,FBgn0030085,FBgn0030093,
FBgn0030365,FBgn0030432,FBgn0030507,FBgn00306
31,FBgn0030699,FBgn0031227,FBgn0031309,FBgn003
1321,FBgn0031643,FBgn0031851,FBgn0032130,FBgn0
032400,FBgn0032956,FBgn0033010,FBgn0033507,FBg
n0033859,FBgn0033921,FBgn0033998,FBgn0034065,F
Bgn0034310,FBgn0034564,FBgn0034614,FBgn003465
0,FBgn0035064,FBgn0035153,FBgn0035246,FBgn0035
318,FBgn0035397,FBgn0035900,FBgn0035986,FBgn00
36018,FBgn0036373,FBgn0036374,FBgn0036569,FBgn
0036734,FBgn0036735,FBgn0036754,FBgn0036771,FB
gn0036826,FBgn0036827,FBgn0037109,FBgn0037330,
FBgn0037607,FBgn0037669,FBgn0037716,FBgn00377
22,FBgn0037822,FBgn0037918,FBgn0037926,FBgn003
8390,FBgn0038474,FBgn0038546,FBgn0038592,FBgn0
039182,FBgn0039306,FBgn0039404,FBgn0039462,FBg
n0039740,FBgn0039938,FBgn0039972,FBgn0041103,F
Bgn0043796,FBgn0043900,FBgn0051126,FBgn005155
0,FBgn0051739,FBgn0053504,FBgn0061469,FBgn0250
850,FBgn0259176,FBgn0259938,FBgn0261287,FBgn02
61872,FBgn0263144,FBgn0263237,FBgn0263855,FBgn
0265048,FBgn0265523,FBgn0265623,FBgn0266411,FB
gn0266917,FBgn0267792,FBgn0267821,FBgn0286027 
126 GO:0016
070 
 
 
420 
cellular 
biosyntheti
c process 
0.04693
523 
FBgn0000543,FBgn0000562,FBgn0000591,FBgn00008
10,FBgn0002522,FBgn0002524,FBgn0002542,FBgn000
2566,FBgn0002878,FBgn0002899,FBgn0003042,FBgn0
003044,FBgn0003076,FBgn0003116,FBgn0003512,FBg
n0003515,FBgn0003996,FBgn0004170,FBgn0004396,F
Bgn0004403,FBgn0004406,FBgn0004797,FBgn000483
7,FBgn0004907,FBgn0005674,FBgn0005696,FBgn0005
771,FBgn0010382,FBgn0010438,FBgn0010786,FBgn00
11291,FBgn0011336,FBgn0011591,FBgn0011762,FBgn
0011787,FBgn0013972,FBgn0014023,FBgn0014037,FB
gn0014427,FBgn0014861,FBgn0014949,FBgn0015271,
FBgn0015299,FBgn0015396,FBgn0016070,FBgn00161
20,FBgn0016691,FBgn0016917,FBgn0017577,FBgn001
9644,FBgn0019650,FBgn0023214,FBgn0023545,FBgn0
024194,FBgn0025185,FBgn0025463,FBgn0025680,FBg
n0025741,FBgn0025814,FBgn0026741,FBgn0026879,F
Bgn0027499,FBgn0027560,FBgn0027620,FBgn002834
2,FBgn0029006,FBgn0029718,FBgn0030054,FBgn0030
093,FBgn0030432,FBgn0030683,FBgn0030699,FBgn00
31231,FBgn0031309,FBgn0031663,FBgn0031851,FBgn
0032053,FBgn0032130,FBgn0032290,FBgn0032400,FB
gn0032486,FBgn0032813,FBgn0032956,FBgn0033010,
FBgn0033184,FBgn0033507,FBgn0033555,FBgn00338
15,FBgn0033890,FBgn0033998,FBgn0034141,FBgn003
4310,FBgn0034495,FBgn0034579,FBgn0034650,FBgn0
034938,FBgn0035064,FBgn0035153,FBgn0035246,FBg
n0035374,FBgn0035471,FBgn0035644,FBgn0035918,F
Bgn0036157,FBgn0036258,FBgn0036335,FBgn003637
3,FBgn0036374,FBgn0036569,FBgn0036691,FBgn0036
713,FBgn0036771,FBgn0036826,FBgn0036827,FBgn00
37109,FBgn0037146,FBgn0037305,FBgn0037330,FBgn
0037607,FBgn0037669,FBgn0037722,FBgn0037918,FB
gn0038038,FBgn0038173,FBgn0038224,FBgn0038390,
FBgn0038426,FBgn0038474,FBgn0038546,FBgn00385
92,FBgn0038870,FBgn0038928,FBgn0039159,FBgn003
9258,FBgn0039273,FBgn0039304,FBgn0039403,FBgn0
039462,FBgn0039464,FBgn0039650,FBgn0039740,FBg
n0039938,FBgn0041103,FBgn0042112,FBgn0043575,F
Bgn0043796,FBgn0043900,FBgn0044872,FBgn005049
3,FBgn0051126,FBgn0051450,FBgn0051739,FBgn0053
100,FBgn0053178,FBgn0061469,FBgn0067102,FBgn00
83983,FBgn0085484,FBgn0086358,FBgn0086450,FBgn
0086679,FBgn0259113,FBgn0259176,FBgn0259938,FB
gn0260985,FBgn0261445,FBgn0262449,FBgn0262467,
FBgn0262619,FBgn0263144,FBgn0263237,FBgn02638
55,FBgn0263863,FBgn0265048,FBgn0265523,FBgn026
5623,FBgn0266411,FBgn0267792,FBgn0267821,FBgn0
286506 
180 GO:0044
249 
G1/S 
transition 
of mitotic 
cell cycle 
0.04777
039 
FBgn0004837,FBgn0010382,FBgn0011739,FBgn00383
90,FBgn0039403 
5 GO:0000
082 
regulation 
of cell 
cycle 
0.04881
975 
FBgn0002878,FBgn0003525,FBgn0004170,FBgn00045
83,FBgn0004643,FBgn0004837,FBgn0004889,FBgn001
0314,FBgn0010382,FBgn0024227,FBgn0031549,FBgn0
032047,FBgn0032400,FBgn0034569,FBgn0035249,FBg
n0035644,FBgn0035918,FBgn0037716,FBgn0038390,F
26 GO:0051
726 
 
 
421 
Bgn0039403,FBgn0039638,FBgn0260985,FBgn026323
7,FBgn0263855,FBgn0265523,FBgn0266465 
rRNA 
metabolic 
process 
0.04913
521 
FBgn0002899,FBgn0004403,FBgn0026702,FBgn00300
85,FBgn0031643,FBgn0033507,FBgn0034065,FBgn003
4564,FBgn0035986,FBgn0036754,FBgn0037822,FBgn0
038474,FBgn0039306,FBgn0039404 
14 GO:0016
072 
 
Table 2.4i:Pathway enrichment for hits differentially upregulated in control females relative to 20HE 
males 
Pathway 
enrichment 
p-value Hits Gene 
matche
s 
Pathwa
y ID 
DNA 
replication 
8.09E-
07 
FBgn0005696,FBgn0010438,FBgn0011762,FBgn001486
1,FBgn0017577,FBgn0025832,FBgn0030507,FBgn00328
13,FBgn0035644,FBgn0259113,FBgn0260985,FBgn0262
619 
12 3030 
Mitochondri
al 
translation 
termination 
2.0637
E-05 
FBgn0011787,FBgn0014023,FBgn0026741,FBgn002971
8,FBgn0031231,FBgn0032053,FBgn0032486,FBgn00345
79,FBgn0035374,FBgn0037330,FBgn0038426,FBgn0038
474,FBgn0039159,FBgn0042112,FBgn0051450,FBgn008
3983,FBgn0263863 
17 R-DME-
5419276 
Mitochondri
al 
translation 
2.4345
E-05 
FBgn0011787,FBgn0014023,FBgn0026741,FBgn002971
8,FBgn0031231,FBgn0032053,FBgn0032486,FBgn00345
79,FBgn0035374,FBgn0037330,FBgn0038426,FBgn0038
474,FBgn0039159,FBgn0042112,FBgn0051450,FBgn008
3983,FBgn0263863 
17 R-DME-
5368287 
G1/S 
Transition 
4.1676
E-05 
FBgn0003525,FBgn0004066,FBgn0005696,FBgn001031
4,FBgn0010382,FBgn0011762,FBgn0014861,FBgn00152
71,FBgn0017577,FBgn0023175,FBgn0028694,FBgn0028
695,FBgn0032047,FBgn0035644,FBgn0035918,FBgn003
8390,FBgn0259113,FBgn0263237 
18 R-DME-
69206 
Mitotic G1 
phase and 
G1/S 
transition 
5.6144
E-05 
FBgn0003525,FBgn0004066,FBgn0004889,FBgn000569
6,FBgn0010314,FBgn0010382,FBgn0011762,FBgn00148
61,FBgn0015271,FBgn0017577,FBgn0023175,FBgn0028
694,FBgn0028695,FBgn0032047,FBgn0035644,FBgn003
5918,FBgn0038390,FBgn0259113,FBgn0263237 
19 R-DME-
453279 
Mitochondri
al 
translation 
elongation 
5.7761
E-05 
FBgn0011787,FBgn0014023,FBgn0026741,FBgn002971
8,FBgn0031231,FBgn0032053,FBgn0034579,FBgn00353
74,FBgn0037330,FBgn0038426,FBgn0038474,FBgn0039
159,FBgn0042112,FBgn0051450,FBgn0083983,FBgn026
3863 
16 R-DME-
5389840 
DNA strand 
elongation 
0.0003
6464 
FBgn0005696,FBgn0011762,FBgn0025832,FBgn003940
3,FBgn0259113,FBgn0260985,FBgn0262619 
7 R-DME-
69190 
Synthesis of 
DNA 
0.0005
4656 
FBgn0004066,FBgn0005696,FBgn0010382,FBgn001176
2,FBgn0014861,FBgn0017577,FBgn0023175,FBgn00258
32,FBgn0028694,FBgn0028695,FBgn0032047,FBgn0035
644,FBgn0035918,FBgn0039403,FBgn0259113,FBgn026
0985,FBgn0262619 
17 R-DME-
69239 
S Phase 0.0006
263 
FBgn0004066,FBgn0005696,FBgn0010314,FBgn001038
2,FBgn0011762,FBgn0014861,FBgn0017577,FBgn00231
75,FBgn0025832,FBgn0028694,FBgn0028695,FBgn0032
047,FBgn0035644,FBgn0035918,FBgn0039403,FBgn025
9113,FBgn0260985,FBgn0262619 
18 R-DME-
69242 
Activation 
of the pre-
replicative 
complex 
0.0006
7525 
FBgn0005696,FBgn0011762,FBgn0014861,FBgn001527
1,FBgn0017577,FBgn0035644,FBgn0035918,FBgn02591
13 
8 R-DME-
68962 
 
 
422 
Lagging 
Strand 
Synthesis 
0.0007
3792 
FBgn0005696,FBgn0011762,FBgn0025832,FBgn025911
3,FBgn0260985,FBgn0262619 
6 R-DME-
69186 
DNA 
Replication 
0.0007
6884 
FBgn0004066,FBgn0005696,FBgn0010382,FBgn001176
2,FBgn0014861,FBgn0015271,FBgn0017577,FBgn00231
75,FBgn0025832,FBgn0028694,FBgn0028695,FBgn0032
047,FBgn0035644,FBgn0035918,FBgn0039403,FBgn025
9113,FBgn0260985,FBgn0262619 
18 R-DME-
69306 
Processive 
synthesis on 
the lagging 
strand 
0.0009
9917 
FBgn0005696,FBgn0011762,FBgn0025832,FBgn025911
3,FBgn0262619 
5 R-DME-
69183 
Telomere C-
strand 
synthesis 
initiation 
0.0010
4899 
FBgn0005696,FBgn0011762,FBgn0035644,FBgn025911
3 
4 R-DME-
174430 
DNA 
replication 
initiation 
0.0010
4899 
FBgn0005696,FBgn0011762,FBgn0035644,FBgn025911
3 
4 R-DME-
68952 
Inhibition of 
replication 
initiation of 
damaged 
DNA by 
RB1/E2F1 
0.0017
9059 
FBgn0005696,FBgn0011762,FBgn0038390,FBgn025911
3 
4 R-DME-
113501 
E2F 
mediated 
regulation 
of DNA 
replication 
0.0017
9059 
FBgn0005696,FBgn0011762,FBgn0038390,FBgn025911
3 
4 R-DME-
113510 
Formation 
of ATP by 
chemiosmot
ic coupling 
0.0020
8883 
FBgn0016120,FBgn0016691,FBgn0019644,FBgn002834
2,FBgn0038224 
5 R-DME-
163210 
Cristae 
formation 
0.0020
8883 
FBgn0016120,FBgn0016691,FBgn0019644,FBgn002834
2,FBgn0038224 
5 R-DME-
8949613 
Vitamin B6 
metabolism 
0.0025
6753 
FBgn0014427,FBgn0031048,FBgn0085484 3 750 
Polymerase 
switching 
on the C-
strand of the 
telomere 
0.0028
3042 
FBgn0005696,FBgn0011762,FBgn0259113,FBgn026098
5 
4 R-DME-
174411 
Polymerase 
switching 
0.0028
3042 
FBgn0005696,FBgn0011762,FBgn0259113,FBgn026098
5 
4 R-DME-
69091 
Leading 
Strand 
Synthesis 
0.0028
3042 
FBgn0005696,FBgn0011762,FBgn0259113,FBgn026098
5 
4 R-DME-
69109 
Cell Cycle 0.0034
9065 
FBgn0002878,FBgn0003525,FBgn0004066,FBgn000488
9,FBgn0004907,FBgn0005696,FBgn0010314,FBgn00103
82,FBgn0011762,FBgn0014009,FBgn0014861,FBgn0014
879,FBgn0015271,FBgn0015391,FBgn0017577,FBgn002
3175,FBgn0024227,FBgn0025463,FBgn0025832,FBgn00
28694,FBgn0028695,FBgn0032047,FBgn0034310,FBgn0
035644,FBgn0035918,FBgn0038390,FBgn0039125,FBgn
0039403,FBgn0259113,FBgn0260985,FBgn0262619,FBg
n0263237,FBgn0263855 
33 R-DME-
1640170 
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NOTCH4 
Activation 
and 
Transmissio
n of Signal 
to the 
Nucleus 
0.0043
3111 
FBgn0004907,FBgn0259685 2 R-DME-
9013700 
Formation 
of the 
activated 
STAT92E 
dimer and 
transport to 
the nucleus 
0.0048
8501 
FBgn0016917,FBgn0030904,FBgn0043903 3 R-DME-
209228 
DNA 
Replication 
Pre-
Initiation 
0.0051
1388 
FBgn0004066,FBgn0005696,FBgn0011762,FBgn001486
1,FBgn0015271,FBgn0017577,FBgn0023175,FBgn00286
94,FBgn0028695,FBgn0035644,FBgn0035918,FBgn0259
113 
12 R-DME-
69002 
Removal of 
the Flap 
Intermediate 
0.0060
0359 
FBgn0005696,FBgn0011762,FBgn0025832,FBgn025911
3 
4 R-DME-
69166 
Mismatch 
repair 
0.0065
0023 
FBgn0010438,FBgn0011660,FBgn0032813,FBgn026098
5,FBgn0262619 
5 3430 
Cyclin E 
associated 
events 
during G1/S 
transition  
0.0066
9738 
FBgn0003525,FBgn0004066,FBgn0010314,FBgn001038
2,FBgn0023175,FBgn0028694,FBgn0028695,FBgn00320
47,FBgn0038390,FBgn0263237 
10 R-DME-
69202 
Cell Cycle, 
Mitotic 
0.0071
7698 
FBgn0003525,FBgn0004066,FBgn0004889,FBgn000569
6,FBgn0010314,FBgn0010382,FBgn0011762,FBgn00140
09,FBgn0014861,FBgn0014879,FBgn0015271,FBgn0015
391,FBgn0017577,FBgn0023175,FBgn0024227,FBgn002
5832,FBgn0028694,FBgn0028695,FBgn0032047,FBgn00
34310,FBgn0035644,FBgn0035918,FBgn0038390,FBgn0
039125,FBgn0039403,FBgn0259113,FBgn0260985,FBgn
0262619,FBgn0263237,FBgn0263855 
30 R-DME-
69278 
Dephosphor
ylation by 
PTP61F 
phosphatase
s 
0.0081
339 
FBgn0016917,FBgn0030904,FBgn0043903 3 R-DME-
210688 
Telomere 
Maintenanc
e 
0.0082
0811 
FBgn0005696,FBgn0011762,FBgn0035644,FBgn025911
3,FBgn0260985 
5 R-DME-
157579 
Mitochondri
al 
biogenesis 
0.0082
0811 
FBgn0016120,FBgn0016691,FBgn0019644,FBgn002834
2,FBgn0038224 
5 R-DME-
1592230 
Telomere C-
strand 
(Lagging 
Strand) 
Synthesis 
0.0082
0811 
FBgn0005696,FBgn0011762,FBgn0035644,FBgn025911
3,FBgn0260985 
5 R-DME-
174417 
Extension of 
Telomeres 
0.0082
0811 
FBgn0005696,FBgn0011762,FBgn0035644,FBgn025911
3,FBgn0260985 
5 R-DME-
180786 
Chromosom
e 
Maintenanc
0.0082
0811 
FBgn0005696,FBgn0011762,FBgn0035644,FBgn025911
3,FBgn0260985 
5 R-DME-
73886 
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e 
Starch and 
sucrose 
metabolism 
0.0113
5767 
FBgn0000078,FBgn0001187,FBgn0003076,FBgn002050
6,FBgn0027560,FBgn0040250,FBgn0040261,FBgn00402
62,FBgn0261445 
9 500 
Insulin 
effects 
increased 
synthesis of 
Xylulose-5-
Phosphate 
0.0124
2561 
FBgn0023477,FBgn0037607 2 R-DME-
163754 
TP53 
regulates 
transcription 
of several 
additional 
cell death 
genes whose 
specific 
roles in p53-
dependent 
apoptosis 
remain 
uncertain 
0.0124
2561 
FBgn0028970,FBgn0037293 2 R-DME-
6803205 
Phosphoryla
tion of 
proteins 
involved in 
G1/S 
transition by 
active 
Cyclin 
E:Cdk2 
complexes 
0.0124
2561 
FBgn0010382,FBgn0038390 2 R-DME-
69200 
Signaling by 
NOTCH4 
0.0124
2561 
FBgn0004907,FBgn0259685 2 R-DME-
9013694 
G2/M 
Checkpoints 
0.0172
4178 
FBgn0002878,FBgn0003525,FBgn0004907,FBgn001486
1,FBgn0015271,FBgn0017577,FBgn0035918,FBgn02609
85 
8 R-DME-
69481 
Reversible 
hydration of 
carbon 
dioxide 
0.0176
8199 
FBgn0027843,FBgn0027844,FBgn0039486 3 R-DME-
1475029 
JAK/STAT 
pathway 
0.0176
8199 
FBgn0016917,FBgn0030904,FBgn0043903 3 R-DME-
209405 
Triglyceride 
biosynthesis 
0.0176
8199 
FBgn0004797,FBgn0033215,FBgn0035266 3 R-DME-
75109 
PCNA-
Dependent 
Long Patch 
Base 
Excision 
Repair 
0.0179
0198 
FBgn0025832,FBgn0035644,FBgn0260985,FBgn026261
9 
4 R-DME-
5651801 
Metabolism 0.0189
2694 
FBgn0001187,FBgn0002524,FBgn0003076,FBgn000406
6,FBgn0004797,FBgn0010241,FBgn0010786,FBgn00112
27,FBgn0014427,FBgn0016120,FBgn0016691,FBgn0019
644,FBgn0019982,FBgn0020626,FBgn0022359,FBgn002
92 R-DME-
1430728 
 
 
425 
3175,FBgn0023477,FBgn0025463,FBgn0025814,FBgn00
25839,FBgn0027843,FBgn0027844,FBgn0028342,FBgn0
028694,FBgn0028695,FBgn0029689,FBgn0029708,FBgn
0029994,FBgn0030367,FBgn0030584,FBgn0030638,FBg
n0030683,FBgn0030816,FBgn0031048,FBgn0031248,FB
gn0031663,FBgn0031695,FBgn0032790,FBgn0033205,F
Bgn0033215,FBgn0033238,FBgn0033382,FBgn0033397,
FBgn0033754,FBgn0033756,FBgn0033815,FBgn003396
1,FBgn0034919,FBgn0034938,FBgn0035266,FBgn00354
71,FBgn0036157,FBgn0036290,FBgn0036691,FBgn0036
824,FBgn0037109,FBgn0037146,FBgn0037186,FBgn003
7305,FBgn0037370,FBgn0037607,FBgn0037845,FBgn00
37891,FBgn0038224,FBgn0038260,FBgn0038271,FBgn0
038752,FBgn0039258,FBgn0039304,FBgn0039464,FBgn
0039471,FBgn0039486,FBgn0039637,FBgn0039674,FBg
n0040250,FBgn0040257,FBgn0040383,FBgn0044872,FB
gn0047038,FBgn0050022,FBgn0050344,FBgn0050345,F
Bgn0052669,FBgn0053178,FBgn0067102,FBgn0085484,
FBgn0086450,FBgn0260750,FBgn0261445,FBgn026255
9,FBgn0265523,FBgn0283450 
Respiratory 
electron 
transport, 
ATP 
synthesis by 
chemiosmot
ic coupling, 
and heat 
production 
by 
uncoupling 
proteins. 
0.0193
6936 
FBgn0011227,FBgn0016120,FBgn0016691,FBgn001964
4,FBgn0025839,FBgn0028342,FBgn0033961,FBgn00349
19,FBgn0038224,FBgn0038271,FBgn0047038 
11 R-DME-
163200 
Phosphoryla
tion-
independent 
inhibition of 
YKI 
0.0237
7146 
FBgn0004583,FBgn0011739 2 R-DME-
451806 
Activation 
of ATR in 
response to 
replication 
stress 
0.0250
1701 
FBgn0003525,FBgn0014861,FBgn0015271,FBgn001757
7,FBgn0035918,FBgn0260985 
6 R-DME-
176187 
Cyclin D 
associated 
events in G1 
0.0251
819 
FBgn0004889,FBgn0010314,FBgn0032047,FBgn003839
0,FBgn0263237 
5 R-DME-
69231 
G1 Phase 0.0251
819 
FBgn0004889,FBgn0010314,FBgn0032047,FBgn003839
0,FBgn0263237 
5 R-DME-
69236 
Metabolic 
pathways 
0.0263
6559 
FBgn0000078,FBgn0000261,FBgn0001187,FBgn000252
4,FBgn0003076,FBgn0004406,FBgn0004797,FBgn00056
74,FBgn0005696,FBgn0010786,FBgn0011227,FBgn0011
336,FBgn0011762,FBgn0011770,FBgn0014427,FBgn001
5011,FBgn0015568,FBgn0015575,FBgn0016120,FBgn00
16691,FBgn0019644,FBgn0020506,FBgn0022097,FBgn0
022359,FBgn0023477,FBgn0023545,FBgn0024958,FBgn
0025839,FBgn0028342,FBgn0030596,FBgn0030610,FBg
n0030683,FBgn0031048,FBgn0031663,FBgn0033520,FB
gn0033961,FBgn0034141,FBgn0034938,FBgn0035266,F
70 1100 
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Bgn0035644,FBgn0036157,FBgn0036691,FBgn0036824,
FBgn0037146,FBgn0037186,FBgn0037607,FBgn003789
1,FBgn0038080,FBgn0038224,FBgn0039258,FBgn00392
93,FBgn0039304,FBgn0039464,FBgn0039596,FBgn0040
250,FBgn0040261,FBgn0040262,FBgn0041629,FBgn004
7038,FBgn0052201,FBgn0067102,FBgn0085484,FBgn00
86450,FBgn0259113,FBgn0259170,FBgn0260750,FBgn0
261445,FBgn0262512,FBgn0262559,FBgn0286506 
Resolution 
of AP sites 
via the 
multiple-
nucleotide 
patch 
replacement 
pathway 
0.0271
2762 
FBgn0025832,FBgn0035644,FBgn0260985,FBgn026261
9 
4 R-DME-
110373 
Cell Cycle 
Checkpoints 
0.0287
5638 
FBgn0002878,FBgn0003525,FBgn0004066,FBgn000490
7,FBgn0014861,FBgn0015271,FBgn0017577,FBgn00231
75,FBgn0025463,FBgn0028694,FBgn0028695,FBgn0035
918,FBgn0260985,FBgn0263855 
14 R-DME-
69620 
Drug 
metabolism 
- other 
enzymes 
0.0289
4952 
FBgn0015568,FBgn0015575,FBgn0031663,FBgn003946
4,FBgn0040250,FBgn0040261,FBgn0040262,FBgn00864
50 
8 983 
Nucleotide 
excision 
repair 
0.0321
0262 
FBgn0031309,FBgn0032813,FBgn0035644,FBgn026098
5,FBgn0262619,FBgn0263237 
6 3420 
Oxidative 
phosphoryla
tion 
0.0344
9947 
FBgn0011227,FBgn0016120,FBgn0016691,FBgn001964
4,FBgn0022097,FBgn0025839,FBgn0028342,FBgn00306
10,FBgn0033961,FBgn0034938,FBgn0038224,FBgn0040
529,FBgn0047038,FBgn0262512 
14 190 
Formation 
of the 
activated 
receptor 
complex 
0.0379
0741 
FBgn0030904,FBgn0043903 2 R-DME-
209209 
Synthesis of 
Dolichyl-
phosphate 
0.0379
0741 
FBgn0030683,FBgn0034141 2 R-DME-
446199 
Base 
excision 
repair 
0.0387
3329 
FBgn0025832,FBgn0032813,FBgn0035644,FBgn026261
9 
4 3410 
Metabolism 
of folate and 
pterines 
0.0387
3329 
FBgn0036157,FBgn0037845,FBgn0050344,FBgn005034
5 
4 R-DME-
196757 
Circadian 
Clock 
pathway 
0.0489
5275 
FBgn0004066,FBgn0004889,FBgn0023175,FBgn002568
0,FBgn0028694,FBgn0028695,FBgn0050476,FBgn02599
38,FBgn0264959 
9 R-DME-
432626 
Synthesis of 
PC 
0.0494
9968 
FBgn0031048,FBgn0033382,FBgn0039637 3 R-DME-
1483191 
Regulation 
of lipid 
metabolism 
by 
PPARalpha 
0.0494
9968 
FBgn0025463,FBgn0037109,FBgn0265523 3 R-DME-
400206 
Triglyceride 
metabolism 
0.0494
9968 
FBgn0004797,FBgn0033215,FBgn0035266 3 R-DME-
8979227 
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